FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU KENNEDY, JP
AF KENNEDY, JP
TI NEW BIOMATERIALS BY CARBOCATIONIC PROCESSES
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT 11th International Symposium on Cationic Polymerization and Related
   Ionic Processes
CY JUL 05-08, 1993
CL BOROVETS, BULGARIA
SP INT UNION PURE & APPL CHEM, BULGARIAN ACAD SCI, INST POLYM, NATL SCI FDN USA, TECHNOL UNIV, BOURGAS, NEFTOCHIM CO, BOURGAS, NEOCHIM, DIMITROVGRAD, BANK ECON PROJECTS MINERALBANK, ENGN PLAST EVSTATIEV, SOFIA
ID TOUGHENED POLY(METHYL METHACRYLATE); L-PIB NETWORKS
AB Well-defined macromolecular composites have been prepared by living carbocationic polymerization of isobutylene in combination with other conventional techniques.  The products were designed for biomedical uses as 1) intervertebral disc replacement, 2) improved impact- and fatigue- resistant bone cements, 3) delayed drug release reservoirs, and 4) small diameter nonthrombogenic vascular grafts.  The syntheses are out-lined, and the novelty, main characteristics and properties of these unique materials are summarized.  The era of designed biomaterials is upon us.
RP KENNEDY, JP (reprint author), UNIV AKRON,INST POLYMER SCI,AKRON,OH 44325, USA.
CR ANDERSON JM, 1991, ARTIFICIAL HEART, P45
   CHEN D, 1988, J MACROMOL SCI CHEM, VA25, P389, DOI 10.1080/00222338808053376
   CHEN D, 1989, J BIOMED MATER RES, V23, P1327, DOI 10.1002/jbm.820231109
   Cooper SL, 1982, ADV CHEM SER, V199
   ISHIHARA K, 1984, POLYM J, V16, P625, DOI 10.1295/polymj.16.625
   IVAN B, 1990, POLYM PREPRINTS, V31, P215
   IVAN B, 1990, POLYM PREPR, V31, P217
   Kennedy J. P., 1992, DESIGNED POLYM CARBO
   KENNEDY JP, 1991, J MACROMOL SCI CHEM, VA28, P209, DOI 10.1080/00222339108052096
   KENNEDY JP, 1993, MACROMOLECULES, V26, P567, DOI 10.1021/ma00056a002
   KENNEDY JP, 1983, POLYM BULL, V10, P146
   KENNEDY JP, 1993, J BIOMAT SCI-POLYM E, V4, P1
   KENNEDY JP, 1993, Patent No. 7854421
   KESZLER B, 1993, UNPUB
   KESZLER B, 1992, UNPUB
   KESZLER B, 1992, POLYM B, V29, P689
   KESZLER B, IN PRESS J CONTROLLE
   Kost J, 1986, HYDROGELS MED PHARM, V3, P95
   KYU T, 1993, MACROMOLECULES, V26, P572, DOI 10.1021/ma00056a003
   LANDER LM, 1993, POLYM PREPR, V34, P606
   MACKEY PW, 1991, THESISU AKRON
   Merril EW, 1987, HYDROGELS MED PHARM, V3, P1
   PAPPAS NA, 1987, HYDROGELS MED PHARM, V3, P109
   REFOJO MF, 1980, SYNTHETIC BIOMEDICAL, P171
   SHALABY SW, 1986, POLYM BIOMATERIALS, P323
   STANLEY JC, 1991, VASCULAR SURGERY COM, P275
   Tighe B.J., 1987, HYDROGELS MED PHARM, P53
   VOGLER EA, 1992, LANGMUIR, V8, P2013, DOI 10.1021/la00044a023
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 30
TC 14
Z9 14
U1 0
U2 0
PU HUTHIG & WEPF VERLAG
PI BASEL
PA AUF DEM WOLF 4 FX#001-41-61-317-94-11, CH-4052 BASEL, SWITZERLAND
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD AUG
PY 1994
VL 85
BP 79
EP 96
DI 10.1002/masy.19940850107
PG 18
WC Polymer Science
SC Polymer Science
GA PF834
UT WOS:A1994PF83400006
DA 2018-10-19
ER

PT J
AU LIN, JC
   WANG, YL
   HARIMAN, RJ
AF LIN, JC
   WANG, YL
   HARIMAN, RJ
TI COMPARISON OF POWER DEPOSITION PATTERNS PRODUCED BY MICROWAVE AND
   RADIO-FREQUENCY CARDIAC ABLATION CATHETERS
SO ELECTRONICS LETTERS
LA English
DT Article
DE SAR (BIOLOGICAL); BIOMEDICAL ELECTRONICS
AB Transcatheter microwave and radio frequency (RF) electrodes are used for the ablative treatment of cardiac arrhythmias. The authors compare the power deposition patterns of microwave antennas and RF electrodes in saline phantoms of biological material. The decrease in power deposition as a function of distance away from the electrode is nearly exponential for RF and is considerably steeper than microwave antennas. These results suggest that microwave antennas are capable of heating a larger volume and thus creating a greater lesion than RF.
C1 EDWARD HINES VET ADM MED CTR,DEPT MED,HINES,IL 60141.
RP LIN, JC (reprint author), UNIV ILLINOIS,DEPT ELECT ENGN,M-C 154,851 S MORGAN ST,CHICAGO,IL 60607, USA.
CR HOYT RH, 1986, J APPL CARDIOL, V1, P469
   HUANG SK, 1987, J AM COLL CARDIOL, V9, P349, DOI 10.1016/S0735-1097(87)80388-1
   LANGBERG JJ, 1991, PACE, V4, P2105
   LANGBERG JJ, 1990, PACE, V13, P1241
   Lin J. C., 1993, Chinese Journal of Medical and Biological Engineering, V13, P293
   LIN JC, 1990, EMERGING ELECTROMAGN, P125
NR 6
TC 19
Z9 20
U1 0
U2 2
PU IEE-INST ELEC ENG
PI HERTFORD
PA MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD, ENGLAND SG1 2AY
SN 0013-5194
J9 ELECTRON LETT
JI Electron. Lett.
PD JUN 9
PY 1994
VL 30
IS 12
BP 922
EP 923
DI 10.1049/el:19940682
PG 2
WC Engineering, Electrical & Electronic
SC Engineering
GA NV160
UT WOS:A1994NV16000002
DA 2018-10-19
ER

PT J
AU PARKER, TL
   PARKER, KL
   MCCOLL, IR
   GRANT, DM
   WOOD, JV
AF PARKER, TL
   PARKER, KL
   MCCOLL, IR
   GRANT, DM
   WOOD, JV
TI THE BIOCOMPATIBILITY OF LOW-TEMPERATURE DIAMOND-LIKE CARBON-FILMS - A
   TRANSMISSION ELECTRON-MICROSCOPY, SCANNING ELECTRON-MICROSCOPY AND
   CYTOTOXICITY STUDY
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT Diamond Films 93
CY SEP 20-24, 1993
CL ALBUFEIRA, SPAIN
AB Preliminary studies have shown that diamond-like carbon (DLC) coatings can be adherent on a range of substrate materials, resistant to wear and non-toxic to cells in vitro. This has led to the question of the possible biomedical application of DLC-coated materials, particularly in the field of implantation surgery. Assessment of the biocompatibility of implanted material requires two questions to be addressed: (1) is the implanted material toxic to cell growth, and (2) what is the nature of the cell-DLC layer interaction? In this study we show, by the Kenacid Blue cytotoxicity test, that cells grown on DLC-coated PCF membranes exhibit an initial increased attachment to the carbon substrate, and thereafter exhibit a normal growth rate over the 3-day test periods compared with cells grown on uncoated polystyrene. Scanning electron microscopy shows these cells possess characteristics typical of normal cell attachment and growth. Cells were grown on DLC-coated PCF membranes to facilitate examination of the cell-DLC coating interface by transmission electron microscopy. These results show that cells grown on both DLC-coated and non-coated membranes presented normal morphological characteristics of attachment and growth. These findings indicate that the DLC coating is non-toxic in vitro and sustains normal cell growth.
C1 UNIV NOTTINGHAM,DEPT MAT ENGN & MAT DESIGN,NOTTINGHAM NG7 2RD,ENGLAND.
RP PARKER, TL (reprint author), UNIV NOTTINGHAM,DEPT HUMAN MORPHOL,UNIV PK,NOTTINGHAM NG7 2RD,ENGLAND.
OI Grant, David/0000-0002-6786-7720
CR CLOTHIER R H, 1987, Molecular Toxicology, V1, P571
   MCCOLL IR, 1993, DIAM RELAT MATER, V3, P83
NR 2
TC 45
Z9 46
U1 0
U2 2
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE 1
PA PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD JUN
PY 1994
VL 3
IS 8
BP 1120
EP 1123
DI 10.1016/0925-9635(94)90104-X
PG 4
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA NR554
UT WOS:A1994NR55400008
DA 2018-10-19
ER

PT J
AU TU, R
   SHEN, SH
   LIN, D
   HATA, C
   THYAGARAJAN, K
   NOISHIKI, Y
   QUIJANO, RC
AF TU, R
   SHEN, SH
   LIN, D
   HATA, C
   THYAGARAJAN, K
   NOISHIKI, Y
   QUIJANO, RC
TI FIXATION OF BIOPROSTHETIC TISSUES WITH MONOFUNCTIONAL AND
   MULTIFUNCTIONAL POLYEPOXY COMPOUNDS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID COLLAGEN; GRAFT
AB Collagen from a native tissue is fixed with a polyepoxy compound (PC) for use as a new biologic prosthetic material. Prior studies have shown that this biomaterial has comparable properties with collagen fixed with glutaraldehyde (GA), and thus has great promise for biomedical applications. A prior kinetic study indicated that the reaction between the functional groups of collagen and the multifunctional epoxy EX-313 is a 2.5th-order reaction. The purpose of this study was to understand the mechanism of the amino acid-PC reactions in a fixation process. Bovine arteries were fixed with a monofunctional PC (EX-131) and a multifunctional PC (EX-313) as a function of fixation time. A sequential fixation with a second fixative was used to identify the available remaining reactive sites from a prior fixation. The denaturation temperature (T-d) was measured on each sample. Because the denaturation temperature is a direct indication of crosslinking of individual amino acids with the fixative, the increase in T-d of a subsequent fixation may be indicative of the available remaining amino acids. The fixation index was measured on each sample to reflect the increase of fixation completion in a sequential fixation process. The fixation index and crosslink data also revealed that the reactive amino acids for EX-131 and EX-313 may not be exactly the same. The data in this study suggest that a monofunctional fixative can pre-react with the amino acids of collagen to effectively block further fixation of collagen with a second fixative. This amino acid masking may be associated with collagen branching. Collagen branching and its effect on denaturation temperature are described. (C) 1994 John Wiley & Sons, Inc.
C1 BAXTER EDWARDS CVS DIV,IRVINE,CA.
   YOKOHAMA CITY UNIV,YOKOHAMA 236,JAPAN.
RP TU, R (reprint author), TU BIOSCI LAB,2151 PALERMO,TUSTIN,CA 92680, USA.
CR CARPENTIER A, 1969, J THORAC CARDIOV SUR, V58, P467
   DARDIK H, 1976, ANN SURG, V183, P252, DOI 10.1097/00000658-197603000-00006
   EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441
   HATA C, 1992, ARTIF ORGANS, V16, P263, DOI 10.1111/j.1525-1594.1992.tb00307.x
   Hata C., 1992, International Journal of Artificial Organs, V15, P562
   IMAMURA E, 1988, JPN J ARTIF ORGANS, V17, P1101
   LEE JM, 1991, ARTIF ORGANS, V15, P303
   LOHRE J, 1991, ARTIF ORGANS, V15, P124
   MARCH J, 1985, ADV ORGANIC CHEM REA, P368
   MASUOKA M, 1985, LEATHER CHEM, V30, P223
   MCINTYRE J, 1991, T SOC BIOMATERIALS, V14, P119
   MCINTYRE J, 1992, ABSTR ASAIO, V21, P122
   MORRISON RT, 1986, ORGANIC CHEM, P548
   MURAYAMA Y, 1988, T AM SOC ART INT ORG, V34, P546
   NIMNI ME, 1988, COLLAGEN, V1, P1
   Nimni ME, 1988, COLLAGEN, VIII, P1
   NOIJIRI C, 1987, J THORAC CARDIOVASC, V93, P867
   NOISHIKI Y, 1986, T AM SOC ART INT ORG, V32, P114
   Noishiki Y, 1989, U. S. Patent, Patent No. [4,806,595, 4806595]
   Rosenberg D., 1978, VASCULAR GRAFTS, P261
   SABATINI DD, 1963, J CELL BIOL, V17, P19, DOI 10.1083/jcb.17.1.19
   SAWYER PN, 1983, VASCULAR GRAFTING CL, P331
   SHECHTER L, 1956, IND ENG CHEM, V48, P86, DOI 10.1021/ie50553a028
   SUMA H, 1990, TEX HEART I J, V17, P103
   Sung H. W., 1992, International Journal of Artificial Organs, V15, P562
   SUNG HW, 1992, ARTIF ORGANS, V16, P485, DOI 10.1111/j.1525-1594.1992.tb00328.x
   Tanzer M. L., 1976, BIOCH COLLAGEN, P137
   TU R, 1993, J BIOMED MATER RES, V27, P3, DOI 10.1002/jbm.820270103
   TU R, 1993, JUL ESAO ISAO M AMST
   TU R, 1991, 17TH T ANN M SOC BIO, P163
   TU R, 1991, ABSTR ASAIO, V114
   TU R, 1991, T AM SOC ART INT ORG, V37, P470
   Tu Roger, 1992, International Journal of Artificial Organs, V15, P548
   WAITE JH, 1981, CRC HDB BIOCH AGING
   Yamauchi M., 1988, COLLAGEN, P157
NR 35
TC 55
Z9 57
U1 3
U2 5
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN
PY 1994
VL 28
IS 6
BP 677
EP 684
DI 10.1002/jbm.820280604
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA NL112
UT WOS:A1994NL11200003
PM 8071378
DA 2018-10-19
ER

PT J
AU CERRAI, P
   TRICOLI, M
   LELLI, L
   GUERRA, GD
   DELGUERRA, RS
   CASCONE, MG
   GIUSTI, P
AF CERRAI, P
   TRICOLI, M
   LELLI, L
   GUERRA, GD
   DELGUERRA, RS
   CASCONE, MG
   GIUSTI, P
TI BLOCK-COPOLYMERS OF L-LACTIDE AND POLY(ETHYLENE GLYCOL) FOR BIOMEDICAL
   APPLICATIONS
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 1993 Conference of the European-Society-for-Biomaterials
CY 1993
CL DAVOS, SWITZERLAND
SP EUROPEAN SOC BIOMAT
ID EPSILON-CAPROLACTONE; POLYMERIZATION
AB Poly (L-lactide)-poly (oxyethylene)-poly (L-lactide) block copolymers obtained in bulk, by a ring opening mechanism, from poly(ethylene glycol)s (PEG)s and L-lactide (LA), at 120-140 degrees C, in the absence of added catalysts are described. By using PEGs with different molecular masses, 3000 and 35 000, respectively, and varying the initial molar ratio LA to PEG, two series of copolymers with different molecular masses, relative length of blocks and hydrophilicity were obtained. Physico-chemical characterization of the copolymers had been previously performed. The morphological characteristics of the copolymers were investigated by means of X-ray diffractometry, optical and scanning electron microscopy. The biological properties of the materials were determined by evaluating their cytotoxicity, cytocompatibility, hemocompatibility and degradability using different standard tests. The results obtained indicate that the block copolymers synthesized may be useful for biomedical applications, in particular as resorbable drug vehicles. The materials are brittle and their mechanical properties are not appropriate for implant devices.
C1 CNR,IST FISIOL CLIN,I-56126 PISA,ITALY.
   UNIV PISA,DIPARTIMENTO INGN CHIM,I-56126 PISA,ITALY.
RP CERRAI, P (reprint author), CNR,CTR STUDI PROC IONICI POLIMERIZZAZIONE & PROP FIS,VIA DIOTISALVI 2,I-56126 PISA,ITALY.
CR CERRAI P, 1989, POLYMER, V30, P338, DOI 10.1016/0032-3861(89)90126-2
   CERRAI P, 1993, MAKROMOL CHEM-RAPID, V14, P529
   CERRAI P, 1993, J MATER SCI-MATER M, V5, P33
   CHRISTENSEN U, 1980, THROMB HAEMOSTASIS, V43, P169
   DELGUERRA RS, 1993, ALTERNATIVES LABORAT, V21, P907
   DENG XM, 1990, J POLYM SCI POL LETT, V28, P411, DOI 10.1002/pol.1990.140281303
   GIUSTI P, 1988, PROGR BIOMED ENG, V5, P51
   GUERRA GD, 1993, J BIOMAT SCI-POLYM E, V4, P643, DOI 10.1163/156856293X00852
   JEDLINSKI Z, 1993, MAKROMOL CHEM, V194, P1681
   KIMURA Y, 1989, POLYMER, V30, P1342, DOI 10.1016/0032-3861(89)90058-X
   KRICHELDORF HR, 1993, MAKROMOL CHEM, V194, P463
   ROZENBERG BA, 1992, MAKROMOL CHEM-M SYMP, V60, P177, DOI 10.1002/masy.19920600116
   ZHU KJ, 1990, J APPL POLYM SCI, V39, P1, DOI 10.1002/app.1990.070390101
NR 13
TC 73
Z9 74
U1 4
U2 11
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN-JUL
PY 1994
VL 5
IS 6-7
BP 308
EP 313
DI 10.1007/BF00058953
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PL066
UT WOS:A1994PL06600002
DA 2018-10-19
ER

PT J
AU TANZI, MC
   VERDERIO, P
   LAMPUGNANI, MG
   RESNATI, M
   DEJANA, E
   STURANI, E
AF TANZI, MC
   VERDERIO, P
   LAMPUGNANI, MG
   RESNATI, M
   DEJANA, E
   STURANI, E
TI CYTOTOXICITY OF SOME CATALYSTS COMMONLY USED IN THE SYNTHESIS OF
   COPOLYMERS FOR BIOMEDICAL USE
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 1993 Conference of the European-Society-for-Biomaterials
CY 1993
CL DAVOS, SWITZERLAND
SP EUROPEAN SOC BIOMAT
AB The cytotoxicity of four catalysts commonly used for the synthesis of copolymers for biomedical use, such as segmented polyurethanes, was evaluated towards two types of cells, the first being the well-characterized cell line Swiss 3T3 mouse fibroblasts, the second the actual living system that faces any device in contact with blood, i.e. human endothelial cells (HEC). The catalysts were two tertiary aliphatic amines: TMBDA (tetramethylbutanediamine), and DABCO (1-4 diazo (2,2,2) octane); two alkyl tin compounds: DBTDL (dibutyl-tindilaurate), and SnOct (stannous octoate). Cytotoxicity tests were carried out by adding to the culture medium, after cell adhesion, different concentrations of each catalyst in dimethylsulphoxide, and keeping them in contact with the monolayer for 72 h. All the catalysts proved to be cytotoxic, although at different extent (in the order: DABCO < TMBDA < SnOct < DBTDL); their dose inhibiting 50% of cell growth (IC50) came out to be lower for 3T3 fibroblasts than for HEC, with the exception of DBTDL, which showed a similar toxicity for both the cell fines. As an example, the cytotoxicity of a polyurethane-amide, laboratory synthesized with DBTDL as catalysts, was checked with fibroblasts. By using both the method of the extract, and that of the direct contact (through a microporous membrane), a moderate to severe cell growth inhibition, related to the Sn content in the material, was observed.
C1 IST RIC FARMACOL MARIO NEGRI,MILAN,ITALY.
   UNIV MILAN,DIPARTIMENTO FISIOL & BIOCHIM GEN,MILAN,ITALY.
RP TANZI, MC (reprint author), POLITECN MILAN,DIPARTIMENTO BIOINGN,I-20133 MILAN,ITALY.
RI Verderio, Paolo/B-5034-2017; Tanzi, Maria Cristina/I-4620-2013
OI Verderio, Paolo/0000-0002-9231-1281; Tanzi, Maria
   Cristina/0000-0002-4913-6633; Lampugnani, Maria
   Grazia/0000-0002-4802-7064
CR BRAMBILLA R, 1991, BIOCHEM J, V278, P447, DOI 10.1042/bj2780447
   COHN D, 1990, CLIN IMPLANT MATER, V9, P473
   HAYES WJ, 1980, HDB PESTICIDE TOXICO, V2, P537
   LELAH M, 1986, POLYURETHANES MED, P24
   Reegen SL, 1971, ADV URETHANE SCI TEC, V1, P1
   Sax N. I., 1989, DANGEROUS PROPERTIES, V3
   TANZI MC, 1992, BIOMATERIALS, V13, P425, DOI 10.1016/0142-9612(92)90162-H
   TANZI MC, 1991, 17TH P ANN M SOC BIO, P127
NR 8
TC 115
Z9 117
U1 0
U2 24
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN-JUL
PY 1994
VL 5
IS 6-7
BP 393
EP 396
DI 10.1007/BF00058971
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PL066
UT WOS:A1994PL06600020
DA 2018-10-19
ER

PT J
AU PETILLO, O
   PELUSO, G
   AMBROSIO, L
   NICOLAIS, L
   KAO, WJ
   ANDERSON, JM
AF PETILLO, O
   PELUSO, G
   AMBROSIO, L
   NICOLAIS, L
   KAO, WJ
   ANDERSON, JM
TI IN-VIVO INDUCTION OF MACROPHAGE IA-ANTIGEN (MHC CLASS-II) EXPRESSION BY
   BIOMEDICAL POLYMERS IN THE CAGE IMPLANT SYSTEM
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID ADJUVANT ACTIVITY; IMMUNE-RESPONSE; SURFACTANTS; LIPOPOLYSACCHARIDE;
   INVIVO; BIOCOMPATIBILITY; INFLAMMATION; FORMULATION; INVOLVEMENT;
   ANTIBODIES
AB Examination of the cellular components in the inflammatory exudate, which infiltrates subcutaneous cages, can be used to monitor the progress of an inflammatory response to an implanted material. Of particular interest is the study monocyte/macrophage infiltration into the implanted cages containing biomaterials, as macrophages may initiate a wide spectrum of responses upon interaction with a foreign material. In this study, the authors propose a technique using subcutaneous tissue cages in conjunction with cytofluorimetric analysis of exudate leukocytes to evaluate the monocyte/macrophage cell activation in response to different materials. The studies reported here used several materials (thermoplastic and elastomeric polymers) as the challenging agent, to demonstrate whether polymers, chemically different from each other, could differentially activate macrophages to carry out their proinflammatory role more effectively. The materials tested included: poly(etherurethane ureas) (PEUU A'), poly(etherurethane ureas) with a surface active additive, Methacrol(R), (PEUU C'), polymethylsiloxane (PDMS), polyetherimide, (PEI), and polyetheretherketone, (PEEK). For all the tested materials, the maximum numbers of exudate cells and of Ia-positive macrophages were found on day 7, although the entity of the cell increase was associated with the material used for the implant. Similarly, the percentage of Ia-positive macrophages varied according to the specific polymer present in the cages after 7 days. By day 14 the percentage of Ia-positive macrophages decreased with individual exudates showing 19-32% Ia-positive cells depending on the different type of material. Only in the case of PDMS did the percentage of Ia-positive macrophages remain the same as compared with control empty cage macrophages. (C) 1994 John Wiley and Sons, Inc.
C1 ARCO FELICE,CNR,INST PROT BIOCHEM & ENZYMOL,I-80072 NAPLES,ITALY.
   UNIV NAPLES,DEPT MAT & PROD ENGN,I-80125 NAPLES,ITALY.
   CNR,INST COMPOSITE MAT TECHNOL,I-80125 NAPLES,ITALY.
   CASE WESTERN RESERVE UNIV,INST PATHOL,CLEVELAND,OH 44106.
OI AMBROSIO, LUIGI/0000-0002-8367-2405
FU NHLBI NIH HHS [HL-25239, HL-33849]
CR ALLISON AC, 1986, J IMMUNOL METHODS, V95, P157, DOI 10.1016/0022-1759(86)90402-3
   ANDERSON JM, 1988, ASAIO, V11, P101
   BEHBEHANI K, 1985, J IMMUNOL, V134, P2047
   BEHBEHANI K, 1981, CLIN IMMUNOL IMMUNOP, V198, P190
   BELLER DI, 1980, J IMMUNOL, V124, P1426
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P255, DOI 10.1002/jbm.820270216
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P367, DOI 10.1002/jbm.820270310
   BYARS NE, 1987, VACCINE, V5, P223, DOI 10.1016/0264-410X(87)90105-8
   DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589
   EZEKOWITZ RAB, 1981, J EXP MED, V154, P60, DOI 10.1084/jem.154.1.60
   FUKUMOTO T, 1982, EUR J IMMUNOL, V12, P237, DOI 10.1002/eji.1830120313
   HAMILTON TA, 1987, IMMUNOL TODAY, V8, P151, DOI 10.1016/0167-5699(87)90145-9
   HUNTER R, 1981, J IMMUNOL, V127, P1244
   HUNTER RL, 1984, J IMMUNOL, V133, P3167
   HUNTER RL, 1986, SCAND J IMMUNOL, V23, P287, DOI 10.1111/j.1365-3083.1986.tb01970.x
   JOHNSTON RB, 1988, NEW ENGL J MED, V318, P747, DOI 10.1056/NEJM198803243181205
   KADAR L, 1986, J IMMUNOL, V136, P3166
   KASAMA T, 1992, INT ARCH ALLERGY IMM, V97, P130, DOI 10.1159/000236108
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   MATIS LA, 1983, P NATL ACAD SCI-BIOL, V80, P6019, DOI 10.1073/pnas.80.19.6019
   NATION JL, 1983, STAIN TECHNOL, V58, P347, DOI 10.3109/10520298309066811
   PELUSO G, 1991, J BIOMED MATER RES, V25, P637, DOI 10.1002/jbm.820250507
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   REMICK DG, 1988, AM J PATHOL, V131, P298
   ROBEY WG, 1986, P NATL ACAD SCI USA, V83, P7023, DOI 10.1073/pnas.83.18.7023
   SNIPPE H, 1981, INT ARCH ALLER A IMM, V65, P390, DOI 10.1159/000232780
   STRASSMANN G, 1985, CELL IMMUNOL, V94, P65
   UNANUE ER, 1984, ANNU REV IMMUNOL, V2, P395, DOI 10.1146/annurev.immunol.2.1.395
   UNANUE ER, 1987, SCIENCE, V236, P551, DOI 10.1126/science.2437650
   VONRECUM AF, 1986, HDB BIOMATERIALS EVA
   WARREN KS, 1976, ANN NY ACAD SCI, V278, P7, DOI 10.1111/j.1749-6632.1976.tb47011.x
   WENTWORTH PA, 1989, INFECT IMMUN, V57, P2028
   WU Y, 1991, J BIOMED MATER RES, V25, P725, DOI 10.1002/jbm.820250604
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
   ZIEGLER HK, 1984, J IMMUNOL, V133, P1825
   ZIGTERMAN GJWJ, 1987, J IMMUNOL, V138, P220
NR 36
TC 43
Z9 43
U1 1
U2 15
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD MAY
PY 1994
VL 28
IS 5
BP 635
EP 646
DI 10.1002/jbm.820280514
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA NG210
UT WOS:A1994NG21000013
PM 8027104
DA 2018-10-19
ER

PT J
AU BRINKMAN, UAT
AF BRINKMAN, UAT
TI ONLINE SAMPLE TREATMENT FOR OR VIA COLUMN LIQUID-CHROMATOGRAPHY
SO JOURNAL OF CHROMATOGRAPHY A
LA English
DT Article; Proceedings Paper
CT 6th International Symposium on Handling of Environmental and Biological
   Samples in Chromatography
CY JUL 19-21, 1993
CL UNIV SURREY, GUILDFORD, ENGLAND
SP INT ASSOC ENVIRONM ANAL CHEM, CHROMATOG SOC
HO UNIV SURREY
ID POLYCYCLIC AROMATIC-HYDROCARBONS; CAPILLARY GAS-CHROMATOGRAPHY;
   TREATMENT COUPLED ONLINE; TRACE ENRICHMENT; PRE-COLUMN; BIOLOGICAL
   SAMPLES; MASS-SPECTROMETRY; PACKING MATERIALS; AMINO-ACIDS; PHASE
AB It is generally recognized that sample treatment often is the bottleneck in trace-lever organic analysis. As far as column liquid chromatography (LC) is concerned, the design, and commercialization, of on-line and fully automated precolumn/analytical column LC systems with diode-array UV or mass spectrometric detection is a distinct step towards solving the existing problems. Small precolumns that can be packed with sorbents of divergent selectivity, and also on-line (electro)dialysis modules, have been shown to perform well in many environmental and biomedical applications. In addition, it is noteworthy that LC or rather, LC-type, trace enrichment and clean-up on such precolumns are increasingly being used as an on-line treatment step for aqueous samples prior to capillary gas chromatographic analysis.
RP BRINKMAN, UAT (reprint author), FREE UNIV AMSTERDAM,DEPT ANALYT CHEM,DE BOELELAAN 1083,1081 HV AMSTERDAM,NETHERLANDS.
CR AERTS MML, 1988, J CHROMATOGR, V435, P97, DOI 10.1016/S0021-9673(01)82166-X
   AERTS MML, 1990, J CHROMATOGR, V500, P453, DOI 10.1016/S0021-9673(00)96085-0
   AGASOSTER T, 1991, J CHROMATOGR-BIOMED, V570, P99, DOI 10.1016/0378-4347(91)80204-P
   BAGHERI H, 1992, ANALUSIS, V20, P475
   BOOS KS, 1992, J CHROMATOGR, V600, P189, DOI 10.1016/0021-9673(92)85547-7
   BOURQUE AJ, 1991, J CHROMATOGR, V537, P123, DOI 10.1016/S0021-9673(01)88891-9
   BRINKMAN UAT, 1989, J CHROMATOGR-BIOMED, V492, P251, DOI 10.1016/S0378-4347(00)84471-0
   BRINKMAN UAT, 1987, CHROMATOGRAPHIA, V24, P190, DOI 10.1007/BF02688480
   BROUWER ER, 1990, CHROMATOGRAPHIA, V29, P415, DOI 10.1007/BF02261387
   BUCK RH, 1984, J CHROMATOGR, V315, P279, DOI 10.1016/S0021-9673(01)90745-9
   BULTERMAN AJ, 1993, HRC-J HIGH RES CHROM, V16, P397
   DEBETS AJJ, 1992, J CHROMATOGR, V600, P163, DOI 10.1016/0021-9673(92)85544-4
   DEBETS AJJ, 1990, CHROMATOGRAPHIA, V30, P361, DOI 10.1007/BF02328498
   DEKOK A, 1992, J CHROMATOGR, V623, P265
   DERUITER C, 1988, CHROMATOGRAPHIA, V26, P267, DOI 10.1007/BF02268165
   FARJAM A, 1988, J CHROMATOGR, V452, P419, DOI 10.1016/S0021-9673(01)81465-5
   FARJAM A, 1991, ANAL CHEM, V63, P2481, DOI 10.1021/ac00021a017
   FARJAM A, 1992, J CHROMATOGR, V589, P141, DOI 10.1016/0021-9673(92)80015-M
   FARJAM A, 1991, THESIS VRIJE U AMSTE, pCH1
   GAO C X, 1989, Biochromatography, V4, P224
   Grob K., 1991, LINE COUPLED LC GC
   HAGEN DF, 1990, ANAL CHIM ACTA, V236, P157, DOI 10.1016/S0003-2670(00)83309-7
   HOGENDOORN EA, 1993, J CHROMATOGR, V644, P307, DOI 10.1016/0021-9673(93)80713-I
   HOGENDOORN EA, 1993, THESIS FREE U AMSTER
   IRTH H, 1989, J CHROMATOGR-BIOMED, V491, P321, DOI 10.1016/S0378-4347(00)82850-9
   Kamp R.M., 1991, LC GC EUR, V4, P40
   Krull I.S., 1986, REACTION DETECTION L
   KWAKMAN PJM, 1992, CHROMATOGRAPHIA, V34, P4147
   LAI F, 1993, J PHARMACEUT BIOMED, V11, P117, DOI 10.1016/0731-7085(93)80131-J
   LOW KS, 1984, ANAL LETT, V17, P915
   MARIS FA, 1988, J CHROMATOGR, V445, P129, DOI 10.1016/S0021-9673(01)84514-3
   NIELEN MWF, 1985, ANAL CHEM, V57, P806, DOI 10.1021/ac00281a008
   NONDEK L, 1983, J CHROMATOGR, V282, P141, DOI 10.1016/S0021-9673(00)91598-X
   PINKERTON TC, 1991, J CHROMATOGR, V544, P13, DOI 10.1016/S0021-9673(01)83975-3
   SCHUSTER R, 1988, J CHROMATOGR-BIOMED, V431, P271, DOI 10.1016/S0378-4347(00)83096-0
   SIGVARDSON KW, 1984, J CHROMATOGR, V316, P507, DOI 10.1016/S0021-9673(00)96179-X
   SLOBODNIK J, 1993, J CHROMATOGR, V642, P359, DOI 10.1016/0021-9673(93)80099-T
   SLOBODNIK J, 1992, ANAL CHIM ACTA, V268, P55, DOI 10.1016/0003-2670(92)85248-5
   UNGER KK, 1991, CHROMATOGRAPHIA, V31, P507, DOI 10.1007/BF02262398
   VANDEMERBEL NC, 1993, J CHROMATOGR, V634, P1, DOI 10.1016/0021-9673(93)80308-U
   VANDERHORST FAL, 1990, J CHROMATOGR, V500, P443, DOI 10.1016/S0021-9673(00)96084-9
   VANHOUT PJM, 1993, EUROPEAN WATER POLLU, V3, P29
   VANZOONEN P, 1990, HRC-J HIGH RES CHROM, V13, P483
   VARGA GM, 1990, J CHROMATOGR, V523, P173
   VREULS JJ, 1991, CHROMATOGRAPHIA, V31, P113, DOI 10.1007/BF02274556
   VREULS JJ, IN PRESS J ASS OFFIC
   VREULS JJ, 1993, THESIS FREE U AMSTER
   WERKHOVENGOEWIE CE, 1981, ANAL CHEM, V53, P2072, DOI 10.1021/ac00236a029
   ZECH K, 1986, J CHROMATOGR, V353, P351, DOI 10.1016/S0021-9673(01)87105-3
   ZHOU FX, IN PRESS J CHROMATOG
NR 50
TC 61
Z9 61
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0021-9673
J9 J CHROMATOGR A
JI J. Chromatogr. A
PD APR 15
PY 1994
VL 665
IS 2
BP 217
EP 231
DI 10.1016/0021-9673(94)85052-6
PG 15
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA NH281
UT WOS:A1994NH28100002
PM 8205231
DA 2018-10-19
ER

PT J
AU DEFFONTAINESFOUREZ, M
   DEFFONTAINES, B
   CHICOT, D
   IOST, A
AF DEFFONTAINESFOUREZ, M
   DEFFONTAINES, B
   CHICOT, D
   IOST, A
TI MICROHARDNESS AND SPECTROSCOPY STUDIES OF SURFACE MODIFICATION OF
   TITANIUM-ALLOYS BY MELTED METAPHOSPHATES
SO THIN SOLID FILMS
LA English
DT Article; Proceedings Paper
CT Symposium on Ion Beam, Plasma, Laser and Thermally-Stimulated Deposition
   Processes, at the European-Materials-Research-Society 1993 Spring
   Conference
CY MAY 04-07, 1993
CL STRASBOURG, FRANCE
SP EUROPEAN MAT RES SOC
ID COATINGS; HARDNESS
AB A new method is proposed in order to improve the surface properties of titanium alloys used in biomedical applications. This paper considers the surface modification that appears after the reaction between metaphosphate glasses and titanium alloys (TA6V). The structural characterization of this material has been realized by several spectroscopic methods of investigation such as scanning electron microscopy, energy-dispersive X-ray analysis and wavelength-dispersive spectroscopy. Measurements of Vickers microhardness exhibit a correlation between the phosphorus profile and the evolution of hardness of the modified titanium alloy surface. The relative increase in the Vickers microhardness is about 65%. By application of the composite model, the absolute hardness of the coating was found to be HV0 = 550.
C1 ECOLE NATL SUPER ARTS & METIERS,CER LILLE,F-59046 LILLE,FRANCE.
RP DEFFONTAINESFOUREZ, M (reprint author), UNIV LITTORAL,CTR UNIV CITADELLE,CTR RECH ENVIRONNEMENT IND DUNKERQUE,BP 5526,F-59379 DUNKERQUE,FRANCE.
RI IOST, alain/D-8909-2011
OI IOST, alain/0000-0003-2185-4673; Chicot, Didier/0000-0002-5203-3168;
   DEFFONTAINES, Benoit/0000-0001-5104-8264
CR DEFFONTAINES B, 1992, P INT C RAMAN SPECTR
   DEFFONTAINES B, UNPUB
   DEFFONTAINES B, 1992, P INT S PHOSPHATES C
   DEGROOT K, 1987, CLIN RELAT RES, V225, P147
   DUCHEYNE P, 1985, J BIOMED MATER RES, V19, P273, DOI 10.1002/jbm.820190309
   DUCHEYNE P, 1990, BIOMATERIALS, V11, P244, DOI 10.1016/0142-9612(90)90005-B
   FARGES G, 1989, THIN SOLID FILMS, V181, P365, DOI 10.1016/0040-6090(89)90505-1
   JONSSON B, 1984, THIN SOLID FILMS, V114, P257, DOI 10.1016/0040-6090(84)90123-8
   RIVIERE JP, 1990, SURF COAT TECH, V42, P81, DOI 10.1016/0257-8972(90)90116-T
   Tabor D., 1986, ASTM STP, V889, P129
   Thomas A., 1987, Surface Engineering, V3, P117
   Vingsbo O., 1986, ASTM SPEC TECH PUBL, V889, P257
NR 12
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE 1
PA PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND
SN 0040-6090
J9 THIN SOLID FILMS
JI Thin Solid Films
PD APR 1
PY 1994
VL 241
IS 1-2
BP 230
EP 233
DI 10.1016/0040-6090(94)90431-6
PG 4
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA NG663
UT WOS:A1994NG66300049
DA 2018-10-19
ER

PT J
AU ALLCOCK, HR
   PUCHER, SR
   SCOPELIANOS, AG
AF ALLCOCK, HR
   PUCHER, SR
   SCOPELIANOS, AG
TI POLY[(AMINO-ACID-ESTER)PHOSPHAZENES] - SYNTHESIS, CRYSTALLINITY, AND
   HYDROLYTIC SENSITIVITY IN SOLUTION AND THE SOLID-STATE
SO MACROMOLECULES
LA English
DT Article
ID POLYPHOSPHAZENES
AB Fifteen different poly[(amino acid ester)phosphazenes] were synthesized to study their crystalline character and hydrolysis behavior in the solution and solid states. The polyphosphazenes synthesized were poly[bis(methyl glycinat-N-yl)phosphazene], poly[bis(ethyl glycinat-N-yl)phosphazene], poly[bis(tert-butyl glycinat-N-yl)phosphazene], poly[bis(benzyl glycinat-N-yl)phosphazene], poly[bis(methyl alaninat-N-yl)phosphazene], poly[bis(ethyl alaninat-N-yl)phosphazene], poly[bis(tert-butyl alaninat-N-yl)phos-phazene], poly[bis(benzyl alaninat-N-yl)phosphazene], poly[bis(methyl valinat-N-yl)phosphazene], poly-[bis(ethyl valinat-N-yl)phosphazene], poly[bis(tert-butyl valinat-N-yl)phosphazene],poly[bis(benzyl valinat-N-yl)phosphazene], poly[bis(methyl phenylalaninat-N-yl)phosphazene], poly[bis(ethyl phenylalaninat-N-yl)phosphazene], and poly[bis(tert-butyl phenylalaninat-N-yl)phosphazene]. The fully-substituted polymers were obtained by treatment of poly(dichlorophosphazene) with a large excess of the appropriate amino acid ester. Several of these polymers were crystalline as measured by differential scanning calorimetry and by polarized optical microscopy. Hydrolysis studies were performed to estimate the rates of decomposition of the polymers and the duration over which the polymers maintained their structural integrity. The polymers are potential biomedical materials.
C1 ETHICON INC,A JOHNSON & JOHNSON CO,SOMERVILLE,NJ 08876.
RP ALLCOCK, HR (reprint author), PENN STATE UNIV,DEPT CHEM,UNIV PK,PA 16801, USA.
CR ALLCOCK HR, 1991, MACROMOLECULES, V24, P23, DOI 10.1021/ma00001a005
   ALLCOCK HR, 1977, MACROMOLECULES, V10, P824, DOI 10.1021/ma60058a020
   ALLCOCK HR, 1965, J AM CHEM SOC, V87, P4216, DOI 10.1021/ja01096a056
   ALLCOCK HR, 1985, CHEM ENG NEWS, V63, P22, DOI 10.1021/cen-v063n011.p022
   ALLCOCK HR, 1982, INORG CHEM, V21, P515, DOI 10.1021/ic00132a009
   ALLCOCK HR, 1988, MACROMOLECULES, V21, P1980, DOI 10.1021/ma00185a015
   DOMB AJ, 1990, J POLYM SCI, V21, P973
   ELEMA H, 1990, COLLOID POLYM SCI, V268, P1082, DOI 10.1007/BF01410673
   GROLLEMAN C W J, 1986, Journal of Controlled Release, V3, P143, DOI 10.1016/0168-3659(86)90075-1
   HOSKINS IA, 1991, SURG GYNECOL OBSTET, V172, P108
   LAURENCIN CT, 1987, J BIOMED MATER RES, V21, P1231, DOI 10.1002/jbm.820211006
   LAURENCIN CT, UNPUB J BIOM MAT RES
NR 12
TC 144
Z9 158
U1 0
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD FEB 28
PY 1994
VL 27
IS 5
BP 1071
EP 1075
DI 10.1021/ma00083a001
PG 5
WC Polymer Science
SC Polymer Science
GA MZ653
UT WOS:A1994MZ65300001
DA 2018-10-19
ER

PT J
AU WU, HM
   OLIER, R
   JAFFREZICRENAULT, N
   CLECHET, P
   NYAMSI, A
   MARTELET, C
AF WU, HM
   OLIER, R
   JAFFREZICRENAULT, N
   CLECHET, P
   NYAMSI, A
   MARTELET, C
TI COVALENT IMMOBILIZATION OF GLUCOSE-OXIDASE ONTO GRAPHITIC ELECTRODES
SO ELECTROCHIMICA ACTA
LA English
DT Article
DE CARBON FIBER; GRAPHITE; CARBONACEOUS MATERIALS; ENZYME MODIFIED
   ELECTRODE; BIOSENSOR
ID CARBON ELECTRODES; ACTIVATED CARBON; ENZYME ELECTRODE; GLASSY-CARBON;
   CODEPOSITION; FIBERS
AB Graphitic substrates (plates and carbon fibre 7 mu m in diameter) have been used and characterized in order to obtain glucose sensitive electrodes. Preparation of such electrodes before enzymatic sensitization and after cleaning involves a specific electrochemical pretreatment of oxidation at +2.3 V/sce. Further covalent immobilization of glucose oxidase proceeds through a grafting between surface carboxyl group and a carbodiimide reagent Performances of enzymatic electrodes such as their stability up to two months make them well suited for further application in the biomedical field.
C1 ECOLE CENT LYON,PHYSICOCHIM INTERFACES LAB,CNRS,URA 404,F-69131 ECULLY,FRANCE.
   LAB TRIBOL & DYNAM SYST,CNRS,URA 855,F-69131 ECULLY,FRANCE.
CR BARBIER B, 1990, J ELECTROCHEM SOC, V137, P1757, DOI 10.1149/1.2086794
   Bardeletti G., 1991, BIOSENSOR PRINCIPLES, P7
   BARTON SS, 1975, CARBON, V13, P283, DOI 10.1016/0008-6223(75)90029-9
   BIANCO P, 1990, J ELECTROANAL CHEM, V293, P151, DOI 10.1016/0022-0728(90)80059-F
   BOURDILLON C, 1980, J AM CHEM SOC, V102, P4231, DOI 10.1021/ja00532a040
   BOWLING R, 1989, LANGMUIR, V5, P683, DOI 10.1021/la00087a022
   CESPUGLIO R, 1992, 14TH ANN INT C IEEE, P181
   CHO YK, 1979, BIOTECHNOL BIOENG, V21, P461, DOI 10.1002/bit.260210308
   CHO YK, 1978, BIOTECHNOL BIOENG, V20, P1651, DOI 10.1002/bit.260201011
   CHUN BW, 1992, CARBON, V30, P177, DOI 10.1016/0008-6223(92)90078-B
   CSOREGI E, 1993, ANAL CHIM ACTA, V273, P59, DOI 10.1016/0003-2670(93)80145-B
   DONG SJ, 1989, ELECTROANAL, V1, P99, DOI 10.1002/elan.1140010203
   ELLIOTT CM, 1976, ANAL CHEM, V48, P1247, DOI 10.1021/ac50002a046
   FITZER E, 1991, J ADHESION, V36, P139, DOI 10.1080/00218469108027068
   GREEN MJ, 1986, J CHEM SOC FARAD T 1, V82, P1237, DOI 10.1039/f19868201237
   GUILBAULT GG, 1973, ANAL CHIM ACTA, V64, P439, DOI 10.1016/S0003-2670(01)82476-4
   GUNASINGHAM H, 1989, ELECTROANAL, V1, P223, DOI 10.1002/elan.1140010306
   HENDJI AN, 1993, SENSOR ACTUAT B-CHEM, V15, P127
   PISHKO MV, 1991, ANAL CHEM, V63, P2268, DOI 10.1021/ac00020a014
   WANG J, 1992, ANAL CHEM, V64, P456, DOI 10.1021/ac00028a023
   WANG J, 1989, ELECTROANAL, V1, P151, DOI 10.1002/elan.1140010210
NR 21
TC 22
Z9 22
U1 1
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0013-4686
J9 ELECTROCHIM ACTA
JI Electrochim. Acta
PD FEB
PY 1994
VL 39
IS 3
BP 327
EP 331
DI 10.1016/0013-4686(94)80070-7
PG 5
WC Electrochemistry
SC Electrochemistry
GA MU762
UT WOS:A1994MU76200002
DA 2018-10-19
ER

PT J
AU ISHIHARA, K
   TSUJI, T
   KUROSAKI, T
   NAKABAYASHI, N
AF ISHIHARA, K
   TSUJI, T
   KUROSAKI, T
   NAKABAYASHI, N
TI HEMOCOMPATIBILITY ON GRAFT-COPOLYMERS COMPOSED OF
   POLY(2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE) SIDE-CHAIN AND
   POLY(N-BUTYL METHACRYLATE) BACKBONE
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID PROTEIN ADSORPTION; 2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE;
   PHOSPHOLIPID POLYMERS; ALKYL METHACRYLATES; BLOOD COMPATIBILITY; HUMAN
   PLASMA; SURFACES; MEMBRANE
AB To improve the hemocompatibility on hydrophobic biomedical materials by a simple coating technique, graft: copolymers composed of a hydrophilic side chain with phospholipid polar groups and a hydrophobic backbone were synthesized. The hydrophilic chain had phospholipid polar groups, poly[2-methacryloyloxyethyl phosphorylcholine (MPC)], and the hydrophobic backbone was poly[n-butyl methacrylate (BMA)]. Because the graft copolymers obtained could dissolve in ethanol, they could be used as a coating material. When the poly(MPC-graft-BMA) was coated onto a poly(BMA) membrane, the composition of the MPC units on the surface was maintained in the bulk graft copolymer even after immersion in water. Protein adsorption on the membrane coated with the graft copolymer from human plasma detected by a gold-colloid labeled immunoassay was drastically decreased compared with that on glass and the original membrane. Moreover, blood cell adhesion, activation, and aggregation on the membrane after contact with human citrated whole blood were suppressed by the coating of the graft copolymer. These results clearly show that the poly(MPC-graft-BMA) is a suitable material for improving hemocompatibility on the biomedical devices because of its protein adsorption and cell adhesion resistant properties. (C) 1994 John Wiley and Sons, Inc.
C1 TOKYO INST POLYTECH,FAC ENGN,ATSUGI,KANAGAWA 24302,JAPAN.
RP ISHIHARA, K (reprint author), TOKYO MED & DENT UNIV,INST MED & DENT ENGN,CHIYODA KU,2-3-10 KANDA SURUGADAI,TOKYO,TOKYO 101,JAPAN.
CR AKISAWA T, 1989, T AM SOC ART INT ORG, V35, P333
   BAMFORD CH, 1992, VROMAN EFFECT
   Brash JL, 1991, BLOOD COMPATIBLE MAT, P3
   FUKUMOTO K, 1992, BIOMATERIALS, V13, P235
   HAYASHI K, 1985, KOBUNSHI RONBUNSHU, V42, P77, DOI 10.1295/koron.42.77
   IDE F, 1987, SURFACE MODIFICATION
   ISHIHARA K, 1989, KOBUNSHI RONBUNSHU, V46, P591, DOI 10.1295/koron.46.591
   ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   ISHIHARA K, 1992, BIOMATERIALS, V13, P145, DOI 10.1016/0142-9612(92)90062-S
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   ISHIHARA K, IN PRESS J POLYM S A
   ISHIHARA K, 1991, SEITAI ZAIRYO, V9, P243
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   LEE JH, 1990, BIOMATERIALS, V11, P455, DOI 10.1016/0142-9612(90)90058-X
   Ratner BD, 1979, J POLYM SCI POLYM S, V66, P363
   REMPP PF, 1984, ADV POLYM SCI, V58, P1
   Tsuruta T., 1989, MULTIPHASE BIOMEDICA
   UEDA T, 1992, POLYM J, V24, P1259, DOI 10.1295/polymj.24.1259
   UEDA T, 1991, J BIOMAT SCI-POLYM E, V3, P185
   YASUDA H, 1982, BIOMATERIALS, V3, P68, DOI 10.1016/0142-9612(82)90036-9
   ZIATS NP, 1990, J LAB CLIN MED, V116, P687
   ZIATS NP, 1991, CELL MATER, V1, P73
NR 24
TC 107
Z9 108
U1 1
U2 15
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 1994
VL 28
IS 2
BP 225
EP 232
DI 10.1002/jbm.820280213
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA MT018
UT WOS:A1994MT01800012
PM 8207035
DA 2018-10-19
ER

PT J
AU HA, HF
AF HA, HF
TI AN OVERVIEW ON STUDY OF IMMOBILIZATION OF BIOACTIVE SPECIES AND DDS BY
   MEANS OF RADIATION TECHNOLOGY IN CHINA
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE RADIATION TECHNOLOGY; IMMOBILIZATION OF BIOACTIVE SPECIES; BIOMEDICAL
   APPLICATION; DRUG DELIVERY SYSTEM (DDS)
AB The present paper gives an overview on the research and application of immobilization of bioactive species and DDS by means of radiation technology that have been carried out in China recently. The following three parts are included in this paper: (1) radiation preparation of biomedical materials; (2) radiation immobilization of bioactive species; (3) DDS.
RP HA, HF (reprint author), BEIJING UNIV,DEPT TECH PHYS,BEIJING 100871,PEOPLES R CHINA.
CR COA J, 1991, J RAD RES RAD PROCES, V9, P219
   DU C, 1984, J RAD RES RAD PROCES, V2, P27
   GU JH, 1990, J RAD RES RAD PROCES, V8, P163
   HA HF, 1985, RADIAT PHYS CHEM, V25, P501
   HA HF, 1991, SINOJAPANESE BILATER
   HA HF, 1990, J RAD RES RAD PROCES, V8, P25
   HA HF, 1977, RADIAT PHYS CHEM, V31, P761
   HA HF, 1989, J RAD RES RAD PROCES, V7, P30
   HA HG, 1992, J RAD RES RAD PROCES, V10, P7
   HA JF, 1988, ACTA POLYM SINICA, V3, P219
   HU W, 1986, 3RD P NAT C RAD PROC, P142
   JIN C, 1988, J RAD RES RAD PROCES, V6, P49
   LI XM, 1991, J RAD RES RAD PROCES, V9, P2
   LI XM, 1988, J CHINA U SCI TECHNO, V18, P319
   LI XM, 1989, ACTA POLYM SINICA, V5, P524
   LI XM, 1989, J RAD RES RAD PROCES, V1, P36
   LI XM, 1982, J CHINA U SCI TECHNO, V12, P4
   LIU PF, IN PRESS
   LIU RZ, 1990, J BIOMED ENG, V8, P308
   LIU YM, 1987, RADIAT PHYS CHEM, V30, P215
   LIU YM, 1988, J RAD RES READ PROCE, V6, P44
   LIU ZM, 1987, J SHANGHAI U SCI TEC, V3, P3
   LU XH, 1991, J RAD RES RAD PROCES, V9, P233
   MA ZT, 1986, J SHANGHAI U SCI TEC, V4, P1
   MA ZT, 1984, J SHANGHAI U SCI TEC, V2, P27
   SHAN J, 1992, IMRP8, P9
   TEH MR, 1986, ACTA CHIM SINICA, V44, P850
   WANG GH, 1988, RADIAT PHYS CHEM, V31, P705
   YAN Q, 1988, J SHANGHAI U SCI TEC, V4
   YANG Y, 1986, 3RD P NAT C RD PROC, P139
   YANG YG, 1986, POLYM COMMUN, V2, P81
   YU U, 1990, J RAD RES RAD PROCES, V8, P168
   ZHAI M, 1992, IMRP8
   ZHANG ZH, 1982, J CHINA U SCI TECHNO, V12
   ZHENG JY, 1990, J ISOTOPES, V3, P242
   孙以实, 1991, Chinese Journal of Polymer Science, V9, P353
NR 36
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD FEB
PY 1994
VL 29
IS 1-2
BP 195
EP 199
DI 10.1016/0168-3659(94)90136-8
PG 5
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA NE024
UT WOS:A1994NE02400021
DA 2018-10-19
ER

PT J
AU LIU, YF
   GUO, ZY
   LIU, XQ
   QU, T
   XIE, JL
AF LIU, YF
   GUO, ZY
   LIU, XQ
   QU, T
   XIE, JL
TI APPLICATIONS OF ACCELERATOR MASS-SPECTROMETRY IN ANALYSIS OF TRACE
   ISOTOPES AND ELEMENTS
SO PURE AND APPLIED CHEMISTRY
LA English
DT Article
ID ATOMIC-ABSORPTION SPECTROMETRY; BIO-MEDICAL SCIENCES; HALF-LIFE;
   CROSS-SECTIONS; ATMOSPHERIC TRANSPORT; INSITU PRODUCTION; COSMOGENIC
   BE-10; NUCLEAR-PHYSICS; SOLAR NEUTRINOS; STRIPA GRANITE
AB Accelerator mass spectrometry (AMS) is mainly employed to measure very low concentrations of a number of long-lived radioisotopes and stable isotopes with very high sensitivities. The predominant application of AMS is in the field of geosciences and is based on chronological evaluations and dating principles. This paper deals with AMS applications other than dating problems, aiming at the analytical aspects of the trace isotopes and trace elements. It addresses non-dating applications in the fields of nuclear physics, geology, hydrology, environmental sciences, material sciences and, in recent years, biomedical sciences which have received increasing attention. Comparison of AMS with other analytical techniques with respect to detection limits and other functions is also discussed.
C1 BEIJING UNIV, INST HEAVY ION PHYS, BEIJING 100871, PEOPLES R CHINA.
RP LIU, YF (reprint author), BEIJING UNIV, DEPT TECH PHYS, BEIJING 100871, PEOPLES R CHINA.
CR ALBURGER DE, 1986, EARTH PLANET SC LETT, V78, P168, DOI 10.1016/0012-821X(86)90058-0
   ALFREY AC, 1976, NEW ENGL J MED, V294, P184, DOI 10.1056/NEJM197601222940402
   ALFREY AC, 1987, TOXICOLOGY METALS CL, P201
   ALLEGRE CJ, 1980, EARTH PLANET SC LETT, V48, P148, DOI 10.1016/0012-821X(80)90177-6
   Alvarez LW, 1939, PHYS REV, V56, P613, DOI 10.1103/PhysRev.56.613
   ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095
   Alvarez LW, 1939, PHYS REV, V56, P379, DOI 10.1103/PhysRev.56.379.2
   ANDREWS JN, 1989, GEOCHIM COSMOCHIM AC, V53, P1803, DOI 10.1016/0016-7037(89)90301-3
   ANNEGARN HJ, 1990, NUCL INSTRUM METH B, V49, P264, DOI 10.1016/0168-583X(90)90258-V
   ANTHONY JM, 1987, NUCL INSTRUM METH B, V29, P77, DOI 10.1016/0168-583X(87)90208-4
   ANTHONY JM, 1989, NUCL INSTRUM METH B, V40-1, P731, DOI 10.1016/0168-583X(89)90465-5
   ANTHONY JM, 1983, NUCL INSTRUM METHODS, V218, P463, DOI 10.1016/0167-5087(83)91022-0
   ANTHONY JM, 1985, NUCL INSTRUM METH B, V10-1, P498, DOI 10.1016/0168-583X(85)90295-2
   ANTHONY JM, 1990, NUCL INSTRUM METH B, V52, P493, DOI 10.1016/0168-583X(90)90464-6
   BAHCALL JN, 1982, REV MOD PHYS, V54, P767, DOI 10.1103/RevModPhys.54.767
   BARD E, 1987, NUCL INSTRUM METH B, V29, P297, DOI 10.1016/0168-583X(87)90253-9
   BARKER J, 1990, NUCL INSTRUM METH B, V52, P540, DOI 10.1016/0168-583X(90)90473-8
   BEER J, 1988, NATURE, V331, P675, DOI 10.1038/331675a0
   BEER J, 1983, RADIOCARBON, V25, P269
   Bennett C L, 1977, Science, V198, P508
   BENNINGHOVEN A, 1986, SECONDARY ION MASS S
   BENTLY HW, 1986, HDB ENV ISOTOPE GEOC, V2, P429
   BROWN L, 1984, ANNU REV EARTH PL SC, V12, P39, DOI 10.1146/annurev.ea.12.050184.000351
   BROWN L, 1989, GEOCHIM COSMOCHIM AC, V53, P135, DOI 10.1016/0016-7037(89)90280-9
   BROWN L, 1987, PHILOS T R SOC A, V323, P75, DOI 10.1098/rsta.1987.0073
   CARROLL BH, 1980, PHOTOGR SCI ENG, V24, P265
   CHANG KH, 1984, THESIS U TORONTO CAN
   CHEW SH, 1984, NUCL INSTRUM METH B, V5, P179, DOI 10.1016/0168-583X(84)90506-8
   CLAUSEN HB, 1973, J GLACIOL, V12, P411
   CREASER RA, 1991, GEOCHIM COSMOCHIM AC, V55, P397, DOI 10.1016/0016-7037(91)90427-7
   CURRIE LA, 1991, RADIOCARBON, V33, P189
   DEMASTER DJ, 1980, EARTH PLANET SC LETT, V48, P209, DOI 10.1016/0012-821X(80)90182-X
   DITTRICH B, 1990, NUCL INSTRUM METH B, V52, P588, DOI 10.1016/0168-583X(90)90481-9
   DONAHUE DJ, 1990, P BEIJING INT WORKSH
   ELMORE D, 1984, NUCL INSTRUM METH B, V5, P109, DOI 10.1016/0168-583X(84)90492-0
   ELMORE D, 1985, NUCL INSTRUM METH B, V10-1, P738, DOI 10.1016/0168-583X(85)90096-5
   ELMORE D, 1987, SCIENCE, V236, P543, DOI 10.1126/science.236.4801.543
   ELMORE D, 1987, BIOL TRACE ELEM RES, V12, P231, DOI 10.1007/BF02796683
   ELMORE D, 1990, NUCL INSTRUM METH B, V52, P531, DOI 10.1016/0168-583X(90)90471-6
   ELMORE D, 1980, PHYS REV LETT, V45, P589, DOI 10.1103/PhysRevLett.45.589
   EMERY JF, 1972, NUCL SCI ENG, V48, P319, DOI 10.13182/NSE72-A22489
   ERDTMANN G, 1986, TREATISE ANAL CHEM 1, V14
   ERNST H, 1984, NUCL INSTRUM METH B, V5, P426, DOI 10.1016/0168-583X(84)90554-8
   FABRYKAMARTIN J, 1987, NUCL INSTRUM METH B, V29, P361, DOI 10.1016/0168-583X(87)90265-5
   FABRYKAMARTIN JT, 1989, GEOCHIM COSMOCHIM AC, V53, P1817, DOI 10.1016/0016-7037(89)90302-5
   FABRYKAMARTIN JT, 1987, P S NATURAL ANALOGUE
   FEHN U, 1986, NATURE, V323, P707, DOI 10.1038/323707a0
   FELTON JS, 1990, NUCL INSTRUM METH B, V52, P517, DOI 10.1016/0168-583X(90)90469-B
   FINK D, 1990, NUCL INSTRUM METH B, V52, P601, DOI 10.1016/0168-583X(90)90483-B
   FINKEL RC, 1991, IN PRESS ADV ANAL GE
   FINKEL RC, 1988, UCAR1006288 ANN REP, P94
   FREEDMAN MS, 1976, SCIENCE, V193, P1117, DOI 10.1126/science.193.4258.1117
   FREEMAN SPHT, 1990, NUCL INSTRUM METH B, V52, P405, DOI 10.1016/0168-583X(90)90446-2
   FREKERS D, 1983, PHYS REV C, V28, P1756, DOI 10.1103/PhysRevC.28.1756
   GOVE HE, 1990, NUCL INSTRUM METH B, V52, P502, DOI 10.1016/0168-583X(90)90466-8
   GOVE HE, 1987, NUCL INSTRUM METH B, V29, pR7, DOI 10.1016/0168-583X(87)90190-X
   GOVE HE, 1978, 1ST P RAD DAT ACC RO, P1
   GRASSERBAUER M, 1988, J RES NAT BUR STAND, V93, P510, DOI 10.6028/jres.093.140
   GRASSERBAUER M, 1987, ANAL CHIM ACTA, V195, P1, DOI 10.1016/S0003-2670(00)85646-9
   GRIME GW, 1991, NUCL INSTRUM METH B, V54, P52, DOI 10.1016/0168-583X(91)95490-5
   HEMMICK TK, 1987, NUCL INSTRUM METH B, V29, P389, DOI 10.1016/0168-583X(87)90271-0
   HENNING W, 1981, 1981 P INT S ACC MAS, P1
   Henning W., 1985, AIP C P, V126, P203
   HENNING W, 1984, P C SOLAR NEUTRINOS
   Heumann K. G, 1988, INORGANIC MASS SPECT, P301
   HOCKETT RS, 1989, APPL PHYS LETT, V54, P1793, DOI 10.1063/1.101266
   HOFFMAN DC, 1971, NATURE, V234, P132, DOI 10.1038/234132a0
   HOFMANN HJ, 1990, NUCL INSTRUM METH B, V52, P544, DOI 10.1016/0168-583X(90)90474-9
   HOFMANN HJ, 1987, NUCL INSTRUM METH B, V29, P32, DOI 10.1016/0168-583X(87)90198-4
   HOFMEIJER GK, 1987, NUCL INSTRUM METH B, V29, P166, DOI 10.1016/0168-583X(87)90229-1
   HUANG DF, 1991, J CHINESE MASS SPECT, V12, P94
   HURST GS, 1988, SPECTROCHIM ACTA B, V43, P715, DOI 10.1016/0584-8547(88)80104-6
   HURST GS, 1988, PRINCIPLES APPLICATI
   IMAMURA M, 1990, NUCL INSTRUM METH B, V52, P595, DOI 10.1016/0168-583X(90)90482-A
   JIANG SS, 1990, NUCL INSTRUM METH B, V52, P608, DOI 10.1016/0168-583X(90)90484-C
   JOHNSSON SAE, 1988, PIXE NOVAL TECHNIQUE
   JONES GA, 1990, NUCL INSTRUM METH B, V52, P278, DOI 10.1016/0168-583X(90)90421-P
   KEILSON J, 1978, 1ST P C RAD DAT ACC, P391
   KLEIN J, 1981, ANLPHY811 REP, P136
   KLEIN J, 1990, BEIJING INT WORKSHOP
   KLEIN J, 1991, IN PRESS EARTH PLANE
   KLOUDA GA, 1984, NUCL INSTRUM METH B, V5, P265, DOI 10.1016/0168-583X(84)90524-X
   KORSCHINEK G, 1990, NUCL INSTRUM METH B, V52, P498, DOI 10.1016/0168-583X(90)90465-7
   KRUCK TPA, 1988, MET IONS BIOL SYST, V24, P285
   KUSAKABE M, 1982, NATURE, V299, P712, DOI 10.1038/299712a0
   KUTSCHERA W, 1988, NUCL INSTRUM METH A, V268, P552, DOI 10.1016/0168-9002(88)90578-5
   KUTSCHERA W, 1984, NUCL INSTRUM METH B, V5, P420, DOI 10.1016/0168-583X(84)90553-6
   KUTSCHERA W, 1986, NUCL INSTRUM METH B, V17, P377, DOI 10.1016/0168-583X(86)90167-9
   KUTSCHERA W, 1984, NUCL INSTRUM METH B, V5, P430, DOI 10.1016/0168-583X(84)90555-X
   KUTSCHERA W, 1990, ANNU REV NUCL PART S, V40, P411
   KUTSCHERA W, 1990, NUCL INSTRUM METH B, V50, P252, DOI 10.1016/0168-583X(90)90364-Z
   KUTSCHERA W, 1989, RADIOCARBON, V31, P311
   KUTSCHERA W, 1980, PHYS REV LETT, V45, P592, DOI 10.1103/PhysRevLett.45.592
   KUTSCHERA W, 1991, RADIOCARBON, V33, P218
   LARUE GS, 1977, PHYS REV LETT, V38, P1011, DOI 10.1103/PhysRevLett.38.1011
   LINDSAY NM, 1988, NUCL INSTRUM METH B, V35, P358, DOI 10.1016/0168-583X(88)90296-0
   LIU XQ, 1991, NAGARA9107 TECHN REP
   LOWE DC, 1987, NUCL INSTRUM METH B, V29, P291, DOI 10.1016/0168-583X(87)90252-7
   LUCK JM, 1983, SCIENCE, V222, P613, DOI 10.1126/science.222.4624.613
   LVOV BV, 1986, SPECTROCHIM ACTA B, V41, P1043, DOI 10.1016/0584-8547(86)80125-2
   LVOV BV, 1990, SPECTROCHIM ACTA B, V45, P633, DOI 10.1016/0584-8547(90)80046-L
   MABUCHI H, 1974, J INORG NUCL CHEM, V36, P1687, DOI 10.1016/0022-1902(74)80493-8
   MAENHAUT W, 1990, NUCL INSTRUM METH B, V49, P518, DOI 10.1016/0168-583X(90)90304-D
   MAGEE CW, 1988, J RES NAT BUR STAND, V93, P390, DOI 10.6028/jres.093.088
   MAKINO T, 1975, SHITSURYO BUNSEKI, V23, P33
   MARTIN FW, 1991, NUCL INSTRUM METH B, V54, P64, DOI 10.1016/0168-583X(91)95491-U
   MEIRAV O, 1990, NUCL INSTRUM METH B, V52, P536, DOI 10.1016/0168-583X(90)90472-7
   MIDDLETON R, 1987, PHILOS T R SOC A, V323, P121, DOI 10.1098/rsta.1987.0077
   MIDDLETON R, 1979, PHYS REV LETT, V43, P429, DOI 10.1103/PhysRevLett.43.429
   MIDDLETON R, 1989, RADIOCARBON, V31, P305
   MILNER RG, 1985, PHYS REV LETT, V54, P1472, DOI 10.1103/PhysRevLett.54.1472
   MONAGHAN MC, 1986, EARTH PLANET SC LETT, V76, P279, DOI 10.1016/0012-821X(86)90079-8
   MORELAND PE, 1965, J INORG NUCL CHEM, V27, P493, DOI 10.1016/0022-1902(65)80252-4
   MULLER RA, 1977, SCIENCE, V196, P521, DOI 10.1126/science.196.4289.521
   MULLER RA, 1977, SCIENCE, V196, P489, DOI 10.1126/science.196.4289.489
   NAKAMURA T, 1987, NUCL INSTRUM METH B, V29, P355, DOI 10.1016/0168-583X(87)90264-3
   NELSON DE, 1977, SCIENCE, V198, P507, DOI 10.1126/science.198.4316.507
   OSTLUND HG, 1987, NUCL INSTRUM METH B, V29, P286, DOI 10.1016/0168-583X(87)90251-5
   PAUL M, 1986, NATURE, V321, P511, DOI 10.1038/321511a0
   PAUL M, 1980, PHYS LETT B, V94, P303, DOI 10.1016/0370-2693(80)90883-7
   PAUL M, 1987, NUCL INSTRUM METH B, V29, P341, DOI 10.1016/0168-583X(87)90262-X
   PAVICH MJ, 1985, GEOLOGY, V13, P39, DOI 10.1130/0091-7613(1985)13<39:BAOAQW>2.0.CO;2
   PERL DP, 1988, MET IONS BIOL SYST, V24, P259
   PHILLIPS FM, 1984, P S TECH U, V1, P47
   PRZYBYLOWICZ W, 1990, NUCL INSTRUM METH B, V49, P509, DOI 10.1016/0168-583X(90)90302-B
   PURDY CB, 1987, NUCL INSTRUM METH B, V29, P372, DOI 10.1016/0168-583X(87)90266-7
   PURSER KH, 1977, REV PHYS APPL, V12, P1487, DOI 10.1051/rphysap:0197700120100148700
   RAISBECK GM, 1985, NATURE, V315, P315, DOI 10.1038/315315a0
   RAISBECK GM, 1981, GEOPHYS RES LETT, V8, P1015, DOI 10.1029/GL008i009p01015
   RAISBECK GM, 1981, NATURE, V292, P825, DOI 10.1038/292825a0
   RAISBECK GM, 1990, NUCL INSTRUM METH B, V52, P211
   RAISBECK GM, 1981, ANLPHY811 REP, P458
   RODHE H, 1990, SCIENCE, V248, P1217, DOI 10.1126/science.248.4960.1217
   ROWLEY JK, 1985, AIP C P, V126, P1
   ROY JC, 1957, CAN J PHYS, V35, P649, DOI 10.1139/p57-069
   RUCKLIDGE JC, 1990, NUCL INSTRUM METH B, V52, P507, DOI 10.1016/0168-583X(90)90467-9
   RUCKLIDGE JC, 1981, NUCL INSTRUM METHODS, V191, P1, DOI 10.1016/0029-554X(81)90973-3
   RUCKLIDGE JC, 1982, CAN MINERAL, V20, P111
   RUCKLIDGE JC, 1987, J TRACE MICROPROBE T, V5, P23
   SCANLON BR, 1987, NUCL INSTRUM METH B, V29, P291
   SCHIFFER JP, 1981, ANLPHY811 REP, P154
   SCHNEIDER RJ, 1987, NUCL INSTRUM METH B, V29, P271, DOI 10.1016/0168-583X(87)90248-5
   SCHWARZSCHILD AZ, 1977, B AM PHYS SOC, V22, P94
   SCHWEIKERT EA, 1989, ANALYST, V114, P269, DOI 10.1039/an9891400269
   SHEU YD, 1986, J ELECTROCHEM SOC, V133, P2136, DOI 10.1149/1.2108356
   SLAVIN W, 1984, GRAPHITE FURNACE AAS, P18
   STEPHENS W, 1980, PHYS REV C, V21, P1664, DOI 10.1103/PhysRevC.21.1664
   STRAUME T, 1990, NUCL INSTRUM METH B, V52, P552, DOI 10.1016/0168-583X(90)90475-A
   SYNAL HA, 1990, NUCL INSTRUM METH B, V52, P483, DOI 10.1016/0168-583X(90)90462-4
   TAKACS S, 1990, NUCL INSTRUM METH B, V49, P195, DOI 10.1016/0168-583X(90)90241-L
   TAYLOR RE, 1987, NUCL INSTRUM METH B, V29, P159, DOI 10.1016/0168-583X(87)90227-8
   TENG RTD, 1987, NUCL INSTRUM METH B, V29, P281, DOI 10.1016/0168-583X(87)90250-3
   TERA F, 1983, METEORITICS, V18, P405
   VALETTESILVER JN, 1986, EARTH PLANET SC LETT, V80, P82, DOI 10.1016/0012-821X(86)90021-X
   VOGEL JS, 1990, NUCL INSTRUM METH B, V52, P524, DOI 10.1016/0168-583X(90)90470-F
   VOGEL JS, 1990, RADIOCARBON, V32, P81
   VOURVOPOULOS G, 1990, NUCL INSTRUM METH B, V52, P451, DOI 10.1016/0168-583X(90)90456-5
   WAHLEN M, 1989, SCIENCE, V245, P286, DOI 10.1126/science.245.4915.286
   WAHLEN M, 1983, EOS T AM GEOPHYS UN, V64, P282
   WANG YA, 1988, J CHINESE MASS SPECT, V9, P3
   WATSON EE, MIRDOSE CODE 1988 VE
   WELZ B, 1985, ATOMIC ABSORPTION SP
   WENDORF F, 1987, NUCL INSTRUM METH B, V29, P155, DOI 10.1016/0168-583X(87)90226-6
   WILHARTITZ P, 1987, FRESEN Z ANAL CHEM, V329, P228, DOI 10.1007/BF00469146
   WING J, 1965, J INORG NUCL CHEM, V27, P487, DOI 10.1016/0022-1902(65)80251-2
   WOLFLI W, 1987, NUCL INSTRUM METH B, V29, P1, DOI 10.1016/0168-583X(87)90193-5
   WOLFLI W, 1984, NUCL INSTRUM METH B, V5, pR5, DOI 10.1016/0168-583X(84)90487-7
   YIOU F, 1972, PHYS REV LETT, V29, P372, DOI 10.1103/PhysRevLett.29.372
NR 168
TC 18
Z9 22
U1 1
U2 2
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0033-4545
EI 1365-3075
J9 PURE APPL CHEM
JI Pure Appl. Chem.
PD FEB
PY 1994
VL 66
IS 2
BP 305
EP 334
DI 10.1351/pac199466020305
PG 30
WC Chemistry, Multidisciplinary
SC Chemistry
GA NE479
UT WOS:A1994NE47900010
OA Bronze
DA 2018-10-19
ER

PT J
AU ALLCOCK, HR
   PUCHER, SR
   SCOPELIANOS, AG
AF ALLCOCK, HR
   PUCHER, SR
   SCOPELIANOS, AG
TI SYNTHESIS OF POLY(ORGANOPHOSPHAZENES) WITH GLYCOLIC ACID ESTER AND
   LACTIC-ACID ESTER SIDE-GROUPS - PROTOTYPES FOR NEW BIOERODIBLE POLYMERS
SO MACROMOLECULES
LA English
DT Article
ID HYDROLYSIS-SENSITIVE POLY<(ORGANO)PHOSPHAZENES>; BIODEGRADABLE POLYMERS;
   POLYPHOSPHAZENES
AB Four different poly(organophosphazenes) bearing esters of glycolic or lactic acid as side groups have been synthesized in order to investigate their stability in aqueous media. The polymers are poly[bis-(ethyl glycolato)phosphazene],poly[bis(ethyl lactato)phosphazene],poly[bis(benzyl glycolato)phosphazene], and poly[bis(benzyl lactato)phosphazene]. The benzyl esters of glycolic and lactic acid were prepared by the base-catalyzed transesterification of their ethyl esters with benzyl alcohol at 90 degrees C. Poly(dichlorophosphazene) was treated with a large excess of the appropriate sodium acid ester at 50 degrees C to yield the fully-substituted polymer. To avoid unwanted molecular weight decline, these polymers were stored-under nitrogen or in vacuum. Hydrolytic decomposition profiles in aqueous media were monitored by P-31 NMR spectroscopy and by gel permeation chromatography (GPC). The possible utility of these polymers as biomedical materials is discussed.
C1 ETHICON INC,SOMERVILLE,NJ 08876.
RP ALLCOCK, HR (reprint author), PENN STATE UNIV,DEPT CHEM,UNIV PK,PA 16802, USA.
CR ALLCOCK HR, 1991, MACROMOLECULES, V24, P23, DOI 10.1021/ma00001a005
   ALLCOCK HR, 1977, MACROMOLECULES, V10, P824, DOI 10.1021/ma60058a020
   ALLCOCK HR, 1965, J AM CHEM SOC, V87, P4216, DOI 10.1021/ja01096a056
   ALLCOCK HR, 1982, INORG CHEM, V21, P515, DOI 10.1021/ic00132a009
   ALLCOCK HR, 1988, MACROMOLECULES, V21, P1980, DOI 10.1021/ma00185a015
   ALLCOCK HR, UNPUB
   CROMMEN JHL, 1992, BIOMATERIALS, V13, P511, DOI 10.1016/0142-9612(92)90102-T
   CROMMEN JHL, 1992, BIOMATERIALS, V13, P601, DOI 10.1016/0142-9612(92)90028-M
   HOSKINS IA, 1991, SURG GYNECOL OBSTET, V172, P108
   LAURENCIN C, 1992, PMSE, V66, P33
   LAURENCIN CT, 1987, J BIOMED MATER RES, V21, P1231, DOI 10.1002/jbm.820211006
   LAURENCIN CT, 1993, J BIOMED MATER RES, V27, P963, DOI 10.1002/jbm.820270716
   MCCALDIN DJ, 1960, CHEM REV, V60, P39, DOI 10.1021/cr60203a004
NR 13
TC 56
Z9 65
U1 1
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD JAN 3
PY 1994
VL 27
IS 1
BP 1
EP 4
DI 10.1021/ma00079a001
PG 4
WC Polymer Science
SC Polymer Science
GA MQ385
UT WOS:A1994MQ38500001
DA 2018-10-19
ER

PT J
AU VRIJENHOEK, RC
AF VRIJENHOEK, RC
TI UNISEXUAL FISH - MODEL SYSTEMS FOR STUDYING ECOLOGY AND EVOLUTION
SO ANNUAL REVIEW OF ECOLOGY AND SYSTEMATICS
LA English
DT Review
DE SEX; ASEXUALITY; CLONES; COEXISTENCE; CONSERVATION
ID POECILIOPSIS PISCES-POECILIIDAE; LIZARDS GENUS CNEMIDOPHORUS; CLONALLY
   INHERITED GENOMES; MITOCHONDRIAL-DNA ANALYSES; RED QUEEN;
   DROSOPHILA-MELANOGASTER; GENETIC DISSECTION; CELL-PROLIFERATION;
   GYNOGENETIC FISH; LINKAGE ANALYSIS
AB Since their discovery in 1932, all-female ''species'' of fish have provided rich material for ecological and evolutionary studies. The significance of these rare organisms lies in the perspective they provide on what is considered normal (i.e. biparental sexuality). Study of these fish and their sexual relatives has contributed to our understanding of: (i) the origins and evolution of asexuality; (ii) the ecology of hybrids; (iii) genotypic and environmental effects on ecologically relevant traits; and (iv) the maintenance of sex in higher organisms. A consistent message emerging from these studies is the significance of genetic diversity for survival in spatially and temporally heterogeneous environments. Consequently, unisexual fish also serve as useful models for studying the role of genetic variation in the survival of small endangered populations. Finally, unisexual fish serve as genetically uniform systems for environmental and biomedical studies. The purpose of this review is to bring wider attention to the range of biological problems that can be attacked with these remarkable organisms.
RP VRIJENHOEK, RC (reprint author), RUTGERS STATE UNIV,CTR THEORET & APPL GENET,NEW BRUNSWICK,NJ 08903, USA.
CR ANGUS RA, 1979, EVOLUTION, V33, P27, DOI 10.1111/j.1558-5646.1979.tb04659.x
   AVISE JC, 1989, EVOLUTION, V43, P1192, DOI 10.1111/j.1558-5646.1989.tb02568.x
   AVISE JC, 1992, EVOL BIOL, V26, P225
   BALSANO JS, 1985, ENVIRON BIOL FISH, V12, P251, DOI 10.1007/BF00005456
   Bell G., 1982, MASTERPIECE NATURE
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   BULGER AJ, 1979, EVOLUTION, V33, P848, DOI 10.1111/j.1558-5646.1979.tb04739.x
   BULGER AJ, 1982, EVOLUTION, V36, P1041, DOI 10.1111/j.1558-5646.1982.tb05472.x
   CASE TJ, 1986, EVOLUTION, V40, P366, DOI 10.1111/j.1558-5646.1986.tb00478.x
   CASE TJ, 1990, OECOLOGIA, V83, P220, DOI 10.1007/BF00317756
   CHARLESWORTH D, 1993, J HERED, V84, P321, DOI 10.1093/oxfordjournals.jhered.a111351
   CIMINO MC, 1972, EVOLUTION, V26, P294, DOI 10.1111/j.1558-5646.1972.tb00195.x
   CLANTON WESLEY, 1934, OCC PAPERS MUS ZOOL UNIV MICH, V290, P1
   COLE CJ, 1985, SYST ZOOL, V34, P359, DOI 10.2307/2413153
   CRADDOCK C, 1993, TRENDS ECOL EVOL, V8, P458, DOI 10.1016/0169-5347(93)90011-D
   CUELLAR O, 1977, SCIENCE, V197, P837, DOI 10.1126/science.887925
   Darlington C. D., 1939, EVOLUTION GENETIC SY
   Dawley Robert M., 1989, New York State Museum Bulletin, V466, P1
   DENSMORE LD, 1989, EVOLUTION, V43, P969, DOI 10.1111/j.1558-5646.1989.tb02543.x
   DROSOPOULOS S, 1978, EVOLUTION, V32, P916, DOI 10.1111/j.1558-5646.1978.tb04645.x
   ECHELLE AA, 1990, SYST ZOOL, V39, P70, DOI 10.2307/2992209
   ECHELLE AA, 1983, EVOLUTION, V37, P722
   Frankel OH, 1981, CONSERVATION EVOLUTI
   FROST DR, 1988, SYST ZOOL, V37, P200, DOI 10.2307/2992277
   Ghiselin MT, 1974, EC NATURE EVOLUTION
   Graf Jean-Daniel, 1989, New York State Museum Bulletin, V466, P289
   HAIGH J, 1978, THEOR POPUL BIOL, V14, P251, DOI 10.1016/0040-5809(78)90027-8
   Hamilton W. D., 1982, Population biology of infectious diseases. (Report of the Dahlem Workshop on Population Biology of Infectious Disease Agents, Berlin, 1982, March 14-19.) (Life Sciences Research Report, 25), P269
   HEDGES SB, 1992, NATURE, V356, P708, DOI 10.1038/356708a0
   HILLIS DM, 1991, SCIENCE, V251, P308, DOI 10.1126/science.1987647
   HOTZ H, 1985, J EXP ZOOL, V236, P199, DOI 10.1002/jez.1402360210
   Hubbs C., 1964, Bulletin of the Texas Memorial Museum, VNo. 8, P1
   Hubbs CL, 1932, SCIENCE, V76, P628, DOI 10.1126/science.76.1983.628
   KEEGANROGERS V, 1984, ANIM BEHAV, V32, P1040, DOI 10.1016/S0003-3472(84)80219-5
   KEEGANROGERS V, 1988, AM NAT, V132, P846, DOI 10.1086/284893
   KIDWELL MG, 1977, GENETICS, V86, P813
   KIRKENDALL LR, 1990, EVOLUTION, V44, P698, DOI 10.1111/j.1558-5646.1990.tb05949.x
   KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0
   KRAUS F, 1990, P NATL ACAD SCI USA, V87, P2235, DOI 10.1073/pnas.87.6.2235
   LADLE RJ, 1992, TRENDS ECOL EVOL, V7, P405, DOI 10.1016/0169-5347(92)90021-3
   LESLIE JF, 1980, EVOLUTION, V34, P1105, DOI 10.1111/j.1558-5646.1980.tb04051.x
   LESLIE JF, 1978, GENETICS, V90, P801
   LESLIE JF, 1982, J HERED, V73, P19, DOI 10.1093/oxfordjournals.jhered.a109568
   LIMA NRW, 1993, THESIS FEDERAL U SAO
   LIVELY CM, 1990, NATURE, V344, P864, DOI 10.1038/344864a0
   Lokki J., 1987, CYTOLOGY EVOLUTION P
   LYNCH M, 1984, Q REV BIOL, V59, P257, DOI 10.1086/413902
   LYNCH M, 1990, EVOLUTION, V44, P1725, DOI 10.1111/j.1558-5646.1990.tb05244.x
   MASLIN TP, 1968, SYST ZOOL, V17, P219, DOI 10.2307/2412001
   MASLIN TP, 1971, AM ZOOL, V11, P361
   Maynard Smith J., 1978, EVOLUTION SEX
   MCKAY FE, 1971, ECOLOGY, V52, P778, DOI 10.2307/1936025
   MICHOD R. E, 1988, EVOLUTION SEX EXAMIN
   MONTOVANI B, 1992, EVOLUTION, V46, P783
   Moore W.S., 1984, P329
   MOORE WS, 1971, ECOLOGY, V52, P791, DOI 10.2307/1936026
   MOORE WS, 1975, ECOLOGY, V56, P791, DOI 10.2307/1936292
   MORITZ C, 1991, P ROY SOC B-BIOL SCI, V244, P145, DOI 10.1098/rspb.1991.0063
   Moritz C, 1989, B NEW YORK STATE MUS, V466, P87
   MORITZ CC, 1989, EVOLUTION, V43, P958, DOI 10.1111/j.1558-5646.1989.tb02542.x
   MUKAI T, 1972, GENETICS, V72, P335
   MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8
   NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771
   NEI M, 1970, AM NAT, V104, P211
   PARKER ED, 1979, EVOLUTION, V33, P1150, DOI 10.1111/j.1558-5646.1979.tb04769.x
   PARKER ED, 1977, EVOLUTION, V31, P836, DOI 10.1111/j.1558-5646.1977.tb01076.x
   QUATTRO JM, 1992, P NATL ACAD SCI USA, V89, P348, DOI 10.1073/pnas.89.1.348
   QUATTRO JM, 1992, GENETICS, V130, P621
   QUATTRO JM, 1989, SCIENCE, V245, P976, DOI 10.1126/science.2772650
   QUATTRO JM, 1991, GENETICS, V127, P391
   RICE WR, 1994, SCIENCE, V263, P230, DOI 10.1126/science.8284674
   ROSENZWEIG ML, 1978, BIOL J LINN SOC, V10, P275, DOI 10.1111/j.1095-8312.1978.tb00016.x
   ROUGHGARDEN J, 1972, AM NAT, V106, P683, DOI 10.1086/282807
   SCHENCK RA, 1986, EVOLUTION, V40, P1060, DOI 10.1111/j.1558-5646.1986.tb00573.x
   SCHENCK RA, 1989, B NEW YORK STATE MUS, V466, P39
   SCHLUPP I, 1994, SCIENCE, V263, P373, DOI 10.1126/science.8278809
   SCHULTZ ME, 1989, ENVIRON RES, V48, P248, DOI 10.1016/S0013-9351(89)80038-6
   SCHULTZ ME, 1982, ENVIRON RES, V27, P337, DOI 10.1016/0013-9351(82)90089-5
   SCHULTZ ME, 1985, EXP MOL PATHOL, V42, P320, DOI 10.1016/0014-4800(85)90082-6
   SCHULTZ ME, 1982, J HERED, V73, P43, DOI 10.1093/oxfordjournals.jhered.a109573
   Schultz R. J., 1977, Evolutionary Biol, V10, P277
   Schultz R.J., 1982, P103
   Schultz R.J., 1973, P207
   SCHULTZ RJ, 1971, AM ZOOL, V11, P351
   SCHULTZ RJ, 1966, BIOL BULL, V130, P415, DOI 10.2307/1539747
   SCHULTZ RJ, 1973, SCIENCE, V179, P180, DOI 10.1126/science.179.4069.180
   SCHULTZ RJ, 1969, AM NAT, V103, P605, DOI 10.1086/282629
   SCHULTZ RJ, 1993, ENVIRON BIOL FISH, V36, P83, DOI 10.1007/BF00005982
   SCHULTZ RJ, 1989, B NEW YORK STAT MUSE, V466, P32
   SIMMONS MJ, 1977, ANNU REV GENET, V11, P49, DOI 10.1146/annurev.ge.11.120177.000405
   SMITH JM, 1986, NATURE, V324, P300
   SMITH JM, 1966, AM NAT, V100, P637, DOI 10.1086/282457
   SMITH JM, 1992, NATURE, V356, P661, DOI 10.1038/356661a0
   SPIELMAN D, 1992, ZOO BIOL, V11, P343, DOI 10.1002/zoo.1430110506
   SPINELLA DG, 1982, GENETICS, V100, P279
   SPOLSKY CM, 1992, NATURE, V356, P706, DOI 10.1038/356706a0
   STANLEY SM, 1975, SCIENCE, V190, P382, DOI 10.1126/science.1179215
   STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.1111/j.1558-5646.1986.tb00560.x
   STENSETH NC, 1985, EVOLUTION, V39, P294, DOI 10.1111/j.1558-5646.1985.tb05667.x
   Templeton A.R., 1982, P75
   TUNNER HG, 1979, NATURWISSENSCHAFTEN, V66, P268, DOI 10.1007/BF00571614
   Turner B.J., 1982, Progress in Clinical and Biological Research, V96, P265
   TURNER BJ, 1983, EVOLUTION, V37, P798, DOI 10.1111/j.1558-5646.1983.tb05601.x
   TURNER BJ, 1980, EVOLUTION, V34, P917, DOI 10.1111/j.1558-5646.1980.tb04029.x
   UZZELL T, 1975, P ACAD NAT SCI PHILA, V127, P13
   UZZELL T, 1970, AM NAT, V104, P433, DOI 10.1086/282678
   Vrijenhoek R.C., 1984, P399
   Vrijenhoek R.C., 1990, P175
   Vrijenhoek R. C, 1984, POPULATION BIOL EVOL, P217, DOI 10.1007/978-3-642-69646-6_18
   VRIJENHOEK RC, 1978, SCIENCE, V199, P549, DOI 10.1126/science.199.4328.549
   VRIJENHOEK RC, 1978, AM NAT, V112, P41, DOI 10.1086/283251
   VRIJENHOEK RC, 1979, AM NAT, V113, P17, DOI 10.1086/283362
   VRIJENHOEK RC, 1985, SCIENCE, V229, P400, DOI 10.1126/science.229.4711.400
   VRIJENHOEK RC, 1992, EVOLUTION, V46, P1642, DOI 10.1111/j.1558-5646.1992.tb01159.x
   VRIJENHOEK RC, 1979, AM ZOOL, V19, P787
   VRIJENHOEK RC, 1982, EVOLUTION, V36, P768, DOI 10.1111/j.1558-5646.1982.tb05443.x
   VRIJENHOEK RC, 1974, EVOLUTION, V28, P205
   VRIJENHOEK RC, 1989, EVOLUTION, V43, P24
   Vrijenhoek RC., 1994, CONSERVATION GENETIC
   Vrijenhoek Robert C., 1989, New York State Museum Bulletin, V466, P19
   WEEKS SC, 1993, AM NAT, V141, P409, DOI 10.1086/285481
   WEEKS SC, 1992, BEHAV ECOL SOCIOBIOL, V30, P1
   WEEKS SC, 1991, THESIS RUTGERS U NJ
   Wetherington J.D., 1989, P259
   WETHERINGTON JD, 1987, EVOLUTION, V41, P721, DOI 10.1111/j.1558-5646.1987.tb05848.x
   WETHERINGTON JD, 1989, EVOLUTION, V43, P635, DOI 10.1111/j.1558-5646.1989.tb04258.x
   WHITE CN, 1994, MOL BIOL EVOL, V11, P106
   White MJD., 1978, MODES SPECIATION
   WHITE MJD, 1973, ANIMAL CYTOLOGY EVOL
   Williams G.C., 1975, SEX EVOLUTION
   WILSON DS, 1989, SPECIATION ITS CONSE, P366
   WRIGHT JW, 1968, COPEIA, P128
   1983, GILA YAQUI TOPMINNOW
NR 133
TC 146
Z9 150
U1 1
U2 20
PU ANNUAL REVIEWS INC
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139
SN 0066-4162
J9 ANNU REV ECOL SYST
JI Annu. Rev. Ecol. Syst.
PY 1994
VL 25
BP 71
EP 96
DI 10.1146/annurev.es.25.110194.000443
PG 26
WC Ecology; Evolutionary Biology
SC Environmental Sciences & Ecology; Evolutionary Biology
GA PU883
UT WOS:A1994PU88300004
DA 2018-10-19
ER

PT S
AU BELL, CL
   PEPPAS, NA
AF BELL, CL
   PEPPAS, NA
BE Mikos, AG
   Murphy, RM
   Bernstein, H
   Peppas, NA
TI POLY(METHACRYLIC ACID-G-ETHYLENE GLYCOL) HYDROGELS AS PH-RESPONSIVE
   BIOMEDICAL MATERIALS
SO BIOMATERIALS FOR DRUG AND CELL DELIVERY
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Biomaterials for Drug and Cell Delivery
CY NOV 29-DEC 01, 1993
CL BOSTON, MA
SP MAT RES SOC
C1 PURDUE UNIV,SCH CHEM ENGN,W LAFAYETTE,IN 47907.
NR 0
TC 10
Z9 10
U1 0
U2 1
PU MATERIALS RESEARCH SOC
PI PITTSBURGH
PA 9800 MCKNIGHT RD, SUITE 327, PITTSBURGH, PA 15237
SN 0272-9172
BN 1-55899-230-8
J9 MATER RES SOC SYMP P
PY 1994
VL 331
BP 199
EP 204
PG 6
WC Materials Science, Multidisciplinary; Pharmacology & Pharmacy
SC Materials Science; Pharmacology & Pharmacy
GA BA69J
UT WOS:A1994BA69J00030
DA 2018-10-19
ER

PT J
AU BAYNE, SC
   SWIFT, EJ
AF BAYNE, SC
   SWIFT, EJ
TI REVIEW OF THE 1993 DENTAL MATERIALS LITERATURE
SO DENTAL MATERIALS
LA English
DT Review
ID GLASS-IONOMER CEMENTS; COMPOSITE RESIN RESTORATIONS; SHEAR BOND
   STRENGTH; OCCLUSAL TOOTH WEAR; SCANNING ELECTRON-MICROSCOPE; 3-YEAR
   FOLLOW-UP; ND-YAG LASER; IRREVERSIBLE HYDROCOLLOID IMPRESSIONS;
   PERFORMANCE POLYETHYLENE FIBER; ALLERGIC CONTACT-DERMATITIS
AB Objectives. Electronic databases are not sufficiently up to date to provide comprehensive notation of the most recent literature for reference in developing scientific papers. The objective of this summary was to identify and categorize the 1993 dental materials scientific literature that dealt with restorative dentistry.
   Methods. 17 primary journals were manually searched via the tables of contents, and 101 secondary journals were manually or electronically searched. Dental materials citations were categorized into 15 major sections and several subsections, excluding case reports and all the literature primarily related to dental implants or biomedical materials outside of dentistry.
   Results. This study identified 786 citations, the largest number being associated with glass ionomers and composites.
   Significance. This citation list provides a comprehensive source for review by academicians and researchers that bridges the gap between initial publication and electronic citation.
RP BAYNE, SC (reprint author), UNIV N CAROLINA, SCH DENT, DEPT OPERAT DENT, CHAPEL HILL, NC 27599 USA.
CR AASRUM E, 1993, AM J ORTHOD DENTOFAC, V104, P48, DOI 10.1016/0889-5406(93)70026-K
   Abdalla A I, 1993, Am J Dent, V6, P295
   ABDALLA AI, 1993, J DENT, V21, P158, DOI 10.1016/0300-5712(93)90026-M
   ABDALLA AI, 1993, J ORAL REHABIL, V20, P257, DOI 10.1111/j.1365-2842.1993.tb01608.x
   ABERER W, 1993, CONTACT DERMATITIS, V28, P163, DOI 10.1111/j.1600-0536.1993.tb03379.x
   ABUASI HA, 1993, J DENT, V21, P360, DOI 10.1016/0300-5712(93)90013-G
   AKERBOOM HBM, 1993, J PROSTHET DENT, V70, P351, DOI 10.1016/0022-3913(93)90221-9
   AKTENER BO, 1993, INT ENDOD J, V26, P137, DOI 10.1111/j.1365-2591.1993.tb00556.x
   AKTENER BO, 1993, J ENDODONT, V19, P228, DOI 10.1016/S0099-2399(06)81296-3
   ALAJAM ADK, 1993, J ENDODONT, V19, P353, DOI 10.1016/S0099-2399(06)81362-2
   ALDUWAIRI Y, 1993, J PROSTHET DENT, V69, P138, DOI 10.1016/0022-3913(93)90130-G
   Alexander J C, 1993, J Clin Orthod, V27, P207
   ALFAWAZ A, 1993, J ENDODONT, V19, P219, DOI 10.1016/S0099-2399(06)81294-X
   Ali S M, 1993, Dent Mater J, V12, P45
   ALMOAYAD M, 1993, BRIT DENT J, V175, P363
   Ambus C, 1993, Am J Dent, V6, P35
   AMDITIS C, 1993, AUST DENT J, V38, P22, DOI 10.1111/j.1834-7819.1993.tb05447.x
   ANAGNOSTOPOULOS T, 1993, DENT MATER, V9, P182, DOI 10.1016/0109-5641(93)90118-A
   Anderson M H, 1993, Dent Clin North Am, V37, P419
   ANDERSON RJ, 1993, J PROSTHET DENT, V69, P1, DOI 10.1016/0022-3913(93)90230-L
   ANDERSSON M, 1993, ACTA ODONTOL SCAND, V51, P59, DOI 10.3109/00016359309041149
   ANDERSSON OH, 1993, BIOMATERIALS, V14, P317, DOI 10.1016/0142-9612(93)90125-L
   ANDERSSON OH, 1993, J BIOMED MATER RES, V27, P941, DOI 10.1002/jbm.820270713
   ANDERSSON OH, 1992, BIOMATERIALS, V13, P172
   ANIC I, 1993, INT ENDOD J, V26, P284, DOI 10.1111/j.1365-2591.1993.tb00573.x
   APPELDOORN RE, 1993, J PROSTHET DENT, V70, P6, DOI 10.1016/0022-3913(93)90029-N
   ARCORIA CJ, 1993, J ORAL REHABIL, V20, P213, DOI 10.1111/j.1365-2842.1993.tb01603.x
   ARCURI MR, 1993, J PROSTHET DENT, V69, P483, DOI 10.1016/0022-3913(93)90157-J
   ARENA CA, 1993, J PROSTHET DENT, V70, P126, DOI 10.1016/0022-3913(93)90006-A
   ARO T, 1993, CONTACT DERMATITIS, V28, P276, DOI 10.1111/j.1600-0536.1993.tb03431.x
   Asad Tehmina, 1993, International Journal of Prosthodontics, V6, P9
   ASMUSSEN E, 1993, J DENT RES, V72, P558, DOI 10.1177/00220345930720030101
   ASMUSSEN E, 1993, ACTA ODONTOL SCAND, V51, P235, DOI 10.3109/00016359309040572
   AZOUKA A, 1993, J ORAL REHABIL, V20, P393, DOI 10.1111/j.1365-2842.1993.tb01623.x
   BAGAMBISA FB, 1993, J BIOMED MATER RES, V27, P1047, DOI 10.1002/jbm.820270810
   BAGAMBISA FB, 1993, CELL MATER, V3, P93
   Bagheri J, 1993, Iowa Dent J, V79, P13
   Bahannan S, 1993, Int J Prosthodont, V6, P502
   Bahcall James K., 1993, General Dentistry, V41, P45
   Baker P S, 1993, Int J Prosthodont, V6, P291
   BALES DJ, 1991, CURR OPIN DENT, V1, P253
   BALES DJ, 1992, CURR OPIN DENT, V2, P183
   BALES DJ, 1991, CURR OPIN DENT, V1, P245
   Ban S, 1993, Dent Mater J, V12, P106
   BAPNA MS, 1993, DENT MATER, V9, P51, DOI 10.1016/0109-5641(93)90106-Z
   BARNES DM, 1993, OPER DENT, V18, P237
   Barrack G, 1993, Quintessence Int, V24, P701
   Barrack G, 1993, Int J Prosthodont, V6, P428
   BARRETT RD, 1993, AM J ORTHOD DENTOFAC, V103, P8, DOI 10.1016/0889-5406(93)70098-9
   Barron D J, 1993, Int J Prosthodont, V6, P495
   BASS JK, 1993, AM J ORTHOD DENTOFAC, V103, P280, DOI 10.1016/0889-5406(93)70009-D
   BEATTY MW, 1993, BIOMATERIALS, V14, P999, DOI 10.1016/0142-9612(93)90192-5
   BEATTY MW, 1993, J BIOMED MATER RES, V27, P403, DOI 10.1002/jbm.820270314
   BECKHAM BM, 1993, J ENDODONT, V19, P388, DOI 10.1016/S0099-2399(06)81501-3
   Beemer R L, 1993, Pediatr Dent, V15, P408
   Ben-Amar A, 1993, Am J Dent, V6, P65
   BEREKALLY TL, 1993, AUST DENT J, V38, P85, DOI 10.1111/j.1834-7819.1993.tb05468.x
   BEREKALLY TL, 1993, AUST DENT J, V38, P229, DOI 10.1111/j.1834-7819.1993.tb03070.x
   BERGENHOLTZ G, 1993, J DENT, V21, P220, DOI 10.1016/0300-5712(93)90133-B
   BERGLUND A, 1993, J DENT RES, V72, P939, DOI 10.1177/00220345930720051601
   Bernal G, 1993, Int J Prosthodont, V6, P286
   Berrong J M, 1993, J Prosthodont, V2, P24, DOI 10.1111/j.1532-849X.1993.tb00377.x
   BERTE JJ, 1993, J PROSTHET DENT, V69, P347, DOI 10.1016/0022-3913(93)90122-5
   BESIMO C, 1993, J PROSTHET DENT, V69, P144, DOI 10.1016/0022-3913(93)90132-8
   BEVENIUS J, 1993, J ORAL REHABIL, V20, P1, DOI 10.1111/j.1365-2842.1993.tb01509.x
   BEZZON OL, 1993, J PROSTHET DENT, V69, P243, DOI 10.1016/0022-3913(93)90098-9
   BIRCHER AJ, 1993, CONTACT DERMATITIS, V29, P275, DOI 10.1111/j.1600-0536.1993.tb03568.x
   BISHARA SE, 1993, AM J ORTHOD DENTOFAC, V103, P115, DOI 10.1016/S0889-5406(05)81760-3
   BISHARA SE, 1993, AM J ORTHOD DENTOFAC, V104, P444, DOI 10.1016/0889-5406(93)70070-5
   BISHARA SE, 1993, AM J ORTHOD DENTOFAC, V104, P170, DOI 10.1016/S0889-5406(05)81007-8
   Blair K F, 1993, Int J Prosthodont, V6, P579
   Blixt M, 1993, Quintessence Int, V24, P203
   BLUNCK U, 1993, ACTA ODONTOL SCAND, V51, P353, DOI 10.3109/00016359309040586
   BOHNE W, 1993, CELL MATER, V3, P377
   Boksman L, 1993, Quintessence Int, V24, P131
   BOUVIER D, 1993, DENT MATER, V9, P365, DOI 10.1016/0109-5641(93)90058-X
   Bowen R L, 1993, J Calif Dent Assoc, V21, P19
   BOWEN RL, 1993, DENT MATER, V9, P290, DOI 10.1016/0109-5641(93)90045-R
   BOYER DB, 1993, J DENT RES, V72, P1244, DOI 10.1177/00220345930720081401
   BOYLE JJ, 1993, J PROSTHET DENT, V69, P19, DOI 10.1016/0022-3913(93)90234-F
   BRAEM MJA, 1993, DENT MATER, V9, P23, DOI 10.1016/0109-5641(93)90100-5
   Brandt R L, 1993, Gen Dent, V41, P157
   BRANTLEY WA, 1993, CELL MATER, V3, P103
   BRANTLEY WA, 1993, J ORAL REHABIL, V20, P61, DOI 10.1111/j.1365-2842.1993.tb01515.x
   BRES EF, 1993, J MICROSC-OXFORD, V170, P147, DOI 10.1111/j.1365-2818.1993.tb03334.x
   Bridgeport D A, 1993, J Prosthodont, V2, P144, DOI 10.1111/j.1532-849X.1993.tb00398.x
   Brouns E M, 1993, Eur J Orthod, V15, P115
   Brown I H, 1993, Am J Dent, V6, P255
   BROWN KB, 1993, OPER DENT, V18, P17
   BUMGARDNER JD, 1993, DENT MATER, V9, P85, DOI 10.1016/0109-5641(93)90080-A
   BUMGARDNER JD, 1993, DENT MATER, V9, P252, DOI 10.1016/0109-5641(93)90070-7
   Burgess J O, 1993, Am J Dent, V6, P137
   Burgess John O., 1993, General Dentistry, V41, P301
   Burke F J, 1993, Dent Update, V20, P109
   Burke F J, 1993, Quintessence Int, V24, P875
   BURKE FJ, 1993, DENT UPDATE, V20, P112
   BURR DB, 1993, J BIOMECH, V26, P613, DOI 10.1016/0021-9290(93)90023-8
   Burrow M F, 1993, Dent Mater J, V12, P97
   BURTSCHER P, 1993, DENT MATER, V9, P218, DOI 10.1016/0109-5641(93)90064-W
   Butson T J, 1993, Int J Prosthodont, V6, P468
   CARDASH HS, 1993, J PROSTHET DENT, V69, P620, DOI 10.1016/0022-3913(93)90293-W
   Carr A B, 1993, Int J Prosthodont, V6, P233
   CARROTTE PV, 1993, BRIT DENT J, V174, P235, DOI 10.1038/sj.bdj.4808129
   CARSTENSEN W, 1993, ANGLE ORTHOD, V63, P221
   CATHERS SJ, 1993, ORAL SURG ORAL MED O, V76, P343, DOI 10.1016/0030-4220(93)90265-6
   CATTANILORENTE MA, 1993, DENT MATER, V9, P57, DOI 10.1016/0109-5641(93)90107-2
   CATTERLIN RK, 1993, J PROSTHET DENT, V69, P57, DOI 10.1016/0022-3913(93)90241-F
   CAUSTO BE, 1993, DENT MATER, V9, P309
   CHADWICK RG, 1993, J DENT, V21, P111, DOI 10.1016/0300-5712(93)90158-M
   Chai J, 1993, J Prosthodont, V2, P167, DOI 10.1111/j.1532-849X.1993.tb00402.x
   Chalker S A, 1993, Eur J Prosthodont Restor Dent, V1, P151
   CHAN FW, 1993, AUST DENT J, V38, P39, DOI 10.1111/j.1834-7819.1993.tb05449.x
   Chan M F, 1993, Eur J Prosthodont Restor Dent, V2, P23
   Chang J C, 1993, J Prosthodont, V2, P110, DOI 10.1111/j.1532-849X.1993.tb00391.x
   Chang J C, 1993, Am J Dent, V6, P53
   Chen L H, 1993, Int J Prosthodont, V6, P573
   CHEN ZP, 1993, J BIOMECH ENG-T ASME, V115, P119, DOI 10.1115/1.2895458
   Cheng A C, 1993, J Prosthodont, V2, P103, DOI 10.1111/j.1532-849X.1993.tb00390.x
   CHENG YY, 1993, BIOMATERIALS, V14, P775, DOI 10.1016/0142-9612(93)90043-2
   Chew C L, 1993, Int J Prosthodont, V6, P528
   CHONG BS, 1993, INT ENDOD J, V26, P218, DOI 10.1111/j.1365-2591.1993.tb00562.x
   CHONG YH, 1993, J ORAL REHABIL, V20, P631, DOI 10.1111/j.1365-2842.1993.tb01651.x
   CHOW TW, 1993, J DENT, V21, P367, DOI 10.1016/0300-5712(93)90014-H
   CHRISTENSEN GJ, 1993, J AM DENT ASSOC, V124, P248, DOI 10.14219/jada.archive.1993.0270
   CHUNG KH, 1993, J ORAL REHABIL, V20, P79, DOI 10.1111/j.1365-2842.1993.tb01517.x
   COLI P, 1993, OPER DENT, V18, P33
   Coli P, 1993, Quintessence Int, V24, P583
   Collis J, 1993, Int J Prosthodont, V6, P440
   COOGAN MM, 1993, INT ENDOD J, V26, P355, DOI 10.1111/j.1365-2591.1993.tb00769.x
   Cooper R B, 1993, J Clin Orthod, V27, P164
   Cortes O, 1993, Am J Dent, V6, P299
   COWIN SC, 1993, J BIOMECH ENG-T ASME, V115, P528, DOI 10.1115/1.2895535
   Cox C J, 1993, Eur J Prosthodont Restor Dent, V1, P179
   CRAIG RG, 1993, J ORAL REHABIL, V20, P483, DOI 10.1111/j.1365-2842.1993.tb01634.x
   CREUGERS NHJ, 1993, J DENT, V21, P281, DOI 10.1016/0300-5712(93)90108-3
   Crim G A, 1993, Am J Dent, V6, P192
   Crim G A, 1993, Am J Dent, V6, P142
   CRIM GA, 1993, J PROSTHET DENT, V69, P561, DOI 10.1016/0022-3913(93)90281-R
   CROLET JM, 1993, J BIOMECH, V26, P677, DOI 10.1016/0021-9290(93)90031-9
   Cua-Benward Gracia B., 1993, Pediatric Dentistry, V15, P353
   CUNNINGHAM JL, 1993, J DENT, V21, P274, DOI 10.1016/0300-5712(93)90106-Z
   Curtis S R, 1993, Int J Prosthodont, V6, P553
   CUSANO F, 1993, CONTACT DERMATITIS, V28, P127, DOI 10.1111/j.1600-0536.1993.tb03369.x
   DAHL BL, 1993, ACTA ODONTOL SCAND, V51, P299, DOI 10.3109/00016359309040581
   DALLOROLOGIO GD, 1993, AM J DENT, V6, P283
   Darbar U R, 1993, Eur J Prosthodont Restor Dent, V1, P117
   Davenport J C, 1993, Dent Update, V20, P221
   Davidson C L, 1993, Am J Dent, V6, P39
   DAVIDSON CL, 1993, J ORAL REHABIL, V20, P291, DOI 10.1111/j.1365-2842.1993.tb01611.x
   DAVIES EH, 1993, BIOMATERIALS, V14, P636, DOI 10.1016/0142-9612(93)90184-4
   Davies Jeffrey P., 1993, Clinical Materials, V12, P121, DOI 10.1016/0267-6605(93)90061-B
   Davis D R, 1993, Clin Mater, V12, P83, DOI 10.1016/0267-6605(93)90054-B
   Davis E L, 1993, Am J Dent, V6, P127
   DAVIS SJ, 1993, PROTEIN ENG, V6, P229, DOI 10.1093/protein/6.2.229
   DECAMARGO LM, 1993, J PROSTHET DENT, V70, P114, DOI 10.1016/0022-3913(93)90003-7
   DEDERICH DN, 1993, J AM DENT ASSOC, V124, P57, DOI 10.14219/jada.archive.1993.0036
   DEGEE AJ, 1993, DENT MATER, V9, P11, DOI 10.1016/0109-5641(93)90097-A
   DEJOU J, 1993, J BIOMED MATER RES, V27, P877, DOI 10.1002/jbm.820270706
   DENISSEN HW, 1993, J PROSTHET DENT, V69, P464, DOI 10.1016/0022-3913(93)90154-G
   DENRY IL, 1993, J DENT RES, V72, P1429, DOI 10.1177/00220345930720101301
   DENRY IL, 1993, J DENT RES, V72, P572, DOI 10.1177/00220345930720030301
   DeSchepper E J, 1993, Am J Dent, V6, P235
   Devlin H, 1993, Dent Update, V20, P21
   DHARMAR S, 1993, J PROSTHET DENT, V69, P369, DOI 10.1016/0022-3913(93)90182-N
   Diaz-Arnold A M, 1993, Am J Dent, V6, P291
   Diaz-Arnold A M, 1993, J Prosthodont, V2, P215, DOI 10.1111/j.1532-849X.1993.tb00412.x
   Dickinson G L, 1993, Am J Dent, V6, P85
   DICKINSON GL, 1993, J AM DENT ASSOC, V124, P68, DOI 10.14219/jada.archive.1993.0265
   DION I, 1993, BIOMATERIALS, V14, P122, DOI 10.1016/0142-9612(93)90222-N
   DITSCHI D, 1993, QUINTESSENCE INT, V24, P281
   Diwan R, 1993, Clin Mater, V12, P117, DOI 10.1016/0267-6605(93)90060-K
   Dixon D L, 1993, Int J Prosthodont, V6, P303
   Donovan T E, 1993, Dent Clin North Am, V37, P433
   DOOTZ ER, 1993, J PROSTHET DENT, V69, P114, DOI 10.1016/0022-3913(93)90250-R
   DOUGHERTY HL, 1993, AM J ORTHOD DENTOFAC, V104, pA23, DOI 10.1016/S0889-5406(05)80999-0
   Douglas W H, 1993, J Clin Dent, V4, P43
   DRAPAL S, 1993, J DENT RES, V72, P587, DOI 10.1177/00220345930720030601
   Driessen C. H., 1993, International Journal of Prosthodontics, V6, P31
   Drummond B. K., 1993, New Zealand Dental Journal, V89, P92
   DRUMMOND JL, 1993, DENT MATER, V9, P68, DOI 10.1016/0109-5641(93)90109-4
   DRUMMOND JL, 1993, DENT MATER, V9, P214, DOI 10.1016/0109-5641(93)90123-8
   Duke E S, 1993, Dent Clin North Am, V37, P329
   DUNNE SM, 1993, BRIT DENT J, V174, P405, DOI 10.1038/sj.bdj.4808186
   Duret F, 1993, J Can Dent Assoc, V59, P445
   DUTTON FB, 1993, J DENT, V21, P52, DOI 10.1016/0300-5712(93)90052-R
   EDGERTON M, 1993, J PROSTHET DENT, V69, P406, DOI 10.1016/0022-3913(93)90190-Y
   Edmunds D H, 1993, Dent Update, V20, P14
   EDMUNDS DH, 1993, DENT UPDATE, V20, P18
   Eick J D, 1993, Quintessence Int, V24, P571
   Eick J D, 1993, Quintessence Int, V24, P632
   EICK JD, 1993, DENT MATER, V9, P123, DOI 10.1016/0109-5641(93)90088-8
   EIDE R, 1993, SCAND J DENT RES, V101, P1
   EKFELDT A, 1993, ACTA ODONTOL SCAND, V51, P99, DOI 10.3109/00016359309041154
   EKSTRAND K, 1993, J PROSTHET DENT, V69, P314, DOI 10.1016/0022-3913(93)90112-2
   ELBADRAWY WAG, 1993, DENT MATER, V9, P63, DOI 10.1016/0109-5641(93)90108-3
   Eldiwany M, 1993, Am J Dent, V6, P222
   ELEY BM, 1993, BRIT DENT J, V175, P355, DOI 10.1038/sj.bdj.4808325
   ELEY BM, 1993, BRIT DENT J, V175, P161
   Elhabashy A, 1993, Am J Dent, V6, P123
   ELIADES G, 1993, DENT MATER, V9, P198, DOI 10.1016/0109-5641(93)90120-F
   ELIADES T, 1993, AM J ORTHOD DENTOFAC, V104, P21, DOI 10.1016/S0889-5406(08)80120-5
   Elkins C J, 1993, Quintessence Int, V24, P271
   Emilson C G, 1993, Quintessence Int, V24, P511
   ERICSON D, 1993, J PROSTHET DENT, V70, P219, DOI 10.1016/0022-3913(93)90055-S
   FAIRHURST CW, 1993, DENT MATER, V9, P269, DOI 10.1016/0109-5641(93)90073-Y
   FEILZER AJ, 1993, DENT MATER, V9, P2, DOI 10.1016/0109-5641(93)90095-8
   FERNANDES CP, 1993, J PROSTHET DENT, V70, P457, DOI 10.1016/0022-3913(93)90085-3
   FERRACANE JL, 1993, DENT MATER, V9, P300, DOI 10.1016/0109-5641(93)90047-T
   Ferrari M, 1993, Quintessence Int, V24, P861
   Ferrari M, 1993, Quintessence Int, V24, P735
   FERRARI M, 1993, J PROSTHET DENT, V70, P465, DOI 10.1016/0022-3913(93)90086-4
   Fischer G M, 1993, Am J Dent, V6, P173
   Fitchie J G, 1993, Quintessence Int, V24, P65
   FITCHIE JG, 1993, DENT MATER, V9, P28, DOI 10.1016/0109-5641(93)90101-U
   FORSS H, 1993, J DENT RES, V72, P1257, DOI 10.1177/00220345930720081601
   FORSTEN L, 1993, ACTA ODONTOL SCAND, V51, P195, DOI 10.3109/00016359309040567
   FOSTER KH, 1993, J ENDODONT, V19, P136, DOI 10.1016/S0099-2399(06)80508-X
   Frangou M J, 1993, Eur J Prosthodont Restor Dent, V1, P111
   Franklin S, 1993, J Clin Orthod, V27, P83
   FRAYSSINET P, 1993, CELL MATER, V3, P383
   FREEDMAN G, 1993, AM J DENT, V6, P55
   Fujisawa S, 1993, Dent Mater J, V12, P69
   FULL CA, 1993, J DENT CHILD, V60, P52
   FULL CA, 1993, J DENT CHILD, V60, P48
   FULL CA, 1993, J DENT CHILD, V60, P57
   Fusayama T, 1993, Quintessence Int, V24, P225
   FYHRIE DP, 1993, J BIOMECH, V26, P955, DOI 10.1016/0021-9290(93)90057-L
   Galan D, 1993, J Ir Dent Assoc, V39, P104
   GANGLER P, 1993, SCAND J DENT RES, V101, P345
   Garcia-Godoy F, 1993, J Clin Pediatr Dent, V17, P83
   Garcia-Godoy F, 1993, Gen Dent, V41, P557
   Garcia-Godoy Franklin, 1993, Pediatric Dentistry, V15, P272
   GARCIAGODOY F, 1993, OPER DENT, V18, P144
   GATES WD, 1993, J PROSTHET DENT, V69, P12, DOI 10.1016/0022-3913(93)90232-D
   GATTI AM, 1993, CELL MATER, V3, P283
   GEE D, 1993, BRIT DENT J, V174, P65, DOI 10.1038/sj.bdj.4808079
   GEERTS GAVM, 1993, J PROSTHET DENT, V70, P406, DOI 10.1016/0022-3913(93)90075-Y
   GEIGER SB, 1993, DENT MATER, V9, P33, DOI 10.1016/0109-5641(93)90102-V
   GEISGERSTORFER J, 1993, DENT MATER, V9, P177, DOI 10.1016/0109-5641(93)90117-9
   Gerbo L R, 1993, Am J Dent, V6, P96
   GERBO LR, 1993, AM J ORTHOD DENTOFAC, V103, P71, DOI 10.1016/0889-5406(93)70109-2
   GERLACH A, 1993, BIOMATERIALS, V14, P770, DOI 10.1016/0142-9612(93)90042-Z
   GILBERT JL, 1993, J BIOMED MATER RES, V27, P1357, DOI 10.1002/jbm.820271103
   GILBERT LC, 1993, MICROSC RES TECHNIQ, V25, P419, DOI 10.1002/jemt.1070250511
   Gilmour A S, 1993, Dent Update, V20, P167
   Gilmour AS, 1993, DENT UPDATE, V20, P171
   GOLDSTEIN GR, 1993, J PROSTHET DENT, V69, P616, DOI 10.1016/0022-3913(93)90292-V
   GOODIS HE, 1993, DENT MATER, V9, P146, DOI 10.1016/0109-5641(93)90111-3
   GOODIS HE, 1993, DENT MATER, V9, P79, DOI 10.1016/0109-5641(93)90079-6
   GOODIS HE, 1993, SCANNING MICROSCOPY, V7, P979
   GREY NJA, 1993, J DENT, V21, P47, DOI 10.1016/0300-5712(93)90051-Q
   GREY NJA, 1993, J DENT, V21, P185, DOI 10.1016/0300-5712(93)90031-K
   GRIEVE AR, 1993, J ORAL REHABIL, V20, P11, DOI 10.1111/j.1365-2842.1993.tb01510.x
   GRIMSDOTTIR MR, 1993, SCAND J DENT RES, V101, P229
   GROSSMAN ES, 1993, J PROSTHET DENT, V69, P469, DOI 10.1016/0022-3913(93)90155-H
   GUERRA L, 1993, CONTACT DERMATITIS, V28, P101, DOI 10.1111/j.1600-0536.1993.tb03351.x
   GUNDLER A, 1993, SCAND J DENT RES, V101, P252
   Gutmann M S, 1993, Am J Dent, V6, P99
   Gutteridge D L, 1993, Clin Mater, V12, P137, DOI 10.1016/0267-6605(93)90064-E
   Gwinnett A J, 1993, Am J Dent, V6, P7
   GWINNETT AJ, 1993, AM J DENT, V6, P207
   HABERMAN AL, 1993, CONTACT DERMATITIS, V28, P157, DOI 10.1111/j.1600-0536.1993.tb03378.x
   HADAVI F, 1993, OPER DENT, V18, P61
   HADAVI F, 1993, OPER DENT, V18, P2
   Hadavi F, 1993, Gen Dent, V41, P49
   Hager T S, 1993, J Prosthodont, V2, P56, DOI 10.1111/j.1532-849X.1993.tb00382.x
   HAHN R, 1993, DENT MATER, V9, P312, DOI 10.1016/0109-5641(93)90049-V
   HALL LHS, 1993, OPER DENT, V18, P246
   HALLER B, 1993, DENT MATER, V9, P191, DOI 10.1016/0109-5641(93)90119-B
   HALLETT KB, 1993, DENT MATER, V9, P306, DOI 10.1016/0109-5641(93)90048-U
   HALLSTROM U, 1993, J DENT CHILD, V60, P143
   HAM HJ, 1993, DENT MATER J SNU, V3, P83
   HAN S, 1993, ANGLE ORTHOD, V63, P67
   Hanawa T, 1993, Dent Mater J, V12, P118
   HANDLEY J, 1993, CONTACT DERMATITIS, V29, P258
   HANSEN EK, 1993, SCAND J DENT RES, V101, P115
   HANSEN EK, 1993, ACTA ODONTOL SCAND, V51, P73, DOI 10.3109/00016359309041151
   HANSEN EK, 1993, SCAND J DENT RES, V101, P62
   HANSEN EK, 1993, SCAND J DENT RES, V101, P176
   HANSSON O, 1993, SCAND J DENT RES, V101, P243
   HARNIRATTISAI C, 1993, OPER DENT, V18, P138
   Harper C, 1993, Br J Orthod, V20, P155
   HARRINGTON E, 1993, J DENT, V21, P305, DOI 10.1016/0300-5712(93)90114-6
   HASEGAWA T, 1993, DENT MATER, V9, P114, DOI 10.1016/0109-5641(93)90086-6
   HAYASHI Y, 1993, J ELECTRON MICROSC, V42, P141
   HAYASHI Y, 1993, J ELECTRON MICROSC, V42, P415
   HAYASHI Y, 1993, J ELECTRON MICROSC, V42, P342
   HEATH JR, 1993, J ORAL REHABIL, V20, P45, DOI 10.1111/j.1365-2842.1993.tb01513.x
   HEATH JR, 1993, J ORAL REHABIL, V20, P517, DOI 10.1111/j.1365-2842.1993.tb01638.x
   HEATH JR, 1993, J ORAL REHABIL, V20, P627, DOI 10.1111/j.1365-2842.1993.tb01650.x
   HEGARTY AM, 1993, BIOMATERIALS, V14, P349, DOI 10.1016/0142-9612(93)90053-5
   HERO H, 1993, DENT MATER, V9, P15, DOI 10.1016/0109-5641(93)90098-B
   HERRSTROM P, 1993, SCAND J DENT RES, V101, P232
   HEYMANN HO, 1993, J AM DENT ASSOC, V124, P27
   Hickham J H, 1993, J Clin Orthod, V27, P215
   Hicks M J, 1993, Am J Dent, V6, P176
   HICKS MJ, 1993, J DENT CHILD, V60, P201
   Hinoura K, 1993, Am J Dent, V6, P69
   Hinoura K, 1993, Int J Prosthodont, V6, P255
   Hirabayashi S, 1993, Dent Mater J, V12, P159
   Hirota Kazushi, 1993, Bio-Medical Materials and Engineering, V3, P147
   Hisatsune K, 1993, Dent Mater J, V12, P233
   Hoard R J, 1993, Oral Health, V83, P15
   HOARD RJ, 1993, ORAL HLTH, V83, P18
   HOJJATIE B, 1993, J DENT RES, V72, P566, DOI 10.1177/00220345930720030201
   HOLLAND RI, 1993, DENT MATER, V9, P99, DOI 10.1016/0109-5641(93)90083-3
   HOLMES J, 1993, AM J ORTHOD DENTOFAC, V104, P188, DOI 10.1016/S0889-5406(05)81009-1
   HUBSCH PF, 1993, J BIOMED ENG, V15, P401, DOI 10.1016/0141-5425(93)90077-C
   Huget E F, 1993, J Tenn Dent Assoc, V73, P16
   HULTERSTROM AK, 1993, ACTA ODONTOL SCAND, V51, P229, DOI 10.3109/00016359309040571
   Hummert T W, 1993, Am J Dent, V6, P305
   HUNG CM, 1993, J PROSTHET DENT, V69, P573, DOI 10.1016/0022-3913(93)90284-U
   HUNT JA, 1993, J BIOMED ENG, V15, P39, DOI 10.1016/0141-5425(93)90091-C
   HUTTON JE, 1993, J PROSTHET DENT, V70, P121, DOI 10.1016/0022-3913(93)90005-9
   HUYSMANS MCDNJM, 1993, J DENT, V21, P57, DOI 10.1016/0300-5712(93)90054-T
   HUYSMANS MCDNJM, 1993, INT ENDOD J, V26, P294, DOI 10.1111/j.1365-2591.1993.tb00574.x
   HUYSMANS MCDNJM, 1993, J DENT, V21, P190
   Ianzano J A, 1993, Am J Dent, V6, P10
   Ibrahim W M, 1993, J Nihon Univ Sch Dent, V35, P225
   Iimuro F T, 1993, Dent Mater J, V12, P136
   Imai Yohji, 1993, Clinical Materials, V12, P107, DOI 10.1016/0267-6605(93)90058-F
   Imbery T A, 1993, Int J Prosthodont, V6, P55
   INOKOSHI S, 1993, OPER DENT, V18, P8
   Inoue M, 1993, Am J Dent, V6, P243
   Inoue T, 1993, J Nihon Univ Sch Dent, V35, P252
   Ironside J G, 1993, Quintessence Int, V24, P867
   ISAKSSON M, 1993, SCAND J DENT RES, V101, P49
   Ishigami K, 1993, J Nihon Univ Sch Dent, V35, P36
   Ishikawa-Nagai S, 1993, Int J Prosthodont, V6, P522
   JAARDA MJ, 1993, J PROSTHET DENT, V69, P416, DOI 10.1016/0022-3913(93)90191-P
   Jacobi R, 1993, Dent Clin North Am, V37, P367
   JACOBSEN T, 1993, J DENT, V21, P150, DOI 10.1016/0300-5712(93)90025-L
   JAMESON MW, 1993, J BIOMECH, V26, P1055, DOI 10.1016/S0021-9290(05)80005-3
   JEAN AH, 1993, CELL MATER, V3, P193
   Jendresen M D, 1993, Quintessence Int, V24, P659
   JENDRESEN MD, 1993, J PROSTHET DENT, V70, P44, DOI 10.1016/0022-3913(93)90036-N
   JEPSON NJA, 1993, J DENT, V21, P163, DOI 10.1016/0300-5712(93)90027-N
   JEPSON NJA, 1993, J DENT, V21, P171, DOI 10.1016/0300-5712(93)90028-O
   JEPSON NJA, 1993, J DENT, V21, P244, DOI 10.1016/0300-5712(93)90137-F
   JOHANNSEN G, 1993, SWED DENT J, V17, P117
   JOHANSSON A, 1993, SCAND J DENT RES, V101, P407
   JOHANSSON A, 1993, J ORAL REHABIL, V20, P463, DOI 10.1111/j.1365-2842.1993.tb01632.x
   JOHANSSON A, 1993, J ORAL REHABIL, V20, P125, DOI 10.1111/j.1365-2842.1993.tb01596.x
   JOHANSSON A, 1993, SCAND J DENT RES, V101, P398
   JOHANSSON G, 1993, SCAND J DENT RES, V101, P78
   JOHNSON GH, 1993, J AM DENT ASSOC, V124, P39
   JOHNSON WW, 1993, DENT MATER, V9, P95, DOI 10.1016/0109-5641(93)90082-2
   JONAS J, 1993, J BIOMECH, V26, P271, DOI 10.1016/0021-9290(93)90365-L
   Jones D W, 1993, J Can Dent Assoc, V59, P155
   JORDAN RE, 1993, J AM DENT ASSOC, V124, P71, DOI 10.14219/jada.archive.1993.0229
   Kanca J, 1993, Am J Dent, V6, P287
   KANERVA L, 1993, CONTACT DERMATITIS, V28, P26, DOI 10.1111/j.1600-0536.1993.tb03319.x
   KANERVA L, 1993, CONTACT DERMATITIS, V28, P268, DOI 10.1111/j.1600-0536.1993.tb03430.x
   Kaplan I, 1993, J Tenn Dent Assoc, V73, P24
   KARLSSON S, 1993, ACTA ODONTOL SCAND, V51, P129, DOI 10.3109/00016359309041158
   KATZ JL, 1993, J BIOMECH ENG-T ASME, V115, P543, DOI 10.1115/1.2895537
   KAWAHARA D, 1993, CONTACT DERMATITIS, V28, P114, DOI 10.1111/j.1600-0536.1993.tb03357.x
   KAWAI K, 1993, DENT MATER, V9, P108, DOI 10.1016/0109-5641(93)90085-5
   Kawano Fumiaki, 1993, International Journal of Prosthodontics, V6, P43
   KEAVENY TM, 1993, J BIOMECH, V26, P991, DOI 10.1016/0021-9290(93)90059-N
   KEAVENY TM, 1993, J BIOMECH ENG-T ASME, V115, P534, DOI 10.1115/1.2895536
   Keith O, 1993, Br J Orthod, V20, P109
   KENNEDY JP, 1993, J BIOMAT SCI-POLYM E, V4, P445
   Kerber L J, 1993, Am J Dent, V6, P216
   KERN M, 1993, J PROSTHET DENT, V70, P449, DOI 10.1016/0022-3913(93)90084-2
   Kern M, 1993, Int J Prosthodont, V6, P585
   KERN M, 1993, DENT MATER, V9, P155, DOI 10.1016/0109-5641(93)90113-5
   KERN M, 1993, J DENT, V21, P185, DOI 10.1016/0300-5712(93)90030-T
   KERN M, 1993, J DENT, V21, P117, DOI 10.1016/0300-5712(93)90160-R
   KERN M, 1993, J DENT, V21, P47
   KEYAK JH, 1993, J BIOMED ENG, V15, P505, DOI 10.1016/0141-5425(93)90066-8
   KHAN AM, 1993, J ORAL REHABIL, V20, P605, DOI 10.1111/j.1365-2842.1993.tb01647.x
   Kidd E A, 1993, Dent Update, V20, P174
   KILPATRICK NM, 1993, J DENT, V21, P67, DOI 10.1016/0300-5712(93)90148-J
   KIM CW, 1993, DENT MATER J SNU, V3, P143
   KIM CW, 1993, DENT MATER J SNU, V3, P121
   KIM CW, 1993, DENT MATER J SNU, V3, P9
   KIM MW, 1993, DENT MATER J SNU, V3, P1
   KLINGE RF, 1993, ACTA ODONTOL SCAND, V51, P223, DOI 10.3109/00016359309040570
   Knight G T, 1993, Int J Prosthodont, V6, P475
   KNOWLES JC, 1993, J BIOMED MATER RES, V27, P1591, DOI 10.1002/jbm.820271217
   KODAKA T, 1993, SCANNING MICROSCOPY, V7, P247
   KODAKA T, 1993, MICROSC RES TECHNIQ, V24, P429, DOI 10.1002/jemt.1070240508
   KOHRI M, 1993, BIOMATERIALS, V14, P299, DOI 10.1016/0142-9612(93)90122-I
   KOLODNEY H, 1993, J PROSTHET DENT, V70, P474, DOI 10.1016/0022-3913(93)90088-6
   Kon M, 1993, Dent Mater J, V12, P12
   KOVARIK RE, 1993, J PROSTHET DENT, V69, P557, DOI 10.1016/0022-3913(93)90280-2
   KOVARIK RE, 1993, DENT MATER, V9, P222, DOI 10.1016/0109-5641(93)90065-X
   KREJCI I, 1993, J PROSTHET DENT, V69, P425, DOI 10.1016/0022-3913(93)90192-Q
   KREJCI I, 1993, J DENT, V21, P39, DOI 10.1016/0300-5712(93)90048-U
   KREJCI I, 1993, J DENT RES, V72, P490, DOI 10.1177/00220345930720020401
   KREULEN CM, 1993, J DENT CHILD, V60, P310
   KREULEN CM, 1993, J DENT CHILD, V60, P95
   KREULEN CM, 1993, J DENT CHILD, V60, P304
   Krishnan V K, 1993, Clin Mater, V12, P149
   Kurata S, 1993, Dent Mater J, V12, P127
   KUTSCH VKM, 1993, J AM DENT ASSOC, V124, P49, DOI 10.14219/jada.archive.1993.0038
   LADIZESKY NH, 1993, AUST DENT J, V38, P28, DOI 10.1111/j.1834-7819.1993.tb05448.x
   LADIZESKY NH, 1993, DENT MATER, V9, P128, DOI 10.1016/0109-5641(93)90089-9
   LAI JH, 1993, DENT MATER, V9, P139, DOI 10.1016/0109-5641(93)90091-4
   LARMAS MA, 1993, SCAND J DENT RES, V101, P185
   LATTA GH, 1993, J PROSTHET DENT, V70, P109, DOI 10.1016/0022-3913(93)90001-5
   Lautenschlager E P, 1993, Int Dent J, V43, P245
   LEAVOR RO, 1993, BRIT DENT J, V175, P400, DOI 10.1038/sj.bdj.4808338
   LEE SY, 1993, J DENT, V21, P373, DOI 10.1016/0300-5712(93)90015-I
   LEE YK, 1993, DENT MATER J SNU, V3, P49
   LEE YK, 1993, DENT MATER J SNU, V3, P103
   Leinfelder K F, 1993, Dent Clin North Am, V37, P411
   LEINFELDER KF, 1993, J AM DENT ASSOC, V124, P40, DOI 10.14219/jada.archive.1993.0129
   LEINFELDER KF, 1993, J AM DENT ASSOC, V124, P62, DOI 10.14219/jada.archive.1993.0180
   Lew Kenneth K. K., 1993, Clinical Materials, V12, P89, DOI 10.1016/0267-6605(93)90055-C
   LEWINSTEIN I, 1993, J ORAL REHABIL, V20, P107, DOI 10.1111/j.1365-2842.1993.tb01520.x
   Lewis Gladius, 1993, Bio-Medical Materials and Engineering, V3, P167
   LI JG, 1993, BIOMATERIALS, V14, P1186, DOI 10.1016/0142-9612(93)90165-X
   LI JG, 1993, BIOMATERIALS, V14, P229, DOI 10.1016/0142-9612(93)90028-Z
   Lidums A, 1993, Am J Dent, V6, P185
   Liebenberg W H, 1993, Quintessence Int, V24, P881
   LIN FH, 1993, J BIOMED ENG, V15, P481, DOI 10.1016/0141-5425(93)90063-5
   LIN JHC, 1993, DENT MATER, V9, P286
   LINDE F, 1993, J BIOMECH, V26, P1249, DOI 10.1016/0021-9290(93)90072-M
   Liou A D, 1993, Int J Prosthodont, V6, P377
   Liu C C, 1993, Int J Prosthodont, V6, P60
   LIU CC, 1993, DENT MATER, V9, P37, DOI 10.1016/0109-5641(93)90103-W
   LIU PR, 1993, J AM DENT ASSOC, V124, P59, DOI 10.14219/jada.archive.1993.0089
   LOCARDI B, 1993, BIOMATERIALS, V14, P437, DOI 10.1016/0142-9612(93)90146-S
   Loiacono Carla, 1993, General Dentistry, V41, P378
   Loney R W, 1993, Int J Prosthodont, V6, P390
   Lorey R E, 1993, J Prosthodont, V2, P151, DOI 10.1111/j.1532-849X.1993.tb00399.x
   LORSCHEIDER FL, 1993, FASEB J, V7, P1432
   LOVE WC, 1993, OPER DENT, V18, P195
   LU GH, 1993, J DENT, V21, P289, DOI 10.1016/0300-5712(93)90111-3
   LYGRE H, 1993, ACTA ODONTOL SCAND, V51, P45, DOI 10.3109/00016359309041147
   LYTTLE HA, 1993, J DENT RES, V72, P1320, DOI 10.1177/00220345930720091101
   MAHLER DB, 1993, DENT MATER, V9, P162, DOI 10.1016/0109-5641(93)90114-6
   MAMMONE JF, 1993, J BIOMECH, V26, P439, DOI 10.1016/0021-9290(93)90007-2
   MANABE A, 1993, J DENT, V21, P344, DOI 10.1016/0300-5712(93)90009-F
   Mandras R S, 1993, Am J Dent, V6, P119
   Mandras Rozalia S., 1993, General Dentistry, V41, P133
   Mangum Frank I. Jr., 1993, General Dentistry, V41, P139
   MANTE F, 1993, DENT MATER, V9, P325, DOI 10.1016/0109-5641(93)90051-Q
   Mante F K, 1993, Int J Prosthodont, V6, P546
   MARCUSHAMER M, 1993, J DENT CHILD, V60, P300
   MAREK M, 1993, J DENT RES, V72, P1315, DOI 10.1177/00220345930720091001
   MARKS LW, 1993, J BIOMED ENG, V15, P474, DOI 10.1016/0141-5425(93)90061-3
   MARQUEZ F, 1993, BIOMATERIALS, V14, P313, DOI 10.1016/0142-9612(93)90124-K
   Marshall G W Jr, 1993, Quintessence Int, V24, P606
   MARSHALL GW, 1993, DENT MATER, V9, P265, DOI 10.1016/0109-5641(93)90072-X
   MARTIN FE, 1993, AUST DENT J, V38, P102, DOI 10.1111/j.1834-7819.1993.tb05470.x
   MASH LK, 1993, J DENT, V21, P350, DOI 10.1016/0300-5712(93)90010-N
   MASUMI S, 1993, J ORAL REHABIL, V20, P97, DOI 10.1111/j.1365-2842.1993.tb01519.x
   MATSUMURA H, 1993, J PROSTHET DENT, V70, P296, DOI 10.1016/0022-3913(93)90211-6
   MATSUMURA H, 1993, J PROSTHET DENT, V70, P207, DOI 10.1016/0022-3913(93)90053-Q
   Matsumura H, 1993, Am J Dent, V6, P43
   MAY KB, 1993, J PROSTHET DENT, V70, P410, DOI 10.1016/0022-3913(93)90076-Z
   MCALARNEY ME, 1993, AM J ORTHOD DENTOFAC, V104, P575, DOI 10.1016/S0889-5406(05)80441-X
   MCALOON J, 1993, AUST DENT J, V38, P306, DOI 10.1111/j.1834-7819.1993.tb05503.x
   McCaughey A D, 1993, Dent Update, V20, P153
   McConnell R J, 1993, J Calif Dent Assoc, V21, P38
   McCormick J T, 1993, Quintessence Int, V24, P405
   MCINTYRE FM, 1993, J PROSTHET DENT, V69, P564, DOI 10.1016/0022-3913(93)90282-S
   MCKEE MD, 1993, J DENT RES, V72, P1406, DOI 10.1177/00220345930720101001
   MELVIN JW, 1993, J BIOMECH ENG-T ASME, V115, P549, DOI 10.1115/1.2895538
   MENTINK AGB, 1993, J ORAL REHABIL, V20, P455, DOI 10.1111/j.1365-2842.1993.tb01631.x
   MENTINK AGB, 1993, J ORAL REHABIL, V20, P577, DOI 10.1111/j.1365-2842.1993.tb01645.x
   MERMSEN RJ, 1993, DENT MATER, V9, P332
   MEYER RD, 1993, J PROSTHET DENT, V69, P141, DOI 10.1016/0022-3913(93)90131-7
   MICHEL MC, 1993, J BIOMECH, V26, P453, DOI 10.1016/0021-9290(93)90009-4
   MILLER M, 1993, J AM DENT ASSOC, V124, P32, DOI 10.14219/jada.archive.1993.0034
   Miller T E, 1993, Compendium, V14, P802
   MILLER TE, 1993, COMPENDIUM, V14, P806
   MILLER TE, 1993, COMPENDIUM, V14, P802
   Millett D, 1993, Br J Orthod, V20, P117
   MILLS CM, 1993, DRUG SAFETY, V9, P280, DOI 10.2165/00002018-199309040-00006
   MILLS RW, 1993, OPER DENT, V18, P148
   Milosevic A, 1993, Eur J Prosthodont Restor Dent, V1, P173
   MILOSEVIC A, 1993, INT ENDOD J, V26, P106, DOI 10.1111/j.1365-2591.1993.tb00551.x
   MINIOTIS NJ, 1993, J DENT RES, V72, P1045, DOI 10.1177/00220345930720060901
   MISRA DN, 1993, J DENT RES, V72, P1418, DOI 10.1177/00220345930720101101
   Miura H, 1993, Dent Mater J, V12, P209
   Mixson J M, 1993, Am J Dent, V6, P72
   Miyakawa O, 1993, Dent Mater J, V12, P171
   MIYAWAKI H, 1993, J ORAL REHABIL, V20, P653, DOI 10.1111/j.1365-2842.1993.tb01653.x
   Miyawaki H, 1993, Dent Mater J, V12, P62
   MIYAZAKI K, 1993, DENT MATER, V9, P46, DOI 10.1016/0109-5641(93)90105-Y
   MIYAZAKI K, 1993, DENT MATER, V9, P41, DOI 10.1016/0109-5641(93)90104-X
   MJOR IA, 1993, J DENT, V21, P338, DOI 10.1016/0300-5712(93)90006-C
   MJOR IA, 1993, OPER DENT, V18, P82
   MJOR IA, 1993, QUINTESSENCE INT, V242, P343
   MJOR IA, 1993, INT DENT J, V46, P466
   MOLIN M, 1993, ACTA ODONTOL SCAND, V51, P201, DOI 10.3109/00016359309040568
   MOLONEY LG, 1993, J ENDODONT, V19, P59, DOI 10.1016/S0099-2399(06)81195-7
   MOMOI Y, 1993, DENT MATER, V9, P151, DOI 10.1016/0109-5641(93)90112-4
   MONSENEGO G, 1993, J PROSTHET DENT, V69, P106, DOI 10.1016/0022-3913(93)90249-N
   MORGANO SM, 1993, J PROSTHET DENT, V70, P11, DOI 10.1016/0022-3913(93)90030-R
   MORI T, 1993, AUST DENT J, V38, P220, DOI 10.1111/j.1834-7819.1993.tb03068.x
   MORRA M, 1993, DENT MATER, V9, P375, DOI 10.1016/0109-5641(93)90060-4
   Mount G J, 1993, Quintessence Int, V24, P99
   MUELLER HJ, 1993, CELLS MATERIALS, V3, P23
   MURATA H, 1993, J ORAL REHABIL, V20, P177, DOI 10.1111/j.1365-2842.1993.tb01600.x
   1993, AM J DENT, V6, P320
   Murphy D G, 1993, J Mich Dent Assoc, V75, P42
   Myers M L, 1993, Am J Dent, V6, P77
   NAGASE M, 1993, BIOMATERIALS, V14, P1039, DOI 10.1016/0142-9612(93)90199-C
   NAKABAYASHI N, 1993, DENT MATER J SNU, V3, P35
   Neve A D, 1993, Clin Mater, V12, P113, DOI 10.1016/0267-6605(93)90059-G
   NORDBO H, 1993, J PROSTHET DENT, V69, P155, DOI 10.1016/0022-3913(93)90134-A
   O'Kane C, 1993, Br J Orthod, V20, P297
   O'Keefe K L, 1993, Int J Prosthodont, V6, P558
   OBRIEN WJ, 1993, DENT MATER, V9, P242, DOI 10.1016/0109-5641(93)90068-2
   OGUNTEBI B, 1993, J DENT RES, V72, P484, DOI 10.1177/00220345930720020301
   OILO G, 1993, ACTA ODONTOL SCAND, V51, P263, DOI 10.3109/00016359309040576
   Okamoto A, 1993, Dent Mater J, V12, P225
   Okamoto A, 1993, Dent Mater J, V12, P54
   OLSSON S, 1993, SCAND J DENT RES, V101, P180
   ONEAL SJ, 1993, J AM DENT ASSOC, V124, P48, DOI 10.14219/jada.archive.1993.0253
   OOMENS CWJ, 1993, J BIOMECH, V26, P617, DOI 10.1016/0021-9290(93)90024-9
   Osborne J W, 1993, J Ala Dent Assoc, V77, P12
   OSHIDA Y, 1993, DENT MATER, V9, P234, DOI 10.1016/0109-5641(93)90067-Z
   Oshida Yoshiki, 1993, Bio-Medical Materials and Engineering, V3, P117
   Oshida Yoshiki, 1993, Bio-Medical Materials and Engineering, V3, P185
   OSMAN YI, 1993, J PROSTHET DENT, V70, P94, DOI 10.1016/0022-3913(93)90038-P
   OSTMANANDERSSON E, 1993, SWED DENT J, V17, P139
   Owen C P, 1993, Int J Prosthodont, V6, P480
   OWEN DH, 1993, J ANDROL, V14, P210
   Owens B M, 1993, Compendium, V14, P1306
   OWENS BM, 1993, COMPENDIUM, V14, P214
   OWENS BM, 1993, COMPENDIUM, V14, P1304
   OWENS BM, 1993, COMPENDIUM, V14, P212
   OWENS BM, 1993, COMPENDIUM, V14, P1306
   OZATA F, 1993, INT ENDOD J, V26, P241, DOI 10.1111/j.1365-2591.1993.tb00565.x
   PAGE AE, 1993, J BIOMECH, V26, P571, DOI 10.1016/0021-9290(93)90018-A
   PAGHDIWALA AF, 1993, SCANNING MICROSCOPY, V7, P989
   PAGNIANO RP, 1993, J PROSTHET DENT, V70, P214, DOI 10.1016/0022-3913(93)90054-R
   PALLAV P, 1993, J DENT RES, V72, P56, DOI 10.1177/00220345930720010801
   Palmqvist S, 1993, Int J Prosthodont, V6, P279
   PANIGHI M, 1993, J BIOMED MATER RES, V27, P975, DOI 10.1002/jbm.820270802
   Papa J, 1993, Quintessence Int, V24, P93
   Papa J, 1993, Quintessence Int, V24, P715
   PAPADOGIANNIS Y, 1993, DENT MATER, V9, P118, DOI 10.1016/0109-5641(93)90087-7
   PAPAZOGLOU E, 1993, J PROSTHET DENT, V70, P386, DOI 10.1016/0022-3913(93)90072-V
   Park Kitae, 1993, Pediatric Dentistry, V15, P418
   Pashley E L, 1993, Am J Dent, V6, P189
   Pashley E L, 1993, Am J Dent, V6, P116
   PASHLEY EL, 1993, DENT MATER, V9, P19, DOI 10.1016/0109-5641(93)90099-C
   PASHLEY EL, 1993, QUINTESSENCE INT, V24, P618
   Paul S J, 1993, J Esthet Dent, V5, P179, DOI 10.1111/j.1708-8240.1993.tb00775.x
   Paul S J, 1993, J Esthet Dent, V5, P5, DOI 10.1111/j.1708-8240.1993.tb00737.x
   Paul S J, 1993, J Esthet Dent, V5, P51, DOI 10.1111/j.1708-8240.1993.tb00748.x
   Pearson G. J., 1993, Clinical Materials, V12, P77, DOI 10.1016/0267-6605(93)90053-A
   Perdigao J, 1993, Am J Dent, V6, P61
   PETERS MCRB, 1993, J DENT RES, V72, P1537, DOI 10.1177/00220345930720111301
   PEZZOLI M, 1993, J DENT, V21, P312, DOI 10.1016/0300-5712(93)90115-7
   Pick R M, 1993, Dent Clin North Am, V37, P281
   PICK RM, 1993, J AM DENT ASSOC, V124, P37, DOI 10.14219/jada.archive.1993.0027
   Pilcher E S, 1993, J Prosthodont, V2, P174, DOI 10.1111/j.1532-849X.1993.tb00403.x
   PINHEIRO ALB, 1993, BRIT J ORAL MAX SURG, V31, P239, DOI 10.1016/0266-4356(93)90147-O
   Pires J A, 1993, Quintessence Int, V24, P517
   PLASMANS PJJM, 1993, J ORAL REHABIL, V20, P561, DOI 10.1111/j.1365-2842.1993.tb01643.x
   PLASMANS PJJM, 1993, J DENT, V21, P228, DOI 10.1016/0300-5712(93)90134-C
   PLASMANS PJJM, 1993, OPER DENT, V18, P66
   Polyzois G L, 1993, Eur J Prosthodont Restor Dent, V2, P41
   POLYZOIS GL, 1993, J PROSTHET DENT, V70, P26, DOI 10.1016/0022-3913(93)90033-K
   POLYZOIS GL, 1993, J PROSTHET DENT, V69, P374, DOI 10.1016/0022-3913(93)90183-O
   Potoky J R, 1993, Gen Dent, V41, P550
   POUMARAT G, 1993, BIOMATERIALS, V14, P337, DOI 10.1016/0142-9612(93)90051-3
   Powell Tammy L., 1993, Pediatric Dentistry, V15, P104
   Powers J M, 1993, Am J Dent, V6, P232
   PRATI C, 1993, DENT MATER, V9, P338, DOI 10.1016/0109-5641(93)90053-S
   Probster L, 1993, Int J Prosthodont, V6, P259
   PUY MCL, 1993, QUINTESSENCE INT, V24, P429
   QUALTROUGH AJE, 1993, BRIT DENT J, V174, P450, DOI 10.1038/sj.bdj.4808196
   QVIST V, 1993, ACTA ODONTOL SCAND, V51, P253, DOI 10.3109/00016359309040575
   RABBE LM, 1994, CLIN MATER, V15, P221, DOI 10.1016/0267-6605(94)90049-3
   RABCHINSKY J, 1993, DENT MATER, V9, P378
   Rada R E, 1993, Quintessence Int, V24, P793
   RADFORD DR, 1993, INT J PROSTHODONT, V60, P50
   RAFTOPOULOS D, 1993, J BIOMED ENG, V15, P60, DOI 10.1016/0141-5425(93)90095-G
   RAGAIN JC, 1993, OPER DENT, V18, P218
   Ramer M S, 1993, J Prosthodont, V2, P156, DOI 10.1111/j.1532-849X.1993.tb00400.x
   RAMMELSBERG P, 1993, J PROSTHET DENT, V70, P300, DOI 10.1016/0022-3913(93)90212-7
   RANDOW K, 1993, ACTA ODONTOL SCAND, V51, P153, DOI 10.3109/00016359309041161
   RANDOW K, 1993, ACTA ODONTOL SCAND, V51, P333, DOI 10.3109/00016359309040584
   RATHINAM K, 1993, BIOMAT ARTIF CELL IM, V21, P91, DOI 10.3109/10731199309118300
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Ray N J, 1993, J Ir Dent Assoc, V39, P30
   RAY NJ, 1993, J IR DENT ASS, V39, P63
   RAY NJ, 1993, J IR DENT ASS, V38, P89
   Razavi R, 1993, J Prosthodont, V2, P224, DOI 10.1111/j.1532-849X.1993.tb00414.x
   Reagan S E, 1993, Am J Dent, V6, P225
   Rebitski G, 1993, Am J Dent, V6, P204
   Regan D, 1993, Eur J Orthod, V15, P125
   Reid J S, 1993, Am J Dent, V6, P81
   REINHARDT JW, 1993, OPER DENT, V18, P56
   Retief D H, 1993, Am J Dent, V6, P17
   RHO JY, 1993, J BIOMECH, V26, P111, DOI 10.1016/0021-9290(93)90042-D
   RICHARDS JM, 1993, AM J ORTHOD DENTOFAC, V104, P224, DOI 10.1016/S0889-5406(05)81723-8
   RICHARDS ND, 1993, DENT MATER, V9, P91, DOI 10.1016/0109-5641(93)90081-Z
   RIMNAC CM, 1993, J BIOMECH, V26, P219, DOI 10.1016/0021-9290(93)90360-Q
   ROBINSON JG, 1993, DENT MATER, V9, P355, DOI 10.1016/0109-5641(93)90056-V
   RODFORD RA, 1993, BIOMATERIALS, V14, P781, DOI 10.1016/0142-9612(93)90044-3
   ROGGENSACK M, 1993, DENT MATER, V9, P104, DOI 10.1016/0109-5641(93)90084-4
   Rosenstiel S F, 1993, Int J Prosthodont, V6, P298
   ROSENSTIEL SF, 1993, J BIOMED MATER RES, V27, P415, DOI 10.1002/jbm.820270315
   ROSENSTIEL SF, 1993, DENT MATER, V9, P274, DOI 10.1016/0109-5641(93)90074-Z
   RUBBI E, 1993, DENT MATER, V9, P361, DOI 10.1016/0109-5641(93)90057-W
   Rueggeberg F A, 1993, Quintessence Int, V24, P391
   Rueggeberg F A, 1993, Am J Dent, V6, P91
   Rueggeberg F A, 1993, Int J Prosthodont, V6, P364
   RUEGGEBERG FA, 1993, OPER DENT, V18, P48
   SADEGH AM, 1993, J BIOMECH, V26, P167, DOI 10.1016/0021-9290(93)90047-I
   SAIKU JM, 1993, OPER DENT, V18, P172
   Sam W H, 1993, Br J Orthod, V20, P225
   SASAKI N, 1993, J BIOMECH, V26, P77, DOI 10.1016/0021-9290(93)90615-L
   SASAKI N, 1993, J BIOMECH, V26, P1369, DOI 10.1016/0021-9290(93)90088-V
   SASANALUCKIT P, 1993, BIOMATERIALS, V14, P906, DOI 10.1016/0142-9612(93)90132-L
   Satoh Y, 1993, J Nihon Univ Sch Dent, V35, P49
   Satoh Y, 1993, J NIHON U SCH DENT, V35, P192
   Scherrer S S, 1993, Int J Prosthodont, V6, P462
   SEGURA A, 1993, J ORAL REHABIL, V20, P495, DOI 10.1111/j.1365-2842.1993.tb01636.x
   Sekiya K, 1993, Dent Mater J, V12, P145
   SEPPA L, 1993, J DENT RES, V72, P1310, DOI 10.1177/00220345930720090901
   Settembrini Leonard, 1993, Journal of Clinical Dentistry, V4, P55
   SHALABY SW, 1993, CELL MATER, V3, P419
   SHAREEF MY, 1993, BIOMATERIALS, V14, P69, DOI 10.1016/0142-9612(93)90078-G
   SHEARER AC, 1993, J DENT, V21, P302, DOI 10.1016/0300-5712(93)90113-5
   SHEEN DH, 1993, ANGLE ORTHOD, V63, P225
   SHIAU JY, 1993, ANGLE ORTHOD, V63, P213
   SHIAU JY, 1993, J DENT RES, V72, P1291, DOI 10.1177/00220345930720090601
   SHIMIZU K, 1993, J BIOMED MATER RES, V27, P729, DOI 10.1002/jbm.820270605
   SHIN WS, 1993, DENT MATER, V9, P317, DOI 10.1016/0109-5641(93)90050-Z
   Shortall A C, 1993, Eur J Prosthodont Restor Dent, V1, P185
   Sidhu S K, 1993, Quintessence Int, V24, P553
   Sidhu S K, 1993, Clin Mater, V12, P11, DOI 10.1016/0267-6605(93)90022-Y
   Sikri V K, 1993, Indian J Dent Res, V4, P13
   Sim C, 1993, Int J Prosthodont, V6, P36
   SMALES RJ, 1993, J DENT, V21, P147, DOI 10.1016/0300-5712(93)90024-K
   SMALES RJ, 1993, OPER DENT, V18, P130
   Smith R M, 1993, Am J Dent, V6, P111
   SMITH RT, 1993, AM J ORTHOD DENTOFAC, V103, P448, DOI 10.1016/S0889-5406(05)81795-0
   SODERHOLM KJM, 1993, J DENT RES, V72, P1050, DOI 10.1177/00220345930720061001
   SOH G, 1993, CLIN MATER, V12, P73
   Sohmura T, 1993, Dent Mater J, V12, P190
   SOUZA MHS, 1983, AM J DENT, V6, P148
   SPEARS IR, 1993, J DENT RES, V72, P1526, DOI 10.1177/00220345930720111101
   STACEY GD, 1993, J PROSTHET DENT, V70, P395, DOI 10.1016/0022-3913(93)90073-W
   STAGGERS JA, 1993, ANGLE ORTHOD, V63, P141
   STANINEC M, 1993, DENT MATER, V9, P204, DOI 10.1016/0109-5641(93)90121-6
   Stanley H R, 1993, J Esthet Dent, V5, P208, DOI 10.1111/j.1708-8240.1993.tb00782.x
   STANLEY HR, 1993, J AM DENT ASSOC, V124, P76, DOI 10.14219/jada.archive.1993.0199
   STANLEY HR, 1993, J DENT RES, V72, P1362, DOI 10.1177/00220345930720100101
   STASTNY K, 1993, BIOMATERIALS, V14, P1105, DOI 10.1016/0142-9612(93)90212-K
   STENBERG R, 1993, ACTA ODONTOL SCAND, V51, P91, DOI 10.3109/00016359309041153
   STOKES AN, 1993, DENT MATER, V9, P370, DOI 10.1016/0109-5641(93)90059-Y
   STOKES AN, 1993, J ORAL REHABIL, V20, P89, DOI 10.1111/j.1365-2842.1993.tb01518.x
   Stol M, 1993, J Biomater Appl, V7, P224, DOI 10.1177/088532829300700302
   STUPP SI, 1993, J BIOMED MATER RES, V27, P289, DOI 10.1002/jbm.820270303
   STUPP SI, 1993, J BIOMED MATER RES, V27, P301, DOI 10.1002/jbm.820270304
   SULIMAN AA, 1993, DENT MATER, V9, P6, DOI 10.1016/0109-5641(93)90096-9
   SULIMAN AA, 1993, J DENT RES, V72, P1532, DOI 10.1177/00220345930720111201
   SULIMAN AHA, 1993, J PROSTHET DENT, V70, P118, DOI 10.1016/0022-3913(93)90004-8
   SUMMITT JB, 1993, OPER DENT, V18, P88
   SUMMITT JB, 1993, OPER DENT, V18, P209
   SUMMITT JB, 1993, OPER DENT, V18, P42
   SUMMITT JB, 1993, OPER DENT, V18, P37
   Sutherland J K, 1993, J Can Dent Assoc, V59, P430
   SUTHERLAND JK, 1993, J CAN DENT ASSOC, V59, P163
   SUTHERLAND JK, 1993, J CAN DENT ASSOC, V59, P155
   Suzuki S, 1993, Quintessence Int, V24, P885
   Suzuki S, 1993, Am J Dent, V6, P199
   Swift E J Jr, 1993, Am J Dent, V6, P88
   Swift E J Jr, 1993, Am J Dent, V6, P162
   SYDISKIS RJ, 1993, J PROSTHET DENT, V69, P431, DOI 10.1016/0022-3913(93)90193-R
   Syu J Z, 1993, Int J Prosthodont, V6, P25
   Tagami J, 1993, Am J Dent, V6, P145
   TAIRA M, 1993, DENT MATER, V9, P167, DOI 10.1016/0109-5641(93)90115-7
   TAKAHASHI H, 1993, J PROSTHET DENT, V70, P261, DOI 10.1016/0022-3913(93)90062-S
   Takahashi J, 1993, Dent Mater J, V12, P245
   Takahashi J, 1993, Dent Mater J, V12, P238
   TAKAHASHI K, 1993, DENT MATER, V9, P350, DOI 10.1016/0109-5641(93)90055-U
   TAKEMORI T, 1993, DENT MATER, V9, P136, DOI 10.1016/0109-5641(93)90090-D
   TAM LE, 1993, J DENT RES, V72, P953, DOI 10.1177/00220345930720051801
   TAMBURIC SD, 1993, INT ENDOD J, V26, P125, DOI 10.1111/j.1365-2591.1993.tb00554.x
   TAN HK, 1993, J PROSTHET DENT, V69, P250, DOI 10.1016/0022-3913(93)90101-S
   TAN HK, 1993, J PROSTHET DENT, V70, P532, DOI 10.1016/0022-3913(93)90267-R
   Tanaka J, 1993, Dent Mater J, V12, P1
   Tanaka J, 1993, Dent Mater J, V12, P196
   Tani C, 1993, Dent Mater J, V12, P219
   Tani Y, 1993, Dent Mater J, V12, P182
   Tate W H, 1993, Am J Dent, V6, P195
   TAYLOR MJ, 1993, J DENT, V21, P265, DOI 10.1016/0300-5712(93)90104-X
   Terata R, 1993, Dent Mater J, V12, P18
   TEWFIK HM, 1993, J ENDODONT, V19, P492, DOI 10.1016/S0099-2399(06)81489-5
   Thayer K E, 1993, Int J Prosthodont, V6, P264
   TISELIUS HG, 1993, SCANNING MICROSCOPY, V7, P381
   Tjan A H, 1993, Quintessence Int, V24, P211
   TOCCHIO RM, 1993, AM J ORTHOD DENTOFAC, V103, P155, DOI 10.1016/S0889-5406(05)81765-2
   TORRES V, 1993, CONTACT DERMATITIS, V29, P102, DOI 10.1111/j.1600-0536.1993.tb03499.x
   TOUATI B, 1993, J ESTHET DENT, V5, P10
   TOYOOKA H, 1993, J ORAL REHABIL, V20, P615, DOI 10.1111/j.1365-2842.1993.tb01648.x
   Triolo P T Jr, 1993, Am J Dent, V6, P302
   Tsuchiya H, 1993, Dent Mater J, V12, P253
   TSUCHIYA H, 1993, J DENT, V21, P240, DOI 10.1016/0300-5712(93)90136-E
   TUNCER N, 1993, J PROSTHET DENT, V69, P333, DOI 10.1016/0022-3913(93)90116-6
   TUNG MS, 1993, J ENDODONT, V19, P383, DOI 10.1016/S0099-2399(06)81500-1
   TURCK MD, 1993, J PROSTHET DENT, V69, P340, DOI 10.1016/0022-3913(93)90117-7
   TURNER CW, 1993, OPER DENT, V18, P187
   Turner P J, 1993, Br J Orthod, V20, P307
   TYAS MJ, 1993, AUST DENT J, V38, P46, DOI 10.1111/j.1834-7819.1993.tb05450.x
   TYAS MJ, 1993, AUST DENT J, V38, P294, DOI 10.1111/j.1834-7819.1993.tb05501.x
   TYAS MJ, 1993, AUST DENT J, V38, P225, DOI 10.1111/j.1834-7819.1993.tb03069.x
   UCTASLI S, 1993, J ORAL REHABIL, V20, P423, DOI 10.1111/j.1365-2842.1993.tb01626.x
   UMENMOTO K, 1993, DENT MATER J, V12, P29
   USAMI Y, 1993, DENT MATER, V9, P344, DOI 10.1016/0109-5641(93)90054-T
   VALLITTU PK, 1993, J ORAL REHABIL, V20, P533, DOI 10.1111/j.1365-2842.1993.tb01640.x
   VALLITTU PK, 1993, ACTA ODONTOL SCAND, V51, P363, DOI 10.3109/00016359309040587
   VALLITTU PK, 1993, J ORAL REHABIL, V20, P241, DOI 10.1111/j.1365-2842.1993.tb01606.x
   van der Zel J M, 1993, Quintessence Int, V24, P769
   VANDERVARST PGT, 1993, J DENT RES, V72, P1249, DOI 10.1177/00220345930720081501
   VANHOLDER R, 1993, BIOMATERIALS, V14, P737, DOI 10.1016/0142-9612(93)90037-3
   VANMEERBEEK B, 1993, J DENT RES, V72, P1423, DOI 10.1177/00220345930720101201
   VANMEERBEEK B, 1993, J DENT, V21, P195, DOI 10.1016/0300-5712(93)90126-B
   VANMEERBEEK B, 1993, J DENT RES, V72, P1434, DOI 10.1177/00220345930720101401
   VANMEERBEEK B, 1993, J DENT RES, V72, P495, DOI 10.1177/00220345930720020501
   VANMEERBEEK B, 1993, J PROSTHET DENT, V70, P308, DOI 10.1016/0022-3913(93)90213-8
   VANNOORT R, 1993, J DENT, V21, P5, DOI 10.1016/0300-5712(93)90046-S
   VANNOORT R, 1993, J DENT, V21, P209, DOI 10.1016/0300-5712(93)90128-D
   Vassilakos N, 1993, Eur J Prosthodont Restor Dent, V2, P29
   VASSILAKOS N, 1993, J DENT, V21, P297, DOI 10.1016/0300-5712(93)90112-4
   VENHOVEN BAM, 1993, BIOMATERIALS, V14, P871, DOI 10.1016/0142-9612(93)90010-Y
   VENZ S, 1993, J DENT RES, V72, P582, DOI 10.1177/00220345930720030501
   VERBEECK RMH, 1993, J DENT RES, V72, P577, DOI 10.1177/00220345930720030401
   VIAZIS AD, 1993, AM J ORTHOD DENTOFAC, V103, P537, DOI 10.1016/0889-5406(93)70094-5
   Vieira A C, 1993, J Clin Pediatr Dent, V18, P7
   VONBEETZEN M, 1993, OPER DENT, V18, P103
   VONFRAUNHOFER JA, 1993, ANGLE ORTHOD, V63, P73
   VONGSAVAN N, 1993, INT ENDOD J, V26, P10, DOI 10.1111/j.1365-2591.1993.tb00532.x
   VOSS A, 1993, ANGLE ORTHOD, V63, P149
   WAGNER WC, 1993, J BIOMED MATER RES, V27, P531, DOI 10.1002/jbm.820270414
   WAHLE JJ, 1993, J PROSTHET DENT, V69, P160, DOI 10.1016/0022-3913(93)90135-B
   WAKABAYASHI H, 1993, INT ENDOD J, V26, P153
   WALKER EB, 1993, J PROSTHET DENT, V70, P553, DOI 10.1016/0022-3913(93)90275-S
   Walsh W. R., 1993, Bio-Medical Materials and Engineering, V3, P75
   WANG BC, 1993, J BIOMED MATER RES, V27, P1315, DOI 10.1002/jbm.820271012
   WANG WN, 1993, AM J ORTHOD DENTOFAC, V104, P251, DOI 10.1016/S0889-5406(05)81726-3
   WANIS TM, 1993, J ORAL REHABIL, V20, P379, DOI 10.1111/j.1365-2842.1993.tb01621.x
   Wasson E A, 1993, Clin Mater, V12, P181, DOI 10.1016/0267-6605(93)90070-N
   WASSON EA, 1993, J DENT RES, V72, P481, DOI 10.1177/00220345930720020201
   WASSON EA, 1993, J DENT, V21, P122, DOI 10.1016/0300-5712(93)90161-I
   WATAHA JC, 1993, DENT MATER, V9, P172, DOI 10.1016/0109-5641(93)90116-8
   Watanabe I, 1993, Quintessence Int, V24, P335
   WATSON TF, 1993, INT ENDOD J, V26, P11, DOI 10.1111/j.1365-2591.1993.tb00533.x
   WATTS DC, 1993, DENT MATER, V9, P74, DOI 10.1016/0109-5641(93)90078-5
   WEBER H, 1993, J PROSTHET DENT, V69, P222, DOI 10.1016/0022-3913(93)90144-D
   Weinstein A R, 1993, Dent Clin North Am, V37, P391
   WENDT SL, 1993, ORAL SURG ORAL MED O, V75, P353, DOI 10.1016/0030-4220(93)90150-3
   WESTERGAARD J, 1993, SCAND J DENT RES, V101, P265
   WHITE JM, 1993, J AM DENT ASSOC, V124, P45, DOI 10.14219/jada.archive.1993.0273
   WHITE JM, 1993, SCANNING MICROSCOPY, V7, P239
   White S N, 1993, J Calif Dent Assoc, V21, P30
   White S N, 1993, Int J Prosthodont, V6, P384
   White S N, 1993, Int J Prosthodont, V6, P248
   WHITE SN, 1993, J PROSTHET DENT, V69, P568, DOI 10.1016/0022-3913(93)90283-T
   WHITE SN, 1993, DENT MATER, V9, P260, DOI 10.1016/0109-5641(93)90071-W
   WHITE SN, 1993, J PROSTHET DENT, V69, P28, DOI 10.1016/0022-3913(93)90235-G
   WIDSTROM E, 1993, SCAND J DENT RES, V101, P238
   WIESMANN HP, 1993, SCANNING MICROSCOPY, V7, P711
   WIGDOR H, 1993, J AM DENT ASSOC, V124, P65, DOI 10.14219/jada.archive.1993.0041
   Wilkie R, 1993, Am J Dent, V6, P181
   WILLEMS G, 1993, J DENT, V21, P74, DOI 10.1016/0300-5712(93)90149-K
   WILLEMS G, 1993, J BIOMED MATER RES, V27, P747, DOI 10.1002/jbm.820270607
   Willems G, 1993, Quintessence Int, V24, P641
   WILLEMS G, 1993, J DENT, V21, P79, DOI 10.1016/0300-5712(93)90150-O
   WILLIAMS JA, 1993, BIOMATERIALS, V14, P551, DOI 10.1016/0142-9612(93)90245-W
   Williams P T, 1993, J Can Dent Assoc, V59, P538
   Williamson R T, 1993, J Prosthodont, V2, P115, DOI 10.1111/j.1532-849X.1993.tb00392.x
   Wilson A D, 1993, Am J Dent, V6, P280
   WILSON J, 1993, OPER DENT, V18, P155
   WILSON J, 1993, INT DENT J, V43, P25
   Wilson P R, 1993, Int J Prosthodont, V6, P397
   WILSON PR, 1993, AUST DENT J, V38, P97, DOI 10.1111/j.1834-7819.1993.tb05469.x
   Wolf D M, 1993, Am J Dent, V6, P155
   WOLINSKY LE, 1993, J DENT RES, V72, P72, DOI 10.1177/00220345930720011101
   Wood M, 1993, Dent Clin North Am, V37, P445
   WOOD RE, 1993, OPER DENT, V18, P94
   Wood W E, 1993, J Prosthodont, V2, P13, DOI 10.1111/j.1532-849X.1993.tb00375.x
   WOODS PW, 1993, J AM DENT ASSOC, V124, P60, DOI 10.14219/jada.archive.1993.0108
   WOOLFORD M, 1993, J DENT, V21, P379, DOI 10.1016/0300-5712(93)90017-K
   WOOLFORD MJ, 1993, J ORAL REHABIL, V20, P249, DOI 10.1111/j.1365-2842.1993.tb01607.x
   WOZNIAK WT, 1993, DENT MATER, V9, P229, DOI 10.1016/0109-5641(93)90066-Y
   Wright G. Z., 1993, Pediatric Dentistry, V15, P425
   XIE J, 1993, DENT MATER, V9, P295, DOI 10.1016/0109-5641(93)90046-S
   Yamada K, 1993, Int J Prosthodont, V6, P242
   Yamaga M, 1993, Dent Mater J, V12, P36
   YAMAGISHI T, 1993, J PROSTHET DENT, V70, P264, DOI 10.1016/0022-3913(93)90063-T
   YEN TW, 1993, J PROSTHET DENT, V70, P224, DOI 10.1016/0022-3913(93)90056-T
   YONEYAMA T, 1993, J BIOMED MATER RES, V27, P399, DOI 10.1002/jbm.820270313
   YORK AK, 1993, OPER DENT, V18, P203
   Yoshida K, 1993, Am J Dent, V6, P13
   YOSHIDA K, 1993, J PROSTHET DENT, V69, P357, DOI 10.1016/0022-3913(93)90180-V
   Yu X Y, 1993, J Calif Dent Assoc, V21, P23
   Yubao L, 1993, Biomaterials, V14, P969
   ZAKARIASEN KL, 1993, J AM DENT ASSOC, V124, P30, DOI 10.14219/jada.archive.1993.0046
   ZENAROLA P, 1993, CONTACT DERMATITIS, V29, P157, DOI 10.1111/j.1600-0536.1993.tb03518.x
   Zenkner J E, 1993, Quintessence Int, V24, P783
NR 805
TC 6
Z9 6
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
EI 1879-0097
J9 DENT MATER
JI Dent. Mater.
PD JAN
PY 1994
VL 10
IS 1
BP 59
EP 76
DI 10.1016/0109-5641(94)90023-X
PG 18
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA PG946
UT WOS:A1994PG94600010
PM 7995478
DA 2018-10-19
ER

PT S
AU ALLCOCK, HR
AF ALLCOCK, HR
BE WisianNeilson, P
   Allcock, HR
   Wynne, KJ
TI MACROMOLECULAR AND MATERIALS DESIGN USING POLYPHOSPHAZENES
SO INORGANIC AND ORGANOMETALLIC POLYMERS II: ADVANCED MATERIALS AND
   INTERMEDIATES
SE ACS SYMPOSIUM SERIES
LA English
DT Article; Proceedings Paper
CT Symposium on Inorganic and Organometallic Polymers II - Advanced
   Materials and Intermediates, at the 205th National Meeting of the
   American-Chemical-Society
CY MAR 28-APR 02, 1993
CL DENVER, CO
SP AMER CHEM SOC, DIV POLYM CHEM INC
ID LIQUID-CRYSTALLINE POLY(ORGANOPHOSPHAZENE); CROSS-LINKABLE
   POLYPHOSPHAZENE; THERMAL TRANSITION BEHAVIOR; SIDE GROUPS;
   SMALL-MOLECULE; PHOSPHAZENES; POLYMERS; LINKING;
   POLY<BIS(TRIFLUOROETHOXY)PHOSPHAZENE>; HYDROGELS
AB Polyphosphazenes are among the most versatile of all polymers. This is a consequence of the unique properties of the phosphorus-nitrogen backbone and the ease with which a wide range of different side groups can be introduced mainly by macromolecular substitution, but also by the polymerization of different ''monomers''. This field has reached a stage where the fundamental chemistry now allows the design and synthesis of a broad range of new materials that are valuable for properties such as elasticity, high refractive index, liquid crystallinity, ferroelectric-, NLO-, and photochromic attributes, and for uses as solid ionic conductors, biomedical microencapsulation polymers, and materials with controlled surface properties.
RP ALLCOCK, HR (reprint author), PENN STATE UNIV,DEPT CHEM,152 DAVEY LAB,UNIVERSITY PK,PA 16802, USA.
CR ALLCOCK HR, 1993, MACROMOLECULES, V26, P11, DOI 10.1021/ma00053a002
   ALLCOCK HR, 1989, MACROMOLECULES, V22, P4179, DOI 10.1021/ma00201a008
   ALLCOCK HR, 1992, MACROMOLECULES, V25, P5573, DOI 10.1021/ma00047a002
   ALLCOCK HR, 1988, BIOMATERIALS, V9, P509, DOI 10.1016/0142-9612(88)90046-4
   ALLCOCK HR, 1986, MACROMOLECULES, V19, P1508, DOI 10.1021/ma00160a003
   ALLCOCK HR, 1989, MACROMOLECULES, V22, P75, DOI 10.1021/ma00191a015
   ALLCOCK HR, 1992, CHEM MATER, V4, P296, DOI 10.1021/cm00020a015
   ALLCOCK HR, 1991, MACROMOLECULES, V24, P2841, DOI 10.1021/ma00010a031
   ALLCOCK HR, 1991, MACROMOLECULES, V24, P2846, DOI 10.1021/ma00010a032
   ALLCOCK HR, 1966, INORG CHEM, V5, P1716, DOI 10.1021/ic50044a017
   ALLCOCK HR, 1966, INORG CHEM, V5, P1709, DOI 10.1021/ic50044a016
   ALLCOCK HR, 1990, CHEM MATER, V2, P425, DOI 10.1021/cm00010a021
   ALLCOCK HR, 1977, INORG CHEM, V16, P3362, DOI 10.1021/ic50178a081
   ALLCOCK HR, 1972, MACROMOLECULES, V5, P231, DOI 10.1021/ma60026a026
   ALLCOCK HR, 1965, J AM CHEM SOC, V87, P4216, DOI 10.1021/ja01096a056
   ALLCOCK HR, 1991, CHEM MATER, V3, P442, DOI 10.1021/cm00015a017
   ALLCOCK HR, 1991, CHEM MATER, V3, P450, DOI 10.1021/cm00015a018
   ALLCOCK HR, 1992, CHEM MATER, V4, P769, DOI 10.1021/cm00022a006
   ALLCOCK HR, 1991, CHEM MATER, V3, P1120, DOI 10.1021/cm00018a032
   ALLCOCK HR, 1988, BIOMATERIALS, V9, P500, DOI 10.1016/0142-9612(88)90045-2
   ALLCOCK HR, 1991, MACROMOLECULES, V24, P2024, DOI 10.1021/ma00008a048
   ALLCOCK HR, 1990, MACROMOLECULES, V23, P3881, DOI 10.1021/ma00219a003
   ALLCOCK HR, 1989, MACROMOLECULES, V22, P2596, DOI 10.1021/ma00196a009
   ALLCOCK HR, 1992, CHEM PROCESSING ADV, P704
   ALLCOCK HR, 1993, UNPUB
   ALLCOCK HR, 1994, UNPUB
   ALLCOCK HR, 1992, INORGANIC POLYM, P61
   ALLCOCK HR, 1992, CHEMMATER, V4, P75
   ALLCOCK HR, 1987, POLYM PREPR, V28, P321
   ANDRIANOV AK, 1993, POLYM PREPR AM CHEM, V34, P233
   BANO MC, 1991, BIO-TECHNOL, V9, P468, DOI 10.1038/nbt0591-468
   BENNETT JL, 1989, CHEM MATER, V1, P14
   BENNETT JL, 1989, POLYM PREPR AM CHEM, V30, P437
   BLONSKY PM, 1984, J AM CHEM SOC, V106, P6854, DOI 10.1021/ja00334a071
   BLONSKY PM, 1985, POLYM MATER SCI ENG, V53, P118
   BLONSKY PM, 1986, SOLID STATE IONICS, V19, P258
   COHEN S, 1990, J AM CHEM SOC, V112, P7832, DOI 10.1021/ja00177a074
   COHEN S, 1993, CLIN MATER, V13, P3, DOI 10.1016/0267-6605(93)90082-I
   DEMBEK AA, 1990, CHEM MATER, V2, P97, DOI 10.1021/cm00008a005
   DEMBEK AA, 1991, ACS SYM SER, V455, P258
   FLINDT EP, 1977, Z ANORG ALLG CHEM, V428, P204, DOI 10.1002/zaac.19774280125
   KIM C, 1987, MACROMOLECULES, V20, P1726, DOI 10.1021/ma00173a050
   LERNER MM, 1991, CHEM MATER, V3, P1117, DOI 10.1021/cm00018a031
   LIANG M, 1991, J AM CHEM SOC, V113, P4044, DOI 10.1021/ja00010a085
   MONTAGUE RA, 1990, J AM CHEM SOC, V112, P6721, DOI 10.1021/ja00174a047
   NEILSON RH, 1988, CHEM REV, V88, P541, DOI 10.1021/cr00085a005
   NELSON CJ, 1991, CHEM MATER, V3, P786, DOI 10.1021/cm00017a010
   SENNETT MS, 1983, POLYM MAT SCI ENG, V49, P297
   SHRIVER DF, 1987, POLYM PREPR, V28, P438
   SINGLER RE, 1990, ACS SYM SER, V435, P185
   SINGLER RE, 1991, MACROMOLECULES, V24, P510, DOI 10.1021/ma00002a026
   SINGLER RE, 1987, MACROMOLECULES, V20, P1727, DOI 10.1021/ma00173a051
   SINGLER RE, 1975, POLYM ENG SCI, V15, P321, DOI 10.1002/pen.760150502
   SINGLER RE, 1987, POLYM PREPR, V28, P448
   Tate D.P., 1974, J POLYM SCI POLYM S, V48, P33
   WELKER MF, 1994, ACS SYM SER, V537, P293
   WISIANNEILSON P, 1980, J AM CHEM SOC, V102, P2848, DOI 10.1021/ja00528a060
NR 57
TC 24
Z9 24
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036
SN 0097-6156
BN 0-8412-3036-6
J9 ACS SYM SER
PY 1994
VL 572
BP 208
EP 231
PG 24
WC Chemistry, Multidisciplinary; Chemistry, Inorganic & Nuclear; Polymer
   Science
SC Chemistry; Polymer Science
GA BC69C
UT WOS:A1994BC69C00017
DA 2018-10-19
ER

PT J
AU KHODZHAEVA, ID
   KISLINOVSKAJA, NV
   SMUROVA, EV
AF KHODZHAEVA, ID
   KISLINOVSKAJA, NV
   SMUROVA, EV
TI STABILITY OF CIS-1,4-POLYISOPRENE AND ITS VULCANIZATES IN AQUEOUS AND
   BIOLOGICALLY-ACTIVE MEDIA
SO INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS
LA English
DT Article; Proceedings Paper
CT International Conference on Regulation of Polymeric Materials Stability
CY OCT 12-15, 1992
CL INST CHEM PHYS, MOSCOW, RUSSIA
SP WESTERN CO NETHERLANDS, CIBA GEIGY SWITZERLAND, UNIROYAL CHEM & KISER RES USA, AMC SPREA & MONTEDISON ITALY
HO INST CHEM PHYS
DE BIOLOGICAL STABILITY; ELASTOMERS; CIS-1,4-POLYISOPRENE; VULCANIZED
   ELASTOMERS
AB The biological stability of natural and synthetic cis-1,4-polyisoprene is investigated with the objective to develop new highly elastic materials for biomedical applications.
C1 MV LOMONOSOV FINE CHEM TECHNOL INST,MOSCOW 117571,RUSSIA.
   AN BAKULEV CARDIOVASC SURG INST,MOSCOW,RUSSIA.
CR BEHIZI J, 1989, BIOMED MATER, V4, P2
   BRALEY SA, 1971, RUBBER CHEM TECH, V44, P363
   BRISTOW BM, 1985, NR TECHNOL, V16, P29
   Cunneen J. I., 1968, RUBBER REV, V41, P182
   DAVIES BJ, 1989, MECHANICAL INCORPORA, V1, P91
   GORTON ADT, 1977, NR TECHNOL, V8, P79
   IMAI Y, 1970, T AM SOC ART INT ORG, V16, P17
   KHILKO VA, 1982, VNUTRISOSUDISTAYA NE
   KISLINOVSKAJA NV, 1992, IN PRESS INT J POLYM
   PORTER M, 1989, P INT POLYM LATEX C
   SMUROVA EV, 1984, POLYM MED BIOL, P15
   Southern E, 1980, ACS SYM SER, V127, P375
   THOMAS AG, 1987, POLYMER, V28, P408, DOI 10.1016/0032-3861(87)90193-5
NR 13
TC 2
Z9 2
U1 0
U2 0
PU GORDON BREACH SCI PUBL LTD
PI READING
PA C/O STBS LTD PO BOX 90, READING, BERKS, ENGLAND RG1 8JL
SN 0091-4037
J9 INT J POLYM MATER
JI Int. J. Polym. Mater.
PY 1994
VL 25
IS 1-2
BP 107
EP 115
DI 10.1080/00914039408028582
PG 9
WC Polymer Science
SC Polymer Science
GA PZ142
UT WOS:A1994PZ14200011
DA 2018-10-19
ER

PT J
AU KAO, WYJ
   ZHAO, QH
   HILTNER, A
   ANDERSON, JM
AF KAO, WYJ
   ZHAO, QH
   HILTNER, A
   ANDERSON, JM
TI THEORETICAL-ANALYSIS OF IN-VIVO MACROPHAGE ADHESION AND FOREIGN-BODY
   GIANT-CELL FORMATION ON POLYDIMETHYLSILOXANE, LOW-DENSITY POLYETHYLENE,
   AND POLYETHERURETHANES
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID INVIVO; POLYURETHANE; BIOCOMPATIBILITY; BIOSTABILITY; MONOCYTES;
   CRACKING; KINETICS; INVITRO; FUSION; UREA)
AB Quantitative description of foreign body giant cell (FBGC) formation on implanted polymer surfaces as a function of time can conceivably correlate cell adhesion with polymer properties and possibly predict the behavior of the polymer in vivo. In the present study, the formation of FBGCs on various biomedical polymers was quantified by two parameters: the density of adherent macrophages present initially that participate in FBGC formation (d(o)) and the rate constant for cell fusion (k); both kinetic parameters were used to calculate the time-dependent FBGC density (d(fc)).
   The materials used were: three Pellethane poly(etherurethanes) (PEUs) varying in weight percent of hard segment, one poly(etherurethane urea) (PEUU), and NHLBI-DTB primary reference materials: low density polyethylene (LDPE), silica-free polydimethylsiloxane (PDMS). The results indicated that up to 5 weeks of implantation, FBGCs were formed from the fusion of one population of adherent macrophages present by 3 days post-implantation. Furthermore, only a small fraction (<8%) of this initial adherent macrophage population participated in FBGC formation. Based on the results of previous studies and the current study, it was concluded that increase in PEU hard segment weight percent, surface hardness and hydrophobicity increased total protein adsorption and effectively increased d(o) and d(fc). No further correlations between the material properties of all polymers and the cell kinetics can be made at this time. However, this study demonstrated that macrophage adhesion and FBGC formation can be quantified with the cell fusion model, and are modulated by various polymer properties. (C) 1994 John Wiley and Sons, Inc.
C1 CASE WESTERN RESERVE UNIV,INST PATHOL,CLEVELAND,OH 44106.
   CASE WESTERN RESERVE UNIV,DEPT MACROMOLEC SCI,CLEVELAND,OH 44106.
FU NHLBI NIH HHS [HL-25239, HL-33849, HL-47300]
CR ABE E, 1987, ENDOCRINOLOGY, V121, P271, DOI 10.1210/endo-121-1-271
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   ANDERSON JM, 1988, ASAIO, V11, P101
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P255, DOI 10.1002/jbm.820270216
   BRUNSTEDT MR, 1993, J BIOMED MATER RES, V27, P367, DOI 10.1002/jbm.820270310
   BRUNSTEDT MR, 1990, BIOMATERIALS, V11, P8
   FLORY PJ, 1953, PRINCIPLES POLYMER C, pCH7
   HASSAN NF, 1989, J IMMUNOL, V143, P2179
   KAO WJ, UNPUB J BIOMED MATER
   Lambert RA, 1912, J EXP MED, V15, P510, DOI 10.1084/jem.15.5.510
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   MOHANTY M, 1992, BIOMATERIALS, V13, P651, DOI 10.1016/0142-9612(92)90123-6
   MURCH AR, 1982, J PATHOL, V137, P177, DOI 10.1002/path.1711370302
   OGHISO Y, 1992, J LEUKOCYTE BIOL, V52, P421
   PAPADIMITRIOU JM, 1973, AM J PATHOL, V73, P349
   PAPADIMITRIOU JM, 1978, MEMBRANE FUSION, P181
   SMETANA K, 1987, EXP MOL PATHOL, V46, P258, DOI 10.1016/0014-4800(87)90048-7
   Szycher M, 1991, J Biomater Appl, V6, P110, DOI 10.1177/088532829100600202
   SZYCHER M, 1992, MED DEVICE TECHNOL, V11, P41
   WU Y, 1991, J BIOMED MATER RES, V25, P725, DOI 10.1002/jbm.820250604
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
   ZHAO Q, 1987, POLYMER, V28, P2040, DOI 10.1016/0032-3861(87)90038-3
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   ZHAO QH, 1992, J BIOMED MATER RES, V26, P1019, DOI 10.1002/jbm.820260805
NR 25
TC 57
Z9 57
U1 0
U2 2
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JAN
PY 1994
VL 28
IS 1
BP 73
EP 79
DI 10.1002/jbm.820280110
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA MM133
UT WOS:A1994MM13300009
PM 8126032
DA 2018-10-19
ER

PT J
AU ZEZIN, AB
   ROGACHEVA, VB
   KABANOV, VA
AF ZEZIN, AB
   ROGACHEVA, VB
   KABANOV, VA
TI INTERPOLYMER COMPLEXES FORMED BY POLYELECTROLYTE GELS
SO JOURNAL OF INTELLIGENT MATERIAL SYSTEMS AND STRUCTURES
LA English
DT Note
ID POLY-ELECTROLYTE NETWORKS; ACTIVE-TRANSPORT; LINEAR POLYIONS
AB The approaches to synthesis and modification of polymers based on the assembly of chemically complementary macromolecules have been recently widely developed. Interpoly-electrolyte complexes (IPEC) are more common polymers of this type. They are the products of interaction between oppositely charged polyelectrolytes (Bixler and Michaels, 1969; Tsushida and Abe, 1982). IPEC are of special interest as the effective adhesives for solving ecological, biomedical and agrotechnological problems due to their unique structure (Zezin and Baranovskii, 1983; Zezin et al., 1987). The utilization of cross-linked polyelectrolytes gives new opportunities for the construction of polycomplex substances and materials. These opportunities are based on the phenomenon of active transport of linear polyelectrolytes into oppositely charged networks (Rogacheva et al., 1988; Kabanov et al., 1988; Kabanov et al., 1989). The driving force of this transport and the mechanism of transport of linear polyions in polyelectrolyte gels are directly connected with the interpolyelectrolyte reaction (IPR) which proceeds between polyions and gel. Slightly cross-linked polyelectrolytes absorb oppositely charged linear polyions from aqueous solutions. This gradual uptake is followed by production of small counter ions of linear and cross-linked polyelectrolytes. For example, the reaction between slightly cross-linked poly(2-dimethylaminoethyl methacrylate) (PDMA) and linear poly(acrylic acid) (PAA) is presented in Scheme (I).
RP ZEZIN, AB (reprint author), MOSCOW MV LOMONOSOV STATE UNIV,FAC CHEM,DEPT POLYMER SCI,MOSCOW,RUSSIA.
RI Zezin, Aleksandr/D-2638-2015
OI Zezin, Aleksandr/0000-0002-6268-1927
CR Bixler HJ, 1969, ENCYCLOPEDIA POLYMER, V10, P765
   KABANOV VA, 1985, MAKROMOL CHEM, P137
   KABANOV VA, 1990, VYSOKOMOL SOEDIN B, V32, P83
   KABANOV VA, 1988, DOKL AKAD NAUK SSSR+, V303, P399
   KABANOV VA, 1989, MAKROMOL CHEM, V190, P2211
   KABANOV VA, 1990, MAKROMOL CHEM-M SYMP, V39, P155, DOI 10.1002/masy.19900390114
   ROGACHEVA VB, 1988, VYSOKOMOL SOEDIN A+, V30, P2120
   TANAKA T, 1978, PHYS REV LETT, V40, P820, DOI 10.1103/PhysRevLett.40.820
   TSUCHIDA E, 1982, ADV POLYM SCI, V45, P1
   ZEZIN AB, 1972, VYSOKOMOL SOEDIN A, V14, P772
   ZEZIN AB, 1987, KHIM FARM ZH, V7, P788
   ZEZIN AB, 1983, KHIMYA ZHIZN, V3, P22
   ZEZIN AB, 1989, FRONTIERS MACROMOLEC, P219
NR 13
TC 9
Z9 10
U1 1
U2 5
PU TECHNOMIC PUBL CO INC
PI LANCASTER
PA 851 NEW HOLLAND AVE, BOX 3535, LANCASTER, PA 17604
SN 1045-389X
J9 J INTEL MAT SYST STR
JI J. Intell. Mater. Syst. Struct.
PD JAN
PY 1994
VL 5
IS 1
BP 144
EP 146
DI 10.1177/1045389X9400500119
PG 3
WC Materials Science, Multidisciplinary
SC Materials Science
GA NC276
UT WOS:A1994NC27600019
DA 2018-10-19
ER

PT J
AU HEYDORN, K
AF HEYDORN, K
TI ANALYTICAL TECHNIQUES AND QUALITY-CONTROL IN BIOMEDICAL TRACE-ELEMENT
   RESEARCH
SO JOURNAL OF TRACE ELEMENTS IN EXPERIMENTAL MEDICINE
LA English
DT Article
DE CHORION VILLI; CONTAMINATION CONTROL; INTERFERENCE CONTROL; REFERENCE
   MATERIALS; TRACEABILITY
AB The small number of analytical results in trace element research calls for special methods of quality control. It is shown that when the analytical methods are in statistical control, only small numbers of duplicate or replicate results are needed to ascertain the absence of systematic errors caused by sample contamination or interference from other elements. The distribution of determinations of Cu in chorion villi from normal pregnant women is used as an example, and after screening it proved to be closely approximated by a logarithmic normal distribution with a mean value of 0.6 mg/kg. Measurement compatibility is obtained by control of traceability to certified reference materials, (C) 1994 Wiley-Liss, Inc.
RP HEYDORN, K (reprint author), RISO NATL LAB,DIV ISOTOPE,POB 49,DK-4000 ROSKILDE,DENMARK.
CR ANGLOV T, 1990, FRESEN J ANAL CHEM, V338, P530, DOI 10.1007/BF00322531
   HEYDORN K, 1973, TALANTA, V20, P835, DOI 10.1016/0039-9140(73)80199-7
   HEYDRON K, 1984, NEUTRON ACTIVATION A, V2, P44
   HORN N, 1992, Journal of Trace Elements in Experimental Medicine, V5, P115
NR 4
TC 3
Z9 3
U1 0
U2 0
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0896-548X
J9 J TRACE ELEM EXP MED
JI J. Trace Elem. Exp. Med.
PY 1994
VL 7
IS 1
BP 33
EP 38
PG 6
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA NW929
UT WOS:A1994NW92900004
DA 2018-10-19
ER

PT B
AU AMBROSIO, L
   IANNACE, S
   MENSITIERI, M
   NETTI, PA
   NICOLAIS, L
AF AMBROSIO, L
   IANNACE, S
   MENSITIERI, M
   NETTI, PA
   NICOLAIS, L
BE Drake, K
   Bauer, J
   Serafini, T
   Cheng, P
TI STRUCTURAL MATERIALS FOR BIOMEDICAL APPLICATIONS
SO MOVING FORWARD WITH 50 YEARS OF LEADERSHIP IN ADVANCED MATERIALS - 39TH
   INTERNATIONAL SAMPE SYMPOSIUM AND EXHIBITION, VOL 39, BOOKS 1 AND 2
LA English
DT Proceedings Paper
CT 39th International SAMPE Symposium and Exhibition: Moving Forward With
   50 Years of Leadership in Advanced Materials
CY APR 11-14, 1994
CL ANAHEIM, CA
SP Soc Adv Mat & Proc Engn
DE APPLICATIONS, MEDICAL; BIOMATERIALS; COMPOSITES
C1 UNIV NAPLES FEDERICO 2,DEPT MAT & PROD ENGN,NAPLES,ITALY.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SOC ADVANCEMENT MATERIAL & PROCESS ENGINEERING
PI COVINA
PA 843 W GLENTANA ST, PO BOX 2459, COVINA, CA 91722
BN 0-938994-69-7
PY 1994
BP 979
EP 988
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA BB69T
UT WOS:A1994BB69T00091
DA 2018-10-19
ER

PT J
AU SAKURAI, S
   NOKUWA, S
   MORIMOTO, M
   SHIBAYAMA, M
   NOMURA, S
AF SAKURAI, S
   NOKUWA, S
   MORIMOTO, M
   SHIBAYAMA, M
   NOMURA, S
TI CHANGES IN STRUCTURE AND PROPERTIES DUE TO MECHANICAL FATIGUE FOR
   POLYURETHANES CONTAINING POLY(DIMETHYL SILOXANE)
SO POLYMER
LA English
DT Article
DE POLYURETHANES; MECHANICAL FATIGUE; MICRODOMAINS
ID MICROPHASE SEPARATED STRUCTURE; X-RAY-SCATTERING; SEGMENTED
   POLY(URETHANEUREA)S; HARD SEGMENT; ORIENTATIONAL BEHAVIOR; BLOOD
   COMPATIBILITY; ELASTOMERS; COMPONENTS
AB Changes in structure and properties due to mechanical fatigue for segmented polyurethanes containing a block segment of poly(ethylene oxide)-block-poly(dimethyl siloxane)-block-poly(ethylene oxide) (PES) were investigated by mechanical and thermal analyses and a small-angle X-ray scattering (SAXS) technique. Six types of specimens designated KP-x-y were studied, where x and y denote, respectively, the fraction of PES component (x = 0 or 13 wt%) and the molecular weight of the soft-segment block, poly(tetramethylene glycol) (PTMG) (y = 1000, 2000 or 3000). The SAXS experiments revealed that dissociation of the hard-segment microdomains was induced by mechanical fatigue. The changes in the mechanical properties due to fatigue were discussed in relation to the PTMG soft-segment crystallization which can be triggered by the dissociation of the hard-segment microdomains. As already reported, KP-13-2000 has better antithrombogenicity and more suitable viscoelastic properties for use as a biomedical material than any of the others. It was found in this study that KP-13-2000 has strong resistance against mechanical fatigue as well, which is one of the most important characteristics required for biomedical materials. Although the microdomain structure was fractured by fatigue, the mechanical property of KP-13-2000 was not changed because the PES component prevents the PTMG soft segments from crystallizing.
RP SAKURAI, S (reprint author), KYOTO INST TECHNOL,DEPT POLYMER SCI & ENGN,SAKYO KU,KYOTO 606,JAPAN.
RI Shibayama, Mitsuhiro/E-1646-2015
OI Shibayama, Mitsuhiro/0000-0002-8683-5070
CR CLOGH SB, 1968, J MACROMOL SCI PHY B, V2, P553
   FAKIROV S, 1991, POLYMER, V32, P1173, DOI 10.1016/0032-3861(91)90218-8
   HOFFMANN K, 1983, MAKROMOL CHEM, V184, P1529
   HUH DS, 1971, POLYM ENG SCI, V11, P36
   ISHIHARA H, 1984, J MACROMOL SCI PHYS, VB22, P713, DOI 10.1080/00222348308215209
   KAJIYAMA T, 1969, MACROMOLECULES, V2, P254, DOI 10.1021/ma60009a009
   KAWANO S, 1990, REP PROG POLYM PHYS, V33, P319
   KIMURA I, 1974, MACROMOLECULES, V7, P355, DOI 10.1021/ma60039a018
   KIRA K, 1983, J JPN SOC BIOMATER, V1, P29
   KOBERSTEIN JT, 1983, J POLYM SCI POL PHYS, V21, P1439, DOI 10.1002/pol.1983.180210814
   Lelah M. D., 1986, POLYURETHANES MED
   LI C, 1990, POLYMER, V31, P3, DOI 10.1016/0032-3861(90)90339-Z
   MCKENNA LW, 1969, MACROMOLECULES, V2, P58, DOI 10.1021/ma60007a011
   MILLER JA, 1985, MACROMOLECULES, V18, P32, DOI 10.1021/ma00143a005
   PLANCK H, 1984, POLYURETHANES BIOMED
   SHIBAYAMA M, 1991, MACROMOLECULES, V24, P6254, DOI 10.1021/ma00023a031
   SHIBAYAMA M, 1990, POLYMER, V31, P749, DOI 10.1016/0032-3861(90)90299-E
   SHIBAYAMA M, 1987, POLYM J, V19, P1067, DOI 10.1295/polymj.19.1067
   SHIBAYAMA M, 1986, POLYM J, V18, P719, DOI 10.1295/polymj.18.719
   TAKAHARA A, 1985, KOBUNSHI RONBUNSHU, V42, P793, DOI 10.1295/koron.42.793
   TAKAHARA A, 1982, KOBUNSHI RONBUNSHU, V39, P203, DOI 10.1295/koron.39.203
   TAKAHARA A, 1985, POLYMER, V26, P978, DOI 10.1016/0032-3861(85)90217-4
   TAKAHARA A, 1985, POLYMER, V26, P987, DOI 10.1016/0032-3861(85)90218-6
   TRANCONG Q, IN PRESS POLYMER
   UEKI T, 1985, BIOPHYS CHEM, V23, P115, DOI 10.1016/0301-4622(85)80069-7
   YAMAMOTO T, 1989, POLYM J, V21, P895, DOI 10.1295/polymj.21.895
NR 26
TC 21
Z9 21
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0032-3861
J9 POLYMER
JI Polymer
PY 1994
VL 35
IS 3
BP 532
EP 539
DI 10.1016/0032-3861(94)90507-X
PG 8
WC Polymer Science
SC Polymer Science
GA MV153
UT WOS:A1994MV15300012
DA 2018-10-19
ER

PT S
AU TOMIHATA, K
   BURCZAK, K
   SHIRAKI, K
   IKADA, Y
AF TOMIHATA, K
   BURCZAK, K
   SHIRAKI, K
   IKADA, Y
BE Shalaby, SW
   Ikada, Y
   Langer, R
   Williams, J
TI CROSS-LINKING AND BIODEGRADATION OF NATIVE AND DENATURED COLLAGEN
SO POLYMERS OF BIOLOGICAL AND BIOMEDICAL SIGNIFICANCE
SE ACS SYMPOSIUM SERIES
LA English
DT Article; Proceedings Paper
CT Symposium on Polymers of Biological and Biomedical Significance, at the
   204th National Meeting of the American Chemical Society
CY AUG 24-28, 1992
CL WASHINGTON, DC
SP AMER CHEM SOC, DIV POLYM CHEM INC
ID FIBERS
AB Collagens are known to have wide biomedical applications. They are for hemostatic agent, blood vessel, heart valve, tendon and ligament, burn dressing, intradermal augmentation, drug delivery systems and so on (1). The denatured type collagen, gelatin, has also been used in medicine as plasma expander, wound dressing, adhesives, and absorbent pad for surgical use (2). Recently it has been reported that both collagen and gelatin can be effectively used as materials for nerve conduits (3,4). Furthermore, it should be noted that crosslinked gelatin has been long used as a material for embolization in endovascular surgery (5). The biodegradation rate of collagen-based implants is known to be strongly affected by the crosslinking density (6-8). Crosslinking can also improve the tensile properties of the materials to such a level as they are handled and sutured with ease. The purpose of this work is to compare different methods for crosslinking of native collagen and denatured gelatin. The crosslinking agents to be employed in this study include glutaraldehyde, water-soluble carbodiimide, bisepoxy compounds, UV radiation, and dehydrothermal treatment.
RP TOMIHATA, K (reprint author), KYOTO UNIV,BIOMED ENGN RES CTR,SAKYO KU,53 KAWAHARA CHO,SHOGO-IN,KYOTO 606,JAPAN.
CR CHVAPIL M, 1977, J BIOMED MATER RES, V11, P297, DOI 10.1002/jbm.820110213
   EYBL E, 1989, J BIOMED MATER RES, V23, P1355, DOI 10.1002/jbm.820231111
   IKADA Y, 1992, NEUROSURGEONS, V11, P236
   KATO YP, 1989, BIOMATERIALS, V10, P38, DOI 10.1016/0142-9612(89)90007-0
   LAW JK, 1989, J BIOMED MATER RES, V23, P961, DOI 10.1002/jbm.820230902
   LEE G, 1992, 30TH ANN M JAP SOC A, P93
   LI ST, 1991, BIOTECHNOLOGY AND POLYMERS, P281
   MILTHORPE BK, 1990, ADV BIOMAT, V9, P1
   PIAO DS, 1982, POLYM PREPRINTS JPN, V31, P2609
   PIEZ KA, 1989, ENCY POLYM SCI ENG, V3, P699
   Rose PJ, 1989, ENCY POLYM SCI ENG, V7, P488
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   VANLUYN MJA, 1992, BIOMATERIALS, V13, P1017, DOI 10.1016/0142-9612(92)90153-F
   WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815
   Wong S. S., 1991, CHEM PROTEIN CONJUGA, P195
NR 15
TC 13
Z9 13
U1 0
U2 17
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036
SN 0097-6156
BN 0-8412-2732-2
J9 ACS SYM SER
PY 1994
VL 540
BP 275
EP 286
PG 12
WC Chemistry, Multidisciplinary; Medicine, Research & Experimental; Polymer
   Science
SC Chemistry; Research & Experimental Medicine; Polymer Science
GA BZ58M
UT WOS:A1994BZ58M00025
DA 2018-10-19
ER

PT J
AU MACRINA, FL
   MUNRO, CL
AF MACRINA, FL
   MUNRO, CL
TI GRADUATE TEACHING IN PRINCIPLES OF SCIENTIFIC INTEGRITY
SO ACADEMIC MEDICINE
LA English
DT Article
AB Training in the responsible conduct of research in the biomedical sciences is on its way to being a standard component in the graduate biomedical curriculum. Emphasis in this area has been catalyzed by certain requirements for such training imposed by the National Institutes of Health and by an increased awareness of relevant issues created by the publicity and discussion of incidents of scientific misconduct. The authors describe the development and formalization of a course about the responsible conduct of science for students in the biomedical disciplines at Virginia Commonwealth University. In addition, they discuss general considerations of course content important in teaching scientific integrity; examine the use of published resource materials and documents from professional societies, institutions, states, and the federal government as teaching tools; and describe the importance of case studies as vehicles for teaching scientific integrity.
C1 VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT MED SURG NURSING,RICHMOND,VA 23298.
RP MACRINA, FL (reprint author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT MICROBIOL & IMMUNOL,POB 678 MCV,RICHMOND,VA 23298, USA.
CR MARTIN RG, UNPUB STAMPEDE ZEBRA
NR 1
TC 8
Z9 8
U1 0
U2 4
PU HANLEY & BELFUS INC
PI PHILADELPHIA
PA 210 S 13TH ST, PHILADELPHIA, PA 19107
SN 1040-2446
J9 ACAD MED
JI Acad. Med.
PD DEC
PY 1993
VL 68
IS 12
BP 879
EP 884
DI 10.1097/00001888-199312000-00003
PG 6
WC Education, Scientific Disciplines; Health Care Sciences & Services
SC Education & Educational Research; Health Care Sciences & Services
GA MM253
UT WOS:A1993MM25300003
PM 8259956
OA Bronze
DA 2018-10-19
ER

PT J
AU FANO, V
   MA, WY
   ORTALLI, I
   POZELA, K
AF FANO, V
   MA, WY
   ORTALLI, I
   POZELA, K
TI THERMAL CONTRACTION OF SILICONE-BASED IMPRESSION MATERIALS
SO NUOVO CIMENTO DELLA SOCIETA ITALIANA DI FISICA D-CONDENSED MATTER ATOMIC
   MOLECULAR AND CHEMICAL PHYSICS FLUIDS PLASMAS BIOPHYSICS
LA English
DT Article
DE OTHER TOPICS IN BIOPHYSICS, MEDICAL PHYSICS, AND BIOMEDICAL ENGINEERING;
   MATERIALS TESTING; THEORETICAL EXPANSION AND THERMOMECHANICAL EFFECTS
ID DIMENSIONAL STABILITY
AB Linear thermal contraction of impression materials has been measured in the 40-18-degrees-C temperature range immediately after the polymerization shrinkage. Samples of 2 em in length have been analysed by a scanned laser beam micrometer and the coefficient of thermal contraction has been calculated. Silicone-based specimens of different viscosities have been tested. The temperature-induced shrinkage has been compared with the time-dependent shrinkage.
RP FANO, V (reprint author), UNIV PARMA,IST SCI FIS,I-43100 PARMA,ITALY.
CR BURDAIRON G, 1984, BIOMATERIALI DENTARI, P173
   CANCY JM, 1983, J ORAL REHABIL, V10, P325
   FANO V, 1992, DENT MATER, V8, P105, DOI 10.1016/0109-5641(92)90064-J
   FANO V, 1992, 6 MED C MED BIOL ENG, P119
   MANSFIELD MA, 1975, BRIT DENT J, V139, P267, DOI 10.1038/sj.bdj.4803587
   MCCAULEY JW, 1988, MTLTR8830 NTIS, P22
   SIMIONATO F, 1985, TECNOLOGIE MATERIALI, P1
   WILLIAMS PT, 1984, J PROSTHET DENT, V52, P120, DOI 10.1016/0022-3913(84)90194-X
   WILSON H, 1991, MATERIALI DENTARI LO
NR 9
TC 0
Z9 0
U1 0
U2 1
PU EDITRICE COMPOSITORI BOLOGNA
PI BOLOGNA
PA VIA STALINGRADO 97/2, I-40128 BOLOGNA, ITALY
SN 0392-6737
J9 NUOVO CIMENTO D
JI Nuovo Cimento Soc. Ital. Fis. D-Condens. Matter At. Mol. Chem. Phys.
   Fluids Plasmas Biophys.
PD DEC
PY 1993
VL 15
IS 12
BP 1533
EP 1538
DI 10.1007/BF02451944
PG 6
WC Physics, Multidisciplinary
SC Physics
GA NB558
UT WOS:A1993NB55800006
DA 2018-10-19
ER

PT J
AU OXLEY, HR
   CORKHILL, PH
   FITTON, JH
   TIGHE, BJ
AF OXLEY, HR
   CORKHILL, PH
   FITTON, JH
   TIGHE, BJ
TI MACROPOROUS HYDROGELS FOR BIOMEDICAL APPLICATIONS - METHODOLOGY AND
   MORPHOLOGY
SO BIOMATERIALS
LA English
DT Article
DE HYDROGELS; MEMBRANES; POLYMERIZATION; POROSITY
AB Macroporous hydrogel membranes have been fabricated using two complementary techniques, both involving the polymerization of a solution of monomers around a crystalline matrix which is subsequently removed. The first of these is the freeze-thaw technique, in which aqueous systems are used to form ice-based crystalline matrices. Whereas in the second, the porosigen technique, a crystalline compound (e.g. sucrose) is dispersed in the monomer solution prior to polymerization. Both copolymer composition and the polymerization conditions were found to influence membrane morphology and the limitations in the range of morphologies attainable using each technique are discussed. Careful choice of technique and polymerization conditions enables macroporous hydrogels with a wide range of morphologies to be fabricated, which are potentially valuable in a variety of biomedical applications. The suitability of these techniques described for the production of materials for use in affinity chromatography, as cell separation substrates and as synthetic articular cartilage as well as more general areas of biomedicine, is discussed.
C1 ASTON UNIV, DEPT CHEM ENGN & APPL CHEM, SPECIALTY MAT RES GRP, BIRMINGHAM B4 7ET, W MIDLANDS, ENGLAND.
CR ATKINS TW, 1992, J BIOMAT SCI-POLYM E, V3, P261, DOI 10.1163/156856292X00178
   CORKHILL PH, IN PRESS J BIOMATER
   FITTON JH, 1992, 4TH P WORLD BIOM C B, P670
   Haldon R.A., 1972, BR POLYM J, V4, P491
   KON M, 1981, PLAST RECONSTR SURG, V67, P289, DOI 10.1097/00006534-198103000-00002
   KRAUCH CH, 1968, NATURWISSENSCHAFTEN, V55, P539, DOI 10.1007/BF00660126
   MCCUTCHEN CW, 1969, LUBRICATION WEAR JOI, P117
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   MURPHY SM, 1992, J MATER CHEM, V2, P1007, DOI 10.1039/jm9920201007
   ONEILL C, 1990, J CELL SCI, V95, P577
   SKELLY PJ, 1979, POLYMER, V20, P1051, DOI 10.1016/0032-3861(79)90289-1
NR 11
TC 110
Z9 112
U1 2
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 1993
VL 14
IS 14
BP 1064
EP 1072
DI 10.1016/0142-9612(93)90207-I
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA MH266
UT WOS:A1993MH26600007
PM 8312461
DA 2018-10-19
ER

PT J
AU UGELSTAD, J
   STENSTAD, P
   KILAAS, L
   PRESTVIK, WS
   HERJE, R
   BERGE, A
   HORNES, E
AF UGELSTAD, J
   STENSTAD, P
   KILAAS, L
   PRESTVIK, WS
   HERJE, R
   BERGE, A
   HORNES, E
TI MONODISPERSE MAGNETIC POLYMER PARTICLES - NEW BIOCHEMICAL AND BIOMEDICAL
   APPLICATIONS
SO BLOOD PURIFICATION
LA English
DT Review
DE MONODISPERSE PARTICLES; MAGNETIC PARTICLES; CELL SEPARATION;
   MICROBIOLOGY; MOLECULAR BIOLOGY
AB The method of activated swelling of polymer particles developed by the authors allows the preparation of monodisperse spherical beads of predictable size from 1 to 100 mu m in diameter. The polymer particles may be prepared from a number of different monomeric materials and with various morphologies including macroporous structures. The porous beads form the basis for magnetizable monodisperse polymer particles which have magnetic iron oxides distributed as small grains all through the volume of the beads. The magnetic particles are being used extensively for selective cell separation and for Cell separation immunomagnetic separation within microbiology and molecular biology. A review of recent work within these fields is given. New methods for positive cell separation are announced.
C1 UNIV TRONDHEIM,IND CHEM LAB,TRONDHEIM,NORWAY.
   NORWEGIAN COLL VET MED,OSLO,NORWAY.
   DYNAL AS,OSLO,NORWAY.
RP UGELSTAD, J (reprint author), SINTEF,APPL CHEM,N-7034 TRONDHEIM,NORWAY.
NR 0
TC 96
Z9 105
U1 3
U2 41
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0253-5068
J9 BLOOD PURIFICAT
JI Blood Purif.
PD NOV-DEC
PY 1993
VL 11
IS 6
BP 349
EP 369
DI 10.1159/000170129
PG 21
WC Hematology; Urology & Nephrology
SC Hematology; Urology & Nephrology
GA NR865
UT WOS:A1993NR86500002
PM 8043257
DA 2018-10-19
ER

PT J
AU SHELLOCK, FG
   MORISOLI, S
   KANAL, E
AF SHELLOCK, FG
   MORISOLI, S
   KANAL, E
TI MR PROCEDURES AND BIOMEDICAL IMPLANTS, MATERIALS, AND DEVICES - 1993
   UPDATE
SO RADIOLOGY
LA English
DT Article
DE MAGNETIC RESONANCE (MR), SAFETY
ID HIGH-FIELD-STRENGTH; METALLIC BALLISTIC FRAGMENTS; IMAGING ARTIFACTS;
   DENTAL MATERIALS; POTENTIAL HAZARDS; MAGNETIC-FIELDS; SURGICAL CLIPS;
   RETINAL TACKS; FERROMAGNETISM; SAFETY
AB PURPOSE: To provide information on ferromagnetic metallic implants, materials, and devices that may be exposed to static magnetic fields during magnetic resonance (MR) imaging or spectroscopy.
   MATERIALS AND METHODS: An updated compilation of the results of more than 80 studies lists the specific object tested, the material used to construct the object, whether the object was deflected or moved during exposure to the static magnetic field, and the highest field strength used for testing the object (range, 0.147-4.7 T).
   RESULTS: The ferromagnetic qualities of 338 objects (32 aneurysm and hemostatic clips; six biopsy needles; five carotid artery vascular clamps; 18 dental devices or materials; 11 halo vests; 29 heart valve prostheses; 20 intravascular coils, filters, and stents; 22 ocular implants; 30 orthopedic implants, materials, and devices; 62 otologic implants; 23 pellets and bullets; 13 penile implants; 38 vascular access ports; and 29 miscellaneous objects) are reported.
   CONCLUSION: MR imaging or spectroscopy may be contraindicated in patients with such objects because of the risk of movement or dislodgment of the object.
C1 TOWER IMAGING, LOS ANGELES, CA 90048 USA.
   ST JOHNS HOSP, DEPT MED IMAGING, SANTA MONICA, CA USA.
   UNIV PITTSBURGH, DEPT RADIOL, PITTSBURGH, PA 15260 USA.
   PITTSBURGH NMR INST, PITTSBURGH, PA USA.
RP SHELLOCK, FG (reprint author), UNIV CALIF LOS ANGELES, SCH MED, DEPT RADIOL SCI, LOS ANGELES, CA USA.
FU NCI NIH HHS [1 R01 CA44014-05]
CR ALBERT DW, 1990, ARCH OPHTHALMOL-CHIC, V108, P320, DOI 10.1001/archopht.1990.01070050018007
   APPLEBAUM EL, 1990, ANN OTO RHINOL LARYN, V99, P801, DOI 10.1177/000348949009901009
   APPLEBAUM EL, 1985, ARCH OTOLARYNGOL, V111, P820
   BALLOCK RT, 1989, J BONE JOINT SURG AM, V71A, P431, DOI 10.2106/00004623-198971030-00020
   BARRAFATO D, 1984, CAN J SURG, V27, P509
   BECKER RL, 1988, AM J NEURORADIOL, V9, P885
   BELLON EM, 1984, MAGN RESON IMAGING, V2, P41
   BERNARDINO ME, 1986, RADIOLOGY, V158, P57, DOI 10.1148/radiology.158.1.3940398
   BROWN MA, 1987, MAGN RESON IMAGING, V5, P443, DOI 10.1016/0730-725X(87)90378-X
   CLAYMAN DA, 1990, AM J NEURORADIOL, V11, P385
   DAVIS PL, 1981, AM J ROENTGENOL, V137, P857, DOI 10.2214/ajr.137.4.857
   DEKEIZER RJ, 1984, DOC OPHTHALMOL, V61, P281
   DUJOVNY M, 1985, NEUROSURGERY, V17, P543, DOI 10.1227/00006123-198510000-00002
   DUPUY DE, 1993, AM J ROENTGENOL, V160, P893, DOI 10.2214/ajr.160.4.8456685
   FACHE JS, 1987, AM J NEURORADIOL, V8, P837
   FINN EJ, 1985, RADIOLOGY, V156, P139, DOI 10.1148/radiology.156.1.4001400
   GEGAUFF AG, 1990, J ORAL REHABIL, V17, P403, DOI 10.1111/j.1365-2842.1990.tb01411.x
   GILLINGS B R D, 1990, Dental Clinics of North America, V34, P683
   GO KG, 1989, CLIN NEUROL NEUROSUR, V91, P109, DOI 10.1016/S0303-8467(89)80030-7
   GOLD JP, 1989, ANN THORAC SURG, V48, P643, DOI 10.1016/0003-4975(89)90780-7
   Grassi C J, 1992, J Vasc Interv Radiol, V3, P535, DOI 10.1016/S1051-0443(92)72008-9
   HASSLER M, 1986, Journal de Radiologie (Paris), V67, P661
   HATHOUT G, 1992, JMRI-J MAGN RESON IM, V2, P93, DOI 10.1002/jmri.1880020117
   HINSHAW DB, 1988, RADIOLOGY, V166, P777, DOI 10.1148/radiology.166.3.3340777
   KAGETSU NJ, 1991, RADIOLOGY, V179, P505, DOI 10.1148/radiology.179.2.2014301
   KANAL E, 1990, RADIOLOGY, V176, P593, DOI 10.1148/radiology.176.3.2202008
   KANAL E, 1993, RADIOLOGY, V187, P612, DOI 10.1148/radiology.187.3.8497603
   KELLY WM, 1986, AM J NEURORADIOL, V7, P243
   KELSEY CA, 1991, RADIOLOGY, V180, P282, DOI 10.1148/radiology.180.1.2052711
   KLUCZNIK RP, 1993, RADIOLOGY, V187, P855, DOI 10.1148/radiology.187.3.8497645
   KUETHE DO, 1991, INVEST RADIOL, V26, P1, DOI 10.1097/00004424-199101000-00001
   LAAKMAN RW, 1985, AJR, V8, P837
   LEIBMAN CE, 1988, AJR, V150, P1174
   LEMMENS JAM, 1986, FORTSCHR RONTG NEUEN, V145, P311
   LEON JA, 1987, MAGN RESON IMAGING, V5, P405, DOI 10.1016/0730-725X(87)90130-5
   LIANG MD, 1989, MAGN RESON IMAGING, V7, P541, DOI 10.1016/0730-725X(89)90407-4
   LISSAC M, 1991, INVEST RADIOL, V26, P40, DOI 10.1097/00004424-199101000-00008
   LUFKIN R, 1988, AM J NEURORADIOL, V9, P953
   LYONS CJ, 1989, SPINE, V14, P670, DOI 10.1097/00007632-198907000-00004
   MARK AS, 1987, RADIOLOGY, V162, P311, DOI 10.1148/radiology.162.2.3797642
   MARSHALL MW, 1991, CARDIOVASC INTER RAD, V14, P163, DOI 10.1007/BF02577720
   MATSUMOTO AH, 1989, RADIOLOGY, V170, P753, DOI 10.1148/radiology.170.3.2916029
   MATTUCCI KF, 1986, OTOLARYNG HEAD NECK, V94, P441, DOI 10.1177/019459988609400407
   MECHLIN M, 1984, AM J ROENTGENOL, V143, P1281, DOI 10.2214/ajr.143.6.1281
   MESGARZADEH M, 1985, SKELETAL RADIOL, V14, P205, DOI 10.1007/BF00355565
   NEW PFJ, 1983, RADIOLOGY, V147, P139, DOI 10.1148/radiology.147.1.6828719
   POHOST GM, 1992, ANN NY ACAD SCI, V649, P302, DOI 10.1111/j.1749-6632.1992.tb49618.x
   POWER W, 1988, LANCET, V2, P227
   Pusey E, 1986, Radiographics, V6, P891
   RANDALL PA, 1988, AM J CARDIOL, V62, P973, DOI 10.1016/0002-9149(88)90907-1
   ROBERTS CW, 1990, ARCH OPHTHALMOL-CHIC, V108, P320
   SEIFF SR, 1991, ARCH OPHTHALMOL-CHIC, V109, P319, DOI 10.1001/archopht.1991.01080030021014
   SHELLOCK F G, 1989, Magnetic Resonance Quarterly, V5, P243
   SHELLOCK FG, 1992, JMRI-J MAGN RESON IM, V2, P225, DOI 10.1002/jmri.1880020217
   SHELLOCK FG, 1991, RADIOLOGY, V180, P541, DOI 10.1148/radiology.180.2.2068325
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P811, DOI 10.2214/ajr.151.4.811
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P389, DOI 10.2214/ajr.151.2.389
   SHELLOCK FG, 1990, AM J ROENTGENOL, V154, P631, DOI 10.2214/ajr.154.3.2106233
   SHELLOCK FG, 1991, JMRI-J MAGN RESON IM, V1, P97, DOI 10.1002/jmri.1880010114
   SHELLOCK FG, 1991, AM J NEURORADIOL, V12, P279
   SHELLOCK FG, 1992, RADIOLOGY, V185, P288
   SHELLOCK FG, 1992, APPL RADIOL      NOV, P44
   SHELLOCK FG, 1987, BOOK ABSTRACTS SOC M, P915
   SHELLOCK FG, 1990, RADIOLOGY P, V177, P271
   SHELLOCK FG, 1992, REV MAGN RESON IMAGI, V4, P21
   SHELLOCK FG, 1989, MAGN RESON IMAGIN S1, V7, P38
   SHELLOCK FG, 1988, MRI DECISIONS, V2, P25
   Shellock FG, 1987, RADIOLOGY, V165, P150
   SHELLOCK FG, IN PRESS MAGNETIC RE
   SHELLOCK FG, IN PRESS CURRENT PRA
   SHELLOCK FG, 1991, JMRI-J MAGN RESON IM, V1, P243
   SOULEN RL, 1985, RADIOLOGY, V154, P705, DOI 10.1148/radiology.154.3.3969474
   SOULEN RL, 1986, RADIOLOGY, V158, P279
   TEITELBAUM GP, 1990, RADIOLOGY, V175, P855, DOI 10.1148/radiology.175.3.2343136
   TEITELBAUM GP, 1988, RADIOLOGY, V168, P713, DOI 10.1148/radiology.168.3.3406402
   TEITELBAUM GP, 1990, RADIOLOGY, V177, P883, DOI 10.1148/radiology.177.3.2244005
   TEITELBAUM GP, 1989, CARDIOVASC INTER RAD, V12, P125, DOI 10.1007/BF02577374
   TEITELBAUM GP, 1988, RADIOLOGY, V166, P657, DOI 10.1148/radiology.166.3.3340759
   TEITELBAUM GP, 1990, AM J NEURORADIOL, V11, P267
   TO SYC, 1989, COMPUT MED IMAG GRAP, V13, P469, DOI 10.1016/0895-6111(89)90288-7
   VONROEMELING R, 1991, JMRI-J MAGN RESON IM, V1, P77
   WATANABE AT, 1990, RADIOLOGY, V177, P578, DOI 10.1148/radiology.177.2.2217801
   WHITE DW, 1987, AM J OTOL, V8, P290
   WILLIAMSON MR, 1988, ANGIOLOGY, V12, P1022
   YUH WTC, 1991, JMRI-J MAGN RESON IM, V1, P711, DOI 10.1002/jmri.1880010617
   ZHEUTLIN JD, 1987, AM J OPHTHALMOL, V103, P831, DOI 10.1016/S0002-9394(14)74404-6
   1988, HTLH DEVICES ALERT, V1
   1988, PREMARKET NOTIFICATI
   1993, MED DEVICES B, P1
NR 89
TC 118
Z9 121
U1 1
U2 5
PU RADIOLOGICAL SOC NORTH AMERICA
PI OAK BROOK
PA 820 JORIE BLVD, OAK BROOK, IL 60523 USA
SN 0033-8419
J9 RADIOLOGY
JI Radiology
PD NOV
PY 1993
VL 189
IS 2
BP 587
EP 599
DI 10.1148/radiology.189.2.8210394
PG 13
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA MD563
UT WOS:A1993MD56300043
PM 8210394
DA 2018-10-19
ER

PT J
AU GARG, AN
   WEGINWAR, RG
   CHUTKE, NL
AF GARG, AN
   WEGINWAR, RG
   CHUTKE, NL
TI RADIOCHEMICAL NEUTRON-ACTIVATION ANALYSIS OF FE, CO, ZN, SB AND SE IN
   BIOMEDICAL AND ENVIRONMENTAL-SAMPLES
SO SCIENCE OF THE TOTAL ENVIRONMENT
LA English
DT Article
DE RADIOCHEMICAL NAA; IRON; COBALT; ZINC; ANTIMONY; SELENIUM; ENVIRONMENTAL
   SAMPLES
ID TRACE-ELEMENTS; BIOLOGICAL-MATERIALS; SEPARATION; SELENIUM; METALS;
   FOODS
AB A radiochemical neutron activation method has been developed for the simultaneous determination of Fe, Co, Zn, Sb and Se levels in cancerous breast tissue, milk samples and fugitive cement dust particulates. Various Standard Reference Materials from NIST, USA (Bovine Liver 1577a, Milk Powder 1549, Coal Fly Ash 1633a and Urban Particulate Matter 1648), IAEA Vienna (Animal Muscle H-4, Milk powder A-11 and Soil-5) and NIES Japan (Pond Sediment) were also analysed for quality control. Samples together with standards were irradiated at a thermal neutron fluence of 10(13) ncm-2 s-1 for 2 weeks. After dissolution/fusion together with carriers, the Fe was first separated by extracting with diethyl ether followed by extraction with cupferron in chloroform. From the aqueous phase Co and Zn were extracted using alpha-nitroso-beta-naphthol in chloroform and 2-thenoyltrifluoroacetone in isobutylmethyl ketone, respectively. From another aliquot, Se was first complexed with o-phenylenediamine and extracted in benzene. Later Sb was extracted using KI and 4-(2-pyridylazo)-resorcinol (PAR) in benzene. The method yields reasonably accurate data for monitoring of trace elements in biomedical and environmental specimens.
RP GARG, AN (reprint author), NAGPUR UNIV, DEPT CHEM, NAGPUR 440010, MAHARASHTRA, INDIA.
CR ADEPETU JA, 1988, J RADIOAN NUCL CH AR, V121, P141, DOI 10.1007/BF02041455
   ALJABORI SM, 1990, J RADIOANAL NUCL CHE, V144, P229
   ANGERER J, 1990, FRESEN J ANAL CHEM, V337, P589, DOI 10.1007/BF00323093
   ARUNACHALAM J, 1979, NUCL ACTIVATION TECH, P499
   Berman E, 1980, TOXIC METALS THEIR A
   BHAT KR, 1982, SCI TOTAL ENVIRON, V22, P169, DOI 10.1016/0048-9697(82)90033-X
   BOGEN J, 1973, ATMOS ENVIRON, V7, P1117, DOI 10.1016/0004-6981(73)90220-5
   BYRNE AR, 1987, FRESEN Z ANAL CHEM, V326, P723, DOI 10.1007/BF00473540
   Chatt A., 1980, HAIR TRACE ELEMENTS, P46
   CHEEMA MN, 1981, RADIOCHIM ACTA, V28, P149
   CUNNINGHAM WC, 1987, J RADIOAN NUCL CH AR, V113, P423, DOI 10.1007/BF02050516
   DANG HS, 1984, J RADIOANAL NUCL CH, V84, P177, DOI 10.1007/BF02038194
   DEBSKI B, 1987, AM I NUTR, P1091
   DERMELJ M, 1986, J RADIOAN NUCL CH LE, V106, P91, DOI 10.1007/BF02162554
   EHMANN WD, 1989, CRC CR REV ANAL CHEM, V20, P405, DOI 10.1080/10408348908050073
   FOSTER HD, 1988, J NUTR, V118, P237
   FRANSSON GB, 1983, PEDIATR RES, V17, P912, DOI 10.1203/00006450-198311000-00015
   GANTHER HE, 1984, TRACE ELEMENT ANAL C, V3, P3
   GARG AN, 1990, BIOL TRACE ELEM RES, V26-7, P485, DOI 10.1007/BF02992704
   HAAS HF, 1986, FRESEN Z ANAL CHEM, V324, P13, DOI 10.1007/BF00469626
   IYENGAR GV, 1987, J RADIOAN NUCL CH AR, V110, P503, DOI 10.1007/BF02035540
   KALOUSKOVA J, 1989, J RADIOAN NUCL CH AR, V129, P59, DOI 10.1007/BF02037568
   KOSTA L, 1986, FRESEN Z ANAL CHEM, V324, P649, DOI 10.1007/BF00468374
   LEE RE, 1990, BIOL TRACE ELEM RES, V26-7, P321, DOI 10.1007/BF02992686
   LEVINSON AA, 1978, INVEST UROL, V15, P270
   MEYER BS, 1965, PLANT PHYSIOL, P473
   MORRISON GH, 1979, CRC CR REV ANAL CHEM, V8, P287, DOI 10.1080/10408347908085594
   PIETRA R, 1986, J RADIOAN NUCL CH AR, V102, P69, DOI 10.1007/BF02037950
   SAMUDRALWAR DL, 1987, J RADIOAN NUCL CH AR, V109, P363, DOI 10.1007/BF02037879
   SARMANI S, 1990, BIOL TRACE ELEM RES, V26-7, P497, DOI 10.1007/BF02992705
   Underwood E, 1977, TRACE ELEMENTS HUMAN
   WEGINWAR RG, 1990, OCT INT C ACT AN ITS, P261
   WILLIAMS RJP, 1987, POLYHEDRON, V6, P61, DOI 10.1016/S0277-5387(00)81239-5
   WU CY, 1987, J RADIOAN NUCL CH AR, V112, P133, DOI 10.1007/BF02037284
   XILEI L, 1988, ANAL CHIM ACTA, V211, P231, DOI 10.1016/S0003-2670(00)83683-1
   1989, REPORT JOINT WHO IAE
NR 36
TC 10
Z9 10
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0048-9697
J9 SCI TOTAL ENVIRON
JI Sci. Total Environ.
PD NOV 1
PY 1993
VL 140
BP 421
EP 430
PG 10
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA MH628
UT WOS:A1993MH62800037
PM 8272847
DA 2018-10-19
ER

PT J
AU STEYNBERG, S
   ROSSOUW, SF
AF STEYNBERG, S
   ROSSOUW, SF
TI THE AVAILABILITY OF RESEARCH JOURNALS IN SOUTH-AFRICAN ACADEMIC
   MEDICAL-LIBRARIES
SO SOUTH AFRICAN MEDICAL JOURNAL
LA English
DT Article
AB Biomedical researchers depend on the journals of science as a primary source of information. The spiralling cost of journals threatens the ability of libraries to provide their users' information needs. In this study the availability of a representative sample of journals used by South African biomedical researchers was determined at each of the seven medical faculty libraries. The application of a standardised document delivery test is described and the results are interpreted in terms of. (i) the capability index, which includes material obtainable through inter-library loans; and (ii) an availability index, or measure of the probability that a user will find an item without delay in his/her own library. The current status of availability of biomedical journals was found to be high at all the libraries; indeed, the scores compare favourably with results obtained at academic libraries overseas. There is, however, real concern that the financial crisis in tertiary education will cause the situation to deteriorate. Repetition of this test is recommended to monitor the (probably declining) level of journal availability. The information would support efforts to rationalise and subsequently strengthen academic medical libraries' collective holdings as a strategic national resource.
C1 CAPE TECHNIKON,SCH BUSINESS INFORMAT,CAPE TOWN,SOUTH AFRICA.
RP STEYNBERG, S (reprint author), UNIV CAPE TOWN,UNIV LIB,CAPE TOWN,SOUTH AFRICA.
CR Braun T., 1985, SCIENTOMETRIC INDICA
   Cronin B., 1984, CITATION PROCESS
   KANTOR P, 1984, OBJECTIVE PERFORMANC
   MANSBRIDGE J, 1986, LIBR INF SCI REV, V6, P299
   ORR RH, 1964, FED PROC, V23, P1310
   ORR RH, 1964, FED PROC, V23, P1297
   ORR RH, 1968, B MED LIBR ASSOC, V56, P241
   PROZESKY OW, 1990, BACKGROUND INFORMATI, P40
   VANHEERDEN PDR, 1992, S AFR MED J, V81, P243
NR 9
TC 4
Z9 4
U1 0
U2 1
PU MED ASSOC S AFRICA
PI JOHANNESBURG
PA MED HOUSE CENTRAL SQ 7430 PINELANDS JOHANNESBURG, SOUTH AFRICA
SN 0038-2469
J9 S AFR MED J
JI S. Afr. Med. J.
PD NOV
PY 1993
VL 83
IS 11
BP 837
EP 839
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA MG631
UT WOS:A1993MG63100011
PM 7839215
DA 2018-10-19
ER

PT J
AU CALDWELL, G
   NEUSE, EW
   STEPHANOU, A
AF CALDWELL, G
   NEUSE, EW
   STEPHANOU, A
TI SYNTHESIS OF WATER-SOLUBLE POLYAMIDOAMINES FOR BIOMEDICAL APPLICATIONS
   .2. POLYMERS POSSESSING INTRACHAIN-TYPE SECONDARY AMINO-GROUPS SUITABLE
   FOR SIDE-CHAIN ATTACHMENT
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
AB As part of a program to synthesize water-soluble polymeric carriers suitable for drug binding, the polyaddition reaction of methylenebisacrylamide with comonomers containing two primary amino groups is investigated. The copolymerization of the bisacrylamide with equimolar quantities of primary diamines under properly controlled experimental conditions is found to proceed in a linear propagation, giving rise to the formation of polyamides comprising two or more secondary amino groups in the recurring unit. Selected diamine monomers include ethylenediamine, diethylenetriamine, triethylenetetramine, 1,2-bis(3-aminopropylamino) ethane, and three 0,0'-bis-(2-aminopropyl) derivatives of poly(ethylene glycol) of different chain length, the last three monomers being chosen because of their outstanding hydrosolubilizing properties. Use of two different diamines in the proper stoichiometry leads to corresponding copolymers. The reactions are conducted in aqueous phase over periods of 1-3 days at 65-degrees-C, and the polymeric products, possessing the linear polyamidoamine structures 1 and 2, are fractionated by dialysis in membrane tubing with 12000-14000 molecular-mass cutoff and are isolated by freeze-drying as solid or resinous materials possessing complete solubility in water. Inherent viscosities are in the range of 8-40 mL g-1. Microanalytical and spectroscopic data confirm the proposed structures. The suitability of the intrachain secondary amine functions for side chain attachment and drug coupling is demonstrated in model reactions involving N-substitution. (C) 1993 John Wiley & Sons, Inc.
C1 UNIV WITWATERSRAND,DEPT CHEM,JOHANNESBURG 2050,SOUTH AFRICA.
CR BADER H, 1984, ANGEW MAKROMOL CHEM, V123, P457, DOI 10.1002/apmc.1984.051230121
   BARBUCCI R, 1981, J CHEM SOC DALTON, P2559, DOI 10.1039/dt9810002559
   CALDWELL G, 1992, S AFR J CHEM-S-AFR T, V45, P93
   DANUSSO F, 1970, POLYMER, V11, P88, DOI 10.1016/0032-3861(70)90029-7
   FERRUTI P, 1985, POLYMER, V26, P1336, DOI 10.1016/0032-3861(85)90309-X
   FERRUTI P, 1982, J APPL POLYM SCI, V27, P2239, DOI 10.1002/app.1982.070270633
   FERRUTI P, 1981, BIOMEDICAL APPLICATI, P39
   FERRUTI P, 1982, ADV POLYM SCI, V58, P55
   HARRIS JM, 1991, WATER SOLUBLE POLYM, P419
   MOLINEUX P, 1983, WATER SOLUBLE POLYM, V1, P19
NR 10
TC 24
Z9 26
U1 0
U2 5
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD OCT 15
PY 1993
VL 50
IS 3
BP 393
EP 401
DI 10.1002/app.1993.070500303
PG 9
WC Polymer Science
SC Polymer Science
GA LZ134
UT WOS:A1993LZ13400003
DA 2018-10-19
ER

PT J
AU SWINWOOD, JF
   FRASER, FM
AF SWINWOOD, JF
   FRASER, FM
TI ENVIRONMENTAL APPLICATION OF GAMMA-TECHNOLOGY - UPDATE ON THE CANADIAN
   SLUDGE IRRADIATOR
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 8TH INTERNATIONAL MEETING ON RADIATION PROCESSING
CY SEP 13-18, 1992
CL BEIJING, PEOPLES R CHINA
DE SLUDGE; DISINFECTION; RECYCLING; WASTE IRRADIATION
AB Waste treatment and disposal technologies have recently been subjected to increasing public and regulatory scrutiny. Concern for the environment and a heightened awareness of potential health hazards that could result from insufficient or inappropriate waste handling methods have combined to push waste generators in their search for new treatment alternatives. Gamma technology can offer a new option for the treatment of potentially infectious wastes, including municipal sewage sludge.
   Sewage sludge contains beneficial plant nutrients and a high organic component that make it ideal as a soil conditioning agent or fertilizer bulking material. It also carries potentially infectious microorganisms which limit opportunities for beneficial recycling of sludges. Gamma irradiation-disinfection of these sludges offers a reliable, fast and efficient method for safe sludge recycling.
   Nordion International's Market Development Division was created in 1987 as part of a broad corporate reorganization. It was given an exclusive mandate to develop new applications of gamma irradiation technology and markets for these new applications. Nordion has since explored and developed opportunities in food irradiation, pharmaceutical/cosmetic products irradiation, biomedical waste sterilization, airline waste disinfection, and sludge disinfection for recycling. This paper focuses on the last of these -a proposed sludge recycling facility that incorporates a cobalt 60 sludge irradiator.
RP SWINWOOD, JF (reprint author), NORDION INT INC,POB 13500,KANATA K2K 1X8,ON,CANADA.
NR 0
TC 8
Z9 8
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0146-5724
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD OCT-DEC
PY 1993
VL 42
IS 4-6
BP 683
EP 687
DI 10.1016/0969-806X(93)90352-U
PG 5
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA LK325
UT WOS:A1993LK32500026
DA 2018-10-19
ER

PT J
AU ALLCOCK, HR
   KLINGENBERG, EH
   WELKER, MF
AF ALLCOCK, HR
   KLINGENBERG, EH
   WELKER, MF
TI ALKANESULFONATION OF CYCLIC AND HIGH POLYMERIC PHOSPHAZENES
SO MACROMOLECULES
LA English
DT Article
ID ZWITTERIONIC SURFACTANTS; SIDE GROUPS; POLYPHOSPHAZENE; SULFONATES;
   SULTONES
AB A method for sulfonating aminophosphazenes with the use of 1,3-propanesultone is described. The alkanesulfonation reactions were first developed with small molecule phosphazene cyclic trimers as models for high polymeric phosphazenes. High molecular weight poly(aminophosphazenes) were then sulfonated using similar techniques. The structure and properties of the alkanesulfonated polymers were examined by DSC, intrinsic viscosity, and P-31, C-13, and H-1 NMR spectroscopy. This synthetic approach to sulfonated polymers is valuable for the development of new biomedical materials, membranes, reversibly cross-linkable polymers, surfactants, and polyelectrolytes.
RP ALLCOCK, HR (reprint author), PENN STATE UNIV,DEPT CHEM,UNIV PK,PA 16802, USA.
CR ALLCOCK HR, 1969, J AM CHEM SOC, V91, P5452, DOI 10.1021/ja01048a009
   ALLCOCK HR, 1989, MACROMOLECULES, V22, P75, DOI 10.1021/ma00191a015
   ALLCOCK HR, 1966, INORG CHEM, V5, P1709, DOI 10.1021/ic50044a016
   ALLCOCK HR, 1991, MACROMOLECULES, V24, P993, DOI 10.1021/ma00005a005
   ALLCOCK HR, 1991, CHEM MATER, V3, P1120, DOI 10.1021/cm00018a032
   ALLCOCK HR, 1964, J AM CHEM SOC, V86, P2591, DOI 10.1021/ja01067a015
   ALLCOCK HR, 1991, ORGANOMETALLICS, V10, P677, DOI 10.1021/om00049a029
   ALLEN CW, 1968, INORG CHEM, V7, P2183, DOI 10.1021/ic50069a002
   BECKEGOEHRING M, 1959, Z ANORG ALLG CHEM, V302, P103, DOI 10.1002/zaac.19593020110
   BIKALES NM, 1973, WATER SOLUBLE POLYM
   BRUNEL S, 1989, TETRAHEDRON, V45, P3363, DOI 10.1016/S0040-4020(01)81015-2
   CHAPMAN AC, 1960, J CHEM SOC, P3608, DOI 10.1039/jr9600003608
   CHITTENDEN RA, 1966, SPECTROCHIM ACTA, V22, P1449, DOI 10.1016/0371-1951(66)80138-8
   de Ficquelmont AM, 1939, ANN CHIM FRANCE, V12, P169
   DELL D, 1965, J CHEM SOC, P4070, DOI 10.1039/jr9650004070
   EISENBERG A, 1980, ADV CHEM SERIES, V187
   FEAKINS D, 1964, J CHEM SOC, P1735
   FEISTEL G, 1970, INORG CHEM, V9, P1401
   FEISTEL GR, 1967, J INORG NUCL CHEM, V29, P2731, DOI 10.1016/0022-1902(67)80011-3
   FISCHER RF, 1964, IND ENG CHEM, V56, P41, DOI 10.1021/ie50651a008
   FITZSIMMONS BW, 1964, J CHEM SOC, P1735, DOI 10.1039/jr9640001735
   FITZSIMMONS BW, 1961, CHEM IND-LONDON, P109
   GANAPATHIAPPAN S, 1988, MACROMOLECULES, V21, P2299, DOI 10.1021/ma00185a075
   GOLDSCHMIDT BM, 1974, J HETEROCYCLIC CHEM, V11, P719, DOI 10.1002/jhet.5570110510
   GREGOR HP, 1975, POLYM SCI TECHNOL, V7, P51
   HELBERGER JH, 1949, LIEBIGS ANN CHEM, V565, P22
   HELBERGER JH, 1954, LIEBIGS ANN CHEM, V586, P147
   HIGUCHI A, 1988, J APPL POLYM SCI, V36, P1753, DOI 10.1002/app.1988.070360804
   KEAT R, 1965, J CHEM SOC, P2215, DOI 10.1039/jr9650002215
   KEAT R, 1965, J CHEM SOC, P7193, DOI 10.1039/jr9650007193
   KING JF, 1988, J CHEM SOC CHEM COMM, P415, DOI 10.1039/c39880000415
   LASCHEWSKY A, 1991, POLYMER, V32, P2070, DOI 10.1016/0032-3861(91)90175-I
   LASCHEWSKY A, 1991, POLYMER, V32, P208
   LEHR W, 1967, Z ANORG ALLG CHEM, V350, P18, DOI 10.1002/zaac.19673500104
   MANI NV, 1969, J CHEM SOC, P51
   MCBEE ET, 1966, INORG CHEM, V5, P450, DOI 10.1021/ic50037a026
   MCBEE ET, 1959, AD209666
   MCBEE ET, 1991, AD254984
   MCBEE ET, 1959, AD209669
   MCGEACHIN HM, 1960, CHEM IND-LONDON, P1131
   MOLYNEUX P, 1983, WATER SOLUBLE POLYM, V1
   MONOTONERI E, 1989, MACROMOL CHEM, V190, P191
   MONOTONERI E, 1989, J MACROMOL SCI CHEM, V26, P645
   NICHOLS GM, 1961, ASD612 TECH REP
   PAETZOLD E, 1987, J PRAKT CHEM, V329, P725, DOI 10.1002/prac.19873290423
   PULAY P, 1969, ZS ACTA CHIM ACAD SC, V60, P333
   RATZ R, 1960, J INORG NUCL CHEM, V16, P60, DOI 10.1016/0022-1902(60)80087-5
   RATZ RFW, 1959, Patent No. 2876247
   RAY SK, 1961, J CHEM SOC, P872, DOI 10.1039/jr9610000872
   RAY SK, 1959, CHEM IND-LONDON, P53
   ROBERTS DW, 1987, TETRAHEDRON, V43, P1027, DOI 10.1016/S0040-4020(01)90041-9
   ROESKY HW, 1971, CHEM BER-RECL, V104, P653, DOI 10.1002/cber.19711040232
   ROESKY HW, 1968, INORG NUCL CHEM LETT, V4, P463
   SEEL F, 1958, Z ANORG ALLG CHEM, V295, P316, DOI 10.1002/zaac.19582950506
   UCHIDA M, 1989, MACROMOLECULES, V22, P2381, DOI 10.1021/ma00195a065
   1984, Patent No. 49099979
   1980, Patent No. 55139347
   1987, Patent No. 63112564
NR 58
TC 24
Z9 24
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD SEP 27
PY 1993
VL 26
IS 20
BP 5512
EP 5519
DI 10.1021/ma00072a032
PG 8
WC Polymer Science
SC Polymer Science
GA LZ505
UT WOS:A1993LZ50500032
DA 2018-10-19
ER

PT J
AU BOCQUET, B
   AITABDELMALEK, R
   LEROY, Y
AF BOCQUET, B
   AITABDELMALEK, R
   LEROY, Y
TI DECONVOLUTION AND WIENER FILTERING OF SHORT-RANGE RADIOMETRIC IMAGES
SO ELECTRONICS LETTERS
LA English
DT Article
DE BIOMEDICAL ELECTRONICS; IMAGE PROCESSING
ID MICROWAVE RADIOMETRY; THERMAL STRUCTURES
AB A radiometric probe positioned at different points on the surface of a lossy medium can detect the presence of a subsurface thermal noise source. Radiometric images are obtained by a combination of measured data and calculated weighting functions of the probe associated with the underlying lossy materials. The Letter shows that the quality of these images and their spatial resolution can be greatly improved by Wiener filtering deconvolution of their corresponding data.
RP BOCQUET, B (reprint author), UNIV SCI & TECHNOL LILLE,INST ELECTR & MICROELECTR NORD,DEPT HYPERFREQUENCES & SEMICOND,CNRS,F-59655 VILLENEUVE DASCQ,FRANCE.
CR BARDATI F, 1991, JUL P PIERS CAMBR
   BOCQUET B, 1986, ELECTRON LETT, V22, P120, DOI 10.1049/el:19860084
   CAMPBELL AM, 1992, PHYS MED BIOL, V37, P193, DOI 10.1088/0031-9155/37/1/014
   ENEL L, 1984, ELECTRON LETT, V20, P293, DOI 10.1049/el:19840200
   Kafadar K, 1986, IEEE T INSTRUM MEAS, V35, P492
   Leroy Y., 1987, Automedica, V8, P181
   MAMOUNI A, 1991, IEEE T MICROW THEORY, V39, P124, DOI 10.1109/22.64615
   MIZUSHINA S, 1991, JUL P PIERS CAMBR
   Pratt WK, 1978, DIGITAL IMAGE PROCES
   SOMLO PI, 1979, IEEE T MICROW THEORY, V27, P128, DOI 10.1109/TMTT.1979.1129573
NR 10
TC 10
Z9 11
U1 0
U2 1
PU IEE-INST ELEC ENG
PI HERTFORD
PA MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD, ENGLAND SG1 2AY
SN 0013-5194
J9 ELECTRON LETT
JI Electron. Lett.
PD SEP 2
PY 1993
VL 29
IS 18
BP 1628
EP 1629
DI 10.1049/el:19931084
PG 2
WC Engineering, Electrical & Electronic
SC Engineering
GA MG407
UT WOS:A1993MG40700024
DA 2018-10-19
ER

PT J
AU KUPILARANTALA, T
   HYVONENDABEK, M
   RAISANEN, J
AF KUPILARANTALA, T
   HYVONENDABEK, M
   RAISANEN, J
TI EFFECTS OF PREPARATION METHODS OF BIOMEDICAL SAMPLES ON PIXE MEASUREMENT
   SENSITIVITY
SO APPLIED RADIATION AND ISOTOPES
LA English
DT Article
ID X-RAY-EMISSION; TRACE-ELEMENT ANALYSIS; EXTERNAL BEAM PIXE; PROTON-BEAM;
   TISSUES; TUMORS
AB Instrumental sample preparation techniques for PIXE measurements of human blood serum and bovine muscle were investigated. The techniques studied were direct measurement of a drop, drying on a foil and on an Al cup, lyophilization on a foil, pellet pressing of dried material, microtome sectioning and biopsy preparation. The same serum and muscle were used in each procedure allowing the comparison of detection limits between different methods. The most beneficial technique for both samples was lyophilization and pellet pressing.
RP KUPILARANTALA, T (reprint author), UNIV HELSINKI,DEPT PHYS,POB 9,SF-00014 HELSINKI,FINLAND.
CR AARNIO P, 1990, SAMP90
   ANDERSSON M, 1990, NUCL INSTRUM METH B, V49, P198, DOI 10.1016/0168-583X(90)90242-M
   ANTTILA A, 1985, NUCL INSTRUM METH B, V12, P245, DOI 10.1016/0168-583X(85)90058-8
   BARNES BK, 1975, ADV XRAY ANAL, V18, P343
   BEARSE RC, 1974, ANAL CHEM, V46, P499, DOI 10.1021/ac60340a028
   CAMPBELL JL, 1985, NUCL INSTRUM METH B, V6, P551, DOI 10.1016/0168-583X(85)90017-5
   CAMPBELL JL, 1975, ANAL CHEM, V47, P1542, DOI 10.1021/ac60359a006
   CAMPBELL JL, 1973, ADV XRAY ANALYSIS, V17, P457
   DECONNINCK G, 1977, NUCL INSTRUM METHODS, V142, P275, DOI 10.1016/0029-554X(77)90838-2
   DUREK K, 1983, IEEE T NUCL SCI, V30, P1310, DOI 10.1109/TNS.1983.4332517
   GALUSZKA J, 1984, NUCL INSTRUM METH B, V3, P141, DOI 10.1016/0168-583X(84)90351-3
   HECK D, 1983, IEEE T NUCL SCI, V30, P1220, DOI 10.1109/TNS.1983.4332493
   HYVONENDABEK M, 1984, CLIN CHEM, V30, P529
   HYVONENDABEK M, 1981, J RADIOANAL CHEM, V63, P163, DOI 10.1007/BF02518418
   JOHANSSON E, 1987, NUCL INSTRUM METH B, V22, P179, DOI 10.1016/0168-583X(87)90321-1
   KHAN AH, 1979, NUCL INSTRUM METHODS, V165, P253, DOI 10.1016/0029-554X(79)90279-9
   KIVITS HPM, 1979, NUCL INSTRUM METHODS, V164, P225, DOI 10.1016/0029-554X(79)90239-8
   LAPATTO R, 1989, BIOL TRACE ELEM RES, V19, P161, DOI 10.1007/BF02924293
   MAENHAUT W, 1987, NUCL INSTRUM METH B, V22, P138, DOI 10.1016/0168-583X(87)90311-9
   MAENHAUT W, 1980, NUCL INSTRUM METHODS, V168, P557, DOI 10.1016/0029-554X(80)91310-5
   MAENHAUT W, 1984, NUCL INSTRUM METH B, V3, P135, DOI 10.1016/0168-583X(84)90350-1
   MANGELSON NF, 1977, NUCL INSTRUM METHODS, V142, P133, DOI 10.1016/0029-554X(77)90821-7
   PALLON J, 1981, NUCL INSTRUM METHODS, V181, P71, DOI 10.1016/0029-554X(81)90583-8
   RAISANEN J, 1981, INT J APPL RADIAT IS, V32, P165, DOI 10.1016/0020-708X(81)90108-3
   RAISANEN J, 1982, NUCL INSTRUM METHODS, V196, P489, DOI 10.1016/0029-554X(82)90119-7
   ROBAYE G, 1980, NUCL INSTRUM METHODS, V172, P535, DOI 10.1016/0029-554X(80)90346-8
   SHAO HR, 1990, NUCL INSTRUM METH B, V49, P238, DOI 10.1016/0168-583X(90)90252-P
   TANAKA M, 1987, NUCL INSTRUM METH B, V22, P152, DOI 10.1016/0168-583X(87)90314-4
   TAPPER UAS, 1987, NUCL INSTRUM METH B, V22, P176, DOI 10.1016/0168-583X(87)90320-X
   WALTER RL, 1974, ANAL CHEM, V46, P843, DOI 10.1021/ac60343a038
NR 30
TC 2
Z9 2
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0969-8043
J9 APPL RADIAT ISOTOPES
JI Appl. Radiat. Isot.
PD SEP
PY 1993
VL 44
IS 9
BP 1177
EP 1182
DI 10.1016/0969-8043(93)90061-E
PG 6
WC Chemistry, Inorganic & Nuclear; Nuclear Science & Technology; Radiology,
   Nuclear Medicine & Medical Imaging
SC Chemistry; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA LV300
UT WOS:A1993LV30000003
PM 8401448
DA 2018-10-19
ER

PT J
AU HELSEN, JA
   JAECQUES, SV
   VANHUMBEECK, J
   SIMON, JP
AF HELSEN, JA
   JAECQUES, SV
   VANHUMBEECK, J
   SIMON, JP
TI EVALUATION OF AN ELASTOMER FOR BIOMEDICAL USE IN LOAD-BEARING
   APPLICATIONS .1. IN-VITRO FATIGUE TESTING
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
AB The fatigue behaviour of a medical-grade thermoplastic polyolefin (TPO) was investigated with the objective of using TPOs for endoprosthetical aims in dental and orthopaedic applications. For this purpose, a TPO was subjected to the combined action of shear and compression fatigue while in contact with Hanks' solution. Cyclic loading between 150 and 1500 kPa shear stress and a number of cycles up to 9 x 10(6) was applied. The potential fatigue damage was assessed by in-fatigue-recording of the mechanical hysteresis curves and, after fatigue, by swelling tests in acetic acid solutions, dynamic mechanical thermal analysis, Fourier transform infrared spectroscopy, X-ray diffraction and scanning electron microscopy. The combined and critical application of these techniques allowed us to conclude that this material exhibits a very satisfactory fatigue behaviour under the loads investigated, making this material potentially useful for endoprostheses. Moreover, biomedical prescreening tests (according to USP Class VI) were all negative, stimulating continued research on this type of material.
C1 KATHOLIEKE UNIV LEUVEN,HOSP ORTHOPAED,DEPT ORTHOPAED SURG,B-3212 PELLENBERG,BELGIUM.
RP HELSEN, JA (reprint author), KATHOLIEKE UNIV LEUVEN,DEPT MET & MAT ENGN,CROYLAAN 2,B-3001 LOUVAIN,BELGIUM.
CR ALEXANDER LE, 1979, XRAY DIFFRACTION MET, P176
   EISELE U, 1990, INTRO POLYM PHYSICS, P40
   Engel L, 1981, ATLAS POLYM DAMAGE
   FUYIYAMA M, 1980, J POLYM SCI POL LETT, V18, P105
   MAST F, 1992, 4TH WORLD BIOM C BER, P692
   MURAYAMA T, 1978, DYNAMIC MECHANICAL A
   Rader C. P., 1990, THERMOPLASTIC ELASTO, P159
   REISCH MS, 1992, CHEM ENG NEWS   0504, P29
   Turley J. W., 1965, XRAY DIFFRACTION PAT
   VONCK CG, 1989, XRAY SCATTERING SYNT
   WEAST RC, 1991, CRC HDB CHEM PHYSICS
   1986, ANN BOOK ASTM STANDA, V15, P329
   1980, US PHARMACOPEIA, V20, P950
NR 13
TC 4
Z9 4
U1 0
U2 2
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 1993
VL 4
IS 5
BP 471
EP 480
DI 10.1007/BF00120127
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA MG125
UT WOS:A1993MG12500006
DA 2018-10-19
ER

PT J
AU FOSCHI, D
   CASTOLDI, L
   LESMA, A
   MUSAZZI, M
   BENEVENTO, A
   TRABUCCHI, E
AF FOSCHI, D
   CASTOLDI, L
   LESMA, A
   MUSAZZI, M
   BENEVENTO, A
   TRABUCCHI, E
TI EFFECTS OF ISCHEMIA AND REPERFUSION ON LIVER-REGENERATION IN RATS
SO EUROPEAN JOURNAL OF SURGERY
LA English
DT Article
DE LIVER REGENERATION; HEPATECTOMY; OXYGEN FREE RADICALS; LIPID
   PEROXIDATION
ID HEPATOCYTE GROWTH-FACTOR; LIPID-PEROXIDATION; FREE-RADICALS;
   SUPEROXIDE-DISMUTASE; HEPATIC-INJURY; DAMAGE; PRESERVATION; PREVENTION;
   ISCHEMIA; OXIDASE
AB Objective: To assess the effects of oxygen free radicals on liver regeneration in rats after 80% hepatectomy.
   Design: Open laboratory study.
   Setting: Institute of Biomedical Sciences, University of Milan, Italy.
   Material. Female Sprague-Dawley rats.
   Interventions: After laparotomy 122 rats had ischaemia induced by clamping of the portal vein and hepatic artery, and 93 rats had manipulation of the vessels only. They were then allowed to recover before 80% hepatectomy was done. Absolute controls (n = 16) did not have a laparotomy. Mortality was recorded, and surviving rats were killed one, three, five, and seven days after operation. A further 10 rats had 80% hepatectomies and then underwent a 10 minute period of ischaemia 24 hours later. These animals were killed after three days. In yet more experiments 38 rats underwent 80% hepatectomies and were then divided into four groups: 8 were given allopurinol 50 mg/kg/day starting three days before operation; 8 were given superoxide dismutase 4.16 mg/kg intraperitoneally 30 minutes before induction of ischaemia; 12 were given verapamil 0.1 mg/kg 30 minutes before induction of ischaemia; and 10 were given saline (controls).
   Main outcome measures: Incorporation of tritiated thymidine into DNA, differences in liver weights, and lipid peroxide concentrations.
   Results: 43 rats died after ischaemia/reperfusion and 19 after hepatectomy alone. Ischaemia/reperfusion caused a significant reduction in the incorporation of tritiated thymidine into DNA 24 hours after hepatectomy (p < 0.01), and significant inhibition of recovery of liver weight three (p < 0.01) and five (p < 0.05) days after hepatectomy. These effects were associated with high lipid peroxide concentrations at three days. Allopurinol (p < 0.01, p < 0.05), superoxide dismutase (p < 0.01, p < 0.01) and verapamil (p < 0.01, N.S.) reduced the effects of ischaemia/ reperfusion on liver weights or lipid peroxide concentrations three days after hepatectomy.
   Conclusion: A 10 minute period of ischaemia followed by reperfusion temporarily reduces liver regeneration after 80% hepatectomy in rats.
C1 UNIV MILAN,INST BIOMED SCI L SACCO,DEPT SURG,I-20122 MILAN,ITALY.
   UNIV PAVIA,DEPT SURG,I-27100 PAVIA,ITALY.
RP FOSCHI, D (reprint author), UNIV MILAN,OSPED MAGGIORE,DEPT SURG & SURG THERAPEUT 1,I-20122 MILAN,ITALY.
OI Foschi, Diego/0000-0002-7702-8226
CR ADKISON D, 1986, ACTA PHYSL SCAND S, V548, P101
   ARTHUR MJP, 1985, GASTROENTEROLOGY, V89, P1114, DOI 10.1016/0016-5085(85)90218-5
   BACON BR, 1989, CHEM-BIOL INTERACT, V70, P183, DOI 10.1016/0009-2797(89)90045-8
   BECKER FF, 1963, AM J PATHOL, V43, P497
   BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315
   CHIEN KR, 1977, AM J PATHOL, V88, P539
   COCKERILL MJ, 1983, BIOCHIM BIOPHYS ACTA, V75, P208
   COMPORTI M, 1985, LAB INVEST, V53, P599
   DELMAESTRO RF, 1980, ACTA PHYSL SCAND S, V492, P153
   ENGERSON TD, 1987, J CLIN INVEST, V79, P1564, DOI 10.1172/JCI112990
   FLEIG WE, 1988, SCAND J GASTROENTERO, V23, P31, DOI 10.3109/00365528809095911
   FREEMAN BA, 1982, LAB INVEST, V47, P412
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   JENNISCHE E, 1984, ACTA PATH MICRO IM A, V92, P55
   KAWAMOTO S, 1989, TRANSPLANT P, V21, P1287
   LINDROOS PM, 1991, HEPATOLOGY, V13, P743, DOI 10.1002/hep.1840130422
   MACKENZIE RJ, 1975, BRIT J SURG, V62, P431, DOI 10.1002/bjs.1800620603
   MARUBAYASHI S, 1982, SURGERY, V91, P631
   MARUBAYASHI S, 1986, SURGERY, V99, P184
   MCCORD JM, 1987, FASEB J, V46, P2402
   MCCORD JM, 1983, SURGERY, V94, P412
   MCKELVEY TG, 1988, AM J PHYSIOL, V254, pG753
   MICHALOPOULOS GK, 1992, HEPATOLOGY, V15, P149, DOI 10.1002/hep.1840150125
   NAUTA RJ, 1991, ANN SURG, V213, P137, DOI 10.1097/00000658-199102000-00008
   NORDSTROM G, 1985, SURGERY, V97, P679
   OBERLEY LW, 1979, CANCER RES, V39, P1141
   ONTELL SJ, 1989, ANN SURG, V209, P200, DOI 10.1097/00000658-198902000-00011
   PLACER ZA, 1966, ANAL BIOCHEM, V16, P359, DOI 10.1016/0003-2697(66)90167-9
   PLAYER TJ, 1977, BIOCHEM BIOPH RES CO, V78, P1397, DOI 10.1016/0006-291X(77)91447-4
   SITUNAYAKE RD, 1990, GUT, V31, P1311, DOI 10.1136/gut.31.11.1311
   SOBCZAK J, 1986, BIOCHIMIE, V68, P957, DOI 10.1016/S0300-9084(86)80039-6
   SOBCZAK J, 1989, ONCOGENE, V4, P1503
   SOMIMOTO K, 1987, SURGERY, V102, P821
   SOUTHARD JH, 1987, SURGERY, V101, P566
NR 34
TC 40
Z9 41
U1 0
U2 0
PU SCANDINAVIAN UNIVERSITY PRESS
PI OSLO
PA PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO,
   NORWAY
SN 1102-4151
J9 EUR J SURG
JI Eur. J. Surg.
PD AUG
PY 1993
VL 159
IS 8
BP 393
EP 398
PG 6
WC Surgery
SC Surgery
GA LU761
UT WOS:A1993LU76100002
PM 8218549
DA 2018-10-19
ER

PT J
AU SHIH, CY
   LAI, JY
AF SHIH, CY
   LAI, JY
TI POLYVINYL-ALCOHOL PLASMA-DEPOSITED NYLON-4 MEMBRANE FOR HEMODIALYSIS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID BIOMEDICAL APPLICATIONS; POLYMERIZATION; SURFACES
AB Polyvinyl alcohol (PVA) is a hydrophilic and blood compatible material, but it is easily hydrolyzed in aqueous solution. Various methods, including chemical crosslinking and gamma-ray irradiation, have been investigated by many researchers for overcoming the instability of PVA in aqueous solution. This study suggests a new hemodialysis membrane, which is prepared by plasma depositing vinylacetate (VAc) onto annealled nylon 4 membrane, followed by hydrolysis treatment. This improves the blood compatibility of nylon 4 and overcomes the hydrolysis problem of PVA. In addition to conventional plasma deposition, the plasma initiated interpenetrating network (IPN) method is also investigated.
   The new hemodialysis membranes prepared by both conventional plasma deposited VAc onto nylon 4 (PPVA/N4) and IPN polymer of plasma initiated VAc onto nylon 4 (PIPVA/N4 IPN) show significant improvement in blood compatibility. However, the solute permeabilities of PIPVA/N4 IPN membranes are higher than those of PPVA/N4 membranes. The permeabilities of NaCl, vitamin B12, and albumin for membranes prepared by IPN at 80 W, 30 sec plasma deposited conditions, i.e., the optimized conditions, are 3.614, 0.070, and 0.000 X 10(-5) cm2 /min, respectively. The mole ratio of adsorbed fibrinogen to adsorbed albumin (the mole ratio F/A) for this membrane is 0.20, and it also shows excellent blood compatibility in this study. (C) 1993 John Wiley & Sons, Inc.
C1 CHUNG YUAN CHRISTIAN UNIV,DEPT CHEM ENGN,CHUNGLI 32023,TAIWAN.
   CHENGSHIU JR COLL TECHNOL & COMMERCE,DEPT CHEM ENGN,KAOHSIUNG,TAIWAN.
CR ABSOLOM DR, 1987, J BIOMED MATER RES, V21, P161, DOI 10.1002/jbm.820210202
   COOPES IH, 1982, J MACROMOL SCI CHEM, VA17, P217, DOI 10.1080/00222338208063256
   HUANG RYM, 1981, J APPL POLYM SCI, V26, P1907, DOI 10.1002/app.1981.070260615
   HUANG RYM, 1981, J APPL POLYM SCI, V26, P1135, DOI 10.1002/app.1981.070260407
   JONG A, 1988, J APPL POLYM SCI, V36, P87, DOI 10.1002/app.1988.070360108
   KAIFU K, 1982, J BIOMED MATER RES, V16, P757, DOI 10.1002/jbm.820160602
   KARAKELLE M, 1989, J MEMBRANE SCI, V41, P305, DOI 10.1016/S0376-7388(00)82410-2
   LAI JY, 1992, J MEMBRANE SCI, V66, P169, DOI 10.1016/0376-7388(92)87007-K
   LAI JY, 1990, J APPL POLYM SCI, V39, P2293, DOI 10.1002/app.1990.070391109
   LAI JY, 1989, J APPL POLYM SCI, V37, P1465, DOI 10.1002/app.1989.070370603
   LAI JY, 1986, J APPL POLYM SCI, V32, P4709, DOI 10.1002/app.1986.070320435
   LAI JY, 1991, J APPL POLYM SCI, V43, P1431, DOI 10.1002/app.1991.070430804
   YASUDA H, 1982, BIOMATERIALS, V3, P68, DOI 10.1016/0142-9612(82)90036-9
   YEH YS, 1988, J BIOMED MATER RES, V22, P795, DOI 10.1002/jbm.820220904
   YOON SC, 1982, J APPL POLYM SCI, V27, P3133, DOI 10.1002/app.1982.070270834
NR 15
TC 16
Z9 16
U1 0
U2 9
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 1993
VL 27
IS 8
BP 983
EP 989
DI 10.1002/jbm.820270803
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA LM052
UT WOS:A1993LM05200002
PM 8408126
DA 2018-10-19
ER

PT J
AU BARRETT, B
AF BARRETT, B
TI HEALTH-CARE BEHAVIOR ON NICARAGUA ATLANTIC COAST
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE NICARAGUA; CENTRAL AMERICA; HEALTH BEHAVIOR; ETHNOMEDICINE; TRADITIONAL
   MEDICINE; WESTERN MEDICINE
ID WAR; POLITICS; SERVICES
AB Survey methods are used to investigate health behavior in five communities on Nicaragua's Atlantic Coast. Eighteen health behaviors classified as 'biomedical' or 'traditional' are analyzed according to the ethnicity and educational level of the respondent. Household location (urban vs rural) and material wealth are also analyzed as predictors of health care behavior. Traditional behaviors are found to vary considerably among the six ethnic groups and among the various socioeconomic groupings. Biomedical behaviors are not found to be clearly related to ethnicity, wealth, or education.
RP BARRETT, B (reprint author), JOHNS HOPKINS UNIV,INST NUTR CENT AMER & PANAMA,APARTADO 1188,GUATEMALA CITY,GUATEMALA.
CR AMADOR M, 1991, RAMA WANGKI, V2, P27
   ARAUZ R, 1991, LANCET, V337, P1290, DOI 10.1016/0140-6736(91)92960-A
   Baer Hans A., 1987, ENCOUNTERS BIOMEDICI
   BENT BK, 1991, TRABAJO MONOGRAFICO
   BENTLEY ME, 1988, SOC SCI MED, V27, P75, DOI 10.1016/0277-9536(88)90165-7
   BOSSERT T, 1982, MED ANTHROPOL Q, V15, P773
   BRAVEMAN P, 1987, INT J HEALTH SERV, V17, P169, DOI 10.2190/DB43-MWPL-2V12-WGXY
   BRAVEMAN P, 1985, WORLD HLTH FORUM, V6, P369
   BROWNER CH, 1991, MED ANTHROPOL Q, V5, P99, DOI 10.1525/maq.1991.5.2.02a00010
   *COMM HLTH RIGHTS, 1991, CRIT COND HLTH CAR N
   COREIL J, 1983, CULT MED PSYCHIAT, V7, P131, DOI 10.1007/BF00051846
   COSMINSKY S, 1977, SOC SCI MED, V11, P325, DOI 10.1016/0037-7856(77)90190-1
   *CTR INV DOC COST, 1989, EST ZON ESP II
   *CTR INV DOC COST, 1987, ETHN GROUPS NAT STAT
   DONAHUE J, 1986, NICARAGUAN REVOLUTIO
   DONAHUE JM, 1983, HUM ORGAN, V42, P264, DOI 10.17730/humo.42.3.x737h47hqw3r2785
   ELLSBERG MC, 1982, REV CENTROAM CIENCIA, V23, P145
   ELLSBERG MC, 1983, SCI PEOPLE, V15, P14
   ESCUDERO JC, 1980, INT J HEALTH SERV, V10, P647, DOI 10.2190/NT2B-0K80-EK76-26MV
   Garfield R., 1989, HLTH REVOLUTION NICA
   GARFIELD R, 1987, INT Q COMMUNITY HLTH, V7, P123
   GARFIELD RM, 1989, SOC SCI MED, V28, P669, DOI 10.1016/0277-9536(89)90214-1
   GARFIELD RM, 1987, AM J PUBLIC HEALTH, V77, P615, DOI 10.2105/AJPH.77.5.615
   GARFIELD RM, 1984, AM J PUBLIC HEALTH, V74, P1138, DOI 10.2105/AJPH.74.10.1138
   HALPERIN D, 1982, NEW ENGL J MED, V306, P308
   HEIBY JR, 1981, AM J PUBLIC HEALTH, V71, P514, DOI 10.2105/AJPH.71.5.514
   HELMS M, 1971, ASANG ADAPTIONS CULT
   HHELMS M, 1969, ANNTHR Q, V42, P325
   HODGSON R, 1967, THESIS FACULTAD CIEN
   KLEINMAN A, 1978, AM ANTHROPOL, V80, P661, DOI 10.1525/aa.1978.80.3.02a00170
   Lazarus E. S., 1986, MED ANTHROPOL Q, V17, P136
   LEFTON D, 1984, CAN MED ASSOC J, V130, P781
   LIUISER V, 1985, TE VOY AYUDAR NADA M
   LOEVINSOHN B, 1986, LANCET          0706, P1314
   LOEVINSOHN BP, 1987, AM J PUBLIC HEALTH, V77, P1407, DOI 10.2105/AJPH.77.11.1407
   *NAT CENTR AM HLTH, 1991, UNC PROGN HLTH SOL
   NELSON H, 1983, NATIONS HLTH     OCT
   *NICAR MIN SAL, 1991, PLAN TRIEN SAL 1991
   *NICAR MIN SAL REG, 1989, AN EV DIV DOC INV
   *NICAR MIN SAL REG, 1989, INF AN REG 1989
   NIETSCHMANN B, 1972, HUM ECOL, V1, P41, DOI 10.1007/BF01791280
   NIETSCHMANN B, 1969, THESIS U WISCONSIN
   PIJOAN M, 1946, Am Indig, V6, P157
   PIJOAN M, 1946, Am Indig, V6, ppassim
   PIJOAN M, 1944, AM INDIGENA, V4, P255
   RAMNUCCIROSS L, 1969, J HEALTH SOC BEHAV, V10, P201
   SANDIFORD P, 1991, AM J PUBLIC HEALTH, V81, P30, DOI 10.2105/AJPH.81.1.30
   Singer M, 1990, Med Anthropol, V12, P289
   VIISSAINEN K, 1991, REVOLUTION COUNTERRE
   WELLER SC, 1991, MED ANTHR, V13, P57
   *WHO, 1990, HLTH COND AM, P212
   *WHO, 1978, REP INT C PRIM HLTH
   1991, J PUBL HLTH POLICY, V12, P119
NR 53
TC 10
Z9 10
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD AUG
PY 1993
VL 37
IS 3
BP 355
EP 368
DI 10.1016/0277-9536(93)90266-7
PG 14
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA LM907
UT WOS:A1993LM90700008
PM 8356484
DA 2018-10-19
ER

PT J
AU PETERSEN, DR
AF PETERSEN, DR
TI REVIEWS AND COMMENTS ON ALCOHOL RESEARCH
SO ALCOHOL
LA English
DT Editorial Material
ID ACETALDEHYDE; BREATH; ASSAY
AB This section of the journal is designed to provide readers with reviews of recent literature, and to stimulate research on questions that are important in the treatment and prevention of alcohol addiction. Research can provide insight into the causes of alcohol abuse and addiction, as well as answers to questions concerning the biomedical and psychological consequences of alcohol consumption. The ideas and critique expressed in this department are those of the author and do not necessarily represent the views of the editor, editorial board, or publisher of Alcohol. Reference to the original articles is recommended before quoting any of this material in scientific publications.
C1 UNIV COLORADO,HLTH SCI CTR,HEPATOBILIARY RES CTR,DENVER,CO 80262.
RP PETERSEN, DR (reprint author), UNIV COLORADO,HLTH SCI CTR,ALCOHOL RES CTR,DENVER,CO 80262, USA.
CR DANNECKER JR, 1981, ANAL BIOCHEM, V114, P1, DOI 10.1016/0003-2697(81)90442-5
   PHILLIPS M, 1984, ALCOHOL CLIN EXP RES, V8, P293, DOI 10.1111/j.1530-0277.1984.tb05514.x
   STOWELL AR, 1980, BIOCHEM PHARMACOL, V29, P783, DOI 10.1016/0006-2952(80)90557-2
NR 3
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0741-8329
J9 ALCOHOL
JI Alcohol
PD JUL-AUG
PY 1993
VL 10
IS 4
BP 323
EP 323
DI 10.1016/0741-8329(93)90013-E
PG 1
WC Substance Abuse; Pharmacology & Pharmacy; Toxicology
SC Substance Abuse; Pharmacology & Pharmacy; Toxicology
GA LL114
UT WOS:A1993LL11400013
DA 2018-10-19
ER

PT J
AU MOSHER, DF
AF MOSHER, DF
TI ADHESIVE PROTEINS AND THEIR CELLULAR RECEPTORS
SO CARDIOVASCULAR PATHOLOGY
LA English
DT Article
ID GLYCOPROTEIN-IIB-IIIA; PLATELET ACTIVATION; CYTOPLASMIC DOMAIN;
   ENDOTHELIAL-CELLS; INTRACELLULAR PH; VITRONECTIN; SURFACES; INTEGRINS;
   PLASMA; PHOSPHORYLATION
AB Many, and perhaps most, important cell adhesion receptors and ligands have been identified and characterized. The reagents, systems, and technologies are therefore available for a ''reductionist'' approach to the roles of cell adhesion in processes such as the interaction of blood with biomedical materials. Key to the success of this approach is the recognition that the same molecules or families of molecules are responsible for many different processes in organisms that have evolved over hundreds of millions of years. For instance, the alpha(IIb)beta3 integrin receptor that mediates platelet adhesion and aggregation and is defective in Glanzmann thrombasthenia in humans is very similar to the receptor that mediates muscle attachment and is defective in fruitflies with the myospheriod phenotype. The challenges to the field of cell adhesion are to understand the events that control the activities of adhesion receptors and ligands, the signals that emanate from ligated receptors, and how the signals are processed to influence behavior when cells encounter surfaces or other cells. To exemplify these issues, this chapter focuses on the alpha(v)beta3 integrin receptor, an adhesive ligand for the receptor, vitronectin; and modulation of cellular adhesion to vitronectin by high-molecular-weight kininogen. Platelet adhesion to biomaterials is contrasted with the more complex phenomenon of neutrophil adhesion to vascular endothelial cells.
RP MOSHER, DF (reprint author), UNIV WISCONSIN, SCH MED, DIV HEMATOL, MADISON, WI 53706 USA.
CR ALBRECHT RM, 1989, AM J ANAT, V185, P149, DOI 10.1002/aja.1001850208
   ANDRADE JD, 1987, ANN NY ACAD SCI, V516, P158, DOI 10.1111/j.1749-6632.1987.tb33038.x
   ASAKURA S, 1992, J CELL BIOL, V116, P465, DOI 10.1083/jcb.116.2.465
   BALE MD, 1989, BLOOD, V74, P2698
   BRASH JL, 1988, BLOOD, V71, P932
   BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8
   COLLINS WE, 1987, ANN NY ACAD SCI, V516, P291, DOI 10.1111/j.1749-6632.1987.tb33049.x
   Engel J, 1991, CURR OPIN CELL BIOL, V3, P779, DOI 10.1016/0955-0674(91)90050-9
   FABRIZIUSHOMAN DJ, 1992, THROMB HAEMOSTASIS, V68, P194
   FABRIZIUSHOMAN DJ, 1991, J BIOMAT SCI-POLYM E, V3, P27, DOI 10.1163/156856292X00060
   FERRELL JE, 1989, P NATL ACAD SCI USA, V86, P2234, DOI 10.1073/pnas.86.7.2234
   GOLDEN A, 1990, J CELL BIOL, V111, P3117, DOI 10.1083/jcb.111.6.3117
   Grinnell F, 1978, Int Rev Cytol, V53, P65
   HAYMAN EG, 1983, P NATL ACAD SCI-BIOL, V80, P4003, DOI 10.1073/pnas.80.13.4003
   HIBBS ML, 1991, SCIENCE, V251, P1611, DOI 10.1126/science.1672776
   HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O
   INGBER DE, 1990, J CELL BIOL, V110, P1803, DOI 10.1083/jcb.110.5.1803
   KNAPP W, 1989, LEUCOCYTE TYPING, V4
   KORCGRODZICKI B, 1988, BIOCHEM BIOPH RES CO, V157, P1131
   LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D
   MANNING DR, 1991, THROMB HAEMOSTASIS, V66, P393
   MCGUIRE EA, 1988, J BIOL CHEM, V263, P1942
   OTOOLE TE, 1991, SCIENCE, V254, P845, DOI 10.1126/science.1948065
   PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cb.07.110191.001423
   RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957
   SANE DC, 1991, BIOCHEM BIOPH RES CO, V174, P465, DOI 10.1016/0006-291X(91)91439-J
   SCHWARTZ MA, 1991, P NATL ACAD SCI USA, V88, P7849, DOI 10.1073/pnas.88.17.7849
   SCHWARTZ MA, 1991, EXP CELL RES, V195, P533, DOI 10.1016/0014-4827(91)90407-L
   SELIGSOHN U, IN PRESS METABOLIC B
   Shattil SJ, 1991, CURR OPIN CELL BIOL, V3, P869, DOI 10.1016/0955-0674(91)90062-4
   SHIMIZU Y, 1991, FASEB J, V5, P2292
   TAMKUN JW, 1986, CELL, V46, P271, DOI 10.1016/0092-8674(86)90744-0
   Tomasini B R, 1991, Prog Hemost Thromb, V10, P269
   VROMAN L, 1987, ANN NY ACAD SCI, V516, P300, DOI 10.1111/j.1749-6632.1987.tb33050.x
   VROMAN L, 1977, ANN NY ACAD SCI, V283, P557, DOI 10.1111/j.1749-6632.1977.tb41799.x
   YAMADA KM, 1991, J BIOL CHEM, V266, P12809
NR 38
TC 3
Z9 3
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1054-8807
EI 1879-1336
J9 CARDIOVASC PATHOL
JI Cardiovasc. Pathol.
PD JUL-SEP
PY 1993
VL 2
IS 3
SU S
BP S149
EP S155
PG 7
WC Cardiac & Cardiovascular Systems; Pathology
SC Cardiovascular System & Cardiology; Pathology
GA MA485
UT WOS:A1993MA48500015
DA 2018-10-19
ER

PT J
AU WANG, TLD
   LYMAN, DJ
AF WANG, TLD
   LYMAN, DJ
TI MORPHOLOGY OF BLOCK COPOLYURETHANES .4. EFFECT OF SYNTHETIC PROCEDURE ON
   CHAIN STRUCTURE
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE COPOLYURETHANES; COPOLYETHER-URETHANE-UREAS; SYNTHESIS; MORPHOLOGY;
   INFRARED SPECTRA
ID LENGTH DISTRIBUTION; BLOOD-PLATELETS; COPOLYMERS; POLYMER
AB Analysis of products formed in the end-capping step during the synthesis of two block copolyurethanes being studied as biomedical materials has shown the presence of dimeric soft segments and free diisocyanate. In this standard two-step synthesis, the presence of these compounds lead to block copolyether-urethane-ureas containing sizeable amounts of dimeric hard and soft segments. These standard copolymers are compared in terms of IR spectra, stress-strain properties, and dynamic mechanical properties to their pure analogs which contain no dimeric segments.
C1 UNIV UTAH,DEPT MAT SCI & ENGN,SALT LAKE CITY,UT 84112.
CR EISENBACH CD, 1986, ADV ELASTOMERS RUBBE, P51
   ESTES GM, 1970, J MACROMOL SCI-REV M, VC  4, P313
   GOWER LA, UNPUB
   KATAOKA K, 1978, MAKROMOL CHEM, V179, P1121
   KNUTSON K, 1981, BIOMEDICAL DENTAL AP, P173
   LEGGE NR, 1987, ELASTOMERS COMPREHEN, P13
   LYMAN DJ, 1971, T AM SOC ART INT ORG, V17, P456
   LYMAN DJ, 1975, T AM SOC ART INT ORG, V21, P49
   LYMAN DJ, 1974, T AM SOC ART INT ORG, VB 20, P474
   LYMAN DJ, 1972, KINETICS MECHANISMS, V3, pCH3
   LYMAN DJ, 1981, STRUCTURAL ORDER POL, P205
   MILLER JA, 1985, MACROMOLECULES, V18, P32, DOI 10.1021/ma00143a005
   MORBITZER L, 1972, J APPL POLYM SCI, V16, P2697, DOI 10.1002/app.1972.070161022
   OKANO T, 1981, J BIOMED MATER RES, V15, P393, DOI 10.1002/jbm.820150310
   PEEBLES LH, 1974, MACROMOLECULES, V7, P872, DOI 10.1021/ma60042a034
   TAKAHARA A, 1985, POLYMER, V26, P987, DOI 10.1016/0032-3861(85)90218-6
   THOMPSON CM, 1990, J POLYM SCI POL CHEM, V28, P333, DOI 10.1002/pola.1990.080280209
   VANBOGART JWC, 1983, J POLYM SCI POL PHYS, V21, P65, DOI 10.1002/pol.1983.180210106
   WANG CB, 1983, MACROMOLECULES, V16, P775, DOI 10.1021/ma00239a014
NR 19
TC 25
Z9 25
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD JUL
PY 1993
VL 31
IS 8
BP 1983
EP 1995
DI 10.1002/pola.1993.080310806
PG 13
WC Polymer Science
SC Polymer Science
GA LG759
UT WOS:A1993LG75900006
DA 2018-10-19
ER

PT J
AU AUSTRIAN, R
AF AUSTRIAN, R
TI THE PNEUMOCOCCUS AND SOME MEN WHO CAME TO YALE
SO YALE JOURNAL OF BIOLOGY AND MEDICINE
LA English
DT Article
ID PROTECTIVE EFFICACY; VACCINE
AB Yale has been fortunate indeed to have had Dorothy Horstmann as a member of its faculty for all but one of the last 50 years. It has had also the wisdom to take cognizance of her value as an individual and of her contributions to biomedical science and human welfare on two occasions in recent years. Her studies of poliomyelitis, hepatitis, and rubella, executed with perceptiveness, rigor and modesty, have benefited countless numbers; and for her many achievements all are in her debt. I am beholden to her colleagues for this opportunity to pay tribute to a wise and gracious friend.
   In casting about for a subject befitting this occasion, the thought occurred that it might be of interest to examine the contributions of some former and present members of Yale's faculty to the subject of a group of infections still endemic in all human societies, namely those caused by Streptococcus pneumoniae or the pneumococcus. The list is doubtless not exhaustive but includes such notables as Winternitz, Blake, Paul, Trask, Eaton, and Beeson of former days. as well as reflecting ongoing investigations today by Eugene Shapiro and his colleagues. In reviewing some of this earlier work, it will be my endeavor to place it in the context of contemporary understanding. In the interest of some semblance of order, the material will be examined in topical rather than in chronological order, dealing with bacteriologic and immunologic, pathogenctic, therapeutic, and prophylactic considerations in that sequence.
RP AUSTRIAN, R (reprint author), UNIV PENN,SCH MED,JOHN HERR MUSSER DEPT RES MED,PHILADELPHIA,PA 19104, USA.
CR AUSTRIAN R, 1959, J EXP MED, V110, P585, DOI 10.1084/jem.110.4.585
   AUSTRIAN R, 1976, MT SINAI J MED, V43, P699
   AUSTRIAN R, 1960, BACTERIOL REV, V24, P261
   AUSTRIAN R, 1979, JOHNS HOPKINS MED J, V144, P192
   AUSTRIAN R, 1953, J EXP MED, V98, P21, DOI 10.1084/jem.98.1.21
   AUSTRIAN R, 1977, T AM CLIN CLIMAT ASS, V39, P141
   Beeson PB, 1938, P SOC EXP BIOL MED, V38, P160
   Beeson PB, 1940, J IMMUNOL, V38, P231
   Beeson PB, 1939, J EXP MED, V70, P239, DOI 10.1084/jem.70.3.239
   Blake FG, 1936, MEDICINE, V15, P1, DOI 10.1097/00005792-193602000-00001
   Blake FG, 1938, J AMER MED ASSOC, V111, P581, DOI 10.1001/jama.1938.02790330001001
   Blake FG, 1920, J EXP MED, V31, P499, DOI 10.1084/jem.31.5.499
   Blake FG, 1920, J EXP MED, V31, P445, DOI 10.1084/jem.31.4.445
   Blake FG, 1917, J EXP MED, V26, P67, DOI 10.1084/jem.26.1.67
   Blake FG, 1933, J BACTERIOL, V25, P289
   Blake FG, 1920, J EXP MED, V31, P403, DOI 10.1084/jem.31.4.403
   BLAKE FG, 1917, ARCH INTERN MED, V26, P779
   Cecil RL, 1918, J EXP MED, V28, P19, DOI 10.1084/jem.28.1.19
   Cecil RL, 1919, J EXP MED, V29, P457, DOI 10.1084/jem.29.5.457
   Cecil RL, 1920, J EXP MED, V32, P1, DOI 10.1084/jem.32.1.1
   Cecil RL, 1920, J EXP MED, V31, P685, DOI 10.1084/jem.31.6.685
   Cecil RL, 1920, J EXP MED, V31, P657, DOI 10.1084/jem.31.6.657
   Cecil RL, 1920, J EXP MED, V31, P519, DOI 10.1084/jem.31.5.519
   CLEMENS JD, 1984, REV INFECT DIS, V6, P589
   Eaton MD, 1935, J BACTERIOL, V30, P119
   Eaton MD, 1934, J BACTERIOL, V27, P271
   Frisch AW, 1942, J EXP MED, V76, P505, DOI 10.1084/jem.76.6.505
   Goebel WF, 1939, J BIOL CHEM, V129, P455
   Greenwood M, 1913, LANCET, V1, P158
   Hirschfelder AD, 1913, J EXP MED, V17, P666, DOI 10.1084/jem.17.6.666
   HORSTMANN DM, 1975, BIOGRAPHICAL MEMOIRS, V47, P323
   KAPLAN MH, 1950, J EXP MED, V91, P15
   Kline BS, 1915, J EXP MED, V21, P311, DOI 10.1084/jem.21.4.311
   Kline BS, 1913, J EXP MED, V18, P61, DOI 10.1084/jem.18.1.61
   Kline BS, 1915, J EXP MED, V21, P304, DOI 10.1084/jem.21.4.304
   Kline BS, 1913, J EXP MED, V18, P50, DOI 10.1084/jem.18.1.50
   MACLEOD CM, 1945, J EXP MED, V82, P445, DOI 10.1084/jem.82.6.445
   MacLeod CM, 1938, J CLIN INVEST, V17, P739, DOI 10.1172/JCI101002
   Paul JR, 1934, J BACTERIOL, V28, P45
   PAUL JR, 1972, YALE J BIOL MED, V45, P22
   PAUL JR, 1970, YALE J BIOL MED, V43, P110
   Paul JR, 1927, J EXP MED, V46, P807, DOI 10.1084/jem.46.5.807
   Paul JR, 1927, J EXP MED, V46, P793, DOI 10.1084/jem.46.5.793
   Paul JR, 1934, J BACTERIOL, V28, P69
   PAUL JR, 1952, YALE J BIOL MED, V24, P436
   Petersdorf R G, 1973, Trans Assoc Am Physicians, V86, P46
   POMALESLEBRON A, 1949, P SOC EXP BIOL MED, V70, P612
   SCHIEMANN O., 1927, ZEITSCHR HYG U INFEKTIONSKRANKH, V108, P220, DOI 10.1007/BF02176583
   SCHIFFMAN G, 1980, J IMMUNOL METHODS, V33, P133, DOI 10.1016/S0022-1759(80)80004-4
   SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101
   SHAPIRO ED, 1984, ANN INTERN MED, V101, P325, DOI 10.7326/0003-4819-101-3-325
   SIBER GR, 1982, ANN INTERN MED, V96, P580, DOI 10.7326/0003-4819-96-5-580
   Winternitz MC, 1913, J EXP MED, V17, P657, DOI 10.1084/jem.17.6.657
   Winternitz MC, 1915, J EXP MED, V21, P320, DOI 10.1084/jem.21.4.320
   Winternitz MC, 1920, B JOHNS HOPKINS HOSP, V31, P63
   WINTERNITZ MC, 1913, J EXP MED, V17, P662
   WINTERNITZ MC, 1913, J EXP MED, V17, P660
   Yurchak A M, 1966, Trans Assoc Am Physicians, V79, P368
   1952, YALE J BIOL MED, V24, P444
NR 59
TC 0
Z9 0
U1 0
U2 1
PU YALE J BIOL MED INC
PI NEW HAVEN
PA 333 CEDAR ST, NEW HAVEN, CT 06510
SN 0044-0086
J9 YALE J BIOL MED
JI Yale J. Biol. Med.
PD JUL-AUG
PY 1993
VL 66
IS 4
BP 315
EP 324
PG 10
WC Biology; Medicine, General & Internal; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; General & Internal Medicine;
   Research & Experimental Medicine
GA ND096
UT WOS:A1993ND09600002
PM 8209563
DA 2018-10-19
ER

PT J
AU LOPEZ, GP
   RATNER, BD
   RAPOZA, RJ
   HORBETT, TA
AF LOPEZ, GP
   RATNER, BD
   RAPOZA, RJ
   HORBETT, TA
TI PLASMA DEPOSITION OF ULTRATHIN FILMS OF POLY(2-HYDROXYETHYL
   METHACRYLATE) - SURFACE-ANALYSIS AND PROTEIN ADSORPTION MEASUREMENTS
SO MACROMOLECULES
LA English
DT Article
ID POLYMER SURFACES; HYDROXYETHYL METHACRYLATE; STATIC SIMS; COPOLYMER;
   FIBRINOGEN; XPS; MICROENCAPSULATION; ELUTABILITY; HYDROGELS; MEMBRANES
AB A method for the preparation of ultrathin films of poly(2-hydroxyethyl methacrylate) (PHEMA) by simultaneous condensation and RF plasma deposition of 2-hydroxyethyl methacrylate (HEMA) is described. Interactions of proteins with plasma-deposited and model PHEMA surfaces (spin-cast PHEMA, radiation-grafted PHEMA, and bulk PHEMA gels) were examined. Films prepared by conventional plasma deposition (i.e., without enhancing HEMA condensation by substrate temperature reduction) were also studied. I-125-radiolabeled fibrinogen was used to study the protein adsorption and retention characteristics of these materials. Kinetic protein adsorption and free iodide uptake studies were performed. In addition, gravimetric analysis, X-ray photoelectron spectroscopy, static secondary ion mass spectrometry, and water contact angle measurements were made to compare physical and chemical properties of the various hydrogel specimens and to gain insight into the reasons for their different protein interactions. Results demonstrate that plasma deposition of HEMA on substrates at low substrate temperatures is a viable method for preparing ultrathin, hydrogel films for biomedical applications.
C1 UNIV WASHINGTON,CTR BIOENGN,BF-10,SEATTLE,WA 98195.
   UNIV WASHINGTON,DEPT CHEM ENGN,SEATTLE,WA 98195.
CR ALBIN G, 1985, Journal of Controlled Release, V2, P153, DOI 10.1016/0168-3659(85)90041-0
   ARICA Y, 1987, BIOMATERIALS, V8, P489, DOI 10.1016/0142-9612(87)90087-1
   BOHNERT JL, 1986, J COLLOID INTERF SCI, V111, P363, DOI 10.1016/0021-9797(86)90040-8
   BRIGGS D, 1986, SURF INTERFACE ANAL, V9, P391
   BROWN A, 1986, SURF INTERFACE ANAL, V8, P75, DOI 10.1002/sia.740080207
   CASTNER DG, 1990, SURF INTERFACE ANAL, V15, P479, DOI 10.1002/sia.740150807
   CASTNER DG, 1988, SURFACE CHARACTERIZA
   CHILKOTI A, IN PRESS MACROMOLECU
   CHIRILA TV, 1989, J CATARACT REFR SURG, V15, P504, DOI 10.1016/S0886-3350(89)80106-3
   COHN D, 1984, J APPL POLYM SCI, V29, P2645, DOI 10.1002/app.1984.070290819
   COLLINS WE, 1987, SCANNING MICROSCOPY, V1, P1669
   DAWSON RM, 1987, BIOMATERIALS, V8, P360, DOI 10.1016/0142-9612(87)90006-8
   DENIZLI A, 1988, BIOMATERIALS, V9, P363, DOI 10.1016/0142-9612(88)90034-8
   DILKS A, 1981, ELECTRON SPECTROSCOP
   FISCHER JP, 1977, 17TH IUPAC PRAG MICR
   GOURLAY SJ, 1975, T AM SOC ART INT ORG, V21, P28
   HAQUE Y, 1986, J APPL POLYM SCI, V32, P4369, DOI 10.1002/app.1986.070320407
   HAYASHI K, 1985, KOBUNSHI RONBUNSHU, V42, P77, DOI 10.1295/koron.42.77
   HEARN MJ, 1988, SURF INTERFACE ANAL, V11, P198, DOI 10.1002/sia.740110405
   HEARN MJ, 1986, SURF INTERFACE ANAL, V9, P411
   HOFFMAN AS, 1983, RADIAT PHYS CHEM, V22, P267, DOI 10.1016/0146-5724(83)90211-X
   HOFFMAN AS, 1982, T SOC BIOMATERIALS, V5, P36
   HOLLY FJ, 1975, J BIOMED MATER RES, V9, P315, DOI 10.1002/jbm.820090307
   HORBETT TA, 1986, HYDROGELS MED PHARM
   HORBETT TA, 1980, ADHESION ADSORPTION
   HORBETT TA, 1982, ADV BIOMATERIALS
   JANSEN B, 1984, BIOMATERIALS BIOMECH
   KATAOKA K, 1988, BIOMATERIALS, V9, P218, DOI 10.1016/0142-9612(88)90087-7
   KATAOKA K, 1988, CRIT REV BIOCOMPAT, V4, P341
   KATAOKA K, 1988, ARTIF ORGANS, V12, P505
   KORBELAR P, 1988, J BIOMED MATER RES, V22, P751, DOI 10.1002/jbm.820220902
   KRESA Z, 1988, OTOLARYNG HEAD NECK, V98, P242, DOI 10.1177/019459988809800312
   LOPEZ GG, UNPUB
   LOPEZ GP, 1992, J POLYM SCI POL CHEM, V30, P2415, DOI 10.1002/pola.1992.080301116
   LOPEZ GP, 1991, SURF INTERFACE ANAL, V17, P267, DOI 10.1002/sia.740170508
   LOPEZ GP, 1992, J POLYM SCI POL CHEM, V30, P2427, DOI 10.1002/pola.1992.080301117
   LOPEZ GP, 1991, LANGMUIR, V7, P766, DOI 10.1021/la00052a027
   LOPEZ GP, 1990, J APPL POLYM SCI APP, V46, P493
   MARGULES GS, 1987, J BIOMED ENG, V9, P21, DOI 10.1016/0141-5425(87)90095-1
   MARUYAMA A, 1989, BIOMATERIALS, V10, P393, DOI 10.1016/0142-9612(89)90131-2
   MATEO NB, 1989, INVEST OPHTH VIS SCI, V30, P853
   MEABURN GM, 1978, INT J APPL RADIAT IS, V29, P233, DOI 10.1016/0020-708X(78)90047-9
   Peppas N A, 1981, Contact Intraocul Lens Med J, V7, P300
   PIJPERS AP, 1985, J POLYM SCI POL CHEM, V23, P453, DOI 10.1002/pol.1985.170230219
   RAPOZA RJ, 1990, J COLLOID INTERF SCI, V136, P480, DOI 10.1016/0021-9797(90)90395-5
   RATNER BD, 1972, J POLYM SCI A1, V10, P2425, DOI 10.1002/pol.1972.150100818
   RATNER BD, 1981, BIOCOMPATIBILITY CLI
   RATNER BD, IN PRESS SURFACE ANA
   Ratner BD, 1990, PLASMA DEPOSITION TR
   RATNER BD, 1976, ACS S SERIES
   ROBERT C C R, 1987, Journal of Controlled Release, V5, P151, DOI 10.1016/0168-3659(87)90006-X
   SEFTON MV, 1980, J PHARM SCI, V69, P208, DOI 10.1002/jps.2600690225
   SMETANA K, 1987, J BIOMED MATER RES, V21, P1247, DOI 10.1002/jbm.820211007
   STEVENSON WTK, 1987, BIOMATERIALS, V8, P449, DOI 10.1016/0142-9612(87)90081-0
   STEVENSON WTK, 1988, BIOMATER ARTIF CELL, V16, P747, DOI 10.3109/10731198809117567
   WARD CA, 1979, ANN BIOMED ENG, V7, P451, DOI 10.1007/BF02364221
   WARD CA, 1986, J COLLOID INTERF SCI, V114, P323, DOI 10.1016/0021-9797(86)90418-2
   WINTERS HF, 1985, MATER SCI ENG, V70, P53, DOI 10.1016/0025-5416(85)90268-X
   Yasuda H., 1981, Journal of Polymer Science, Polymer Physics Edition, V19, P1285, DOI 10.1002/pol.1981.180190901
   YASUDA H, 1985, PLASMAS POLYM, P345
   YOSHIDA M, 1987, BIOMATERIALS, V8, P124, DOI 10.1016/0142-9612(87)90101-3
   Yuee F, 1988, J MEMBRANE SCI, V39, P1
NR 62
TC 69
Z9 69
U1 0
U2 8
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD JUN 21
PY 1993
VL 26
IS 13
BP 3247
EP 3253
DI 10.1021/ma00065a001
PG 7
WC Polymer Science
SC Polymer Science
GA LJ088
UT WOS:A1993LJ08800001
DA 2018-10-19
ER

PT J
AU GIDDINGS, JC
AF GIDDINGS, JC
TI FIELD-FLOW FRACTIONATION - ANALYSIS OF MACROMOLECULAR, COLLOIDAL, AND
   PARTICULATE MATERIALS
SO SCIENCE
LA English
DT Review
ID MOLECULAR-WEIGHT DISTRIBUTIONS; SIZE CHARACTERIZATION;
   THERMAL-DIFFUSION; PARTICLE-SIZE; RIVER WATER; SEDIMENTATION;
   SEPARATION; CELLS; CHROMATOGRAPHY; PROTEINS
AB Field-flow fractionation (FFF) is a family of flexible elution techniques capable of simultaneous separation and measurement. Its sample domain extends across a broad macromolecular-colloidal-particulate continuum from about 1 nanometer to more than 100 micrometers and incorporates both simple and complex macromaterials of biological, biomedical, industrial, and environmental relevance. Complex materials are separated into components to simplify measurement. Component properties measurable by FFF include mass, size, density, charge, diffusivity, and thickness of adsorbed layers. When characterization by these properties is inadequate, other measurement tools can be readily coupled to FFF, either off-line or on-line, by virtue of its flow-elution operation. This article describes the principles and major subtechniques of the FFF family along with application of its measurement and separative capabilities.
RP GIDDINGS, JC (reprint author), UNIV UTAH, DEPT CHEM, FIELD FLOW FRACTIONAT RES CTR, SALT LAKE CITY, UT 84112 USA.
FU NIGMS NIH HHS [GM10851-36]
CR ARLAUSKAS RA, 1993, ACS SYM SER, V521, P2
   ARNER EC, 1989, BIOCHIM BIOPHYS ACTA, V993, P100, DOI 10.1016/0304-4165(89)90148-7
   BARMAN BN, 1989, POWDER TECHNOL, V59, P53, DOI 10.1016/0032-5910(89)80095-6
   BARMAN BN, 1992, LANGMUIR, V8, P51, DOI 10.1021/la00037a012
   BARMAN BN, IN PRESS ANAL BIOCH
   BECKETT R, 1987, ENVIRON TECHNOL LETT, V8, P339, DOI 10.1080/09593338709384493
   BECKETT R, 1987, ENVIRON SCI TECHNOL, V21, P289, DOI 10.1021/es00157a010
   BECKETT R, 1988, WATER RES, V22, P1535, DOI 10.1016/0043-1354(88)90166-2
   BECKETT R, 1990, J CHROMATOGR, V517, P435, DOI 10.1016/S0021-9673(01)95739-5
   BECKETT R, 1991, LANGMUIR, V7, P2040, DOI 10.1021/la00058a013
   BECKETT R, IN PRESS ENV TECHNOL
   BECKETT R, 1989, ACS SYM SER, V219, P65
   BECKETT R, 1993, ENV PARTICLES, V2, P157
   BENINCASA MA, 1992, ANAL CHEM, V64, P790, DOI 10.1021/ac00031a016
   BIGELOW JC, 1991, ACS SYM SER, V464, P146
   CALDWELL KD, 1988, ANAL CHEM, V60, pA959, DOI 10.1021/ac00168a001
   CALDWELL KD, 1972, SCIENCE, V176, P296, DOI 10.1126/science.176.4032.296
   CALDWELL KD, 1981, J PHARM SCI, V70, P1350, DOI 10.1002/jps.2600701216
   CALDWELL KD, 1981, COLLOID SURFACE, V3, P233, DOI 10.1016/0166-6622(81)80040-6
   CALDWELL KD, 1989, J COLLOID INTERF SCI, V132, P256, DOI 10.1016/0021-9797(89)90235-X
   CALDWELL KD, 1984, INVEST OPHTH VIS SCI, V25, P153
   CALDWELL KD, 1992, J CHROMATOGR, V604, P63, DOI 10.1016/0021-9673(92)85529-3
   CALDWELL KD, 1981, J CHROMATOGR, V215, P323, DOI 10.1016/S0021-9673(00)81411-9
   CALDWELL KD, 1980, J VIROL METHODS, V1, P241, DOI 10.1016/0166-0934(80)90022-1
   CALDWELL KD, 1984, CELL BIOPHYS, V6, P233, DOI 10.1007/BF02788630
   CALDWELL KD, IN PRESS ANAL CHEM
   CARDOT PJP, 1991, J CHROMATOGR-BIOMED, V568, P93, DOI 10.1016/0378-4347(91)80343-B
   CHASE MW, 1985, J PHYS CHEM REF DATA, V14, P1
   CHITTLEBOROUGH DJ, 1992, SOIL SCI, V153, P341, DOI 10.1097/00010694-199205000-00001
   Cox R. G., 1977, International Journal of Multiphase Flow, V3, P201, DOI 10.1016/0301-9322(77)90001-5
   COX RG, 1968, CHEM ENG SCI, V23, P147, DOI 10.1016/0009-2509(68)87059-9
   DAVIS JM, 1991, ANAL CHIM ACTA, V246, P161, DOI 10.1016/S0003-2670(00)80673-X
   Giddings J. C., 1966, SEPARATION SCI, V1, P123, DOI DOI 10.1080/01496396608049439
   GIDDINGS JC, 1981, SEPAR SCI TECHNOL, V16, P549, DOI 10.1080/01496398108058117
   GIDDINGS JC, 1981, ANAL CHEM, V53, P1170, DOI 10.1021/ac00234a001
   GIDDINGS JC, 1983, J COLLOID INTERF SCI, V92, P66, DOI 10.1016/0021-9797(83)90117-0
   GIDDINGS JC, 1991, ACS SYM SER, V472, P198
   GIDDINGS JC, 1991, ACS SYM SER, V464, P128
   GIDDINGS JC, 1988, CHEM ENG NEWS, V66, P34, DOI 10.1021/cen-v066n041.p034
   GIDDINGS JC, 1976, SCIENCE, V193, P1244, DOI 10.1126/science.959835
   GIDDINGS JC, 1987, J CHROMATOGR, V395, P19, DOI 10.1016/S0021-9673(01)94097-X
   GIDDINGS JC, 1989, J CHROMATOGR, V480, P21, DOI 10.1016/S0021-9673(01)84277-1
   GIDDINGS JC, 1979, SEPAR SCI TECHNOL, V14, P611, DOI 10.1080/01496397908057159
   GIDDINGS JC, 1977, ANAL BIOCHEM, V81, P395, DOI 10.1016/0003-2697(77)90710-2
   GIDDINGS JC, 1979, PURE APPL CHEM, V51, P1459, DOI 10.1351/pac197951071459
   GIDDINGS JC, 1991, ANAL CHEM, V63, P2869, DOI 10.1021/ac00024a013
   GIDDINGS JC, 1981, SEPAR SCI TECHNOL, V16, P607, DOI 10.1080/01496398108058119
   GIDDINGS JC, 1974, ANAL CHEM, V46, P1917, DOI 10.1021/ac60349a046
   GIDDINGS JC, 1976, J CHROMATOGR, V125, P3, DOI 10.1016/S0021-9673(00)93808-1
   GIDDINGS JC, 1978, SEPAR SCI TECHNOL, V13, P637, DOI 10.1080/01496397808057119
   GIDDINGS JC, 1977, J VIROL, V21, P131
   GIDDINGS JC, 1975, SEPAR SCI, V10, P133, DOI 10.1080/00372367508058996
   Giddings JC, 1991, KONA, V9, P200
   GIDDINGS JC, 1989, PHYSICAL METHODS C B, V3, P867
   GIDDINGS JC, 1991, UNIFIED SEPARATION S
   GILBART J, 1987, J CHROMATOGR, V387, P428, DOI 10.1016/S0021-9673(01)94548-0
   GRUSHKA E, 1973, SEPAR PURIF METHOD, V2, P127, DOI 10.1080/03602547408068793
   GUNDERSON JJ, 1984, SEPAR SCI TECHNOL, V19, P667, DOI 10.1080/01496398408060668
   HO BP, 1974, J FLUID MECH, V65, P365, DOI 10.1017/S0022112074001431
   HOFFSTETTERKUHN S, 1992, ANAL BIOCHEM, V206, P300, DOI 10.1016/0003-2697(92)90370-M
   JANCA J, 1983, TRAC-TREND ANAL CHEM, V2, P278, DOI 10.1016/0165-9936(83)87054-X
   JONSSON JA, 1989, ANAL CHEM, V61, P11
   KARAISKAKIS G, 1982, INT J ENVIRON AN CH, V12, P1, DOI 10.1080/03067318208071566
   KIRKLAND JJ, 1983, J CHROMATOGR, V255, P255, DOI 10.1016/S0021-9673(01)88289-3
   KIRKLAND JJ, 1992, J CHROMATOGR, V593, P339, DOI 10.1016/0021-9673(92)80303-C
   KIRKLAND JJ, 1988, ANAL CHEM, V60, P610, DOI 10.1021/ac00158a002
   LANGWOST B, 1992, CHROMATOGRAPHIA, V34, P317, DOI 10.1007/BF02268362
   LEVIN S, 1991, BIOMED CHROMATOGR, V5, P133, DOI 10.1002/bmc.1130050308
   LI JT, 1991, LANGMUIR, V7, P2034, DOI 10.1021/la00058a012
   LITZEN A, 1989, J CHROMATOGR, V476, P413, DOI 10.1016/S0021-9673(01)93885-3
   LITZEN A, UNPUB
   LIU G, 1992, CHROMATOGRAPHIA, V34, P483, DOI 10.1007/BF02290241
   Liu M., UNPUB
   LIU MK, IN PRESS MACROMOLECU
   LOU J, UNPUB
   MARTIN M, 1992, NATO ADV SCI INST SE, V383, P513
   MARTIN M, 1980, ANAL CHEM, V52, P2293, DOI 10.1021/ac50064a014
   MARTIN M, 1993, ANAL CHEM, V65, pA315, DOI 10.1021/ac00054a722
   MARTIN M, 1987, PARTICLE SIZE ANAL 1, P65
   MCCARTHY JF, 1989, ENVIRON SCI TECHNOL, V23, P496, DOI 10.1021/es00063a602
   MERINODUGAY A, 1992, J CHROMATOGR-BIOMED, V579, P73, DOI 10.1016/0378-4347(92)80364-V
   MOON MH, 1992, ANAL CHEM, V64, P3029, DOI 10.1021/ac00047a027
   MOON MH, IN PRESS J PHARM BIO
   MOZERSKY SM, 1988, ANAL BIOCHEM, V172, P113, DOI 10.1016/0003-2697(88)90419-8
   MYERS MN, 1982, ANAL CHEM, V54, P2284, DOI 10.1021/ac00250a032
   MYERS MN, 1993, ACS SYM SER, V521, P47
   MYERS MN, 1974, SEPAR SCI, V9, P47, DOI 10.1080/01496397408080043
   RATANATHANAWONG SK, UNPUB
   RATANATHANAWONGS SK, 1992, ANAL CHEM, V64, P6, DOI 10.1021/ac00025a003
   RATANATHANAWONGS SK, 1991, ACS SYM SER, V472, P229
   RATANATHANAWONGS SK, 1993, ACS SYM SER, V521, P13
   SCHALLINGER LE, 1984, SCIENCE, V225, P434, DOI 10.1126/science.6377495
   SCHIMPF ME, 1989, J POLYM SCI POL PHYS, V27, P1317, DOI 10.1002/polb.1989.090270610
   SCHIMPF ME, 1993, ACS SYM SER, V521, P63
   SCHIMPF ME, 1990, J POLYM SCI POL PHYS, V28, P2673, DOI 10.1002/polb.1990.090281313
   SCHIMPF ME, 1993, AM LAB SHELTON   FEB, P21
   SGIDDINGS JC, 1970, J PHYS CHEM-US, V74, P4291
   SHARMA RV, IN PRESS APPL ENV MI
   SHIUNDU PM, UNPUB
   SINCLAIR P, 1989, HYDROBIOLOGIA, V176, P239, DOI 10.1007/BF00026559
   SKLAVIADIS T, 1992, VIRUS RES, V26, P241, DOI 10.1016/0168-1702(92)90016-3
   TAYLOR HE, 1992, ANAL CHEM, V64, P2036, DOI 10.1021/ac00042a005
   WAHLUND KG, 1989, J CHROMATOGR, V461, P73, DOI 10.1016/S0021-9673(00)94276-6
   WILLIAMS PS, 1992, CHEM ENG COMMUN, V111, P121, DOI 10.1080/00986449208935984
   WILLIAMS PS, 1987, ANAL CHEM, V59, P2038, DOI 10.1021/ac00144a007
   YANG FJ, 1974, ANAL CHEM, V46, P1924, DOI 10.1021/ac60349a009
   YANG FS, 1983, J COLLOID INTERF SCI, V93, P115, DOI 10.1016/0021-9797(83)90391-0
   YANG FS, 1984, ANAL BIOCHEM, V138, P488, DOI 10.1016/0003-2697(84)90844-3
   YONKER CR, 1985, J VIROL METHODS, V11, P145, DOI 10.1016/0166-0934(85)90038-2
NR 109
TC 859
Z9 868
U1 13
U2 199
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD JUN 4
PY 1993
VL 260
IS 5113
BP 1456
EP 1465
DI 10.1126/science.8502990
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LF058
UT WOS:A1993LF05800027
PM 8502990
DA 2018-10-19
ER

PT J
AU ALCALA, JR
   YU, C
   YEH, GJ
AF ALCALA, JR
   YU, C
   YEH, GJ
TI DIGITAL PHOSPHORIMETER WITH FREQUENCY-DOMAIN SIGNAL-PROCESSING -
   APPLICATION TO REAL-TIME FIBEROPTIC OXYGEN SENSING
SO REVIEW OF SCIENTIFIC INSTRUMENTS
LA English
DT Article
ID FLUORESCENCE LIFETIME DISTRIBUTIONS; PARALLEL ACQUISITION; PHASE;
   FLUOROMETER; KINETICS; PROTEINS
AB An instrument to measure the excited-state lifetimes of phosphorescent materials in real time is described. This apparatus uses pulsed and frequency-doubled Nd:YAG solid-state laser for excitation, sampler for data acquisition, and frequency domain methods for data fitting. The instrument amplifies the ac components of the detector output and band limits the signal to 25 kHz. The fundamental frequency of the excitation is then set to obtain a desired number of harmonics. This band limited signal is sampled and averaged over few thousand cycles in the time domain. The frequency domain representation of the data is obtained by employing fast Fourier transform algorithms. The phase delay and the modulation ratio of each sampled harmonic is then computed. Ten to a hundred values of the phase and modulations are averaged before computing the sensor lifetime. The instrument is capable of measuring precise and accurate excited-state lifetimes from subpicowatt luminescent signals in 100 mum optical fibers. To monitor oxygen for biomedical applications the response time of the system is decreased by collecting only 8 or 16 harmonics. A least-squares fit yields the lifetimes of single exponentials. A component of zero lifetime is introduced to account for the backscatter excitation. The phosphorescence lifetimes measured reproducibly to three parts in a thousand are used to monitor oxygen. Oxygen concentrations are computed employing empirical polynomials. The system drift is less than 1% over 100 h of continuous operation. This instrument is used to measure oxygen concentrations in vitro and in vivo with 2 s update times and 90 s full response times. Examples of measurements in saline solutions and in dogs are presented.
C1 BOC GRP INC,MURRAY HILL,NJ 07974.
RP ALCALA, JR (reprint author), CASE WESTERN RESERVE UNIV,DEPT BIOMED ENGN,CLEVELAND,OH 44106, USA.
CR ALCALA JR, 1987, BIOPHYS J, V51, P925, DOI 10.1016/S0006-3495(87)83420-3
   ALCALA JR, 1987, BIOPHYS J, V51, P597, DOI 10.1016/S0006-3495(87)83384-2
   ALCALA JR, 1987, BIOPHYS J, V51, P587, DOI 10.1016/S0006-3495(87)83383-0
   ALCALA JR, 1985, ANAL INSTRUM, V14, P225
   ALCALA JR, 1991, REV SCI INSTRUM, V62, P1672, DOI 10.1063/1.1142528
   ALCALA JR, 1987, THESIS U ILLINOIS UR
   Bagnich S. A., 1990, Optics and Spectroscopy, V69, P833
   FEDDERSEN BA, 1989, REV SCI INSTRUM, V60, P2929, DOI 10.1063/1.1140629
   GRATTAN KTV, 1988, REV SCI INSTRUM, V59, P1328, DOI 10.1063/1.1140257
   GRATTON E, 1983, BIOPHYS J, V44, P315, DOI 10.1016/S0006-3495(83)84305-7
   GRATTON E, 1984, REV SCI INSTRUM, V55, P486, DOI 10.1063/1.1137777
   JAMES DR, 1985, CHEM PHYS LETT, V120, P455, DOI 10.1016/0009-2614(85)85640-2
   LAKOWICZ JR, 1981, J BIOCHEM BIOPH METH, V5, P131, DOI 10.1016/0165-022X(81)90012-9
   LAKOWICZ JR, 1986, REV SCI INSTRUM, V57, P2499, DOI 10.1063/1.1139215
   LAKOWICZ JR, 1992, LASER FOCUS WORL MAY, P60
   MASUMO K, 1985, B CHEM SOC JPN, V58, P2451, DOI 10.1246/bcsj.58.2451
   MORANTZ DJ, 1985, POLYM COMMUN, V26, P170
   NEWHOUSE EI, 1988, CHEM PHYS LETT, V143, P106, DOI 10.1016/0009-2614(88)87020-9
   OCONNOR DV, 1984, TIME CORRELATED SING
   OCONNOR DV, 1984, TIME CORRELATED SING, P170
   PAPKOVSKY DB, 1992, BIOSENS BIOELECTRON, V7, P199, DOI 10.1016/0956-5663(92)87016-I
   Press WH, 1988, NUMERICAL RECIPIES
   SPENCER RD, 1969, ANN NY ACAD SCI, V158, P361, DOI 10.1111/j.1749-6632.1969.tb56231.x
   WEBER G, 1981, J PHYS CHEM-US, V85, P949, DOI 10.1021/j150608a006
   WILD UP, 1977, REV SCI INSTRUM, V48, P1621, DOI 10.1063/1.1134962
   ZHANG ZY, 1992, REV SCI INSTRUM, V63, P3869, DOI 10.1063/1.1143285
   1985, LAB TENDER INSTALLAT
NR 27
TC 18
Z9 18
U1 1
U2 3
PU AMER INST PHYSICS
PI WOODBURY
PA CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999
SN 0034-6748
J9 REV SCI INSTRUM
JI Rev. Sci. Instrum.
PD JUN
PY 1993
VL 64
IS 6
BP 1554
EP 1560
DI 10.1063/1.1144026
PG 7
WC Instruments & Instrumentation; Physics, Applied
SC Instruments & Instrumentation; Physics
GA LF965
UT WOS:A1993LF96500034
DA 2018-10-19
ER

PT J
AU CROMMEN, J
   VANDORPE, J
   SCHACHT, E
AF CROMMEN, J
   VANDORPE, J
   SCHACHT, E
TI DEGRADABLE POLYPHOSPHAZENES FOR BIOMEDICAL APPLICATIONS
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article; Proceedings Paper
CT 2ND EUROPEAN SYMP ON CONTROLLED DRUG DELIVERY
CY APR 01-03, 1992
CL NOORDWIJK AAN ZEE, NETHERLANDS
SP DUTCH EXECUT AGCY TECHNOL POLICY, ORGANON INT, SANDOZ PHARMA, DUPHAR, SCHWARZ PHARMA, THERATECH, HOFFMANN LA ROCHE, MEDISOB TECHNOL, THREE M MEDICA
DE DEGRADABLE POLYPHOSPHAZENE; HYDROLYTIC DEGRADATION
ID POLY(ORGANOPHOSPHAZENES)
AB Polyphosphazene derivatives having amino acid ester side groups were prepared by reaction of poly (dichloro phosphazene) with ethyl esters of amino acids and dipeptides. In vitro degradation studies demonstrated that the rate of degradation depends on the nature of the amino acids. Introducing small amounts of depsipeptide ester co-substituents resulted in a drastic increase of the degradation. The rate of hydrolytic degradation of the polyphosphazene materials could be controlled by the content of the depsipeptide ester side groups or by blending poly[amino acid ester) phosphazenes] with poly [ (amino acid ester) -co- (depsipeptide ester) phosphazenes ]. A more detailed study of the degradation process indicated that in the initial stage of polymer degradation the amino acid ethyl ester is released, with subsequent formation of amino acid, ethanol and polymer backbone cleavage. Polyphosphazenes substituted with ethyl glycinate (D.S.>99%) are partially crystalline. D.S.C. experiments demonstrated that the degree of crystallinity and the morphology of the crystalline phase depends on the storage conditions.
C1 STATE UNIV GHENT,ORGAN CHEM LAB,AFDELING POLYMEERCHEM,KRIJGSLAAN 281-S4,B-9000 GHENT,BELGIUM.
   STATE UNIV GHENT,POLYMER CHEM LAB,B-9000 GHENT,BELGIUM.
CR Allcock H.R., 1979, CONT TOPICS POLYM SC, V3, P55
   ALLCOCK HR, 1986, MAKROMOL CHEM-M SYMP, V6, P101, DOI 10.1002/masy.19860060112
   ALLCOCK HR, 1972, CHEM REV, V72, P315, DOI 10.1021/cr60278a002
   ALLCOCK HR, 1983, MACROMOLECULES, V16, P715, DOI 10.1021/ma00239a001
   ALLCOCK HR, 1977, MACROMOLECULES, V10, P824, DOI 10.1021/ma60058a020
   ALLCOCK HR, 1982, INORG CHEM, V21, P515, DOI 10.1021/ic00132a009
   ALLCOCK HR, 1983, MACROMOLECULES, V16, P1401, DOI 10.1021/ma00243a001
   CROMMEN JHL, 1992, BIOMATERIALS, V13, P511, DOI 10.1016/0142-9612(92)90102-T
   CROMMEN JHL, 1992, BIOMATERIALS, V13, P601, DOI 10.1016/0142-9612(92)90028-M
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   GOEDEMOED JH, 1991, J CONTROL RELEASE, V17, P245, DOI 10.1016/0168-3659(91)90143-2
   GOEDEMOED JH, 1990, POLYPHOSPHAZENE DRUG, pCH1
   GOEDEMOED JH, 1990, POLYPHOSPHAZENE DRUG, pCH7
   GROLLEMAN C W J, 1986, Journal of Controlled Release, V4, P119, DOI 10.1016/0168-3659(86)90047-7
   INTVELD PJ, 1990, MAKROMOL CHEM, V191, P1831
   LAURENCIN CT, 1987, J BIOMED MATER RES, V21, P1231, DOI 10.1002/jbm.820211006
   Lewis D. H., 1990, BIODEGRADABLE POLYM, P1
   MASARU Y, 1990, MAKROMOL CHEM-RAPID, V11, P337
   Schindler A, 1977, CONT TOPICS POLYM SC, V2, P251
   SCHWYZER R, 1955, HELV CHIM ACTA, V18, P69
   WERMUTH CG, 1980, CHEM IND, V7, P433
NR 21
TC 70
Z9 71
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD MAY 1
PY 1993
VL 24
IS 1-3
BP 167
EP 180
DI 10.1016/0168-3659(93)90176-6
PG 14
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA LF865
UT WOS:A1993LF86500014
DA 2018-10-19
ER

PT J
AU TUDOR, AM
   MELIA, CD
   DAVIES, MC
   ANDERSON, D
   HASTINGS, G
   MORREY, S
   DOMINGOSSANDOS, J
   BARBOSA, M
AF TUDOR, AM
   MELIA, CD
   DAVIES, MC
   ANDERSON, D
   HASTINGS, G
   MORREY, S
   DOMINGOSSANDOS, J
   BARBOSA, M
TI THE ANALYSIS OF BIOMEDICAL HYDROXYAPATITE POWDERS AND HYDROXYAPATITE
   COATINGS ON METALLIC MEDICAL IMPLANTS BY NEAR-IR FOURIER-TRANSFORM
   RAMAN-SPECTROSCOPY
SO SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
LA English
DT Article
AB In this paper we discuss the application of Fourier transform Raman (FM) spectroscopy to the in situ analysis of the inorganic bioceramic hydroxyapatite in both powder form and as a thermally sprayed hydroxyapatite coating on metals currently employed in medical implants for orthopaedic surgery. The derivation of the FTR spectrum of hydroxyapatite is attempted by the analysis of the pure powders of its known constituents. The FTR spectra of hydroxyapatite powders sintered up to 1300-degrees-C suggest significant structural changes in the region of 1250-degrees-C. The FTR spectra of coated metal systems clearly distinguish between samples of differing crystallinity and provide some information on the effect of the coating process on the hydroxyapatite material. The preliminary examination of hydroxyapatite coated dental screws shows a change in the nature of the hydroxyapatite coating on recovery after clinical use.
C1 UNIV NOTTINGHAM, DEPT PHARMACEUT SCI, NOTTINGHAM NG7 2RD, ENGLAND.
   PLASMA BIOTAL, TIDESWELL SK17 8DY, DERBY, ENGLAND.
   UNIV LONDON QUEEN MARY COLL, DEPT MAT, LONDON E1 4NS, ENGLAND.
   UNIV PORTO, DEPT ENGN & MET, P-4099 OPORTO, PORTUGAL.
RI Barbosa, Mario/F-5964-2011
OI Barbosa, Mario/0000-0003-3568-7482; Santos, Jose
   Domingos/0000-0002-6871-9850; Davies, Martyn/0000-0001-7695-0596
CR ARENDS J, 1982, J BIOL BUCCALE, V10, P125
   BIGI A, 1980, BIOMATERIALS, V1, P140, DOI 10.1016/0142-9612(80)90036-8
   BRES EF, 1990, J MICROSC-OXFORD, V160, P183, DOI 10.1111/j.1365-2818.1990.tb03057.x
   COOK SD, 1988, CLIN ORTHOP RELAT R, P303
   GEESINK RGT, 1987, CLIN ORTHOP RELAT R, P147
   HENCH LL, 1991, MRS B            SEP, P62
   LEMONS JE, 1988, CLIN ORTHOP RELAT R, P220
   NELSON DGA, 1981, J DENT RES, V60, P1621, DOI 10.1177/002203458106000312011
   NIE S, 1991, SPECTROSC INT, V3, P20
   OONISHI H, 1991, BIOMATERIALS, V12, P171, DOI 10.1016/0142-9612(91)90196-H
   TUDOR AM, 1991, SPECTROCHIM ACTA A, V47, P1389, DOI 10.1016/0584-8539(91)80229-C
   TUDOR AM, 1990, J PHARMACEUT BIOMED, V8, P717, DOI 10.1016/0731-7085(90)80109-3
   TUDOR AM, 1991, ANALYST, V114, P1061
   WALTERS MA, 1990, J INORG BIOCHEM, V39, P193, DOI 10.1016/0162-0134(90)84002-7
   WATTS PJ, 1991, PHARMACEUT RES, V8, P1323, DOI 10.1023/A:1015872300730
NR 15
TC 30
Z9 30
U1 1
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0584-8539
J9 SPECTROCHIM ACTA A
JI Spectroc. Acta Pt. A-Molec. Biomolec. Spectr.
PD MAY-JUN
PY 1993
VL 49
IS 5-6
BP 675
EP 680
DI 10.1016/0584-8539(93)80089-S
PG 6
WC Spectroscopy
SC Spectroscopy
GA LB910
UT WOS:A1993LB91000008
DA 2018-10-19
ER

PT J
AU BOLLINI, D
   CERVELLERA, F
   EGENI, GP
   MAZZOLDI, P
   MOSCHINI, G
   ROSSI, P
   RUDELLO, V
AF BOLLINI, D
   CERVELLERA, F
   EGENI, GP
   MAZZOLDI, P
   MOSCHINI, G
   ROSSI, P
   RUDELLO, V
TI THE MICROBEAM FACILITY OF THE AN-2000 ACCELERATOR OF THE
   LABORATORI-NAZIONALI-DI-LEGNARO
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS
   SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT
LA English
DT Article; Proceedings Paper
CT 6TH INTERNATIONAL CONF ON ELECTROSTATIC ACCELERATORS AND ASSOCIATED
   BOOSTERS
CY JUN 01-05, 1992
CL MONTEGROTTO TERME, ITALY
SP IST NAZL FIS NUCL, UNIV PADOVA, EUROPEAN PHYS SOC, MUNICIPAL ABANO TERME, MUNICIPAL MONTEGROTTO TERME, BRUKER SPECTROSPIN ITALIANA, DEPRETTO ESCHER WYSS, E ZANON
AB The setting-up of a nuclear microprobe facility (LPM) is described. The facility makes use of the dedicated AN-2000 accelerator of the Laboratori Nazionali di Legnaro, and therefore emphasis is placed on reliable and precise performance of the individual components, and thereby on on- and off-line data acquisition and processing. For the investigation of biomedical and material microstructures, the LPM is demonstrated to be an ideal example of the potentialities and limits of a nuclear microprobe system.
C1 INFN,LAB NAZL LEGNARO,LEGNANO,ITALY.
   INFN,SEZIONE PADOVA,PADUA,ITALY.
   UNIV BOLOGNA,DIPARTIMENTO FIS,I-40126 BOLOGNA,ITALY.
   UNIV PADUA,DIPARTIMENTO FIS,I-35100 PADUA,ITALY.
RP BOLLINI, D (reprint author), INFN,SEZIONE BOLOGNA,BOLOGNA,ITALY.
CR GRIME GW, 1991, NUCL INSTRUM METH B, V54, P52, DOI 10.1016/0168-583X(91)95490-5
   JAMIESON DN, 1989, NUCL INSTRUM METH B, V40-1, P669, DOI 10.1016/0168-583X(89)91072-0
   JOHANSSON TB, 1970, NUCL INSTRUM METHODS, V84, P141, DOI 10.1016/0029-554X(70)90751-2
NR 3
TC 22
Z9 22
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-9002
J9 NUCL INSTRUM METH A
JI Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc.
   Equip.
PD APR 15
PY 1993
VL 328
IS 1-2
BP 173
EP 176
DI 10.1016/0168-9002(93)90621-N
PG 4
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Nuclear; Physics, Particles & Fields
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA KW190
UT WOS:A1993KW19000031
DA 2018-10-19
ER

PT J
AU PAUL, M
AF PAUL, M
TI NEW DEVELOPMENTS AND CHALLENGES IN ACCELERATOR MASS-SPECTROMETRY
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS
   SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT
LA English
DT Article; Proceedings Paper
CT 6TH INTERNATIONAL CONF ON ELECTROSTATIC ACCELERATORS AND ASSOCIATED
   BOOSTERS
CY JUN 01-05, 1992
CL MONTEGROTTO TERME, ITALY
SP IST NAZL FIS NUCL, UNIV PADOVA, EUROPEAN PHYS SOC, MUNICIPAL ABANO TERME, MUNICIPAL MONTEGROTTO TERME, BRUKER SPECTROSPIN ITALIANA, DEPRETTO ESCHER WYSS, E ZANON
ID BIO-MEDICAL SCIENCES; NEGATIVE-IONS; TANDEM ACCELERATOR; CA-41
AB The paper reviews the basic concepts of accelerator mass spectrometry and presents new areas of research investigated in various disciplines. Recent biomedical studies are described. Measurements of cosmogenic Ni-59 in samples of extra-terrestrial material at different AMS facilities equipped with large-size accelerators are reviewed. Comparison is made between the different experimental methods used for Ni-59 detection. Exploratory experiments in accelerator mass spectrometry combined with selective excitation of ions by a laser are described.
RP PAUL, M (reprint author), HEBREW UNIV JERUSALEM,RACAH INST PHYS,IL-91904 JERUSALEM,ISRAEL.
CR BENTE B, 1991, 9091 BESCHL U MUENCH
   BERKOVITS D, 1989, NUCL INSTRUM METH A, V281, P663, DOI 10.1016/0168-9002(89)91507-6
   BERKOVITS D, 1990, NUCL INSTRUM METH B, V52, P378, DOI 10.1016/0168-583X(90)90441-V
   BERKOVITS D, 1992, REV SCI INSTRUM, V63, P2825, DOI 10.1063/1.1142818
   BOARETTO E, 1992, UNPUB 203RD AM CHEM
   BONANI G, P INT S ARGR ALP DER
   ELMORE D, 1987, SCIENCE, V236, P543, DOI 10.1126/science.236.4801.543
   ELMORE D, 1987, BIOL TRACE ELEM RES, V12, P231, DOI 10.1007/BF02796683
   ELMORE D, 1990, NUCL INSTRUM METH B, V52, P531, DOI 10.1016/0168-583X(90)90471-6
   FAESTERMANN H, 1990, NUCL INSTRUM METH B, V50, P275, DOI 10.1016/0168-583X(90)90368-5
   FELTON JS, 1990, NUCL INSTRUM METH B, V52, P517, DOI 10.1016/0168-583X(90)90469-B
   FIFIELD LK, 1990, NUCL INSTRUM METH B, V52, P233, DOI 10.1016/0168-583X(90)90412-N
   FINK D, 1991, EARTH PLANET SC LETT, V107, P115, DOI 10.1016/0012-821X(91)90048-M
   GARWAN MA, 1990, NUCL INSTRUM METH B, V52, P512, DOI 10.1016/0168-583X(90)90468-A
   HEANEY RP, 1958, J CLIN ENDOCR METAB, V18, P1246, DOI 10.1210/jcem-18-11-1246
   HENNING W, 1981, 2ND P INT S ACC MASS, P320
   HONDA M, 1961, J GEOPHYS RES, V66, P3541, DOI 10.1029/JZ066i010p03541
   HONDA M, 1967, HDB PHYSIK, V46, P613
   HOTOP H, 1985, J PHYS CHEM REF DATA, V14, P731, DOI 10.1063/1.555735
   KILIUS LR, 1991, NUCL INSTRUM METH B, V56, P868
   KORSCHINEK G, 1987, NUCL INSTRUM METH B, V29, P67, DOI 10.1016/0168-583X(87)90206-0
   KUTSCHERA W, 1990, ANNU REV NUCL PART S, V40, P411
   KUTSCHERA W, IN PRESS NUCL INSTR
   LANZEROTTI LJ, 1972, SCIENCE, V179, P1232
   LITHERLAND AE, 1980, ANNU REV NUCL PART S, V30, P437, DOI 10.1146/annurev.ns.30.120180.002253
   MEIRAV O, 1991, AM J PHYSIOL, V260, pF466
   MEIRAV O, 1990, NUCL INSTRUM METH B, V52, P536, DOI 10.1016/0168-583X(90)90472-7
   MUELLER D, 1992, NUCL INSTRUM METH B, V68, P313
   NISHIIZUMI K, 1981, RADIOCHIM ACTA, V29, P113
   PAUL M, 1989, NUCL INSTRUM METH A, V277, P418, DOI 10.1016/0168-9002(89)90771-7
   PAUL ML, UNPUB
   RAISBECK GM, 1980, REV ARCHEOMETRIE, V4, P121
   REEDY RC, 1990, P LUNAR PLANET SCI, V21, P1003
   REEDY RC, 1991, SUN TIME
   SPERGEL MS, 1986, J GEOPHYS RES-SOLID, V91, pD483, DOI 10.1029/JB091iB04p0D483
   STEINHOF A, 1987, NUCL INSTRUM METH B, V29, P59, DOI 10.1016/0168-583X(87)90204-7
   SUTER M, 1990, NUCL INSTRUM METH B, V52, P211, DOI 10.1016/0168-583X(90)90409-N
   TRAVERS MJ, UNPPUB
   VOGEL JS, 1990, NUCL INSTRUM METH B, V52, P524, DOI 10.1016/0168-583X(90)90470-F
   1970, GEOCHIM COSMOCHIM S1, V2, P1503
   1982, PUBLICATION INT CO S, V30
NR 41
TC 11
Z9 11
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-9002
J9 NUCL INSTRUM METH A
JI Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc.
   Equip.
PD APR 15
PY 1993
VL 328
IS 1-2
BP 330
EP 337
DI 10.1016/0168-9002(93)90649-3
PG 8
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Nuclear; Physics, Particles & Fields
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA KW190
UT WOS:A1993KW19000059
DA 2018-10-19
ER

PT J
AU CLYMAN, JI
   POWSNER, SM
   PATON, JA
   MILLER, PL
AF CLYMAN, JI
   POWSNER, SM
   PATON, JA
   MILLER, PL
TI USING A NETWORK MENU AND THE UMLS INFORMATION-SOURCES MAP TO FACILITATE
   ACCESS TO ONLINE REFERENCE MATERIALS
SO BULLETIN OF THE MEDICAL LIBRARY ASSOCIATION
LA English
DT Article
AB As computer technology advances, clinicians and biomedical researchers are becoming more dependent upon information from online databases and information systems. By using specially configured computer workstations and high-speed computer networks, it is now possible to access this information in a rapid and straightforward manner. To empower users by providing these capabilities, the authors are assembling a variety of network workstations to be located throughout Yale-New Haven Medical Center. At the heart of the workstation is NetMenu, a program designed to help users connect to a number of important online information systems, including a hospital order entry and results reporting system, a drug reference, bibliographic retrieval systems, and educational programs. In addition, as part of the National Library of Medicine's Unified Medical Language System(TM) (UMLS(R)) project, the authors have developed a local prototype of the UMLS Information Sources Map (ISM) and a companion query assistant program to complement the NetMenu in helping users select and connect automatically to information services relevant to a particular question. The ISM query assistant draws from a listing of many online information sources accessible via local and international networks.
C1 YALE UNIV,SCH MED,DEPT PSYCHIAT,NEW HAVEN,CT 06510.
   YALE UNIV,SCH MED,OFF ACAD COMP,NEW HAVEN,CT 06510.
   YALE UNIV,SCH MED,CTR MED INFORMAT,DEPT ANESTHESIOL,NEW HAVEN,CT 06510.
RP CLYMAN, JI (reprint author), YALE UNIV,SCH MED,DEPT ANESTHESIOL MED INFORMAT,NEW HAVEN,CT 06510, USA.
CR CLAYTON PD, 1992, 15TH P ANN S COMP AP, P109
   CLYMAN JI, 1992, AM MED INFORMATICS A
   HUMPHREYS BL, 1992, 7TH P WORLD C MED IN, P1495
   KAHLE B, 1991, ONLINE, V15, P56
   LEVITT J, 1990, UNIX TODAY       OCT
   MASYS DR, 1992, 7TH P WORLD C MED IN, P151
   MASYS DR, 1992, 16TH P ANN S COMP AP
   MILLER PL, MEDINFO 92
   *NAT INF STAND ORG, 1988, ANSIZ3950
   Paton J. A., 1990, Fourteenth Annual Symposium on Computer Applications in Medical Care. Standards in Medical Informatics. A Conference of the American Medical Informatics Association, P709
   PATON JA, 1992, IN PRESS 16TH P ANN
   STAIR TO, 1990, ACAD MED, V65, P20, DOI 10.1097/00001888-199001000-00005
   STEINER JG, 1988, PROJECT ATHENA
   Tuttle M. S., 1992, MEDINFO 92. Proceedings of the Seventh World Congress on Medical Informatics, P1506
   1988, DIRECTORY ONLINE DAT
NR 15
TC 6
Z9 6
U1 0
U2 0
PU MED LIBRARY ASSN
PI CHICAGO
PA SUITE 300 6 N MICHIGAN AVE, CHICAGO, IL 60602
SN 0025-7338
J9 B MED LIBR ASSOC
JI Bull. Med. Libr. Assoc.
PD APR
PY 1993
VL 81
IS 2
BP 207
EP 216
PG 10
WC Information Science & Library Science
SC Information Science & Library Science
GA KX031
UT WOS:A1993KX03100009
PM 8472006
DA 2018-10-19
ER

PT J
AU SOBOL, WT
AF SOBOL, WT
TI LABORATORY INFORMATION-SYSTEM FOR NUCLEAR-MAGNETIC-RESONANCE RELAXOMETRY
   IN BIOMEDICAL MATERIALS (NMR LIS) .1. DATA-ACQUISITION AND EXPERIMENT
   CONTROL
SO COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE
LA English
DT Article
DE NUCLEAR MAGNETIC RESONANCE; COMPUTER CONTROL; LABORATORY EQUIPMENT
   INTERFACES
AB A large and comprehensive Laboratory Information System (LIS) was developed for a laboratory that specializes in the studies of nuclear magnetic resonance (NMR) relaxation behavior in biomedical materials. Several programs have been developed (data acquisition and hardware control, data analysis, theoretical modeling, utilities like plotting, FFT, and peak fitting), and several other are under development (data postprocessing, database management, linkage to other systems). This paper describes a software module that was developed to control the hardware (to communicate with the NMR spectrometer pulse programmer, magnet power supply, temperature controller), to achieve efficient data acquisition through a parallel interface to the ADC devices, and to provide a user friendly interface to a complex laboratory system.
RP SOBOL, WT (reprint author), UNIV ALABAMA,DEPT RADIOL,619 S 19TH ST,BIRMINGHAM,AL 35233, USA.
CR CARR HY, 1954, PHYS REV, V94, P630, DOI 10.1103/PhysRev.94.630
   Farrar T. C, 1971, PULSE FOURIER TRANSF
   Fukushima E., 1981, EXPT PULSE NMR NUTS
   HAHN EL, 1950, PHYS REV, V80, P580, DOI 10.1103/PhysRev.80.580
   MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296
   PEEMOELLER H, 1980, J MAGN RESON, V41, P358, DOI 10.1016/0022-2364(80)90085-2
   VOLD RL, 1968, J CHEM PHYS, V48, P3831, DOI 10.1063/1.1669699
NR 7
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0169-2607
J9 COMPUT METH PROG BIO
JI Comput. Meth. Programs Biomed.
PD APR
PY 1993
VL 39
IS 3-4
BP 225
EP 232
DI 10.1016/0169-2607(93)90025-G
PG 8
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Theory & Methods; Engineering, Biomedical; Medical Informatics
SC Computer Science; Engineering; Medical Informatics
GA LF237
UT WOS:A1993LF23700009
PM 8334875
DA 2018-10-19
ER

PT J
AU SOBOL, WT
AF SOBOL, WT
TI LABORATORY INFORMATION-SYSTEM FOR NUCLEAR-MAGNETIC-RESONANCE RELAXOMETRY
   IN BIOMEDICAL MATERIALS (NMR LIS) .2. DATA-ANALYSIS
SO COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE
LA English
DT Article
DE NUCLEAR MAGNETIC RESONANCE; COMPUTER CONTROL; LABORATORY EQUIPMENT
   INTERFACES
ID PROGRAM; MODELS; DECAY
AB Data analysis modules for Nuclear Magnetic Resonance Relaxometry LIS are described. Since the experimental NMR results from biomedical samples often exhibit complex structure that arises from complexity of tissue, the analysis methods focus on search, investigation, and evaluation of complex multiexponential relaxation features. Two algorithms have been implemented: an enhanced spin grouping method that is based on a multiexponential curve stripping algorithm, and an eigenvalue decomposition method, implemented as modified DISCRETE program.
RP SOBOL, WT (reprint author), UNIV ALABAMA,DEPT RADIOL,619 S 19TH ST,BIRMINGHAM,AL 35233, USA.
CR DISTEFANO JJ, 1984, AM J PHYSIOL, V246, pR651
   DUNNE A, 1986, J PHARM PHARMACOL, V38, P97, DOI 10.1111/j.2042-7158.1986.tb04519.x
   GARDNER DG, 1959, J CHEM PHYS, V31, P978, DOI 10.1063/1.1730560
   GARFINKEL D, 1984, AM J PHYSIOL, V246, pR641
   GUARDABASSO V, 1988, COMPUT METH PROG BIO, V27, P55, DOI 10.1016/0169-2607(88)90103-4
   JENNRICH RI, 1979, ANNU REV BIOPHYS BIO, V8, P195, DOI 10.1146/annurev.bb.08.060179.001211
   Kirkup L., 1988, Computers in Physics, V2, P64
   LANDAHL HD, 1963, ANN NY ACAD SCI, V108, P331, DOI 10.1111/j.1749-6632.1963.tb13384.x
   LANDAW EM, 1984, AM J PHYSIOL, V246, pR665
   PECK CC, 1979, J PHARMACOKINET BIOP, V7, P537, DOI 10.1007/BF01062394
   PEDERSEN PV, 1977, J PHARMACOKINET BIOP, V5, P513, DOI 10.1007/BF01061732
   PEEMOELLER H, 1980, J MAGN RESON, V41, P358, DOI 10.1016/0022-2364(80)90085-2
   Provencher S. W., 1976, Journal of Chemical Physics, V64, P2772, DOI 10.1063/1.432601
   PROVENCHER SW, 1976, BIOPHYS J, V16, P27, DOI 10.1016/S0006-3495(76)85660-3
   SEDMAN AJ, 1976, J PHARM SCI, V65, P1006, DOI 10.1002/jps.2600650713
   SMITH MR, 1976, TECHNOMETRICS, V18, P467, DOI 10.2307/1268663
   SOBOL WT, 1987, MAGNET RESON MED, V4, P537, DOI 10.1002/mrm.1910040605
   SOBOL WT, 1989, B MAGN RESON, V11, P69
   SOBOL WT, COMPUT METHODS PROGR
   YAMAOKA K, 1978, J PHARMACOKINET BIOP, V6, P165, DOI 10.1007/BF01117450
   ZIERLER K, 1981, ANNU REV BIOPHYS BIO, V10, P531, DOI 10.1146/annurev.bb.10.060181.002531
NR 21
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0169-2607
J9 COMPUT METH PROG BIO
JI Comput. Meth. Programs Biomed.
PD APR
PY 1993
VL 39
IS 3-4
BP 233
EP 241
DI 10.1016/0169-2607(93)90026-H
PG 9
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Theory & Methods; Engineering, Biomedical; Medical Informatics
SC Computer Science; Engineering; Medical Informatics
GA LF237
UT WOS:A1993LF23700010
PM 8334876
DA 2018-10-19
ER

PT J
AU ROATH, S
AF ROATH, S
TI BIOLOGICAL AND BIOMEDICAL ASPECTS OF MAGNETIC FLUID TECHNOLOGY
SO JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
LA English
DT Article; Proceedings Paper
CT 6TH INTERNATIONAL CONF ON MAGNETIC FLUIDS ( ICMF 6 )
CY JUL 20-24, 1992
CL PARIS, FRANCE
SP FRENCH MINIST RES & TECHNOL, FRENCH GEN DIRECT ARMAMENT, UNIV PIERRE & MARIE CURIE, UNIV PARIS 7, UNESCO, LAB GUERBET, JAPAN SOC MAGNET FLUID RES, EXXON, FERROFLUIDICS, BIOL & IND
ID ASSEMBLIES; SEPARATION; ANTIBODY; BLOOD
AB Magnetic fluid technology has undergone study and development in its biological and biomedical aspects, principally in image enhancement and in the use of a variety of Separation techniques in the purification of biological materials or in the identification of very small amounts of organisms, cells, or genomic material. Many of these processes are already applied to small scale laboratory processing or manufacturing. A variety of magnetic materials are used; no standard technique has yet been consolidated but efficiency of separation especially is rapidly increasing. Clinical applications may be related both to diagnosis in areas of low level infection or contamination and also in ex-vivo processing of materials such as human bone marrow or peripheral blood where specific cell populations can be extracted. This may be a valuable tool in human bone marrow processing and in the coming field of gene transfer technology, as well as in the purification of genomic material.
RP ROATH, S (reprint author), UNIV SOUTHAMPTON,SOUTHAMPTON GEN HOSP,LEVEL F,S ACAD BLOCK,SOUTHAMPTON S09 4XY,ENGLAND.
CR CHARLES SW, 1990, J MAGN MAGN MATER, V85, P277, DOI 10.1016/0304-8853(90)90066-Y
   GABARIELSEN OS, 1989, NUCLEAR ACIDS RES, V17, P6253
   GEE AP, 1991, BONE MARROW PURGING
   GLUCKSMAN MJ, 1986, SCIENCE, V231, P1273, DOI 10.1126/science.3945822
   HORNES E, 1993, IN PRESS GENETIC ANA
   HORTON JK, 1991, MAGNETIC SEPARATION, P107
   JACKSON CJ, 1990, J CELL SCI, V96, P257
   JAKOBSON KS, 1990, NUCLEIC ACIDS RES, V12, P18
   KARLSSON GB, 1991, ANAL BIOCHEM, V199, P219, DOI 10.1016/0003-2697(91)90093-9
   KEMPSHEAD JT, 1990, PROGR CLIN RES, V333
   LAUFFER RB, 1987, CHEM REV, V87, P901, DOI 10.1021/cr00081a003
   LONNEMARK M, 1988, ACTA RADIOL, V29, P599, DOI 10.3109/02841858809171945
   LONNEMARK M, 1988, ACTA RADIOL, V29, P232
   OWEN CS, 1981, CELL BIOPHYS, V3, P141, DOI 10.1007/BF02788130
   Patel PD, 1991, MAGNETIC SEPARATION, P93
   PAUL F, 1978, BRIT J HAEMATOL, V38, P273, DOI 10.1111/j.1365-2141.1978.tb01043.x
   PAUL F, 1981, LANCET
   ROATH S, 1990, J MAGN MAGN MATER, V85, P285, DOI 10.1016/0304-8853(90)90067-Z
   ROATH S, 1992, ADV BONE MARROW PURG, P239
   ROATH S, 1980, AIME S FINE PARTICLE, P1287
   RUUGE EK, 1993, J MAGN MAGN MATER, V122, P335, DOI 10.1016/0304-8853(93)91104-F
   SAMBROOK J, 1989, MOL CLONING LABORATO, V1, pCH7
   STRAUSS LC, 1991, AM J PEDIAT HEMATOL, V13, P217
   WILKSTROM M, 1992, ACTA RADIOL S, V33, P292
NR 24
TC 39
Z9 40
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-8853
J9 J MAGN MAGN MATER
JI J. Magn. Magn. Mater.
PD APR
PY 1993
VL 122
IS 1-3
BP 329
EP 334
DI 10.1016/0304-8853(93)91103-E
PG 6
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA LD485
UT WOS:A1993LD48500079
DA 2018-10-19
ER

PT J
AU LIU, NQ
   ZHOU, CN
   YAN, LN
   LI, XJ
   CHAO, ZY
   REN, ZG
   ZHOU, SJ
AF LIU, NQ
   ZHOU, CN
   YAN, LN
   LI, XJ
   CHAO, ZY
   REN, ZG
   ZHOU, SJ
TI A PRELIMINARY-STUDY ON THE POSITIONAL DISTRIBUTION OF CISPLATIN AND
   OTHER ELEMENTS IN THE LIVER OF NORMAL MICE
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 6TH INTERNATIONAL CONF ON PIXE ( PARTICLE INDUCED X-RAY EMISSION ) AND
   ITS ANALYTICAL APPLICATIONS
CY JUL 20-24, 1992
CL WASADEA UNIV CONF HALL, TOKYO, JAPAN
SP WASEDA UNIV, COMMEMORAT ASSOC JAPAN WORLD EXPOSIT, INOUE FDN SCI, KAJIMA FDN, MURATA SCI FDN, NIPPON SHEET GLASS FDN MAT SCI
HO WASADEA UNIV CONF HALL
ID MICROPROBE
AB In the BEPC 4W1A station, synchrotron radiation has been used to induce X-ray fluorescence for measuring the concentration of elements in various materials, including biomedical samples. In this paper we present the 2D distribution map of platinum in liver slices of normal mice after Cisplatin treatment, and the correlation of the concentrations of the measured elements by mini-SXRF. The results show a positive correlation of the Fe concentration to those of Zn and Cu, and a positive relation of P to S in different points (150 x 150 mum2)  of the liver slice. In order to obtain more information, the same sample has also been measured by micro-PIXE at Fudan University. The possibilities and limitations of the two probes for analyzing biomedical samples are discussed.
C1 CHINESE ACAD MED SCI,INST CANC,ELECTRON MICROSCOPE LAB,BEIJING 100021,PEOPLES R CHINA.
   FUDAN UNIV,DEPT PHYS 2,SHANGHAI 200433,PEOPLES R CHINA.
RP LIU, NQ (reprint author), ACAD SINICA,INST HIGH ENERGY PHYS,POB 2732,BEIJING 100080,PEOPLES R CHINA.
CR BMAN J, 1988, TRACE ELEMENT ANAL C, P304
   GORDON BM, 1990, NUCL INSTRUM METH B, V45, P527, DOI 10.1016/0168-583X(90)90892-X
   LINDH U, 1990, NUCL INSTRUM METH B, V49, P451, DOI 10.1016/0168-583X(90)90292-3
   MUTSAERS PHA, 1990, NUCL INSTRUM METH B, V45, P557, DOI 10.1016/0168-583X(90)90899-6
   Ren Chigang, 1991, Nuclear Science and Techniques, V2, P13
NR 5
TC 4
Z9 10
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD APR
PY 1993
VL 75
IS 1-4
BP 571
EP 575
PG 5
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA KY498
UT WOS:A1993KY49800120
DA 2018-10-19
ER

PT J
AU SLIERENDREGT, BL
   OTTING, N
   JONKER, M
   BONTROP, RE
AF SLIERENDREGT, BL
   OTTING, N
   JONKER, M
   BONTROP, RE
TI MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II DQ DIVERSITY IN RHESUS
   MACAQUES
SO TISSUE ANTIGENS
LA English
DT Article
DE MHC; MHCMAMU; RFLP; RHESUS MACAQUE
ID HLA-DQ; BETA-CHAIN; RFLP ANALYSIS; ALPHA-CHAIN; DNA; POLYMORPHISM;
   SEQUENCE; PRIMATES; ANTIGENS; CLONING
AB By the use of restriction fragment length polymorphism analysis 10 Taq I fragments could be identified for the MhcMamu-DQA1 region. A strong correlation exists between the occurrence of Mamu-DQA1/Taq I fragments and Mamu-DAQ1 allelic sequence variation. Most restriction fragments correspond with a unique Mamu-DQA1 allele, with one exception being the Taq I 4.5 kb fragment that is associated with two Mamu-DQA1 alleles. The RFLP technique allowed the identification of 15 Mamu-DQB1/Taq I restriction fragments, whereas sequence analysis has permitted the characterization of at least 20 different Mamu-DQB1 alleles. In this communication two unpublished Mamu-DQB1 sequences are described. For Mamu-DQB1, on only four occasions was it possible to demonstrate a correlation between a certain fragment and an allelic sequence. These analyses, performed on material from truly homozygous animals, allowed us to define which combinations of Mamu-DQA1 and - DQB1 molecules form heterodimers at the cell surface. In addition, these studies are helpful in typing non-human primate species that are used in biomedical research.
RP SLIERENDREGT, BL (reprint author), TNO,INST APPL RADIOBIOL & IMMUNOL,DEPT CHRON & INFECT DIS,LANGE KLEIWEG 151,2288 GJ RIJSWIJK,NETHERLANDS.
RI Bontrop, Ronald/J-3628-2012
OI Bontrop, Ronald/0000-0003-0874-6467
CR AUFFRAY C, 1982, P NATL ACAD SCI-BIOL, V79, P6337, DOI 10.1073/pnas.79.20.6337
   BAKKER NPM, 1992, J EXP MED, V175, P933, DOI 10.1084/jem.175.4.933
   BELL J, 1986, LANCET, V1, P1058
   BONTROP RE, 1987, IMMUNOGENETICS, V25, P305, DOI 10.1007/BF00404423
   BONTROP RE, 1989, IMMUNOGENETICS, V30, P432, DOI 10.1007/BF02421175
   BONTROP RE, 1987, IMMUNOBIOLOGY HLA, V1, P815
   CHARRON DJ, 1984, NATURE, V312, P157, DOI 10.1038/312157a0
   GYLLENSTEN UB, 1989, P NATL ACAD SCI USA, V86, P9986, DOI 10.1073/pnas.86.24.9986
   GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652
   JONKER M, 1991, HUM IMMUNOL, V32, P31, DOI 10.1016/0198-8859(91)90114-O
   KAPPES D, 1988, ANNU REV BIOCHEM, V57, P991, DOI 10.1146/annurev.bi.57.070188.005015
   KENTER M, 1992, IMMUNOGENETICS, V36, P71, DOI 10.1007/BF00215282
   KIENY MP, 1983, GENE, V26, P91, DOI 10.1016/0378-1119(83)90039-2
   KLEIN J, 1990, IMMUNOGENETICS, V31, P217
   KWOK WW, 1989, J IMMUNOL, V143, P3598
   KWOK WW, 1988, J IMMUNOL, V141, P3123
   LARHAMMAR D, 1982, P NATL ACAD SCI-BIOL, V79, P3687, DOI 10.1073/pnas.79.12.3687
   LETVIN NL, 1985, SCIENCE, V230, P71, DOI 10.1126/science.2412295
   LIPOING Y, 1991, J IMMUNOL, V147, P4393
   LONG EO, 1982, P NATL ACAD SCI-BIOL, V79, P7465, DOI 10.1073/pnas.79.23.7465
   MARCADET A, 1987, IMMUNOBIOLOGY HLA, V1, P553
   MARSH SGE, 1991, TISSUE ANTIGENS, V37, P181, DOI 10.1111/j.1399-0039.1991.tb01870.x
   OTTING N, 1992, J IMMUNOL, V149, P461
   RIEB O, 1990, IMMUNOGENETICS, V32, P110
   ROEP BO, 1988, HUM IMMUNOL, V23, P271, DOI 10.1016/0198-8859(88)90062-6
   SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SCHARF SJ, 1986, SCIENCE, V233, P1076, DOI 10.1126/science.3461561
   SLIERENDREGT BL, 1991, HUM IMMUNOL, V30, P11, DOI 10.1016/0198-8859(91)90064-G
   SLIERENDREGT BL, 1992, HUM IMMUNOL, V35, P29, DOI 10.1016/0198-8859(92)90092-2
   SO AKL, 1988, ARTHRITIS RHEUM, V31, P990
NR 31
TC 11
Z9 11
U1 0
U2 0
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0001-2815
J9 TISSUE ANTIGENS
JI Tissue Antigens
PD APR
PY 1993
VL 41
IS 4
BP 178
EP 185
DI 10.1111/j.1399-0039.1993.tb01999.x
PG 8
WC Cell Biology; Immunology; Pathology
SC Cell Biology; Immunology; Pathology
GA LG606
UT WOS:A1993LG60600003
PM 8103245
DA 2018-10-19
ER

PT J
AU QUEVAUVILLER, P
AF QUEVAUVILLER, P
TI IMPACT OF REFERENCE MATERIALS ON THE QUALITY OF CHEMICAL MEASUREMENTS
SO ANALUSIS
LA English
DT Article
AB Many analyses are performed every year for a multitude of purposes, including reports on the quality of goods and food, the state of the environment and the health of patients. That these results are accurate is a prerequisite for the interpretation of the data obtained. One of the most powerful tools for quality control of the analysis is to use reference materials (RMs) and certified reference materials (CRMs). These materials are necessary for processes including the following: method validation (CRM), monitoring of statistical control (RM), use of samples in intercomparisons (RMs). This contribution describes what is required of RMs and CRMs in chemical analyses and how they are used, and gives some examples of materials currently used in environmental, food and biomedical analysis.
RP QUEVAUVILLER, P (reprint author), COMMISS EUROPEAN COMMUNITIES,PROGRAMME MEASUREMENTS & TESTING BCR,200 RUE LOI,B-1049 BRUSSELS,BELGIUM.
CR ALLEN DW, 1989, APPL ORGANOMET CHEM, V1, P311
   BELLIARDO JJ, 1988, FRESEN Z ANAL CHEM, V332, P533, DOI 10.1007/BF00472637
   CAMPBELL MJ, 1992, J ANAL ATOM SPECTROM, V7, P617, DOI 10.1039/ja9920700617
   CANTILLO AY, 1992, STANDARD REFERENCE M
   COLINET E, IN PRESS MICROCHEM J
   CORNELIS R, 1992, FOOD CHEM, V43, P307, DOI 10.1016/0308-8146(92)90218-Q
   GRIEPINK B, 1991, FRESEN J ANAL CHEM, V339, P599, DOI 10.1007/BF00325544
   GRIEPINK B, 1990, FRESEN J ANAL CHEM, V338, P360, DOI 10.1007/BF00322493
   GRIEPINK B, 1992, HAZARDOUS METALS ENV, V17, P517
   HARTLEY TH, COMPUTERIZED QUALITY
   MAIER EA, 1991, TRAC-TREND ANAL CHEM, V10, P340, DOI 10.1016/0165-9936(91)87011-T
   MAIER EA, IN PRESS ANAL CHIM A
   MOOIJMAN KA, 1992, EUR14375EN CEC REP
   QUEVAUVILLER P, 1992, FRESEN J ANAL CHEM, V343, P335, DOI 10.1007/BF00322865
   QUEVAUVILLER P, 1992, MAR POLLUT BULL, V24, P601, DOI 10.1016/0025-326X(92)90280-J
   TAYLOR JK, 1985, NBS SPECIAL PUBL, V260
   TORO EC, 1990, IAEARL128 INT AT EN
   WELLS DE, IN P RESS MAR POLLUT
   1990, MARINE SEDIMENT REFE
   1976, PURE APPL CHEM, V48, P503
   1992, BCR REFERENCE MATERI
   1985, ISO IEC351985 INT OR
NR 22
TC 14
Z9 14
U1 0
U2 0
PU EDITIONS SCIENTIFIQUES ELSEVIER
PI PARIS CEDEX 15
PA 141 RUE JAVEL, 75747 PARIS CEDEX 15, FRANCE
SN 0365-4877
J9 ANALUSIS
JI Analusis
PD MAR
PY 1993
VL 21
IS 2
BP M47
EP M53
PG 7
WC Chemistry, Analytical
SC Chemistry
GA KQ284
UT WOS:A1993KQ28400011
DA 2018-10-19
ER

PT J
AU Muck, M
AF Mueck, Michael
TI PROGRESS IN RF-SQUIDS
SO IEEE TRANSACTIONS ON APPLIED SUPERCONDUCTIVITY
LA English
DT Article
AB At present, dc-SQUIDS made of conventional superconductors are recognised as the most sensitive devices for measuring magnetic flux. The growing interest in high-Tc superconducting electronics, however, has also increased the interest in rf-SQUIDS again. Here, rf-SQUIDS offer several advantages like the requirement for only one single Josephson junction and a low l/f noise. With relatively high bias frequencies (> 100 MHz) it is possible to obtain values of the white flux noise comparable to dc-SQUIDS. Starting from bulk material devices with relatively high flux noise levels, at preseat, the best high-Tc rf-SQUIDS offer a field sensitivily of less than 200 fT/root Hz (@ 1Hz). This is already sufficient for a number of biomedical applications. This paper reviews recent developments towards practical rf-SQUIDs made of high-Tc as well as conventional superconductors.
C1 [Mueck, Michael] Forschungszentrum Julich GmbH KFA, Inst Schicht & Ionentech, POB 1913,W 5170, Julich, Germany.
RP Muck, M (reprint author), Forschungszentrum Julich GmbH KFA, Inst Schicht & Ionentech, POB 1913,W 5170, Julich, Germany.
CR Ahola H., 1979, Journal of Low Temperature Physics, V35, P313, DOI 10.1007/BF00115582
   Behm W., 1985, THESIS TU BRAUNSCHWE
   BELOHOUBEK E, 1975, IEEE T MICROW THEORY, VMT23, P522, DOI 10.1109/TMTT.1975.1128615
   BETTS K, 1989, IEEE T MAGN, V25, P965
   Buhrman R. A., 1979, IEEE T MAG, V13, P879
   CAVALLERI A, 1992, SPRINGER PROG PHYS, V64, P252
   COLCLOUGH MS, 1987, NATURE, V328, P47, DOI 10.1038/328047a0
   Cui G., 1991, SUPERCOND SCI TECH, V4, P130
   DALY KP, 1991, IEEE T MAGN, V27, P3066, DOI 10.1109/20.133857
   DALY KP, 1991, APPL PHYS LETT, V58, P543, DOI 10.1063/1.104581
   Erne S., 1980, SQUID 80 SUPERCONDUC, P955
   Gaerttner M. R., 1974, PUBL IEEE, V74 CHO 852-4-MAG
   HERRMAN K, 1991, SUPERCOND SCI TECH, V4, P583, DOI 10.1088/0953-2048/4/11/007
   HOLLENHORST JN, 1979, IEEE T MAGN, V15, P474, DOI 10.1109/TMAG.1979.1060170
   JACKEL LD, 1975, J LOW TEMP PHYS, V19, P201, DOI 10.1007/BF00116178
   JACKEL LD, 1978, J APPL PHYS, V49, P471, DOI 10.1063/1.324366
   KAMPER RA, 1972, APPL PHYS LETT, V20, P270, DOI 10.1063/1.1654144
   KANTER H, 1977, IEEE T MAGN, V13, P389, DOI 10.1109/TMAG.1977.1059461
   KURKIJARVI J, 1973, J APPL PHYS, V44, P3729, DOI 10.1063/1.1662830
   Kurkijarvi J., 1972, IEEE PUB, VCHO 682-5-TABSC, P581
   LIKHACHEV AG, 1990, SUPERCOND SCI TECH, V3, P148, DOI 10.1088/0953-2048/3/3/009
   LONG AP, 1980, SQUID 80 SUPERCONDUC, P207
   McAvoy B. R., 1987, IEEE T MAG, VMAG-25, P389
   Miick M., 1992, APPL PH IN PRESS SEP
   MUCK M, 1992, APPL PHYS A-MATER, V54, P475, DOI 10.1007/BF00324323
   MUCK M, 1992, REV SCI INSTRUM, V63, P2268
   PIERCE JM, 1974, IEEE T MAGN, VMA10, P599, DOI 10.1109/TMAG.1974.1058427
   Rogalla H., 1976, SQUID SUPERCONDUCTIN, P339
   ROGALLA H, 1985, SQUID 85 SUPERCONDUC, P671
   Shnyrkov V. I., 1991, Modern Physics Letters B, V5, P1281, DOI 10.1142/S0217984991001568
   SMITH AD, 1987, IEEE T MAGN, V23, P1079, DOI 10.1109/TMAG.1987.1064875
   Tavrin Y., CRYOGENICS UNPUB
   TINCHEV SS, 1989, ELECTRON LETT, V25, P1579, DOI 10.1049/el:19891060
   WHEELER HA, 1965, IEEE T MICROW THEORY, VMT13, P172, DOI 10.1109/TMTT.1965.1125962
   ZAKOSARENKO VM, 1989, IEEE T MAGN, V25, P946, DOI 10.1109/20.92444
   ZANI MJ, 1991, IEEE T MAGN, V27, P2557, DOI 10.1109/20.133738
   ZHANG Y, 1992, APPL PHYS LETT, V60, P645, DOI 10.1063/1.106580
   ZHANG Y, 1992, APPL PHYS LETT, V60, P2303, DOI 10.1063/1.107011
   Zhang Y., 1990, APPL PHYS LETT, V56, P1597
   Zhang Y., CLIN PHYS PHYS UNPUB
   ZIMMERMAN JE, 1987, APPL PHYS LETT, V51, P617, DOI 10.1063/1.98365
NR 41
TC 16
Z9 16
U1 0
U2 2
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 1051-8223
EI 1558-2515
J9 IEEE T APPL SUPERCON
JI IEEE Trans. Appl. Supercond.
PD MAR
PY 1993
VL 3
IS 1
BP 2003
EP 2010
DI 10.1109/77.233463
PN 4
PG 8
WC Engineering, Electrical & Electronic; Physics, Applied
SC Engineering; Physics
GA V43TI
UT WOS:000209703300052
DA 2018-10-19
ER

PT J
AU JOHANSSON, CB
   LAUSMAA, J
   ROSTLUND, T
   THOMSEN, P
AF JOHANSSON, CB
   LAUSMAA, J
   ROSTLUND, T
   THOMSEN, P
TI COMMERCIALLY PURE TITANIUM AND TI6AL4V IMPLANTS WITH AND WITHOUT
   NITROGEN-ION IMPLANTATION - SURFACE CHARACTERIZATION AND QUANTITATIVE
   STUDIES IN RABBIT CORTICAL BONE
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SPECTROSCOPIC CHARACTERIZATION; TISSUE-RESPONSE; OXIDE-FILMS; WEAR;
   TI-6AL-4V
AB Nitrogen-ion implantation is a surface modification of interest for biomedical materials. In this study screw-shaped commercially pure titanium and Ti6Al4V alloy implants were nitrogen-ion implanted and analysed by scanning electron microscopy (SEM) and scanning Auger electron spectroscopy (AES). The surface topography was essentially similar for treated and non-treated samples. AES survey spectra showed an incorporation of nitrogen into the surface of the nitrogen-ion treated commercially pure titanium and Ti6Al4V implants, as judged by the ratio between the intensities of the peaks at 390 and 420 eV. AES depth profiles revealed a similar oxide thickness (7.5 nm) for the nitrogen-ion implanted and the non-treated samples. In nitrogen-ion implanted screws nitrogen was detected up to depths of about 150 nm below the surface, with a maximum nitrogen concentration at about 50 nm. Light microscopic examination of the 10 mum-thick ground sections 3 months after the insertion of nitrogen-ion implanted and non-treated commercially pure titanium and Ti6Al4V screws in the proximal tibial methaphysis of rabbits showed that bone filled a large portion of the area within the threads. A fibrous capsule was not observed. Light microscopic morphometry did not reveal any statistically significant differences in bone metal contact or bone area within the threads of nitrogen-ion treated and non-treated implants. The ''mirror-image'' analysis showed that for all implants examined significantly more bone was present immediately outside than inside the threads. The results from this study indicate that nitrogen-ion implanted, screw-shaped, commercially pure titanium and Ti6Al4V implants heal as well in cortical bone as non-treated samples.
C1 UNIV GOTEBORG,DEPT ANAT,S-41390 GOTHENBURG,SWEDEN.
   GOTHENBURG UNIV,CHALMERS UNIV TECHNOL,DEPT PHYS,S-41296 GOTHENBURG,SWEDEN.
RP JOHANSSON, CB (reprint author), UNIV GOTEBORG,DEPT HANDICAP RES,BRUNNSGATAN 2,S-41312 GOTHENBURG,SWEDEN.
OI Thomsen, Peter/0000-0003-3910-6665
CR ASK M, 1990, J MATER RES, V5, P1662, DOI 10.1557/JMR.1990.1662
   ASK M, 1988, APPL SURF SCI, V35, P283
   BAIER RE, 1982, BIOMATERIALS, V3, P21
   COOK SD, 1991, CLIN ORTHOP RELAT R, V264, P209
   DAVIS LE, 1978, HDB AUGER ELECTRON S
   DAWSON PT, 1985, SURF SCI, V149, P105, DOI 10.1016/S0039-6028(85)80016-9
   Dearnaley G., 1986, Surface Engineering, V2, P213
   Donath K., 1988, PRAPARATOR, V34, P197
   JOHANSSON C, 1991, THESIS U GOTEBORG
   LALOR PA, 1991, J BONE JOINT SURG BR, V73, P25
   LAUSMAA J, 1990, SURF INTERFACE ANAL, V15, P328, DOI 10.1002/sia.740150506
   LAUSMAA J, 1990, APPL SURF SCI, V44, P133, DOI 10.1016/0169-4332(90)90100-E
   LENNOX DW, 1987, CLIN ORTHOP RELAT R, V225, P171
   NASSER S, 1990, CLIN ORTHOPAEDICS, V261, P171
   OLIVER WC, 1984, METALL TRANS A, V15, P2221, DOI 10.1007/BF02647105
   RIEU J, 1991, BIOMATERIALS, V12, P139, DOI 10.1016/0142-9612(91)90192-D
   ROSTLUND T, 1990, J BIOMED MATER RES, V24, P847, DOI 10.1002/jbm.820240705
   SCALES JT, 1991, J BONE JOINT SURG BR, V73, P534
   SIOSHANSI P, 1987, NUCL INSTRUM METH B, V19-20, P204, DOI 10.1016/S0168-583X(87)80043-5
   WITT JD, 1991, J BONE JOINT SURG BR, V73, P559
NR 20
TC 39
Z9 39
U1 0
U2 1
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 1993
VL 4
IS 2
BP 132
EP 141
DI 10.1007/BF00120382
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA LB029
UT WOS:A1993LB02900007
DA 2018-10-19
ER

PT J
AU KALMAN, PG
   ROTSTEIN, OD
   NIVEN, J
   GLYNN, MFX
   ROMASCHIN, AD
AF KALMAN, PG
   ROTSTEIN, OD
   NIVEN, J
   GLYNN, MFX
   ROMASCHIN, AD
TI DIFFERENTIAL STIMULATION OF MACROPHAGE PROCOAGULANT ACTIVITY BY VASCULAR
   GRAFTS
SO JOURNAL OF VASCULAR SURGERY
LA English
DT Article
ID TISSUE FACTOR GENERATION; HUMAN-MONOCYTES; POLYTETRAFLUOROETHYLENE
   GRAFTS; INTERLEUKIN-1 GENERATION; THROMBOPLASTIN ACTIVITY; COMPLEMENT
   ACTIVATION; FIBRINOLYTIC-ACTIVITY; PLATELET-AGGREGATION; BIOMEDICAL
   POLYMERS; MONONUCLEAR-CELLS
AB Purpose: The mechanism by which some graft materials are more thrombogenic than others is poorly understood. We hypothesized that differential induction of macrophage procoagulant activity (PCA) by various materials may contribute to variable thrombogenicity.
   Methods: Thioglycollate-elicited murine peritoneal macrophages were added to disks of Dacron and expanded polytetrafluoroethylene (ePTFE). After adherence, macrophages were incubated with and without endotoxin (lipopolysaccharide) and then recovered by sonication for determination of PCA with a one-step clotting bioassay.
   Results: PCA was significantly higher in cells after incubation on Dacron compared with ePTFE both in the absence of lipopolysaccharide (243 +/- 76 vs 68 +/- 39 mU, n = 4) and after stimulation with lipopolysaccharide (491 +/- 137 vs 139 +/- 41 mU, n = 4) (p < 0.01, analysis of variance). Using factor-deficient plasmas, we found that this PCA was consistent with tissue factor. This differential induction of PCA was related to increased macrophage adherence to Dacron compared to that to ePTFE (9374 +/- 1158 vs 2111 +/- 330 cells/mm2; n = 4; p < 0.01, analysis of variance).
   Conclusions: The thrombogenic nature of Dacron correlates with its ability to adhere macrophages and induce PCA. Strategies aimed at modulating these effects may reduce the thrombogenicity of vascular grafts and therefore potentially the incidence of graft thrombosis.
C1 UNIV TORONTO, DEPT SURG, TORONTO M5S 1A1, ONTARIO, CANADA.
   INST MED SCI, TORONTO, ON, CANADA.
RP KALMAN, PG (reprint author), TORONTO GEN HOSP, DIV VASC SURG, 9 EATON N, ROOM 215, 200 ELIZABETH ST, TORONTO M5G 2C4, ON, CANADA.
CR BONFIELD TL, 1989, J BIOMED MATER RES, V23, P535, DOI 10.1002/jbm.820230602
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CHAPMAN HA, 1982, CELL, V28, P653, DOI 10.1016/0092-8674(82)90220-3
   CHAPMAN HA, 1983, J IMMUNOL, V130, P261
   DEAN RT, 1984, HAEMOSTASIS, V14, P412
   DUNN CJ, 1981, LYMPHOKINES, V4, P231
   EDWARDS RL, 1980, J IMMUNOL, V125, P606
   FAN ST, 1991, J CLIN INVEST, V87, P50, DOI 10.1172/JCI115000
   Greisler H, 1988, ASAIO Trans, V34, P1051
   Greisler H P, 1990, Ann Vasc Surg, V4, P98, DOI 10.1007/BF02042699
   GREISLER HP, 1989, J VASC SURG, V9, P588, DOI 10.1067/mva.1989.vs0090588
   HAMLIN GW, 1978, BRIT J SURG, V65, P272, DOI 10.1002/bjs.1800650416
   HARTUNG HP, 1983, AGENTS ACTIONS, V13, P415, DOI 10.1007/BF02176404
   JANCO RL, 1985, BLOOD, V65, P545
   KALMAN PG, 1990, J VASC SURG, V11, P591, DOI 10.1067/mva.1990.18048
   LENTZ AJ, 1985, J BIOMED MATER RES, V19, P1101, DOI 10.1002/jbm.820190919
   LYBERG T, 1981, BIOCHEM J, V194, P699, DOI 10.1042/bj1940699
   MILLER KM, 1989, BIOMATERIALS, V10, P187, DOI 10.1016/0142-9612(89)90023-9
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   MUHLFELDER TW, 1979, J CLIN INVEST, V63, P147, DOI 10.1172/JCI109269
   PRYDZ H, 1978, THROMB HAEMOSTASIS, V39, P582
   RICKLES FR, 1977, J LAB CLIN MED, V89, P792
   ROOHK HV, 1976, T AM SOC ART INT ORG, V22, P1
   ROSENTHAL GA, 1989, INFECT IMMUN, V57, P338
   SALTHOUSE TN, 1984, J BIOMED MATER RES, V18, P395, DOI 10.1002/jbm.820180407
   SAPSFORD RN, 1981, J THORAC CARDIOV SUR, V81, P860
   SCHWARTZ BS, 1986, J CLIN INVEST, V78, P1136, DOI 10.1172/JCI112693
   THAKUR ML, 1977, J NUCL MED, V18, P1014
   UNIYAL S, 1982, THROMB HAEMOSTASIS, V47, P285
   VANGINKEL CJW, 1977, BRIT J HAEMATOL, V37, P35
   VEITH FJ, 1986, J VASC SURG, V3, P104
   WARD CA, 1989, MED PROG TECHNOL, V15, P63
   WHITTEMORE AD, 1989, J VASC SURG, V10, P299, DOI 10.1067/mva.1989.14116
   YEAGER A, 1988, T AM SOC ART INT ORG, V34, P88
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
   ZIATS NP, 1990, J LAB CLIN MED, V116, P687
NR 36
TC 20
Z9 20
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0741-5214
J9 J VASC SURG
JI J. Vasc. Surg.
PD MAR
PY 1993
VL 17
IS 3
BP 531
EP 537
DI 10.1016/0741-5214(93)90154-E
PG 7
WC Surgery; Peripheral Vascular Disease
SC Surgery; Cardiovascular System & Cardiology
GA KR851
UT WOS:A1993KR85100010
PM 8445749
DA 2018-10-19
ER

PT J
AU COSOFRET, VV
   LINDNER, E
   BUCK, RP
   KUSY, RP
   WHITLEY, JQ
AF COSOFRET, VV
   LINDNER, E
   BUCK, RP
   KUSY, RP
   WHITLEY, JQ
TI DESIGN OF IONOPHORE-FREE H+-SELECTIVE SOLVENT POLYMERIC MEMBRANES FOR
   FURTHER BIOMEDICAL APPLICATIONS
SO JOURNAL OF ELECTROANALYTICAL CHEMISTRY
LA English
DT Article
ID NEUTRAL-CARRIER; ELECTRODES; LIFETIME
AB Ionophore-free H+-selective solvent polymeric membrane electrodes based on aminated poly(vinyl chloride) (PVC-NH2) are studied. Among the large number of amino-PVC derivatives, the electrodes fabricated from piperazine-modified PVC show the best analytical performances. The new pH electrodes exhibit a Nernstian response between pH 4 and pH 12, and their selectivity coefficients toward biologically interesting cations match the corresponding values of H+ electrodes based on TDDA or ETH 5294. The.new membrane material offers additional prospects for ion-selective electrode fabrication with technologies used in microelectronic device development.
C1 UNIV N CAROLINA,DEPT CHEM,CHAPEL HILL,NC 27599.
   UNIV N CAROLINA,DEPT ORTHODONT,CHAPEL HILL,NC 27599.
CR AMMANN D, 1985, ANAL CHIM ACTA, V171, P119, DOI 10.1016/S0003-2670(00)84189-6
   AMMANN D, 1981, ANAL CHEM, V53, P2267, DOI 10.1021/ac00237a031
   AMMANN D, 1986, ION SELECTIVE MICROE, pCH18
   BAILEY PL, 1980, ANAL ION SELECTIVE E, P49
   Bergveld P., 1988, COMPREHENSIVE ANAL C, VXXIII
   BUCK RP, 1992, BIOSENSORS CHEM SENS
   CHAO P, 1988, PFLUG ARCH EUR J PHY, V411, P216, DOI 10.1007/BF00582318
   CHENG PS, 1980, NATL SCI COUN MONOGR, V8, P313
   CHOJNACKI J, 1990, J ELECTROANAL CHEM, V277, P159, DOI 10.1016/0022-0728(90)85098-P
   COSOFRET VV, 1992, J ELECTROANAL CHEM, V327, P137, DOI 10.1016/0022-0728(92)80142-Q
   COSOFRET VV, 1985, J PHARMACEUT BIOMED, V3, P123, DOI 10.1016/0731-7085(85)80015-7
   DINTEN O, 1991, ANAL CHEM, V63, P596, DOI 10.1021/ac00006a009
   EGOROV VV, 1990, TALANTA, V37, P461, DOI 10.1016/0039-9140(90)80071-M
   ERNE D, 1979, CHIMIA, V33, P88
   HARAME DL, 1987, IEEE T ELECTRON DEV, V34, P1700, DOI 10.1109/T-ED.1987.23140
   HARRISON DJ, 1988, J ELECTROCHEM SOC, V135, P2473, DOI 10.1149/1.2095361
   HUSER M, 1991, ANAL CHEM, V63, P1380, DOI 10.1021/ac00014a009
   KUSY RP, UNPUB
   LINDNER E, 1988, ANAL CHEM, V60, P295, DOI 10.1021/ac00155a004
   Lindner E., 1988, DYNAMIC CHARACTERIST
   MA SC, 1990, MIKROCHIM ACTA, V1, P197
   MA SC, 1988, ANAL CHEM, V60, P2293, DOI 10.1021/ac00171a027
   MOODY GJ, 1970, ANALYST, V95, P910, DOI 10.1039/an9709500910
   OESCH U, 1986, ANAL CHEM, V58, P2285, DOI 10.1021/ac00124a037
   PURVES RD, 1981, BIOL TECHNIQUE SERIE, V6
   SCHULTHESS P, 1981, ANAL CHIM ACTA, V131, P111, DOI 10.1016/S0003-2670(01)93540-8
   STACHWILL T, 1986, J ELECTROANAL CHEM, V202, P75
   TOTH K, 1989, ION SELECTIVE ELECTR, V5, P181
   WU HL, 1987, TALANTA, V34, P577, DOI 10.1016/0039-9140(87)80193-5
NR 29
TC 39
Z9 39
U1 0
U2 2
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE 1
PA PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND
SN 0022-0728
J9 J ELECTROANAL CHEM
JI J. Electroanal. Chem.
PD FEB 15
PY 1993
VL 345
IS 1-2
BP 169
EP 181
DI 10.1016/0022-0728(93)80477-Y
PG 13
WC Chemistry, Analytical; Electrochemistry
SC Chemistry; Electrochemistry
GA KP533
UT WOS:A1993KP53300013
DA 2018-10-19
ER

PT J
AU SAWHNEY, AS
   PATHAK, CP
   HUBBELL, JA
AF SAWHNEY, AS
   PATHAK, CP
   HUBBELL, JA
TI BIOERODIBLE HYDROGELS BASED ON PHOTOPOLYMERIZED POLY(ETHYLENE
   GLYCOL)-CO-POLY(ALPHA-HYDROXY ACID) DIACRYLATE MACROMERS
SO MACROMOLECULES
LA English
DT Article
ID POLYETHYLENE OXIDE; DRUG DELIVERY; DEGRADATION; POLYMERS; WATER;
   COPOLYMERS; POLYESTERS; SURFACES; RELEASE; SYSTEMS
AB Macromers having a poly(ethylene glycol) central block, extended with oligomers of alpha-hydroxy acids such as oligo(dl-lactic acid) or oligo(glycolic acid) and terminated with acrylate groups, were synthesized and characterized with the goal of obtaining a bioerodible hydrogel that could be formed in direct contact with tissues or proteins by photopolymerization of aqueous solutions of the macromer. It was determined that the PEG component of these macromers must be greater than approximately 55 mol % to provide water solubility. The amphiphilic nature of the macromers causes them to assume a micellar conformation, which enables them to undergo rapid photopolymerization. Due to the multifunctionality of the macromers, polymerization results in the formation of cross-linked gels. These gels degrade upon hydrolysis of the oligo(alpha-hydroxy acid) regions into poly(ethylene glycol), the alpha-hydroxy acid, and oligo(acrylic acid). The degradation rates of these gels can be tailored by appropriate choice of the oligo(alpha-hydroxy acid) from less than 1 day to up to 4 months. Using non toxic photoinitiators, the macromers can be rapidly photopolymerized with visible light in direct contact with tissues without excess heating or local toxicity. If polymerized in contact with tissues, the gels adhere to the tissues, presumably by interpenetration; if polymerized prior to contact with tissues, the gels are very nonadhesive, presumably by possession of a large amount of free water which is not hydrogen bonded with the ether linkages of the ethylene glycol mers. These novel materials are suitable for a number of biomedical applications and show potential for use in macromolecular drug delivery.
C1 UNIV TEXAS,DEPT CHEM ENGN,AUSTIN,TX 78712.
RI Hubbell, Jeffrey/A-9266-2008
OI Hubbell, Jeffrey/0000-0003-0276-5456
CR ALLMER K, 1990, J POLYM SCI POL CHEM, V28, P173, DOI 10.1002/pola.1990.080280112
   ANDINI S, 1988, MAKROMOL CHEM-RAPID, V9, P119
   BARBUCCI IR, 1992, 4TH WORLD BIOM C, P461
   BRONDSTED H, 1991, BIOMATERIALS, V12, P584, DOI 10.1016/0142-9612(91)90056-G
   BRUIN P, 1988, MAKROMOL CHEM-RAPID, V9, P584
   BUCK CA, 1987, ANNU REV CELL BIOL, V3, P179, DOI 10.1146/annurev.cb.03.110187.001143
   BURNS JW, 1991, J T SOC BIOMATER, V14, P251
   CHURCHILL JR, 1985, Patent No. 4526938
   COHEN D, 1988, J BIOMED MATER RES, V22, P993
   DELLAVALLE F, 1990, Patent No. 4957744
   DENG XM, 1990, J POLYM SCI POL LETT, V28, P411, DOI 10.1002/pol.1990.140281303
   DESAI NP, 1991, BIOMATERIALS, V12, P144, DOI 10.1016/0142-9612(91)90193-E
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   DOMB AJ, 1989, MACROMOLECULES, V22, P3200, DOI 10.1021/ma00198a002
   DOMB AJ, 1991, J POLYM SCI POL CHEM, V29, P571, DOI 10.1002/pola.1991.080290413
   FUERTGES F, 1990, J CONTROL RELEASE, V11, P139, DOI 10.1016/0168-3659(90)90127-F
   GOMBOTZ WR, 1989, J APPL POLYM SCI, V37, P91, DOI 10.1002/app.1989.070370108
   HELLER J, 1991, BOIDEGRADABLE POLYM, P121
   HOLLAND S J, 1986, Journal of Controlled Release, V4, P155, DOI 10.1016/0168-3659(86)90001-5
   HUNT JA, 1990, J CONTROL RELEASE, V12, P159, DOI 10.1016/0168-3659(90)90092-8
   HUTCHINSON FG, 1990, J CONTROL RELEASE, V13, P279, DOI 10.1016/0168-3659(90)90018-O
   ISHIHARA K, 1989, J BIOMED MATER RES, V23, P1475, DOI 10.1002/jbm.820231209
   ITO K, 1991, MACROMOLECULES, V24, P2348, DOI 10.1021/ma00009a035
   KIM SW, 1992, PHARMACEUT RES, V9, P283, DOI 10.1023/A:1015887213431
   KISSEL T, 1991, J CONTROL RELEASE, V16, P27, DOI 10.1016/0168-3659(91)90028-C
   KOBAYASHI H, 1991, J BIOMED MATER RES, V25, P1481, DOI 10.1002/jbm.820251206
   KULKARNI RK, 1966, ARCH SURG-CHICAGO, V93, P839
   LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494
   LEWIS DH, 1991, BIODEGRADABLE POLYM, P1
   MILLER RA, 1977, J BIOMED MATER RES, V11, P711, DOI 10.1002/jbm.820110507
   PATHAK CP, 1992, J AM CHEM SOC, V114, P8311, DOI 10.1021/ja00047a065
   PITT CG, 1981, BIOMATERIALS, V2, P215
   REED AM, 1981, POLYMER, V22, P494, DOI 10.1016/0032-3861(81)90168-3
   SAWHNEY AS, 1990, J BIOMED MATER RES, V24, P1397, DOI 10.1002/jbm.820241011
   SAWHNEY AS, UNPUB
   SMITH CR, 1988, Patent No. 4741337
   STOREY RF, 1991, J POLYM SCI POL CHEM, V29, P1759, DOI 10.1002/pola.1991.080291209
   TAMADA J, 1992, J BIOMAT SCI-POLYM E, V3, P315, DOI 10.1163/156856292X00402
   THOMPSON DF, 1988, DRUG INTEL CLIN PHAR, V22, P946, DOI 10.1177/106002808802201203
   TSENG YC, 1990, BIOMATERIALS, V11, P73, DOI 10.1016/0142-9612(90)90055-U
   VALDESAGUILERA O, 1992, MACROMOLECULES, V25, P541, DOI 10.1021/ma00028a008
   WELZ MM, 1992, J PHARM SCI-US, V81, P85, DOI 10.1002/jps.2600810117
   YAMAOKA T, 1992, 4TH WORLD BIOM C, P79
   YOKOYAMA M, 1991, CANCER RES, V51, P3229
   YOSHIKAWA M, 1989, NEW POLYM MATER, V1, P223
   1987, Patent No. 4716203
NR 46
TC 743
Z9 761
U1 8
U2 220
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD FEB 15
PY 1993
VL 26
IS 4
BP 581
EP 587
DI 10.1021/ma00056a005
PG 7
WC Polymer Science
SC Polymer Science
GA KM623
UT WOS:A1993KM62300005
DA 2018-10-19
ER

PT J
AU METHE, BM
AF METHE, BM
TI MANAGING RADIOACTIVELY CONTAMINATED INFECTIOUS WASTE AT A LARGE
   BIOMEDICAL FACILITY
SO HEALTH PHYSICS
LA English
DT Article
DE CONTAMINATION; WASTE MANAGEMENT; SCREENING MEASUREMENTS; RADIOACTIVE
   MATERIALS
AB Proper management of infectious waste containing radioactive material depends on three program elements. First, screening methods are required to identify medical waste containing radioactive material. Second, a means of managing the volume of waste identified has to be developed. Management includes identifying the radioisotopes, dealing with the physical requirements of the waste (e.g., the need for cold storage), and treating the material as a mixed waste. Finally, methods to limit production of waste at its source must be implemented. This includes educating the radioactive material users, enabling them with the means of reducing waste volume, and giving them feedback on how well they are implementing the waste reduction practices.
RP METHE, BM (reprint author), ALBANY MED CTR, ALBANY, NY 12208 USA.
CR MILLER K, 1990, RAD PROTECT MGT, V7, P30
   PENNOCK RE, 1980, MED HLTH PHYSICS, P5
   VANDERLICK C, 1980, MED HLTH PHYSICS, P17
NR 3
TC 3
Z9 3
U1 1
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0017-9078
EI 1538-5159
J9 HEALTH PHYS
JI Health Phys.
PD FEB
PY 1993
VL 64
IS 2
BP 187
EP 191
DI 10.1097/00004032-199302000-00010
PG 5
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical
   Imaging
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA KH695
UT WOS:A1993KH69500011
PM 8449714
DA 2018-10-19
ER

PT J
AU ODONOVAN, TL
   CONTLA, PA
   DASGUPTA, DK
AF ODONOVAN, TL
   CONTLA, PA
   DASGUPTA, DK
TI APPLICATION OF GOLAY CODES AND PIEZOELECTRIC ULTRASOUND TRANSDUCERS TO
   BIOMEDICAL NONINVASIVE MEASUREMENT
SO IEEE TRANSACTIONS ON ELECTRICAL INSULATION
LA English
DT Article; Proceedings Paper
CT 7TH INTERNATIONAL SYMP ON ELECTRETS
CY SEP 25-27, 1991
CL BERLIN, GERMANY
AB Golay codes posses the property that combining the products of the two individual codes of the pair causes the self-induced noise to cancel out. This gives significant improvements in the signal to noise ratio obtained with short codes in signal to noise ratio enhancement systems, making the codes useful in biomedical Doppler applications. Present work combines these codes with an experimental piezoelectric ultrasound transducer in a water bath. It is shown that the signal to noise ratio improvements resulting from this are greatest when the input signal to noise ratio is greater than unity and the target is obscured by clutter. Further, it is shown that this system can be used to send multiple codes, with code-identification after detection, to extend the range-velocity limit in medical Doppler systems. It is also shown that pulse shape integrity is important in these systems, and that the required bandwidth is large. Transducers using polar polymeric (i.e. polyvinylidene fluoride, PVDF) sensor material are shown to give increased pulse integrity and bandwidth in comparison with the conventional ceramic (PZT) sensor material.
RP ODONOVAN, TL (reprint author), UNIV COLL N WALES,SCH ELECT ENGN SCI,BANGOR LL57 2UW,GWYNEDD,WALES.
CR CATHIGNOL DJ, 1980, IEEE T BIO-MED ENG, V27, P30, DOI 10.1109/TBME.1980.326688
   GOLAY MJE, 1961, IRE T INFORM THEOR, V7, P82, DOI 10.1109/TIT.1961.1057620
   GORFU Y, 1986, P IEEE ULTRASONICS S, V1, P573
   LAL R, 1989, THESIS U WALES BANGO
   LEE BB, 1983, ULTRASONICS, V21, P153, DOI 10.1016/0041-624X(83)90070-7
   Swartz R.G., 1980, ACOUST IMAGING, V8, P69
   SWARTZ RG, 1979, IEEE T ELECTRON DEV, V26, P1921, DOI 10.1109/T-ED.1979.19797
   TAKEUCHI Y, 1979, ULTRASONICS, V17, P125
NR 8
TC 5
Z9 5
U1 1
U2 3
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394
SN 0018-9367
J9 IEEE T ELECTR INSUL
PD FEB
PY 1993
VL 28
IS 1
BP 93
EP 100
DI 10.1109/14.192244
PG 8
WC Engineering, Electrical & Electronic
SC Engineering
GA KL634
UT WOS:A1993KL63400011
DA 2018-10-19
ER

PT J
AU NEO, M
   KOTANI, S
   NAKAMURA, T
   YAMAMURO, T
   OHTSUKI, C
   KOKUBO, T
   BANDO, Y
AF NEO, M
   KOTANI, S
   NAKAMURA, T
   YAMAMURO, T
   OHTSUKI, C
   KOKUBO, T
   BANDO, Y
TI A COMPARATIVE-STUDY OF ULTRASTRUCTURES OF THE INTERFACES BETWEEN 4 KINDS
   OF SURFACE-ACTIVE CERAMIC AND BONE (JOURNAL OF BIOMEDICAL MATERIALS RES,
   VOL 26, PG 1419, 1992)
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Correction, Addition
C1 KYOTO UNIV,INST CHEM RES,UJI,KYOTO 611,JAPAN.
   NATL INST RES INORGAN MAT,TSUKUBA 305,JAPAN.
RP NEO, M (reprint author), KYOTO UNIV,FAC MED,DEPT ORTHOPED SURG,54 KAWAHARA CHO,SAKYO KU,KYOTO 606,JAPAN.
RI Ohtsuki, Chikara/E-4973-2010
OI Ohtsuki, Chikara/0000-0002-6474-1540
CR NEO M, 1992, J BIOMED MATER RES, V26, P1419, DOI 10.1002/jbm.820261103
NR 1
TC 1
Z9 1
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 1993
VL 27
IS 2
BP 281
EP 281
DI 10.1002/jbm.820270219
PG 1
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA KG410
UT WOS:A1993KG41000018
OA Bronze
DA 2018-10-19
ER

PT J
AU APRIL, GV
   BOUCHARD, M
   DOUCET, M
AF APRIL, GV
   BOUCHARD, M
   DOUCET, M
TI SURFACE-ROUGHNESS CHARACTERIZATION OF DENTAL FILLINGS - A DIFFRACTIVE
   ANALYSIS
SO OPTICAL ENGINEERING
LA English
DT Article
DE BIOMEDICAL OPTICS; COMPOSITE RESINS; SURFACE ROUGHNESS; SPECKLE;
   STATISTICAL OPTICS
ID COMPOSITE RESINS
AB The large number of new materials such as amalgams and the variety of techniques for finishing and polishing in operative dentistry has stimulated interest in simple, nondestructive methods of surface roughness evaluation. We studied an optical method based on the scattering of reflected coherent light on prepared samples of composite resins submitted to different surface treatments. The method should be able to measure the degree of flatness of the samples, thus enabling a classification procedure according to a figure of merit to be defined. The diffraction properties of such moderately rough surfaces has been correlated with mechanical profilometer measurements of the residual granular structure after polishing. Different surface treatments of composite resins result in distinctive levels of surface flatness, and it is shown that a relation between the intensity of the normalized specular reflection of a beam of coherent light and the rms surface roughness can be established for characterization purposes.
RP APRIL, GV (reprint author), UNIV LAVAL,CTR OPT PHOTON & LASER,ST FOY G1K 7P4,PQ,CANADA.
CR ALLARDYCE KJ, 1988, APPL OPTICS, V26, P2364
   Beckmann P., 1963, SCATTERING ELECTROMA
   BENNETT HE, 1961, J OPT SOC AM, V51, P123, DOI 10.1364/JOSA.51.000123
   Bennett J. M., 1989, INTRO SURFACE ROUGHN
   CHEN RCS, 1988, J PROSTHET DENT, V59, P292, DOI 10.1016/0022-3913(88)90175-8
   FUJII H, 1976, OPT COMMUN, V16, P68, DOI 10.1016/0030-4018(76)90052-3
   Goodman J. W., 1975, Laser speckle and related phenomena, P9
   GROENHUIS RAJ, 1980, CARIES RES, V14, P333, DOI 10.1159/000260472
   Konishi R N, 1985, Dent Mater, V1, P55, DOI 10.1016/S0109-5641(85)80025-7
   LUTZ F, 1983, J AM DENT ASSOC, V107, P575, DOI 10.14219/jada.archive.1983.0300
   OHTSUBO J, 1978, OPT COMMUN, V25, P315, DOI 10.1016/0030-4018(78)90136-0
   REDMALM G, 1986, SWED DENT J, V10, P243
   REINHARDT JW, 1983, J PROSTHET DENT, V49, P485, DOI 10.1016/0022-3913(83)90308-6
   RUSS JC, 1986, J MICROSC-OXFORD, V144, P329, DOI 10.1111/j.1365-2818.1986.tb02810.x
   ULUSOY N, 1987, J PROSTHET DENT, V57, P286, DOI 10.1016/0022-3913(87)90299-X
NR 15
TC 1
Z9 1
U1 0
U2 2
PU SOC PHOTO-OPT INSTRUM ENG
PI BELLINGHAM
PA PO BOX 10, BELLINGHAM, WA 98227-0010
SN 0091-3286
J9 OPT ENG
JI Opt. Eng.
PD FEB
PY 1993
VL 32
IS 2
BP 334
EP 341
DI 10.1117/12.60748
PG 8
WC Optics
SC Optics
GA KL365
UT WOS:A1993KL36500020
DA 2018-10-19
ER

PT J
AU SMITH, RW
AF SMITH, RW
TI REACTIVE PLASMA SPRAY FORMING FOR ADVANCED MATERIALS SYNTHESIS
SO POWDER METALLURGY INTERNATIONAL
LA English
DT Article
ID POWDERS
AB The economic production of wear-resistant materials and advanced composite structural materials is of growing importance. Fiber, particulate, or intermetallic reinforced metal or ceramic matrices are all proposed for use in many varied applications, ranging from aircraft components, biomedical implants, to automotive engines. The acceptance of such hard materials or composites with Ni3Al or TiAl with SiC or Al2O3 fibers or particles, titanium alloys with carbide reinforcement, alumina or zirconia with SiAlON fibers, phase toughened MoSi2 with SiC dispersions, or aluminum alloys with ceramic particulate reinforcement all depend on viable and economic production methods. Reactive plasma spray processing is being investigated as a method by which to produce such materials and is already finding application in the production of wear-resistant materials, advanced composites, diamond, and high T(c) oxide superconductors. In these processes, the reactive thermal plasma state produces new phases, even as reinforcements in matrix materials, starting with particulates, liquids, and/or gases. This paper reviews recent investigations into the production of intermetallic alloys, composite materials such as TiAl, Ti/TiC, Ti/TiN, Mo/MoSi2, MoSi2/SiC, and Al2O3/SiAlON by reactive plasma spraying in controlled atmospheres. Research on diamond and high T(c) oxide superconductors is also discussed. In addition, the advantages, limitations, and research needs for this emerging technology are presented.
C1 RHEIN WESTFAL TH AACHEN,LEHR & FORSCH GEBIET WERKSTOFFWISSENSCH,W-5100 AACHEN,GERMANY.
RP SMITH, RW (reprint author), DREXEL UNIV,DEPT MAT ENGN,CTR PLASMA PROC MAT,PHILADELPHIA,PA 19104, USA.
CR ARSENAULT B, 1990, 3RD P NAT THERM SPRA
   CASTRO R, 1991, THESIS DREXEL U PHIL
   INAL OT, 1982, THIN SOLID FILMS, V95, P195, DOI 10.1016/0040-6090(82)90242-5
   ISHIZAKI K, 1989, J MATER SCI, V24, P3553, DOI 10.1007/BF02385739
   JAEGER DA, 1992, C P ITSC 92, P69
   KOBASHI K, 1987, 8TH P INT S PLASM CH, V4, P2475
   KONG PC, 1983, 6TH P INT S PLASM CH, V1, P219
   MATSUMOTO S, 1987, 8TH P INT S PLASM CH, V4, P2458
   MEYER TN, 1987, 8TH P INT S PLASM CH, P2006
   MITROFANOV B, 1981, MATER SCI ENG, V48, P21, DOI 10.1016/0025-5416(81)90062-8
   MUEHLBERGER E, 1974, 7TH P INT THERM SPRA, P245
   MULLER U, 1992, 3RD P INT C NEW DIAM
   MUTASIM ZZ, 1991, 4TH P NATL THERM SPR, P273
   OHMORI A, 1992, C P ITSC 92, P201
   PEHLIVANTURK NY, 1986, ION NITRIDING, P179
   SAMPATH S, 1989, 11TH P INT THERM SPR
   SMITH RW, 1989, J PLASMA CHEM, V9
   SMITH RW, 1993, IN PRESS
   SMITH RW, 1984, PLASMA PROCESSING SY, P30
   SMITH RW, 1991, POWDER METALLURGY IN, V23
   SMITH RW, 1981, J MET, V33, P23
   SMITH RW, 1989, 9TH P INT UN PUR APP
   SMITH RW, 1992, J THERM SPRAY TECHN, V1, P57
   TANAKA K, 1987, J MATER SCI, V22, P2192, DOI 10.1007/BF01132959
   THORPE M, 1991, CHEM ENG         NOV, P54
   Toth L. E., 1971, TRANSITIONAL METAL C
   TSAI C, 1992, 3RD P INT C NEW DIAM
   TSANTRIZOS PG, 1992, INT ADV COATING TECH, P195
   ZHU H, 1991, MAT SCI ENG A-STRUCT, V139, P352
   1989, MATERIALS SCI ENG 19
NR 30
TC 40
Z9 44
U1 0
U2 4
PU VERLAG SCHMID GMBH
PI FREIBURG
PA PO BOX 6609, D-79042 FREIBURG, GERMANY
SN 0048-5012
J9 POWDER METALL INT
PD FEB
PY 1993
VL 25
IS 1
BP 9
EP 16
PG 8
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA KU976
UT WOS:A1993KU97600001
DA 2018-10-19
ER

PT J
AU KAETSU, I
AF KAETSU, I
TI RADIATION SYNTHESIS OF POLYMERIC MATERIALS FOR BIOMEDICAL AND
   BIOCHEMICAL APPLICATIONS
SO ADVANCES IN POLYMER SCIENCE
LA English
DT Review
ID GLASS-FORMING MONOMERS; LOW-TEMPERATURES; 2-HYDROXYETHYL METHACRYLATE;
   ENZYME IMMOBILIZATION; CELL-CULTURE; HYDROGELS; CELLULASE; SURFACES;
   RELEASE
AB The study of Radiation Induced Polymerization in the supercooled state is reviewed. This polymerization has remarkable characteristics owing to a rapid increase of viscosity, such as a large polymerization rate at low temperatures and a maximum rate at temperatures above the glass transition temperature (T(g)).
   Applications of polymerization in a supercooled state to the immobilization of various biofunctional components is reviewed. Those applications show advantages because in the low temperature biofunctional components such as proteins, drugs and cells are entrapped or adhered effectively in the polymerized matrix. The immobilized composites are used for biomedical and biochemical systems and processes, such as immuno-diagnosis, artificial organs, drug delivery systems and cell cultures.
RP KAETSU, I (reprint author), KINKI UNIV,FAC SCI & TECHNOL,DEPT NUCL REACTOR ENGN,KOWAKAE 3-4-1,OSAKA,OSAKA 577,JAPAN.
CR ASANO M, 1985, KOBUNSHI RONBUNSHU, V42, P783, DOI 10.1295/koron.42.783
   ASANO M, 1982, POLYM PREPR-JAPAN, V39, P612
   ASANO M, 1985, BIOMATERIALS JAPAN, V3, P85
   ASANO M, 1982, POLYM PREPR-JAPAN, V39, P327
   ASANO M, 1983, POLYM PREPR-JAPAN, V40, P525
   ASANO M, 1982, J BIOACTIVE BIOCOMPA, V39, P333
   BARKALOV IM, 1962, DOKL AKAD NAUK SSSR+, V147, P395
   BEDDOWS CG, 1981, BIOTECHNOL BIOENG, V23, P2885, DOI 10.1002/bit.260231222
   BOCCU E, 1981, BIOTECHNOL BIOENG, V15, P1
   CATTK, 1967, J LAP CLIN MED, V70, P820
   CHAPIRO A, 1967, CR ACAD SCI C CHIM, V264, P285
   CHAPIRO A, 1967, J POLYM SCI C, V16, P767
   DOBO J, 1970, ACTA CHIM HUNG, V63, P435
   DUVAL D, 1987, IAEATECDOC486, P129
   FUJIMURA T, 1980, Z NATURFORSCH C, V35, P477
   FUJIMURA T, 1981, Z NATURFORSCH C, V37, P102
   GAO DY, 1988, EUR POLYM J, V24, P1037
   HA HF, 1985, IAEA4065RB PROGR REP
   HARDY G, 1962, 1962 P TIH S RAD CHE, P205
   HOFFMAN A S, 1986, Journal of Controlled Release, V4, P213
   HOFFMAN AS, 1972, T AM SOC ART INT ORG, V18, P10
   HOFFMAN AS, 1986, RADIAT PHYS CHEM, V25, P375
   IMAI K, 1986, PROSTATE, V8, P325, DOI 10.1002/pros.2990080404
   IRIE M, 1990, ADV POLYM SCI, V94, P28
   ISHIHARA K, 1984, POLYM J, V16, P625, DOI 10.1295/polymj.16.625
   KAESU I, 1983, Z NATURFORSCH C, V38, P821
   KAETSU I, 1980, J BIOMED MATER RES, V14, P185, DOI 10.1002/jbm.820140302
   KAETSU I, 1973, J POLYM SCI POL CHEM, V11, P1811, DOI 10.1002/pol.1973.170110803
   KAETSU I, 1980, J BIOMED MATER RES, V14, P199, DOI 10.1002/jbm.820140303
   KAETSU I, 1979, BIOTECHNOL BIOENG, V21, P847, DOI 10.1002/bit.260210508
   KAETSU I, 1972, J POLYM SCI A1, V10, P2203, DOI 10.1002/pol.1972.150100801
   KAETSU I, 1988, DRUG DEV IND PHARM, V14, P2519, DOI 10.3109/03639048809152030
   KAETSU I, 1985, RADIAT PHYS CHEM, V25, P517, DOI 10.1016/0146-5724(85)90131-1
   KAETSU I, 1981, RADIAT PHYS CHEM, V18, P343, DOI 10.1016/0146-5724(81)90086-8
   KAETSU I, 1985, RADIAT PHYS CHEM, V25, P879, DOI 10.1016/0146-5724(85)90169-4
   KAETSU I, 1969, J MACROMOL SCI CHEM, VA  3, P1509, DOI 10.1080/10601326908051949
   KAETSU I, 1972, J POLYM SCI A1, V10, P2661, DOI 10.1002/pol.1972.150100913
   KAETSU I, 1986, RADIAT PHYS CHEM, V27, P245
   KAETSU I, 1972, J POLYM SCI A1, V10, P2215, DOI 10.1002/pol.1972.150100802
   KAETSU I, 1967, J POLYM SCI A1, V5, P1899, DOI 10.1002/pol.1967.150050808
   KAETSU I, 1980, BIOMATERIALS, V1, P17, DOI 10.1016/0142-9612(80)90052-6
   KAETSU I, 1987, RADIAT PHYS CHEM, V29, P191
   KAETSU I, 1973, J POLYM SCI POL CHEM, V11, P1149, DOI 10.1002/pol.1973.170110603
   KAETSU I, 1979, BIOTECHNOL BIOENG, V21, P863, DOI 10.1002/bit.260210509
   KAETSU I, 1975, POLYM PREPRINT, V16, P465
   KAETSU I, 1990, INT J ARTIF ORGANS, V85, P75
   KAETSU I, 1988, J CONTROL RELEASE, V6, P249
   KARGIN V, 1967, J POLYM SCI C, V4, P767
   KAWASHIMA K, 1974, BIOTECHNOL BIOENG, V16, P609, DOI 10.1002/bit.260160505
   KRAETSU I, 1989, 16TH INT S CONTR REL
   KUMAKURA M, 1984, BIOTECHNOL BIOENG, V26, P17, DOI 10.1002/bit.260260105
   KUMAKURA M, 1984, ACTA CHIM HUNG, V116, P345
   KUMAKURA M, 1984, INT J APPL RADIAT IS, V35, P471, DOI 10.1016/0020-708X(84)90166-2
   KUMAKURA M, 1984, ANAL CHIM ACTA, V161, P109, DOI 10.1016/S0003-2670(00)85782-7
   KUMAKURA M, 1983, APPL BIOCHEM BIOTECH, V8, P87, DOI 10.1007/BF02778089
   KUMAKURA M, 1984, IMMUNOL COMM, V13, P199
   LANDO JB, 1964, J POLYM SCI C, V4, P789
   LEININGER RI, 1966, SCIENCE, V152, P1625, DOI 10.1126/science.152.3729.1625
   LEININGER RI, 1980, SCIENCE, V1, P17
   LIDDY JM, 1975, J POLYM S, V49, P109
   MAEDA H, 1973, BIOTECHNOL BIOENG, V15, P872
   NAKAMURA M, 1980, GAN TO KAGAKURYOHO, V7, P1824
   PEKALA W, 1986, RADIAT PHYS CHEM, V27, P275
   REMBAUM A, 1976, MACROMOLECULES, V9, P328, DOI 10.1021/ma60050a030
   TAMADA M, 1986, BIOTECHNOL BIOENG, V28, P1227, DOI 10.1002/bit.260280814
   TAMADA M, 1987, J FERMENT TECHNOL, V65, P73
   TANAKA T, 1982, SCIENCE, V218, P467, DOI 10.1126/science.218.4571.467
   YAMANAKA H, 1986, HORMONES CLIN, V34, P95
   YOSHIDA M, 1987, BIOMATERIALS, V8, P124, DOI 10.1016/0142-9612(87)90101-3
   YOSHII F, 1983, APPL BIOCHEM BIOTECH, V8, P115, DOI 10.1007/BF02778092
   YOSHII F, 1983, APPL BIOCHEM BIOTECH, V8, P505, DOI 10.1007/BF02780383
   YOSHII F, 1978, J APPLIED POLYM SCI, V22, P289
NR 72
TC 37
Z9 37
U1 0
U2 5
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0065-3195
J9 ADV POLYM SCI
JI Adv. Polym. Sci.
PY 1993
VL 105
BP 81
EP 97
PG 17
WC Polymer Science
SC Polymer Science
GA MB983
UT WOS:A1993MB98300004
DA 2018-10-19
ER

PT J
AU STACHOWICZ, W
   BURLINSKA, G
   MICHALIK, J
   DZIEDZICGOCLAWSKA, A
   OSTROWSKI, K
AF STACHOWICZ, W
   BURLINSKA, G
   MICHALIK, J
   DZIEDZICGOCLAWSKA, A
   OSTROWSKI, K
TI APPLICATIONS OF EPR SPECTROSCOPY TO RADIATION TREATED MATERIALS IN
   MEDICINE, DOSIMETRY, AND AGRICULTURE
SO APPLIED RADIATION AND ISOTOPES
LA English
DT Article; Proceedings Paper
CT 3RD INTERNATIONAL SYMP ON ESR ( ELECTRON SPIN RESONANCE ) DOSIMETRY AND
   APPLICATIONS
CY OCT 14-18, 1991
CL NIST, GAITHERSBURG, MD
SP US DEPT COMMERCE, US DEF NUCL AGCY, US DOE
HO NIST
DE EPR; IRRADIATION; PARAMAGNETIC CENTERS; BONE; MINERALIZED TISSUES; FOOD;
   DOSIMETRY
ID RESONANCE
AB Survey is given of the EPR studies on irradiated bone mineral referred to transplantology, physiology, pathology, dosimetry and to the detection of irradiated food. Stability, dose-dependency and nature of radiation-induced EPR signal in bone mineral (hydroxyapatite) are discussed. Paramagnetic centers produced by radiation as ''labels'' as applied to biomedical experiments and dosimetry are evaluated. Results on the detection of irradiated fruits, vegetables, and other dry food products are presented.
C1 SCH MED WARSZAWA,PL-02004 WARSAW,POLAND.
RP STACHOWICZ, W (reprint author), INST NUCL CHEM & TECHNOL,DORODNA 16,PL-03195 WARSAW,POLAND.
CR ASCENZI A, 1977, CALC TISS RES, V23, P7, DOI 10.1007/BF02012760
   CEVC P, 1972, RADIAT RES, V51, P581, DOI 10.2307/3573626
   DESROSIERS MF, 1991, HEALTH PHYS, V61, P859, DOI 10.1097/00004032-199112000-00018
   DODD NJF, 1985, RADIAT PHYS CHEM, V26, P451, DOI 10.1016/0146-5724(85)90234-1
   DZIEDZICGOCLAWS.A, 1991, CLIN ORTHOP RELAT R, V272, P30
   DZIEDZICGOCLAWSKA A, 1984, BASIC APPL HISTOCHEM, V28, P21
   HENNING GH, 1980, NATURE, V292, P533
   MOENS P, 1991, J CHEM SOC FARADAY T, V87, P3137, DOI 10.1039/ft9918703137
   OSTROWSKI K, 1971, CALC TISS RES, V7, P58, DOI 10.1007/BF02062593
   OSTROWSKI K, 1980, CALCIFIED TISSUE INT, V30, P179, DOI 10.1007/BF02408625
   OSTROWSKI K, 1972, HISTOCHEMISTRY, V32, P342
   OSTROWSKI K, 1991, CLIN ORTHOP RELAT R, V272, P21
   OSTROWSKI K, 1975, NUKLEONIKA, V20, P876
   Ostrowski K, 1980, FREE RADICAL BIO MED, V4, P321
   Raffi J.J., 1989, ANN FALSIF EXPERT CH, V82, P279
   SLAGER UT, 1964, RADIAT RES, V22, P556, DOI 10.2307/3571741
   Stachowicz W., 1970, PANEL P SERIES IAEA, P15
   SWARTZ HM, 1965, RADIAT RES, V24, P579, DOI 10.2307/3571876
NR 18
TC 12
Z9 12
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0969-8043
J9 APPL RADIAT ISOTOPES
JI Appl. Radiat. Isot.
PD JAN-FEB
PY 1993
VL 44
IS 1-2
BP 423
EP 427
DI 10.1016/0969-8043(93)90260-H
PG 5
WC Chemistry, Inorganic & Nuclear; Nuclear Science & Technology; Radiology,
   Nuclear Medicine & Medical Imaging
SC Chemistry; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA KP625
UT WOS:A1993KP62500075
PM 8386048
DA 2018-10-19
ER

PT J
AU MAROM, G
   REUVENI, A
   COHN, D
AF MAROM, G
   REUVENI, A
   COHN, D
TI STIFFNESS VARIABILITY AND STRESS-DEPENDENT ELASTIC RESPONSE OF SYNTHETIC
   FIBER-REINFORCED COMPOSITES FOR BIOMEDICAL APPLICATIONS
SO BIOMATERIALS
LA English
DT Article
DE MECHANICAL PROPERTIES; COMPOSITE MATERIALS; SYNTHETIC FIBER; YOUNG
   MODULUS
AB A major design requirement of biomaterial prostheses is to match their elastic properties with those of the natural host tissue. Composite materials address this requirement because their elastic properties can be altered accurately through composition and directionality parameters, and they can be designed to match closely the elastic properties of the biological tissues, in isocompliance, modulus gradient and anisotropy. This adds to a range of advantages of synthetic composite materials with respect to potential biomedical applications, which draw on their heterogeneity and anisotropy. This paper focuses on the elastic properties of synthetic fibre-reinforced composite materials that pertain to biomedical applications, and demonstrates the range of stiffnesses obtainable through selection of constituents and by choice of angle of reinforcement.
RP MAROM, G (reprint author), HEBREW UNIV JERUSALEM,GRAD SCH APPL SCI & TECHNOL,CASALI INST APPL CHEM,IL-91904 JERUSALEM,ISRAEL.
CR AGARWLA BD, 1990, ANAL PEFORMANCE COMP
   Chou TW, 1992, MICROSTRUCTURAL DESI
   COHN D, 1992, J BIOMED MATER RES, V26, P1185, DOI 10.1002/jbm.820260909
   GERSHON B, 1990, Clinical Materials, V5, P13, DOI 10.1016/0267-6605(90)90068-7
   GERSHON B, 1990, BIOMATERIALS, V11, P548, DOI 10.1016/0142-9612(90)90076-3
   GERSHON B, 1982, BIOMATERIALS, V13, P38
   SCHEER W, 1981, PROCESSING USES CARB, P251
NR 7
TC 10
Z9 10
U1 1
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PY 1993
VL 14
IS 2
BP 127
EP 131
DI 10.1016/0142-9612(93)90224-P
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA KK595
UT WOS:A1993KK59500008
PM 8435456
DA 2018-10-19
ER

PT J
AU ANTICH, PP
   REEVE
AF ANTICH, PP
   REEVE
TI ULTRASOUND STUDY OF BONE IN-VITRO
SO CALCIFIED TISSUE INTERNATIONAL
LA English
DT Article
DE ULTRASOUND; BIOMECHANICAL COMPETENCE; BONE STRENGTH; OSTEOPOROSIS
ID VIBRATION TESTING INSITU; CORTICAL BONE; ELASTIC PROPERTIES; TIBIAL
   STIFFNESS; CANCELLOUS BONE; TRABECULAR BONE; MINERAL DENSITY; STRENGTH;
   VELOCITY; QUALITY
AB Ultrasound has been investigated as a tool for characterizing the biomechanical competence of bone. The rationale for using ultrasound rests on two points. First, its interaction with tissues can be used to measure their density, velocity, and structure, and thus to characterize the elasticity and to infer the strength of bone. Second, ultrasound may be used to characterize tissue properties over a wide range of spatial dimensions and organizational levels, ranging from its constituents (e.g., trabeculae for cancellous bone) to the entire organ' Different ultrasound techniques can be used to investigate diverse bone properties, but two techniques have emerged as having the potential for providing useful information on problems of current biomedical interest. These measure two parameters, density and velocity, which correlate with the elastic and ultimate properties of bone. In particular, the elasticity E is formally related to the product of density and velocity squared, E = rhov2. Moreover, it has been shown by mechanical testing that there is a single linear correlation between elasticity and strength at all orientations, both in cortical and in cancellous bone, materials with a strong intrinsic anisotropy. At the tissue level, it may therefore be expected that the ultrasound parameters will prove to be useful predictors of bone strength and of its dependence on orientation. In vitro ultrasound studies have shown that these properties can be measured specifically and quantitatively, and that they vary under different physiological conditions.
C1 UNIV TEXAS, SW MED CTR, CTR MINERAL METAB & CLIN RES, DALLAS, TX 75235 USA.
RP ANTICH, PP (reprint author), UNIV TEXAS, SW MED CTR, DEPT RADIOL, DALLAS, TX 75235 USA.
CR ABENDSCHEIN W, 1970, CLIN ORTHOP RELAT R, P294
   ANAST G T, 1958, Am J Phys Med, V37, P157
   ANTICH PP, 1991, J BONE MINER RES, V6, P417
   ANTICH PP, 1993, J BONE MINER RES, V8, P301
   ANTICH PP, 1992, J BONE MINER RES, V7, pS198
   ASHMAN RB, 1987, J BIOMECH, V20, P979, DOI 10.1016/0021-9290(87)90327-7
   ASHMAN RB, 1988, J BIOMECH, V21, P177, DOI 10.1016/0021-9290(88)90167-4
   ASHMAN RB, 1984, J BIOMECH, V17, P349, DOI 10.1016/0021-9290(84)90029-0
   CHANDRA K, 1990, ANN INT C IEEE ENG M, V12, P1400
   CHRISTENSEN AB, 1986, J BIOMECH, V19, P53, DOI 10.1016/0021-9290(86)90108-9
   CORNELISSEN M, 1987, J BIOMECH, V20, P333, DOI 10.1016/0021-9290(87)90041-8
   CORNELISSEN P, 1986, J BIOMECH, V19, P551, DOI 10.1016/0021-9290(86)90128-4
   CURREY JD, 1970, CLIN ORTHOP RELAT R, P210
   GEUSENS P, 1992, J BONE MINER RES, V7, P599
   GOSS SA, 1978, J ACOUST SOC AM, V64, P423, DOI 10.1121/1.382016
   HAYES WC, 1985, BONE MINERAL RES
   HEANEY RP, 1989, BONE MINER, V6, P1, DOI 10.1016/0169-6009(89)90018-4
   HEANEY RP, 1989, JAMA-J AM MED ASSOC, V261, P2986, DOI 10.1001/jama.261.20.2986
   JEFFCOTT LB, 1985, VET REC, V116, P337, DOI 10.1136/vr.116.13.337
   KATZ JL, 1987, J BIOMECH, V20, P1063, DOI 10.1016/0021-9290(87)90024-8
   LAKES R, 1986, J BIOMED ENG, V8, P143, DOI 10.1016/0141-5425(86)90049-X
   Langton C M, 1984, Eng Med, V13, P89
   LEES S, 1992, CALCIFIED TISSUE INT, V50, P88, DOI 10.1007/BF00297303
   LEES S, 1979, J ACOUST SOC AM, V66, P641, DOI 10.1121/1.383689
   LEES S, 1986, TISSUE CHARACTERIZAT, V2, P207
   MCCLOSKEY EV, 1990, CLIN SCI, V78, P221, DOI 10.1042/cs0780221
   MCKELVIE ML, 1989, BONE, V10, P101, DOI 10.1016/8756-3282(89)90005-7
   RICE JC, 1988, J BIOMECH, V21, P155, DOI 10.1016/0021-9290(88)90008-5
   THEISMANN H, 1949, Strahlentherapie, V80, P607
   TURNER CH, 1991, CALCIFIED TISSUE INT, V49, P116, DOI 10.1007/BF02565132
   TURNER CH, 1992, J ORTHOPAED RES, V10, P581, DOI 10.1002/jor.1100100413
   WHITING JF, 1977, ULTRASOUND MED, P1629
   WRIGHT LL, 1987, PEDIATR RES, V22, P541, DOI 10.1203/00006450-198711000-00014
   YOON HS, 1976, J BIOMECH, V9, P459, DOI 10.1016/0021-9290(76)90089-0
   ZERWEKH JE, 1991, J BONE MINER RES, V6, P239
   ZERWEKH JE, 1992, BONE MINER, V18, P65, DOI 10.1016/0169-6009(92)90800-S
   ZIMMERMAN MC, 1989, J ORTHOP RES, V7, P607, DOI 10.1002/jor.1100070420
   ZIMMERMAN MC, 1990, IEEE T BIO-MED ENG, V37, P433, DOI 10.1109/10.55634
NR 38
TC 21
Z9 21
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0171-967X
EI 1432-0827
J9 CALCIFIED TISSUE INT
JI Calcif. Tissue Int.
PY 1993
VL 53
SU 1
BP S157
EP S161
DI 10.1007/BF01673428
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA LW987
UT WOS:A1993LW98700032
PM 8275372
DA 2018-10-19
ER

PT J
AU VALLANA, F
   PASQUINO, E
   RINALDI, S
   GALLONI, M
   GATTI, AM
   MODICA, F
   BENECH, A
AF VALLANA, F
   PASQUINO, E
   RINALDI, S
   GALLONI, M
   GATTI, AM
   MODICA, F
   BENECH, A
TI CARBOFILM(TM) - PRESENT AND FUTURE APPLICATIONS IN BIOMEDICAL DEVICES
SO CERAMICS INTERNATIONAL
LA English
DT Article
ID IMPLANTS; CARBON
AB Carbofilm is a thin film of pyrolytic carbon that can be deposited on materials, such as polymers and metals, suitable for implantable-prosthesis production. In this way, the coated material acquires the well-known biocompatibility characteristics of pyrolytic carbon.
C1 UNIV TURIN,SCH VET MED,DEPT MORPHOPHYSIOL,TURIN,ITALY.
   UNIV MODENA,SCH MED,BIOMAT LAB,MODENA,ITALY.
   UNIV TURIN,SCH MED,DEPT MAXILLOFACIAL SURG,TURIN,ITALY.
RP VALLANA, F (reprint author), SORIN BIOMED SPA,DIV CARDIOVASC,SALUGGIA,ITALY.
OI Modica, Fabio/0000-0002-1704-8081; BENECH, Arnaldo/0000-0003-1905-1089
CR AEBISCHER P, 1988, BIOMATERIALS, V9, P80, DOI 10.1016/0142-9612(88)90075-0
   AEBISHER P, 1986, 12TH ANN M SOC BIOM
   AISENBERG S, 1971, J APPL PHYS, V42, P2953, DOI 10.1063/1.1660654
   BERNEX F, 1992, 38TH ANN M AM SOC AR
   BOCCHIOTTI G, 1993, PLAST RECONSTR SURG, V19, P80
   BOCCHIOTTI G, 1989, 38TH C NAZ SOC IT CH
   BOKROS JC, 1977, CARBON, V15, P355
   CHIU TH, 1976, T AM SOC ART INT ORG, V22, P498
   CHU WK, 1978, BACKSCATTERING SPECT
   CZANDERNA AW, 1975, METHODS SURFACE ANAL, pCH4
   DONATH K, 1990, EXACT
   FENG L, 1991, J BIOMED MATER RES
   HAUBOLD AD, 1983, ASAIO J, V29, P88
   HAUBOLD AD, 1981, BIOCOMPATIBILITY CLI, V2
   KELLER JC, 1987, J BIOMED MATER RES, V21, P305, DOI 10.1002/jbm.820210304
   MARINKOVIC Z, 1976, CARBON, V14, P329, DOI 10.1016/0008-6223(76)90005-1
   MONDIERE CM, 1990, ANN VASC SURG, V4, P52
   NOERA G, 1989, CHIR TORAC, V42, P401
   PACCAGNELLA A, 1986, 6 SAT S WORLD C HIGH
   Paccagnella A, 1986, J ARTIF ORGANS, V9, P115
   PILLIAR RM, 1987, J BIOMED MATER RES-A, V21, P1
   RAMELLO A, 1985, COMMUNICATION
   RIVERO DP, 1988, J BIOMED MATER RES, V22, P191, DOI 10.1002/jbm.820220304
   ROSSI C, 1988, 17 WORLD C INT SOC C
   SBARBATI R, 1991, INT J ARTIF ORGANS, V14, P491
   SHIM HS, 1978, J BIOENG, V2, P341
   SHIM HS, 1976, J BIOENG, V1, P45
NR 27
TC 12
Z9 12
U1 1
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0272-8842
J9 CERAM INT
JI Ceram. Int.
PY 1993
VL 19
IS 3
BP 169
EP 179
DI 10.1016/0272-8842(93)90038-S
PG 11
WC Materials Science, Ceramics
SC Materials Science
GA MF763
UT WOS:A1993MF76300005
DA 2018-10-19
ER

PT J
AU RAO, BR
   DAMARAJU, CV
   ALHUMOUD, JM
AF RAO, BR
   DAMARAJU, CV
   ALHUMOUD, JM
TI COVARIATE EFFECT ON THE LIFE EXPECTANCY AND PERCENTILE RESIDUAL LIFE
   FUNCTIONS UNDER THE PROPORTIONAL HAZARDS AND THE ACCELERATED LIFE MODELS
SO COMMUNICATIONS IN STATISTICS-THEORY AND METHODS
LA English
DT Article
DE HAZARD RATE; SURVIVAL FUNCTION; WEIBULL AND GOMPERTZ DISTRIBUTIONS;
   CANCER RISK ASSESSMENT
ID ZERO PROPERTY; CLOCK BACK; TIME; TUMOR
AB The present paper is concerned with statistical models for the dependence of survival time or time to occurrence of an event, such as time to tumor, on a vector X of covariates or prognostic variables such as age, sex, blood pressure, length of exposure to a toxic material, etc., measured on a group of individuals in biomedical investigations. It is assumed that the covariates influence the distribution of time to tumor only through a linear predictor eta = beta'X.
   The object of our paper is to investigate the effect due to the covariates on the Life Expectancy and the Percentile Residual Life (PRL) function of a family of organisms under the proportional hazards and the accelerated life models. The key result is that the families of survival distributions under these models have the 'setting the clock back to zero' property if the family of baseline survival distributions does. This property is a generalization of the lack of memory property of the exponential distribution. Simple examples of the members of this family are the linear hazard exponential, Pareto and Gompertz life distributions.
   As a simple application of the main results obtained in the present paper, we have considered a stochastic survival model recently proposed by Chiang and Conforti (1989) for the time-to-tumor distribution in the context of a large-scale serial sacrifice experiment by the National Center of Toxicological Research (NCTR). This involves some mice that were fed 2-AAF from infancy and those that developed bladder and/or liver neoplasms, see Farmer et al (1980). It is shown that their stochastic model for tumor incidence intensity at time t leads to a family of survival models that has the setting the clock back to zero property. The survival functions and the effect of the vector X of covariates on the PRL and the tumor-free life expectancies are evaluated for the proportional hazards and accelerated life models.
C1 UNIV PITTSBURGH, GRAD SCH PUBL HLTH, DEPT BIOSTAT, PITTSBURGH, PA 15261 USA.
   UNIV PITTSBURGH, DEPT CIVIL ENGN, PITTSBURGH, PA 15261 USA.
CR BAIN LJ, 1978, STATISTICAL ANAL REL
   BARLOW R, 1975, STATISTICAL THEORY R
   CHIANG CL, 1989, MATH BIOSCI, V94, P1, DOI 10.1016/0025-5564(89)90070-9
   CHIANG CL, 1968, INTRO STOCHASTIC PRO
   COX DR, 1972, J R STAT SOC B, V34, P187
   FARMER JH, 1980, J ENVIRON PATHOL TOX, V3, P55
   FEIGL P, 1965, BIOMETRICS, V21, P826, DOI 10.2307/2528247
   GARG ML, 1970, APPLIED STATISTICS, V19, P152
   GLASSER M, 1967, J AM STAT ASSOC, V62, P561, DOI 10.2307/2283983
   HAINES AL, 1984, RELIABILITY BIOMETRY
   KARLIN S, 1966, 1ST COURSE STOCHASTI
   LAIRD AK, 1965, GROWTH, V29, P233
   LITTLEFIELD NA, 1980, J ENVIRON PATHOL TOX, V3, P17
   MCCULLAGH P, 1983, GENERALIZED LINEAR M
   OAKES D, 1991, STATISTICAL THEORY M
   RAO BR, 1989, MATH BIOSCI, V96, P95
   RAO BR, 1990, J STAT PLAN INFER, V24, P347, DOI 10.1016/0378-3758(90)90053-W
   RAO BR, 1990, COMMUN STAT-THEOR M, V19, P583
   ZIPPIN C, 1966, BIOMETRICS, V22, P665, DOI 10.2307/2528067
NR 19
TC 1
Z9 1
U1 0
U2 1
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0361-0926
EI 1532-415X
J9 COMMUN STAT-THEOR M
JI Commun. Stat.-Theory Methods
PY 1993
VL 22
IS 1
BP 257
EP 281
PG 25
WC Statistics & Probability
SC Mathematics
GA KD981
UT WOS:A1993KD98100016
DA 2018-10-19
ER

PT J
AU CASCONE, MG
   TRICOLI, M
   CERRAI, P
   DELGUERRA, RS
AF CASCONE, MG
   TRICOLI, M
   CERRAI, P
   DELGUERRA, RS
TI CELL-CULTURES IN THE BIOCOMPATIBILITY STUDY OF SYNTHETIC MATERIALS
SO CYTOTECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 12TH NATIONAL CONGRESS OF THE ITALIAN CELL CULTURE ASSOC
CY DEC 09-11, 1992
CL GENOA, ITALY
SP ITALIAN CELL CULTURE ASSOC
AB In vitro cytotoxicity (Neutral Red uptake, Kenacid Blue and MTT) and cytocompatibility (cell adhesion and proliferation) tests were applied to the biocompatibility study of a series of poly(ester-ether-ester) block copolymers of potential interest as biomaterials. Our results indicate that the copolymer extracts after 72 hours incubation with a 3T3 mouse fibroblast cell line do not induce significant toxic effects. Furthermore, human umbilical vein endothelial cells seeded on thin copolymer films show a normal pattern            of growth. We conclude that the in vitro tests used are a valid instrument to evaluate the potential toxic action of synthetic materials on different cell compartments and that the tested materials seem to be promising for future applications in the field of biomedical devices.
C1 CNR,INST CLIN PHYS,I-56127 PISA,ITALY.
   CNR,CTR STUDI PROC IONICI,I-56126 PISA,ITALY.
RP CASCONE, MG (reprint author), DEPT CHEM ENGN,VIA DIOTISALVI 2,I-56126 PISA,ITALY.
CR SBARBATIDELGUER.R, 1993, IN PRESS IN VITRO VA
   Williams D. F., 1987, DEFINITIONS BIOMATER
   FOUND REPLACEMENT AN
NR 3
TC 8
Z9 8
U1 0
U2 0
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0920-9069
J9 CYTOTECHNOLOGY
JI Cytotechnology
PY 1993
VL 11
SU 1
BP 137
EP 139
PG 3
WC Biotechnology & Applied Microbiology; Cell Biology
SC Biotechnology & Applied Microbiology; Cell Biology
GA LF815
UT WOS:A1993LF81500042
PM 22358679
DA 2018-10-19
ER

PT J
AU BERNDT, CC
   LIN, CK
AF BERNDT, CC
   LIN, CK
TI MEASUREMENT OF ADHESION FOR THERMALLY SPRAYED MATERIALS
SO JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY
LA English
DT Review
DE ACOUSTIC EMISSION; ADHESION; ADHESION MEASUREMENT; COATING FAILURE;
   DEGRADATION; DOUBLE CANTILEVER BEAM TEST; FRACTURE MECHANICS;
   INDENTATION; LIFETIME MODELING; SCRATCH TEST; THERMALLY SPRAYED COATINGS
ID STABILIZED ZIRCONIA COATINGS; CERAMIC COATINGS; SCRATCH ADHESION;
   BARRIER COATINGS; FRACTURE-TOUGHNESS; SUBSTRATE ADHESION; PLASMA;
   INDENTATION; ENERGY
AB Thermally sprayed coatings have a distinctive microstructure which can be described as 'a three-dimensional layered structure of discs which are interlaced to form a material of composite nature'. The coatings are normally greater than 25 mu m in thickness and can thus be described as bulk coatings. The minimum microstructural detail would be a single splat (often described as a lamella), which is about 5 mu m in thickness and up to 80 mu m in diameter. This paper focuses on methods used to define and measure; the adhesion of coatings or deposits formed by thermal spray technology. The properties distinguished include those of strength and toughness. Measurements such as the tensile adhesion (according to ASTM C633) and double cantilever beam (DCB) tests will be addressed to illustrate the relevance (if any) of such methods to present industrial practice. Acoustic emission studies have also assessed a function termed as the 'crack density function', i.e. a product of the number of cracks and crack size. Other measuring methods applied to this technology include microhardness and scratch testing. The former technique has demonstrated that the material properties of coatings are anisotropic, and the latter method is being considered within the biomedical industry to assess the adhesion of hydroxyapatite to orthopedic prostheses. These techniques, among others, may be used for both fundamental understanding of coating performance (i.e. life prediction and cracking mechanisms)and as tests for quality control.
RP BERNDT, CC (reprint author), SUNY STONY BROOK,DEPT MAT SCI & ENGN,THERMAL SPRAY LAB,STONY BROOK,NY 11794, USA.
CR ANDERSON CW, 1992, 1992 P INT THERM SPR, P695
   APPS RL, 1974, CHEM ENG, V292, P769
   BASCOM WD, 1977, J MATER SCI, V12, P1401, DOI 10.1007/BF00540854
   BECHER PF, 1977, J MATER SCI, V12, P90, DOI 10.1007/BF00738474
   BECHER PF, 1978, FRACTURE MECHANICS C, V3, P463
   BELASHCHENKO VE, 1992, 1992 INT THERM SPRAY, P433
   BELTZUNG F, 1989, THIN SOLID FILMS, V181, P407, DOI 10.1016/0040-6090(89)90509-9
   BENJAMIN P, 1960, PROC R SOC LON SER-A, V254, P163, DOI 10.1098/rspa.1960.0012
   Berndt C.C., 1981, T INT ENG, V6, P53
   BERNDT CC, 1989, J MATER SCI, V24, P3511, DOI 10.1007/BF02385733
   BERNDT CC, 1984, THIN SOLID FILMS, V119, P173, DOI 10.1016/0040-6090(84)90532-7
   BERNDT CC, 1992, 1991 NAT THERM SPRAY, P199
   BERNDT CC, 1980, THESIS MONASH U AUST
   BERNDT CC, 1985, MAY THERM BARR COAT, P127
   BERNDT CC, 1984, ADV FRACTURE RES, V4, P2545
   BERNDT CC, 1992, 1992 INT THERM SPRAY
   BERNDT CC, 1992, 1992 INT THERM SPRAY, P941
   BERNECKI TF, 1992, 1991 NAT THERM SPRAY
   BESHISH GK, 1993, J THERM SPRAY TECHN, V2, P35
   BINNER JGP, 1984, BRIT CERAM TRANS J, V83, P168
   BISGAARD S, 1991, 1990 NAT THERM SPRAY, P661
   BLUMSANDMEIER S, 1991, 2ND PLASM TECHN S P
   BORDEAUX F, 1992, SURF COAT TECH, V54, P70, DOI 10.1016/0257-8972(92)90142-W
   BOX G, 1988, TECHNOMETRICS, V30, P1, DOI 10.2307/1270311
   BULL SJ, 1988, SURF COAT TECH, V36, P503, DOI 10.1016/0257-8972(88)90178-8
   BULL SJ, 1991, SURF COAT TECH, V50, P25, DOI 10.1016/0257-8972(91)90188-3
   BULL SJ, 1989, BRIT CERAM TRANS J, V88, P177
   BURNETT PJ, 1987, THIN SOLID FILMS, V154, P403, DOI 10.1016/0040-6090(87)90382-8
   CHALKER PR, 1991, MAT SCI ENG A-STRUCT, V140, P583, DOI 10.1016/0921-5093(91)90482-3
   CHANG GC, 1987, SURF COAT TECH, V30, P13, DOI 10.1016/0257-8972(87)90004-1
   COMYN J, 1990, INT J ADHES ADHES, V10, P161, DOI 10.1016/0143-7496(90)90099-J
   COX LC, 1988, SURF COAT TECH, V36, P807, DOI 10.1016/0257-8972(88)90021-7
   DALMASCHIO R, 1992, 1992 INT THERM SPRAY, P947
   DAS DK, 1991, SURF COAT TECH, V46, P331, DOI 10.1016/0257-8972(91)90175-V
   DEMASI JT, 1991, NASA CR182230 FIN RE
   DUNEGAN HL, 1975, PREVENTION STRUCTURA, P86
   FILAGGI MJ, 1991, J MATER SCI, V26, P5383
   FURUKUBO K, 1992, 1992 INT THERM SPRAY, P705
   GRISAFFE SJ, 1965, NASA TN D3113
   GRUTZNER H, 1991, SURF COAT TECH, V45, P317, DOI 10.1016/0257-8972(91)90238-R
   GUGDE M, 1991, 1990 NAT THERM SPRAY, P331
   HEINTZE GN, 1988, SURF COAT TECH, V36, P125, DOI 10.1016/0257-8972(88)90142-9
   HEINTZE GN, 1988, SURF COAT TECH, V34, P15, DOI 10.1016/0257-8972(88)90084-9
   HEINTZE GN, 1988, 1987 NAT THERM SPRAY, P271
   HENDRICKS RC, 1981, NASA TM81743
   HERMAN H, 1989, SCI AM, V256, P112
   HILLERY RV, 1987, NASA CR180807 FIN RE
   HOWARD SJ, 1991, SURF COAT TECH, V45, P333, DOI 10.1016/0257-8972(91)90240-W
   IWAMOT N, 1992, 1992 INT THERM SPRAY, P259
   Jones T.N.R., 1990, SURF COAT TECH, V43-44, P402
   JULIASCHMUTZ C, 1991, SURF COAT TECH, V48, P1, DOI 10.1016/0257-8972(91)90121-C
   KIES JA, 1969, FRACTURE 1969
   LAWN B, 1975, J MATER SCI, V10, P1049, DOI 10.1007/BF00823224
   Lawn B. R., 1975, FRACTURE BRITTLE SOL
   LIN CK, 1993, 1993 NAT THERM SPRAY, P561
   LOPEZ E, 1989, J MATER SCI LETT, V8, P346, DOI 10.1007/BF00725519
   LUGSCHEIDER E, 1992, 1992 INT THERM SPRAY, P647
   LYASHENKO BA, 1969, SOV POWDER METALL, V8, P331
   MATTHEWS JR, 1983, ACOUSTIC EMISSION
   MATTING A, 1963, METALLWISS TECH, V17, P905
   MATTING A, 1963, METALLWISS TECH, V17, P583
   MATTING A, 1963, METALL, V17, P1213
   MAYURAM MM, 1992, 1992 INT THERM SPRAY, P711
   MCPHERSON R, 1989, SURF COAT TECH, V39, P173, DOI 10.1016/0257-8972(89)90052-2
   MEIER SM, 1991, NASA CR18911 FIN REP
   MILLER RA, 1984, J AM CERAM SOC, V67, P517, DOI 10.1111/j.1151-2916.1984.tb19162.x
   MILLER RA, 1987, SURF COAT TECH, V30, P1, DOI 10.1016/0257-8972(87)90003-X
   MILLER RA, 1989, J ENG GAS TURB POWER, V11, P301
   Mittal K. L., 1987, Journal of Adhesion Science and Technology, V1, P247, DOI 10.1163/156856187X00265
   MITTAL KL, 1978, ASTM STP, V640
   MOSTOVOY S, 1967, J MATER, V2, P661
   NAKAHIRA H, 1992, 1992 INT THERM SPRAY, P519
   NAYEBHASHEMI H, 1991, EXP MECH, P366
   NERZ TC, 1992, 1992 INT THERM SPRAY, P405
   NEUFUSS K, 1992, AUSTCERAM 1992, P124
   NOONE MJ, 1974, FRACTURE MECHANICS C, V1, P201
   OSTOJIC P, 1988, J AM CERAM SOC, V71, P891, DOI 10.1111/j.1151-2916.1988.tb07542.x
   OSTOJIC P, 1986, THESIS MONASH U AUST
   OUTWATER JO, 1969, J ADHESION, V1, P290, DOI 10.1080/00218466908072191
   PATRICK RL, 1967, TREATISE ADHESION AD, V1
   PERRY AJ, 1988, SURF COAT TECH, V36, P559, DOI 10.1016/0257-8972(88)90182-X
   RICHARD C, 1992, 1992 P INT THERM SPR, P11
   RICKERBY DS, 1988, SURF COAT TECH, V36, P541, DOI 10.1016/0257-8972(88)90181-8
   RYKALIN NN, 1976, PURE APPL CHEM, V48, P179, DOI 10.1351/pac197648020179
   SCHWEITZER KK, 1991, SURF COAT TECH, V48, P103, DOI 10.1016/0257-8972(91)90133-H
   SCOTT KT, 1991, ADV SURFACE COATINGS, P217
   SCOTT LG, 1991, BASIC ACOUSTIC EMISS
   SEKLER J, 1988, SURF COAT TECH, V36, P519, DOI 10.1016/0257-8972(88)90179-X
   STANTON WE, 1973, 7TH P INT MET SPRAYI, P157
   STEEPER TJ, 1992, 1992 INT THERM SPRAY, P415
   STEFFENS HD, 1987, SURF COAT TECH, V32, P327, DOI 10.1016/0257-8972(87)90117-4
   STRANGMAN TE, 1987, NASA CR179648 FIN RE
   SUHARA T, 1973, 7TH P INT MET SPRAYI, P179
   Taguchi G, 1987, TAGUCHI METHODS ORTH
   Thouless M.D., 1988, MATER RES SOC S P, V119, P51
   TOSS P, 1988, TAGUCHI TECHNIQUES Q
   TSURU T, 1987, CORROSION, V43, P703, DOI 10.5006/1.3583853
   WEISS LE, 1992, J THERM SPRAY TECHN, V1, P231
   WILMS V, 1976, THIN SOLID FILMS, V39, P251, DOI 10.1016/0040-6090(76)90643-X
   ZAKHAROV BM, 1970, SOV POWDER METALL, V9, P925
   ZATT JH, 1983, ANNU REV MATER SCI, V13, P9
   1985, P THERMAL BARRIER CO
   1991, D90791B AM SOC TEST
   1972, STP AM SOC TESTING M, V505
NR 104
TC 39
Z9 40
U1 1
U2 15
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0169-4243
J9 J ADHES SCI TECHNOL
JI J. Adhes. Sci. Technol.
PY 1993
VL 7
IS 12
BP 1235
EP 1264
DI 10.1163/156856193X00088
PG 30
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA MQ145
UT WOS:A1993MQ14500001
DA 2018-10-19
ER

PT J
AU MERRILL, EW
AF MERRILL, EW
TI POLY(ETHYLENE OXIDE) STAR MOLECULES - SYNTHESIS, CHARACTERIZATION, AND
   APPLICATIONS IN MEDICINE AND BIOLOGY
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
AB It was an honor to be invited to honor Allan Hoffman on the occasion of his 60th birthday. It seems like yesterday that Allan and I shared an office in old Building 12 on the M.I.T. campus. At that time Allan had lost a bout with a snow covered mountain while on skis, and consequently moved about awkwardly in our already small room on crutches with a heavy cast. Despite these impediments, he carried on his classroom activities with typical energy. It was even earlier that at M.I.T., under the supervision of Ed Gilliland and myself, he carried out his doctoral research on the radiation grafting of styrene to polyethylene. Both he and I have dabbled in radiation chemistry on and off since then-he far more than I. Neither of us at that epoch had much idea about biomaterials or medical applications of materials-at least I did not-perhaps Allan had it in the back of his mind.
   The University of Washington, Seattle, is recognized as one of the great centers of biomedical engineering in the world, both in scope and in depth, and Allan has played a stellar role in the evolution of Seattle's reputation. He has also developed a reputation for outstanding work in biomaterials and is one of the most visible and internationally recognized leaders in the field.
RP MERRILL, EW (reprint author), MIT,DEPT CHEM ENGN,CAMBRIDGE,MA 02139, USA.
CR BAUER BJ, 1989, MACROMOLECULES, V22, P2337, DOI 10.1021/ma00195a058
   FRANCOIS J, 1985, EUR POLYM J, V21, P165, DOI 10.1016/0014-3057(85)90049-7
   GNANOU Y, 1988, MAKROMOL CHEM, V189, P2885
   Harris J. M., 1992, POLYETHYLENE GLYCOL
   LUTZ P, 1988, MAKROMOL CHEM, V189, P1051
   LUTZ P, 1991, COMMUNICATION
   MERRILL EW, 1992, Patent No. 5171264
   MERRILL EW, 1990, SOC BIOMATERIALS P
   REMPP P, 1990, POLYM PREPR AM CHEM, V31, P215
   REMPP P, 1991, POLYM PREPR-ACS, V32, P687
NR 10
TC 49
Z9 51
U1 0
U2 10
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1993
VL 5
IS 1-2
BP 1
EP 11
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA MG099
UT WOS:A1993MG09900001
PM 8297822
DA 2018-10-19
ER

PT J
AU GRIJPMA, DW
   KROEZE, E
   NIJENHUIS, AJ
   PENNINGS, AJ
AF GRIJPMA, DW
   KROEZE, E
   NIJENHUIS, AJ
   PENNINGS, AJ
TI POLY(L-LACTIDE) CROSS-LINKED WITH SPIRO-BIS-DIMETHYLENE-CARBONATE
SO POLYMER
LA English
DT Article
DE POLY(L-LACTIDE); POLY(LACTONES); CROSS-LINKING; BICYCLIC BISCARBONATE;
   SWELLING BEHAVIOR; MECHANICAL PROPERTIES; THERMAL PROPERTIES
ID MOLECULAR-WEIGHT; L-LACTIDE; AMORPHOUS POLYMERS; INTERNAL-FIXATION;
   PLATES; SCREWS; COPOLYMERS; FRACTURES; NETWORKS; STRENGTH
AB Poly(L-lactide) and other poly(lactones) can be crosslinked by ring opening polymerization of the corresponding cyclic esters in the presence of a tetrafunctional bicyclic biscarbonate. Spiro-bis-dimethylene-carbonate was synthesized from pentaerythritol and diethylene-carbonate and used to prepare polyester networks for use in biomedical applications. Bulk copolymerization Of L-lactide with only small amounts of this crosslinker leads to networks with very high gel percentages of up to 100%. The initial crystallinity of these crosslinked poly(L-lactides), as well as the melting temperature, is very much reduced when compared with the homo poly(L-lactide). The degradation of the polymer in vivo is therefore expected to be enhanced and more benign at longer durations. Tensile strength and impact resistance are also greatly influenced by copolymerization with spiro-bis-dimethylene-carbonate.  Much tougher and stronger materials can be obtained in this way. These favourable properties allow the material to be used in the preparation of degradable implants such as fracture fixation devices.
C1 UNIV GRONINGEN,DEPT POLYMER SCI,NIJENBORGH 4,9747 AG GRONINGEN,NETHERLANDS.
CR BERLOW E, 1958, ACS MONOGRAPH SERIES, V136
   BERSTED BH, 1990, J APPL POLYM SCI, V39, P499, DOI 10.1002/app.1990.070390302
   BERSTED BH, 1979, J APPL POLYM SCI, V24, P37, DOI 10.1002/app.1979.070240105
   BOS RRM, 1987, J ORAL MAXIL SURG, V45, P751, DOI 10.1016/0278-2391(87)90194-7
   BOS RRM, 1989, INT J ORAL MAX SURG, V18, P365, DOI 10.1016/S0901-5027(89)80035-9
   BOS RRM, 1989, BRIT J ORAL MAX SURG, V27, P467, DOI 10.1016/S0266-4356(89)80004-X
   BRANT DA, 1969, MACROMOLECULES, V2, P228, DOI 10.1021/ma60009a003
   Carothers WH, 1930, J AM CHEM SOC, V52, P314, DOI 10.1021/ja01364a045
   DANIELS AU, 1990, J APPL BIOMATER, V1, P57, DOI 10.1002/jab.770010109
   deGennes PG, 1979, SCALING CONCEPTS POL
   DONALD AM, 1982, J POLYM SCI POL PHYS, V20, P899, DOI 10.1002/pol.1982.180200512
   Ferry J. D., 1980, VISCOELASTIC PROPERT
   FISCHER EW, 1973, KOLLOID Z Z POLYM, V251, P980, DOI 10.1007/BF01498927
   Flory P. J, 1953, PRINCIPLES POLYM CHE
   FLORY PJ, 1979, MACROMOLECULES, V12, P119, DOI 10.1021/ma60067a025
   GRIJPMA DW, 1990, POLYMER, V31, P2201, DOI 10.1016/0032-3861(90)90096-H
   GRIJPMA DW, 1991, POLYM BULL, V25, P335, DOI 10.1007/BF00316903
   GRIJPMA DW, 1992, POLYM BULL, V29, P571, DOI 10.1007/BF00296720
   GRIJPMA DW, IN PRESS
   Kausch H. H., 1987, POLYM FRACTURE
   KRIMM H, 1984, Patent No. 57360
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P70, DOI 10.1016/0142-9612(87)90034-2
   LEENSLAG JW, 1987, MAKROMOL CHEM, V188, P1809
   LEENSLAG JW, 1987, POLYM COMMUN, V28, P92
   LLORENTE MA, 1979, J CHEM PHYS, V71, P682, DOI 10.1063/1.438354
   Mark J.E., 1988, RUBBERLIKE ELASTICIT
   MARK JE, 1982, RUBBER CHEM TECHNOL, V55, P762, DOI 10.5254/1.3535902
   MARK JE, 1981, PURE APPL CHEM, V53, P1495, DOI 10.1351/pac198153081495
   Mullins L., 1959, J APPL POLYM SCI, V2, P1
   NAKAMURA T, 1989, J BIOMED MATER RES, V23, P1115, DOI 10.1002/jbm.820231003
   NIJENHUIS AJ, IN PRESS
   ORWOLL RA, 1977, RUBBER CHEM TECHNOL, V50, P451, DOI 10.5254/1.3535155
   PENNINGS AJ, 1990, COLLOID POLYM SCI, V268, P2, DOI 10.1007/BF01410416
   PENNINGS AJ, 1968, PUBLICATION NATIONAL, V1573
   Pitt CG, 1984, J CONTROL RELEASE, V1, P3
   ROZEMA FR, UNPUB J BIOMED MATER
   ROZEMA FR, 1991, THESIS U GRONINGEN
   SCHULTZ JM, 1984, POLYM ENG SCI, V24, P770, DOI 10.1002/pen.760241007
   TRELOAR LRG, 1975, PHYSICS RUBBER ELAST
   TUNC D, 1988, Patent No. 321176
   TUNC D, 1990, Patent No. 4905680
   Vert M., 1984, MACROMOLECULAR BIOMA, P120
   ZHU KJ, 1991, MACROMOLECULES, V24, P1736, DOI 10.1021/ma00008a008
NR 43
TC 38
Z9 40
U1 0
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0032-3861
J9 POLYMER
JI Polymer
PY 1993
VL 34
IS 7
BP 1496
EP 1503
DI 10.1016/0032-3861(93)90868-B
PG 8
WC Polymer Science
SC Polymer Science
GA KW744
UT WOS:A1993KW74400025
DA 2018-10-19
ER

PT J
AU HOSAKA, S
   MURAO, Y
   TAMAKI, H
   MASUKO, S
   MIURA, K
   KAWABATA, Y
AF HOSAKA, S
   MURAO, Y
   TAMAKI, H
   MASUKO, S
   MIURA, K
   KAWABATA, Y
TI MONODISPERSE MICROSPHERES OF COPOLYMERS OF GLYCIDYL METHACRYLATE AND ITS
   DERIVATIVES AS MATERIALS FOR BIOMEDICAL APPLICATION
SO POLYMER INTERNATIONAL
LA English
DT Article; Proceedings Paper
CT INTERNATIONAL SYMP ON POLYMERIC MICROSPHERES
CY OCT 23-26, 1991
CL FUKUI, JAPAN
SP HOKURIKU IND ADVANCE CTR, KUSAKABE GRIFFITH ACAD & CULTURE EXCHANGE FDN, CIBA GEIGY FDN JAPAN PROMOT SCI, YOSHIDA FDN SCI & TECHNOL, FUKUI MUNICIPAL GOVT
DE MONODISPERSE MICROSPHERES; POLYMER MICROSPHERES; GLYCIDYL METHACRYLATE;
   HYDROXYLATION; AMINATION
ID LUMINOL-BINDING MICROSPHERES; POLYMER PARTICLES; OXYGEN
AB Monodisperse microspheres of copolymers of glycidyl methacrylate were prepared by dispersion polymerization in organic media. The microsphere diameter could be adjusted in the range from 0.5 mum to 5 mum by changing the monomer concentration, the type of dispersion medium and the content of the comonomers' Terpolymers of glycidyl methacrylate, 2-hydroxyethyl methacrylate and tri(ethylene glycol) dimethacrylate were analysed by thermal decomposition gas chromatography and the compositions of the polymers agreed well with those of the monomer mixtures. The epoxide of the polymer microspheres was hydrolysed to alpha,beta-diol with dilute sulphuric acid without side reactions except the slight formation of sulphate. It was confirmed by the C-13 FT-NMR spectrum that the main structure of the hydrolysate was that of poly(glyceryl methacrylate). In the reaction of the epoxide with ammonia, the predominant production of tertiary amine was presumed by the relationship between the conversion of the epoxide and the nitrogen content of the reaction product. The amination of the epoxide with secondary amines resulted in the quantitative formation of the corresponding tertiary amines.
RP HOSAKA, S (reprint author), TORAY INDUSTRIES LTD,BASIC RES LABS,1111 TEBIRO,KAMAKURA,KANAGAWA 248,JAPAN.
CR HOSAKA S, 1983, IMMUNOL COMMUN, V12, P509, DOI 10.3109/08820138309051968
   KAWAGUCHI H, 1991, POLYM J, V23, P955, DOI 10.1295/polymj.23.955
   KOHASHI O, 1988, JPN J INFLAM, V8, P41
   MASUKO S, 1991, ARTIF ORGANS TODAY, V1, P245
   MATSUMOTO S, 1986, CHEM PHARM BULL, V34, P4775
   PAINE AJ, 1990, J POLYM SCI A, V28, P1485
   SUDOL ED, 1986, J POLYM SCI POL CHEM, V24, P3499, DOI 10.1002/pola.1986.080241230
   SUZUKI K, 1986, J LEUKOCYTE BIOL, V39, P475
   SUZUKI K, 1985, IGAKU AYUMI, V13, P741
   TAKEUCHI A, 1988, INT J TISSUE REACT, V10, P169
   TSENG CM, 1986, J POLYM SCI POL CHEM, V24, P2995, DOI 10.1002/pola.1986.080241126
   UCHIDA T, 1985, BIOCHEM BIOPH RES CO, V127, P584, DOI 10.1016/S0006-291X(85)80200-X
   UCHIDA T, 1982, IMMUNOL COMMUN, V11, P467, DOI 10.3109/08820138209050743
   UCHIDA T, 1985, J IMMUNOL METHODS, V77, P55, DOI 10.1016/0022-1759(85)90183-8
   UCHIDA T, 1986, J BIOACTIVE BIOCOMPA, V1, P172
   UCHIDA T, 1986, POLYM MED, P149
   UCHIDA T, 1988, ACTA HAMETOL JAPAN, V51, P579
   UCHIDA T, 1986, MACROPHAGE BIOL, P545
   UGELSTAD J, 1980, ADV COLLOID INTERFAC, V13, P101, DOI 10.1016/0001-8686(80)87003-5
   Vanderhoff JW, 1986, POLYM MATER SCI ENG, V54, P587
   YAMAMOTO H, 1986, Japanese Journal of Alcohol Studies and Drug Dependence, V21, P183
   YOKOO T, 1987, IGAKU NO AYUMI, V142, P349
NR 22
TC 8
Z9 8
U1 0
U2 3
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX, ENGLAND PO19 1UD
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PY 1993
VL 30
IS 4
BP 505
EP 511
DI 10.1002/pi.4990300414
PG 7
WC Polymer Science
SC Polymer Science
GA KM097
UT WOS:A1993KM09700013
DA 2018-10-19
ER

PT J
AU BIDE, M
   PHANEUF, M
   OZAKI, C
   ALESSI, J
   QUIST, W
   LOGERFO, F
AF BIDE, M
   PHANEUF, M
   OZAKI, C
   ALESSI, J
   QUIST, W
   LOGERFO, F
TI THE USE OF DYEING TECHNOLOGY IN BIOMEDICAL APPLICATIONS
SO TEXTILE CHEMIST AND COLORIST
LA English
DT Article
DE ANTIBIOTICS; ARTERIAL GRAFTS; BIOMEDICAL TEXTILES; KNITTED DACRON
   GRAFTS; TEXTILES IN MEDICINE
ID RELEASE SYSTEM; POLYTETRAFLUOROETHYLENE; ANTIBIOTICS; PROSTHESES;
   DACRON; GRAFT
AB Prosthetic arterial grafts of knitted polyester are widely used to replace blocked or damaged arteries. Despite all precautions, some grafts fail, proving incompatible with the body or succumbing to infection. Efforts to modify grafts to eliminate these failures have yet to be commercially successful, but co-operation between the disparate worlds of textile chemistry and cardiovascular surgery has led to some novel approaches to the problem.
   A series of experiments used common textile products and procedures such as alkali treatment, nonionic surfactants, dyes and soil release finishes to modify the surface of the graft and allow binding of anticlotting proteins. Dyes were also examined for antibiotic activity, and antibiotics were modified and applied using both exhaust and pad-heat procedures to provide infection resistant grafts.
   In a detailed study, two antibiotics were applied to polyester. The treated material was tested both in vitro and in vivo for long term antibiotic activity. The treated products are said to have great promise, and to represent a significant advance.
C1 HARVARD UNIV,NEW ENGLAND DEACONESS HOSP,SCH MED,BOSTON,MA 02215.
CR BENVENISTY AI, SURG FORUM, P433
   BENVENISTY AI, 1987, SURG GYNECOL OBSTET, V164, P143
   CHERVU A, 1991, J VASC SURG, V13, P897
   CHERVU A, 1991, J VASC SURG, V14, P521, DOI 10.1016/0741-5214(91)90246-Q
   CHRISTINA AG, 1987, SCIENCE, V237, P1588
   Golan J F, 1989, Infect Dis Clin North Am, V3, P247
   GROHE, 1992, CHEM BRIT, V28, P34
   GUIDOIN R, 1989, BIOMATERIALS, V10, P156, DOI 10.1016/0142-9612(89)90018-5
   GUIDOIN R, 1984, ANN THORAC SURG, V37, P457, DOI 10.1016/S0003-4975(10)61131-9
   HARVEY RA, 1981, ANN SURG, V194, P642, DOI 10.1097/00000658-198111000-00015
   HARVEY RA, 1984, AM J SURG, V147, P205, DOI 10.1016/0002-9610(84)90089-8
   HARVEY RA, 1982, SURGERY, V92, P504
   HARVEY RA, 1988, J VASC SURG, V8, P600
   HARVEY RA, 1985, ARCH SURG-CHICAGO, V120, P71
   HARVEY RA, 1980, SURG FORUM, V31, P29
   HAVERICH A, 1992, J VASC SURG, V15, P187, DOI 10.1016/0741-5214(92)70027-I
   ITO R, 1990, CARDIOVASCULAR SCI T
   ITO RK, 1991, BLOOD COAGUL FIBRIN, V2, P77, DOI 10.1097/00001721-199102000-00012
   JOKLEK W, 1984, ZINSSER MICROBIOLOGY, pCH9
   KISSA E, 1983, HDB FIBER SCI TECHNO, V2, pCH3
   MOORE W, 1991, VASCULAR SURG COMPRE, pCH16
   ROBERTS H, 1992, HOSPITAL PRACTI 0115, P73
   RUMISEK J, 1989, SURGERY, V10, P654
   Sugarman B, 1989, Infect Dis Clin North Am, V3, P187
   WOOD MJ, 1988, BRIT J CLIN PRACT, V42, P469
NR 25
TC 11
Z9 11
U1 0
U2 1
PU AMER ASSN TEXT CHEM COLOR
PI RES TRIANGLE PK
PA PO BOX 12215, RES TRIANGLE PK, NC 27709
SN 0040-490X
J9 TEXT CHEM COLOR
JI Text. Chem. Color.
PD JAN
PY 1993
VL 25
IS 1
BP 15
EP 19
PG 5
WC Materials Science, Textiles
SC Materials Science
GA KH658
UT WOS:A1993KH65800001
DA 2018-10-19
ER

PT J
AU MARTIN, BD
   AMPOFO, SA
   LINHARDT, RJ
   DORDICK, JS
AF MARTIN, BD
   AMPOFO, SA
   LINHARDT, RJ
   DORDICK, JS
TI BIOCATALYTIC SYNTHESIS OF SUGAR-CONTAINING POLY(ACRYLATE)-BASED
   HYDROGELS
SO MACROMOLECULES
LA English
DT Article
ID CHEMOENZYMATIC SYNTHESIS; ENZYMATIC-SYNTHESIS; ORGANIC-SOLVENTS;
   POLYMERS; DERIVATIVES; ESTERS
AB A chemoenzymatic approach has been developed to prepare monosaccharide-based poly-(acrylate)s. The lipase from Pseudomonas cepacia catalyzed the transesterification of a variety of monosaccharides with vinyl acrylate in pyridine to give the 6-acryloyl esters. The acrylate esters were polymerized in DMF with AIBN to give the poly(acrylate) products. Such a synthetic strategy has led to the synthesis of poly(methyl 6-acryloyl-beta-galactoside) with M(w) = 135 000 and M(n) = 58 000 for a polydispersity of 2.3. The overall yield from methyl beta-galactoside was 56 %. The polymer was highly water soluble and soluble in polar organic solvents. Replacing the methyl aglycon with phenyl or 2-nitrophenyl moieties resulted in polymers with poor water solubilities and improved organic solvent solubilities. In the case of the phenyl aglycon the polymer was prepared in 40 % isolated yield from phenyl beta-galactoside. The poly(phenyl 6-acryloyl-beta-galactoside) had an M(w) = 52 700 and an M(n) = 28 900 for a polydispersity of 1.8. Addition of ethylene glycol dimethacrylate as a cross-linker during AIBN-catalyzed polymerization in DMF resulted in water-insoluble polymers that swelled in aqueous solution. In the presence of 0.3 % cross-linker, a poly(methyl 6-acryloyl-beta-galactoside-hema) copolymer swelled to contain 98 % water and, hence, hold nearly 50-fold its weight in water. Such materials may be useful as biocompatible hydrogels for biomedical and membrane applications.
C1 UNIV IOWA,DEPT CHEM & BIOCHEM ENGN,IOWA CITY,IA 52242.
   UNIV IOWA,DEPT MED & NAT PROD CHEM,IOWA CITY,IA 52242.
CR ALLCOCK HR, 1991, MACROMOLECULES, V24, P23, DOI 10.1021/ma00001a005
   ALLCOCK HR, 1983, MACROMOLECULES, V16, P715, DOI 10.1021/ma00239a001
   BALLARD JM, 1980, CARBOHYD RES, V83, P138, DOI 10.1016/S0008-6215(00)85374-4
   BEDNARSKI MD, 1991, APPLIED BIOCATALYSIS, P87
   CARREA G, 1989, J CHEM SOC PERK T 1, P1057, DOI 10.1039/p19890001057
   DELINCK DL, 1990, TETRAHEDRON LETT, V31, P3093, DOI 10.1016/S0040-4039(00)94703-8
   DORDICK JS, 1989, ENZYME MICROB TECH, V11, P194, DOI 10.1016/0141-0229(89)90094-X
   GHOGARE A, 1990, J CHEM SOC CHEM COMM, P134, DOI 10.1039/c39900000134
   GLASS JE, 1990, ACS SYM SER, P443
   HAINES AH, 1981, ADV CARBOHYD CHEM BI, V39, P13
   HODGE P, 1988, SYNTHESIS SEPARATION, P43
   HOUGH L, 1975, CARBOHYD RES, V44, P37, DOI 10.1016/S0008-6215(00)84333-5
   KLIBANOV AM, 1990, ACCOUNTS CHEM RES, V23, P114, DOI 10.1021/ar00172a004
   Kondo K., 1987, FUNCTIONAL MONOMERS, P47
   MARGOLIN AL, 1991, J AM CHEM SOC, V113, P4693, DOI 10.1021/ja00012a055
   MARGOLIN AL, 1990, J AM CHEM SOC, V112, P2849, DOI 10.1021/ja00164a001
   MURPHY SM, 1988, POLYMER, V29, P1887, DOI 10.1016/0032-3861(88)90407-7
   OTAKE T, 1972, B CHEM SOC JPN, V43, P3199
   PALCIC MM, 1989, CARBOHYD RES, V190, P1, DOI 10.1016/0008-6215(89)84141-2
   PATIL DR, 1991, MACROMOLECULES, V24, P3462, DOI 10.1021/ma00011a068
   PATIL DR, 1991, BIOTECHNOL BIOENG, V37, P639, DOI 10.1002/bit.260370706
   Ratner B. D., 1976, ACS SYM SER, V31, P1, DOI DOI 10.1021/SYMPOSIUM
   RIVA S, 1988, J AM CHEM SOC, V110, P584, DOI 10.1021/ja00210a045
   ROBYT JF, 1982, BIOORG CHEM, V11, P115, DOI 10.1016/0045-2068(82)90024-4
   Selegny E, 1979, OPTICALLY ACTIVE POL
   SIMON ES, 1988, J AM CHEM SOC, V110, P7159, DOI 10.1021/ja00229a033
   THERISOD M, 1986, J AM CHEM SOC, V108, P5638, DOI 10.1021/ja00278a053
   WANG YF, 1988, J AM CHEM SOC, V110, P7200, DOI 10.1021/ja00229a041
   Whitesides G.M., 1983, ALDRICHIM ACTA, V16, P27
NR 29
TC 99
Z9 104
U1 0
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD DEC 21
PY 1992
VL 25
IS 26
BP 7081
EP 7085
DI 10.1021/ma00052a001
PG 5
WC Polymer Science
SC Polymer Science
GA KE277
UT WOS:A1992KE27700001
DA 2018-10-19
ER

PT J
AU LIOU, FJ
   NIU, GCC
   WANG, YJ
AF LIOU, FJ
   NIU, GCC
   WANG, YJ
TI PREPARATION AND CHARACTERIZATION OF 2 HEMA/PVA COPOLYMERS -
   POLY[HEMA-CO-(PVA-AA)] AND POLY[HEMA-CO-(PVA-MA)]
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
AB The copolymers of poly [HEMA-co-(PVA-AA)] and poly[HEMA-co-(PVA-MA)] were synthesized and characterized. The presence of PVA-AA in the copolymer increased the mechanical strength but decreased the water content of the material. The presence of PVA-MA, on the other hand, caused a decrease of mechanical strength and an increase of water content. The ionization of acidic group in poly [HEMA-co-(PVA-MA)] resulted in the swelling of the copolymer, and the swelling extent was controlled by the change of pH. Both copolymers have great potential in biomedical application.
C1 NATL YANG MING MED COLL,INST BIOMED ENGN,TAIPEI,TAIWAN.
CR BRUCK S D, 1973, Biomaterials Medical Devices and Artificial Organs, V1, P79
   CHIANG CT, 1990, J APPL BIOMATER, V1, P321, DOI 10.1002/jab.770010408
   CHIANG WY, 1985, J APPL POLYM SCI, V30, P3895, DOI 10.1002/app.1985.070300928
   GEBELEIN CG, 1984, POLYM MATERIALS MED
   HIRAI T, 1989, J APPL POLYM SCI, V38, P491, DOI 10.1002/app.1989.070380309
   HOFFMAN AS, 1974, J BIOMED MATER RES S, V5, P77
   JOHN MS, 1973, J BIOMED MATER RES, V7, P509
   MOLYNEUX P, 1983, WATER SOLUBLE SYNTHE, V1, pCH4
   NATHAN P, 1976, T AM SOC ART INT ORG, V22, P30
   Pedley DG, 1980, BRIT POLYM J, V12, P99
   PEPPAS NA, 1987, HYDROGELS MED PHARM, V2, pCH1
   RATNER BD, 1979, J POLYM SCI POLYM S, V66, P313
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
NR 13
TC 13
Z9 13
U1 0
U2 2
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD DEC 15
PY 1992
VL 46
IS 11
BP 1967
EP 1972
DI 10.1002/app.1992.070461109
PG 6
WC Polymer Science
SC Polymer Science
GA JX763
UT WOS:A1992JX76300009
DA 2018-10-19
ER

PT J
AU CAMBROSIO, A
   KEATING, P
AF CAMBROSIO, A
   KEATING, P
TI A MATTER OF FACS - CONSTITUTING NOVEL ENTITIES IN IMMUNOLOGY
SO MEDICAL ANTHROPOLOGY QUARTERLY
LA English
DT Article
ID ACTIVATED CELL SORTER; CANCER-RESEARCH; ANTIBODY; ANTIGENS;
   DIFFERENTIATION; ANTHROPOLOGY
AB This article contributes to the development of an anthropology of biomedicine that takes as its subject matter the content of biomedical knowledge and practices. It offers an ethnographic account of the establishment of the international classification of white blood cells, known as the "CD nomenclature, " and goes beyond the assertion that biomedical knowledge is "socially constructed, " providing a fine-textured analysis of how, in this specific case, knowledge was constituted. The CD nomenclature found its way into newspapers and daily medical practice mainly through the involvement of the CD4 subclass of lymphocytes (white blood cells) in AIDS definition and diagnosis. The establishment of the CD nomenclature is thus part of the recent movement of immunology to the center stage of the biomedical sciences. This study analyzes the articulation of the elements (institutions, tools, concepts) that made the classification possible. By focusing on the material practices of immunologists, the analysis shows that the present-day classification of lymphocytes has as its precondition the constitution of a network for the establishment of identities between immunological reagents produced by different laboratories. Furthermore, it is argued that the standards by which identities are established are inseparable from the entities (lymphocyte subsets) that are classified. Finally, it is claimed that an ethnography of the practices by which such a network comes into being provides an adequate analysis of the constitution of knowledge, specifically, of scientific information about the entities known as lymphocyte subsets.
C1 UNIV QUEBEC,DEPT HIST,MONTREAL H3C 3P8,QUEBEC,CANADA.
RP CAMBROSIO, A (reprint author), MCGILL UNIV,DEPT HUMANITIES & SOCIAL STUDIES MED,MONTREAL H3A 2T5,QUEBEC,CANADA.
CR ABBAS AK, 1991, CELULAR MOL IMMUNOLO
   Akrich M., 1992, SHAPING TECHNOLOGY B, P205
   Bernard A., 1984, LEUCOCYTE TYPING
   Callon M., 1991, FIGURES IRREVERSIBIL, P195
   CAMBROSIO A, 1992, J HIST BIOL, V25, P175, DOI 10.1007/BF00162840
   CANTOR H, 1975, CELL IMMUNOL, V15, P180, DOI 10.1016/0008-8749(75)90174-4
   CHARVOLIN F, 1991, 24TH ANN M SOC SOC S
   CHESS L, 1976, MANUAL CLIN IMMUNOLO, P77
   Clarke A., 1992, RIGHT TOOLS JOB WORK, P3
   Collins HM, 1985, CHANGING ORDER REPLI
   COLVIN RB, 1983, TRANSPLANT P, V15, P1166
   DAUSSET J, 1984, LEUCOCYTE TYPING HUM, P2
   DOWNEY GL, 1992, IN PRESS KNOWLEDGE S, V9
   EDELMAN GM, 1975, MOL APPROACHES IMMUN, P23
   FATHMAN CG, 1975, CELL IMMUNOL, V15, P109, DOI 10.1016/0008-8749(75)90169-0
   Fleck L., 1979, GENESIS DEV SCI FACT
   Ford WL., 1980, BLOOD PURE ELOQUENT, P457
   FORSYTHE DE, 1990, CS908 U PITTSB COMP
   FUJIMURA JH, 1987, SOC STUD SCI, V17, P257, DOI 10.1177/030631287017002003
   FUJIMURA JH, 1988, SOC PROBL, V35, P261, DOI 10.1525/sp.1988.35.3.03a00050
   FUJIMURA JH, 1992, SCI PRACTICE CULTURE, P169
   GOSSEL PP, 1992, RIGHT TOOLS JOB WORK, P287
   HACKING I, 1991, CRIT INQUIRY, V17, P253, DOI 10.1086/448583
   HARAWAY D, 1989, DIFFERENCES, V1, P3
   HAYNES BF, 1985, LEUCOCYTE TYPING, V1, P3
   HERZENBERG LA, 1979, MOL BASIS IMMUNE CEL, P315
   HERZENBERG LA, 1975, GM173670711 NIH GRAN
   HULETT HR, 1969, SCIENCE, V166, P747, DOI 10.1126/science.166.3906.747
   HULETT HR, 1973, CLIN CHEM, V19, P813
   JACOBI D, 1990, LANGAGES, V98, P103
   JULIUS MH, 1975, MAMMALIAN CELLS PROB, P107
   KARUSH F, 1989, IMMUNOLOGY, P73
   KEATING P, 1992, UNPUB SCI INSTRUMENT
   KNORRCETINA KD, 1981, MANUFACTURE KNOWLEDG
   KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0
   LATOUR B, 1990, STUD HIST PHILOS SCI, V21, P145, DOI 10.1016/0039-3681(90)90018-4
   LATOUR B, 1986, LABORATORY LIFE SOCI
   Latour B., 1987, SCI ACTION
   Latour Bruno, 1986, KNOWLEDGE SOC STUDIE, V6, P1
   LOCK M, KNOWLEDGE POWER PRAC
   LOKEN MR, 1975, ANN NY ACAD SCI, V254, P163, DOI 10.1111/j.1749-6632.1975.tb29166.x
   Lowy I, 1986, Int J Technol Assess Health Care, V2, P195
   LOWY I, 1990, HIST STUD PHYS BIOL, V21, P87
   LOWY I, 1987, MINERVA, V25, P171, DOI 10.1007/BF01096863
   LYNCH M, 1985, ART ARTIFACT LABORAT
   MARTIN E, 1990, MED ANTHROPOL Q, V4, P410, DOI 10.1525/maq.1990.4.4.02a00030
   MILSTEIN C, 1986, SCIENCE, V231, P1261, DOI 10.1126/science.3080810
   MILSTEIN C, 1987, LEUCOCYTE TYPING, V3, P1
   MILSTEIN C, 1989, LEUCOCYTE TYPING, V4, P1
   MOLLER G, 1988, SCAND J IMMUNOL, V27, P247, DOI 10.1111/j.1365-3083.1988.tb02344.x
   Moulin A. M, 1991, DERNIER LANGAGE MED
   NANNICOSTA A, 1987, TRANSPLANT P, V19, P1600
   *NAT COMM CLIN LAB, 1989, H42P DOC
   NAVARRO M, 1991, NY TIMES        0808, pD21
   OUDSHOORN N, 1990, B HIST MED, V64, P243
   PANEM S, 1984, INTERFERON CRUSADE
   Pickering A., 1992, SCI PRACTICE CULTURE, P1
   PINCH T, 1985, SOC STUD SCI, V15, P3, DOI 10.1177/030631285015001001
   RABINOW P, 1991, UNPUB SOCIOBIOLOGY B
   ROITT IM, 1989, IMMUNOLOGY
   SHAW S, 1987, IMMUNOL TODAY, V8, P1, DOI 10.1016/0167-5699(87)90816-4
   Silverstein AM, 1989, HIST IMMUNOLOGY
   STILLWELL CR, 1991, UNPUB IMMUNOLOGY SIF
   TRAWEEK S, 1908, BEAMTIMES LIFETIMES
   YELTON DE, 1980, AM SCI, V68, P510
   YELTON DE, 1981, ANNU REV BIOCHEM, V50, P657, DOI 10.1146/annurev.bi.50.070181.003301
   YOUNG A, 1991, MAR ANN M AM ASS ADV
   ZOLA H, 1982, MONOCLONAL HYBRIDOMA, P1
NR 68
TC 22
Z9 22
U1 0
U2 1
PU AMER ANTHROPOLOGICAL ASSOC
PI ARLINGTON
PA 4350 NORTH FAIRFAX DRIVE SUITE 640, ARLINGTON, VA 22203
SN 0745-5194
J9 MED ANTHROPOL Q
JI Med. Anthropol. Q.
PD DEC
PY 1992
VL 6
IS 4
BP 362
EP 384
DI 10.1525/maq.1992.6.4.02a00040
PG 23
WC Anthropology; Public, Environmental & Occupational Health; Social
   Sciences, Biomedical
SC Anthropology; Public, Environmental & Occupational Health; Biomedical
   Social Sciences
GA KB915
UT WOS:A1992KB91500003
DA 2018-10-19
ER

PT J
AU PUTTERS, JLM
   SUKUL, DMKSK
   DEZEEUW, GR
   BIJMA, A
   BESSELINK, PA
AF PUTTERS, JLM
   SUKUL, DMKSK
   DEZEEUW, GR
   BIJMA, A
   BESSELINK, PA
TI COMPARATIVE CELL-CULTURE EFFECTS OF SHAPE MEMORY METAL (NITINOL(R)),
   NICKEL AND TITANIUM - A BIOCOMPATIBILITY ESTIMATION
SO EUROPEAN SURGICAL RESEARCH
LA English
DT Article
DE BIOCOMPATIBILITY; CELL CULTURES; MITOSIS INHIBITION TEST; NICKEL;
   NITINOL(R); TITANIUM
ID TISSUE
AB Nitinol(R) is an equiatomic alloy of nickel and titanium which has been attracting increasing interest in the field of biomedical engineering. To quantify toxicity as a preliminary evaluation of biocompatibility, inhibition of mitosis in human fibroblasts in tissue cultures exposed to test materials is an accepted screening method, although a dose-effect relationship had never been investigated. In this experiment, the effect of an increasing dose exposure to Nitinol, nickel or titanium on human fibroblasts in cell cultures was tested in subgroups in comparison with a control group. The results showed that nickel induces a significant (p less-than-or-equal-to 0.05) inhibition of mitosis in human fibroblasts, whereas no significant effects of this kind were found for titanium or Nitinol. According to the results of these studies, Nitinol is to be considered in this respect biocompatible and comparable to titanium, which would seem to justify application as a surgical implant.
C1 UNIV ROTTERDAM,HOSP DIJKZIGT,DEPT TRAUMATOL GEN SURG,DR MOLEWATERPLEIN 40,3015 GD ROTTERDAM,NETHERLANDS.
   ERASMUS UNIV,EXPTL SURG LAB,3000 DR ROTTERDAM,NETHERLANDS.
   MEM MET HOLLAND,ENSCHEDE,NETHERLANDS.
CR BENSMANN G, 1982, TECH MITT KRUPP FORS, V40, P123
   BUEHLER WJ, 1963, J APPL PHYS, V34, P1475, DOI 10.1063/1.1729603
   CASTLEMAN LS, 1976, J BIOMED MATER RES, V10, P695, DOI 10.1002/jbm.820100505
   CASTLEMAN LS, 1981, BIOCOMPATIBILITY CLI, P129
   CUTRIGHT DE, 1973, ORAL SURG ORAL MED O, V35, P578, DOI 10.1016/0030-4220(73)90017-0
   DAI KR, 1986, 1986 P ICOMAT NAR, P6430
   FERGUSON AB, 1960, J BONE JOINT SURG AM, V42, P77, DOI 10.2106/00004623-196042010-00007
   GRAY BA, 1987, AM J MED GENET, V28, P521, DOI 10.1002/ajmg.1320280236
   Kuo P P, 1989, Orthopedics, V12, P111
   LAING PATRICK G., 1967, J BIOMED MAT RES, V1, P135, DOI 10.1002/jbm.820010113
   PAPPAS AM, 1986, J BONE JOINT SURG AM, V50, P535
   TURNER JE, 1973, J BIOMED MATER RES, V7, P39, DOI 10.1002/jbm.820070104
   VINCENTINI B, 1986, 1986 P SHAP MEM ALL, P447
   WILLIAMS DF, 1974, P BIOMED ENG EXHIBIT, P207
   WOOD NK, 1970, J BIOMED MATER RES, P1
   ZUFENG Z, 1986, 1986 P ICOMAT NARA, P416
NR 16
TC 91
Z9 93
U1 2
U2 13
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0014-312X
J9 EUR SURG RES
JI Eur. Surg. Res.
PD NOV-DEC
PY 1992
VL 24
IS 6
BP 378
EP 382
DI 10.1159/000129231
PG 5
WC Surgery
SC Surgery
GA KK236
UT WOS:A1992KK23600008
PM 1292941
DA 2018-10-19
ER

PT J
AU ALLCOCK, HR
   PUCHER, SR
   TURNER, ML
   FITZPATRICK, RJ
AF ALLCOCK, HR
   PUCHER, SR
   TURNER, ML
   FITZPATRICK, RJ
TI POLY(ORGANOPHOSPHAZENES) WITH POLY(ALKYL ETHER) SIDE GROUPS - A STUDY OF
   THEIR WATER SOLUBILITY AND THE SWELLING CHARACTERISTICS OF THEIR
   HYDROGELS
SO MACROMOLECULES
LA English
DT Article
AB Five different poly[(alkyl ether)phosphazenes] were synthesized for studies of their water solubility as well as the swellabilities of their corresponding hydrogels in aqueous media. They are poly-[bis(methoxyethoxy)phosphazene], poly[bis[(aminoethoxy)ethoxy]phosphazene], poly[bis[(methoxyethoxy)ethoxy] phosphazene], poly[bis[(ethoxyethoxy)ethoxy]phosphazene], and poly[bis[(butoxyethoxy)ethoxy]phosphazene]. Lower critical solution temperatures (LCST) were detected for four of the polymers. This phenomenon was independent of polymer concentration. However, poly[bis[(aminoethoxy)ethoxy]phosphazene] possessed no LCST in aqueous media and remained fully soluble at all polymer concentrations. Hydrogels of these polymers were prepared by subjecting them to gamma radiation (1, 5, and 10 Mrad). The cross-linked polyphosphazenes behaved in a manner similar to that of their soluble counterparts. As the temperature of the aqueous media was increased, the hydrogels became opaque and released water. During these experiments, the percentage of water lost by the hydrogels was independent of both the pH of the aqueous media and the radiation dose received by the gels. No detectable decomposition of the soluble polymers was found nor was any loss of integrity of the hydrogels detected through several heating and cooling cycles. This solubility phenomenon was characteristic only of the interaction with water and was not detected in organic solvents. The potential biomedical applications of these materials are discussed.
RP ALLCOCK, HR (reprint author), PENN STATE UNIV,DEPT CHEM,UNIV PK,PA 16802, USA.
RI Turner, Michael/B-9217-2018
OI Turner, Michael/0000-0003-2853-5632
CR ALLCOCK HR, 1986, MACROMOLECULES, V19, P1508, DOI 10.1021/ma00160a003
   ALLCOCK HR, 1988, MACROMOLECULES, V21, P1, DOI 10.1021/ma00179a001
   ALLCOCK HR, 1965, J AM CHEM SOC, V87, P4216, DOI 10.1021/ja01096a056
   ALLCOCK HR, 1991, MACROMOLECULES, V24, P993, DOI 10.1021/ma00005a005
   ALLCOCK HR, 1988, BIOMATERIALS, V19, P509
   ALLCOCK HR, 1988, BIOMATERIALS, V19, P500
   BENNETT JL, 1989, CHEM MATER, V1, P14
   BLONSKY PM, 1984, J AM CHEM SOC, V106, P6854, DOI 10.1021/ja00334a071
   DONG LC, 1987, ACS SYM SER, V350, P236
   EAGLAND D, 1991, EUR POLYM J, V27, P299, DOI 10.1016/0014-3057(91)90109-2
   Flory P. J, 1953, PRINCIPLES POLYM CHE
   Heskins M., 1968, J MACROMOL SCI CHEM, V2, P1441, DOI [10.1080/10601326808051910, DOI 10.1080/10601326808051910]
   KINIEDA H, 1975, ACS SYM SER, V9, P278
   MALCOLM GN, 1957, T FARADAY SOC, V53, P921, DOI 10.1039/tf9575300921
   TANIGAMI T, 1989, MACROMOLECULES, V22, P1397, DOI 10.1021/ma00193a065
NR 15
TC 65
Z9 67
U1 2
U2 6
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD OCT 12
PY 1992
VL 25
IS 21
BP 5573
EP 5577
DI 10.1021/ma00047a002
PG 5
WC Polymer Science
SC Polymer Science
GA JT846
UT WOS:A1992JT84600002
DA 2018-10-19
ER

PT J
AU SHIGEMASA, Y
   SASHIWA, H
   TANIOKA, S
   SAIMITO, H
   TANIGAWA, T
   TANAKA, Y
AF SHIGEMASA, Y
   SASHIWA, H
   TANIOKA, S
   SAIMITO, H
   TANIGAWA, T
   TANAKA, Y
TI BEHAVIOR OF MOUSE MACROPHAGE CELL-LINE AND MOUSE FIBROBLAST ON
   COPOLYMERS CONTAINING CELLULOSE TRIACETATE
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE COPOLYMER; CELLULOSE TRIACETATE; DIPHENYLMETHANE DIISOCYANATE; MOUSE
   MACROPHAGE; MOUSE FIBROBLAST
ID POLYMERS
AB Copolymers containing cellulose triacetate were prepared under various conditions. A bacteriological plastic dish was coated with the copolymer (HCTA-MDI copolymer) composed of hydrolysed cellulose triacetate (HCTA) and diphenylmethane diisocyanate (MDI). The deacetylated copolymer (DA-copolymer) was prepared by the deacetylation of HCTA-MDI copolymer. The behaviour of animal cells such as a mouse macrophage cell line (A640-BB-2 cells) and a mouse fibroblast (3T6 cells) on prepared dishes was investigated morphologically. A640-BB-2 cells showed good adhesion and smooth spreading, and 3T6 cells also showed good adhesion and sufficient cell growth on the dish coated with HCTA-MDI copolymer. These results suggest that these copolymers are useful for biomedical materials.
C1 TOTTORI UNIV,FAC MED,DEPT BACTERIOL,YONAGO,TOTTORI 683,JAPAN.
RP SHIGEMASA, Y (reprint author), TOTTORI UNIV,FAC ENGN,DEPT MAT SCI,TOTTORI 680,JAPAN.
CR AARONSON SA, 1968, J CELL PHYSIOL, V72, P141, DOI 10.1002/jcp.1040720208
   AMICK R, 1980, POLYMER, V21, P648, DOI 10.1016/0032-3861(80)90322-5
   IMAI Y, 1978, KAGAKU SOSETSU, P55
   IMANISHI Y, 1986, IYO KOBUNSHI ZAIRYO
   KATSUMOTO T, 1978, J ELECTRON MICROSC, V27, P275
   KIM S, 1973, J POLYM SCI POL LETT, V11, P731, DOI 10.1002/pol.1973.130111201
   KOBAYASHI A, 1986, MAKROMOL CHEM-RAPID, V7, P645
   OTSU T, 1972, KOBUNSHI GOSEI JIKKE, P299
   SHARON N, 1984, TRENDS BIOCHEM SCI, V9, P198, DOI 10.1016/0968-0004(84)90139-7
   STEINMANN HW, 1970, POLYMER PREPRINTS, V11, P285
   TAKAYAMA H, 1986, BIOMED RES-TOKYO, V7, P11, DOI 10.2220/biomedres.7.11
   TANIGAWA T, 1983, J CELL PHYSIOL, V116, P303, DOI 10.1002/jcp.1041160307
NR 12
TC 7
Z9 7
U1 0
U2 2
PU BUTTERWORTH-HEINEMANN LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD OCT
PY 1992
VL 14
IS 5
BP 274
EP 278
DI 10.1016/S0141-8130(05)80040-6
PG 5
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA JU802
UT WOS:A1992JU80200005
PM 1419965
DA 2018-10-19
ER

PT J
AU CARPENTER, JF
   HANSEN, TN
AF CARPENTER, JF
   HANSEN, TN
TI ANTIFREEZE PROTEIN MODULATES CELL-SURVIVAL DURING CRYOPRESERVATION -
   MEDIATION THROUGH INFLUENCE ON ICE CRYSTAL-GROWTH
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID RECRYSTALLIZATION; INHIBITION; FISHES
AB Antifreeze proteins (AFPs) are extremely efficient at inhibiting ice recrystallization in frozen solutions. Knight and Duman [Knight, C. A. & Duman, J. G. (1986) Cryobiology 23, 256-263] have proposed that this may be an important function of the proteins in freeze-tolerant organisms. We have tested this proposal in vitro by characterizing the influence of AFP on the recovery of cryopreserved cells, which often can survive cooling and yet subsequently be damaged by ice crystal growth during warming. Relatively low concentrations (e.g., 5-150 mug/ml) of winter flounder (Pseudopleuronectes americanus) AFP enhance survival of red blood cells cryopreserved in hydroxyethyl starch solutions. This effect is most apparent in samples warmed at suboptimal rates, i.e., where ice recrystallization would be exaggerated. Cryomicroscopy demonstrates that AFP inhibits ice recrystallization in the extracellular regions during the latter stages of the warming cycle. AFP concentrations that enhance survival of red cells confer partial inhibition of recrystallization. Relatively high concentrations of AFP (e.g., 1.54 mg/ml) are much more effective at inhibiting extracellular recrystallization. However, extensive growth of ice around the cell, and concomitant cell damage, is noted. The mechanism for this AFP-induced ice growth is unknown. We propose that there is a delicate balance between AFP-induced enhancement of cell preservation and AFP-induced enhancement of cell damage and that this balance hinges on the degrees of inhibition of ice recrystallization and of preferential growth of ice around the cells. We conclude that, under appropriate conditions, one of the proposed functions of AFPs in nature can be emulated, and perhaps have application, in cryopreservation of materials of biomedical interest.
RP CARPENTER, JF (reprint author), CRYOLIFE INC,2211 NEW MARKET PKWY,SUITE 142,MARIETTA,GA 30067, USA.
CR DAVIES PL, 1990, FASEB J, V4, P2460
   DEVRIES AL, 1982, COMP BIOCHEM PHYS A, V73, P627, DOI 10.1016/0300-9629(82)90270-5
   DEVRIES AL, 1984, PHILOS T R SOC B, V304, P575
   DUMAN J, 1983, ANNU REV PHYSIOL, V45, P261, DOI 10.1146/annurev.ph.45.030183.001401
   Duman J.G., 1991, P94
   DUMAN JG, 1974, NATURE, V247, P237, DOI 10.1038/247237a0
   DUMAN JG, 1984, J EXP ZOOL, V230, P355, DOI 10.1002/jez.1402300304
   FAHY GM, 1987, CRYOBIOLOGY, V24, P196, DOI 10.1016/0011-2240(87)90023-X
   FEENEY RE, 1973, NATURE, V243, P357, DOI 10.1038/243357a0
   KNIGHT CA, 1986, CRYOBIOLOGY, V23, P256, DOI 10.1016/0011-2240(86)90051-9
   KNIGHT CA, 1988, CRYOBIOLOGY, V25, P55, DOI 10.1016/0011-2240(88)90020-X
   KNIGHT CA, 1984, NATURE, V308, P295, DOI 10.1038/308295a0
   LIONETTI FJ, 1976, CRYOBIOLOGY, V13, P489, DOI 10.1016/0011-2240(76)90142-5
   MacFarlane DR, 1987, BIOPHYSICS ORGAN CRY, P237
   MAZUR P, 1984, AM J PHYSIOL, V247, pC125
   MAZUR P, 1970, SCIENCE, V168, P939, DOI 10.1126/science.168.3934.939
   PEGG DE, 1984, CRYOBIOLOGY, V21, P491, DOI 10.1016/0011-2240(84)90047-6
   RUBINSKY B, 1992, CRYOBIOLOGY, V29, P69, DOI 10.1016/0011-2240(92)90006-N
   RUBINSKY B, 1989, Cryobiology, V26, P580, DOI 10.1016/0011-2240(89)90207-1
   SPUTTEK A, 1991, CLIN APPL CRYOBIOLOG, P95
   THEEDE H, 1976, MAR BIOL, V36, P183, DOI 10.1007/BF00388441
   URRUTIA ME, 1992, BIOCHIM BIOPHYS ACTA, V1121, P199, DOI 10.1016/0167-4838(92)90355-H
   WILLIAMS RJ, 1970, CRYOBIOLOGY, V20, P521
NR 23
TC 110
Z9 115
U1 3
U2 34
PU NATL ACAD PRESS
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD OCT 1
PY 1992
VL 89
IS 19
BP 8953
EP 8957
DI 10.1073/pnas.89.19.8953
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JQ934
UT WOS:A1992JQ93400020
PM 1409591
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU ARNDT, KA
AF ARNDT, KA
TI INFORMATION EXCESS IN MEDICINE - OVERVIEW, RELEVANCE TO DERMATOLOGY, AND
   STRATEGIES FOR COPING
SO ARCHIVES OF DERMATOLOGY
LA English
DT Article
ID CONSENSUS; PHYSICIANS; KNOWLEDGE; AMERICAN; JOURNALS; TRENDS
AB Background.-The amount of biomedical information contained in scientific journals has grown to the point that complete coverage of this material is impossible. The number of articles and journals being published has been growing at an exponential rate since 1750. Thirty-four thousand references from 4000 journals are added each month to the National Library of Medicine MEDLINE database from among the more than 100 000 scientific journals now published. This increase in scientific literature reflects not greater productivity but simply a larger number of scientists at work. Most articles written are eventually published in the medical literature, but a large number of scientific articles are of less than optimal quality, and most scientific articles that are published are never cited. Articles of higher quality and usefulness cluster in a few journals that enjoy great use in medical libraries and high scores on bibliometric scores such as the Science Citation Index.
   Observations.-To assess the reading habits of dermatologic trainees and evaluate how they cope with this information excess, a survey was distributed to 36 residents in three training programs. The average number of medical journal reading hours per month was 17; the number of hours devoted to reading issues of the Archives of Dermatology, the Journal of the American Academy of Dermatology, and the Journal of Investigative Dermatology were 3.2, 5.0, and 1.4, respectively; and the average resident read seven peer-reviewed journals, two to four dermatologic tabloids, and four peer-reviewed medical journals.
   Conclusions.-Critically and consistently reading a limited number of high-quality peer-reviewed journals as well as taking advantage of information available through computer networks and bibliographic and full-text databases is the best approach to coping with the volume of medical literature. Translating this information into a change in attitude and modification of physician behavior is best accomplished when local role models incorporate new ideas into their practice and teaching. Modifications that would, in fact, bring about truly useful changes, such as decreasing the number of new publications, melding journals already present into smaller numbers of publications rather than instituting new journals, altering the "publish-or-perish" rules, and writing more comprehensive articles rather than multiple small contributions, all await fundamental alterations in long-accepted policies in medicine.
RP ARNDT, KA (reprint author), BETH ISRAEL HOSP,DEPT DERMATOL,330 BROOKLINE AVE,BOSTON,MA 02215, USA.
CR ABT HA, 1981, PUBL ASTRON SOC PAC, V93, P269, DOI 10.1086/130820
   ARNDT KA, 1992, ARCH DERMATOL, V128, P101, DOI 10.1001/archderm.128.1.101
   BRADFORD SC, 1946, COMPLETE DOCUMENTATI, P729
   BRANSCOMB LM, 1968, SCI RES, V31, P49
   DOBROV GM, 1971, WISSENSCHAFTSORGANIS
   DOSZKOCS TE, 1980, SCIENCE, V208, P25, DOI 10.1126/science.6987735
   DURACK DT, 1978, NEW ENGL J MED, V298, P773, DOI 10.1056/NEJM197804062981405
   FYE WB, 1990, ANN INTERN MED, V113, P317, DOI 10.7326/0003-4819-113-4-317
   GARFIELD E, 1986, ANN INTERN MED, V105, P313, DOI 10.7326/0003-4819-105-2-313
   GARFIELD E, 1978, COPING BIOMEDICAL LI, P68
   GARVEY WD, 1979, COMMUNICATION ESSENC, P85
   GLANTZ SA, 1980, CIRCULATION, V61, P1, DOI 10.1161/01.CIR.61.1.1
   GOFFMAN W, 1970, SCI INFORMATION SYST, V226, P922
   Greer A L, 1988, Int J Technol Assess Health Care, V4, P5
   GREER AL, 1987, JAMA-J AM MED ASSOC, V258, P2739, DOI 10.1001/jama.258.19.2739
   HARRIS WE, 1983, PUBL ASTRON SOC PAC, V95, P989, DOI 10.1086/131278
   HEALY B, 1988, NEW ENGL J MED, V319, P1058, DOI 10.1056/NEJM198810203191605
   JONAS HS, 1989, JAMA-J AM MED ASSOC, V262, P1011, DOI 10.1001/jama.262.8.1011
   KOSECOFF J, 1987, JAMA-J AM MED ASSOC, V258, P2708, DOI 10.1001/jama.258.19.2708
   KRYSTAL A, 1989, NY TIMES BOOK R 0326, V1, P22
   LEBEDEV GA, 1975, NAUCNO TECHNISCESKAJ, V1, P3
   Lock SP, 1989, CBE VIEWS, V12, P57
   LOMAS J, 1989, NEW ENGL J MED, V321, P1306, DOI 10.1056/NEJM198911093211906
   Lundberg G. D., 1992, JAMA B MED LIB ASS, V80, P110
   MIHAJLOV AL, 1972, RIV INFORMAZIONE, V31, P74
   MORTON LT, 1972, USE MED LIT
   PRICE DD, 1975, SCI BABYLON, P165
   PRICE DJD, 1981, COPITN BIOMEDICAL LI
   QUINE WV, 1974, DAEDALUS, V103, P38
   RABINOWITZ HK, 1987, J MED EDUC, V62, P58
   REIDENBERG MM, 1989, CLIN PHARMACOL THER, V45, P337, DOI 10.1038/clpt.1989.38
   RENNIE D, 1986, JAMA-J AM MED ASSOC, V256, P2391, DOI 10.1001/jama.256.17.2391
   Rescher Nicholas, 1982, WISSENSCHAFTLICHER F
   RIORDAN PJ, 1981, B MED LIBR ASSOC, V69, P387
   SHELLEY WB, 1988, ARCH DERMATOL, V124, P1119, DOI 10.1001/archderm.124.7.1119
   SHULKIN DJ, 1990, JAMA-J AM MED ASSOC, V264, P453, DOI 10.1001/jama.1990.03450040041020
   STEINBROOK R, 1990, JAMA-J AM MED ASSOC, V263, P2078, DOI 10.1001/jama.263.15.2078
   STROSS JK, 1989, JAMA-J AM MED ASSOC, V262, P2721, DOI 10.1001/jama.262.19.2721
   TENNER E, 1988, HARVARD MAGAZINE APR, P23
   TRIMBLE V, 1984, NATURE, V310, P542, DOI 10.1038/310542a0
   WAKSMAN BH, 1980, J IMMUNOL, V124, P1009
   WARREN KS, 1981, COPING BIOMEDICAL LI, P19
   WARREN KS, 1978, COPING BIOMEDICAL LI
   WEISS P, 1986, HLTH BIOMEDICAL INFO
   ZUCKERMAN H, 1971, MINERVA, V9, P66, DOI 10.1007/BF01553188
   1990, SPECIALTY J READERSH
   1987, ANN INTERN MED, V106, P598
NR 47
TC 52
Z9 53
U1 0
U2 4
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 515 N STATE ST, CHICAGO, IL 60610
SN 0003-987X
J9 ARCH DERMATOL
JI Arch. Dermatol.
PD SEP
PY 1992
VL 128
IS 9
BP 1249
EP 1256
DI 10.1001/archderm.128.9.1249
PG 8
WC Dermatology
SC Dermatology
GA JM059
UT WOS:A1992JM05900012
PM 1519941
DA 2018-10-19
ER

PT J
AU KLINGER, T
   PFUTZNER, H
   SCHONHUBER, P
   HOFFMANN, K
   BACHL, N
AF KLINGER, T
   PFUTZNER, H
   SCHONHUBER, P
   HOFFMANN, K
   BACHL, N
TI MAGNETOSTRICTIVE AMORPHOUS SENSOR FOR BIOMEDICAL MONITORING
SO IEEE TRANSACTIONS ON MAGNETICS
LA English
DT Article; Proceedings Paper
CT 1992 INTERNATIONAL MAGNETICS CONF ( INTERMAG 92 ) - MAGNETIC RECORDING
   HEADS : INDUCTIVE THIN FILM AND LAMINATED
CY APR 13-16, 1992
CL ST LOUIS, MO
SP ALLEGHENY LUDLUM, ALLIED SIGNAL, APPL MAGNET, BASF MAGNET, BOHLMAN TACHNET, CRUCIBLE MAGNET, EASTMAN KODAK, F G JONES ASSOC, FUJITSU, GEC
AB A new sensor, very simple and inexpensive to manufacture, and with adjustable sensitivity, was developed for the monitoring of articular movements and lung ventilation. This sensor makes use of the change in permeability with respect to mechanical stress or strain. If an amorphous ribbon is glued on a plastic ribbon which shows considerably higher thickness, bending this compound sensor will cause plain tensile stress or compression in the amorphous magnetostrictive material. In the same way, using a pre-bent plastic ribbon yields an effective sensor for elongation in the connecting line of the sandwich ends.
C1 UNIV TECHNOL VIENNA,INST BASIC ENGN & MECH HANDLING,A-1040 VIENNA,AUSTRIA.
   UNIV VIENNA,INST SPORT SCI,A-1150 VIENNA,AUSTRIA.
RP KLINGER, T (reprint author), UNIV TECHNOL VIENNA,INST FUNDAMENTALS & THEORY ELECTROTECH,DIV BIOELECT & MAGNETISM,A-1040 VIENNA,AUSTRIA.
CR MEYDAN T, 1981, IEEE T MAGN, V17, P3376, DOI 10.1109/TMAG.1981.1061661
   MOHRI K, 1987, IEEE T MAGN, V23, P2212, DOI 10.1109/TMAG.1987.1065639
   PFUTZNER H, 1990, Frontiers of Medical and Biological Engineering, V2, P53
NR 3
TC 14
Z9 15
U1 0
U2 0
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394
SN 0018-9464
J9 IEEE T MAGN
JI IEEE Trans. Magn.
PD SEP
PY 1992
VL 28
IS 5
BP 2400
EP 2402
DI 10.1109/20.179505
PN 2
PG 3
WC Engineering, Electrical & Electronic; Physics, Applied
SC Engineering; Physics
GA JN877
UT WOS:A1992JN87700099
DA 2018-10-19
ER

PT J
AU WABERS, HD
   HERGENROTHER, RW
   COURY, AJ
   COOPER, SL
AF WABERS, HD
   HERGENROTHER, RW
   COURY, AJ
   COOPER, SL
TI THROMBUS DEPOSITION ON POLYURETHANES DESIGNED FOR BIOMEDICAL
   APPLICATIONS
SO JOURNAL OF APPLIED BIOMATERIALS
LA English
DT Article
ID EXVIVO BLOOD COMPATIBILITY; SEGMENTED POLYURETHANES; SURFACES; INVITRO;
   BIOSTABILITY; OXIDATION; PROPERTY
AB Thrombogenicity was assessed by measuring the amount of In-111-platelets and I-125-fibrinogen deposited on the inner luminal surface of six polyurethanes for up to 60 min of blood contact in a canine ex-vivo shunt model. Commercial and laboratory synthesized polymers were examined. Two of the commercially synthesized polyurethanes (Biostable PURs) do not contain ether linkages in the polymer backbone and have previously shown resistance to oxidative and hydrolytic degradation. Static contact angle measurements, dynamic contact angle measurements, and ESCA were used to characterize the surfaces of these polyurethanes. The effectiveness of an acetone extraction used to remove extrusion waxes from Pellethane 2363-80A was similarly studied. Both Pellethane 2363-80A and the ether-free materials had relatively nonthrombogenic surfaces, as indicated by low platelet and fibrinogen deposition, making them potentially good candidates for biomedical applications.
C1 UNIV WISCONSIN,DEPT CHEM ENGN,MADISON,WI 53706.
FU NHLBI NIH HHS [HL-21001, HL-24046]
CR Andrade J. D., 1985, SURFACE INTERFACIAL, P249
   ANDRADE JD, 1986, SURF INTERFACE ANAL, V8, P253, DOI 10.1002/sia.740080606
   BOUVIER M, 1991, J BIOMED MATER RES, V25, P773, DOI 10.1002/jbm.820250607
   Coury A J, 1988, J Biomater Appl, V3, P130, DOI 10.1177/088532828800300202
   COURY AJ, 1987, LIFE SUPPORT SYST, V5, P25
   GRASEL TG, 1989, J BIOMED MATER RES, V23, P311, DOI 10.1002/jbm.820230304
   GRASEL TG, 1987, THESIS U WISCONSIN
   GREGONIS DE, 1981, ACS ORG COATINGS, V45, P347
   HAMILTON WC, 1972, J COLLOID INTERF SCI, V40, P219, DOI 10.1016/0021-9797(72)90011-2
   LARSSON N, 1990, J MATER SCI MATER ME, P157
   Lelah M. D., 1986, POLYURETHANES MED
   LELAH MD, 1984, J BIOMED MATER RES, V18, P475, DOI 10.1002/jbm.820180503
   LELAH MD, 1985, J COLLOID INTERF SCI, V104, P422, DOI 10.1016/0021-9797(85)90051-7
   LELAH MD, 1983, J BIOMED MATER RES, V17, P1, DOI 10.1002/jbm.820170102
   LELAH MD, 1985, J BIOMED MATER RES, V19, P1011, DOI 10.1002/jbm.820190913
   MCGRATH JE, 1987, THERMOPLASTIC ELASTO, P470
   OKKEMA A Z, 1989, Journal of Biomaterials Science Polymer Edition, V1, P43, DOI 10.1163/156856289X00055
   OKKEMA AZ, 1991, BIOMATERIALS, V12, P668, DOI 10.1016/0142-9612(91)90115-Q
   RATNER BD, 1988, J BIOMED MATER RES, V22, P509, DOI 10.1002/jbm.820220607
   STOKES K, 1987, POLYURETHANES BIOMED, V2, P109
   STOKES K, 1984, POLYURETHANES BIOMED, P243
   TAKAHARA A, 1991, BIOMATERIALS, V12, P324, DOI 10.1016/0142-9612(91)90042-9
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P341, DOI 10.1002/jbm.820250306
   TAKAHARA A, 1990, ARTIFICIAL HEART, V3
   THOMA RJ, 1987, J BIOMED MATER RES, V21, P525, DOI 10.1002/jbm.820210411
   TINGEY KG, 1988, POLYM SURFACE DYNAMI, P153
   ZHAO Q, 1987, POLYMER, V28, P2040, DOI 10.1016/0032-3861(87)90038-3
NR 27
TC 5
Z9 5
U1 0
U2 5
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 1045-4861
J9 J APPL BIOMATER
JI J. Appl. Biomater.
PD FAL
PY 1992
VL 3
IS 3
BP 167
EP 176
DI 10.1002/jab.770030302
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA JH983
UT WOS:A1992JH98300001
PM 10147713
DA 2018-10-19
ER

PT J
AU ELSON, ML
AF ELSON, ML
TI SOFT-TISSUE AUGMENTATION OF PERIORBITAL FINE LINES AND THE ORBITAL
   GROOVE WITH ZYDERM-I AND FINE-GAUGE NEEDLES
SO JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY
LA English
DT Article
ID INJECTABLE COLLAGEN
AB A new procedure utilizing Zyderm-I (Collagen Biomedical, Palo Alto, CA)and a 32-gauge needle for augmentation of the periorbital fine lines and the orbital groove is described. This advanced soft tissue augmentation technique is described in detail in 30 patients with before, after, and 1-week post-augmentation photographs presented by the author. This technique requires familiarity with soft tissue augmentation and the use of collagen injectable materials as well as specific training on a one-to-one basis with someone experienced with this particular technique.
RP ELSON, ML (reprint author), DERMATOL CTR INC,4535 HARDING RD,SUITE 300,NASHVILLE,TN 37205, USA.
CR CUCIN RL, 1983, PLAST RECONSTR SURG, V71, P731, DOI 10.1097/00006534-198305000-00032
   ELSON ML, 1989, J DERMATOL SURG ONC, V15, P301, DOI 10.1111/j.1524-4725.1989.tb03163.x
   ELSON ML, 1988, J AM ACAD DERMATOL, V18, P707, DOI 10.1016/S0190-9622(88)70094-8
   ELSON ML, 1987, SEMIN DERMATOL, V6, P77
   ELSON ML, 1991, COSMET DERMATOL, V4, P8
   ELSON ML, 1990, COSM DERMATOL, V3, P16
   HANKE CW, 1991, J AM ACAD DERMATOL, V25, P319, DOI 10.1016/0190-9622(91)70200-L
   KLEIN AW, 1983, J AM ACAD DERMATOL, V9, P224, DOI 10.1016/S0190-9622(83)70133-7
NR 8
TC 4
Z9 5
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010
SN 0148-0812
J9 J DERMATOL SURG ONC
PD SEP
PY 1992
VL 18
IS 9
BP 779
EP 782
DI 10.1111/j.1524-4725.1992.tb03035.x
PG 4
WC Oncology; Dermatology; Surgery
SC Oncology; Dermatology; Surgery
GA JL730
UT WOS:A1992JL73000002
PM 1512310
DA 2018-10-19
ER

PT J
AU ABE, M
   ITOH, T
   TAMAURA, Y
AF ABE, M
   ITOH, T
   TAMAURA, Y
TI MAGNETIC AND BIOMAGNETIC FILMS OBTAINED BY FERRITE PLATING IN
   AQUEOUS-SOLUTION
SO THIN SOLID FILMS
LA English
DT Article; Proceedings Paper
CT 1ST INTERNATIONAL WORKSHOP ON THE SCIENCE AND TECHNOLOGY OF THIN FILMS
   FOR THE 21ST-CENTURY
CY JUL 28-AUG 02, 1991
CL NORTHWESTERN UNIV, EVANSTON, IL
SP NATL SCI FDN, NORTHWESTERN UNIV, MAT RES SOC, INT UNION MAT RES SOC
HO NORTHWESTERN UNIV
ID THIN-FILM
AB Ferrite plating enables crystalline spinel ferrite films to be formed in an aqueous solution at low temperatures (less than 100-degrees-C). This technique allows the fabrication of new ferrite film devices on non-heat-resistant substrate materials such as plastics, GaAs integrated circuits etc. Ferrite-plated films prepared from aqueous solution exhibit strong compatibility with water and organic compounds which enable the films to be used in biomedical applications as biosensors and immunoassays.
   The low temperature synthesis of magnetite in ferrite plating bears a close analogy to the biological synthesis of magnetite in organisms such as magnetotactic bacteria and chitons.
C1 TOKYO INST TECHNOL,DEPT CHEM,MEGURO KU,TOKYO 152,JAPAN.
RP ABE, M (reprint author), TOKYO INST TECHNOL,DEPT PHYS ELECTR,O OKAYAMA,MEGURO KU,TOKYO 152,JAPAN.
CR ABE M, 1987, IEEE T MAGN, V23, P3432, DOI 10.1109/TMAG.1987.1065550
   ABE M, 1983, JPN J APPL PHYS 2, V22, pL511, DOI 10.1143/JJAP.22.L511
   ABE M, 1987, IEEE T MAGN, V23, P3736, DOI 10.1109/TMAG.1987.1065205
   ABE M, 1984, J APPL PHYS, V55, P2614, DOI 10.1063/1.333254
   ABE M, 1990, 5TH P INT C FERR BOM, P1131
   ABE M, 1985, ADV CERAM, V5, P639
   ABE M, 1991, UNPUB
   ABE M, 1991, IN PRESS SPR P MRS M
   BLAKEMORE RP, 1980, NATURE, V286, P384, DOI 10.1038/286384a0
   HORI S, UNPUB JPN J APPL PHY
   IBATA A, 1989, 13TH ANN C MAGN SOC, P251
   ISHIKAWA K, 1987, APR DIG INT C TOK
   ITOH T, 1991, J APPL PHYS, V69, P5911, DOI 10.1063/1.347837
   ITOH T, 1989, IEEE T MAGN, V25, P4230, DOI 10.1109/20.42578
   ITOH T, 1990, JPN J APPL PHYS 2, V29, pL1458, DOI 10.1143/JJAP.29.L1458
   ITOH T, UNPUB JPN J APPL PHY
   ITOH T, 1989, J MAGN SOC JPN, V13, P869
   LOWENSTAM HA, 1967, SCIENCE, P1371
   MINAKAWA H, 1990, CLIN CHEM, V36, P1090
   SAITO T, 1989, J METAL FINISHING SO, V40, P42
   TALISA SH, 1988, J APPL PHYS, V64, P5819, DOI 10.1063/1.342217
   TAMAURA Y, 1983, J CHEM SOC DALTON, P189, DOI 10.1039/dt9830000189
NR 22
TC 50
Z9 50
U1 2
U2 8
PU ELSEVIER SCIENCE SA LAUSANNE
PI LAUSANNE 1
PA PO BOX 564, 1001 LAUSANNE 1, SWITZERLAND
SN 0040-6090
J9 THIN SOLID FILMS
JI Thin Solid Films
PD AUG 28
PY 1992
VL 216
IS 1
BP 155
EP 161
DI 10.1016/0040-6090(92)90887-H
PG 7
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA JK300
UT WOS:A1992JK30000032
DA 2018-10-19
ER

PT J
AU VANLUYN, MJA
   VANWACHEM, PB
   DAMINK, LO
   DIJKSTRA, PJ
   FEIJEN, J
   NIEUWENHUIS, P
AF VANLUYN, MJA
   VANWACHEM, PB
   DAMINK, LO
   DIJKSTRA, PJ
   FEIJEN, J
   NIEUWENHUIS, P
TI RELATIONS BETWEEN INVITRO CYTOTOXICITY AND CROSS-LINKED DERMAL SHEEP
   COLLAGENS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID FIXED PERICARDIUM; GLUTARALDEHYDE; BIOMATERIALS; TOXICITY; DEGRADATION;
   CELLS; RAT
AB Collagen-based biomaterials have found various applications in the biomedical field.  However, collagen-based biomaterials may induce cytotoxic effects.  This study evaluated possible cytotoxic effects of (crosslinked) dermal sheep collagen (DSC) using a 7-d-methylcellulose cell culture with human skin fibroblasts.  Noncrosslinked DSC (NDSC), hexamethylene-diisocyanate-crosslinked DSC (HDSC), and glutaraldehyde-crosslinked DSC (GDSC), their extracts (1 x 10 d to 4 x 10 d extracts), or the corresponding extracted DSC samples were tested.  Cell growth was evaluated by cell counting, while cell morphology was assessed by light microscopy and transmission-electron microscopy.  Both GDSC and, to a lesser extent, HDSC, induced cytotoxicity, observed as inhibited cell growth and deviant cell morphology.  The deviant morphology consisted of extensive accumulations of lipid, reduction in the amount and dilatation of rough endoplasmatic reticulum, increased inclusions of cell remnants, and relatively rounded cell membranes.  With HDSC, both primary cytotoxicity, due to extractable products from the material, and secondary cytotoxicity, possibly due to a release of cytotoxic products resulting from enzymatic cell-biomaterial interactions, could be discriminated.  With GDSC, however, no clear distinction between primary and secondary cytotoxicity could be made.  With NDSC, only primary cytotoxicity, measured as low inhibition of cell proliferation, but without deviant morphology, was observed.  These remarkable differences in cytotoxicity are discussed in relation to residual agents and specific crosslinks present in DSCs as a consequence of processing and the crosslinking agents used.  The residual agents and the specific crosslinks give rise to differences in direct release of products and in sensitivity to hydrolysis and enzymatic breakdown.
C1 TWENTE UNIV,DEPT CHEM TECHNOL,7500 AE ENSCHEDE,NETHERLANDS.
RP VANLUYN, MJA (reprint author), UNIV GRONINGEN,DEPT HISTOL & CELL BIOL,BIOMAT RES SECT,OOSTERSINGEL 69-2,9713 EZ GRONINGEN,NETHERLANDS.
RI Dijkstra, Pieter/N-9328-2013
CR BAJPAI PK, 1980, IRCS MED SCI-BIOCHEM, V8, P642
   BERODE M, 1988, BIOCH INT, V17, P1
   BROWN WE, 1982, TOXICOL APPL PHARM, V63, P45, DOI 10.1016/0041-008X(82)90025-4
   CHANG KC, 1984, CLIN ALLERGY, V14, P329, DOI 10.1111/j.1365-2222.1984.tb02213.x
   Chvapil M, 1973, Int Rev Connect Tissue Res, V6, P1
   CHVAPIL M, 1983, J SURG RES, V35, P402, DOI 10.1016/0022-4804(83)90029-X
   CHVAPIL M, 1982, J BIOMED MATER RES, V16, P245, DOI 10.1002/jbm.820160306
   COOKE A, 1983, BRIT J EXP PATHOL, V64, P172
   EVERTS V, 1987, THESIS U AMSTERDAM N
   EYBL E, 1989, J BIOMED MATER RES, V23, P1355, DOI 10.1002/jbm.820231111
   GENDLER E, 1984, J BIOMED MATER RES, V18, P727, DOI 10.1002/jbm.820180703
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   HUC A, 1985, J AM LEATHER CHEM AS, V80, P195
   HULSTAERT CE, 1983, HISTOCHEMISTRY, V78, P71, DOI 10.1007/BF00491113
   ISCOVE NN, 1979, IMMUNOLOGICAL METHOD, P379
   JOHANNSEN FR, 1987, J APPL TOXICOL, V7, P259, DOI 10.1002/jat.2550070407
   KENNEDY GL, 1986, J APPL TOXICOL, V6, P145, DOI 10.1002/jat.2550060302
   KLEINMAN HK, 1981, J CELL BIOL, V88, P473, DOI 10.1083/jcb.88.3.473
   LAZARUS SL, 1969, J INVEST DERMATOL, V52, P6
   MURPHY G, 1985, BIOESSAYS, V2, P55, DOI 10.1002/bies.950020204
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   NIMNI ME, 1988, COLLAGEN, V1, P1
   PHARRISS BB, 1980, J AM LEATHER CHEM AS, V75, P474
   SHUBIK VM, 1978, J HYG EPID MICROB IM, V22, P408
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   SPEER DP, 1981, J BIOMED MATER RES, V15, P913
   TRAUBEL H, 1977, LEDER, P150
   TRAUBEL H, 1977, LEDER, P181
   ULREICH JB, 1981, J BIOMED MATER RES, V15, P913, DOI 10.1002/jbm.820150615
   VANGULIK TM, 1987, NETH J SURG, V39, P90
   VANGULIK TM, 1981, THESIS U AMSTERDAM
   VANLUYN MJA, 1991, J MATER SCI-MATER M, V2, P142, DOI 10.1007/BF00692972
   VANWACHEM PB, 1991, BIOMATERIALS, V12, P215, DOI 10.1016/0142-9612(91)90203-M
   VANWACHEM PB, IN PRESS CELLS MATER
   WOODROOF EA, 1978, J BIOENG, V2, P1
   Woolley D. E., 1984, EXTRACELLULAR MATRIX, P119
   YAJIMA T, 1986, CELL TISSUE RES, V245, P253
   YANO E, 1981, Japanese Journal of Industrial Health, V23, P537
NR 38
TC 112
Z9 112
U1 0
U2 12
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD AUG
PY 1992
VL 26
IS 8
BP 1091
EP 1110
DI 10.1002/jbm.820260810
PG 20
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA JD962
UT WOS:A1992JD96200009
PM 1429758
DA 2018-10-19
ER

PT J
AU ALLCOCK, HR
   FITZPATRICK, RJ
   VISSCHER, K
   SALVATI, L
AF ALLCOCK, HR
   FITZPATRICK, RJ
   VISSCHER, K
   SALVATI, L
TI THIN-LAYER GRAFTS OF POLY[BIS((METHOXYETHOXY)ETHOXY)PHOSPHAZENE] ON
   ORGANIC POLYMER SURFACES
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID POLY<BIS(TRIFLUOROETHOXY)PHOSPHAZENE>; POLY(ORGANOPHOSPHAZENES);
   POLYPHOSPHAZENES; INTERFACE
AB Poly[bis((methoxyethoxy)ethoxy)phosphazene] (1) was covalently bonded and cross-linked to the surfaces of several organic polymers. Polypropylene, poly(vinyl chloride), poly(ethylene terephthalate), poly(bisphenol A carbonate), and poly(methyl methacrylate) were coated with polymer 1, and the coated materials were then exposed to 5 Mrad of Co-60-gamma-rays. The resultant surfaces were studied by ATR-IR, XPS, SEM, and contact angle techniques. The modified surfaces showed marked increases in hydrophilicity or hydrogel character and are excellent candidates for a number of biochemical, biomedical, and electrochemical uses.
C1 PERKIN ELMER CORP,PHYS ELECTR LAB,EDISON,NJ 08820.
RP ALLCOCK, HR (reprint author), PENN STATE UNIV,DEPT CHEM,UNIV PK,PA 16802, USA.
CR ALLCOCK HR, 1972, INORG CHEM, V11, P2584, DOI 10.1021/ic50117a003
   ALLCOCK HR, 1986, MACROMOLECULES, V19, P1508, DOI 10.1021/ma00160a003
   ALLCOCK HR, 1991, CHEM MATER, V3, P442, DOI 10.1021/cm00015a017
   ALLCOCK HR, 1991, CHEM MATER, V3, P450, DOI 10.1021/cm00015a018
   ALLCOCK HR, 1983, MACROMOLECULES, V16, P1401, DOI 10.1021/ma00243a001
   ALLCOCK HR, 1986, MACROMOLECULES, V19, P1502, DOI 10.1021/ma00160a002
   ALLCOCK HR, 1991, CHEM MATER, V3, P1120, DOI 10.1021/cm00018a032
   ALLCOCK HR, IN PRESS CHEM MATER
   ALLCOCK HR, IN PRESS BIOMATERIAL
   ALLCOCK HR, 1988, BIOMATERIALS, V19, P509
   ALLCOCK HR, IN PRESS RING OPENIN
   ALLCOCK HR, 1988, BIOMATERIALS, V19, P500
   BABIC D, 1986, RADIAT PHYS CHEM, V28, P169
   BENNETT JL, 1989, CHEM MATER, V1, P14
   BENNETT JL, 1989, POLYM PREPR AM CHEM, V30, P437
   BLONSKY PM, 1986, SOLID STATE IONICS, V18-9, P258, DOI 10.1016/0167-2738(86)90123-2
   BLONSKY PM, 1984, J AM CHEM SOC, V106, P6854, DOI 10.1021/ja00334a071
   BLONSKY PM, 1985, POLYM MATER SCI ENG, V53, P118
   HOLMESFARLEY SR, 1988, LANGMUIR, V4, P921, DOI 10.1021/la00082a025
   LAI JY, 1990, J APPL POLYM SCI, V39, P2293, DOI 10.1002/app.1990.070391109
   LAURENCIN CT, 1987, J BIOMED MATER RES, V21, P1231, DOI 10.1002/jbm.820211006
   LEE KW, 1988, MACROMOLECULES, V21, P309, DOI 10.1021/ma00180a005
   LERNER MM, 1991, CHEM MATER, V3, P1117, DOI 10.1021/cm00018a031
   NELSON CJ, 1991, CHEM MATER, V3, P786, DOI 10.1021/cm00017a010
   Peppas NA, 1987, HYDROGELS MED PHARM
   VISSCHER KB, 1990, MACROMOLECULES, V23, P4885, DOI 10.1021/ma00224a022
   VISSCHER KB, UNPUB ACS S SER
   WHITESIDES GM, 1990, LANGMUIR, V6, P87, DOI 10.1021/la00091a013
   WHITESIDES GM, 1988, CHEMTRACTS, V1, P171
   YANAI S, 1984, RADIAT PHYS CHEM, V23, P489, DOI 10.1016/0146-5724(84)90143-2
NR 30
TC 25
Z9 25
U1 0
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD JUL-AUG
PY 1992
VL 4
IS 4
BP 775
EP 780
DI 10.1021/cm00022a007
PG 6
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA JG698
UT WOS:A1992JG69800007
DA 2018-10-19
ER

PT J
AU SIGAL, VL
   MYSAK, OA
AF SIGAL, VL
   MYSAK, OA
TI CHARACTER OF THE WETTABILITY OF BIOMEDICAL CARBON DRESSINGS
SO COLLOID JOURNAL OF THE RUSSIAN ACADEMY OF SCIENCES
LA English
DT Article
ID ADSORPTION
AB The kinetics of impregnation of carbon granular and cloth materials used in clinical medicine as dressings for treating wounds and bums with water and decane were investigated and analyzed Impregnation with polar and nonpolar liquids can be used to evaluate the hydrophobic-hydrophilic properties of polymer medical dressings responsible for their protective and therapeutic functions in different stages of the wound process.
RP SIGAL, VL (reprint author), UKRAINIAN ACAD SCI,INST PROBLEMS ONCOL & RADIOBIOL,KIEV,UKRAINE.
CR Aksel'rud G. A., 1983, INTRO CAPILLARY CHEM
   BIZHKO IP, 1988, SORBENTS MED USE MEC, P241
   DERYABIN II, 1985, NEW AGENTS AREAS CLI, P166
   DERYAGIN BV, 1953, INSTRUMENT DETERMINA, P11
   DUNSTAN D, 1986, J COLLOID INTERF SCI, V111, P60, DOI 10.1016/0021-9797(86)90007-X
   FELDSHTEIN MM, 1981, CHEM TECHNOLOGY MACR, V16, P120
   GILES CH, 1974, J COLLOID INTERF SCI, V47, P766, DOI 10.1016/0021-9797(74)90253-7
   KARTEL NT, 1985, NOVYE SREDSTVA SFERY, P176
   KUCHER RV, 1980, KOLLOID ZH, V52, P790
   KUZMICH AV, 1988, ITMO AN BSSR10 PREPR
   LYUBINETSKII AL, 1988, SORBENTS MED USE MEC, P136
   MAEVSKAYA LN, 1977, KOLLOID ZH, V39, P1081
   NIKOLAEV VG, 1984, EXPT CLIN METHOD BLO
   OZEKI S, 1989, LANGMUIR, V5, P186, DOI 10.1021/la00085a035
   Porkhaev A.P, 1949, KOLLOID ZH, V11, P346
   SHEVELEVA IV, ADSORPTION UNCHARGED
   SHOOP G, 1982, SOLUTION ENG PROBLEM
   SIGAL VL, 1991, KOLLOID ZH, V53, P1092
   SIGAL VL, 1987, ZH PRIKL KHIM, V60, P1766
   SOBCHISHIN SN, 1988, SORBENTS MED USE MEC, P192
   Summ B. D., 1976, PHYSICOCHEMICAL PRIN
   TOMASHUK IP, 1988, SORBENTS MED USE MEC, P203
   Volfkovich Yu, 1980, ELEKTROKHIMIYA, V16, P1620
   VOYUTSKII SS, 1969, PHYSICOCHEMICAL PRIN
   WOLKOWA LW, 1934, KOLL Z, V67, P280
   YAMPOLSKY BY, 1968, KOLLOID ZH, V30, P299
   GOST1260582 USSR STA
NR 27
TC 0
Z9 0
U1 0
U2 1
PU PLENUM PUBL CORP
PI NEW YORK
PA CONSULTANTS BUREAU 233 SPRING ST, NEW YORK, NY 10013
SN 1061-933X
J9 COLLOID J RUSS ACAD+
PD JUL-AUG
PY 1992
VL 54
IS 4
BP 586
EP 590
PG 5
WC Chemistry, Physical
SC Chemistry
GA KZ124
UT WOS:A1992KZ12400029
DA 2018-10-19
ER

PT J
AU JOHNSON, SD
   ANDERSON, JM
   MARCHANT, RE
AF JOHNSON, SD
   ANDERSON, JM
   MARCHANT, RE
TI BIOCOMPATIBILITY STUDIES ON PLASMA POLYMERIZED INTERFACE MATERIALS
   ENCOMPASSING BOTH HYDROPHOBIC AND HYDROPHILIC SURFACES
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID INVIVO LEUKOCYTE INTERACTIONS; CELL-ADHESION; BIOMEDICAL POLYMERS;
   HUMAN-MONOCYTES; BIOMATERIALS; FIBRONECTIN; INVITRO;
   N-VINYL-2-PYRROLIDONE; INTERLEUKIN-1; POLYSTYRENE
AB The biocompatibility of radiofrequency plasma polymerized films (< 100 nm thick) deposited on biomedical polymer supports has been characterized by in vitro and in vivo methods. The polymer interface materials covered a wide range of elemental composition and surface properties, and were prepared from N-vinyl-2-pyrrolidone, gamma-butyrolactone, n-hexane, and hexamethyldisilazane (PPHMDSZ). The biocompatibility studies showed that the interface materials were noncytotoxic to mouse and human fibroblasts, as shown by morphologic evaluation, and by determination of extracellular LDH; and they did not stimulate interleukin-1-like production from human monocytes, as indicated by a thymocyte proliferation assay. The human fibroblast proliferation assay showed that three of the polymers supported cell growth at levels comparable to, or greater than, polymer controls, while the hydrophobic PPHMDSZ inhibited both cell attachment and proliferation. The response to subcutaneous implantation for all test materials was indicative of biocompatibility, with rapid resolution of the acute phase response and normal wound healing. The wide range of composition and surface properties for the plasma polymerized films evaluated in this study suggest that this general class of materials is likely to exhibit excellent biocompatibility.
C1 CASE WESTERN RESERVE UNIV, DEPT BIOMED ENGN, CLEVELAND, OH 44106 USA.
   CASE WESTERN RESERVE UNIV, DEPT PATHOL, CLEVELAND, OH 44106 USA.
FU NCRR NIH HHS [RR-20224]; NHLBI NIH HHS [HL-33849, HL-40047]
CR ABSOLOM DR, 1988, J BIOMED MATER RES, V22, P215, DOI 10.1002/jbm.820220306
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   AUTIAN J, 1977, ARTIF ORGANS, V1, P53
   BAIER RE, 1982, J BIOMECH ENG-T ASME, V104, P257, DOI 10.1115/1.3138358
   BONFIELD TL, 1989, J BIOMED MATER RES, V23, P535, DOI 10.1002/jbm.820230602
   CURTIS ASG, 1983, J CELL BIOL, V97, P1500, DOI 10.1083/jcb.97.5.1500
   DANILICH MJ, IN PRESS J BIOMATER
   DEKKER A, 1991, BIOMATERIALS, V12, P130, DOI 10.1016/0142-9612(91)90191-C
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   DUCHEYNE P, 1988, J BIOMED MATER RES, V22, P1137, DOI 10.1002/jbm.820221207
   ERTEL SI, 1990, J BIOMED MATER RES, V24, P1637, DOI 10.1002/jbm.820241207
   Fasol R, 1985, Trans Am Soc Artif Intern Organs, V31, P276
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   Grinnell F, 1978, Int Rev Cytol, V53, P65
   HO CP, 1988, J BIOMED MATER RES, V22, P919, DOI 10.1002/jbm.820221007
   HYNES RO, 1982, J CELL BIOL, V95, P369, DOI 10.1083/jcb.95.2.369
   JANSEN JA, 1991, BIOMATERIALS, V12, P25, DOI 10.1016/0142-9612(91)90127-V
   JOHNSON SD, UNPUB EFFECT MONOMER
   LEWANDOWSKA K, 1989, J CELL PHYSIOL, V141, P334, DOI 10.1002/jcp.1041410215
   LYDON MJ, 1985, BIOMATERIALS, V6, P396, DOI 10.1016/0142-9612(85)90100-0
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P1169, DOI 10.1002/jbm.820180917
   MARCHANT RE, 1992, J COLLOID INTERF SCI, V148, P261, DOI 10.1016/0021-9797(92)90135-9
   MARCHANT RE, 1990, J BIOMED MATER RES, V24, P1521, DOI 10.1002/jbm.820241108
   MARCHANT RE, 1989, FUND APPL TOXICOL, V13, P217, DOI 10.1016/0272-0590(89)90258-3
   MARCHANT RE, 1989, J POLYM SCI POL CHEM, V27, P881, DOI 10.1002/pola.1989.080270314
   MAROUDAS NG, 1975, J THEOR BIOL, V49, P417, DOI 10.1016/0022-5193(75)90182-4
   MCAUSLAN BR, 1988, J BIOMED MATER RES, V22, P963, DOI 10.1002/jbm.820221102
   MCCAULEY R, 1980, J SURG RES, V49, P103
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   NATHAN C, 1991, J CELL BIOL, V113, P981, DOI 10.1083/jcb.113.5.981
   RAE T, 1986, TECHNIQUES BIOCOMPAT, V2, P81
   ROBBINS SL, 1989, PATHOLOGIC BASIS DIS, P39
   SALTHOUSE TN, 1976, J BIOMED MATER RES, V10, P197, DOI 10.1002/jbm.820100204
   SCHMIDT JA, 1991, BIOMATERIALS, V12, P385, DOI 10.1016/0142-9612(91)90006-V
   SPILIZEWSKI KL, 1987, BIOMATERIALS, V8, P12, DOI 10.1016/0142-9612(87)90021-4
   SUKENIK CN, 1990, J BIOMED MATER RES, V24, P1307, DOI 10.1002/jbm.820241004
   UYAMA Y, 1991, BIOMATERIALS, V12, P71, DOI 10.1016/0142-9612(91)90135-W
   VIRTANEN I, 1982, NATURE, V298, P660, DOI 10.1038/298660a0
   YU DS, 1989, MACROMOLECULES, V22, P2957, DOI 10.1021/ma00197a014
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 42
TC 61
Z9 62
U1 2
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL
PY 1992
VL 26
IS 7
BP 915
EP 935
DI 10.1002/jbm.820260707
PG 21
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA HZ522
UT WOS:A1992HZ52200006
PM 1607373
DA 2018-10-19
ER

PT J
AU MCDANIEL, FD
   MATTESON, S
   WEATHERS, DL
   DUGGAN, JL
   MARBLE, DK
   HASSAN, I
   ZHAO, ZY
   ANTHONY, JM
AF MCDANIEL, FD
   MATTESON, S
   WEATHERS, DL
   DUGGAN, JL
   MARBLE, DK
   HASSAN, I
   ZHAO, ZY
   ANTHONY, JM
TI RADIONUCLIDE DATING AND TRACE-ELEMENT ANALYSIS BY ACCELERATOR
   MASS-SPECTROMETRY
SO JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY-ARTICLES
LA English
DT Article
ID MOLECULAR-BEAM EPITAXY; NEGATIVE-IONS; ELECTRONIC MATERIALS;
   COSMIC-RAYS; TIME SCALE; C-14; BE-10; GAAS; AMS; CALIBRATION
AB Accelerator Mass Spectrometry (AMS) is being used for both radionuclide dating and stable isotope trace element determination with limits of high sensitivity. The areas of applications of radionuclide AMS include oceanography, terrestrial studies, glaciology, hydrology, environmental studies, meterology, archaeology, anthropology, analysis of crude oils, biomedical and materials sciences, etc. The techniques and applications of radionuclide AMS are reviewed. The applications of stable element AMS include the measurements of trace impurities in electronic and other materials. The techniques and applications of stable element AMS are discussed with particular emphasis on electronic materials such as Si, GaAs, and HgCdTe. The design of the University of North Texas stable element AMS facility built in collaboration with Texas Instruments Incorporated is discussed.
C1 TEXAS INSTRUMENTS INC, CENT RES LAB, DALLAS, TX 75265 USA.
   UNIV N TEXAS, CTR MAT CHARACTERIZAT, DENTON, TX 76203 USA.
RP MCDANIEL, FD (reprint author), UNIV N TEXAS, DEPT PHYS, DENTON, TX 76203 USA.
CR Alvarez LW, 1939, PHYS REV, V56, P613, DOI 10.1103/PhysRev.56.613
   Alvarez LW, 1939, PHYS REV, V56, P379, DOI 10.1103/PhysRev.56.379.2
   ANDERSON EC, 1947, PHYS REV, V72, P931, DOI 10.1103/PhysRev.72.931
   ANTHONY JM, 1987, NUCL INSTRUM METH B, V29, P77, DOI 10.1016/0168-583X(87)90208-4
   ANTHONY JM, 1991, NUCL INSTRUM METH B, V56-7, P873, DOI 10.1016/0168-583X(91)95050-N
   ANTHONY JM, 1989, NUCL INSTRUM METH B, V40-1, P731, DOI 10.1016/0168-583X(89)90465-5
   ANTHONY JM, 1983, NUCL INSTRUM METHODS, V218, P463, DOI 10.1016/0167-5087(83)91022-0
   ANTHONY JM, 1985, NUCL INSTRUM METH B, V10-1, P498, DOI 10.1016/0168-583X(85)90295-2
   ANTHONY JM, 1990, NUCL INSTRUM METH B, V52, P493, DOI 10.1016/0168-583X(90)90464-6
   ANTHONY JM, 1990, NUCL INSTRUM METH B, V50, P262, DOI 10.1016/0168-583X(90)90365-2
   ARRALE AM, 1991, NUCL INSTRUM METH B, V56-7, P886, DOI 10.1016/0168-583X(91)95053-G
   BARD E, 1990, NATURE, V345, P405, DOI 10.1038/345405a0
   BARD E, 1990, NUCL INSTRUM METH B, V52, P461, DOI 10.1016/0168-583X(90)90458-7
   Bennett C L, 1977, Science, V198, P508
   BENNINGHOVEN A, 1986, SECONDARY ION MASS S
   Bentley HW, 1986, HDB ENV ISOTOPE GE B, V2, P422
   BONANI G, 1986, RADIOCARBON, V28, P246
   CURRIE LA, 1984, NUCL INSTRUM METH B, V5, P371, DOI 10.1016/0168-583X(84)90544-5
   DAMON PE, 1989, NATURE, V337, P611, DOI 10.1038/337611a0
   DAVIS SN, 1981, 1981 WORKSH IS HYDR
   DINAN JH, 1985, J VAC SCI TECHNOL A, V3, P851, DOI 10.1116/1.573329
   DUGGAN JL, 1989, NUCL INSTRUM METH B, V40-1, P709, DOI 10.1016/0168-583X(89)90460-6
   DUPUIS RD, 1987, APPL PHYS LETT, V50, P407, DOI 10.1063/1.98185
   ELMORE D, 1987, SCIENCE, V236, P543, DOI 10.1126/science.236.4801.543
   ELMORE D, 1979, NATURE, V277, P22, DOI 10.1038/277022a0
   ELMORE D, 1979, NATURE, V277, P246, DOI 10.1038/277246c0
   FELDMAN RD, 1988, J APPL PHYS, V63, P2872, DOI 10.1063/1.340944
   FELTON JS, 1990, NUCL INSTRUM METH B, V52, P517, DOI 10.1016/0168-583X(90)90469-B
   FINCH EC, 1973, NUCL INSTRUM METHODS, V113, P41, DOI 10.1016/0029-554X(73)90475-8
   FISCHER CF, 1987, PHYS REV LETT, V59, P2263, DOI 10.1103/PhysRevLett.59.2263
   GARWAN MA, 1990, NUCL INSTRUM METH B, V52, P512, DOI 10.1016/0168-583X(90)90468-A
   GOVE HE, 1990, NUCL INSTRUM METH B, V52, P502, DOI 10.1016/0168-583X(90)90466-8
   GOVE HE, 1987, NUCL INSTRUM METH B, V29, pR7, DOI 10.1016/0168-583X(87)90190-X
   GOVE HE, 1978, 1ST P C RAD DAT ACC
   HEDGES REM, 1987, 1986 P WORKSH TECHN
   HENNING W, 1987, SCIENCE, V236, P725, DOI 10.1126/science.236.4802.725
   HENNING W, 1982, 1981 P S ACC MASS SP
   HENNING W, 1986, P WORKSHOP TECHNIQUE, P196
   Hotop H., 1975, Journal of Physical and Chemical Reference Data, V4, P539
   HOTOP H, 1985, J PHYS CHEM REF DATA, V14, P731, DOI 10.1063/1.555735
   KILIUS LR, 1990, NUCL INSTRUM METH B, V52, P357, DOI 10.1016/0168-583X(90)90437-Y
   KUTSCHERA W, 1988, NUCL INSTRUM METH A, V268, P552, DOI 10.1016/0168-9002(88)90578-5
   KUTSCHERA W, 1986, NUCL INSTRUM METH B, V17, P377, DOI 10.1016/0168-583X(86)90167-9
   KUTSCHERA W, 1990, NUCL INSTRUM METH B, V50, P252, DOI 10.1016/0168-583X(90)90364-Z
   LAL D, 1984, TECTONOPHYSICS, V105, P383, DOI 10.1016/0040-1951(84)90215-4
   LEEM JY, 1990, APPL PHYS LETT, V57, P2228, DOI 10.1063/1.103899
   LIBBY WF, 1949, SCIENCE, V109, P227, DOI 10.1126/science.109.2827.227
   LIBBY WF, 1946, PHYS REV, V69, P671, DOI 10.1103/PhysRev.69.671.2
   LITHERLAND AE, 1980, ANNU REV NUCL PART S, V30, P437, DOI 10.1146/annurev.ns.30.120180.002253
   LOOSLI HH, 1968, EARTH PLANET SC LETT, V5, P191, DOI 10.1016/S0012-821X(68)80039-1
   MANGINI A, 1984, NUCL INSTRUM METH B, V5, P353, DOI 10.1016/0168-583X(84)90541-X
   MATTESON S, 1990, NUCL INSTRUM METH B, V45, P575, DOI 10.1016/0168-583X(90)90903-8
   MATTESON S, 1989, NUCL INSTRUM METH B, V40-1, P759, DOI 10.1016/0168-583X(89)90471-0
   MATTESON S, 1991, NUCL INSTRUM METH B, V56-7, P1091, DOI 10.1016/0168-583X(91)95104-L
   MATTESON S, 1990, NUCL INSTRUM METH B, V52, P237
   MCDANIEL FD, 1990, NUCL INSTRUM METH B, V52, P310, DOI 10.1016/0168-583X(90)90428-W
   MCDANIEL FD, 1990, 1989 P HIGH EN HEAV, P269
   MULLER RA, 1977, SCIENCE, V196, P489, DOI 10.1126/science.196.4289.489
   NELSON DE, 1977, SCIENCE, V198, P507, DOI 10.1126/science.198.4316.507
   NISHIIZUMI K, 1986, NATURE, V319, P134, DOI 10.1038/319134a0
   OESCHGER H, 1982, ACS SYM SER, V176, P5
   PEARSON GW, 1986, RADIOCARBON, V28, P911
   POLACH HA, 1987, NUCL INSTRUM METH B, V29, P415, DOI 10.1016/0168-583X(87)90275-8
   PURSER KH, 1977, REV PHYS APPL, V12, P1487, DOI 10.1051/rphysap:0197700120100148700
   Purser KH, 1977, United States Patent, Patent No. [4,037,100, 4037100]
   RAISBECK GM, 1987, NATURE, V326, P273, DOI 10.1038/326273a0
   RAISBECK GM, 1978, SCIENCE, V202, P215, DOI 10.1126/science.202.4364.215
   RUCKLIDGE JC, 1990, NUCL INSTRUM METH B, V52, P507, DOI 10.1016/0168-583X(90)90467-9
   RUSSELL WA, 1978, GEOCHIM COSMOCHIM AC, V42, P1075, DOI 10.1016/0016-7037(78)90105-9
   SARAFIN R, 1984, NUCL INSTRUM METH B, V5, P411, DOI 10.1016/0168-583X(84)90551-2
   STUIVER M, 1982, RADIOCARBON, V24, P1
   STUIVER M, 1986, RADIOCARBON, V28, P177
   Suess HE, 1979, RADIOCARBON DATING, P777
   SUTER M, 1990, NUCL INSTRUM METH B, V52, P211, DOI 10.1016/0168-583X(90)90409-N
   SUTER M, 1984, NUCL INSTRUM METH B, V5, P242, DOI 10.1016/0168-583X(84)90519-6
   VOSKO SH, 1989, PHYS REV A, V39, P446, DOI 10.1103/PhysRevA.39.446
   WEATHERS DL, 1991, NUCL INSTRUM METH B, V56-7, P889, DOI 10.1016/0168-583X(91)95054-H
   WOLFLI W, 1987, NUCL INSTRUM METH B, V29, P1, DOI 10.1016/0168-583X(87)90193-5
   WOLFLI W, 1984, NUCL INSTRUM METH B, V5, pR5, DOI 10.1016/0168-583X(84)90487-7
   YIOU F, 1990, NUCL INSTRUM METH B, V52, pR5, DOI 10.1016/0168-583X(90)90406-K
   YOKOYAMA Y, 1977, EARTH PLANET SC LETT, V36, P44, DOI 10.1016/0012-821X(77)90186-8
NR 81
TC 7
Z9 7
U1 0
U2 1
PU AKADEMIAI KIADO RT
PI BUDAPEST
PA PRIELLE K U 19, PO BOX 245,, H-1117 BUDAPEST, HUNGARY
SN 0236-5731
J9 J RADIOAN NUCL CH AR
JI J. Radioanal. Nucl. Chem.-Artic.
PD JUL
PY 1992
VL 160
IS 1
BP 119
EP 140
DI 10.1007/BF02041663
PG 22
WC Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science &
   Technology
SC Chemistry; Nuclear Science & Technology
GA JF677
UT WOS:A1992JF67700013
DA 2018-10-19
ER

PT J
AU JEDLINSKI, Z
AF JEDLINSKI, Z
TI NOVEL RING-OPENING POLYMERIZATION INDUCED BY ALKALI-METAL ANIONS
SO MAKROMOLEKULARE CHEMIE-MACROMOLECULAR SYMPOSIA
LA English
DT Article
ID POTASSIUM SOLUTIONS; BETA-LACTONES; CROWN ETHERS; K-39 NMR
AB Novel homogeneous initiation systems consisting of organic alkali metal complexes: Me+/Ligand, Me- enable synthesis of "living" tailor made polymers and copolymers - promising materials for engineering and biomedical applications. The mechanism of this polymerization has been elucidated.
RP JEDLINSKI, Z (reprint author), POLISH ACAD SCI, INST POLYMER CHEM, PL-41800 ZABRZE, POLAND.
CR ALEV S, 1980, J POLYM SCI POL CHEM, V18, P1155, DOI 10.1002/pol.1980.170180402
   ALEV S, 1980, J POLYM SCI POL CHEM, V18, P1166
   BOILEAU S, 1974, J POLYM SCI POL LETT, V12, P211, DOI 10.1002/pol.1974.130120406
   DAINTON FS, 1960, J POLYM SCI, V45, P111, DOI 10.1002/pol.1960.1204514510
   DYE JL, 1970, J AM CHEM SOC, V92, P5226, DOI 10.1021/ja00720a043
   EDWARDS PP, 1985, NATURE, V317, P242, DOI 10.1038/317242a0
   GROBELNY J, 1991, MAGN RES CHEM, V29
   JACOBS C, 1991, MACROMOLECULES, V24, P3027, DOI 10.1021/ma00011a001
   JEDLINSKI Z, 1985, MACROMOLECULES, V18, P2679, DOI 10.1021/ma00154a052
   JEDLINSKI Z, 1989, MACROMOLECULES, V22, P3242, DOI 10.1021/ma00198a008
   JEDLINSKI Z, 1986, MAKROMOL CHEM, V187, P1651
   JEDLINSKI Z, 1988, J CHEM SOC CHEM COMM, P1261, DOI 10.1039/c39880001261
   JEDLINSKI Z, 1989, J ORG CHEM, V54, P1500, DOI 10.1021/jo00268a005
   JEDLINSKI Z, 1983, MAKROMOL CHEM-RAPID, V4, P355
   JEDLINSKI Z, 1984, J PHYS CHEM-US, V88, P6094, DOI 10.1021/j150669a006
   KURCOK P, IN PRESS MACROMOLECU
   LACOSTE J, 1976, J POLYM SCI POL LETT, V14, P201, DOI 10.1002/pol.1976.130140404
   SOKOL M, 1990, MAGN RESON CHEM, V28, P934, DOI 10.1002/mrc.1260281106
   SZWARC M, 1956, NATURE, V178, P1168, DOI 10.1038/1781168a0
   TINKHAM ML, 1985, J AM CHEM SOC, V107, P6129, DOI 10.1021/ja00307a063
   YASUDA T, 1984, MACROMOLECULES, V17, P2217, DOI 10.1021/ma00141a003
NR 21
TC 6
Z9 6
U1 0
U2 1
PU HUTHIG & WEPF VERLAG
PI BASEL
PA AUF DEM WOLF 4, CH-4052 BASEL, SWITZERLAND
SN 0258-0322
J9 MAKROMOL CHEM-M SYMP
PD JUL
PY 1992
VL 60
BP 235
EP 245
DI 10.1002/masy.19920600121
PG 11
WC Polymer Science
SC Polymer Science
GA JH980
UT WOS:A1992JH98000020
DA 2018-10-19
ER

PT J
AU SAGI, A
   AVIDORZEHAVI, A
   SHITZER, A
   GERSTMANN, M
   AKSELROD, S
   KATZIR, A
AF SAGI, A
   AVIDORZEHAVI, A
   SHITZER, A
   GERSTMANN, M
   AKSELROD, S
   KATZIR, A
TI HEATING OF BIOLOGICAL TISSUE BY LASER IRRADIATION - TEMPERATURE
   DISTRIBUTION DURING LASER ABLATION
SO OPTICAL ENGINEERING
LA English
DT Article
DE BIOMEDICAL OPTICS; LASER IRRADIATION; TISSUE DAMAGE; LASER ABLATION
ID ANGIOPLASTY; RADIATION
AB A numerical model was developed for calculating the temperature distribution in material exposed to a laser beam. The model takes into account the different stages undergone by the tissue before material removal is achieved. The consecutive steps considered are: heating to the boiling temperature of water, boiling and evaporation of the water content, heating of the dehydrated tissue to its ablation temperature, removal of the relevant material, and adapting the new geometrical boundaries of the remaining tissue. The temperature field was computed by the model and measured experimentally in biological tissue exposed to pulses of highly absorbed laser radiation. Good agreement was obtained between the theoretical and the experimental results. This model may be applied to optimize the irradiation conditions for a specific application, to determine the temperature distribution during laser cutting, and to minimize the resulting thermal damage.
C1 TECHNION ISRAEL INST TECHNOL,DEPT MECH ENGN,IL-32000 HAIFA,ISRAEL.
RP SAGI, A (reprint author), TEL AVIV UNIV,RAYMOND & BEVERLY SACKLER FAC EXACT SCI,SCH PHYS & ASTRON,IL-69978 TEL AVIV,ISRAEL.
CR BOWMAN HF, 1975, ANNU REV BIOPHYS BIO, V4, P43, DOI 10.1146/annurev.bb.04.060175.000355
   FUKUMOT I, 1981, 4TH P C INT SOC LAS
   HENRIQUES FC, 1947, AM J PATHOL, V23, P531
   HENRIQUES FC, 1947, ARCH PATHOL, V43, P489
   PARTOVI F, 1987, LASER SURG MED, V7, P141, DOI 10.1002/lsm.1900070202
   Poppendiek H. F., 1966, CRYOBIOLOGY, V3, P318
   SAGI A, 1992, OPT ENG, V31, P1417, DOI 10.1117/12.58733
   SPECKHART FH, 1976, CSMP CONTINUOUS SYST
   SPELLS KE, 1960, PHYS MED BIOL, V5, P139, DOI 10.1088/0031-9155/5/2/304
   TAKATA AN, 1977, SAMTR7738 REP
   TAKATA AN, 1974, IITRI JTR746324
   VANGEMERT MJC, 1985, LASER SURG MED, V5, P219, DOI 10.1002/lsm.1900050304
   WALSH JT, 1988, LASER SURG MED, V8, P264, DOI 10.1002/lsm.1900080308
   WELCH AJ, 1984, IEEE J QUANTUM ELECT, V20, P1471, DOI 10.1109/JQE.1984.1072339
   WELCH AJ, 1985, LASER SURG MED, V5, P251, DOI 10.1002/lsm.1900050307
   WELCH AJ, 1987, CIRCULATION, V76, P1353, DOI 10.1161/01.CIR.76.6.1353
NR 16
TC 14
Z9 15
U1 0
U2 0
PU SOC PHOTO-OPT INSTRUM ENG
PI BELLINGHAM
PA PO BOX 10, BELLINGHAM, WA 98227-0010
SN 0091-3286
J9 OPT ENG
JI Opt. Eng.
PD JUL
PY 1992
VL 31
IS 7
BP 1425
EP 1431
DI 10.1117/12.58734
PG 7
WC Optics
SC Optics
GA JD558
UT WOS:A1992JD55800006
DA 2018-10-19
ER

PT J
AU WANG, JY
AF WANG, JY
TI CYLINDRICAL WAVE-GUIDE EVANESCENT FIELD ELLIPSOMETRY
SO OPTICAL ENGINEERING
LA English
DT Article
DE BIOMEDICAL OPTICS; ELLIPSOMETRY; WAVE-GUIDES; BIOSENSORS; LIGHT
   PROPAGATION
ID INTERFACE; SENSORS
AB The recent use of fiber optic waveguides for biochemical analyses is based mainly on light intensity changes. Waveguide evanescent field ellipsometry (WEFE) is proposed for biosensor applications. The WEFE is based on the principle of ellipsometry. A laser beam coupled into the waveguide propagates in the waveguide with two fundamental modes with transverse electric fields parallel and perpendicular to the sensing surface. The evanescent waves interact with the adsorbed or conjugated layer of biomolecules, producing changes in the relative phase and amplitude upon interaction. The ellipsometric parameters change with biomolecule adsorption or conjugation on the sensing surface. From the ellipsometric parameter changes, we can estimate the surface concentration and thus the concentration of the biomolecules in solution. The principles of WEFE including light propagation in the waveguide, ellipsometry parameter analysis, the WEFE arrangement, materials and methods, and preliminary experimental results are presented.
RP WANG, JY (reprint author), UNIV UTAH,DEPT BIOENGN,SALT LAKE CITY,UT 84112, USA.
CR ANDRADE JD, 1985, IEEE T ELECTRON DEV, V32, P1175, DOI 10.1109/T-ED.1985.22096
   ASPNES DE, 1976, OPTICAL PROPERTIES S
   Azzam R. M. A., 1977, ELLIPSOMETRY POLARIZ
   BORN M, 1975, PRINCIPLES OPTICS, P23
   CUYPERS PA, 1983, J BIOL CHEM, V258, P2426
   HARRICK NJ, 1967, INTERNAL REFLECTION, P35
   HIRSCHFELD T, 1984, SCIENCE, V226, P312, DOI 10.1126/science.226.4672.312
   KAWAGUCHI M, 1988, LANGMUIR, V4, P411, DOI 10.1021/la00080a026
   KIM MW, 1989, MACROMOLECULES, V22, P2682, DOI 10.1021/ma00196a026
   KOOYMAN RPH, 1991, TRANSDUCERS 91
   Marcuse D, 1974, THEORY DIELECTRIC OP
   PETERSON JI, 1984, SCIENCE, V224, P123, DOI 10.1126/science.6422554
   SEITZ WR, 1984, ANAL CHEM, V56, pA16, DOI 10.1021/ac00265a001
   SMARDZEWSKI RR, 1988, TALANTA, V35, P95, DOI 10.1016/0039-9140(88)80045-6
   Snyder A. W., 1983, OPTICAL WAVEGUIDE TH
   WOHLTJEN H, 1984, ANAL CHEM, V56, pA87, DOI 10.1021/ac00265a002
NR 16
TC 1
Z9 1
U1 0
U2 2
PU SOC PHOTO-OPT INSTRUM ENG
PI BELLINGHAM
PA PO BOX 10, BELLINGHAM, WA 98227-0010
SN 0091-3286
J9 OPT ENG
JI Opt. Eng.
PD JUL
PY 1992
VL 31
IS 7
BP 1432
EP 1435
DI 10.1117/12.57699
PG 4
WC Optics
SC Optics
GA JD558
UT WOS:A1992JD55800007
DA 2018-10-19
ER

PT J
AU GOLDEN, JP
   SHRIVERLAKE, LC
   ANDERSON, GP
   THOMPSON, RB
   LIGLER, FS
AF GOLDEN, JP
   SHRIVERLAKE, LC
   ANDERSON, GP
   THOMPSON, RB
   LIGLER, FS
TI FLUOROMETER AND TAPERED FIBER OPTIC PROBES FOR SENSING IN THE EVANESCENT
   WAVE
SO OPTICAL ENGINEERING
LA English
DT Article
DE BIOMEDICAL OPTICS; BIOSENSORS; FIBER OPTIC SENSORS; EVANESCENT WAVES
ID IMMUNOASSAY
AB To develop an improved fiber optic biosensor both the optical component selection and the signal coupling efficiency were investigated. The emission filter and fiber connectors were carefully chosen to reduce their contribution to noise in the system. We used long, fused silica fibers that had several centimeters of cladding removed along the distal end. This exposed core is coated with the recognition molecules that bind analyte-fluorophore complexes from the sample solution. A fluorescent signal generated in the evanescent wave region of the unclad, immersed portion of the probe is lost as it enters the cladded portion of the fiber because of a V-number mismatch. To minimize the mismatch, the core radius is reduced along the uncladded region to form a continuous taper. An assay using the tapered fiber and the described optical configuration is presented that demonstrates instantaneous signal generation in response to nanogram amounts of a toxic material.
RP GOLDEN, JP (reprint author), USN,RES LAB,CTR BIOMOLEC SCI & ENGN,CODE 6090,4555 OVERLOOK AVE SW,WASHINGTON,DC 20375, USA.
RI Golden, Joel/K-4567-2017; Anderson, George/D-2461-2011
OI Golden, Joel/0000-0002-6908-0489; Anderson, George/0000-0001-7545-9893
CR ANDERSON G P, 1992, Biophysical Journal, V61, pA169
   ANDERSON GP, 1992, JAN SPIE C BIOM OPT
   ANDRADE JD, 1985, IEEE T ELECTRON DEV, V32, P1175, DOI 10.1109/T-ED.1985.22096
   BHATIA SK, 1989, ANAL BIOCHEM, V178, P408, DOI 10.1016/0003-2697(89)90662-3
   CAMPBELL J, 1990, Patent No. 7635019
   HIRSCHFELD TE, 1984, Patent No. 4447546
   KRONICK MN, 1975, J IMMUNOL METHODS, V8, P235, DOI 10.1016/0022-1759(75)90116-7
   Ligler F. S., 1991, U.S. patent, Patent No. [5,077,210, 5077210]
   MARCUSE D, 1988, IEEE J LIGHTWAVE TEC, V6, P1273
   SNYDER AW, 1983, OPTICAL WAVEGUIDE TH, P315
   Thompson R.B., 1988, P SOC PHOTO-OPT INS, V904, P27
   Thompson R. B., 1991, US Patent, Patent No. [5061857S, 5061857]
   THOMPSON RB, 1990, P SOC PHOTO-OPT INS, V1204, P35, DOI 10.1117/12.17684
   THOMPSON RB, 1990, APPL SPECTROSC, V44, P117, DOI 10.1366/0003702904085958
   THOMPSON RB, 1991, BIOSENSORS FIBEROPTI, P111
   THOMPSON RB, 1989, 11TH P IEEE EMBS INT, P1102
   WISE DL, 1991, BIOSENSORS FIBEROPTI, P1
   Wolfbeis O. S., 1991, FIBER OPTIC CHEM SEN, V1, p303f
NR 18
TC 55
Z9 59
U1 0
U2 3
PU SOC PHOTO-OPT INSTRUM ENG
PI BELLINGHAM
PA PO BOX 10, BELLINGHAM, WA 98227-0010
SN 0091-3286
J9 OPT ENG
JI Opt. Eng.
PD JUL
PY 1992
VL 31
IS 7
BP 1458
EP 1462
DI 10.1117/12.58764
PG 5
WC Optics
SC Optics
GA JD558
UT WOS:A1992JD55800012
DA 2018-10-19
ER

PT J
AU ANDREOPOULOS, AG
AF ANDREOPOULOS, AG
TI PREPARATION OF HYDROPHILIC POLYMER NETWORKS BY POST-CURING REACTION
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
ID POLY(2-HYDROXYETHYL METHACRYLATE); HYDROGEL MATRIX; DRUG DELIVERY;
   RELEASE; WATER
AB Hydrophilic gels are a very important class of polymeric materials with extensive applications as biomedical products. The critical properties of hydrogels, such as sorption and desorption, mechanical behavior, swelling properties, etc., are controlled by network characteristics, i.e. degree of crosslinking and the density, distribution and length of crosslinks. Hydrogels prepared by copolymerization of 2-hydroxyethyl methacrylate (HEMA) with ethylene glycol dimethacrylate (EGDMA) have already been studied in detail. In this work, hydrophilic networks were prepared by crosslinking HEMA with EGDMA, and poly(2-hydroxy-ethel methacrylate) (PHEMA) with diphenylmethane-4,4'-diisocyanate (MDI). The swelling properties of both types of networks were studied and the differences in behavior were attributed to the different techniques applied for network formation.
RP ANDREOPOULOS, AG (reprint author), NATL TECH UNIV ATHENS,DEPT CHEM ENGN,SPECIAL CHEM TECHNOL LAB,42 PATISS STR,GR-10682 ATHENS,GREECE.
CR ANDREOPOULOS AG, 1989, J APPL POLYM SCI, V37, P2121, DOI 10.1002/app.1989.070370804
   ANDREOPOULOS AG, 1989, BIOMATERIALS, V10, P101, DOI 10.1016/0142-9612(89)90040-9
   DAVANKOV VA, 1974, J POLYM SCI PS, V47, P95
   DAVIDSON CWR, 1986, J CONTROL RELEASE, V3, P259
   Davidson III GWR, 1986, J CONTROL RELEASE, V3, P243, DOI DOI 10.1016/0168-3659(86)90096-9
   GREGONIS DE, 1978, POLYMER, V19, P1279, DOI 10.1016/0032-3861(78)90305-1
   HOPFENBERG HB, 1976, POLYMER, V17, P195, DOI 10.1016/0032-3861(76)90099-9
   HUGLIN MB, 1982, POLYMER, V23, P340, DOI 10.1016/0032-3861(82)90331-7
   Korsmeyer R. W., 1983, J CONTROL RELEASE, V1, P89
   LEE PI, 1983, POLYM COMMUN, V24, P45
   LINHARDT RJ, 1983, POLYM PREPR-ACS, V24, P47
   LOSHAEK S, 1953, J AM CHEM SOC, V75, P3544, DOI 10.1021/ja01110a068
   MESLARD JC, 1986, MAKROMOL CHEM, V187, P787
   MIGLIARESI C, 1984, POLYMER, V25, P686, DOI 10.1016/0032-3861(84)90037-5
   MIGLIARESI C, 1980, INT J ARTIF ORGANS, V3, P114
   MIGLIARESI C, 1983, J BIOMED MATER RES, V17, P1
   MITRA SB, 1983, POLYM PREPR-ACS, V24, P51
   NEGRE M, 1979, ANGEW MAKROMOL CHEM, V80, P19, DOI 10.1002/apmc.1979.050800102
   PEPPAS N A, 1987, Journal of Controlled Release, V5, P143, DOI 10.1016/0168-3659(87)90005-8
   PINCHUK L, 1984, J APPL POLYM SCI, V29, P1749, DOI 10.1002/app.1984.070290528
   PONCHEL G, 1987, Journal of Controlled Release, V5, P129, DOI 10.1016/0168-3659(87)90004-6
   RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   SEQOTCHICQ S, 1986, J CONTROL RELEASE, V3, P193
   SUNG YK, 1981, J APPL POLYM SCI, V26, P3719, DOI 10.1002/app.1981.070261118
   Wichterle O., 1971, ENCYCLOPEDIA POLYMER, P273
NR 26
TC 7
Z9 7
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JUN 25
PY 1992
VL 45
IS 6
BP 1005
EP 1010
DI 10.1002/app.1992.070450609
PG 6
WC Polymer Science
SC Polymer Science
GA HV699
UT WOS:A1992HV69900009
DA 2018-10-19
ER

PT J
AU WHYTE, SR
AF WHYTE, SR
TI PHARMACEUTICALS AS FOLK MEDICINE - TRANSFORMATIONS IN THE
   SOCIAL-RELATIONS OF HEALTH-CARE IN UGANDA
SO CULTURE MEDICINE AND PSYCHIATRY
LA English
DT Article
AB The deterioration of government health services in Uganda since 1971 has been accompanied by a process of privatization which has made pharmaceuticals readily available outside of biomedical institutions. On the basis of material from eastern Uganda, the article analyses this development in terms of the 'sector model' of health care systems, with special attention to the relations between the professional and folk sectors. Folk practitioners of pharmaceutical medicine include a broad range of specialists, from government trained paramedicals in private practice to vendors bringing medicine to local markets. Like other folk specialists, they respect the customer's opinion, provide treatment by proxy and adjust their services to the customer's ability to pay. Although there are negative aspects of this development, from the local point of view there are also positive ones, which deserve the consideration of health planners.
RP WHYTE, SR (reprint author), UNIV COPENHAGEN,INST ANTHROPOL,FREDERIKSHOLMS KANAL 4,DK-1220 COPENHAGEN,DENMARK.
OI Whyte, Susan/0000-0001-7253-6478
CR ALLAND A, 1970, ADAPTATION CULTURAL
   BENNETT FJ, 1989, SOC SCI MED, V28, P1085, DOI 10.1016/0277-9536(89)90392-4
   Bledsoe C., 1988, CONTEXT MED DEV COUN, P253
   BURGHART R, 1988, CONTEXT MED DEV COUN, P289
   Dodge Cole P., 1985, CRISIS UGANDA BREAKD
   DODGE CP, 1987, CRISIS DEV ISSUES UG, P101
   ETKIN NL, 1990, SOC SCI MED, V30, P919, DOI 10.1016/0277-9536(90)90220-M
   FERGUSON A, 1985, CONTEXT MED DEV COUN, P19
   Foster George, 1978, MED ANTHR
   Freidson E., 1970, PROFESSIONAL DOMINAN
   *HLTH POL REV COMM, 1987, REP REC HLTH POL REV
   JAMAL V, 1987, CRISIS DEV ISSUES UG, P121
   JANZEN J, 1978, QUEST THERAPY MED PL, P37
   JANZEN JM, 1978, SOC SCI MED-MED ANTH, V12, P121, DOI 10.1016/0160-7987(78)90020-0
   Justice J., 1986, POLICIES PLANS PEOPL
   KINUKA R, 1985, ESSENTIAL DRUGS MANA
   Kironde Erisa, 1985, CRISIS UGANDA BREAKD, P65
   KLEINMAN A, 1980, PATIENTS HEALERS CON, P655
   Last M., 1986, PROFESSIONALISATION, P1
   LESLIE C, 1980, SOC SCI MED-MED ANTH, V14, P191, DOI 10.1016/0160-7987(80)90044-7
   LESLIE C, 1975, COMP STUDIES HLTH CA, P401
   Leslie Charles, 1976, ASIAN MED SYSTEMS CO, P356
   MacCormack C., 1986, PROFESSIONALIZATION, P151
   MINDE KK, 1985, CRISIS UGANDA BREAKD, P239
   NICHTER M, 1989, CULT MED PSYCHIAT, V13, P367, DOI 10.1007/BF00052046
   ODURKENE JN, 1988, THESIS
   PRICE LJ, 1989, SOC SCI MED, V28, P905, DOI 10.1016/0277-9536(89)90315-8
   STOCK R, 1985, STUDIES 3RD WORLD SO, V34, P115
   TAYLOR CE, 1976, ASIAN MED SYSTEMS CO, P285
   *UGANDA ESS DRUGS, 1990, FIND 1986 1989
   van der Geest S., 1989, MED ANTHROPOL Q, V3, P345, DOI DOI 10.1525/MAQ.1989.3A.02A00030
   VANDERGEEST S, 1991, CULT MED PSYCHIAT, V15, P69, DOI 10.1007/BF00050828
   VANDERGEEST S, 1988, CONTEXT MED DEV COUN, P131
   WHYTE M, 1990, CREATIVE COMMUNION A, P307
   WHYTE MA, 1990, ADAPTIVE STRATEGIES IN AFRICAN ARID LANDS, P121
   WHYTE SR, 1982, SOC SCI MED, V16, P2055, DOI 10.1016/0277-9536(82)90161-7
   WHYTE SR, 1988, CONTEXT MED DEV COUN, P217
   Whyte SR, 1991, CHANGING UGANDA DILE, P130
   Whyte Susan R, 1991, AFRICAN DIVINATION S, P153
   Whyte Susan R, 1990, J RELIG AFR, V20, P41
   WOLFFERS I, 1988, CONTEXT MED DEV COUN, P47
NR 41
TC 30
Z9 31
U1 0
U2 6
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0165-005X
J9 CULT MED PSYCHIAT
JI Cult. Med. Psychiatr.
PD JUN
PY 1992
VL 16
IS 2
BP 163
EP 186
DI 10.1007/BF00117017
PG 24
WC Anthropology; Psychiatry; Social Sciences, Biomedical
SC Anthropology; Psychiatry; Biomedical Social Sciences
GA JH295
UT WOS:A1992JH29500002
PM 1395694
DA 2018-10-19
ER

PT J
AU CARENZA, M
AF CARENZA, M
TI RECENT ACHIEVEMENTS IN THE USE OF RADIATION POLYMERIZATION AND GRAFTING
   FOR BIOMEDICAL APPLICATIONS
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article
ID NATURAL-RUBBER TUBES; DRUG DELIVERY; COPOLYMERIC MICROSPHERES;
   N-ACRYLOXYSUCCINIMIDE; GLUCOSE-OXIDASE; IMMOBILIZATION; POLYMERS;
   RELEASE; POLYETHERURETHANE; METHACRYLATE
AB Papers mainly published in the last few years on radiation processing of polymeric systems for biomedical applications carried out in different laboratories are reviewed. Radiation-induced polymerization to obtain hydrogels as carriers for immobilization of bioactive agents and for controlled release of drugs is described. Radiation modification of polymers by graft copolymerization and/or crosslinking for the same purposes is also reported. The second part of the paper deals with the work recently carried out in the author's laboratory. Radiation-induced polymerization at low temperatures to obtain matrices susceptible to entrap drugs, including peptides and proteins, is discussed. Radiation grafting of hydrophilic monomers onto relatively new inorganic polymers, i.e. polyphosphazenes, and the properties of such modified polymeric materials, together with their biocompatibility, are summarized.
RP CARENZA, M (reprint author), CNR,IST FOTOCHIM & RADIAZIONI DALTA ENERGIA,SEZ LEGNARO,VIA ROMEA 4,I-35020 LEGNANO,ITALY.
CR ALBIN G, 1985, Journal of Controlled Release, V2, P153, DOI 10.1016/0168-3659(85)90041-0
   Allcock HR, 1972, PHOSPHORUS NITROGEN
   BEDDOWS CG, 1988, J APPL POLYM SCI, V35, P135, DOI 10.1002/app.1988.070350112
   BOCCU E, 1987, APPL BIOCHEM BIOTECH, V15, P1, DOI 10.1007/BF02798502
   BUSULINI L, 1977, MAKROMOL CHEM, V178, P277
   CARENZA M, 1983, CHIM IND-MILAN, V65, P261
   CARENZA M, 1988, RADIAT PHYS CHEM, V31, P657
   CARENZA M, 1989, Annali di Microbiologia ed Enzimologia, V39, P257
   CARENZA M, 1987, EUR POLYM J, V23, P741, DOI 10.1016/0014-3057(87)90117-0
   CARENZA M, 1990, ANN NY ACAD SCI, V613, P547, DOI 10.1111/j.1749-6632.1990.tb18218.x
   CARENZA M, 1990, CHIM OGGI, V8, P41
   CHABANESARI M, UNPUB
   CHAPIRO A, 1980, RADIAT PHYS CHEM, V15, P423, DOI 10.1016/0146-5724(80)90163-6
   CHAPIRO A, 1983, EUR POLYM J, V19, P859, DOI 10.1016/0014-3057(83)90038-1
   CHAPIRO A, 1981, RADIAT PHYS CHEM, V18, P1203, DOI 10.1016/0146-5724(81)90311-3
   CHARLESBY A, 1987, RAD CHEM PRINCIPLES, P451
   DASILVA MA, 1990, J APPL POLYM SCI, V41, P1629, DOI 10.1002/app.1990.070410722
   DASILVA MA, 1990, RADIAT PHYS CHEM, V35, P98
   DENIZLI A, 1988, BIOMATERIALS, V9, P363, DOI 10.1016/0142-9612(88)90034-8
   DENIZLI A, 1988, BIOMATERIALS, V9, P257, DOI 10.1016/0142-9612(88)90094-4
   DEVI S, 1990, RADIAT PHYS CHEM, V36, P697
   DEVI S, 1990, RADIAT PHYS CHEM, V36, P703
   DOBO J, 1970, ACTA CHIM HUNG, V63, P453
   DONG L C, 1986, Journal of Controlled Release, V4, P223, DOI 10.1016/0168-3659(86)90006-4
   DONG LC, 1990, J CONTROL RELEASE, V13, P21, DOI 10.1016/0168-3659(90)90071-Z
   DONG LC, 1986, RADIAT PHYS CHEM, V28, P177
   FAUCITANO A, 1991, RADIAT PHYS CHEM, V37, P573
   FUJIMURA T, 1988, RADIAT PHYS CHEM, V31, P653
   GARNETT JL, 1985, RADIAT PHYS CHEM, V25, P509, DOI 10.1016/0146-5724(85)90130-X
   GARNETT JL, 1986, RADIAT PHYS CHEM, V27, P301
   GLERIA M, 1988, CHIM IND MILAN S11, V70, P15
   GOMBOTZ W R, 1985, Journal of Controlled Release, V2, P375, DOI 10.1016/0168-3659(85)90059-8
   Gombotz W.R., 1986, HYDROGELS MED PHARM, P95
   HA HF, 1988, RADIAT PHYS CHEM, V31, P761
   HA HF, 1985, RADIAT PHYS CHEM, V25, P501
   HAYASHI K, 1986, RADIAT PHYS CHEM, V27, P317
   HOFFMAN A S, 1987, Journal of Controlled Release, V6, P297, DOI 10.1016/0168-3659(87)90083-6
   HOFFMAN AS, 1986, RADIAT PHYS CHEM, V27, P265
   HOFFMAN AS, 1990, ACS POLYM PREPR, V31, P220
   JANSEN B, 1984, J BIOMED MATER RES, V18, P655, DOI 10.1002/jbm.820180607
   JANSEN B, 1985, J BIOMED MATER RES, V19, P1085, DOI 10.1002/jbm.820190918
   Jansen B, 1987, J Biomater Appl, V1, P502
   KABANOV VY, 1989, RADIAT PHYS CHEM, V33, P51
   KAETSU I, 1972, J POLYM SCI A1, V10, P2203, DOI 10.1002/pol.1972.150100801
   KAETSU I, 1985, RADIAT PHYS CHEM, V25, P517, DOI 10.1016/0146-5724(85)90131-1
   KAETSU I, 1981, RADIAT PHYS CHEM, V18, P343, DOI 10.1016/0146-5724(81)90086-8
   KAETSU I, 1986, RADIAT PHYS CHEM, V27, P245
   Kiremitci M, 1986, PROGR ARTIFICIAL ORG, P1010
   KOST J, 1985, J BIOMED MATER RES, V19, P1117, DOI 10.1002/jbm.820190920
   KUMAKURA M, 1990, J APPL POLYM SCI, V41, P177, DOI 10.1002/app.1990.070410115
   LIU YM, 1990, RADIAT PHYS CHEM, V35, P122
   LIU YM, 1987, RADIAT PHYS CHEM, V30, P215
   LORA S, 1990, RADIAT PHYS CHEM, V35, P117
   LORA S, 1991, BIOMATERIALS, V12, P275, DOI 10.1016/0142-9612(91)90034-8
   LORA S, 1988, RADIAT PHYS CHEM, V31, P629
   LORA S, 1976, MAKROMOL CHEM, V177, P299
   LORA S, 1987, Patent No. 19435
   MECHAIN B, IN PRESS BIOMATERIAL
   MIKI M, 1982, BIOTECHNOL BIOENG, V24, P2587, DOI 10.1002/bit.260241121
   MING LY, 1987, 3RD CHIN JAP BIL S R
   MORITA Y, 1987, COLLOID POLYM SCI, V265, P916, DOI 10.1007/BF01421822
   MULLERSCHULTE D, 1990, J CHROMATOGR, V510, P115, DOI 10.1016/S0021-9673(01)93744-6
   MULLERSCHULTE D, 1990, RADIAT PHYS CHEM, V35, P93
   PEKALA W, 1986, RADIAT PHYS CHEM, V27, P275
   PEZZIN G, 1991, CHEM IND MILAN, V73, P185
   PISKIN K, 1984, APPL BIOCHEM BIOTECH, V10, P73, DOI 10.1007/BF02783737
   RAZZAK MT, 1988, J APPL POLYM SCI, V36, P645, DOI 10.1002/app.1988.070360315
   RAZZAK MT, 1989, J APPL POLYM SCI, V38, P829, DOI 10.1002/app.1989.070380506
   ROSIAK J, 1983, RADIAT PHYS CHEM, V22, P907, DOI 10.1016/0146-5724(83)90111-5
   SAFRANJ A, 1990, 1ST IAEA RES COORD M
   SILVERMAN J, 1977, RADIAT PHYS CHEM, V9, P1, DOI 10.1016/0146-5724(77)90069-3
   SINGLER RE, 1988, ACS SYM SER, V360, P268
   STANNETT VT, 1990, RADIAT PHYS CHEM, V35, P82
   SUN Y, 1987, ACS POLYM PREPR, V28, P292
   SUN YH, 1986, J BIOACT COMPAT POL, V1, P316
   TAKEHISA M, 1987, RAD CHEM, P601
   TAYLOR LD, 1975, J POLYM SCI POL CHEM, V13, P2551, DOI 10.1002/pol.1975.170131113
   UENOYAMA S, 1988, RADIAT PHYS CHEM, V32, P605
   VEONESE FM, 1990, IN PRESS POLYM MED, V4
   Veronese F M, 1988, Ann N Y Acad Sci, V542, P115, DOI 10.1111/j.1749-6632.1988.tb25815.x
   Veronese F. M., 1989, J BIOACT COMPAT POLY, V4, P42
   VERONESE FM, 1991, J CONTROL RELEASE, V16, P291, DOI 10.1016/0168-3659(91)90005-X
   VERONESE FM, 1990, RADIAT PHYS CHEM, V35, P88
   WANG GH, 1988, RADIAT PHYS CHEM, V31, P705
   YANG HC, 1988, RADIAT PHYS CHEM, V31, P721
   YANG HC, 1985, RADIAT PHYS CHEM, V25, P375, DOI 10.1016/0146-5724(85)90285-7
   Yoshida M, 1991, Drug Des Deliv, V7, P159
   YOSHIDA M, 1987, BIOMATERIALS, V8, P124, DOI 10.1016/0142-9612(87)90101-3
   YOSHIDA M, 1989, EUR POLYM J, V25, P1197, DOI 10.1016/0014-3057(89)90081-5
   YOSHIDA M, 1990, EUR POLYM J, V26, P121, DOI 10.1016/0014-3057(90)90174-3
   YOSHIDA M, 1987, RADIAT PHYS CHEM, V30, P39
   YOSHIDA M, 1989, COLLOID POLYM SCI, V267, P986, DOI 10.1007/BF01410159
   YOSHIDA M, 1989, J POLYM SCI POL LETT, V27, P437, DOI 10.1002/pol.1989.140271107
   YOSHIDA M, 1989, BIOMATERIALS, V10, P16, DOI 10.1016/0142-9612(89)90004-5
   YOSHIDA M, 1990, POLYMER, V31, P371, DOI 10.1016/0032-3861(90)90136-M
NR 95
TC 65
Z9 65
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0146-5724
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD JUN
PY 1992
VL 39
IS 6
BP 485
EP 493
PG 9
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA JD388
UT WOS:A1992JD38800009
DA 2018-10-19
ER

PT J
AU KUMAKURA, M
   YOSHIDA, M
   ASANO, M
   YAMANAKA, H
AF KUMAKURA, M
   YOSHIDA, M
   ASANO, M
   YAMANAKA, H
TI RADIATION PROCESSING TECHNOLOGY FOR PREPARATION OF FINE SHAPED
   BIOMEDICAL MATERIALS
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article
AB Radiation processing technology for the preparation of fine shaped biomedical materials was studied from the aspect of a development of the technology and its application. Electron beam irradiation technology was applied to the preparation of fine shaped biomedical materials such as thin polymer films in diagnosis, in which enzyme and antibody were used as a bioactive substance. Electron beam cast-polymerization and electron beam repeat surface-polymerization, that are surface irradiation techniques of homogeneous hydrophilic monomer solution containing enzymes made it possible to form the immobilized antibody films. In this technique, the films with various thicknesses (50-500-mu-m) were obtained by regulating the electron beam energy. The thin polymer films immobilizing anti-alpha-fetoprotein were evaluated from the aspect of immunoagents for diagnosis of liver cancer
C1 JAPAN ATOM ENERGY RES INST,TAKASAKI RADIAT CHEM RES ESTAB,TAKASAKI,GUNMA 37012,JAPAN.
   GUNMA UNIV,SCH MED,MAEBASHI,GUNMA 371,JAPAN.
CR DEMARTEAU W, 1984, RAD CURING       FEB, P12
   SCHARPE SL, 1979, CLIN CHEM, V25, P733
   URS VL, 1990, RADIAT PHYS CHEM, V35, P30
   WISDOM GB, 1976, CLIN CHEM, V22, P1243
   WOO J, 1976, AM J CLIN PATHOL, V66, P854
NR 5
TC 3
Z9 3
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0146-5724
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD JUN
PY 1992
VL 39
IS 6
BP 577
EP 581
PG 5
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA JD388
UT WOS:A1992JD38800023
DA 2018-10-19
ER

PT J
AU MACHI, S
AF MACHI, S
TI INTERNATIONAL-SYMPOSIUM ON RADIATION TECHNOLOGY IN BIOMEDICAL MATERIALS
   - 18-19 OCTOBER 1990, TAKASAKI, JAPAN - OPENING ADDRESS
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Editorial Material
C1 JAPAN ATOM ENERGY RES INST,TAKASAKI RADIAT CHEM RES ESTAB,TAKASAKI,GUNMA 37012,JAPAN.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0146-5724
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD JUN
PY 1992
VL 39
IS 6
BP R7
EP R7
PG 1
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA JD388
UT WOS:A1992JD38800002
DA 2018-10-19
ER

PT J
AU MACHI, S
   KUMAKURA, M
   TABATA, Y
AF MACHI, S
   KUMAKURA, M
   TABATA, Y
TI INTERNATIONAL-SYMPOSIUM ON RADIATION TECHNOLOGY IN BIOMEDICAL MATERIALS
   - 18-19 OCTOBER 1990, TAKASAKI, JAPAN - PREFACE
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Editorial Material
C1 JAPAN ATOM ENERGY RES INST,TAKASAKI RADIAT CHEM RES ESTAB,TAKASAKI,GUNMA 37012,JAPAN.
   TOKAI UNIV,DEPT NUCL ENGN,HIRATSUKA,KANAGAWA 25912,JAPAN.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0146-5724
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD JUN
PY 1992
VL 39
IS 6
BP R5
EP R5
PG 1
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA JD388
UT WOS:A1992JD38800001
DA 2018-10-19
ER

PT J
AU MARKOVIC, V
AF MARKOVIC, V
TI INTERNATIONAL-SYMPOSIUM ON RADIATION TECHNOLOGY IN BIOMEDICAL MATERIALS
   - 18-19 OCTOBER 1990, TAKASAKI, JAPAN - WELCOME ADDRESS
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Editorial Material
C1 INT ATOM ENERGY AGCY,CHEM SECT,A-1011 VIENNA,AUSTRIA.
RP MARKOVIC, V (reprint author), INT ATOM ENERGY AGCY,DEPT RES & ISOTOPES IND APPLICAT,A-1011 VIENNA,AUSTRIA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0146-5724
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD JUN
PY 1992
VL 39
IS 6
BP R11
EP R11
PG 1
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA JD388
UT WOS:A1992JD38800004
DA 2018-10-19
ER

PT J
AU TABATA, Y
AF TABATA, Y
TI INTERNATIONAL-SYMPOSIUM ON RADIATION TECHNOLOGY IN BIOMEDICAL MATERIALS
   - 18-19 OCTOBER 1990, TAKASAKI, JAPAN - WELCOME ADDRESS
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0146-5724
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD JUN
PY 1992
VL 39
IS 6
BP R9
EP R9
PG 1
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA JD388
UT WOS:A1992JD38800003
DA 2018-10-19
ER

PT J
AU PARTRIDGE, G
AF PARTRIDGE, G
TI GLASS-CERAMICS IN BIOMEDICAL APPLICATIONS
SO ADVANCED MATERIALS
LA English
DT Editorial Material
ID BIOMATERIALS HIGHLIGHTS; INORGANIC MATERIALS; IMPLANTS
AB Research News/Inorganic Materials VI:  Glass ceramics play a crucial role in many surgical procedures ranging from hip replacements to dentistry.  The surface morhology, chemical composition, and the structural properties of the materials are of utmost importance when deciding the suitability of the materials for particular applications.  The various factors involved are discussed.
CR BARRETT JM, 1983, Patent No. 2041349
   DeGroot K., 1981, SCI CERAM, V11, P433
   GROSSMAN DG, 1985, DENT CLIN N AM, V29, P725
   HAHN C, 1980, BER DENT KERAM GES, V57, P208
   HEIMKE G, 1990, ADV MATER, V2, P548, DOI 10.1002/adma.19900021109
   HEIMKE G, 1990, ADV MATER, V2, P375
   HEIMKE G, 1991, ADV MATER, V3, P108, DOI 10.1002/adma.19910030210
   Heimke G., 1990, Advanced Materials, V2, P189, DOI 10.1002/adma.19900020408
   HEIMKE G, 1991, ADV MATER, V3, P320, DOI 10.1002/adma.19910030613
   HEIMKE G, 1989, ADV MATER, V1, P345
   HEIMKE G, 1990, ADV MATER, V2, P45
   HEIMKE G, 1989, ADV MATER, V1, P60122
   HEIMKE G, 1989, ADV MATER, V1, P234
   HOLAND W, 1991, J NON-CRYST SOLIDS, V129, P152, DOI 10.1016/0022-3093(91)90091-J
   HYDE AR, 1991, 1 MECH ENG C EUR DIR
   KRAJEWSKI A, 1981, SCI CERAM, V11, P85
   LIN FH, 1989, J AUST CERAM SOC, V1, P41
   MACK J, 1987, MATER EDGE       SEP, P38
   MOUATT CAL, 1988, MATER SCI FORUM, V34, P403
   NIEDERAUER GG, 1991, AM CERAM SOC BULL, V70, P1010
   PARTRIDGE G, 1990, ADV MATER, V2, P318, DOI 10.1002/adma.19900020612
   Partridge G., 1990, Advanced Materials, V2, P147, DOI 10.1002/adma.19900020308
   PARTRIDGE G, 1990, ADV MATER, V2, P553, DOI 10.1002/adma.19900021111
   PARTRIDGE G, 1992, ADV MATER, V4, P51, DOI 10.1002/adma.19920040112
   TAIRA M, 1990, BRIT CERAM TRANS J, V89, P203
   TIWARI VP, 1988, CENTRAL GLASS CERAM, V35, P11
   VAJDA TT, 1988, MATER SCI FORUM, V34, P379
   VOGEL W, 1990, J NON-CRYST SOLIDS, V123, P349, DOI 10.1016/0022-3093(90)90807-X
   WIVEN A, 1988, MATER SCI FORUM, V34, P395
   1989, BIOMED MATER, V5, P2
NR 30
TC 1
Z9 1
U1 1
U2 3
PU VCH PUBLISHERS INC
PI DEERFIELD BEACH
PA 303 NW 12TH AVE, DEERFIELD BEACH, FL 33442-1788
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD MAY
PY 1992
VL 4
IS 5
BP 364
EP 367
DI 10.1002/adma.19920040511
PG 4
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA HV497
UT WOS:A1992HV49700010
DA 2018-10-19
ER

PT J
AU SANDERS, AB
   KEIM, SM
   SKLAR, D
   ADAMS, J
AF SANDERS, AB
   KEIM, SM
   SKLAR, D
   ADAMS, J
TI EMERGENCY PHYSICIANS AND THE BIOMEDICAL INDUSTRY
SO ANNALS OF EMERGENCY MEDICINE
LA English
DT Article
DE BIOMEDICAL INDUSTRY
AB The relationship of physicians to biomedical industry has been a matter of concern and scrutiny by medical organizations, the public, industry, and government. 1-10 In a competitive marketplace, the biomedical industry must advertise its products to physician consumers. Nevertheless, gift-giving to physicians, industry support for education and research, and industry promotional activities that reward physicians can result in conflict of interest for physicians. A physician's clinical, educational, and research decisions should be based on scientific evidence and not be influenced by commercialism. Promotional materials developed by biomedical industry may not be designed to give physicians objective scientific data regarding a product. It is particularly disturbing that physicians may not be aware of the undue influence that promotional material and gift-giving has on their clinical decisions. 7 Acceptance of a gift from a biomedical company establishes a relationship between the physician and the company. This relationship may not be in the best interest of the patient and may, in fact, conflict with the physician's obligation to the patient. Furthermore, money spent on promotional materials and gift-giving to physicians ultimately is paid for by patients as part of the cost of the item. 6 The Society for Academic Emergency Medicine is concerned about the ethical conflicts arising from the relationship of physicians to biomedical industry. In this paper, we discuss three general issues related to physicians and the biomedical industry and recommend guidelines for the emergency physician. The three issues are as follows.
RP SANDERS, AB (reprint author), SOC ACAD EMERGENCY MED,ETH COMM,SUBCOMM BIOMED IND RELATIONSHIPS,900 W OTTAWA ST,LANSING,MI 48915, USA.
NR 0
TC 9
Z9 9
U1 1
U2 1
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0196-0644
J9 ANN EMERG MED
JI Ann. Emerg. Med.
PD MAY
PY 1992
VL 21
IS 5
BP 556
EP 558
DI 10.1016/S0196-0644(05)82524-7
PG 3
WC Emergency Medicine
SC Emergency Medicine
GA HR031
UT WOS:A1992HR03100014
PM 1570913
DA 2018-10-19
ER

PT J
AU NAGABHOOSHANAM, M
   DUMKE, VR
AF NAGABHOOSHANAM, M
   DUMKE, VR
TI CHEMOMECHANICAL EFFECTS ON CRACK-PROPAGATION - POLYCRYSTALLINE
   ALPHA-AL2O3
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID MEASURING FRACTURE-TOUGHNESS; SHARP CONTACT CRACKING; SODA-LIME GLASS;
   INDENTATION TECHNIQUES; MICROHARDNESS; DEFORMATION; HARDNESS
AB The role of environment on microcracks in Al2O3 is important as the material has applications in the biomedical field, such as artificial bones. The indentation method of producing radial cracks and measuring hardness is good in that it is reproducible. The radial crack lengths in alpha-Al2O3 are found to be sensitive towards the environment, and the load applied on the indentor. Long-time Vickers' microhardness and radial crack-length measurements in the presence of bio-simulating, aqueous and non-aqueous environments on the surface of alpha-Al2O3 are analysed. In each environment considered, the crack propagation showed a linear variation with the applied load, and the microhardness decreased similarly with time. Evidence was sought to show that the presence of water in bio-simulating liquid helps crack propagation under load. The results are explained in terms of possible interactions between the molecules of Al2O3 and the chemical environment and surface energies in the presence of that environment.
C1 UNIV FED PARANA,DEPT FIS,BR-81531 CURITIBA,PARANA,BRAZIL.
CR ANSTIS GR, 1981, J AM CERAM SOC, V64, P533, DOI 10.1111/j.1151-2916.1981.tb10320.x
   BERNHARDT EO, 1941, Z METALLKD, V33, P135
   CHAN HM, 1988, J AM CERAM SOC, V71, P29, DOI 10.1111/j.1151-2916.1988.tb05756.x
   CHANTIKUL P, 1981, J AM CERAM SOC, V64, P539, DOI 10.1111/j.1151-2916.1981.tb10321.x
   CHAUDHRI MM, 1986, PHILOS MAG A, V53, pL55
   EVANS AG, 1976, J AM CERAM SOC, V59, P371, DOI 10.1111/j.1151-2916.1976.tb10991.x
   FAIRBANKS CJ, 1982, J MATER SCI LETT, V1, P391, DOI 10.1007/BF00724848
   FROHLICH F, 1977, PHYS STATUS SOLIDI A, V42, P79, DOI 10.1002/pssa.2210420106
   GUNASEKERA SP, 1973, PHYS CHEM GLASSES, V14, P45
   HAGAN JT, 1980, J MATER SCI, V15, P1417, DOI 10.1007/BF00752121
   HAGAN JT, 1978, J PHYS D APPL PHYS, V11, P2091, DOI 10.1088/0022-3727/11/15/007
   HIRAO K, 1987, J AM CERAM SOC, V70, P497, DOI 10.1111/j.1151-2916.1987.tb05683.x
   HIRAO K, 1987, J AM CERAM SOC, V70, P377, DOI 10.1111/j.1151-2916.1987.tb05654.x
   Kranich J. F., 1976, GLASTECH BER, V49, P135
   LAWN B, 1975, J MATER SCI, V10, P1049, DOI 10.1007/BF00823224
   LAWN BR, 1983, J MATER SCI, V18, P2785, DOI 10.1007/BF00547596
   LAWN BR, 1983, FRACTURE MECHANICS C, V5, P1
   LAWN BR, 1985, STRENGTH INORGANIC G, P67
   MARSHALL DB, 1979, J MATER SCI, V14, P2225, DOI 10.1007/BF00688429
   MARSHALL DB, 1979, J MATER SCI, V14, P2001, DOI 10.1007/BF00551043
   MICHALSKE TA, 1984, J APPL PHYS, V56, P2686, DOI 10.1063/1.333789
   MICHALSKE TA, 1985, J AM CERAM SOC, V68, P586, DOI 10.1111/j.1151-2916.1985.tb16160.x
   TOMOZAWA M, 1987, J MATER SCI LETT, V6, P867, DOI 10.1007/BF01729041
   WESTBROOK JH, 1968, AM MINERAL, V53, P1899
   Westbrook JH, 1965, T AIME, V223, P425
   WESTBROOK JH, 1966, ENV SENSITIVE MECHAN, P247
   YAMANAKA K, 1982, J APPL PHYS, V53, P846, DOI 10.1063/1.330591
NR 27
TC 5
Z9 5
U1 0
U2 2
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD MAY 1
PY 1992
VL 27
IS 9
BP 2377
EP 2382
DI 10.1007/BF01105046
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA HT187
UT WOS:A1992HT18700015
DA 2018-10-19
ER

PT J
AU YANCH, JC
   ZHOU, XL
   SHEFER, RE
   KLINKOWSTEIN, RE
AF YANCH, JC
   ZHOU, XL
   SHEFER, RE
   KLINKOWSTEIN, RE
TI ACCELERATOR-BASED EPITHERMAL NEUTRON BEAM DESIGN FOR NEUTRON-CAPTURE
   THERAPY
SO MEDICAL PHYSICS
LA English
DT Article
DE EPITHERMAL NEUTRONS; ACCELERATOR; NCT; MCNP
AB Recent interest in the production of epithermal neutrons for use in boron neutron capture therapy (BNCT) has prompted an investigation into the feasibility of generating such neutrons with a high current proton accelerator. Energetic protons (2.5 MeV) on a Li-7 target produce a spectrum of neutrons with maximum energy of roughly 800 keV. A number of combinations of D2O moderator, lead reflector, Li-6 thermal neutron filtration, and D2O/Li-6 shielding will result in a useful epithermal flux of 1.6 X 10(8) n/s at the patient position. The neutron beam is capable of delivering 3000 RBE-cGy to a tumor at a depth-of 7.5 cm in a total treatment time of 60-93 min (depending on RBE values used and based on a 24-cm diameter X 19-cm length D2O moderator). Treatment of deeper tumors with therapeutic advantage would also be possible. Maximum advantage depths (RBE weighted) of 8.2-9.2 (again depending on RBE values and precise moderator configuration) are obtained in a right-circular cylindrical phantom composed of brain-equivalent material with an advantage ratio of 4.7-6.3. A tandem cascade accelerator (TCA), designed and constructed at Science Research Laboratory (SRL) in Somerville MA, can provide the required proton beam parameters for BNCT of deep-seated tumors. An optimized configuration of materials required to shift the accelerator neutron spectrum down to therapeutically useful energies has been designed using Monte Carlo simulation in the Whitaker College Biomedical Imaging and Computation Laboratory at MIT. Actual construction of the moderator/reflector assembly is currently underway.
C1 MIT,WHITAKER COLL HLTH SCI & TECHNOL,CAMBRIDGE,MA 02139.
   SCI RES LAB INC,SOMERVILLE,MA 02143.
RP YANCH, JC (reprint author), MIT,DEPT NUCL ENGN,CAMBRIDGE,MA 02139, USA.
CR BARTH RF, 1990, CANCER RES, V50, P1061
   BARTH RF, 1990, SCI AM           OCT, P100
   Briesmeister J, 1986, LA7396M LOS AL NAT L
   BROOKS RA, 1980, J COMPUT ASSIST TOMO, V4, P489, DOI 10.1097/00004728-198008000-00016
   BRUGGER RM, 1990, NEUTRON BEAM DESIGN
   CASWELL RS, 1982, INT J APPL RADIAT IS, V33, P1227, DOI 10.1016/0020-708X(82)90246-0
   CHOI JR, 1990, IN PRESS 4TH P INT S
   CHOI JR, 1990, NEUTRON BEAM DESIGN
   CLEMENT SD, 1990, NEUTRON BEAM DESIGN
   FAIRCHILD RG, 1990, MED PHYS, V17, P1045, DOI 10.1118/1.596455
   FAIRCHILD RG, 1990, NEUTRON BEAM DESIGN
   GRUSELL E, 1990, NEUTRON BEAM DESIGN
   Paulsen A., 1975, NUCL DATA TABLES, V15, P57
   ROUSSIN R, 1990, DLC75 RAD SHIELD INF
   SHEFER RE, 1990, IN PRESS 4TH P INT S
   SHEFER RE, 1990, NEUTRON BEAM DESIGN
   WANG CK, 1990, NEUTRON BEAM DESIGN
   WANG CKC, 1989, NUCL TECHNOL, V84, P93, DOI 10.13182/NT89-A34199
   YANCH JC, 1991, RADIAT RES, V126, P1, DOI 10.2307/3578165
   YANCH JC, 1990, IN PRESS 4TH P INT S
   ZAMENHOF R G, 1975, Medical Physics (Woodbury), V2, P47, DOI 10.1118/1.594168
   1960, NUCLEAR DATA TABLE 3
NR 22
TC 61
Z9 61
U1 0
U2 3
PU AMER INST PHYSICS
PI WOODBURY
PA CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999
SN 0094-2405
J9 MED PHYS
JI Med. Phys.
PD MAY-JUN
PY 1992
VL 19
IS 3
BP 709
EP 721
DI 10.1118/1.596815
PG 13
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA HZ958
UT WOS:A1992HZ95800028
PM 1324392
DA 2018-10-19
ER

PT J
AU MORRA, M
   OCCHIELLO, E
   GARBASSI, F
AF MORRA, M
   OCCHIELLO, E
   GARBASSI, F
TI ON THE EFFECT OF STAGE SPEED AND VISCOSITY ON SOLID LIQUID INTERFACIAL
   BEHAVIOR DURING DYNAMIC CONTACT-ANGLE MEASUREMENT - APPLICATION TO
   BIOMEDICAL AND COMPOSITE-MATERIALS
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 IST G DONEGANI SPA MONTEDISON,I-28100 NOVARA,ITALY.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD APR 5
PY 1992
VL 203
BP 100
EP COLL
PN 1
PG 0
WC Chemistry, Multidisciplinary
SC Chemistry
GA HK161
UT WOS:A1992HK16101615
DA 2018-10-19
ER

PT J
AU BYRNE, AR
AF BYRNE, AR
TI SOME CONSIDERATIONS REGARDING REFERENCE MATERIALS AND THEIR ROLE IN
   ENVIRONMENTAL MONITORING - PLENARY LECTURE
SO ANALYST
LA English
DT Article
DE REFERENCE MATERIALS; ENVIRONMENTAL MONITORING; QUALITY CONTROL
ID BIOLOGICAL REFERENCE MATERIALS; ATOMIC-ABSORPTION DETERMINATION;
   BOTANICAL REFERENCE MATERIALS; NEUTRON-ACTIVATION ANALYSIS;
   QUALITY-CONTROL; TRACE-METALS; METHYLMERCURY; MERCURY; BLOOD;
   IDENTIFICATION
AB After a brief introduction indicating the principal function of reference materials (RMs) in ensuring that the analytical measurement programme is performing reliably, the availability, different types and sources of information on RMs are described. Next, the correspondence of available RMs to present sample demands is discussed, particularly with regard to the adequacy of matrices and analytes, the availability of RMs for 'difficult' trace elements, and the preparation and certification of speciation RMs. The role of RMs in quality control is indicated, and their usage and certain problems which can thereby arise, including total dissolution, homogeneity and their representativeness in relation to samples, are discussed. The application of truly representative RMs in low-level trace element work, as a means of quality control of sampling and storage procedures, is mentioned. Strategies open to the analyst in the total absence of certified RMs are presented, and the importance of publication of independent results by alternative methods for such materials, as a means of establishing consensus values, is stressed. In the situation where results for a particular analyte obtained by different groups for the same (but not identical) biomedical or environmental system differ markedly, a progressive multi-stage exchange scheme is proposed, which is designed to reveal whether the differences arise from analytical factors, sampling effects or real system differences.
RP BYRNE, AR (reprint author), J STEFAN INST, LJUBLJANA 61000, YUGOSLAVIA.
CR ALVAREZ R, 1982, ANAL CHEM, V54, pA226, DOI 10.1021/ac00249a001
   ANGERER J, 1990, FRESEN J ANAL CHEM, V337, P589, DOI 10.1007/BF00323093
   [Anonymous], 1989, ANALYST, V114, P1693
   BEAUCHEMIN D, 1988, ANAL CHEM, V60, P2209, DOI 10.1021/ac00171a009
   BERMAN SS, 1988, FRESEN Z ANAL CHEM, V332, P546, DOI 10.1007/BF00472639
   BERMAN SS, 1989, FRESEN Z ANAL CHEM, V333, P641, DOI 10.1007/BF00496938
   BOWEN HJM, 1967, ANALYST, V92, P124, DOI 10.1039/an9679200124
   BYRNE AR, 1988, TALANTA, V35, P161, DOI 10.1016/0039-9140(88)80058-4
   BYRNE AR, 1988, FRESEN Z ANAL CHEM, V332, P666, DOI 10.1007/BF00472665
   BYRNE AR, 1986, J ENVIRON RADIOACTIV, V4, P133, DOI 10.1016/0265-931X(86)90038-X
   BYRNE AR, 1987, FRESEN Z ANAL CHEM, V326, P723, DOI 10.1007/BF00473540
   BYRNE AR, 1990, TRACE ELEM BIOL RES, V338, P399
   CALI JP, 1975, NBS SPECIAL PUBLICAT, V148
   CALI JP, 1976, ACCURACY TRACE ANALS
   CANTILLO AY, 1989, NOAA NOS OMA51 NAT O
   CHATT A, 1990, FRESEN J ANAL CHEM, V338, P399, DOI 10.1007/BF00322503
   CHAU YK, 1991, FRESEN J ANAL CHEM, V339, P640, DOI 10.1007/BF00325551
   CLADNEY ES, 1987, NBS260111 SPEC PUBL
   Cortes Toro E., 1990, IAEARL128
   CURRIE LA, 1982, PURE APPL CHEM, V54, P715, DOI 10.1351/pac198254040715
   CURRIE LA, 1991, ACS SYM SER, V445, P74
   DAS HA, 1990, J RADIOAN NUCL CH AR, V140, P387, DOI 10.1007/BF02039511
   DEBRUIN M, 1987, J RADIOAN NUCL CH AR, V112, P199, DOI 10.1007/BF02037291
   DEBRUIN M, 1988, J RADIOAN NUCL CH AR, V123, P227, DOI 10.1007/BF02036393
   DEGOEIJ JJM, 1983, ANAL CHIM ACTA, V146, P161, DOI 10.1016/S0003-2670(00)80602-9
   GREENBERG RR, 1990, FRESEN J ANAL CHEM, V338, P394, DOI 10.1007/BF00322502
   GRIEPINK B, 1991, FRESEN J ANAL CHEM, V339, P599, DOI 10.1007/BF00325544
   GRIFFITHS NM, 1974, NEW ZEAL MED J, V80, P199
   HEYDORN K, 1980, ANAL CHEM, V52, P1045, DOI 10.1021/ac50057a012
   HORVAT M, 1990, TALANTA, V37, P207, DOI 10.1016/0039-9140(90)80024-A
   HORVAT M, 1992, ANALYST, V117, P665, DOI 10.1039/an9921700665
   HORVAT M, 1991, WATER AIR SOIL POLL, V56, P95, DOI 10.1007/BF00342264
   Horvat M, 1988, APPL ORGANOMET CHEM, V2, P515
   HORWITZ W, 1988, PURE APPL CHEM, V60, P855, DOI 10.1351/pac198860060855
   HORWITZ W, 1980, J ASSOC OFF ANA CHEM, V63, P1344
   HORWITZ W, 1991, ACS SYM SER, V445, P50
   IHNAT M, 1982, COMMUN SOIL SCI PLAN, V13, P969, DOI 10.1080/00103628209367325
   IHNAT M, 1988, SCI TOTAL ENVIRON, V71, P85, DOI 10.1016/0048-9697(88)90302-6
   INGAMELLS CO, 1973, TALANTA, V20, P547, DOI 10.1016/0039-9140(73)80135-3
   INGAMELLS CO, 1974, TALANTA, V21, P141, DOI 10.1016/0039-9140(74)80036-6
   IYENGAR GV, 1989, ELEMENTAL ANAL BIOL, V1
   IYENGAR V, 1988, CLIN CHEM, V34, P474
   KLICH H, 1988, FRESEN Z ANAL CHEM, V332, P552, DOI 10.1007/BF00472641
   KOSTA L, 1982, J RADIOANAL CHEM, V69, P117, DOI 10.1007/BF02515918
   KOSTA L, 1980, IAEA TECHNICAL REPOR, V197, P317
   LIBRANDO V, 1991, FRESEN J ANAL CHEM, V339, P613, DOI 10.1007/BF00325547
   LINDSTROM RM, 1990, FRESEN J ANAL CHEM, V338, P569, DOI 10.1007/BF00322541
   MAGOS L, 1971, ANALYST, V96, P847, DOI 10.1039/an9719600847
   MAGOS L, 1972, J ASSOC OFF ANA CHEM, V55, P966
   MANNINEN PKG, 1991, FRESEN J ANAL CHEM, V339, P620, DOI 10.1007/BF00325548
   MARCHANDISE H, 1987, FRESEN Z ANAL CHEM, V326, P613, DOI 10.1007/BF00473514
   MARCHANDUSE H, 1988, EUROANALYSIS, V6, P65
   MAY K, 1987, TOXICOL ENVIRON CHEM, V13, P153, DOI 10.1080/02772248709357178
   MCLAREN JW, 1990, FRESEN J ANAL CHEM, V337, P721, DOI 10.1007/BF00323105
   MEGLEN RR, 1990, FRESEN J ANAL CHEM, V338, P363, DOI 10.1007/BF00322494
   MINOIA C, 1990, SCI TOTAL ENVIRON, V95, P89, DOI 10.1016/0048-9697(90)90055-Y
   PARR RM, 1985, NUTR RES S, V1, P5
   PSENNER R, 1984, Archiv fuer Hydrobiologie Supplement, V70, P111
   RUTLEDGE DN, 1990, FRESEN J ANAL CHEM, V338, P441, DOI 10.1007/BF00322513
   SUTARNO R, 1985, TALANTA, V32, P439, DOI 10.1016/0039-9140(85)80253-8
   TAYLOR JK, 1987, MAR CHEM, V22, P109, DOI 10.1016/0304-4203(87)90002-8
   TAYLOR JK, 1983, ANAL CHEM, V55, pA600, DOI 10.1021/ac00257a001
   TAYLOR JK, 1981, ANAL CHEM, V53, pA588, DOI 10.1021/ac00237a001
   TAYLOR JK, 1987, QUALITY ASSURANCE CH
   TESSIER A, 1979, ANAL CHEM, V51, P844, DOI 10.1021/ac50043a017
   THOMPSON M, 1989, 3RD P INT S HARM QUA, P183
   TOLOSA I, 1991, FRESEN J ANAL CHEM, V339, P646, DOI 10.1007/BF00325552
   TOPPING G, 1986, SCI TOTAL ENVIRON, V49, P9, DOI 10.1016/0048-9697(86)90231-7
   URIANO GA, 1977, ACS SYM SER, P140
   VERSIECK J, 1987, J RADIOAN NUCL CH AR, V113, P299, DOI 10.1007/BF02036070
   VERSIECK J, 1988, ANAL CHIM ACTA, V204, P63, DOI 10.1016/S0003-2670(00)86346-1
   VERSIECK J, 1989, TRACE ELEMENTS HUMAN
   WOLF WR, 1985, BIOL REFERENCE MATER, P89
   WOLF WR, 1987, TRACE ELEMENTS HUMAN, V1, P57
   WOLF WR, 1985, BIOL REFERENCE MATER
   WOLF WR, 1ST P INT S BIOL REF
   1985, INT ORG STANDARDIZAT, V35
   1987, FRESENISU Z ANAL CHE, V326, P597
   1989, ANALYST, V114, P1699
   1989, ISOREMCO18J
   1990, STANDARD REFERENCE M
   1989, INT ORG STANDARDIZAT, V33
   1990, FRESEN Z ANAL CHEM, V338, P359
   1989, ANALYST, V114, P1497
   1981, INT ORG STANDARDIZAT, V30
   1988, FRESENISU Z ANAL CHE, V332, P517
   1989, CERTIFICATE ANAL
NR 87
TC 11
Z9 11
U1 0
U2 0
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0003-2654
EI 1364-5528
J9 ANALYST
JI Analyst
PD MAR
PY 1992
VL 117
IS 3
BP 251
EP 258
DI 10.1039/an9921700251
PG 8
WC Chemistry, Analytical
SC Chemistry
GA HM863
UT WOS:A1992HM86300008
PM 1580365
DA 2018-10-19
ER

PT J
AU KARLSSON, LM
   CRUZORIVE, LM
AF KARLSSON, LM
   CRUZORIVE, LM
TI THE NEW STEREOLOGICAL TOOLS IN METALLOGRAPHY - ESTIMATION OF PORE-SIZE
   AND NUMBER IN ALUMINUM
SO JOURNAL OF MICROSCOPY-OXFORD
LA English
DT Article
DE ALUMINUM; CAVALIERI PRINCIPLE; DISECTOR; DISTRIBUTION OF PARTICLE
   VOLUMES; ERROR VARIANCE; MEAN PARTICLE VOLUME; POINT-SAMPLED INTERCEPTS;
   PORE NUMBER; PORE VOLUME; SECTION THICKNESS; SELECTOR; STEREOLOGY;
   3-DIMENSIONAL MICROSCOPY; VOLUME-WEIGHTED MEAN PARTICLE VOLUME
ID LINEAR UNBIASED ESTIMATORS; ARBITRARY PARTICLES; SURFACE-AREA;
   PATHOLOGICAL RESEARCH; VERTICAL SECTIONS; VOLUME; EFFICIENCY; DIAGNOSIS;
   DISECTOR; BIOLOGY
AB A number of simple, unbiased and efficient methods are now available in stereology for estimating the number and size of arbitrary particles or voids in a material, with the only assumption that particles must be identifiable on serial sections or confocal planes through the material.  In recent years, these methods have been developed and applied mainly in a biomedical context:  this paper reviews and illustrates them with the aid of a metallographic example, namely the pore population of a sand-cast aluminium alloy.  Our goal is to convey the fact that stereology is sampling in three dimensions, and therefore its principles remain valid and applicable in no matter what context.  The disector, the selector, and an indirect method to estimate the distance between two parallel planes of polish are thereby illustrated.  It is also shown how to split the error variance of the estimator of the pore volume fraction ('porosity') into the three components due to blocks, sections within blocks and systematic point counting on sections.
C1 UNIV BERN,DEPT ANAT,STEREOL UNIT,CH-3000 BERN 9,SWITZERLAND.
RP KARLSSON, LM (reprint author), AVESTA AB,RES & DEV,S-77401 AVESTA,SWEDEN.
CR BADDELEY AJ, 1986, J MICROSC-OXFORD, V142, P259, DOI 10.1111/j.1365-2818.1986.tb04282.x
   Cochran W. G., 1977, SAMPLING TECHNIQUES
   CRUZORIVE LM, 1990, AM J PHYSIOL, V258, pL148
   CRUZORIVE LM, 1987, J MICROSC-OXFORD, V145, P121
   CRUZORIVE LM, 1986, J MICROSC-OXFORD, V143, P47, DOI 10.1111/j.1365-2818.1986.tb02765.x
   CRUZORIVE LM, 1989, J MICROSC-OXFORD, V153, P315, DOI 10.1111/j.1365-2818.1989.tb01480.x
   CRUZORIVE LM, 1980, BIOMETRICS, V36, P595, DOI 10.2307/2556113
   CRUZORIVE LM, 1983, J MICROSC-OXFORD, V131, P265, DOI 10.1111/j.1365-2818.1983.tb04255.x
   CRUZORIVE LM, 1980, J MICROSC-OXFORD, V120, P15
   CRUZORIVE LM, 1982, J MICROSC-OXFORD, V125, P89, DOI 10.1111/j.1365-2818.1982.tb00325.x
   CRUZORIVE LM, 1987, ACTA STEREOL S2, V6, P43
   GUNDERSEN HJG, 1981, J MICROSC-OXFORD, V121, P65, DOI 10.1111/j.1365-2818.1981.tb01199.x
   GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x
   GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x
   GUNDERSEN HJG, 1977, J MICROSC-OXFORD, V111, P219, DOI 10.1111/j.1365-2818.1977.tb00062.x
   GUNDERSEN HJG, 1985, J MICROSC-OXFORD, V138, P127, DOI 10.1111/j.1365-2818.1985.tb02607.x
   GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x
   GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x
   HOWARD V, 1985, J MICROSC-OXFORD, V138, P203, DOI 10.1111/j.1365-2818.1985.tb02613.x
   JENSEN EB, 1987, SCAND J STAT, V14, P161
   JENSEN EB, 1986, BIOMETRICS, V42, P735, DOI 10.2307/2530690
   JENSEN EB, 1985, J APPL PROBAB, V22, P82, DOI 10.2307/3213750
   KARLSSON LM, 1991, AM SOC TEST MATER, V1094, P277, DOI 10.1520/STP17272S
   Matheron G, 1965, VARIABLES REGIONALIS
   Matheron G, 1971, CAHIERS CTR MORPHOLO, V5
   MATTFELDT T, 1990, J MICROSC-OXFORD, V159, P301, DOI 10.1111/j.1365-2818.1990.tb03036.x
   MCCANCE I, 1989, NEWS PHYSIOL SCI, V4, P172
   MICHEL RP, 1988, J MICROSC-OXFORD, V150, P117, DOI 10.1111/j.1365-2818.1988.tb04603.x
   MILES RE, 1977, J MICROSC-OXFORD, V110, P27, DOI 10.1111/j.1365-2818.1977.tb00010.x
   MILES RE, 1976, J MICROSC-OXFORD, V107, P211, DOI 10.1111/j.1365-2818.1976.tb02444.x
   MILES RE, 1978, LECTURE NOTES BIOMAT, V23, P115
   MOSS MC, 1989, J MICROSC-OXFORD, V156, P79, DOI 10.1111/j.1365-2818.1989.tb02907.x
   RUSS JC, 1989, J MICROSC-OXFORD, V155, pRP1
   Saltykov S. A., 1974, STEREOMETRISCHE META
   Silverman BW., 1986, DENSITY ESTIMATION S
   STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x
   Stoyan D, 1987, STOCHASTIC GEOMETRY
   UNDERWOOD EE, 1970, QUANTITATIVE STEREOL
   WEIBEL ER, 1979, STEREOLOGICAL METHOD, V1
   ZHAO HQ, 1991, THESIS U MANCHESTER
NR 40
TC 26
Z9 26
U1 1
U2 5
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL
SN 0022-2720
J9 J MICROSC-OXFORD
JI J. Microsc.-Oxf.
PD MAR
PY 1992
VL 165
BP 391
EP 415
DI 10.1111/j.1365-2818.1992.tb01495.x
PN 3
PG 25
WC Microscopy
SC Microscopy
GA HK455
UT WOS:A1992HK45500005
DA 2018-10-19
ER

PT J
AU EMERY, R
   JEANNETTE, M
   SPRAU, D
AF EMERY, R
   JEANNETTE, M
   SPRAU, D
TI CHARACTERIZATION OF LOW-LEVEL RADIOACTIVE-WASTE GENERATED BY A LARGE
   UNIVERSITY HOSPITAL COMPLEX
SO HEALTH PHYSICS
LA English
DT Article
DE WASTE MANAGEMENT; WASTE, LOW-LEVEL; COMPUTERS; REGULATIONS
ID INCINERATION; MICROSPHERES
AB Descriptions of the physical characteristics and radioactive contents of waste generated by a large university/hospital complex were recorded in a computerized data base for 1 y. The data were summarized to create a waste stream profile so that major waste sources could be identified and minimization efforts quantified. The resultant profile provides a comprehensive description of the low-level radioactive waste produced by a large biomedical research and patient care facility, and projects the methods that will be used to process and ultimately dispose of the material.
RP EMERY, R (reprint author), E CAROLINA UNIV, OFF RADIAT & BIOL SAFETY, GREENVILLE, NC 27834 USA.
CR BREKKE DD, 1985, HEALTH PHYS, V48, P339
   BUSH D, 1973, HEALTH PHYS, V24, P564
   CLASSIC K, 1985, HEALTH PHYS, V49, P1270
   EMERY RJ, 1990, HEALTH PHYS, V59, P911, DOI 10.1097/00004032-199012000-00014
   LANDOLT RR, 1983, HEALTH PHYS, V44, P671
   MCKETTY MH, 1991, HEALTH PHYS, V60, P453, DOI 10.1097/00004032-199103000-00017
   1989, STANDARDS PROTECT 20
   1989, BIOSAFETY LABORATORY
NR 8
TC 7
Z9 7
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0017-9078
EI 1538-5159
J9 HEALTH PHYS
JI Health Phys.
PD FEB
PY 1992
VL 62
IS 2
BP 183
EP 185
DI 10.1097/00004032-199202000-00009
PG 3
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical
   Imaging
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA HA640
UT WOS:A1992HA64000010
PM 1730561
DA 2018-10-19
ER

PT J
AU DOREMUS, RH
AF DOREMUS, RH
TI BIOCERAMICS
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID X-RAY-DIFFRACTION; DENTAL IMPLANTS; HYDROXY-APATITE; GLASS-CERAMICS;
   HYDROXYLAPATITE; BEHAVIOR; TITANIUM; BIOMATERIALS; INTERFACE; COMPOSITE
AB Ceramics, glasses, and glass-ceramics are increasingly being tested for use in the human body. These materials often have excellent chemical properties for biomedical use, but they are brittle and show fatigue. Careful analysis of their mechanical properties is needed to determine appropriate applications. Hydroxylapatite is emerging as the most promising bioceramic because it shows no foreign body reactions and bonds strongly to bone; if properly made without pores or second phases it has excellent fatigue resistance. Glass-ceramics containing hydroxylapatite crystals also show good promise for many applications. Different forms of these materials, such as dense, granular, mixed granular with plaster of Paris, and coatings on metals are being tested and have very good potential as bioceramics.
RP DOREMUS, RH (reprint author), RENSSELAER POLYTECH INST,DEPT MAT ENGN,TROY,NY 12180, USA.
CR Adair P J, 1984, Int J Periodontics Restorative Dent, V4, P32
   BLACK J, 1989, J BIOMED MATER RES, V23, P1243, DOI 10.1002/jbm.820231102
   BLENCKE BA, 1978, J BIOMED MATER RES, V12, P307, DOI 10.1002/jbm.820120305
   BLOCK MS, 1987, J ORAL MAXIL SURG, V45, P601, DOI 10.1016/0278-2391(87)90270-9
   BRACKETT SE, 1989, BIOMEDICAL MATERIALS, P579
   Bucholz R W, 1987, J Orthop Trauma, V1, P260, DOI 10.1097/00005131-198701030-00013
   BUCHOLZ RW, 1989, CLIN ORTHOP RELAT R, V240, P53
   BURKE JE, 1971, CERAMICS SEVERE ENV, P435
   CARNEVALE RA, 1989, BIOMEDICAL MATERIALS, P257
   CHARLES RJ, 1958, J APPL PHYS, V29, P1657, DOI 10.1063/1.1723019
   COOK SD, 1988, CLIN ORTHOP RELAT R, V230, P303
   DALGLEISH BJ, 1981, J BIOMED MATER RES, V15, P527, DOI 10.1002/jbm.820150408
   DAMIEN CJ, 1990, J BIOMED MATER RES, V24, P639, DOI 10.1002/jbm.820240602
   de Groot K, 1989, J Biomed Mater Res, V23, P1367, DOI 10.1002/jbm.820231112
   de Groot K, 1983, BIOCERAMICS CALCIUM
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   DEGROOT K, 1983, BIOCERAMICS CALCIUM, P115
   DELANGE GL, 1990, J BIOMED MATER RES, V24, P829, DOI 10.1002/jbm.820240704
   DELANGE GL, 1989, J DENT RES, V68, P509, DOI 10.1177/00220345890680031601
   DELISLE MP, 1984, UNPUB
   DEWITH G, 1981, J MATER SCI, V16, P1592
   DEWITH G, 1989, J MATER SCI, V24, P3411, DOI 10.1007/BF01139073
   Doremus R., 1973, GLASS SCI, P237
   Doremus R. H., 1982, TREATISE MATERIALS S, V22, P169
   DOREMUS RH, 1980, ENG FRACT MECH, V13, P945, DOI 10.1016/0013-7944(80)90024-7
   DOREMUS RH, 1983, J APPL PHYS, V54, P193, DOI 10.1063/1.331731
   DOREMUS RH, 1984, METAL CERAMIC BIOMAT, V1, P107
   DOREMUS RH, 1984, METAL CERAMIC BIOMAT, V2
   DOREMUS RH, 1985, STRENGTH INORGANIC G, P231
   Douglas R. W., 1972, HIST GLASSMAKING
   DUCHEYNE P, 1988, J BIOMED MATER RES, V22, P1137, DOI 10.1002/jbm.820221207
   Ducheyne P., 1984, METAL CERAMIC BIOMAT, VII
   DUCHEYNE P, 1984, METAL CERAMIC BIOMAT, V1
   DUCHEYNE P, 1988, ANN NEW YORK ACADEMY, V523
   ELDEEB M, 1988, J ORAL MAXIL SURG, V46, P33
   ELDEEB M, 1988, J ORAL MAXIL SURG, V46, P758
   EPSTEIN N, 1989, SMITHSONIAN      DEC, P98
   GROSSMAN DG, 1985, DENT CLIN N AM, V29, P725
   HABAL MB, 1989, BIOMEDICAL MATERIALS, P205
   HANGST K, 1989, BIOMEDICAL MATERIALS, P269
   HANKER JS, 1988, SCIENCE, V242, P885, DOI 10.1126/science.3055300
   HANKER JS, 1989, BIOMEDICAL MATERIALS
   HAYASHI K, 1989, J BIOMED MATER RES, V23, P1247, DOI 10.1002/jbm.820231103
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HOBO S, 1985, QUINTESSENCE INT, V16, P451
   HOBO S, 1985, QUINTESSENCE INT, V16, P135
   Hobo S., 1985, QUINTESSENCE INT, V16, P207
   HOBO S, 1985, QUINTESSENCE INT, V16, P509
   HOLMES RE, 1986, J BONE JOINT SURG AM, V68A, P904, DOI 10.2106/00004623-198668060-00013
   Hulbert SF, 1971, CERAMICS SEVERE ENV, P417
   Inglis C. E, 1913, T I NAVAL ARCHITEC 1, V55, P219
   JARCHO M, 1979, J MATER SCI, V14, P142, DOI 10.1007/BF01028337
   JARCHO M, 1976, J MATER SCI, V11, P2027, DOI 10.1007/BF02403350
   JARCHO M, 1977, J BIOENG, V1, P79
   KABUTANI Y, 1989, J BIOMED MATER RES, V23, P781
   KAY JF, 1977, THESIS RENSSELAER PO
   KITSAGO T, 1990, J BIOMED MATER RES, V24, P331
   KITSUGI T, 1986, J BIOMED MATER RES, V20, P1295, DOI 10.1002/jbm.820200906
   KITSUGI T, 1990, J BIOMED MATER RES, V24, P259, DOI 10.1002/jbm.820240211
   KLEIN CPAT, 1987, BIOMATERIALS, V8, P308
   KOCH B, 1990, J BIOMED MATER RES, V24, P655, DOI 10.1002/jbm.820240603
   KUKUBO T, 1985, J MATER SCI, V20, P2001
   KUKUBO T, 1982, YOGYO-KYOKAI-SHI, V90, P151
   KUKUBO T, 1987, J BIOMED MATER RES, V22, P4067
   KUKUBOI T, 1983, GLASTECH BER, V56, P695
   MALAMENT KA, 1987, J PROSTHET DENT, V57, P674, DOI 10.1016/0022-3913(87)90362-3
   MCLEAN JW, 1987, QUINTESSENCE INT, V18, P97
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   Richerson DW, 1982, MODERN CERAMIC ENG
   RITCHIE RO, 1990, J BIOMED MATER RES, V24, P189, DOI 10.1002/jbm.820240206
   RIVERO DP, 1988, J BIOMED MATER RES, V22, P191, DOI 10.1002/jbm.820220304
   SCHEPERS E, 1977, THESIS U FLORIDA GAI, P178
   TERRY BC, 1989, BIOMEDICAL MATERIALS, P187
   THOMAS KA, 1987, J BIOMED MATER RES, V21, P1395, DOI 10.1002/jbm.820211205
   THOMAS KA, 1989, J BIOMED MATER RES, V23, P1369
   THOMAS MB, 1980, J MATER SCI, V16, P891
   THOMAS MB, 1983, AM CERAM SOC B, V60, P258
   Tooley F. V., 1974, HDB GLASS MANUFACTUR
   TRACY BM, 1984, J BIOMED MATER RES, V18, P719, DOI 10.1002/jbm.820180702
   URATSIYI M, 1989, BIOMEDICAL MATERIALS, P199
   VANBLITTERSWIJK CA, 1990, J BIOMED MATER RES, V24, P433, DOI 10.1002/jbm.820240403
   WALKER MM, 1984, THESIS RENSSELAER PO
   WITTKAMPF ARM, 1988, J ORAL MAXIL SURG, V46, P1019, DOI 10.1016/0278-2391(88)90344-8
   ZIDE MF, 1987, J ORAL MAXIL SURG, V45, P481, DOI 10.1016/S0278-2391(87)80006-X
   1978, ENCY CHEM TECHNOLOGY, V4, P556
NR 85
TC 160
Z9 169
U1 1
U2 23
PU CHAPMAN HALL LTD
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD JAN 15
PY 1992
VL 27
IS 2
BP 285
EP 297
DI 10.1007/BF00543915
PG 13
WC Materials Science, Multidisciplinary
SC Materials Science
GA HB978
UT WOS:A1992HB97800001
DA 2018-10-19
ER

PT J
AU DESAI, NP
   HUBBELL, JA
AF DESAI, NP
   HUBBELL, JA
TI SURFACE PHYSICAL INTERPENETRATING NETWORKS OF
   POLY(ETHYLENE-TEREPHTHALATE) AND POLY(ETHYLENE OXIDE) WITH BIOMEDICAL
   APPLICATIONS
SO MACROMOLECULES
LA English
DT Article
ID SLOW SPINODAL DECOMPOSITION; BINARY-LIQUID MIXTURES; POLY(METHYL
   METHACRYLATE); POLYMER NETWORKS; MOLECULAR-WEIGHT; BLENDS; MISCIBILITY;
   HYDROGEL; CHAINS
AB Poly(ethylene terephthalate) (PET) films were modified by diffusing poly(ethylene oxide) (PEO) into the surface of the PET, which was swollen in a mutual solvent.  Subsequent rapid deswelling in a nonsolvent for PET resulted in the stable entrapment of the PEO within the surface of the PET.  The PET/PEO systems produced by this technique were phase-mixed nonequilibrium surface structures, kinetically stable below the T(g) for PET.  The surface-localized structure is referred to as a surface physical interpenetrating network (SPIN), due to the similarity of the forming technique to that for a sequential interpenetrating polymer network.  Analyses of these materials by X-ray photoelectron spectroscopy (XPS) and NMR spectroscopy revealed PEO incoroporation as high as 23 mol % or 6.4 wt %, with a preferential localization of the PEO near the surface of the PET film.  Differential scanning calorimetry (DSC) indicated a phase-mixed structure, despite the thermodynamic incompatibility of PEO and PET, which could be induced to phase separate upon heating above the PET T(g).  These materials were stable at 37-degrees-C for several months in an aqueous environment, but PEO leaching occurred upon incubation in water at temperatures near the PET T(g) as well as upon swelling the PET with organic solvents at room temperature.  These materials have been previously shown by us to be extraordinarily resistant to cellular adhesion.
C1 UNIV TEXAS,DEPT CHEM ENGN,AUSTIN,TX 78712.
RI Hubbell, Jeffrey/A-9266-2008
OI Hubbell, Jeffrey/0000-0003-0276-5456
CR BRINKMAN E, 1990, BIOMATERIALS, V11, P200, DOI 10.1016/0142-9612(90)90156-K
   CHISATO N, 1989, T AM SOC ART INT ORG, V35, P357
   Desai N. P., 1990, POLYM MAT SCI ENG, V62, P731
   DESAI NP, 1991, BIOMATERIALS, V12, P144, DOI 10.1016/0142-9612(91)90193-E
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   DESAI NP, IN PRESS BIOMATERIAL
   Fox T.G., 1956, B AM PHYS SOC, V1, P123
   GASHGARI MA, 1988, MACROMOLECULES, V21, P2782, DOI 10.1021/ma00187a024
   GOMBOTZ WR, 1989, J APPL POLYM SCI, V37, P91, DOI 10.1002/app.1989.070370108
   GRAINGER DW, 1989, J BIOMED MATER RES, V23, P979, DOI 10.1002/jbm.820230903
   Grulke E.A., 1989, POLYM HDB, pVII/519
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   HUNTER SK, 1983, T AM SOC ART INT ORG, V29, P250
   ICHIHARA S, 1971, POLYM J, V2, P640, DOI 10.1295/polymj.2.640
   IZUMITANI T, 1985, J CHEM PHYS, V83, P3694, DOI 10.1063/1.449124
   LAWTON EL, 1989, POLYM HDB, P101
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   MAECHLINGSTRASSER C, 1989, J BIOMED MATER RES, V23, P1385, DOI 10.1002/jbm.820231202
   MARCO C, 1990, MACROMOLECULES, V23, P2183, DOI 10.1021/ma00210a011
   MARUTA J, 1988, POLYMER, V29, P2056, DOI 10.1016/0032-3861(88)90180-2
   MERRILL EW, 1982, T AM SOC ART INT ORG, V28, P482
   MORI Y, 1982, T AM SOC ART INT ORG, V28, P459
   MUKAE K, 1990, POLYM J, V22, P250, DOI 10.1295/polymj.22.250
   NAGAOKA S, 1990, BIOMATERIALS, V11, P119, DOI 10.1016/0142-9612(90)90126-B
   NISHIMOTO M, 1991, POLYMER, V32, P272, DOI 10.1016/0032-3861(91)90013-9
   PFENNIG JLG, 1986, J APPL POLYM SCI, V32, P3657, DOI 10.1002/app.1986.070320221
   SEFTON MV, 1990, P ACS DIV POLYM MATE, V62, P741
   SHULTZ AR, 1980, MACROMOLECULES, V13, P663, DOI 10.1021/ma60075a034
   SHULTZ AR, 1976, J APPL POLYM SCI PS, V54, P341
   Sperling L.H., 1981, INTERPENETRATING POL
   SUNG C, 1990, POLYMER, V31, P556, DOI 10.1016/0032-3861(90)90402-K
   TAKENAKA M, 1987, MACROMOLECULES, V20, P2257, DOI 10.1021/ma00175a034
   TORNALA P, 1979, EUR POLYM J, V10, P519
NR 33
TC 119
Z9 121
U1 0
U2 18
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD JAN 6
PY 1992
VL 25
IS 1
BP 226
EP 232
DI 10.1021/ma00027a038
PG 7
WC Polymer Science
SC Polymer Science
GA GZ539
UT WOS:A1992GZ53900038
DA 2018-10-19
ER

PT J
AU PACE, SJ
   HAMERSLAG, JD
AF PACE, SJ
   HAMERSLAG, JD
TI THICK-FILM MULTILAYER ION SENSORS FOR BIOMEDICAL APPLICATIONS
SO ACS SYMPOSIUM SERIES
LA English
DT Review
ID SELECTIVE MEMBRANE ELECTRODE; CARBONATE ION
AB Planar format thick film ion sensors have been designed for biomedical applications. The multilayer sensor structure consists of layers sequentially deposited on a ceramic substrate using a screen printing process. All layers are of solid composition with the uppermost chemically active layer consisting of polyvinyl chloride (PVC). Because no aqueous layers are used in the construction, the resulting devices are stable and robust. The PVC layer serves as a common membrane vehicle for a multitude of ion specific ligands that may be patterned on a substrate. This paper describes the chemical and electrochemical principles of design, construction and measurement of ion sensing devices for blood electrolytes; K+, Na+, Cl-, HCO3-, pH and the potential for many other clinically significant tests. The more pragmatic issues of packaging design and materials of construction are treated in the context of device performance (i.e., analytical efficacy, reliability and stability) for the biological application intended.
RP PACE, SJ (reprint author), DUPONT CO, MED PROD, GLASGOW SITE, BOX 509, POB 6101, NEWARK, DE 19714 USA.
CR AMMANN D, 1981, ANAL CHEM, V53, P2267, DOI 10.1021/ac00237a031
   COETZEE CJ, 1969, ANAL CHEM, V41, P1128, DOI 10.1021/ac60277a017
   COETZEE CJ, 1968, ANAL CHEM, V40, P2071, DOI 10.1021/ac60269a036
   HAMBLEN DP, 1977, Patent No. 4053381
   HERMAN HB, 1975, ANAL CHIM ACTA, V76, P155, DOI 10.1016/S0003-2670(01)81997-8
   HERMAN HB, 1974, SCIENCE, V184, P1074, DOI 10.1126/science.184.4141.1074
   KEDEM O, 1970, Patent No. 2027128
   PACE SJ, 1985, 3RD P INT C SOL STAT
   PACE SJ, 1986, 2ND P INT M CHEM SEN
   PACE SJ, 1980, CHEM SENSITIVE ELECT
   PACE SJ, 1985, MED INSTRUM, V40, P168
   PIODA LAR, 1969, ANAL LETT, V2, P665, DOI 10.1080/00032716908051343
   SHULTHESS P, 1981, ANAL CHIM ACTA, P131
   SIMON W, 1989, Patent No. 479870
   TOHDA K, 1990, ANAL SCI, V6, P227, DOI 10.2116/analsci.6.227
NR 15
TC 1
Z9 1
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0097-6156
J9 ACS SYM SER
JI ACS Symp. Ser.
PY 1992
VL 487
BP 261
EP 273
PG 13
WC Chemistry, Multidisciplinary
SC Chemistry
GA HX624
UT WOS:A1992HX62400022
DA 2018-10-19
ER

PT J
AU LIM, CK
AF LIM, CK
TI POROUS GRAPHITIC CARBON IN BIOMEDICAL APPLICATIONS
SO ADVANCES IN CHROMATOGRAPHY
LA English
DT Review
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; PACKING MATERIAL; SEPARATION;
   ADSORBENT; RETENTION; COLUMNS; BLACK; PHASE
RP LIM, CK (reprint author), CLIN RES CTR,DIV CLIN CELL BIOL,HARROW HA1 3UJ,MIDDX,ENGLAND.
CR BASSLER BJ, 1989, J CHROMATOGR SCI, V27, P162, DOI 10.1093/chromsci/27.4.162
   BASSLER BJ, 1989, J CHROMATOGR, V461, P139, DOI 10.1016/S0021-9673(00)94283-3
   BERRIDGE JC, 1988, J CHROMATOGR, V449, P317
   CABRERA K, 1990, INT LAB, V20, P28
   CHIANTORE O, 1988, ANAL CHEM, V60, P638, DOI 10.1021/ac00158a007
   CICCIOLI P, 1981, J CHROMATOGR, V206, P35, DOI 10.1016/S0021-9673(00)82603-5
   COLIN H, 1976, J CHROMATOGR, V126, P43, DOI 10.1016/S0021-9673(01)84062-0
   COLIN H, 1976, J CHROMATOGR, V119, P41, DOI 10.1016/S0021-9673(00)86769-2
   COLIN H, 1976, J CHROMATOGR, V122, P233
   DOLPHIN J, 1989, LAB PRACT, V38, P71
   EMERY MF, 1989, J CHROMATOGR, V479, P212, DOI 10.1016/S0021-9673(01)83336-7
   FELL AF, 1988, J CHROMATOGR-BIOMED, V434, P377, DOI 10.1016/S0378-4347(88)80004-5
   GILBERT MT, 1982, CHROMATOGRAPHIA, V16, P138, DOI 10.1007/BF02258884
   GU GH, 1990, J CHROMATOGR, V515, P183, DOI 10.1016/S0021-9673(01)89312-2
   KALISZAN R, 1990, J CHROMATOGR, V499, P333, DOI 10.1016/S0021-9673(00)96983-8
   Kaur B., 1990, LC GC, V3, P41
   KNOX JH, 1986, J CHROMATOGR, V352, P3, DOI 10.1016/S0021-9673(01)83368-9
   KNOX JH, 1983, J LIQ CHROMATOGR, V6, P1, DOI 10.1080/01483918308067647
   KNOX JH, 1989, HIGH PERFORMANCE LIQ, P189
   LIM CK, 1989, BIOMED CHROMATOGR, V3, P92, DOI 10.1002/bmc.1130030212
   MAMA JE, 1989, ANAL P, V26, P7
   PATZELOVA V, 1978, J CHROMATOGR, V148, P53, DOI 10.1016/S0021-9673(00)99321-X
   PLZAK Z, 1978, J CHROMATOGR, V147, P137, DOI 10.1016/S0021-9673(00)85125-0
   SMITH NW, HPLC 88 WASHINGTON
   UNGER K, 1980, J CHROMATOGR, V202, P3, DOI 10.1016/S0021-9673(00)80071-0
   WARD TJ, 1988, CHROMATOGRAPHIC SCI, V40, P131
   ZWIER TA, 1981, ANAL CHEM, V53, P812, DOI 10.1021/ac00229a017
NR 27
TC 19
Z9 19
U1 1
U2 8
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016
SN 0065-2415
J9 ADV CHROMATOGR
JI Adv. Chromatogr.
PY 1992
VL 32
BP 1
EP 19
PG 19
WC Chemistry, Analytical
SC Chemistry
GA HF542
UT WOS:A1992HF54200001
PM 1727327
DA 2018-10-19
ER

PT J
AU BEARD, RB
   HUNG, BN
   SCHMUKLER, R
AF BEARD, RB
   HUNG, BN
   SCHMUKLER, R
TI BIOCOMPATIBILITY CONSIDERATIONS AT STIMULATING ELECTRODE INTERFACES
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article; Proceedings Paper
CT MINI SYMP ON BIOELECTRODES, AT THE 12TH ANNUAL MEETING OF THE
   ENGINEERING IN MEDICINE AND BIOLOGY SOC OF IEEE
CY NOV, 1990
CL PHILADELPHIA, PA
SP IEEE, ENGN MED & BIOL SOC, IEEE, ELECTROBIOLOGY, PRINCETON APPL RES
DE BIOCOMPATIBILITY; STIMULATING ELECTRODES; INFLAMMATION; PH AND ELECTRODE
   POTENTIAL
AB The choice of biocompatible stimulating electrodes for various biomedical applications varies with the type of electrode-tissue interface, biomolecules present, electrolyte background, preparation of electrode, interfacial potential current density, electrode material porosity, geometry, and inflammatory response. Illustrative examples are given to demonstrate the importance of these parameters. Topics discussed are: A) DC electrodes applied to partially keratinized epithelial membranes: B) Variation of the electrical impedance and biocompatibility of stimulating electrodes with electrode potential and surrounding pH; C) Influence of electrode geometry, porosity and pore size on biocompatibility: D) Body defense mechanisms at the sites of implantable stimulating electrodes; E) Thrombus formation at stimulating electrode interfaces and F) Sterilization of electrodes to ensure biocompatibility.
C1 US FDA,CTR DEVICES & RADIOL HLTH,ROCKVILLE,MD 20857.
   CHUNG YUAN CHRISTIAN UNIV,CHUNGLI,TAIWAN.
RP BEARD, RB (reprint author), DREXEL UNIV,INST BIOMED ENGN & SCI,PHILADELPHIA,PA 19104, USA.
CR ANDRADE JD, 1985, SURFACE INTERFACIAL, V2
   Bard A. J., 1980, ELECTROCHEMICAL METH
   BATES JB, 1992, ANN BIOMED ENG, V20, P349, DOI 10.1007/BF02368536
   BERNARDE MA, 1970, DISINFECTION
   BROWNSTEIN M, 1979, THESIS DREXEL U PHIL
   BROWNSTEIN M, 1978, THESIS DREXEL U PHIL
   BUCK RP, 1992, ANN BIOMED ENG, V20, P363, DOI 10.1007/BF02368537
   De Levie R., 1965, Electrochimica Acta, V10, P113, DOI 10.1016/0013-4686(65)87012-8
   DELEVIE R, 1992, ANN BIOMED ENG, V20, P337, DOI 10.1007/BF02368535
   DELLAVECCHIA MA, 1984, THESIS DREXEL U PHIL
   DEROSA J, 1973, COMMUNICATION
   DEROSA JF, 1977, IEEE T BIO-MED ENG, V24, P260, DOI 10.1109/TBME.1977.326211
   DYMOND AM, 1976, IEEE T BME, V23
   FENG D, 1991, THESIS DREXEL U PHIL
   GEDDES LA, 1989, PRINCIPLES APPLIED B
   GOULD MR, 1982, THESIS DREXEL U PHIL
   GREENE ND, 1973, CORROSION, V29
   Ham A.W., 1965, HISTOLOGY
   HENCH LL, 1975, ADV BIOMEDICAL ENG, V5
   HIRSHORN MS, 1981, PACE, V4, P380, DOI 10.1111/j.1540-8159.1981.tb03716.x
   Hoare J. P., 1968, ELECTROCHEMISTRY OXY
   Hoare JP, 1967, ADV ELECTROCHEMISTRY, V6
   HUANG MY, 1977, THESIS U PENNSYLVANI
   HULBERT SF, 1972, J BIOMED MATER RES, V6, P347, DOI 10.1002/jbm.820060505
   HUNG BN, 1979, ELECTRICAL PROPERTIE, P249
   HUNG BN, 1979, THESIS DREXEL U PHIL
   HUNG BN, 1975, THESIS DREXEL U PHIL
   LAWRENCE CA, 1968, DISINFECTION STERILI
   LEITES SS, 1973, ELEKTROKHIMIYA, V9, P620
   MALE, 1988, ADV IMMUNOLOGY
   MARGULIES N, 1986, THESIS DREXEL U PHIL
   MCADAMS ET, ANN BIOMED ENG, V20, P307
   MCCREERY DB, 1987, IEEE T BIO-MED ENG, V34, P664, DOI 10.1109/TBME.1987.325990
   MOUSSAURI M, 1991, COMMUNICATION
   MUND M, 1979, SIEMENS FORSCH U ENT, V8, P3
   Neuman M. R., 1978, MED INSTRUMENTATION
   ONARAL B, 1982, MED BIOL ENG COMPUT, V20, P299, DOI 10.1007/BF02442796
   ONARAL B, 1978, THESIS U PENNSYLVANI
   PLONSEY R, 1988, BIOELECTRICITY QUANT
   Pourbaix M., 1974, ATLAS ELECTROCHEMICA
   RANDLES JEB, 1947, DISCUSS FARADAY SOC, V1, P11, DOI 10.1039/df9470100011
   REINMUTH WH, 1962, ANAL CHEM, V34, P1446, DOI 10.1021/ac60191a030
   Richard BB, 1989, US Patent, Patent No. 4854865
   SAWYER PN, 1974, J ELECTROCHEM SOC C, V221
   SCHMUKLER RE, 1976, THESIS DREXEL U PHIL
   SCHWAN HP, 1963, PHYSICAL TECHNIQUE B, V6
   SCOLES KT, 1989, ISHM 89 P
   SIMPSON RW, 1976, THESIS U PENNSYLVANI
   SLUYTERS JH, 1960, RECL TRAV CHIM PAY B, V29, P1092
   STURM LJ, 1974, THESIS DREXEL U PHIL
   SUN HH, 1983, T BIOMED ENG, V30
   TUNIMER B, 1968, J ELECTROANAL CHEM, V18, P93
   WILKINSON PG, 1974, NATURE, V252, P58
NR 53
TC 22
Z9 23
U1 1
U2 8
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PY 1992
VL 20
IS 3
BP 395
EP 410
DI 10.1007/BF02368539
PG 16
WC Engineering, Biomedical
SC Engineering
GA JB791
UT WOS:A1992JB79100011
PM 1443832
DA 2018-10-19
ER

PT B
AU SALITO, A
   BARBEZAT, G
   FILMER, H
   HOCHSTRASSER, J
   NICOLL, AR
   TROTTA, F
AF SALITO, A
   BARBEZAT, G
   FILMER, H
   HOCHSTRASSER, J
   NICOLL, AR
   TROTTA, F
BE RAVAGLIOLI, A
   KRAJEWSKI, A
TI PLASMA SPRAY SYSTEMS FOR THE DEPOSITION OF MATERIALS FOR BIOMEDICAL
   APPLICATIONS
SO BIOCERAMICS AND THE HUMAN BODY
LA English
DT Proceedings Paper
CT INTERNATIONAL CONGRESS ON BIOCERAMICS AND THE HUMAN BODY
CY APR 02-05, 1991
CL FAENZA, ITALY
SP CNR
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER APPL SCI PUBL LTD
PI BARKING ESSEX
PA BARKING ESSEX
BN 1-85166-748-2
PY 1992
BP 156
EP 165
PG 10
WC Engineering, Biomedical; Materials Science, Ceramics
SC Engineering; Materials Science
GA BW91A
UT WOS:A1992BW91A00020
DA 2018-10-19
ER

PT B
AU VALLANA, F
   ARRU, P
   SANTI, M
AF VALLANA, F
   ARRU, P
   SANTI, M
BE RAVAGLIOLI, A
   KRAJEWSKI, A
TI BULK AND THIN-FILM CARBON MATERIALS FOR BIOMEDICAL APPLICATIONS -
   QUALITY-CONTROL CRITERIA AND PROCEDURES
SO BIOCERAMICS AND THE HUMAN BODY
LA English
DT Proceedings Paper
CT INTERNATIONAL CONGRESS ON BIOCERAMICS AND THE HUMAN BODY
CY APR 02-05, 1991
CL FAENZA, ITALY
SP CNR
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER APPL SCI PUBL LTD
PI BARKING ESSEX
PA BARKING ESSEX
BN 1-85166-748-2
PY 1992
BP 461
EP 470
PG 10
WC Engineering, Biomedical; Materials Science, Ceramics
SC Engineering; Materials Science
GA BW91A
UT WOS:A1992BW91A00064
DA 2018-10-19
ER

PT J
AU CLAROTTI, G
   SCHUE, F
   SLEDZ, J
   BENAOUMAR, AA
   GECKELER, KE
   ORSETTI, A
   PALEIRAC, G
AF CLAROTTI, G
   SCHUE, F
   SLEDZ, J
   BENAOUMAR, AA
   GECKELER, KE
   ORSETTI, A
   PALEIRAC, G
TI MODIFICATION OF THE BIOCOMPATIBLE AND HAEMOCOMPATIBLE PROPERTIES OF
   POLYMER SUBSTRATES BY PLASMA-DEPOSITED FLUOROCARBON COATINGS
SO BIOMATERIALS
LA English
DT Article
DE PLASMA COATING; SURFACE TREATMENT; SURFACE CHARACTERIZATION
ID SURFACES; FILMS
AB The polymerization of gases present in a low temperature plasma is a technique particularly well suited for biomedical material processing. Therefore, the possibilities this technique offers to increase the biocompatibility and haemocompatibility of polysulphone and poly(hydroxybutyrate) membranes to be used in a new bioartificial pancreas device were studied. The deposition of thin fluorocarbon coatings from an argon plasma containing perfluorohexane gave very smooth and hydrophobic surfaces without affecting the filtering properties of the treated membranes. Adding hydrogen increased the reaction yield, but gave rougher and less hydrophobic coatings. We characterized the biological properties of the treated surfaces and discussed the influence of the modified surface properties on the biological behaviour of the treated polymers. The good biocompatibility of the deposited coatings was established by following in vitro the insulin secretion of Langerhans islets cultured on the treated membranes and by examining the fibrous capsule that developed on plasma-treated polymer disks after three months of in vivo incubation in the peritoneum of Wistar rats. Rough and haemocompatible films of poly(hydroxybutyrate) and smoother, but more thrombogenic, polysulphone films were treated by perfluorohexane and perfluorohexane + H-2 plasmas to study the relative influence of surface roughness and surface energy on polymer thrombogenicity. In vitro protein adsorption and total blood clotting tests proved that the surface roughness influences the thrombogenicity more than the other surface properties. This study seems to show that the plasma deposition of smooth and hydrophobic fluorocarbon coatings can increase the biocompatibility and reduce the surface thrombogenicity of the treated membranes without affecting their filtering properties.
C1 CHR LAPEYRONIE,EXPLORAT HORMONES LAB,MONTPELLIER,FRANCE.
   CTR TRANSFUS SANGUINE,HEMOSTASE LAB,MONTPELLIER,FRANCE.
   UNIV TUBINGEN,INST ORGAN CHEM,W-7400 TUBINGEN 1,GERMANY.
RP CLAROTTI, G (reprint author), UNIV MONTPELLIER 2,CHIM MACROMOLEC LAB,PL E BATAILLON,F-34095 MONTPELLIER 2,FRANCE.
CR ABSOLOM DR, 1987, J BIOMED MATER RES, V21, P161, DOI 10.1002/jbm.820210202
   Andrade JD, 1986, ADV POLYM SCI, V79, P3
   AOUMAR AAB, 1989, C INSERM, V177, P208
   AOUMAR AAB, 1989, THESIS U MONTPELLIER
   BRUCK SD, 1980, PROPERTIES BIOMATERI
   CHAWLA AS, 1986, POLYM BIOMATERIALS, P231
   CHICK WL, 1977, SCIENCE, V197, P780, DOI 10.1126/science.407649
   CLAROTTI G, 1991, MAKROMOL CHEM, V192, P2581
   DAWIDS S, 1986, BLOOD COMPATIBLE MAT
   GIRIFALCO J, 1957, PHYS CHEM, V16, P417
   HOFFMAN AS, 1984, ADV POLYM SCI, V57, P141
   HOFFMANN AS, 1987, CRIT REV BIOCOMPAT, V4, P1
   IKADA Y, 1984, ADV POLYM SCI, V57, P104
   MATSUDA T, 1984, T AM SOC ART INT ORG, V30, P353
   NICHOLS MF, 1979, J BIOMED MATER RES, V13, P299, DOI 10.1002/jbm.820130210
   ORSETTI A, 1986, J EUR SOC ARTIF O S2, V4, P374
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   SCHUE F, 1988, POLYM MED, V3, P136
   VROMAN L, 1977, ANN NY ACAD SCI, V283
   YASUDA H, 1981, MACROMOL REV, V16, P199
   YASUDA H, 1982, BIOMATERIALS, V3, P68, DOI 10.1016/0142-9612(82)90036-9
   1978, US PHARMACOPEIA 19
NR 22
TC 45
Z9 45
U1 1
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PY 1992
VL 13
IS 12
BP 832
EP 840
DI 10.1016/0142-9612(92)90176-O
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA JV211
UT WOS:A1992JV21100004
PM 1457676
DA 2018-10-19
ER

PT J
AU SLUTSKII, LI
   SEVASTJANOVA, NA
   OZOLANTA, IL
   KUZMINA, IV
   DOMBROVSKA, LE
AF SLUTSKII, LI
   SEVASTJANOVA, NA
   OZOLANTA, IL
   KUZMINA, IV
   DOMBROVSKA, LE
TI REACTOGENICITY OF BIOMATERIALS AS STUDIED BY BIOCHEMICAL, MORPHOLOGICAL
   AND ULTRASTRUCTURAL TECHNIQUES
SO CELLS AND MATERIALS
LA English
DT Article
DE BIOMATERIALS; IMPLANTS; REACTOGENICITY; CONNECTIVE TISSUE REACTION;
   INFLAMMATION; GRANULOFIBROUS TISSUE; SURGICAL THREADS; METHODS OF STUDY
ID WOUND REPAIR; POLYMER SURFACES; TISSUE REACTION; CARRAGEENIN GRANULOMA;
   BIOMEDICAL POLYMERS; COLLAGEN PRODUCTION; IMPLANT INTERFACE;
   GUINEA-PIGS; FIBRONECTIN; INVITRO
AB Reactogenicity is a characteristic of biocompatible materials that provokes the reparative and proliferative reaction of connective tissues, a compulsory stage of which is inflammation. Thus, reactogenicity studies should include experiments in vivo. A quantitative assessment of reactogenicity can be obtained by subcutaneous implantation of standard olive-shaped specimens covered by the biomaterial under study followed by biochemical, histological and scanning electron microscopical studies of the capsule developing around the implant. Reactogenicity of surgical threads is evaluated by semiquantitative histological analysis of the wound healing process after suture application. Biomaterial reactogenicity can be modified by changing the structure of the surface and its chemical characteristics, and in particular, by applying different biologically active substances including atrane-containing compounds. The reactogenicity indices suggested present the results of the interaction between the biomaterials and the cells.
RP SLUTSKII, LI (reprint author), LATVIAN TRAUMATOL & ORTHOPAED RES INST, 226005 RIGA, LATVIA, USSR.
CR ABSOLOM DR, 1987, J BIOMED MATER RES, V21, P161, DOI 10.1002/jbm.820210202
   AGELLI M, 1986, CLIN EXP RHEUMATOL, V4, P379
   AMUDESWARI S, 1986, J BIOMED MATER RES, V20, P1103, DOI 10.1002/jbm.820200804
   ANDREASSEN TT, 1985, EUR SURG RES, V17, P264, DOI 10.1159/000128477
   ASMAN B, 1988, ARCH ORAL BIOL, V33, P65, DOI 10.1016/0003-9969(88)90097-0
   BAGNALL RD, 1980, BIOMATERIALS, V1, P97, DOI 10.1016/0142-9612(80)90006-X
   BAKKER D, 1988, J BIOMED MATER RES, V22, P423, DOI 10.1002/jbm.820220506
   BARBUL A, 1989, SURGERY, V105, P764
   BARNES D, 1988, METHOD ENZYMOL, V163, P707
   BATEMAN JF, 1986, J BIOL CHEM, V261, P4198
   BEAHAN P, 1982, J BIOMED MATER RES, V16, P827, DOI 10.1002/jbm.820160608
   BELL PB, 1980, BIOMEDICAL RES APPLI, V2, P1
   BERNHARD WF, 1980, J THORAC CARDIOV SUR, V79, P552
   BOBYN JD, 1982, J BIOMED MATER RES, V16, P571, DOI 10.1002/jbm.820160505
   BOYLE E, 1980, BRIT J EXP PATHOL, V61, P351
   BRETCHER MS, 1988, J CELL BIOL, V106, P235, DOI 10.1083/jcb.106.2.235
   BROWDER W, 1988, SURGERY, V104, P224
   BRUIN P, 1990, J BIOMED MATER RES, V24, P217, DOI 10.1002/jbm.820240208
   CAFFEE HH, 1990, ANN PLAS SURG, V24, P197, DOI 10.1097/00000637-199003000-00001
   CHEGINI N, 1988, J BIOMED MATER RES, V22, P71, DOI 10.1002/jbm.820220108
   CHENG CY, 1988, ARCH DERMATOL, V124, P221, DOI 10.1001/archderm.124.2.221
   CHIU TC, 1981, J BIOMED MATER RES, V15, P781, DOI 10.1002/jbm.820150513
   CHRINTZ H, 1989, BRIT J SURG, V76, P204, DOI 10.1002/bjs.1800760232
   CHRISTENSON L, 1989, J BIOMED MATER RES, V23, P705, DOI 10.1002/jbm.820230704
   CLARK AE, 1976, J BIOMED MATER RES, V10, P161, DOI 10.1002/jbm.820100202
   CLARK RAF, 1988, ARCH DERMATOL, V124, P201, DOI 10.1001/archderm.124.2.201
   CLARK RAF, 1985, J AM ACAD DERMATOL, V13, P701, DOI 10.1016/S0190-9622(85)70213-7
   CLERC C, 1990, CLIN CHIM ACTA, V189, P181, DOI 10.1016/0009-8981(90)90090-F
   DANON D, 1989, P NATL ACAD SCI USA, V86, P2018, DOI 10.1073/pnas.86.6.2018
   DATUBOBROWN DD, 1990, BRIT J PLAST SURG, V43, P70, DOI 10.1016/0007-1226(90)90047-4
   DELANGE GL, 1989, BIOMATERIALS, V10, P121, DOI 10.1016/0142-9612(89)90044-6
   DIEGELMANN RF, 1985, FUND APPL TOXICOL, V5, P219, DOI 10.1016/0272-0590(85)90070-3
   DIEGELMANN RF, 1986, J SURG RES, V40, P229, DOI 10.1016/0022-4804(86)90156-3
   DIEGELMANN RF, 1986, CLIN IMMUNOL IMMUNOP, V41, P331, DOI 10.1016/0090-1229(86)90004-8
   DOILLON CJ, 1986, BIOMATERIALS, V7, P3, DOI 10.1016/0142-9612(86)90080-3
   DOILLON CJ, 1985, COLLAGEN REL RES, V5, P481
   ECKERSLEY JRT, 1988, BRIT MED BULL, V44, P423, DOI 10.1093/oxfordjournals.bmb.a072259
   EXBRAYAT P, 1987, BIOMATERIALS, V8, P385, DOI 10.1016/0142-9612(87)90010-X
   FAGA A, 1985, PLAST RECONSTR SURG, V76, P570, DOI 10.1097/00006534-198510000-00016
   FALANGA V, 1988, J AM ACAD DERMATOL, V19, P559, DOI 10.1016/S0190-9622(88)80317-7
   FIGUERAS T, 1986, COLLAGEN REL RES, V6, P379
   FUKASAWA M, 1988, J SURG RES, V45, P460, DOI 10.1016/0022-4804(88)90196-5
   GAY S, 1978, ACTA CHIR SCAND, V144, P205
   GILBERT DL, 1987, J BIOMED MATER RES, V21, P643, DOI 10.1002/jbm.820210509
   GOSLEN JB, 1988, J DERMATOL SURG ONC, V14, P959, DOI 10.1111/j.1524-4725.1988.tb03734.x
   HAYASHI T, 1979, J BIOCHEM-TOKYO, V86, P453, DOI 10.1093/oxfordjournals.jbchem.a132544
   HENSON PM, 1987, J CLIN INVEST, V79, P669, DOI 10.1172/JCI112869
   HORSLEVPETERSEN K, 1988, EUR J CLIN INVEST, V18, P352, DOI 10.1111/j.1365-2362.1988.tb01023.x
   HOUCK JC, 1976, J INVEST DERMATOL, V67, P124, DOI 10.1111/1523-1747.ep12512997
   IGISU K, 1986, THROMB RES, V44, P455, DOI 10.1016/0049-3848(86)90324-5
   ITO G, 1987, J BIOMED MATER RES, V21, P485, DOI 10.1002/jbm.820210408
   JALKANEN M, 1983, CELL BIOL INT REP, V7, P745, DOI 10.1016/0309-1651(83)90202-3
   JAYAKUMARI N, 1989, J BIOMED MATER RES, V23, P1261, DOI 10.1002/jbm.820231104
   KALNBERZS VK, 1983, ADV BIOMATER, V3, P649
   KANZLER MH, 1986, J DERMATOL SURG ONC, V12, P1156, DOI 10.1111/j.1524-4725.1986.tb02099.x
   KAUFMAN T, 1985, ANN PLAS SURG, V14, P420, DOI 10.1097/00000637-198505000-00004
   KELLER F, 1985, Zeitschrift fuer Experimentelle Chirurgie Transplantation und Kuenstliche Organe, V18, P9
   KELLER JC, 1984, J BIOMED MATER RES, V18, P829, DOI 10.1002/jbm.820180713
   KENYON AJ, 1986, AM J VET RES, V47, P96
   Knofler W, 1984, Z Exp Chir Transplant Kunstliche Organe, V17, P316
   KNOX P, 1986, J CELL BIOL, V102, P2318, DOI 10.1083/jcb.102.6.2318
   KOPECEK J, 1983, PROG POLYM SCI, V9, P1
   KOTOURA Y, 1985, ARCH ORTHOP TRAUM SU, V104, P15, DOI 10.1007/BF00449950
   KRAJEWSKI A, 1988, J BIOMED MATER RES, V22, P445, DOI 10.1002/jbm.820220602
   KRIZEK TJ, 1983, BIOMATERIALS RECONST, P9
   KSANDER GA, 1988, ANN PLAS SURG, V20, P215, DOI 10.1097/00000637-198803000-00004
   KSANDER GA, 1981, J SURG RES, V31, P433, DOI 10.1016/0022-4804(81)90083-4
   LANGER RS, 1981, BIOMATERIALS, V2, P201, DOI 10.1016/0142-9612(81)90059-4
   LEAPER DJ, 1986, J ANTIMICROB CHEMOTH, V17, P135, DOI 10.1093/jac/17.2.135
   Lemons J E, 1986, J Arthroplasty, V1, P143, DOI 10.1016/S0883-5403(86)80053-5
   LENTZ AJ, 1985, J BIOMED MATER RES, V19, P1101, DOI 10.1002/jbm.820190919
   LINDNER J, 1983, HAMOSTASEOLOGIE, V1, P8
   LIPATOVA TE, 1979, J POLYM SCI PS, V66, P239
   LIPSKY MH, 1989, J BIOMED MATER RES, V23, P1441, DOI 10.1002/jbm.820231207
   LUNDBERG C, 1983, INFLAMMATORY REACTIO
   LUSTSKII LI, 1982, POLYTRAUMA, P213
   LYDON MJ, 1985, BIOMATERIALS, V6, P396, DOI 10.1016/0142-9612(85)90100-0
   LYNCH SE, 1989, J CLIN INVEST, V84, P640, DOI 10.1172/JCI114210
   MAKISALO SE, 1989, BIOMATERIALS, V10, P105, DOI 10.1016/0142-9612(89)90041-0
   MARCHANT RE, 1984, POLYM BIOMATERIALS, P209
   MARSHALL WR, 1989, ANN PLAS SURG, V23, P401, DOI 10.1097/00000637-198911000-00004
   MARTINEZ IR, 1987, CLIN DERMATOL, V5, P37, DOI 10.1016/0738-081X(87)90026-5
   MATLAGA BF, 1976, J BIOMED MATER RES, V10, P391, DOI 10.1002/jbm.820100308
   MATSUDA T, 1987, J BIOMED MATER RES, V21, P499, DOI 10.1002/jbm.820210409
   MCCAULEY RL, 1990, J SURG RES, V49, P103, DOI 10.1016/0022-4804(90)90118-L
   MCCOY BJ, 1984, PLAST RECONSTR SURG, V73, P924, DOI 10.1097/00006534-198406000-00012
   MENDES DG, 1985, J BONE JOINT SURG BR, V67, P645
   MERKER PC, 1984, FED PROC, V43, P2791
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   MIYAMOTO T, 1989, J BIOMED MATER RES, V23, P125, DOI 10.1002/jbm.820230110
   MUIR IFK, 1990, BRIT J PLAST SURG, V43, P61, DOI 10.1016/0007-1226(90)90046-3
   MURABAYASHI S, 1986, ARTIF ORGANS, V10, P114, DOI 10.1111/j.1525-1594.1986.tb02529.x
   MURRAY DW, 1989, J BONE JOINT SURG BR, V71, P632
   NAGELSCHMIDT M, 1987, J TRAUMA, V27, P1267
   NEUPERT G, 1987, Zeitschrift fuer Experimentelle Chirurgie Transplantation und Kuenstliche Organe, V20, P139
   NIEDNER R, 1986, BRIT J DERMATOL, V115, P41, DOI 10.1111/j.1365-2133.1986.tb02106.x
   PARDO A, 1983, J HISTOCHEM CYTOCHEM, V31, P641, DOI 10.1177/31.5.6302163
   Park JB, 1979, BIOMATERIALS INTRO
   PARRY DAD, 1982, FEBS LETT, V149, P1, DOI 10.1016/0014-5793(82)81060-0
   PASYK KA, 1984, J SURG RES, V36, P125, DOI 10.1016/0022-4804(84)90077-5
   PESSA ME, 1987, J SURG RES, V42, P207, DOI 10.1016/0022-4804(87)90120-X
   PETERSON JM, 1987, SURGERY, V102, P300
   PICHA GJ, 1990, PLAST RECONSTR SURG, V85, P903, DOI 10.1097/00006534-199006000-00011
   PILLIAR RM, 1987, J BIOMED MATER RES-A, V21, P1
   PIZZOFERRATO A, 1985, BIOMATERIALS, V6, P346
   POSTLETHWAIT RW, 1979, ANN SURG, V190, P54, DOI 10.1097/00000658-197907000-00012
   PREISSNER KT, 1988, BLOOD, V71, P1581
   PRICOLO VE, 1990, J SURG RES, V48, P534, DOI 10.1016/0022-4804(90)90226-R
   QUEEN D, 1987, BURNS, V13, P218, DOI 10.1016/0305-4179(87)90170-7
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   REICHELT H, 1988, Zeitschrift fuer Experimentelle Chirurgie Transplantation und Kuenstliche Organe, V21, P71
   REILLY JT, 1988, J CLIN PATHOL, V41, P1269, DOI 10.1136/jcp.41.12.1269
   RIGG BM, 1982, PLAST RECONSTR SURG, V69, P566, DOI 10.1097/00006534-198203000-00043
   SALAMON A, 1980, ACTA CHIR HUNG, V21, P32
   SALTHOUSE TN, 1984, J BIOMED MATER RES, V18, P395, DOI 10.1002/jbm.820180407
   SALTHOUSE TN, 1976, J BIOMED MATER RES, V10, P197, DOI 10.1002/jbm.820100204
   SALTHOUSE TN, 1983, BIOMATERIALS RECONST, P131
   SANZ LE, 1988, OBSTET GYNECOL, V71, P418
   SCHAKENRAAD JM, 1988, BIOMATERIALS, V9, P116, DOI 10.1016/0142-9612(88)90082-8
   SCHAKENRAAD JM, 1987, BIOMATERIALS, V8, P207, DOI 10.1016/0142-9612(87)90065-2
   SCHAKENRAAD JM, 1988, CELL BIOPHYS, V13, P75, DOI 10.1007/BF02797367
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   SCHAKENRAAD JM, 1987, THESIS U GRONINGEN N
   SCHECHTER AB, 1984, ARCH PATHOL, V46, P20
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   SCHREIBER H, 1990, Zeitschrift fuer Experimentelle Chirurgie Transplantation und Kuenstliche Organe, V23, P23
   SCHREUDERS PD, 1988, J BIOMED MATER RES, V22, P121, DOI 10.1002/jbm.820220205
   SCHUBERT R, 1988, Zeitschrift fuer Experimentelle Chirurgie Transplantation und Kuenstliche Organe, V21, P20
   SEITZ TL, 1982, J BIOMED MATER RES, V16, P195, DOI 10.1002/jbm.820160303
   SEVASTJANOVA NA, 1987, BIOMATERIALS, V8, P242, DOI 10.1016/0142-9612(87)90110-4
   SEWELL WR, 1955, SURG GYNECOL OBSTET, V100, P483
   Slutskii L.I., 1969, BIOCH NORMAL PATHOLO
   SLUTSKII LI, 1984, BIOMATERIALS BIOMECH, P367
   SLUTSKII LI, 1981, P LATVIAN ACAD SCI, P94
   STRONG AB, 1987, J BIOMED MATER RES, V21, P1039, DOI 10.1002/jbm.820210810
   TAYLOR D E M, 1986, Journal of the Royal College of Surgeons of Edinburgh, V31, P13
   TAYLOR SR, 1983, J BIOMED MATER RES, V17, P205, DOI 10.1002/jbm.820170202
   THOMAS IT, 1986, BIOMATERIALS, V7, P301, DOI 10.1016/0142-9612(86)90055-4
   VANMULLEM PJ, 1988, J CRANIO MAXILL SURG, V16, P99, DOI 10.1016/S1010-5182(88)80029-5
   VANMULLEM PJ, 1988, ANN PLAS SURG, V21, P576, DOI 10.1097/00000637-198812000-00015
   VANRIJSSEL EJC, 1988, EUR J OBSTET GYN R B, V27, P165, DOI 10.1016/0028-2243(88)90011-1
   VERBURG AD, 1988, ARCH ORTHOP TRAUM SU, V107, P293, DOI 10.1007/BF00451510
   VITALE T D, 1988, Journal of Foot Surgery, V27, P533
   VONBECKER R, 1985, Z EXP CHIR TRANSPLAN, V18, P318
   Voronkov M G, 1979, Top Curr Chem, V84, P77
   WARD PA, 1980, CLIN BIOCHEM, V13, P187, DOI 10.1016/S0009-9120(80)80021-X
   Whalen R L, 1988, ASAIO Trans, V34, P887
   WILDEVUUR CRH, 1987, BIOMATERIALS, V8, P418, DOI 10.1016/0142-9612(87)90076-7
   YAN JYJ, 1989, J BIOMED MATER RES, V23, P171, DOI 10.1002/jbm.820230204
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 150
TC 2
Z9 2
U1 0
U2 1
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666 USA
SN 1051-6794
J9 CELL MATER
JI Cells Mat.
PY 1992
VL 2
IS 2
BP 119
EP 134
PG 16
WC Cell Biology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Cell Biology; Research & Experimental Medicine; Materials Science
GA JU596
UT WOS:A1992JU59600004
DA 2018-10-19
ER

PT J
AU CUPERUS, PL
   VANDERMEI, HC
   REID, G
   BRUCE, AW
   KHOURY, AE
   ROUXHET, PG
   BUSSCHER, HJ
AF CUPERUS, PL
   VANDERMEI, HC
   REID, G
   BRUCE, AW
   KHOURY, AE
   ROUXHET, PG
   BUSSCHER, HJ
TI THE EFFECT OF SERIAL PASSAGING OF LACTOBACILLI IN LIQUID-MEDIUM ON THEIR
   PHYSICOCHEMICAL AND STRUCTURAL SURFACE CHARACTERISTICS
SO CELLS AND MATERIALS
LA English
DT Article
DE LACTOBACILLI; SERIAL PASSAGING; ZETA-POTENTIAL; CONTACT ANGLE;
   HYDROPHOBICITY; XPS; FTIR; SURFACE COMPOSITION; RR-STAINING LAYER
ID BACTERIA
AB The aim of this study was to examine the effect of serial passaging in liquid medium on physico-chemical and structural surface characteristics of two lactobacillus strains. To this end, starting cultures (p = 1) of uro-genital isolate L. acidophilus RC14 and poultry isolate L. fermentum B54 were serially passaged in liquid medium up to 20 times (p = 20).  In both strains, similar physico-chemical and structural changes were observed following serial passaging. According to water contact angle measurements, cells in p = 20 cultures became less hydrophobic. Microelectrophoresis showed that isoelectric points shifted towards the acidic region upon serial passaging. In addition, the strains had become heterogeneous with respect to the pH dependence of their zeta potentials. According to FTIR and XPS, the surfaces of p = 20 cultures of both strains showed decreasing amounts of proteinaceous material and increasing amounts of polysaccharide-like substances as compared to p = 1 cultures. Heterogeneity of p = 20 strains was also reflected in structural features of the cell surface at the electron microscopic level. In p = 1 cultures of both strains, all cells had a stained layer: in contrast, in p = 20 cultures about half of the cells became devoid of this layer. The study clearly showed that surface characteristics of lactobacilli may change following serial passaging in liquid medium.  Knowledge of these changes is of importance because these microorganisms are considered for use in biomedical applications like the restoration of a healthy vaginal microflora by cell seeding.
C1 UNIV GRONINGEN,MAT TECHN LAB,ANTONIUS DEUSINGLAAN 1,9713 AV GRONINGEN,NETHERLANDS.
   UNIV WESTERN ONTARIO,DEPT MICROBIOL & IMMUNOL,LONDON N6A 5B8,ON,CANADA.
   UNIV TORONTO,DEPT SURG,DIV UROL,TORONTO M5G 1X8,ON,CANADA.
   UNIV CATHOLIQUE LOUVAIN,FAC SCI AGRON,B-1348 LOUVAIN,BELGIUM.
CR CUPERUS PL, 1993, IN PRESS J COLL INTE
   EISEN A, 1989, MICROBIAL ECOL, V17, P17, DOI 10.1007/BF02025590
   Hiemenz P.C, 1977, PRINCIPLES COLLOID S, P452
   KUNIN CM, 1966, NEW ENGL J MED, V274, P1155, DOI 10.1056/NEJM196605262742101
   MARDH PA, 1991, AM J OBSTET GYNECOL, V165, P1163, DOI 10.1016/S0002-9378(12)90721-8
   NAGY E, 1991, APMIS, V99, P739, DOI 10.1111/j.1699-0463.1991.tb01253.x
   NOORDMANS J, 1993, IN PRESS J COLL INTE
   REID G, 1990, CLIN MICROBIOL REV, V3, P335
   REID G, 1992, APPL ENVIRON MICROB, V58, P1549
   VANDERMEI HC, 1988, COLLOID SURFACE, V32, P297, DOI 10.1016/0166-6622(88)80024-6
   VANDERMEI HC, 1987, J MICROBIOL METH, V6, P277, DOI 10.1016/0167-7012(87)90065-0
   VANDERMEI HC, 1991, MICROBIAL CELL SURFA, P262
   VANOSS CJ, 1972, J RETICULOENDOTH SOC, V12, P283
   WAGNER CD, 1981, SURF INTERFACE ANAL, V3, P211, DOI 10.1002/sia.740030506
   1991, LANCET, V338, P857
NR 15
TC 14
Z9 14
U1 0
U2 0
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666
SN 1051-6794
J9 CELL MATER
JI Cells Mat.
PY 1992
VL 2
IS 4
BP 271
EP 280
PG 10
WC Cell Biology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Cell Biology; Research & Experimental Medicine; Materials Science
GA KP120
UT WOS:A1992KP12000001
DA 2018-10-19
ER

PT J
AU RAWLS, HR
   MARSHALL, MV
   CARDENAS, HL
   BHAGAT, HR
   CABASSO, I
AF RAWLS, HR
   MARSHALL, MV
   CARDENAS, HL
   BHAGAT, HR
   CABASSO, I
TI CYTOTOXICITY EVALUATION OF A NEW RADIOPAQUE RESIN ADDITIVE TRIPHENYL
   BISMUTH
SO DENTAL MATERIALS
LA English
DT Article
ID DENTAL MATERIALS; CELL-CULTURE; INVITRO
AB Triphenyl bismuth (Ph3Bi) is a promising new additive for making biomedical resins visible on x-ray images.  We evaluated the cytotoxicity of Ph3Bi, both alone and as a component of a denture resin, as an initial step in determining its biocompatibility.  These experimental materials were compared with several types of dental materials that are in current clinical use (PMMA denture acrylic resin, two photo-cured sealants, and two glass-ionomer cements).  Human embryonic lung fibroblast tissue cultures (Wl-38 cells) were exposed to 24-hour aqueous extracts of the materials.  Changes in cell growth, cell viability, and the visual appearance of cells were used for the assessment of toxic response.  Only a slight degree of cytotoxicity was observed for Ph3Bi, both alone and in combination with selfcured PMMA.  All clinical materials showed a higher level of cytotoxicity than did Ph3Bi.  The sealants and cements exhibited the most cytotoxicity and PMMA acrylic the least.  The cytotoxicity of PMMA was elevated slightly by inclusion of Ph3Bi, probably due to decreased monomer covnersion.  When stored in water, the already low levels of cytotoxicity of both PMMA and PMMA with added Ph3Bi were reduced even further.  From these results, we can predict a high level of safety for Ph3Bi as a radiopaque additive for biomedical resins.  Any toxicity associated with Ph3Bi-containing resins can be reduced or avoided by prior extraction.  Alternatively, curing conditions can be selected that would drive the polymerization reaction to a higher level of conversion.
C1 SUNY SYRACUSE,DEPT CHEM,INST POLYMER,SYRACUSE,NY.
   UNIV TEXAS,HLTH SCI CTR,DEPT MED,SAN ANTONIO,TX 78284.
   UNIV MARYLAND,DEPT PHARMACEUT,BALTIMORE,MD 21201.
RP RAWLS, HR (reprint author), UNIV TEXAS,HLTH SCI CTR,DIV BIOMAT,7703 FLOYD CURL DR,SAN ANTONIO,TX 78284, USA.
FU NIDCR NIH HHS [R01 DE06179]
CR BRAUER GM, 1981, J AM DENT ASSOC, V101, P347
   CABASSO I, 1990, B BISMUTH I, V60, P1
   DELAVIZ Y, 1989, POLYM PREPR AM CHEM, V30, P215
   HANKS CT, 1981, J ORAL PATHOL MED, V10, P101, DOI 10.1111/j.1600-0714.1981.tb01255.x
   KASTEN FH, 1982, IN VITRO CELL DEV B, V18, P650, DOI 10.1007/BF02796398
   KASTEN FH, 1989, IN VITRO CELL DEV B, V25, P57
   KAWAHARA H, 1977, DENTAL OUTLOOK, V50, P623
   NAKAMURA M, 1984, J PROSTHET DENT, V52, P694, DOI 10.1016/0022-3913(84)90144-6
   RAWLS HR, 1990, J DENT RES, V69, P342
   RAWLS HR, 1990, DENT MATER, V6, P250, DOI 10.1016/S0109-5641(05)80006-5
   RUYTER IE, 1982, J BIOMED MATER RES, V16, P741, DOI 10.1002/jbm.820160520
   SMID J, 1987, MAKROMOL CHEM-RAPID, V8, P543
   Smid J., 1989, U. S. patent, Patent No. 4882392
   WENNBERG A, 1986, ATLA-ALTERN LAB ANIM, V13, P194
NR 14
TC 23
Z9 23
U1 1
U2 8
PU ACAD DENTAL MATERIALS
PI DALLAS
PA BAYLOR COLLEGE DENTISTRY, 3302 GASTON AVE, DALLAS, TX 75266-0677
SN 0109-5641
J9 DENT MATER
JI Dent. Mater.
PD JAN
PY 1992
VL 8
IS 1
BP 54
EP 59
DI 10.1016/0109-5641(92)90054-G
PG 6
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA HL975
UT WOS:A1992HL97500011
PM 1521685
DA 2018-10-19
ER

PT B
AU HASTINGS, GW
AF HASTINGS, GW
BE CULSHAW, B
   GARDINER, PT
   MCDONACH, AM
TI SMART STRUCTURES AND INTELLIGENT MATERIALS FOR BIOMEDICAL APPLICATIONS
SO FIRST EUROPEAN CONFERENCE ON SMART STRUCTURES AND MATERIALS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 1ST EUROPEAN CONF ON SMART STRUCTURES AND MATERIALS
CY MAY 12-14, 1992
CL GLASGOW, SCOTLAND
SP EUROPEAN COMMISS BRITE EURAM, EUROPEAN OPT SOC, SOC PHOTO OPT INSTRUMENTAT ENGINEERS, SMART STRUCTURES RES INST, INST PHYS, GLASGOW DEV AGCY, USN, OFF NAVAL RES, EUROPEAN OFF, USA, RES & DEV STAND GRP, EUROPEAN OFF, NATL WESTMINISTER BANK, IEEE
NR 0
TC 0
Z9 0
U1 0
U2 0
PU IOP PUBLISHING LTD
PI BRISTOL
PA BRISTOL
BN 0-7503-0222-4
J9 P SOC PHOTO-OPT INS
PY 1992
VL 1777
BP 357
EP 362
PG 6
WC Engineering, Electrical & Electronic; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA BW74V
UT WOS:A1992BW74V00075
DA 2018-10-19
ER

PT J
AU RATNER, BD
AF RATNER, BD
TI PLASMA DEPOSITION FOR BIOMEDICAL APPLICATIONS - A BRIEF REVIEW
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE PLASMA DEPOSITION; SURFACE CHARACTERIZATION; VASCULAR GRAFT; CELL
   GROWTH; NONFOULING; PROTEIN ADSORPTION; INTRAOCULAR LENS; CONTACT LENS
ID ENDOTHELIAL-CELL GROWTH; OXYGEN-CONTAINING FILMS; POLYMER SURFACES;
   FIBRONECTIN; POLYSTYRENE; ADSORPTION; PRECURSORS
AB Radio frequency plasma-deposited thin films offer an advantageouS mechanism to alter the surface properties of biomaterials and medical devices without affecting the mechanical properties or primary fabrication. Such coatings are tightly adherent, conformal, and easily applied. They also exhibit excellent biocompatibility qualities. Examples are presented of four different thin film plasma treatments that show promise for reducing the platelet reactivity of materials, enhancing their ability to grow cells, preventing protein pickup by surfaces, and improving the biocompatibility of opthalmic devices.
RP RATNER, BD (reprint author), UNIV WASHINGTON,NATL ESCA & SURF ANAL CTR BIOMED PROBLEMS,BF-10,SEATTLE,WA 98195, USA.
CR Boenig H.V., 1988, FUNDAMENTALS PLASMA
   CHILKOTI A, 1991, CHEM MATER, V3, P51, DOI 10.1021/cm00013a016
   CHILKOTI A, 1991, ANAL CHEM, V63, P1612, DOI 10.1021/ac00015a022
   CHINN JA, 1989, J COLLOID INTERF SCI, V127, P67, DOI 10.1016/0021-9797(89)90008-8
   ERTEL SI, 1990, J BIOMED MATER RES, V24, P1637, DOI 10.1002/jbm.820241207
   ERTEL SI, 1991, J COLLOID INTERF SCI, V147, P433, DOI 10.1016/0021-9797(91)90176-9
   ERTEL SI, 1991, J BIOMAT SCI-POLYM E, V3, P163, DOI 10.1163/156856291X00269
   Feldman LE, 1986, FUNDAMENTALS SURFACE
   GARDELLA JA, 1990, ANAL CHEM, V62, pA645, DOI 10.1021/ac00210a002
   GARFINKLE AM, 1984, T AM SOC ART INT ORG, V30, P432
   HOFFMAN AS, 1985, POLYM MED, V2, P157
   HOFFMAN S, 1986, SURF INTERFACE ANAL, V9, P3
   KANE PF, 1974, CHARACTERIZATION SOL
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   LOPEZ GP, IN PRESS J POLYM S A
   MATEO NB, 1989, INVEST OPHTH VIS SCI, V30, P853
   NAGAOKA S, 1984, POLYM BIOMATERIALS, P361
   Ratner BD, 1990, PLASMA DEPOSITION TR, P463
   RATNER BD, 1990, CONCISE ENCY MED DEN, P337
   RATNER BD, 1988, SURFACE CHARACTERIZA
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   YASUDA H, 1982, BIOMATERIALS, V3, P68, DOI 10.1016/0142-9612(82)90036-9
NR 22
TC 61
Z9 62
U1 0
U2 18
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1992
VL 4
IS 1
BP 3
EP 11
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA JX501
UT WOS:A1992JX50100001
PM 1463698
DA 2018-10-19
ER

PT J
AU PISKIN, E
AF PISKIN, E
TI PLASMA PROCESSING OF BIOMATERIALS
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE PLASMA PROCESSING; BIOMATERIALS; HEMOPERFUSION; OXYGENATORS; CELL
   CULTURING; POLYURETHANES
ID SURFACE MODIFICATION; CATHETER MATERIALS; DISCHARGE
AB Surface properties of biomaterials can easily be modified by glow-discharge plasma processing for very diverse biomedical appliations. Activated carbon granules can be coated with a verv thin polymeric membrane by plasma polymerization to improve their blood compatibilities without changing their adsorption capabilities. The problems associated with the microporous polypropylene oxygenator membranes can be eliminated by coating with a nonporous thin polymeric film in a glow-discharge reactor. Cell attachment and growth on polystyrene microcarriers can significantly be increased by alkylamine plasma treatment. Physical and chemical properties of polyurethane biomaterials can be tailor-made by plasma modification.
RP PISKIN, E (reprint author), HACETTEPE UNIV,DEPT CHEM ENGN,ANKARA,TURKEY.
CR CHANG TMS, 1978, ARTIF ORGANS, V2, P359
   ESATO K, 1975, J THORAC CARDIOV SUR, V69, P690
   EVREN V, 1986, PROGR ARTIFICIA ORGA
   GOMBOTZ WR, 1987, CRIT REV BIOCOMPAT, V4, P1
   HOFFMAN AS, 1984, ADV POLYM SCI, V57, P141
   KIREMITCI M, 1991, Clinical Materials, V8, P9, DOI 10.1016/0267-6605(91)90004-Y
   KIREMITCI M, 1990, Clinical Materials, V6, P227, DOI 10.1016/0267-6605(90)90060-9
   KIREMITCI M, 1988, THESIS HACETTEPE U A
   KNIGHT PM, 1975, AM INTRAOCULAR IMPLA, V5, P123
   KREEZE CR, 1983, SCIENCE, V219, P1448
   MUTLU M, 1990, MED BIOL ENG COMPUT, V28, P232, DOI 10.1007/BF02442672
   MUTLU M, 1990, J CLIN MATER, V4, P61
   OZDURAL AR, 1980, AM SOC ARTIF INTERN, V3, P116
   Piskin E, 1986, Life Support Syst, V4 Suppl 1, P2
   PISKIN E, 1983, PAST PRESENT FUTURE
   PISKIN E, 1992, UNPUB J BIOMATER SCI
   TRIOLO PM, 1983, J BIOMED MATER RES, V17, P149, DOI 10.1002/jbm.820170112
   TRIOLO PM, 1983, J BIOMED MATER RES, V17, P129, DOI 10.1002/jbm.820170111
   VANWEZEL AL, 1985, ANIMAL CELL BIOTECHN
   YASUDA H, 1982, BIOMATERIALS, V3, P68, DOI 10.1016/0142-9612(82)90036-9
   1981, PRODUCT INFORMATION
NR 21
TC 25
Z9 25
U1 0
U2 5
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1992
VL 4
IS 1
BP 45
EP 60
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA JX501
UT WOS:A1992JX50100006
PM 1463701
DA 2018-10-19
ER

PT J
AU GROTH, T
   VASSILIEFF, C
   WOLF, H
   RICHTER, G
   FOERSTER, F
AF GROTH, T
   VASSILIEFF, C
   WOLF, H
   RICHTER, G
   FOERSTER, F
TI DEVELOPMENT OF A NEW DYNAMIC METHOD FOR QUANTITATIVE-EVALUATION OF
   INVITRO HEMOCOMPATIBILITY OF BIOMEDICAL MATERIALS
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE HEMOCOMPATIBILITY OF FOILS OR SHEETS; WHOLE BLOOD; LAMINAR FLOW;
   PLATELET RETENTION; LEUKOCYTE ADHESION; DETACHMENT OF PLATELET
   AGGREGATES
ID CELL-ADHESION; PLATELET; SURFACES; AGGREGATION
AB In this study a new dynamic method is introduced allowing the estimation of blood cell adhesion on flat test surfaces by measuring the cell loss in the bulk phase of surface contacting test blood under defined rheological conditions. This was achieved by constructing a novel test chamber permitting the contact of small amounts of blood with a large geometrical test surface. The construction consists of a spiral-shaped flow channel of 0.3 cm width, 0.02 cm height and 78 cm length covered with the biomaterials to be tested from both sides. Laminarity of blood flow in the conduit was confirmed theoretically by the calculation of an equivalent to the Reynolds number for curved systems the so-called Dean number. Furthermore, flow laminarity was proved experimentally finding that the flow rate of blood with different hematocrit values was proportional to the hydrostatic pressure applied. The applicability of the novel 'spiral method' for the estimation of hemocompatibility was demonstrated by evaluation of platelet adhesion onto different polymers in comparison to siliconized and fibrinogen coated glass as reference surfaces. Additionally, it was possible under distinct conditions to determine the adhesion of leucocytes and the detachment of platelet aggregates. Therefore, it was concluded that the spiral method can be used for the assessment of the hemocompatibility of flat biomedical polymers. As main advantages of the new method can be considered the high time efficiency and accuracy without labelling or optical detection of adherent cells.
C1 UNIV SOFIA, FAC CHEM, BU-1126 SOFIA, BULGARIA.
RP GROTH, T (reprint author), HUMBOLDT UNIV, SCH MED, BIOMAT RES UNIT TUCHOLSKYSTR 2, O-1040 BERLIN, GERMANY.
OI Groth, Thomas/0000-0001-6647-9657
CR ADAMS GA, 1985, PLATELETS PHYSL PHAR, P1
   BAIER RE, 1985, J BIOMED MATER RES, V19, P1157, DOI 10.1002/jbm.820190922
   BAUMGARTNER HR, 1976, PLATELETS BIOL PATHO, P23
   BERRETTINI M, 1981, INT J ARTIF ORGANS, V4, P218
   BIRD RB, 1960, TRANSPORT PHENOMENA
   CHIEN S, 1966, J APPL PHYSIOL, V21, P81
   FEUERSTEIN IA, 1987, ANN NY ACAD SCI, V516, P484, DOI 10.1111/j.1749-6632.1987.tb33068.x
   HOENICH NA, 1986, J BIOMED ENG, V8, P3, DOI 10.1016/0141-5425(86)90024-5
   JAMAHA KA, 1983, ANNU REV BIOCHEM, V52, P761
   KANG IK, 1988, J BIOMED MATER RES, V22, P595, DOI 10.1002/jbm.820220702
   KARWATH R, 1989, STUD BIOPHYS, V131, P117
   KATAOKA K, 1980, J BIOMED MATER RES, V14, P817, DOI 10.1002/jbm.820140613
   KVARSTEIN B, 1969, SCAND J CLIN LAB INV, V24, P41, DOI 10.3109/00365516909080130
   LASSLO A, 1983, MED PROG TECHNOL, V10, P71
   LEONARD EF, 1972, ANN NY ACAD SCI, V201, P329, DOI 10.1111/j.1749-6632.1972.tb16309.x
   LINDON JN, 1978, J LAB CLIN MED, V92, P904
   MARCUS AJ, 1987, ANN NY ACAD SCI, V516, P407, DOI 10.1111/j.1749-6632.1987.tb33059.x
   MCINTYRE DE, 1976, PLATELETS BIOL PATHO, P61
   MOHANDAS N, 1974, J BIOMED MATER RES, V8, P119, DOI 10.1002/jbm.820080203
   OWENS NF, 1987, J CELL SCI, V87, P667
   PACKHAM MA, 1969, J LAB CLIN MED, V73, P686
   POOT A, 1988, BIOMATERIALS, V9, P126, DOI 10.1016/0142-9612(88)90110-X
   ROWAN RM, 1983, BLOOD CELL VOLUME AN
   SALZMAN E, 1963, J LAB CLIN MED, V62, P724
   TILSNER V, 1986, GERINNUNGSDIAGNOSTIK
   TRUCKENBRODT E, 1980, FLUID MECHANICS
   WILLIAMS CE, 1985, MED LAB SCI, V42, P262
   WINTER G, 1983, THESIS HUMBOLDT U BE
   WU KK, 1974, LANCET, V2, P924
   ZAPRYANOV Z, 1980, INT J HEAT MASS TRAN, V23, P873, DOI 10.1016/0017-9310(80)90042-3
NR 30
TC 7
Z9 7
U1 0
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1992
VL 3
IS 4
BP 285
EP 300
DI 10.1163/156856292X00385
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA HM117
UT WOS:A1992HM11700002
PM 1596475
DA 2018-10-19
ER

PT J
AU TAMADA, J
   LANGER, R
AF TAMADA, J
   LANGER, R
TI THE DEVELOPMENT OF POLYANHYDRIDES FOR DRUG DELIVERY APPLICATIONS
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Review
DE POLYANHYDRIDE; BIODEGRADABLE POLYMER; DRUG DELIVERY; CONTROLLED RELEASE
ID CONTROLLED-RELEASE POLYMER; BIOERODIBLE POLYANHYDRIDES; CARRIER
   MATRICES; SOLVENT REMOVAL; BIOCOMPATIBILITY; POLY(ANHYDRIDES);
   MICROSPHERES; MORPHOLOGY; SYSTEMS; BRAIN
AB This paper reviews the development of the polyanhydrides as bioerodible polymers for drug delivery applications. The topics include design and synthesis of the polymer, physical properties, techniques to fabricate the polymer into drug delivery devices, evaluation of biocompatibility, and example applications of the polyanhydrides. Discussion of the interrelationship between the physical-chemical properties of the polyanhydrides, fabrication methods, and drug release rates is included. One section is devoted to a case study to provide a historical perspective of the development a polyanhydride-based drug delivery treatment from the conception of the idea to the final stages of human clinical trials. This section includes an outline of the extensive in vitro and in vivo testing that is necessary for development of a new material for biomedical applications.
RP TAMADA, J (reprint author), MIT,DEPT CHEM ENGN,ROOM E25-342,CAMBRIDGE,MA 02139, USA.
CR BINDSCHAEDLER C, 1988, J PHARM SCI, V77, P696, DOI 10.1002/jps.2600770811
   BREM H, 1991, J NEUROSURG, V74, P441, DOI 10.3171/jns.1991.74.3.0441
   BREM H, 1989, SELECT CANCER THER, V5, P55, DOI 10.1089/sct.1989.5.55
   BREM H, 1988, 1988 ANN M AM ASS NE, P212
   Bucher JE, 1909, J AM CHEM SOC, V31, P1319, DOI 10.1021/ja01942a009
   CHASIN M, 1990, DRUG DEV IND PHARM, V16, P2579, DOI 10.3109/03639049009058548
   CHASIN M, 1990, BIODEGRADABLE POLYM, P43
   COHEN S, 1991, PHARMACEUT RES, V8, P713, DOI 10.1023/A:1015841715384
   CONIX A, 1957, MAKROMOLEKUL CHEM, V24, P76
   CONIX A, 1958, J POLYM SCI, V29, P343, DOI 10.1002/pol.1958.1202912002
   DOMB A, 1988, MAKROMOL CHEM-M SYMP, V19, P189, DOI 10.1002/masy.19880190115
   DOMB AJ, 1988, MACROMOLECULES, V21, P1925, DOI 10.1021/ma00185a008
   DOMB AJ, 1989, MACROMOLECULES, V22, P3200, DOI 10.1021/ma00198a002
   DOMB AJ, 1987, J POLYM SCI POL CHEM, V25, P3373, DOI 10.1002/pola.1987.080251217
   DOMB AJ, 1989, MACROMOLECULES, V22, P2117, DOI 10.1021/ma00195a018
   DOMB AJ, 1991, J POLYM SCI POL CHEM, V29, P571, DOI 10.1002/pola.1991.080290413
   GROSSMAN S, UNPUB
   HELLER J, 1990, BIODEGRADABLE POLYM, P121
   HILL J, 1962, J AM CHEM SOC, V54, P1569
   Hill JW, 1930, J AM CHEM SOC, V52, P4110, DOI 10.1021/ja01373a053
   HOWARD MA, 1989, J NEUROSURG, V71, P105, DOI 10.3171/jns.1989.71.1.0105
   LAURENCIN C, 1990, J BIOMED MATER RES, V24, P1463, DOI 10.1002/jbm.820241105
   LAURENCIN C, UNPUB J ORTHOPAEDIC
   LEONG K, 1989, ENCY POLYM SCI ENG S
   LEONG KW, 1986, J BIOMED MATER RES, V20, P51, DOI 10.1002/jbm.820200106
   LEONG KW, 1987, MACROMOLECULES, V20, P705, DOI 10.1021/ma00170a001
   LEONG KW, 1985, J BIOMED MATER RES, V19, P941, DOI 10.1002/jbm.820190806
   Lewis D. H., 1990, BIODEGRADABLE POLYM, P1
   MATHIOWITZ E, 1987, Journal of Controlled Release, V5, P13, DOI 10.1016/0168-3659(87)90033-2
   MATHIOWITZ E, 1990, POLYMER, V31, P547, DOI 10.1016/0032-3861(90)90401-J
   MATHIOWITZ E, 1988, J APPL POLYM SCI, V35, P755, DOI 10.1002/app.1988.070350316
   MATHIOWITZ E, 1990, SCANNING MICROSCOPY, V4, P329
   MATHIOWITZ E, 1990, MACROMOLECULES, V23, P3212, DOI 10.1021/ma00215a003
   MATHIOWITZ E, IN PRESS MICROCAPSUL
   MATHIOWITZ E, IN PRESS J APPL POLY
   MIKOS AG, 1991, J COLLOID INTERF SCI, V143, P366, DOI 10.1016/0021-9797(91)90270-I
   RON E, 1991, MACROMOLECULES, V24, P2278, DOI 10.1021/ma00009a024
   ROSEN HB, 1983, BIOMATERIALS, V4, P131, DOI 10.1016/0142-9612(83)90054-6
   STAUBLI A, 1990, J AM CHEM SOC, V112, P4419, DOI 10.1021/ja00167a045
   TAMADA JA, 1990, JUL P INT S CONTR RE, V17, P156
   TAMARGO RJ, 1989, J BIOMED MATER RES, V23, P253, DOI 10.1002/jbm.820230209
   TAMARGO RJ, 1989, 1988 ANN M AM ASS NE, P88
   WEISS R, 1991, SCIENCE, V252, P1037
   YODA N, 1959, B CHEM SOC JPN, V32, P1120, DOI 10.1246/bcsj.32.1120
   YODA N, 1962, MAKROMOLEKUL CHEM, V55, P174
   YODA N, 1963, J POLYM SCI PART A, V1, P1323, DOI 10.1002/pol.1963.100010421
   YODA N, 1962, MAKROMOLEKUL CHEM, V56, P10
   YODA N, 1962, B CHEM SOC JPN, P36
NR 48
TC 147
Z9 149
U1 2
U2 29
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1992
VL 3
IS 4
BP 315
EP 353
DI 10.1163/156856292X00402
PG 39
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA HM117
UT WOS:A1992HM11700004
PM 1350734
DA 2018-10-19
ER

PT J
AU BRAATZ, JA
   HEIFETZ, AH
   KEHR, CL
AF BRAATZ, JA
   HEIFETZ, AH
   KEHR, CL
TI A NEW HYDROPHILIC POLYMER FOR BIOMATERIAL COATINGS WITH LOW PROTEIN
   ADSORPTION
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE BIOPOL(R) POLYURETHANE POLYMERS; HYPOL(R)POLYMERS; PROTEIN ADSORPTION;
   POLYMER COATED SURFACES; BIOMEDICAL COATINGS
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; SURFACE INTERACTIONS; POLYETHYLENE
   OXIDE; SILICA; PHASE
AB BIOPOL(R) polyurethane polymers, an extension of the HYPOL(R) Polymer series of foamable hydrophilic polymers, have been developed which exhibit improved performance for selected biomedical applications. Members of the BIOPOL polyurethane polymer series, with molecular weights in the range of 7000 to 30000, are larger molecules than HYPOL polymers (MW < 3000) and produce hydrogels, rather than foams, when mixed with water. The prototype material in this series, BIOPOL XP-5, is a liquid prepolymer which chain extends in water and forms a hydrogel which can contain > 85% water. The time required for polymerization with water was dependent on the prepolymer: water ratio. This prepolymer was coated onto silica and medical grade tubing and then cured in place with water to form a stable coating which was resistant to non-specific protein binding. In addition, soluble, isocyanate-free forms of the prepolymer were tested for toxicity and shown to produce no adverse effects when injected intravenously into mice or when applied to a chicken chorioallantoic membrane. BIOPOL polymers can be useful in applications where protein adsorption is an undesirable event.
C1 WR GRACE & CO CONN RES DIV,DEPT DESIGNED POLYMERS RES,COLUMBIA,MD 21044.
RP BRAATZ, JA (reprint author), WR GRACE & CO CONN RES DIV,DEPT MAMMALIAN CELL RES,7379 ROUTE 32,COLUMBIA,MD 21044, USA.
CR Agostoni A, 1989, J Biomater Appl, V4, P102, DOI 10.1177/088532828900400202
   ANDRADE JD, 1987, T AM SOC ART INT ORG, V33, P75
   Andrade JD, 1985, SURFACE INTERFACIAL, V2, P1
   BRAATZ JA, 1984, J NATL CANCER I, V72, P841
   BRAATZ JA, 1991, AM SOC ART INT ORG A, V20, P23
   BRAATZ JA, 1989, Patent No. 4886866
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CHANG JP, 1988, CHROMATOGRAPHIA, V25, P350, DOI 10.1007/BF02324714
   CHANG JP, 1985, J CHROMATOGR, V319, P396, DOI 10.1016/S0021-9673(01)90578-3
   CLAESSON PM, 1986, J CHEM SOC FARAD T 1, V82, P2735, DOI 10.1039/f19868202735
   ENGELHARDT H, 1981, CHROMATOGRAPHIA, V14, P325, DOI 10.1007/BF02259229
   FOLKMAN J, 1986, CANCER RES, V46, P467
   HARDEGEN FJ, 1980, Patent No. 4237229
   HORBETT TA, 1977, J BIOENG, V1, P61
   HORBETT TA, 1987, PROTEINS INTERFACES, P1
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   KILLMANN E, 1975, ANGEW MAKROMOL CHEM, V43, P53, DOI 10.1002/apmc.1975.050430105
   Lelah M. D., 1986, POLYURETHANES MED
   MARCINKA K, 1972, ACTA VIROL, V16, P52
   Merrill EW, 1983, AM SOC ARTIF INTERN, V6, P60
   NAGAOKA S, 1987, J AM SOC ART INT ORG, V10, P76
   PARHAM ME, 1989, Patent No. 4787976
   PARHAM ME, 1989, Patent No. 4794090
   RUBIO J, 1976, J COLLOID INTERF SCI, V57, P132, DOI 10.1016/0021-9797(76)90182-X
   SAUNDERS JH, 1962, POLYURETHANES CHEM T, V1, P11
   SAUNDERS JH, 1964, POLYURETHANES CHEM T, V2, P8
   SIGGIA S, 1963, QUANTITATIVE ORGANIC, P559
   Wood L. L., 1976, J CELL PLAST, V12, P285
NR 29
TC 12
Z9 12
U1 0
U2 6
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 1992
VL 3
IS 6
BP 451
EP 462
DI 10.1163/156856292X00439
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA JH313
UT WOS:A1992JH31300003
PM 1419974
DA 2018-10-19
ER

PT J
AU BARBARO, V
   DANIELE, C
   GRIGIONI, M
   PALOMBO, A
   SARGENTINI, A
AF BARBARO, V
   DANIELE, C
   GRIGIONI, M
   PALOMBO, A
   SARGENTINI, A
TI INVITRO EVALUATION OF PROSTHETIC HEART-VALVES - TOWARDS COMPARABLE
   TESTING
SO JOURNAL OF MEDICAL ENGINEERING & TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT CONF ON HEART VALVE REPLACEMENT : PAST PERFORMANCE AND FUTURE PROSPECTS
CY SEP, 1991
CL SHEFFIELD, ENGLAND
SP DEPT CARDIAC SURG ENGLAND, DEPT MED PHYS & CLIN ENGN ENGLAND, UNIV SHEFFIELD, INST BIOMED EQUIPMENT EVALUAT & SERV
AB The Laboratory of Biomedical Engineering (of the National Health Institute, technical body of the Italian Health Service) performs in vitro testing of prosthetic heart valves for mechanical characteristics of materials, fatigue life, and fluidodynamic performance. Testing of materials is directed towards the physico-mechanical characterization of the structural components. of the valves, e.g. elasticity and resistance to stress of biological tissues and stents. Long-term fatigue life tests are conducted by means of systems which make valves beat at more than 1200 cycles/min. These tests are preceded and followed by geometrical characterization and by steady flow testing in order to obtain information about stenosis and leakage. Special attention is devoted to pulsatile flow testing which is performed on two pulse duplicators: the Dynatek system and the system developed by the University of Sheffield. The same valve was tested with these systems according to their different possible set-ups within the general requirements established by ISO-DIS 5840. This paper presents significant measurements, laking into account their dependence on the systems adopted. Results show (a) the difficulties in comparing test results because of different operating conditions, and (b) the systems' sensitivity with regards to some parameters which affect measurements under comparable set-up conditions (FDA Interlaboratory Comparison Testing Protocol).
RP BARBARO, V (reprint author), IST SUPER SANITA,BIOMED ENGN LAB,I-00161 ROME,ITALY.
RI Grigioni, Mauro/J-8744-2016; DANIELE, CARLA/E-6672-2015
OI Grigioni, Mauro/0000-0002-8231-8156; 
CR BARBARO V, 1991, INT J ARTIF ORGANS, V14, P343
   BARBARO V, 1991, 1ST EUR C BIOM ENG N
   BARBARO V, 1989, 5 P MED C MED BIOL E
   BARBARO V, 1991, WORLD C MED PHYS 2 S, V29, P1269
   GABBAY S, 1986, T AM SOC ART INT ORG, V32, P282
   Martin T. R. P., 1978, Engineering in Medicine, V7, P229
   REUL H, 1984, 2 P INT C APPL PHYS
   REUL H, 1988, J THORACIC CARDIOVAS, V96, P952
   SWANSON WM, 1977, J BIOENG, V1, P135
   1985, TEST PROTOCOL INTERL
NR 10
TC 4
Z9 4
U1 0
U2 5
PU TAYLOR & FRANCIS LTD
PI LONDON
PA ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE
SN 0309-1902
J9 J MED ENG TECHNOL
JI J. Med. Eng. Technol.
PD JAN-FEB
PY 1992
VL 16
IS 1
BP 10
EP 14
DI 10.3109/03091909209021951
PG 5
WC Engineering, Biomedical; Medical Informatics; Medical Laboratory
   Technology
SC Engineering; Medical Informatics; Medical Laboratory Technology
GA JE697
UT WOS:A1992JE69700003
PM 1640442
DA 2018-10-19
ER

PT B
AU OKI, S
   GOHDA, S
   SHOMURA, T
   KIMURA, TH
   YOSHIOKA, T
AF OKI, S
   GOHDA, S
   SHOMURA, T
   KIMURA, TH
   YOSHIOKA, T
GP AMER SOC MET INT
TI PLASMA SPRAYING OF TITANIUM AND APATITE TO BIOMEDICAL MATERIALS
SO THERMAL SPRAY COATINGS : PROPERTIES, PROCESSES AND APPLICATIONS
LA English
DT Proceedings Paper
CT 4TH NATIONAL CONF ON THERMAL SPRAY
CY MAY 04-10, 1991
CL PITTSBURGH, PA
SP AMER SOC MET INT, THERMAL SPRAY DIV, HIGH TEMP SOC JAPAN, JAPAN THERMAL SPRAY SOC, METALLIZING SERV CONTRACTORS
NR 0
TC 1
Z9 1
U1 0
U2 0
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA MATERIALS PARK
BN 0-87170-437-4
PY 1992
BP 491
EP 495
PG 5
WC Engineering, Multidisciplinary; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BV92Y
UT WOS:A1992BV92Y00070
DA 2018-10-19
ER

PT J
AU MINOR, JR
   HAMBURG, MA
AF MINOR, JR
   HAMBURG, MA
TI THE AIDS RESEARCH AGENDA AT THE NATIONAL-INSTITUTES-OF-HEALTH
SO AMERICAN JOURNAL OF HOSPITAL PHARMACY
LA English
DT Article
DE ACQUIRED IMMUNODEFICIENCY SYNDROME; ACQUIRED IMMUNODEFICIENCY SYNDROME
   VACCINES; ADMINISTRATION; ANTIVIRALS; DRUG INFORMATION; HIV INFECTIONS;
   INFORMATION; NATIONAL-INSTITUTES-OF-HEALTH; PHARMACISTS; RESEARCH
AB The foundation, goals, and components of the research strategy developed by the National Institutes of Health to combat AIDS and HIV infection are discussed.
   The AIDS research agenda, based on systems originally designed to coordinate cancer research, involves a national effort to study various aspects of the disease, disseminate information, and rapidly develop and test drugs and vaccines to treat and prevent AIDS and HIV disease. AIDS research makes up approximately 10% of the total NIH budget of $7.6 billion, and the largest portion of that allocation goes to improving current treatments and developing new agents. Drug discovery efforts are supported by the National Institute of Allergy and Infectious Diseases (NIAID) through the Division of Intramural Research, in which biomedical and clinical research is conducted, and the Division of AIDS, which coordinates extramural research in university-based centers and community programs. By providing educational materials and sponsoring conferences, NIAID also helps to disseminate the results of the research it coordinates. Pharmacists support AIDS research through their involvement with study drug products and their role in protocol development, regulatory affairs, product development, and accumulation and distribution of drug information.
   Research initiatives sponsored by the federal government combine resources of investigators from government, academia, and the pharmaceutical and biotechnological industries to meet the challenges posed by the AIDS epidemic.
C1 NEW YORK CITY DEPT HLTH,FAMILY HLTH SERV,NEW YORK,NY 10013.
RP MINOR, JR (reprint author), NIH,CTR CLIN,DEPT PHARM,BLDG 10,ROOM 1 N257,BETHESDA,MD 20892, USA.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU AMER SOC HEALTH-SYSTEM PHARMACISTS
PI BETHESDA
PA 7272 WISCONSIN AVE, BETHESDA, MD 20814
SN 0002-9289
J9 AM J HOSP PHARM
JI Am. J. Hosp. Pharm.
PD DEC
PY 1991
VL 48
IS 12
BP 2662
EP 2666
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA GR456
UT WOS:A1991GR45600031
PM 1667566
DA 2018-10-19
ER

PT J
AU JAYABALAN, M
   KUMAR, NS
   RATHINAM, K
   KUMARI, TV
AF JAYABALAN, M
   KUMAR, NS
   RATHINAM, K
   KUMARI, TV
TI INVIVO BIOCOMPATIBILITY OF AN ALIPHATIC CROSS-LINKED POLYURETHANE IN
   RABBIT
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID LEUKOCYTE INTERACTIONS; POLYETHYLENE; QUANTITATION; KINETICS
AB A cage implantation technique has been adopted in a rabbit animal model to investigate the biocompatibility of an aliphatic crosslinked polyurethane based on hexamethylene diisocyanate (HDI). In this study, four cages are represented; the cage containing the candidate polyurethane material, biomedical grade polyurethane (Tecoflex), the commercial grade polyvinylchloride (PVC), and an empty cage which were implanted subcutaneously in rabbits. Exudates were aspirated from these cages at 4, 7, 14, and 21 days postimplantation. Exudates were analyzed for variations in proteins, cell counts, and extracellular enzymes. Results with the four types of cage implants showed that the candidate polyurethane caused an inflammatory response comparable to that caused by medical-grade Tecoflex and the empty cage control.
C1 SREE CHITRA TIRUNAL INST MED SCI & TECHNOL,DIV TOXICOL SCREENING BIOMAT,TRIVANDRUM 695012,INDIA.
   SREE CHITRA TIRUNAL INST MED SCI & TECHNOL,DIV PATHOPHYSIOL,TRIVANDRUM 695012,INDIA.
RP JAYABALAN, M (reprint author), SREE CHITRA TIRUNAL INST MED SCI & TECHNOL,DIV TECH EVALUAT BIOMAT,BIOMED TECHNOL WING,TRIVANDRUM 695012,INDIA.
CR ANDERSON JM, 1988, T AM SOC ART INT ORG, V34, P101
   Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   BECKER EL, 1974, J IMMUNOL, V112, P2047
   ISSEKUTZ AC, 1980, LAB INVEST, V42, P310
   ISSEKUTZ AC, 1980, CLIN EXP IMMUNOL, V41, P512
   ISSEKUTZ TB, 1981, AM J PATHOL, V103, P47
   JAYABALAN M, 1989, J BIOSCIENCE, V14, P289, DOI 10.1007/BF02716690
   Kozma C, 1974, BIOL LABORATORY RABB, P50
   KOZMA CK, 1967, J AM VET MED ASSOC, V151, P865
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P1169, DOI 10.1002/jbm.820180917
   MARCHANT RE, 1986, J BIOMED MATER RES, V20, P37, DOI 10.1002/jbm.820200105
   MCNAMARA A, 1981, BIOMATERIALS, V2, P33, DOI 10.1016/0142-9612(81)90085-5
   SPILIZEWSKI KL, 1987, BIOMATERIALS, V8, P12, DOI 10.1016/0142-9612(87)90021-4
   WALTER JB, 1987, GENERAL PATHOLOGY, P81
NR 15
TC 10
Z9 10
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC
PY 1991
VL 25
IS 12
BP 1431
EP 1442
DI 10.1002/jbm.820251203
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA GQ002
UT WOS:A1991GQ00200002
PM 1794993
DA 2018-10-19
ER

PT J
AU KOHJIYA, S
   YAMASHITA, S
AF KOHJIYA, S
   YAMASHITA, S
TI SYNTHESIS AND PHYSICAL-PROPERTIES OF ELASTOMERIC POLY(OXYTETRAMETHYLENE)
   IONENE
SO KAUTSCHUK GUMMI KUNSTSTOFFE
LA English
DT Article; Proceedings Paper
CT 1991 INTERNATIONAL RUBBER CONFERENCE ( IKT/IRC 91 )
CY JUN 24-27, 1991
CL ESSEN, GERMANY
DE ELASTOMERIC IONENE; POLY(OXYTETRAMETHYLENE); ADHESIVES FOR BIOMEDICAL
   USES; PHOTOCHROMIC AND ELECTROCHROMIC POLYMERS
AB Two ionene-type elastomers were synthesized by living cationic polymerization of tetrahydrofuran. In the synthesis of PTI, dimethylamino terminated poly(oxytetramethylene) was reacted with dihalide via the Menschutkin reaction. Bipyridine was used in the synthesis of PTV which had viologen units in its main chain. The resulted polymers (PTI and PTV) were easily formed into a thin film, and the film was found to be highly elastic. When dissolved in polar solvent, the two polymers displayed polyelectrolyte behaviors, while they were non-polyelectrolytes in nonpolar solvent. This dual behavior suggests that both PTI and PTV have an amphiphilic character due to the presence of ionic charges and relatively non-polar poly(oxytetramethylene) segments in the main chain. Tensile properties of the film were found to be highly elastomeric and excellent; very low modulus up to an intermediate strain region, and then an increase of the stress to attain a very good tensile strength. The tensile properties were influenced by counter anion and by water content. These mechanical behaviors are reasonably explained by assuming the aggregation of ionic sites in relatively nonpolar poly(oxytetramethylene) matrix and, the stress-induced crystallization of poly(oxytetramethylene) chains. The ionic aggregates are equivalent to the hard-segment domains, hence PTI and PTV are thermoplastic elastomers. PTI was also found to be a good adhesive towards polymeric materials including human skin. PTV was a photoresponsive polymer due to the presence of viologen units, i.e., it showed photochromic and photomechanical behaviors as well as electrochromism.
RP KOHJIYA, S (reprint author), KYOTO INST TECHNOL,DEPT MAT SCI,KYOTO 606,JAPAN.
NR 0
TC 8
Z9 8
U1 2
U2 4
PU DR ALFRED HUTHIG VERLAG GMBH
PI HEIDELBERG 1
PA POSTFACH 102869, W-69018 HEIDELBERG 1, GERMANY
SN 0022-9520
J9 KAUT GUMMI KUNSTST
JI Kautsch. Gummi Kunstst.
PD DEC
PY 1991
VL 44
IS 12
BP 1128
EP 1132
PG 5
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA GV413
UT WOS:A1991GV41300007
DA 2018-10-19
ER

PT J
AU TINGEY, KG
   ANDRADE, JD
AF TINGEY, KG
   ANDRADE, JD
TI PROBING SURFACE MICROHETEROGENEITY OF POLY(ETHER URETHANES) IN AN
   AQUEOUS ENVIRONMENT
SO LANGMUIR
LA English
DT Article
ID MICROPHASE SEPARATED STRUCTURE; BLOOD COMPATIBILITY; SEGMENTED
   POLY(URETHANEUREAS); HARD-SEGMENT; POLYMERS
AB The morphology and microheterogeneous composition of polymeric surfaces partially determines their adsorption and absorption characteristics.  The surface structure, often significantly different from that of the bulk, is influenced by the environment, and especially by the interfacial energetics of the surrounding medium.  These effects result in dynamic properties with relaxation times that affect the sorptive properties of the materials.  Microheterogeneity on surfaces has been shown to have significant effects on the biological interactions between synthetic materials and proteins and/or cells; however, the in situ surface character, which determines the blood compatibility of biomedical copolymers, has only recently come under investigation.  The objective of this paper is to present a perspective view of several methods for the characterization of microheterogeneity of dynamic surfaces in an aqueous- or fluid-phase environment.  This work focuses on the investigation of the dynamic properties of microheterogeneous biomedical polyurethanes, and on the characterization of these surfaces with novel spectroscopic, surface energetic, and surface imaging techniques.  Contact angle, infrared spectroscopy, and inverse chromatography are used to characterize the surface reorientation and heterogeneous microphase nature of polyurethane surfaces.  The polyurethanes studied are shown to have a multicomponent surface with detectable hard-segment domains.  The chemical structure of the copolymers suggests that the material is composed of domains 150 angstrom in diameter.  Evidence of these domains at the surface is presented.  We have observed that the concentration of hard-segment surface groups, identified by the aromatic groups in the hard segment, varies as a function of polymer composition.  The composition of surface hard segment is minimized with increasing phase purity, indicating the significance of morphology in determining surface composition of these polyurethanes and the ability of the surface to reorient in response to their environment.  We have observed polyurethane surface structural rearrangements induced by hydration of the polymer film.  These infrared and contact angle data indicate reorientation of the surface phase structure to enhance the surface concentration of the more polar phase in an aqueous environment.  From these studies, structural models of selected polyurethane surfaces have been presented and additional analytical methods sensitive to in situ surface morphology have been proposed.
C1 UNIV UTAH,DEPT BIOENGN,SALT LAKE CITY,UT 84112.
CR ALBRECHT TR, 1988, J APPL PHYS, V64, P1178, DOI 10.1063/1.341881
   Andrade J. D., 1985, SURFACE INTERFACIAL, P249
   ANDRADE JD, 1988, POLYM SURFACE DYNAMI, pCH1
   BELISLE J, 1985, J BIOMED MATER RES, V24, P15
   BLACKWELL J, 1983, J POLYM SCI POL PHYS, V21, P2169, DOI 10.1002/pol.1983.180211024
   BOGUE R, 1986, J ADHESION, V20, P15, DOI 10.1080/00218468608073237
   CAMERON DG, 1982, APPL SPECTROSC, V36, P245, DOI 10.1366/0003702824638610
   COOPER SL, 1966, J APPL POLYM SCI, V10, P1837, DOI 10.1002/app.1966.070101204
   DACOSTA VS, 1981, J COLLOID INTERF SCI, V80, P445
   DETTRE RH, 1965, J PHYS CHEM-US, V69, P1507, DOI 10.1021/j100889a012
   GAO SL, 1989, J LIQ CHROMATOGR, V12, P2083
   GARDELLA JA, 1988, SURFACE CHARACTERIZA, P145
   GENDREAU RM, 1986, SPECTROSCOPY BIOMEDI, pCH1
   GOOD RJ, 1978, J COLLOID INTERF SCI, V66, P360, DOI 10.1016/0021-9797(78)90317-X
   GOODMAN SL, 1988, SURFACE CHARACTERIZA, P281
   GRASEL TG, 1986, BIOMATERIALS, V7, P315, DOI 10.1016/0142-9612(86)90002-5
   HANSON SR, 1980, J LAB CLIN MED, V95, P289
   ISHIHARA H, 1974, J MACROMOL SCI PHY B, V10, P52
   Johnson R.E., 1969, SURF COLLOID SCI, V2, P85
   KNUTSON K, 1982, ACS ADV CHEM SER, V199, P109
   LAMBERT JM, 1989, POLYM PREP-ACS, V30, P583
   Lelah M. D., 1986, POLYURETHANES MED
   MACKENZIE RC, 1981, J THERM ANAL, V22, P269, DOI 10.1007/BF01915274
   MANSFIELD KF, 1989, POLYM PREPR, V30, P76
   MATSUDA T, 1983, ORG COAT APPL POLYM, V48, P647
   NISHIJIMA Y, 1984, S REP PROG POLYM PHY, V33, P237
   OKANO T, 1986, J BIOMED MATER RES, V20, P919, DOI 10.1002/jbm.820200707
   OPHIR Z, 1980, J POLYM SCI PP, V18, P1409
   PORATH J, 1977, J CHROMATOGR, V133, P180, DOI 10.1016/S0021-9673(00)89219-5
   RATNER BD, 1987, POLYURETHANES BIOMED, V2, P213
   RATNER BD, 1983, PHYSICOCHEMICAL ASPE, V2, P969
   SAKASHITA J, 1985, REP PROG POLYM PHYS, V28, P457
   SCHULZ GE, 1979, PRINCIPLES PROTEIN S, P87
   SCHWARTZ LW, 1985, LANGMUIR, V1, P219, DOI 10.1021/la00062a007
   SIBRELL K, 1989, 63RD COLL SURF SCI S
   SIBRELL K, UNPUB
   SUZUKI T, 1981, POLYM J, V13, P1027, DOI 10.1295/polymj.13.1027
   TAKAHARA A, 1985, POLYMER, V26, P978, DOI 10.1016/0032-3861(85)90217-4
   TAKAHARA A, 1985, POLYMER, V26, P987, DOI 10.1016/0032-3861(85)90218-6
   TAKAHARA A, 1989, PROGR BIOMEDICAL POL
   TINGEY KG, 1991, 17TH T M SOC BIOM, P83
   WARD RS, 1980, ORG COAT PLAST CHEM, V42, P227
NR 42
TC 104
Z9 111
U1 1
U2 19
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD NOV
PY 1991
VL 7
IS 11
BP 2471
EP 2478
DI 10.1021/la00059a013
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA GQ894
UT WOS:A1991GQ89400015
DA 2018-10-19
ER

PT J
AU BRAYBROOK, JH
AF BRAYBROOK, JH
TI IS IT AS SIMPLE AS ABC - A BIOCOMPATIBILITY CONSENSUS
SO ADVANCED MATERIALS
LA English
DT Editorial Material
AB Research News/Talking Point:  The need for standardization in the analysis of the properties of materials intended for use in biomedical applications is the subject of this discussion-type article.  The various materials and characterization methods are summarized and the status of European and global efforts at coordinating activities examined.
RP BRAYBROOK, JH (reprint author), LAB GOVT CHEMIST,MAT TECHNOL GRP,QUEENS RD,TEDDINGTON TWII 0LY,MIDDX,ENGLAND.
CR BRAYBROOK JH, IN PRESS POLYM INT
   GUESS WL, 1965, J PHARM SCI, V54, P1545, DOI 10.1002/jps.2600541036
   MOSSMANN T, 1983, J IMMUNOL METHODS, V65, P55
   ROSENBLUTH SA, 1965, J PHARM SCI-US, V54, P156, DOI 10.1002/jps.2600540139
   VONRECUM AF, 1986, HDB BIOMATERIALS EVA
   WILLIAMS DF, 1981, CRC SERIES BIOCOMPAT
NR 6
TC 1
Z9 1
U1 0
U2 1
PU VCH PUBLISHERS INC
PI DEERFIELD BEACH
PA 303 NW 12TH AVE, DEERFIELD BEACH, FL 33442-1788
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD OCT
PY 1991
VL 3
IS 10
BP 511
EP 514
DI 10.1002/adma.19910031014
PG 4
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA GL562
UT WOS:A1991GL56200012
DA 2018-10-19
ER

PT J
AU KOKUBO, T
AF KOKUBO, T
TI RECENT PROGRESS IN GLASS-BASED MATERIALS FOR BIOMEDICAL APPLICATIONS
SO NIPPON SERAMIKKUSU KYOKAI GAKUJUTSU RONBUNSHI-JOURNAL OF THE CERAMIC
   SOCIETY OF JAPAN
LA English
DT Article
DE BIOACTIVE GLASS; BIOACTIVE GLASS-CERAMIC; BIOACTIVE CEMENT; BIOACTIVE
   COMPOSITE; BIOACTIVE AND FERRIMAGNETIC GLASS-CERAMIC; RADIOACTIVE GLASS
   SPHERE; GLASS-CERAMIC DENTAL CROWN; HYPERTHERMIA; ARTIFICIAL BONE;
   APATITE; CAO-SIO2-P2O5; BIOACTIVITY
AB Since discovery of Bioglass in 1971, various kinds of bioactive glasses and glass-ceramics with different functions such as high mechanical strength, high machinability, fast-setting ability and ferrimagnetism have been developed. Some of them are already clinically used as important bone-repairing implants and also have been proved to be useful even for cancer treatments. Factors governing the bioactivity have been considerably revealed. On the basis of these findings, new kinds of bioactive materials with other different functions such as high fracture toughness as well as low elastic modulus also might be developed from glasses in near future. Non-bioactive but inert glasses and glass-ceramics with various functions such as good workability, natural appearance and radioactivity also have been shown to be useful for biomedical applications such as dental crown and radioactive carrier for a cancer treatment. Glass-based materials will occupy more important positions in biomedical materials in the next decade.
RP KOKUBO, T (reprint author), KYOTO UNIV,INST CHEM RES,UJI,KYOTO 611,JAPAN.
NR 0
TC 87
Z9 87
U1 1
U2 7
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17 HYAKUNIN-CHO SHINJUKU-KU, TOKYO 169, JAPAN
SN 0914-5400
J9 NIPPON SERAM KYO GAK
PD OCT
PY 1991
VL 99
IS 10
BP 965
EP 973
PG 9
WC Materials Science, Ceramics
SC Materials Science
GA GK934
UT WOS:A1991GK93400014
DA 2018-10-19
ER

PT J
AU KINCHEN, K
   WRIGHT, JD
AF KINCHEN, K
   WRIGHT, JD
TI HYPERTENSION MANAGEMENT IN HEALTH-CARE FOR THE HOMELESS CLINICS -
   RESULTS FROM A SURVEY
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article
ID PHYSICIANS
AB Background.  With the exception of alcohol abuse, hypertension is the most common chronic physical health problem encountered among homeless persons.  The material conditions of homelessness greatly complicate the management of this disorder.  Some of the complications and their solutions are discussed here, based on the experiences of health clinics for the homeless in large US cities.
   Methods.  In 1988, the Stewart B. McKinney Homeless Assistance Act established health care clinics for homeless persons in 108 cities.  We surveyed medical directors in these clinics, asking about the management of hypertension in this difficult-to-treat population; 65 responded.
   Results.  Comparisons between our survey data and those obtained in two recent surveys of clinicians in "normal" clinical practice provide interesting lessons in how medical practice is adapted to respond to the unique needs and problems of the urban homeless.  Although therapeutic goals are similar, the means chosen to achieve them often are not.
   Conclusions.  The treatment of homeless hypertensives illustrates the problems inherent in strict biomedical models of disease and its alleviation.  Preferred treatments, course of disease, and success of intervention are powerfully affected by social factors.
C1 TULANE UNIV,DEPT SOCIOL,220 NEWCOMB HALL,NEW ORLEANS,LA 70118.
CR ADAMSON TE, 1989, J FAM PRACTICE, V29, P93
   [Anonymous], 1988, ARCH INTERN MED, V148, P1023
   CLOHER TP, 1986, ARCH INTERN MED, V146, P529, DOI 10.1001/archinte.146.3.529
   Fedder D O, 1988, Md Med J, V37, P354
   Institute of Medicine, 1988, HOM HLTH HUM NEEDS
   KAPLAN NM, 1986, CLIN HYPERTENSION
   KELLOGG FR, 1985, HLTH CARE HOMELESS P, P109
   KINCHEN K, 1990, THESIS TULANE U NEW
   Klein LE, 1988, HYPERTENSION S2, V11, pII61
   MACMAHON SW, 1986, ANN INTERN MED, V105, P124
   Nyamathi A, 1989, Nurse Pract, V14, P47
   PIANTERI O, 1990, SAFETY NET HLTH SOCI, P250
   THOMSON GE, 1981, AM J PUBLIC HEALTH, V71, P413, DOI 10.2105/AJPH.71.4.413
   WINICK M, 1985, HLTH CARE HOMELESS P
   WRIGHT J, 1989, ADDRESS UNKNOWN HOME
   WRIGHT JD, 1988, SOC PROBL, V35, P182, DOI 10.1525/sp.1988.35.2.03a00060
   WRIGHT JD, 1987, HOMELESSNESS HLTH
NR 17
TC 19
Z9 19
U1 0
U2 1
PU AMER PUBLIC HEALTH ASSN INC
PI WASHINGTON
PA 1015 FIFTEENTH ST NW, WASHINGTON, DC 20005
SN 0090-0036
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD SEP
PY 1991
VL 81
IS 9
BP 1163
EP 1165
DI 10.2105/AJPH.81.9.1163
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GJ839
UT WOS:A1991GJ83900013
PM 1951828
OA Bronze
DA 2018-10-19
ER

PT J
AU LININS, I
   KLEIN, RC
   GERSHEY, EL
AF LININS, I
   KLEIN, RC
   GERSHEY, EL
TI MANAGEMENT OF MIXED WASTES FROM BIOMEDICAL-RESEARCH
SO HEALTH PHYSICS
LA English
DT Article
AB Mixed radioactive and chemical wastes generated by biomedical research were characterized, and various treatment methods for reducing their volume were evaluated. These wastes consist primarily of organic solvents used in the extraction and purification of radiolabeled biomolecules that are contaminated with low levels of the long-lived radionuclides, H-3 and C-14. The Rockefeller University's mixed wastes fall into three broad chemical categories: phenol/chloroform, acetonitrile/water, and mixtures of miscellaneous solvents such as carbon tetra-chloride, benzene, and other hazardous chemicals. Currently, with the exception of liquid scintillation cocktails (deregulated in 1981), there are no commercial disposal outlets for mixed wastes nor may they be stored legally for more than 90-180 d. Most of these mixed wastes can be effectively rendered into nonradioactive chemical and aqueous radioactive waste, both of which can be disposed of in accordance with existing regulations. However, to do so requires a Resource Conservation and Recovery Act (RCRA) Part B permit for licensure as a treatment, storage, and disposal facility. For many university research facilities, this may require financial and personnel resources disproportionate to the small amounts of waste produced. Also, such treatment, if not done properly, presents potential occupational hazards from the direct handling of waste materials. Deregulation of certain mixed wastes would be the safest, most cost-effective, and practical method for dealing with many mixed wastes of biomedical origin. In any event, a national regulatory solution must be found.
RP LININS, I (reprint author), ROCKEFELLER UNIV, 1230 YORK AVE, NEW YORK, NY 10021 USA.
CR BARKER RL, 1986, PERFORMANCE PROTECTI
   BOWERMAN BS, 1986, NUREG CR4433 BROOKH
   COYDAN R, 1987, EPA600287104
   HACKMAN E, 1978, TOXIC ORGANIC CHEM D
   Lunn G, 1990, DESTRUCTION HAZARDOU
   SCHOLZE RJ, 1988, BIOTECHNOLOGY DEGRAD
   Schwope AD, 1987, GUIDELINES SELECTION
   SUCIU DF, 1986, ESLTR8560 AIR FORC E
   TEDDER DW, 1990, AM CHEM SOC S SERIES, V422
   1983, PRUDENT PRACTICES DI
NR 10
TC 1
Z9 1
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0017-9078
EI 1538-5159
J9 HEALTH PHYS
JI Health Phys.
PD SEP
PY 1991
VL 61
IS 3
BP 421
EP 426
DI 10.1097/00004032-199109000-00014
PG 6
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical
   Imaging
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
GA GD979
UT WOS:A1991GD97900014
PM 1880030
DA 2018-10-19
ER

PT J
AU HIRATA, Y
   IFUKUBE, T
   MATSUSHIMA, J
   TOCHINAI, K
AF HIRATA, Y
   IFUKUBE, T
   MATSUSHIMA, J
   TOCHINAI, K
TI EVALUATION OF A STIMULATION ELECTRODE COVERED WITH POLYVINYL-ALCOHOL GEL
   FOR EXTRACOCHLEAR PROSTHESIS
SO IEICE TRANSACTIONS ON COMMUNICATIONS ELECTRONICS INFORMATION AND SYSTEMS
LA English
DT Article
AB Polyvinyl alcohol gel (PVA gel) has been applied in various fields as a biomedical material in Japan since the mechanical and the electrical characteristics are very similar to the human body.  In this paper, the electrical characteristics of the electrode coated with PVA gel containing saline solution are described.  The electrode has been applied to a stimulation electrode in an extracochlear prosthesis.  It is expected that the coated electrode can stick to the round window membrane without scarring it.  From the experimental results, it was found that the electrical impedance of a stimulation electrode coated with PVA gel exhibited good stability and the effective double-layer capacitance of the coated electrode was less dependent on the current than the capacitance of the Pt-Ir electrode.  The electrical characteristics of the PVA electrode were proved to be very stable for long term use in-vivo.  The coated electrode was ascertained to be able to stimulate reliably the auditory nerves of a guinea pig.
RP HIRATA, Y (reprint author), HOKKAIDO UNIV,APPL ELECT RES INST,SAPPORO,HOKKAIDO 060,JAPAN.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU IEICE-INST ELECTRON INFO COMMUN ENG
PI TOKYO
PA KIKAI-SHINKO-KAIKAN BLDG MINATO-KU SHIBAKOEN 3 CHOME, TOKYO 105, JAPAN
SN 0917-1673
J9 IEICE TRANS COMMUN
PD SEP
PY 1991
VL 74
IS 9
BP 2960
EP 2964
PG 5
WC Engineering, Electrical & Electronic
SC Engineering
GA GG846
UT WOS:A1991GG84600065
DA 2018-10-19
ER

PT J
AU CHRISTENSON, L
   WAHLBERG, L
   AEBISCHER, P
AF CHRISTENSON, L
   WAHLBERG, L
   AEBISCHER, P
TI MAST-CELLS AND TISSUE REACTION TO INTRAPERITONEALLY IMPLANTED POLYMER
   CAPSULES
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID BIOMEDICAL POLYMERS; FIBROSIS; INVITRO; DEXAMETHASONE; MACROPHAGES;
   FIBROBLASTS; MODULATION; ACTIVATION; GENERATION; SECRETION
AB The inflammatory reaction to implanted biomaterials often compromises the clinical usefulness of implantable devices.  Dexamethasone, an anti-inflammatory agent, acts on macrophages to decrease production of inflammatory mediators, and on mast cells to prevent degranulation.  Systemic administration of dexamethasone (dms) in rats decreases the tissue reaction to intraperitoneally implanted vinyl chloride-acrylic copolymer capsules.  Local release of even smaller amounts of dms from a polymeric substrate placed inside an acrylic copolymer capsule may control the tissue reaction while avoiding the undesirable side effects of systemic treatment.  Such a system also allows investigation of the local effect of soluble molecules on tissue-material interactions without altering the surface properties of the implant or adding the effect of a releasing material.  In the present study, we investigated the effect of dms released from ethylene vinyl acetate (EVAc) rods placed in acrylic copolymer capsules and implanted in the peritoneal cavity of rats.  In vitro the release of dms from EVAc rods was quasilinear for 5 weeks.  When implanted intraperitoneally into rats, polymer capsules containing EVAc/dms rods generated a tissue reaction that was significantly thinner and featured fewer fibroblast and collagen layers than that around capsules containing pure EVAc rods at all time points studied.  The tissue reaction layer was also thinner than that previously described in rats treated systemically with dms.  The trabeculae of implants with dms-loaded EVAc rods contained significantly more intact mast cells than implants with EVAc alone, suggesting that degranulation of mast cells is involved in the tissue reaction to intraperitoneal polymer implants.
C1 BROWN UNIV,ARTIFICIAL ORGAN LAB,PROVIDENCE,RI 02912.
RI Aebischer, Patrick/E-1387-2013
CR ATKINS FM, 1985, INT ARCH ALLER A IMM, V77, P96, DOI 10.1159/000233760
   CHRISTENSON L, 1989, J BIOMED MATER RES, V23, P705, DOI 10.1002/jbm.820230704
   CLAMAN HN, 1985, IMMUNOL TODAY, V6, P192, DOI 10.1016/0167-5699(85)90115-X
   Cox J S, 1970, Adv Drug Res, V5, P115
   DRUVEFORS P, 1988, VIRCHOWS ARCH B, V55, P187
   Enerback L, 1989, Curr Top Pathol, V79, P169
   FRANZEN L, 1980, CELL TISSUE KINET, V13, P635, DOI 10.1111/j.1365-2184.1980.tb00502.x
   HIGGINBOTHAM RD, 1956, P SOC EXP BIOL MED, V92, P256
   JANES J, 1948, ARCH PATHOL, V45, P622
   LANGER R, 1976, NATURE, V263, P797, DOI 10.1038/263797a0
   MARQUARDT DL, 1983, J IMMUNOL, V131, P934
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   NORRBY K, 1973, VIRCHOWS ARCH B, V15, P75
   NORRBY K, 1984, CELL TISSUE RES, V235, P339
   NORRBY K, 1976, CELL TISSUE RES, V170, P289, DOI 10.1007/BF00219412
   PERSINGER MA, 1983, BRIT J DERMATOL, V108, P179, DOI 10.1111/j.1365-2133.1983.tb00060.x
   RAO PVS, 1983, J IMMUNOL, V130, P341
   SMITH DE, 1958, ANAT RECORD, V132, P93, DOI 10.1002/ar.1091320107
   SNYDER DS, 1982, J IMMUNOL, V129, P1803
   STOSICGRUJICIC S, 1982, CELL IMMUNOL, V69, P235, DOI 10.1016/0008-8749(82)90070-3
   VERGARA JA, 1987, INT J RADIAT ONCOL, V13, P723, DOI 10.1016/0360-3016(87)90291-4
   WAAGE A, 1987, CLIN IMMUNOL IMMUNOP, V45, P348, DOI 10.1016/0090-1229(87)90087-0
   WATANABE S, 1974, LAB INVEST, V31, P555
   YOFFE JR, 1985, BIOCHEM J, V230, P83, DOI 10.1042/bj2300083
NR 26
TC 18
Z9 18
U1 0
U2 0
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP
PY 1991
VL 25
IS 9
BP 1119
EP 1131
DI 10.1002/jbm.820250906
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA GB216
UT WOS:A1991GB21600005
PM 1778997
DA 2018-10-19
ER

PT J
AU CLAROTTI, G
   SCHUE, F
   SLEDZ, J
   GECKELER, KE
   GOPEL, W
   ORSETTI, A
AF CLAROTTI, G
   SCHUE, F
   SLEDZ, J
   GECKELER, KE
   GOPEL, W
   ORSETTI, A
TI PLASMA DEPOSITION OF THIN FLUOROCARBON FILMS FOR INCREASED MEMBRANE
   HEMOCOMPATIBILITY
SO JOURNAL OF MEMBRANE SCIENCE
LA English
DT Article; Proceedings Paper
CT 6TH INTERNATIONAL SYMP ON SYNTHETIC MEMBRANES IN SCIENCE AND INDUSTRY
CY SEP 04-08, 1989
CL TUBINGEN, FED REP GER
DE BIOMEDICAL MEMBRANES; PLASMA POLYMERIZED MEMBRANES; HEMOCOMPATIBILITY;
   BIOCOMPATIBILITY; FLUOROCARBON FILMS; POLYSULFONE MEMBRANE; MEMBRANE
   PREPARATION AND STRUCTURE; SURFACE MODIFICATION; SURFACE
   CHARACTERIZATION
ID POLYMERIZATION
AB Plasma polymerization of gases present in a low temperature plasma is a "clean" technique that is particularly well suited for biomedical material processing.  This paper presents the first results of a project which studies the possibilities offered by this technique to prepare commercial low-cost membranes with the required bio- and hemocompatibility to be implanted in an organism.  The deposition on polysulfone of films from a plasma containing a mixture of ethylene oxide and perfluorohexane in order to obtain very hydrophobic, less hydrophobic and intermediate coatings was studied.  Results obtained by adding hydrogen to perfluorohexane are also discussed.  The deposition of a thin coating from a perfluorohexane and hydrogen to perfluorohexane are also discussed.  The deposition of a thin coating from a perfluorohexane and hydrogen plasma was studied in order to optimize the surface properties of the treated membranes without affecting their filtering properties.  The treated substrates have been characterized by measuring mass variations, by surface profilometry and contact angle techniques as well as by scanning electron microscopy and electron spectroscopy for chemical analysis.
C1 UNIV MONTPELLIER 2,CHIM MACROMOLEC LAB,F-34095 MONTPELLIER 2,FRANCE.
   UNIV TUBINGEN,INST ORGAN CHEM,W-7400 TUBINGEN 1,GERMANY.
   CHR LAPEYRONIE,EXPLORAT HORMONES LAB,MONTPELLIER,FRANCE.
   UNIV TUBINGEN,INST PHYS CHEM,W-7400 TUBINGEN 1,GERMANY.
CR Andrade JD, 1986, ADV POLYM SCI, V79, P3
   Boenig HV, 1982, PLASMA SCI TECHNOLOG
   BROMAN L, 1977, ANN ACAD SCI, P283
   BRUCK SD, 1980, PROPERTIES BIOMATERI
   CHAWLA AS, 1986, REV POLYM BIOMATERIA, P231
   DAWIDS S, 1986, BLOOD COMPATIBLE MAT
   GIRIFALCO J, 1957, PHYS CHEM, V16, P417
   HAQUE Y, 1986, J APPL POLYM SCI, V32, P4369, DOI 10.1002/app.1986.070320407
   HOFFMAN AS, 1984, ADV POLYM SCI, V57, P141
   HOFFMANN AS, 1987, CRIT REV BIOCOMPAT, V4, P1
   IKADA Y, 1984, ADV POLYM SCI, V57, P104
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   SHEN M, 1979, ACS S SER, V108
   YASUDA H, 1981, MACROMOL REV, V16, P199
   YASUDA H, 1978, J POLYM SCI POL CHEM, V16, P743, DOI 10.1002/pol.1978.170160403
   YASUDA H, 1982, BIOMATERIALS, V3, P68, DOI 10.1016/0142-9612(82)90036-9
   YASUDA H, 1978, J POLYM SCI POL CHEM, V16, P229, DOI 10.1002/pol.1978.170160122
   YASUDA H, 1978, J POLYM SCI POL CHEM, V16, P313, DOI 10.1002/pol.1978.170160201
   YASUDA H, 1978, J POLYM SCI POL CHEM, V16, P2587, DOI 10.1002/pol.1978.170161013
NR 19
TC 24
Z9 25
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0376-7388
J9 J MEMBRANE SCI
JI J. Membr. Sci.
PD SEP 1
PY 1991
VL 61
BP 289
EP 301
DI 10.1016/0376-7388(91)80022-X
PG 13
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA GG451
UT WOS:A1991GG45100022
DA 2018-10-19
ER

PT J
AU HELMUS, MN
AF HELMUS, MN
TI OVERVIEW OF BIOMEDICAL MATERIALS
SO MRS BULLETIN
LA English
DT Review
RP HELMUS, MN (reprint author), ST JUDE MED INC,RES PROGRAMS,ST PAUL,MN 55117, USA.
NR 0
TC 9
Z9 9
U1 0
U2 2
PU MATERIALS RESEARCH SOCIETY
PI PITTSBURGH
PA 9800 MC KNIGHT ROAD SUITE 327, PITTSBURGH, PA 15237
SN 0883-7694
J9 MRS BULL
JI MRS Bull.
PD SEP
PY 1991
VL 16
IS 9
BP 33
EP 38
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA GF320
UT WOS:A1991GF32000005
DA 2018-10-19
ER

PT J
AU BARBUCCI, R
   MAGNANI, A
   ALBANESE, A
   TEMPESTI, F
AF BARBUCCI, R
   MAGNANI, A
   ALBANESE, A
   TEMPESTI, F
TI HEPARINIZED POLYURETHANE SURFACE THROUGH IONIC BONDING OF HEPARIN
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE BIOMATERIALS; HEPARIN ADSORPTION; POLYURETHANE; BLOOD COMPATIBILITY
ID POLYMER; CHAINS
AB Surface heparinization through an ionic bond is one of the methods used to improve polyurethane blood compatibility.  Chains of poly(amido-amine), a tertiary aminic polymer capable of forming stable complexes with heparin, were either surface-grafted on polyurethane or interconnected with polyurethane chains using hexamethylenediisocyanate as cross-linking agent.  In the latter case, a new material (PUPA) is formed with a heparin adsorbing capacity higher than poly (amido-amine) surface-grafted polyurethane.  By changing the percentages of the components, different series of PUPA materials can be obtained with different physico-chemical properties.  The ATR/FT-IR technique was used to characterize the new materials in the native and in the heparinized state.  PUPA solution was used to coat commercial biomedical devices and they were also characterized physico-chemically using ATR/FT-IR.
RP BARBUCCI, R (reprint author), UNIV SIENA,CTR DIDATTICO,CRISMA,NUOVO POLICLINICO LE SCOTTE,I-53100 SIENA,ITALY.
RI Magnani, Agnese/E-7999-2017
OI Magnani, Agnese/0000-0002-6960-9418
CR AZZUOLI G, 1987, BIOMATERIALS, V8, P61, DOI 10.1016/0142-9612(87)90032-9
   BARBUCCI R, 1985, POLYMER, V26, P1349, DOI 10.1016/0032-3861(85)90310-6
   BARBUCCI R, 1989, BIOMATERIALS, V10, P299, DOI 10.1016/0142-9612(89)90069-0
   BARBUCCI R, 1989, BIOMATERIALS, V10, P429, DOI 10.1016/0142-9612(89)90136-1
   BARBUCCI R, 1985, MAKROMOL CHEM, V186, P2291
   BARBUCCI R, IN PRESS POLYM
   BASMADJIAN D, 1983, J BIOMED MATER RES, V17, P509, DOI 10.1002/jbm.820170310
   DANUSSO F, 1970, POLYMER, V11, P88, DOI 10.1016/0032-3861(70)90029-7
   GARDNER DL, 1969, ASAIO T, V15, P7
   GOOSEN MFA, 1983, J BIOMED MATER RES, V17, P359, DOI 10.1002/jbm.820170212
   GOTT VL, 1963, SCIENCE, V142, P1297, DOI 10.1126/science.142.3597.1297
   GRODE GA, 1969, ASAIO T, V15, P1
   HEYMAN PW, 1985, J BIOMED MATER RES, V19, P419, DOI 10.1002/jbm.820190407
   ITO Y, 1986, J BIOMED MATER RES, V20, P1017, DOI 10.1002/jbm.820200715
   ITO Y, 1987, BIOMATERIALS APPL, V2, P235
   LARM O, 1983, BIOMATER ARTIF CELL, V11, P161, DOI 10.3109/10731198309118804
   MERRILL EW, 1970, J APPL PHYSIOL, V29, P723
   MIURA Y, 1980, J BIOMED MATER RES, V14, P619, DOI 10.1002/jbm.820140508
   NOISHIKI Y, 1981, ASAIO T, V27, P213
   SALZMAN EW, 1980, J CLIN INVEST, V65, P64, DOI 10.1172/JCI109661
   SHIBUTA R, 1986, J BIOMED MATER RES, V20, P971, DOI 10.1002/jbm.820200712
   SHMER G, 1972, ASAIO T, V18, P321
   TANZAWA H, 1973, T AM SOC ART INT ORG, V19, P188
   TANZI MC, 1986, POLYM MED SURGERY V, V2, P1
   YEN S P S, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P83
NR 25
TC 20
Z9 21
U1 0
U2 3
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD AUG
PY 1991
VL 14
IS 8
BP 499
EP 507
PG 9
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA GE815
UT WOS:A1991GE81500008
PM 1937939
DA 2018-10-19
ER

PT J
AU PEPPAS, NA
   STAUFFER, SR
AF PEPPAS, NA
   STAUFFER, SR
TI REINFORCED UNCROSSLINKED POLY (VINYL ALCOHOL) GELS PRODUCED BY CYCLIC
   FREEZING-THAWING PROCESSES - A SHORT REVIEW
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Review
DE POLY (VINYL ALCOHOL); HYDROGEL; BIOMATERIAL; FREEZING OF SOLUTION;
   SUPERMOLECULAR STRUCTURE
AB Novel methods of preparation of strong poly(vinyl alcohol) hydrogels without utilization of chemical crosslinking or reinforcing agents are reviewed.  Aqueous poly (vinyl alcohol) solutions exposed to several freezing-thawing cycles lead to such materials.  The process of reinforcement of these hydrogels is a densification of the macromolecular structure.  This is probably due to the microparticle-microgel formation within the hydrogel or to microcrystalline structural formations or to partial phase separation.  The densification process is more prominent for gels that are exposed to up to five freezing-thawing cycles.  Important biomedical and pharmaceutical applications of these gels are reviewed.
RP PEPPAS, NA (reprint author), PURDUE UNIV,SCH CHEM ENGN,W LAFAYETTE,IN 47907, USA.
NR 0
TC 164
Z9 167
U1 4
U2 76
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD AUG
PY 1991
VL 16
IS 3
BP 305
EP 310
DI 10.1016/0168-3659(91)90007-Z
PG 6
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA GB151
UT WOS:A1991GB15100007
DA 2018-10-19
ER

PT J
AU KABANOV, VA
AF KABANOV, VA
TI INTERPOLYMER COMPLEXES AS NEW MATERIALS FOR BIOMEDICAL APPLICATIONS
SO MAKROMOLEKULARE CHEMIE-MACROMOLECULAR SYMPOSIA
LA English
DT Article
ID POLY-ELECTROLYTE COMPLEXES
RP KABANOV, VA (reprint author), MV LOMONOSOV STATE UNIV, FAC CHEM, DEPT POLYMER SCI, LENINSKIE GORY, MOSCOW 234, USSR.
CR KABANOV VA, 1989, MAKROMOL CHEM, V190, P2211
   KABANOV VA, 1982, SOV SCI REV B, V4, P207
   MORRISON WR, 1984, US USSR JOINT STUDIE
   ZEZIN AB, 1987, KHIM FARM ZH+, V21, P788
   ZEZIN AB, 1989, FRONTIERS MACROMOLEC, P219
   ZHELEZNOVA IV, 1986, DOKL AKAD NAUK SSSR+, V287, P662
   ZHELEZNOVA IV, 1987, DOKL AKAD NAUK SSSR+, V295, P1156
NR 7
TC 4
Z9 5
U1 0
U2 0
PU HUTHIG & WEPF VERLAG
PI BASEL
PA AUF DEM WOLF 4, CH-4052 BASEL, SWITZERLAND
SN 0258-0322
J9 MAKROMOL CHEM-M SYMP
PD AUG
PY 1991
VL 48-9
BP 425
EP 426
DI 10.1002/masy.19910480131
PG 2
WC Polymer Science
SC Polymer Science
GA GG244
UT WOS:A1991GG24400029
DA 2018-10-19
ER

PT J
AU SHELLOCK, FG
   CURTIS, JS
AF SHELLOCK, FG
   CURTIS, JS
TI MR IMAGING AND BIOMEDICAL IMPLANTS, MATERIALS, AND DEVICES - AN UPDATED
   REVIEW
SO RADIOLOGY
LA English
DT Review
DE MAGNETIC RESONANCE (MR), SAFETY
ID METALLIC BALLISTIC FRAGMENTS; POTENTIAL HAZARDS; DENTAL MATERIALS;
   SURGICAL CLIPS; RETINAL TACKS; ARTIFACTS; SAFETY; FERROMAGNETISM;
   FILTERS; FORCES
AB Certain ferromagnetic metallic implants, materials, and devices are regarded as contraindications for magnetic resonance imaging, primarily because of the risks associated with their movement or dislodgment.  More than 40 publications have reported the ferromagnetic qualities of 261 different metallic objects (aneurysm and hemostatic clips, 32; carotid artery vascular clamps, five; dental devices or materials, 16; heart valve prostheses, 29; intravascular coils, filters, and stents, 14; ocular implants, 12; orthopedic implants, materials, and devices, 15; otologic implants, 56; pellets and bullets, 23; penile implants, nine; vascular access ports, 33; and miscellaneous, 17) on the basis of measurements of deflection forces or attraction during exposure to static magnetic fields at strengths of 0.147-4.7 T.  The results of these studies are listed with respect to the specific object tested, the material used to construct the object (if known), whether or not the object was deflected or moved during exposure to the static magnetic field, and the highest static magnetic field strength used for testing the object.
C1 UNIV CALIF LOS ANGELES,SCH MED,DEPT DIAGNOST RADIOL,LOS ANGELES,CA 90024.
RP SHELLOCK, FG (reprint author), CEDARS SINAI MED CTR,DEPT DIAGNOST RADIOL,TOWER MUSCULOSKELETAL IMAGING CTR,8700 BEVERLY BLVD,LOS ANGELES,CA 90048, USA.
FU NCI NIH HHS [1 RO1 CA44014-03]
CR ALBERT DW, 1990, ARCH OPHTHALMOL-CHIC, V108, P320, DOI 10.1001/archopht.1990.01070050018007
   APPLEBAUM EL, 1990, ANN OTO RHINOL LARYN, V99, P801, DOI 10.1177/000348949009901009
   APPLEBAUM EL, 1985, ARCH OTOLARYNGOL, V111, P820
   BARRAFATO D, 1984, CAN J SURG, V27, P509
   BECKER RL, 1988, AM J NEURORADIOL, V9, P885
   BELLON EM, 1984, MAGN RESON IMAGING, V2, P41
   BROWN MA, 1987, MAGN RESON IMAGING, V5, P443, DOI 10.1016/0730-725X(87)90378-X
   DAVIS PL, 1981, AM J ROENTGENOL, V137, P857, DOI 10.2214/ajr.137.4.857
   DEKEIZER RJW, 1986, DOC OPHTHALMOL, V61, P281, DOI 10.1007/BF00142354
   DUJOVNY M, 1985, NEUROSURGERY, V17, P543, DOI 10.1227/00006123-198510000-00002
   FACHE JS, 1987, AM J NEURORADIOL, V8, P837
   GEGAUFF AG, 1990, J ORAL REHABIL, V17, P403, DOI 10.1111/j.1365-2842.1990.tb01411.x
   GO KG, 1989, CLIN NEUROL NEUROSUR, V91, P109, DOI 10.1016/S0303-8467(89)80030-7
   GOLD JP, 1989, ANN THORAC SURG, V48, P643, DOI 10.1016/0003-4975(89)90780-7
   HASSLER M, 1986, Journal de Radiologie (Paris), V67, P661
   JOONDEPH BC, 1987, ARCH OPHTHALMOL-CHIC, V105, P1479
   KANAL E, 1990, RADIOLOGY, V176, P593, DOI 10.1148/radiology.176.3.2202008
   Kanal E., 1988, MAGN RESON IMAGIN S1, V7, P106
   KELLY WM, 1986, AM J NEURORADIOL, V7, P243
   KUETHE DO, 1991, INVEST RADIOL, V26, P1, DOI 10.1097/00004424-199101000-00001
   LAAKMAN RW, 1985, RADIOLOGY, V157, P711, DOI 10.1148/radiology.157.3.4059558
   LEON JA, 1987, MAGN RESON IMAGING, V5, P405, DOI 10.1016/0730-725X(87)90130-5
   LIANG MD, 1989, MAGN RESON IMAGING, V7, P541, DOI 10.1016/0730-725X(89)90407-4
   LIEBMAN CE, 1988, AM J ROENTGENOL, V150, P1174, DOI 10.2214/ajr.150.5.1174
   LISSAC M, 1991, INVEST RADIOL, V26, P40, DOI 10.1097/00004424-199101000-00008
   LYONS CJ, 1989, SPINE, V14, P670, DOI 10.1097/00007632-198907000-00004
   MARK AS, 1987, RADIOLOGY, V162, P311, DOI 10.1148/radiology.162.2.3797642
   MATSUMOTO AH, 1989, RADIOLOGY, V170, P753, DOI 10.1148/radiology.170.3.2916029
   MATTUCCI KF, 1986, OTOLARYNG HEAD NECK, V94, P441, DOI 10.1177/019459988609400407
   MECHLIN M, 1984, AM J ROENTGENOL, V143, P1281, DOI 10.2214/ajr.143.6.1281
   NEW PFJ, 1983, RADIOLOGY, V147, P139, DOI 10.1148/radiology.147.1.6828719
   POWER W, 1988, LANCET, V2, P227
   Pusey E, 1986, Radiographics, V6, P891
   ROBERTS CW, 1990, ARCH OPHTHALMOL-CHIC, V108, P320
   SHELLOCK F G, 1989, Magnetic Resonance Quarterly, V5, P243
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P811, DOI 10.2214/ajr.151.4.811
   SHELLOCK FG, 1988, AM J ROENTGENOL, V151, P389, DOI 10.2214/ajr.151.2.389
   SHELLOCK FG, 1991, JMRI-J MAGN RESON IM, V1, P97, DOI 10.1002/jmri.1880010114
   SHELLOCK FG, 1991, AM J NEURORADIOL, V12, P279
   SHELLOCK FG, 1991, JMRI, V61, P243
   SHELLOCK FG, 1989, MAGN RESON IMAGIN S1, V7, pP38
   SHELLOCK FG, 1990, RADIOLOGY P, V177, P271
   SHELLOCK FG, 1988, MRI DECISIONS, V2, P25
   SHELLOCK FG, 1987, SOC MAGNETIC RESONAN, P915
   Shellock FG, 1987, RADIOLOGY, V165, P150
   SOULEN RL, 1985, RADIOLOGY, V154, P705, DOI 10.1148/radiology.154.3.3969474
   TEITELBAUM GP, 1990, RADIOLOGY, V175, P855, DOI 10.1148/radiology.175.3.2343136
   TEITELBAUM GP, 1990, RADIOLOGY, V174, P1013, DOI 10.1148/radiology.174.3.174-3-1013
   TEITELBAUM GP, 1988, RADIOLOGY, V168, P713, DOI 10.1148/radiology.168.3.3406402
   TEITELBAUM GP, 1990, RADIOLOGY, V177, P883, DOI 10.1148/radiology.177.3.2244005
   TEITELBAUM GP, 1989, CARDIOVASC INTER RAD, V12, P125, DOI 10.1007/BF02577374
   TEITELBAUM GP, 1988, RADIOLOGY, V166, P657, DOI 10.1148/radiology.166.3.3340759
   TEITELBAUM GP, 1990, AM J NEURORADIOL, V11, P267
   WATANABE AT, 1990, RADIOLOGY, V177, P578, DOI 10.1148/radiology.177.2.2217801
   WHITE DW, 1987, AM J OTOL, V8, P290
   WILLIAMSON MR, 1988, ANGIOLOGY, V12, P1022
   YAMANASHI WS, 1984, PHYSIOL CHEM PHYS, V16, P237
   YUH WTC, IN PRESS AJNR
   ZHEUTLIN JD, 1987, AM J OPHTHALMOL, V103, P831, DOI 10.1016/S0002-9394(14)74404-6
   1988, ECRI HLTH DEVICES AL, P1
NR 60
TC 109
Z9 111
U1 1
U2 3
PU RADIOLOGICAL SOC NORTH AMER
PI EASTON
PA 20TH AND NORTHAMPTON STS, EASTON, PA 18042
SN 0033-8419
J9 RADIOLOGY
JI Radiology
PD AUG
PY 1991
VL 180
IS 2
BP 541
EP 550
DI 10.1148/radiology.180.2.2068325
PG 10
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA FW933
UT WOS:A1991FW93300050
PM 2068325
DA 2018-10-19
ER

PT J
AU ANBAR, M
AF ANBAR, M
TI COMPARING ASSESSMENTS OF STUDENTS KNOWLEDGE BY COMPUTERIZED OPEN-ENDED
   AND MULTIPLE-CHOICE TESTS
SO ACADEMIC MEDICINE
LA English
DT Note
AB At the State University of New York at Buffalo School of Medicine and Biomedical Sciences, interactive computerized tests that accept unrestricted natural-language input were used to assess the knowledge of medical students in a sophomore course on clinical biophysics in 1989.  The course covered the physical bases, scopes, and limitations of the most widely used diagnostic, therapeutic, and prosthetic technologies.  The test was composed of both open-ended sequential questions and multiple-choice questions on the same material.  The scores for the two testing modes were correlated, paying special attention to answers that demonstrated a flagrant lack of knowledge, corroborated by subsequent answers.  The correlation between the qualities of the answers for the two testing modalities was found to be significantly positive for the lower half of the class of students and negative for the upper half, suggesting that the two modes of testing measure different aspects of competence.  The implications of the findings to medical education and accreditation are discussed.
C1 SUNY BUFFALO,SCH MED & BIOMED SCI,DEPT BIOPHYS SCI,BUFFALO,NY 14260.
CR ANBAR M, 1988, MED TEACH, V10, P175, DOI 10.3109/01421598809010540
   ANBAR M, 1981, J MED EDUC, V56, P443
   ANBAR M, 1986, RESIDENT STAFF PHYSI, V32, P91
   ANBAR M, 1988, S ENG COMPUTER BASED, P112
   ANBAR M, 1987, MED ELECT, V18, P118
NR 5
TC 19
Z9 19
U1 0
U2 4
PU HANLEY & BELFUS INC
PI PHILADELPHIA
PA 210 S 13TH ST, PHILADELPHIA, PA 19107
SN 1040-2446
J9 ACAD MED
JI Acad. Med.
PD JUL
PY 1991
VL 66
IS 7
BP 420
EP 422
DI 10.1097/00001888-199107000-00012
PG 3
WC Education, Scientific Disciplines; Health Care Sciences & Services
SC Education & Educational Research; Health Care Sciences & Services
GA FX101
UT WOS:A1991FX10100014
PM 2059271
DA 2018-10-19
ER

PT J
AU LIN, FH
   HUANG, YY
   HON, MH
   WU, SC
AF LIN, FH
   HUANG, YY
   HON, MH
   WU, SC
TI FABRICATION AND BIOCOMPATIBILITY OF A POROUS BIOGLASS CERAMIC IN A
   NA2O-CAO-SIO2-P2O5 SYSTEM
SO JOURNAL OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE BIOGLASS CERAMICS; BIOCOMPATIBILITY; MICROSTRUCTURE
ID PHOSPHATE
AB A porous bioglass ceramic was prepared from a finely pulverized bioglass powder mixed with particles of two sizes (5 and 500-mu-m) of 30% by weight with the foaming agent polyethylene glycol 4000 (HO (C2H4O) nH).  The batch composition of the bioglass was Na2O 12%, CaO 28%, SiO2 50% and P2O5 10% by weight.  The specimens, formed by pressing, were sintered in a high temperature furnace.  In this study we are concerned with the preparation and microstructure of the material and its performance in biological tests.  The microstructure and crystalline phases of the material were investigated by differential thermal analysis, X-ray diffraction analysis, transmission electron microscopy and scanning electron microscopy.  In a biomedical examination, it was shown that the porous material was compatible with animal tissues.  The microstructure of the implant indicated that newly grown bone interlocked well with the glass ceramic and that macropores and micropores were distributed uniformly in the material, which provided channels for bone ingrowth and improved the microscopic bioresorption.
C1 NATL CHENG KUNG UNIV,DEPT MAT ENGN,TAINAN,TAIWAN.
RP LIN, FH (reprint author), NATL TAIWAN UNIV,COLL MED,CTR BIOMED ENGN,TAIPEI,TAIWAN.
CR CARPENTER PR, 1986, J MATER SCI LETT, V5, P1309, DOI 10.1007/BF01729402
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   DEGROOT K, 1980, BIOMATERIALS, V1, P45
   DELLEMAGNE MJ, 1945, SOC CHIM BIOL, V27, P597
   FERRARO JW, 1979, PLAST RECONSTR SURG, V63, P630
   HENCH LL, 1974, P SURFACES INTERFACE, P265
   HENCH LL, 1982, BIOMATERIALS INTERFA, P357
   HON MH, 1988, J MIN METALL ROC, V2, P143
   KINGERY WD, 1976, INTRO CERAMICS, P187
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P159
   LIN FH, 1987, J MATER SCI LETT, V5, P331
   LIN FH, 1985, J MED ENG ROC, V5, P33
   TOMSON MB, 1977, J DENT RES, V56, P1369, DOI 10.1177/00220345770560111501
   TOMSON MB, 1978, SCIENCE, V200, P1059, DOI 10.1126/science.200.4345.1059
   ZHU PN, 1982, J NON-CRYST SOLIDS, V52, P503, DOI 10.1016/0022-3093(82)90326-X
NR 15
TC 20
Z9 20
U1 0
U2 5
PU BUTTERWORTH-HEINEMANN LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0141-5425
J9 J BIOMED ENG
JI J. Biomed. Eng.
PD JUL
PY 1991
VL 13
IS 4
BP 328
EP 334
DI 10.1016/0141-5425(91)90115-N
PG 7
WC Engineering, Biomedical
SC Engineering
GA FU622
UT WOS:A1991FU62200008
PM 1890828
DA 2018-10-19
ER

PT J
AU GREISLER, HP
   ELLINGER, J
   HENDERSON, SC
   SHAHEEN, AM
   BURGESS, WH
   KIM, DU
   LAM, TM
AF GREISLER, HP
   ELLINGER, J
   HENDERSON, SC
   SHAHEEN, AM
   BURGESS, WH
   KIM, DU
   LAM, TM
TI THE EFFECTS OF AN ATHEROGENIC DIET ON MACROPHAGE BIOMATERIAL
   INTERACTIONS
SO JOURNAL OF VASCULAR SURGERY
LA English
DT Article
ID SMOOTH-MUSCLE CELLS; FACTOR-LIKE PROTEIN; GROWTH-FACTOR; BIOMEDICAL
   POLYMERS; HUMAN-MONOCYTES; INTERLEUKIN-1; INVITRO; PROLIFERATION;
   STIMULATION; CULTURE
AB We previously reported that biomaterials differentially induce macrophages to secrete growth factors that mediate reendothelialization.  The present study evaluates the effect of an atherogenic diet on macrophage/biomaterial interactions.  Female New Zealand white rabbits were fed an atherogenic diet.  Peritoneal macrophages were harvested from these as well as rabbits fed a normal diet and cultured in Minimum Essential Medium with platelet-poor serum.  Dacron or polyglactin 910 were added to two of three conditions of both cell groups in passage 2.  Conditioned media were collected weekly through week 15.  Mitogenicity assays were performed with quiescent mouse embryonal (BALB/c3T3) fibroblasts, atherosclerotic rabbit aortic smooth muscle cells, and murine capillary lung (LE-II) endothelial cells.  Mitogenic activity was assayed by scintillation counting of tritiated thymidine incorporation into deoxyribonucleic acid (DNA).  Results showed increased mitogenic activity released by macrophages from atherosclerotic rabbits, in the absence of prosthetic material, when assayed against every cell line.  In normal diet macrophages, polyglactin 910 stimulated mitogen release for every cell line, and Dacron yielded minimal mitogen release.  In lipid diet macrophages polyglactin 910 slightly increased mitogen release for all three cell lines, whereas Dacron resulted in stimulation of DNA synthesis in smooth muscle cells and BALB/c3T3 cells but less DNA synthesis in LE-II cells than in control, no graft material, media.  Western blotting demonstrated immunoreactivity to basic fibroblast growth factor in media from normal diet macrophages but only in the presence of polyglactin 910 or Dacron.  Radioimmunoassay for platelet-derived growth factor B chain was negative in all groups, and polymerase chain reaction techniques to amplify transforming growth factor-beta messenger ribonucleic was negative.  These data demonstrate the effect of in vivo dietary manipulation on macrophage activation as well as the effect of an atherogenic diet in modulating macrophage/biomaterial interactions.  Additionally, different biomaterials differentially induce macrophages to release factors that stimulate and inhibit growth.
C1 VET ADM MED CTR,HINES,IL 60141.
   ST BARNABAS HOSP,LIVINGSTON,NJ 07039.
   AMER RED CROSS,ROCKVILLE,MD.
RP GREISLER, HP (reprint author), LOYOLA UNIV,MED CTR,DEPT SURG,2160 S 1ST AVE,MAYWOOD,IL 60153, USA.
FU NHLBI NIH HHS [R01 HL41272]
CR ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155
   BAIRD A, 1985, BIOCHEM BIOPH RES CO, V126, P358, DOI 10.1016/0006-291X(85)90614-X
   BIANCO C, 1981, METHODS STUDYING MON, P273
   BONFIELD TL, 1989, J BIOMED MATER RES, V23, P535, DOI 10.1002/jbm.820230602
   COZZOLINO E, 1989, BLOOD S1, V74, pA144
   DICORLETO PE, 1983, P NATL ACAD SCI-BIOL, V80, P1919, DOI 10.1073/pnas.80.7.1919
   Greisler H P, 1987, J Vasc Surg, V5, P393
   GREISLER H P, 1987, Archives of Surgery, V122, P715
   Greisler H P, 1986, ASAIO Trans, V32, P346
   GREISLER H P, 1989, Journal of Vascular Surgery, V10, P566
   GREISLER HP, 1986, J VASC SURG, V3, P747, DOI 10.1067/mva.1986.avs0030747
   GREISLER HP, 1985, ARCH SURG-CHICAGO, V120, P315
   GREISLER HP, 1988, J VASC SURG, V7, P697, DOI 10.1067/mva.1988.avs0070697
   GREISLER HP, 1989, J VASC SURG, V9, P588, DOI 10.1067/mva.1989.vs0090588
   GREISLER HP, 1988, CIRCULATION S1, V78, P112
   Hannan R L, 1988, Growth Factors, V1, P7, DOI 10.3109/08977198809000242
   LIBBY P, 1983, J CELL PHYSIOL, V115, P217, DOI 10.1002/jcp.1041150217
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   NILSSON J, 1985, P NATL ACAD SCI USA, V82, P4418, DOI 10.1073/pnas.82.13.4418
   OLD LJ, 1985, SCIENCE, V230, P630, DOI 10.1126/science.2413547
   RAINES EW, 1989, SCIENCE, V243, P393, DOI 10.1126/science.2783498
   ROSS R, 1974, P NATL ACAD SCI USA, V71, P1207, DOI 10.1073/pnas.71.4.1207
   SCHMIDT JA, 1982, J IMMUNOL, V128, P2177
   SHIMOKADO K, 1985, CELL, V43, P277, DOI 10.1016/0092-8674(85)90033-9
   TOSATO G, 1988, SCIENCE, V239, P502, DOI 10.1126/science.2829354
   YAM LT, 1971, AM J CLIN PATHOL, V55, P283
   ZACHARIAS RK, 1988, J VASC SURG, V7, P606
NR 28
TC 14
Z9 15
U1 0
U2 0
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0741-5214
J9 J VASC SURG
JI J. Vasc. Surg.
PD JUL
PY 1991
VL 14
IS 1
BP 10
EP 23
PG 14
WC Surgery; Peripheral Vascular Disease
SC Surgery; Cardiovascular System & Cardiology
GA FW525
UT WOS:A1991FW52500002
PM 1829487
DA 2018-10-19
ER

PT J
AU DALECKI, D
   CARSTENSEN, EL
   PARKER, KJ
   BACON, DR
AF DALECKI, D
   CARSTENSEN, EL
   PARKER, KJ
   BACON, DR
TI ABSORPTION OF FINITE-AMPLITUDE FOCUSED ULTRASOUND
SO JOURNAL OF THE ACOUSTICAL SOCIETY OF AMERICA
LA English
DT Article
ID BIOMEDICAL FREQUENCIES; DIAGNOSTIC ULTRASOUND; NONLINEAR PROPAGATION;
   SOUND BEAMS; TISSUES; TRANSMISSION; INTENSITIES; DISTORTION; PREDICTION;
   FIELDS
AB Predictions of the absorption of focused finite amplitude waves based on weak shock theory have been tested experimentally.  The characteristics of this absorption are qualitatively different from those associated with small signal losses.  Under appropriate conditions, the absorption of finite amplitude ultrasound is determined largely by source amplitude, field geometry, and the nonlinear properties of the medium and is only weakly dependent upon the small signal absorption coefficient of the material.  These effects are seen most dramatically in sharply focused sound fields.  To emphasize nonlinear absorption in an experimental test of these predictions, measurements of heating were made in agar which has a very small linear absorption coefficient.  Under appropriate conditions, nonlinear losses can make the effective absorption coefficient of this poorly absorbing material somewhat greater than the soft tissues of the body.
C1 UNIV ROCHESTER,ROCHESTER CTR BIOMED ULTRASOUND,ROCHESTER,NY 14627.
   NATL PHYS LAB,DIV RADIAT SCI & ACOUST,TEDDINGTON TW11 0LW,MIDDX,ENGLAND.
RP DALECKI, D (reprint author), UNIV ROCHESTER,DEPT ELECT ENGN,ROCHESTER,NY 14627, USA.
OI Dalecki, Diane/0000-0001-7114-9732
FU NIGMS NIH HHS [GM09933]; NCI NIH HHS [CA39241]
CR BACON DR, 1989, ULTRASOUND MED BIOL, V15, P355, DOI 10.1016/0301-5629(89)90047-1
   BACON DR, 1989, PHYS MED BIOL, V34, P1633, DOI 10.1088/0031-9155/34/11/010
   BACON DR, 1984, ULTRASOUND MED BIOL, V10, P189, DOI 10.1016/0301-5629(84)90217-5
   BACON DR, 1990, J ACOUST SOC AM, V88, P26, DOI 10.1121/1.399950
   BACON DR, 1986, THESIS U BATH UK
   BAKHVALOV NS, 1978, SOV PHYS ACOUST+, V24, P10
   BLACKSTO.DT, 1966, J ACOUST SOC AM, V39, P1019, DOI 10.1121/1.1909986
   BLACKSTOCK DT, 1972, AM I PHYSICS HDB
   BLACKSTOCK DT, 1991, IN PRESS J ACOUST SO
   Carslaw H. S., 1959, CONDUCTION HEAT SOLI
   CARSTENSEN EL, 1982, ACUSTICA, V51, P116
   CARSTENSEN EL, 1980, ULTRASOUND MED BIOL, V6, P359, DOI 10.1016/0301-5629(80)90005-8
   CARSTENSEN EL, 1981, J ACOUST SOC AM, V70, P302, DOI 10.1121/1.386777
   CHRISTOPHER PT, 1990, UNPUB J ACOUST SOC A
   CHRISTOPHER PT, 1990, IN PRESS IBM J SUPER
   DICKINSON RJ, 1985, PHYS MED BIOL, V30, P445, DOI 10.1088/0031-9155/30/5/007
   DUCK FA, 1989, PHYS MED BIOL, V34, P1623, DOI 10.1088/0031-9155/34/11/009
   FRY FJ, 1989, ULTRASOUND MED BIOL, V15, P481, DOI 10.1016/0301-5629(89)90101-4
   FRY WJ, 1954, J ACOUST SOC AM, V26, P311, DOI 10.1121/1.1907333
   GOSS SA, 1981, IEEE T SON ULTRASON, V28, P22
   HARAN ME, 1983, J ACOUST SOC AM, V73, P774, DOI 10.1121/1.389043
   HART TS, 1988, J ACOUST SOC AM, V84, P1488, DOI 10.1121/1.396595
   HYNYNEN K, 1987, ULTRASOUND MED BIOL, V13, P85, DOI 10.1016/0301-5629(87)90078-0
   Lighthill M. J., 1956, SURVEYS MECHANICS, P250
   MUIR TG, 1980, ULTRASOUND MED BIOL, V6, P345, DOI 10.1016/0301-5629(80)90004-6
   SHOOTER JA, 1974, J ACOUST SOC AM, V55, P54, DOI 10.1121/1.1919475
   SWINDELL W, 1985, ULTRASOUND MED BIOL, V11, P121, DOI 10.1016/0301-5629(85)90014-6
   SWINDELL W, 1986, P I ACOUST, V8, P79
   Taylor GI, 1910, P R SOC LOND A-CONTA, V84, P371, DOI 10.1098/rspa.1910.0081
NR 29
TC 41
Z9 42
U1 0
U2 2
PU AMER INST PHYSICS
PI WOODBURY
PA CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999
SN 0001-4966
J9 J ACOUST SOC AM
JI J. Acoust. Soc. Am.
PD MAY
PY 1991
VL 89
IS 5
BP 2435
EP 2447
DI 10.1121/1.400976
PG 13
WC Acoustics; Audiology & Speech-Language Pathology
SC Acoustics; Audiology & Speech-Language Pathology
GA FL775
UT WOS:A1991FL77500043
PM 1861004
DA 2018-10-19
ER

PT J
AU MOORE, RL
   GROBE, GL
   GARDELLA, JA
AF MOORE, RL
   GROBE, GL
   GARDELLA, JA
TI AUGER AND X-RAY PHOTOELECTRON STUDY OF SURFACE HETEROGENEITY IN ASTM
   F-75 ALLOY PREPARED FOR BIOMEDICAL IMPLANTATION
SO JOURNAL OF VACUUM SCIENCE & TECHNOLOGY A-VACUUM SURFACES AND FILMS
LA English
DT Article; Proceedings Paper
CT 37TH NATIONAL SYMP OF THE AMERICAN VACUUM SOC
CY OCT 08-12, 1990
CL TORONTO, CANADA
SP AMER VACUUM SOC
ID COBALT BASE ALLOY; CORROSION PRODUCTS; CHROMIUM; SERUM; RELEASE; ESCA
AB Previous studies, which evaluated the tissue bonding and in vivo stability of biomedical devices, paid little attention to the surface chemistry and properties of the biomaterials prior to their implantation.  Better materials characterization before placement of biomedical devices is necessary for the understanding of the chemical and physical properties, which determine biocompatibility.  Biological adhesion, in particular, is strongly affected by surface chemistry changes, which are in turn drastically affected by differing preparations.  The particular focus of this investigation is on the differences between passivated (acid-treated) and nonpassivated (or untreated) ASTM F-75 alloy.  Both types of surfaces were examined utilizing Auger electron spectroscopy and x-ray photoelectron spectroscopy, with moderate emphasis placed on the detection and identification of nickel species.
C1 SUNY BUFFALO,DEPT CHEM,BUFFALO,NY 14214.
RP MOORE, RL (reprint author), PERKIN ELMER CORP,DIV PHYS ELECTR,5 PROGRESS ST,EDISON,NJ 08820, USA.
CR BAER DR, 1984, APPL SURF SCI, V19, P382
   BARTOLOZZI A, 1985, BIOMATERIALS, V6, P2, DOI 10.1016/0142-9612(85)90030-4
   BLACK J, 1983, BIOMATERIALS, V4, P160, DOI 10.1016/0142-9612(83)90003-0
   ERIKSSON JC, 1983, J COLLOID INTERF SCI, V95, P2
   GRAHAM SW, 1982, ANAL CHEM, V54, P2073, DOI 10.1021/ac00249a037
   GROGAN CH, 1957, CANCER, V10, P625, DOI 10.1002/1097-0142(195705/06)10:3<625::AID-CNCR2820100330>3.0.CO;2-F
   HERCULES DM, 1984, J CHEM EDUC, V61, P5
   KOEGEL A, 1984, J BIOMED MATER RES, V18, P513, DOI 10.1002/jbm.820180505
   LAUSMAA J, 1985, 11TH ANN M SOC BIOM
   LAUSMAA J, 1985, BIOMATER, V9, P23
   LINDBERG B, 1983, J COLLOID INTERF SCI, V95, P308, DOI 10.1016/0021-9797(83)90190-X
   NORSETH T, 1980, CANCER, V33, P1219
   OHNSORGE J, 1978, MED PROG TECHNOL, V5, P171
   OHNSORGE J, 1978, 1ST INT C MECH MED B, P1
   ROE FJC, 1969, BRIT J CANCER, V23, P172, DOI 10.1038/bjc.1969.25
   STORP S, 1977, SURF SCI, V68, P10, DOI 10.1016/0039-6028(77)90185-6
   TURNER NH, 1986, ANAL CHEM, V58, pR153, DOI 10.1021/ac00296a014
   TURNER NH, 1986, ANAL CHEM, V58, P5
   WAPNER KL, 1986, J BIOMED MATER RES, V20, P219, DOI 10.1002/jbm.820200211
   WOODMAN JL, 1983, J BIOMED MATER RES, V100, P655
NR 20
TC 11
Z9 11
U1 0
U2 1
PU AMER INST PHYSICS
PI WOODBURY
PA CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999
SN 0734-2101
J9 J VAC SCI TECHNOL A
JI J. Vac. Sci. Technol. A-Vac. Surf. Films
PD MAY-JUN
PY 1991
VL 9
IS 3
BP 1323
EP 1328
DI 10.1116/1.577620
PN 2
PG 6
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA FR763
UT WOS:A1991FR76300018
DA 2018-10-19
ER

PT J
AU NODA, I
AF NODA, I
TI LATEX ELASTOMER WITH A PERMANENTLY HYDROPHILIC SURFACE
SO NATURE
LA English
DT Article
ID POLYETHYLENE
AB WATER wettability is important in many applications of polymeric materials, including fabrics, printing and biomedical uses 1,2.  Various surface-modification techniques are available to convert the intrinsically hydrophobic surfaces of plastic to water-wettable ones, by incorporating chemically polar functional groups at the surface 4-7.  Although such chemically induced surface hydrophilicity can be relatively long-lived while the substrates remain rigid, increases in the mobility of surface molecules, for example, due to increasing temperature, can cause rapid loss of hydrophilicity, driven by the tendency of surfaces to minimize their free energy 2-5.  As the polar groups are not often bound to the polymer matrix (usually being instead free surfactant molecules), they may also be flushed from the surface by repeated exposure to water.  Here I report the preparation of permanently water-wettable elastomeric films from a latex synthesized by polymerization of monomers in the presence of an amphiphilic block copolymer.  By migration of the hydrophilic segments to the surface during film formation, the film is rendered essentially completely wettable by water.  Applications may include flexible coatings that can introduce spatially selective wettability to solid surfaces, for example one-side wettable perforated films used for bandages and disposable diapers 8.
RP NODA, I (reprint author), PROCTER & GAMBLE CO,MIAMI VALLEY LABS,POB 398707,CINCINNATI,OH 45239, USA.
CR BRIGGS D, 1980, POLYMER, V21, P895, DOI 10.1016/0032-3861(80)90244-X
   Noda I., 1988, [No title captured], Patent No. [US 4,735,843, 4735843]
   NUZZO RG, 1984, MACROMOLECULES, V17, P1013, DOI 10.1021/ma00135a007
   RASMUSSEN JR, 1977, J AM CHEM SOC, V99, P4736, DOI 10.1021/ja00456a035
   RATNER BD, 1978, J APPL POLYM SCI, V22, P643, DOI 10.1002/app.1978.070220306
   RUCKENSTEIN E, 1984, J COLLOID INTERF SCI, V101, P436, DOI 10.1016/0021-9797(84)90055-9
   SHARMA AK, 1981, J APPL POLYM SCI, V26, P2205, DOI 10.1002/app.1981.070260709
   Yasuda H., 1981, Journal of Polymer Science, Polymer Physics Edition, V19, P1285, DOI 10.1002/pol.1981.180190901
NR 8
TC 20
Z9 20
U1 1
U2 13
PU MACMILLAN MAGAZINES LTD
PI LONDON
PA 4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF
SN 0028-0836
J9 NATURE
JI Nature
PD MAR 14
PY 1991
VL 350
IS 6314
BP 143
EP 144
DI 10.1038/350143a0
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FB645
UT WOS:A1991FB64500053
DA 2018-10-19
ER

PT J
AU DUNNE, WM
   BURD, EM
AF DUNNE, WM
   BURD, EM
TI INVITRO MEASUREMENT OF THE ADHERENCE OF STAPHYLOCOCCUS-EPIDERMIDIS TO
   PLASTIC BY USING CELLULAR UREASE AS A MARKER
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Note
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; CATHETER SEPSIS; SLIME; PREVENTION;
   STRAINS; MODEL
AB A rapid and sensitive in vitro assay was developed to quantitatively assess the adherence of Staphylococcus epidermidis to a hydrophobic plastic surface.  The assay is based upon the detection of cell-associated urease activity as a marker of bacteria remaining adherent to the polystyrene microwells of flat-bottomed, 96-well tissue culture plates.  Using ATCC 35984, a slime-producing strain of S. epidermidis, the assay could detect as few as 3 X 10(3) bacteria and was linear to 3.5 X 10(7) bacteria.  The adherence of both slime-positive and slime-negative coagulase-negative staphylococci could be evaluated by using this method.  This assay could be used to examine factors which influence the adherence of individual S. epidermidis strains to hydrophobic surfaces and to develop agents or coating materials which suppress the adherence of coagulase-negative staphylococci to biomedical implants.
C1 MED COLL WISCONSIN,CHILDRENS HOSP WISCONSIN,DEPT PEDIAT,MILWAUKEE,WI 53201.
RP DUNNE, WM (reprint author), MED COLL WISCONSIN,CHILDRENS HOSP WISCONSIN,DEPT PATHOL,MILWAUKEE,WI 53201, USA.
CR BAYSTON R, 1987, ZENTRALBL BAKBER 1 S, V16, P133
   CHRISTENSEN GD, 1990, J INFECT DIS, V161, P1153, DOI 10.1093/infdis/161.6.1153
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   CHRISTENSEN GD, 1983, J CLIN MICROBIOL, V18, P258
   DUNNE WM, 1990, ANTIMICROB AGENTS CH, V34, P390, DOI 10.1128/AAC.34.3.390
   DUNNE WM, 1987, PEDIATR INFECT DIS J, V6, P1031
   GRAY ED, 1984, LANCET, V1, P365
   HOGT AH, 1986, INFECT IMMUN, V51, P294
   JOHNSON GM, 1986, INFECT IMMUN, V54, P13
   KARCHMER AW, 1983, ANN INTERNMED, V16, P113
   MAKI DG, 1987, JAMA-J AM MED ASSOC, V258, P2396, DOI 10.1001/jama.258.17.2396
   MCCULLOUGH DC, 1980, CHILD BRAIN, V7, P182
   PETERS G, 1981, ZBL BAKT MIK HYG B, V173, P293
   SANFORD BA, 1989, INFECT IMMUN, V57, P3735
   SATTLER FR, 1984, INFECT CONT HOSP EP, V5, P279, DOI 10.1017/S0195941700060331
   SEGURA M, 1989, J CLIN MICROBIOL, V27, P2656
   STOTTER AT, 1987, JPEN-PARENTER ENTER, V11, P159, DOI 10.1177/0148607187011002159
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   TROOSKIN SZ, 1985, SURGERY, V97, P547
   WEST TE, 1986, J CLIN MICROBIOL, V23, P809
   WILKINSON BJ, 1987, ZENTRALBLATT BAKTE S, V16, P67
   YOUNGER JJ, 1987, J INFECT DIS, V156, P548, DOI 10.1093/infdis/156.4.548
NR 23
TC 17
Z9 17
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171
SN 0099-2240
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD MAR
PY 1991
VL 57
IS 3
BP 863
EP 866
PG 4
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA FA764
UT WOS:A1991FA76400039
PM 2039236
DA 2018-10-19
ER

PT J
AU ANDERSON, G
   SCOTT, M
AF ANDERSON, G
   SCOTT, M
TI DETERMINATION OF PRODUCT SHELF-LIFE AND ACTIVATION-ENERGY FOR 5 DRUGS OF
   ABUSE
SO CLINICAL CHEMISTRY
LA English
DT Article
DE ARRHENIUS PLOTS; ACCELERATED STABILITY TESTING; CONTROL MATERIALS;
   BRACKET TABLE; Q-RULE; ACTIVATION ENERGY
ID STABILITY
AB Estimating the shelf life of reagents and controls is a critical step in evaluating new formulations. We describe several stability assessment techniques, giving particular attention to experimental design. Activation energy was experimentally determined for five major drugs of abuse and metabolites: morphine, 11-nor-DELTA-9-tetrahydrocannabinol-9-carboxylic acid, amphetamine, phenycyclidine, and benzoylecgonine. The use of activation energy in establishing shelf life is illustrated for SENTRY(TM) (Hycor Biomedical Inc.) Drugs of Abuse Screen Control, a liquid urine-based product.
RP ANDERSON, G (reprint author), HYCOR BIOMED INC, RES DEPT, 7272 CHAPMAN AVE, GARDEN GROVE, CA 92641 USA.
CR BENTLEY DL, 1970, J PHARM SCI, V59, P464, DOI 10.1002/jps.2600590405
   Connors K. A., 1973, CHEM STABILITY PHARM, P8
   KENNON L, 1964, J PHARM SCI, V53, P815, DOI 10.1002/jps.2600530726
   KIRKWOOD T B L, 1977, Biometrics, V33, P736
   Lachman L, 1976, KINETIC PRINCIPLES S, P32
   Porterfield R. I., 1984, MED DEVICE DIAGN APR, P45
NR 6
TC 62
Z9 64
U1 1
U2 5
PU AMER ASSOC CLINICAL CHEMISTRY
PI WASHINGTON
PA 2101 L STREET NW, SUITE 202, WASHINGTON, DC 20037-1526 USA
SN 0009-9147
EI 1530-8561
J9 CLIN CHEM
JI Clin. Chem.
PD MAR
PY 1991
VL 37
IS 3
BP 398
EP 402
PG 5
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA FB914
UT WOS:A1991FB91400016
PM 2004447
DA 2018-10-19
ER

PT J
AU GRIJPMA, DW
   ZONDERVAN, GJ
   PENNINGS, AJ
AF GRIJPMA, DW
   ZONDERVAN, GJ
   PENNINGS, AJ
TI HIGH-MOLECULAR-WEIGHT COPOLYMERS OF L-LACTIDE AND EPSILON-CAPROLACTONE
   AS BIODEGRADABLE ELASTOMERIC IMPLANT MATERIALS
SO POLYMER BULLETIN
LA English
DT Article
AB High molecular weight copolymers of L-lactide and epsilon-caprolactone have been synthesized by ring opening copolymerization with stannous octoate as catalyst.  The good mechanical properties of the 50/50 copolymers make it a suitable material for biomedical applications such as nerve guides etc., where degradation of the elastomeric implant is required.  In contrast to the frequently used MDI containing polyurethanes, degradation products of the P(LLA-epsilon-CL) are non toxic.  The use of such a material is therefore preferable.
C1 STATE UNIV GRONINGEN,POLYMER CHEM LAB,NIJENBORGH 16,9747 AG GRONINGEN,NETHERLANDS.
CR DEGROOT JH, UNPUB COLLOID POLYM
   DESANTIS P, 1968, BIOPOLYMERS, V6, P299, DOI 10.1002/bip.1968.360060305
   GOGOLEWSKI S, 1983, MAKROMOL CHEM-RAPID, V4, P675
   GOGOLEWSKI S, 1988, P SPE INT C MED PLAS
   HOPPEN HJ, 1990, BIOMATERIALS, V11, P268
   KRISHELDORF HR, 1987, J MACROMOL SCI CHE A, V24, P1345
   LEENSLAG JW, 1987, MAKROMOL CHEM, V188, P1809
   LELAH MD, 1987, POLYURETHANES MED
   MARCHANT RE, 1987, POLYMER, V28, P2032, DOI 10.1016/0032-3861(87)90037-1
   PENNINGS AJ, 1990, COLLOID POLYM SCI, V268, P2, DOI 10.1007/BF01410416
   ROBINSON PH, 1989, THESIS U GRONINGEN, P89
   ROBINSON PH, IN PRESS BRIT J PLAS
   ROBINSON PH, 1989, THESIS U GRONINGEN, P97
   SCHINDLER A, 1982, J POLYM SCI POL CHEM, V20, P319, DOI 10.1002/pol.1982.170200206
   Schindler A, 1977, CONT TOPICS POLYM SC, V2, P251
   SZYCHER M, 1983, J ELASTOM PLAST, V15, P81, DOI 10.1177/009524438301500205
   ZONDERVAN GJ, IN PRESS
NR 17
TC 144
Z9 151
U1 2
U2 38
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0170-0839
J9 POLYM BULL
JI Polym. Bull.
PD MAR
PY 1991
VL 25
IS 3
BP 327
EP 333
DI 10.1007/BF00316902
PG 7
WC Polymer Science
SC Polymer Science
GA EZ562
UT WOS:A1991EZ56200007
DA 2018-10-19
ER

PT J
AU RAMANI, AV
AF RAMANI, AV
TI PRODUCTION AND USE OF BIO-MEDICAL DEVICES - ITS RELEVANCE TO INDIA
SO CURRENT SCIENCE
LA English
DT Article; Proceedings Paper
CT SYMP ON THE ROLE OF CLINICAL RESEARCH IN HEALTH CARE DELIVERY IN
   DEVELOPING COUNTRIES
CY FEB, 1990
CL MADRAS, INDIA
SP MENON FDN
AB To achieve 'Health for All by 2000 AD.' India needs massive inputs of science and technology.  Rupees 60,000 millions worth of medical supplies will be needed in India by 2000 AD.  The supplies cover biomedical devices made from all classes of materials using precision light engineering techniques.  Indian industry is wary of entering this field because of low perceived demand, unfair competition from imports, need for a strict Good Manufacturing Practice, and unrestricted availability of low cost, poor quality 'look-alikes'.  Education of manufacturers and users, enactment of statutes regulating the making and use of these devices could be the answer.
RP RAMANI, AV (reprint author), SREE CHITRA TIRUNAL INST MED SCI & TECHNOL,BIOTECHNOL WING,TRIVANDRUM 695001,INDIA.
NR 0
TC 0
Z9 0
U1 0
U2 4
PU CURRENT SCIENCE ASSN
PI BANGALORE
PA C V RAMAN AVENUE, PO BOX 8005, BANGALORE 560 080, INDIA
SN 0011-3891
J9 CURR SCI INDIA
JI Curr. Sci.
PD FEB 25
PY 1991
VL 60
IS 4
BP 268
EP 271
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FH116
UT WOS:A1991FH11600016
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU HEIMKE, G
AF HEIMKE, G
TI PERCUTANEOUS IMPLANTS
SO ADVANCED MATERIALS
LA English
DT Article
AB Research News/Biomaterials Highlights VIII:  Increase of the functional life of biomedical implants which extend through the skin or other body tissues, such as dental implants, and catheters, can be achieved by careful selection of materials and bioengineering approaches.  Recent developments are discussed.
C1 CLEMSON UNIV,COLL ENGN,DEPT BIOENGN,CLEMSON,SC 29634.
CR BOYD LM, 1991, IN PRESS CLIN MATER
   GROSSESIESTRUP C, 1984, J BIOMED MATER RES, V18, P357, DOI 10.1002/jbm.820180405
   HEIMKE G, 1990, ADV MATER, V2, P375
   Heimke G., 1990, Advanced Materials, V2, P189, DOI 10.1002/adma.19900020408
   HEIMKE G, 1990, Patent No. 4959054
   HEIMKE G, 1990, Patent No. 4946444
   Holgers K M, 1989, J Invest Surg, V2, P7, DOI 10.3109/08941938909016500
   MAKI DG, 1987, 7TH INT C ANT AG CHE, P110
   POWERS D, 1989, COMMUNICATION
   YOSHIYAMA N, 1990, BIOCERAMICS, V2, P375
NR 10
TC 8
Z9 8
U1 0
U2 2
PU VCH PUBLISHERS INC
PI DEERFIELD BEACH
PA 303 NW 12TH AVE, DEERFIELD BEACH, FL 33442-1788
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD FEB
PY 1991
VL 3
IS 2
BP 108
EP 110
DI 10.1002/adma.19910030210
PG 3
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA EY547
UT WOS:A1991EY54700008
DA 2018-10-19
ER

PT J
AU MASSIA, SP
   HUBBELL, JA
AF MASSIA, SP
   HUBBELL, JA
TI HUMAN ENDOTHELIAL-CELL INTERACTIONS WITH SURFACE-COUPLED ADHESION
   PEPTIDES ON A NONADHESIVE GLASS SUBSTRATE AND 2 POLYMERIC BIOMATERIALS
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
ID FIBRONECTIN FRAGMENTS; FIBROBLAST ADHESION; STRESS FIBERS; ATTACHMENT;
   ADHERENCE; ENZYMES; INVIVO; GRAFTS
AB The attachment, spreading, spreading rate, focal contact formation, and cytoskeletal organization of human umbilical vein endothelial cells (HUVECs) were investigated on substrates that had been covalently grafted with the cell adhesion peptides Arg-Gly-Asp (RGD) and Tyr-IIe-Gly-Ser-Arg (YIGSR).  This approach was used to provide substrates that were adhesive to cells even in the absence of serum proteins and with no prior pretreatment of the surface with proteins of the cell adhesion molecule (CAM) family.  This approach was used to dramatically enhance the cell-adhesiveness of substrates that were otherwise cell-nonadhesive and to improve control of cellular interactions with cell-adhesive materials by providing stably bound adhesion ligands.  Glycophase glass was examined as a model cell-nonadhesive substrate prior to modification, and polyethylene terephthalate (PET) and polytetrafluoroethylene (PTFE) were examined as representative materials for biomedical applications.  The peptides were surface-coupled by their N-terminal amine to surface hydroxyl moieties using tresyl chloride chemistry.  Prior to peptide grafting, the PET and PTFE were surface hydroxylated to yield PETOH and PTFE-OH.  The PET-OH was less cell-adhesive and the PTFE-OH was much more cell-adhesive than the native polymers.  Radioiodination of a C-terminal tyrosine residue was used to quantify the amount of peptide coupled to the surface, and these amounts were 12.1 pmol/cm2 on glycophase glass, 139 fmol/cm2 on PETOH, and 31 fmol/cm2 on PTFE-OH.  Although the glycophase glass did not support adhesion or spreading even in the presence of serum, the RGD- and YIGSR-grafted glycophase glass did support adhesion and spreading, even when the only serum protein that was included was albumin.  Although PET and PTFE-OH supported adhesion when incubated in serum-supplemented medium, neither of these materials supported adhesion with only albumin present, indicating that cell adhesion is mediated by adsorbed CAM proteins.  When these materials were peptide-grafted, however, extensive adhesion and spreading did occur even when only albumin was present.  Since the peptide grafting is quite easily controlled and is temporally stable, while protein adsorption is quite difficult to precisely control and is temporally dynamic, peptide grafting may be advantageous over other approaches employed to improve long-term cell adhesion to biomaterials.
C1 UNIV TEXAS,DEPT CHEM ENGN,AUSTIN,TX 78712.
RI Hubbell, Jeffrey/A-9266-2008
OI Hubbell, Jeffrey/0000-0003-0276-5456
CR AKIYAMA SK, 1985, J BIOL CHEM, V260, P3256
   BRANDLEY BK, 1988, ANAL BIOCHEM, V172, P270, DOI 10.1016/0003-2697(88)90442-3
   BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415
   CHINN JA, 1989, J COLLOID INTERF SCI, V127, P67, DOI 10.1016/0021-9797(89)90008-8
   COSTELLO CA, 1987, MACROMOLECULES, V20, P2819, DOI 10.1021/ma00177a030
   CURTIS ASG, 1964, J CELL BIOL, V20, P199, DOI 10.1083/jcb.20.2.199
   DANILOV YN, 1989, EXP CELL RES, V182, P186, DOI 10.1016/0014-4827(89)90290-5
   ESKIN SG, 1984, MICROVASC RES, V28, P87, DOI 10.1016/0026-2862(84)90031-1
   IVES CL, 1986, IN VITRO CELL DEV B, V22, P500
   IZZARD CS, 1976, J CELL SCI, V21, P129
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   KESLER KA, 1986, J VASC SURG, V3, P58
   MASSIA SP, 1990, ANN NY ACAD SCI, V589, P261, DOI 10.1111/j.1749-6632.1990.tb24251.x
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   MATSUDA T, 1989, T AM SOC ART INT ORG, V35, P677
   NILSSON K, 1981, BIOCHEM BIOPH RES CO, V102, P449, DOI 10.1016/0006-291X(81)91541-2
   OHLSON S, 1978, FEBS LETT, V93, P5, DOI 10.1016/0014-5793(78)80792-3
   PRATT KJ, 1989, J BIOMED MATER RES, V23, P1131, DOI 10.1002/jbm.820231004
   RAMALANJAONA G, 1986, J VASC SURG, V3, P264, DOI 10.1067/mva.1986.avs0030264
   SALACINSKI PRP, 1981, ANAL BIOCHEM, V117, P136, DOI 10.1016/0003-2697(81)90703-X
   SEEGER JM, 1988, J VASC SURG, V8, P476
   STREETER HB, 1987, J CELL BIOL, V105, P507, DOI 10.1083/jcb.105.1.507
   WECHEZAK AR, 1989, J CELL PHYSIOL, V139, P136, DOI 10.1002/jcp.1041390120
   WHITE GE, 1986, J CELL BIOL, V103, P63, DOI 10.1083/jcb.103.1.63
   WONG AJ, 1983, SCIENCE, V219, P867, DOI 10.1126/science.6681677
   WOODS A, 1986, EMBO J, V5, P665, DOI 10.1002/j.1460-2075.1986.tb04265.x
NR 26
TC 229
Z9 233
U1 2
U2 44
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD FEB
PY 1991
VL 25
IS 2
BP 223
EP 242
DI 10.1002/jbm.820250209
PG 20
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA EV472
UT WOS:A1991EV47200008
PM 1829082
DA 2018-10-19
ER

PT J
AU BUSZEWSKI, B
AF BUSZEWSKI, B
TI PROPERTIES AND BIOMEDICAL APPLICATIONS OF PACKINGS WITH HIGH-DENSITY
   COVERAGE OF C-18 CHEMICALLY BONDED PHASE FOR HIGH-PERFORMANCE
   LIQUID-CHROMATOGRAPHY AND SOLID-PHASE EXTRACTION
SO JOURNAL OF CHROMATOGRAPHY
LA English
DT Article
ID MODIFIED SILICA
AB A series of packing materials with high-density coverage of chemically bonded C18 phases (alpha-RP greater-than-or-equal-to 2.8-mu-mol/m2) for high-performance liquid chromatography (HPLC) and clean-up solid-phase extraction columns were prepared.  The resulting packings were characterized by different physico-chemical methods including porosimetric and elemental analysis, cross-polarization magic angle spinning NMR and HPLC.  The packings prepared were used for the purification by solid-phase extraction, isolation and determination of various analytes present in different biological samples.
C1 UNIV TUBINGEN,INST ORGAN CHEM,W-7400 TUBINGEN 1,GERMANY.
RI Buszewski, Boguslaw/A-3187-2009
CR ALBERT K, 1985, J MAGN RESON, V62, P428, DOI 10.1016/0022-2364(85)90212-4
   BAYER E, 1983, J CHROMATOGR, V264, P197, DOI 10.1016/S0021-9673(01)95023-X
   BEREK D, 1981, Patent No. 4255286
   BUSZEWSKI B, 1987, J HIGH RES CHROMATOG, V10, P527
   BUSZEWSKI B, 1987, CHROMATOGRAPHIA, V24, P573, DOI 10.1007/BF02688547
   BUSZEWSKI B, 1990, J CHROMATOGR, V499, P305, DOI 10.1016/S0021-9673(00)96981-4
   BUSZEWSKI B, 1987, CHEM LISTY, V81, P552
   BUSZEWSKI B, 1987, J LIQ CHROMATOGR, V10, P2325, DOI 10.1080/01483918708068915
   BUSZEWSKI B, 1990, J PHARMACEUT BIOMED, V8, P645, DOI 10.1016/0731-7085(90)80095-7
   BUSZEWSKI B, 1987, CHROMATOGRAPHIA, V23, P442, DOI 10.1007/BF02311822
   BUSZEWSKI B, 1990, CHROMATOGRAPHIA, V29, P233, DOI 10.1007/BF02317910
   BUSZEWSKI B, 1988, ANAL CHIM ACTA, V208, P199
   BUSZEWSKI B, 1990, CCHEM STOSOW, V34, P191
   DALDRUP T, 1984, CHROMATOGRAPHIA, V18, P81, DOI 10.1007/BF02268461
   GILPIN RK, 1984, J CHROMATOGR SCI, V22, P371, DOI 10.1093/chromsci/22.9.371
   KNOX JH, 1989, HIGH PERFORMANCE LIQ, P189
   LIM CK, 1986, INT LAB, V16, P60
   NAWROCKI J, 1988, J CHROMATOGR, V449, P1, DOI 10.1016/S0021-9673(00)94364-4
   NOVAK I, 1983, Patent No. 4382070
   PIETRZYK DJ, 1989, HIGH PERFORMANCE LIQ, P223
   SANDER LC, 1987, CRIT REV ANAL CHEM, V18, P299, DOI 10.1080/10408348708545263
   SOLTES L, 1983, Patent No. 234100
   SZABO K, 1984, HELV CHIM ACTA, V67, P2128, DOI 10.1002/hlca.19840670813
   TIPPINS B, 1987, INT LAB, V17, P28
NR 24
TC 9
Z9 9
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0021-9673
J9 J CHROMATOGR
PD FEB 1
PY 1991
VL 538
IS 2
BP 293
EP 301
DI 10.1016/S0021-9673(01)88850-6
PG 9
WC Chemistry, Analytical
SC Chemistry
GA EY985
UT WOS:A1991EY98500008
DA 2018-10-19
ER

PT J
AU KOHN, J
AF KOHN, J
TI DESAMINOTYROSYL TYROSINE ALKYL ESTERS - NEW DIPHENOLIC MONOMERS FOR THE
   DESIGN OF TYROSINE-DERIVED PSEUDOPOLY(AMINO ACIDS)
SO ACS SYMPOSIUM SERIES
LA English
DT Article
ID POLY(IMINOCARBONATES); BIOMATERIALS
AB In peptide chemistry, peptide analogs containing nonnatural backbone linkages are classified as "pseudopeptides".  In analogy, we used the term "pseudopoly(amino acid)" to denote polymers in which amino acids are linked together by bonds other than conventional peptide bonds.  Here we summarize our studies on the identification of desaminotyrosyl-tyrosine alkyl esters as new diphenolic monomers for the design of amino acid derived polyiminocarbonates and polycarbonates.  In particular, desaminotyrosyl-tyrosine hexyl ester was found to lead to mechanically strong polymers with good engineering properties.  These new pseudopoly(amino acids) appear to be promising materials for a number of biomedical applications.
RP KOHN, J (reprint author), RUTGERS STATE UNIV,DEPT CHEM,NEW BRUNSWICK,NJ 08903, USA.
CR BODANSZKY M, 1984, PRACTICE PEPTIDE SYN, P145
   ENGELBERG I, 1991, IN PRESS BIOMATERIAL
   KOHN J, 1986, BIOMATERIALS, V7, P176, DOI 10.1016/0142-9612(86)90098-0
   KOHN J, 1987, J AM CHEM SOC, V109, P817, DOI 10.1021/ja00237a030
   KOHN J, 1988, PEPTIDES CHEM BIOL, P658
   KOHN J, 1984, POLYM MAT SCI ENG, V51, P119
   KOHN JE, UNPUB
   LEONG K, COMMUNICATION
   LI C, 1989, MACROMOLECULES, V22, P2029, DOI 10.1021/ma00195a001
   MOHADGER Y, 1976, J POLYM SCI POL PHYS, V14, P963, DOI 10.1002/pol.1976.180140601
   PULAPURA S, 1990, J BIOMATERIALS, V11, P665
   PULAPURA S, UNPUB TYROSINE DERIV
   PULAPURA S, 1990, POLYM PREPRINTS, V31, P233
   SCHNELL H, 1964, CHEM PHYSICS POLYCAR
   SILVER FH, BIOCOMPATIBILITY DEG
   1982, NAT I OCC SAF HLTH N, P70
NR 16
TC 0
Z9 0
U1 0
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0097-6156
J9 ACS SYM SER
PY 1991
VL 469
BP 155
EP 169
PG 15
WC Chemistry, Multidisciplinary
SC Chemistry
GA GE122
UT WOS:A1991GE12200017
DA 2018-10-19
ER

PT J
AU FOX, JW
   SHANNON, JD
   BJARNASON, JB
AF FOX, JW
   SHANNON, JD
   BJARNASON, JB
TI PROTEINASES AND THEIR INHIBITORS IN BIOTECHNOLOGY
SO ACS SYMPOSIUM SERIES
LA English
DT Article
ID HUMAN IMMUNODEFICIENCY VIRUS; CYSTEINE PROTEINASES; DISULFIDE BONDS;
   CROTALUS-ATROX; PROTEASE; SPECIFICITY; SUBTILISIN; BINDING; ENZYME;
   CELLS
AB Proteases are used in many industrial areas as well as basic research. They are classified by their mechanism of catalysis. Proteases are used in the pharmacological, food and other consumer industries to convert raw materials into a final product or to alter properties of the raw material. In biomedical research, proteases are used to study the structure of other proteins and for synthesis of peptides. The choice of a protease for an application depends in part on its specificity for peptide bonds, activity and stability. Technical advances in protein engineering have enabled alteration of these properties and allowed proteases to be used more effectively. Some easily obtained proteases can be modified so that they can substitute for proteases whose supply is limited.
C1 UNIV ICELAND, INST SCI, REYKJAVIK, ICELAND.
RP FOX, JW (reprint author), UNIV VIRGINIA, SCH MED, DEPT MICROBIOL, CHARLOTTESVILLE, VA 22908 USA.
CR ASBOTH B, 1985, BIOCHEMISTRY-US, V24, P606, DOI 10.1021/bi00324a010
   ASGEIRSSON B, 1989, EUR J BIOCHEM, V180, P85
   Barrett A.J., 1980, CIBA F S, V75, P1
   BARRETT AJ, 1976, ANAL BIOCHEM, V76, P374, DOI 10.1016/0003-2697(76)90298-0
   BARRETT AJ, 1985, BIOCHEM J, V231, P807, DOI 10.1042/bj2310807
   BARRETT AJ, 1986, RES MONOG CELL TISSU, V12, P515
   BECKERSTOFF GF, 1987, ENZYMES IND MED
   BERGER A, 1970, PHILOS T R SOC B, V257, P249, DOI 10.1098/rstb.1970.0024
   Bergmann M, 1937, J BIOL CHEM, V117, P189
   BICKNELL R, 1987, BIOCHEMISTRY-US, V26, P7291, DOI 10.1021/bi00397a014
   BJARNASON JB, 1983, BIOCHEMISTRY-US, V22, P3770, DOI 10.1021/bi00285a009
   CHEETHAM PSJ, 1985, HDB ENZYME BIOTECHNO
   DEBOUCK C, VIRAL PROTEINASES TA
   FLANNERY AV, 1989, PROTEOLYTIC ENZYMES, P145
   Godfrey T, 1983, IND ENZYMOLOGY
   GRIFFIN PR, 1989, TECHNIQUES PROTEIN C, P160
   HANECAK R, 1982, P NATL ACAD SCI-BIOL, V79, P3973, DOI 10.1073/pnas.79.13.3973
   HARTLEY BS, 1960, ANNU REV BIOCHEM, V29, P45, DOI 10.1146/annurev.bi.29.070160.000401
   HIBBS MS, 1985, J BIOL CHEM, V260, P2493
   HULMES JD, 1989, TECHNIQUES PROTEIN C, P7
   ISAAC O, 1977, Patent No. 4004976
   James M. N. G., 1976, PROTEOLYSIS PHYSL RE, P125
   JENSEN G, 1984, A05845 NOV IND ALS I
   JONGENEEL CV, 1989, FEBS LETT, V242, P211, DOI 10.1016/0014-5793(89)80471-5
   KALISZ HM, 1988, ADV BIOCHEM ENG BIOT, V36, P28
   KOHL NE, 1988, P NATL ACAD SCI USA, V85, P4686, DOI 10.1073/pnas.85.13.4686
   LAYMAN PL, 1986, CHEM ENG NEWS
   LIOTTA LA, 1986, ANNU REV BIOCHEM, V55, P1037, DOI 10.1146/annurev.bi.55.070186.005133
   MAZUR RH, 1969, J AM CHEM SOC, V91, P2684, DOI 10.1021/ja01038a046
   MCKEEVER BM, 1989, J BIOL CHEM, V264, P1919
   MELLONI E, 1982, BIOCHEM BIOPH RES CO, V107, P1053, DOI 10.1016/0006-291X(82)90628-3
   MENON AS, 1987, J BIOL CHEM, V262, P14929
   MITCHINSON C, 1989, BIOCHEMISTRY-US, V28, P4807, DOI 10.1021/bi00437a043
   NEURATH H, 1984, SCIENCE, V224, P350, DOI 10.1126/science.6369538
   OKADA Y, 1986, J BIOL CHEM, V261, P14255
   OLAFSDOTTIR S, 1985, ASPARTIC PROTEINASES
   PALTHY L, 1985, CHEM ENG NEWS, V41, P657
   PANTOLIANO MW, 1987, BIOCHEMISTRY-US, V26, P775
   POLGAR L, 1982, BIOCHEM J, V207, P1
   RITSKES TM, 1971, J FISH RES BOARD CAN, V69, P647
   Salvensen G, 1989, PROTEOLYTIC ENZYMES, P83
   SCHLABACH TD, 1989, TECHNIQUES PROTEIN C, P497
   SHANNON JD, 1989, J BIOL CHEM, V264, P11575
   SHANNON JD, 1989, J BIO CHEM, V264, P1157
   SIMPSON BK, 1987, FOOD BIOTECHNOLOGY
   STAUTON R, 1989, FOOD SCI TECHNOLOGY, V2, P180
   TRYGGVASON K, 1987, BIOCHIM BIOPHYS ACTA, V907, P191, DOI 10.1016/0304-419X(87)90006-0
   WEIL TA, 1982, Patent No. 4338399
   WELLS JA, 1986, J BIOL CHEM, V261, P6564
   WILHELM SM, 1987, P NATL ACAD SCI USA, V84, P6725, DOI 10.1073/pnas.84.19.6725
   Young C.L., 1978, ATLAS PROTEIN SEQUEN, P73
NR 51
TC 1
Z9 1
U1 1
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0097-6156
J9 ACS SYM SER
JI ACS Symp. Ser.
PY 1991
VL 460
BP 62
EP 79
PG 18
WC Chemistry, Multidisciplinary
SC Chemistry
GA FM710
UT WOS:A1991FM71000006
DA 2018-10-19
ER

PT J
AU BARNES, RM
AF BARNES, RM
TI INDUCTIVELY COUPLED AND OTHER PLASMA SOURCES - DETERMINATION AND
   SPECIATION OF TRACE-ELEMENTS IN BIOMEDICAL APPLICATIONS
SO ACS SYMPOSIUM SERIES
LA English
DT Review
ID MICROWAVE-INDUCED PLASMA; PERFORMANCE LIQUID-CHROMATOGRAPHY;
   ATOMIC-EMISSION-SPECTROMETRY; SOURCE-MASS SPECTROMETRY; SUPERCRITICAL
   FLUID CHROMATOGRAPHY; LEAD ISOTOPE RATIOS; BIOLOGICAL SAMPLES; STABLE
   ISOTOPES; ABSORPTION SPECTROMETRY; ENVIRONMENTAL-SAMPLES
AB An appraisal of currently popular electrical plasma sources, including the inductively coupled plasma (ICP), microwave induced plasma (MIP), and direct current plasma (DCP), employed with atomic and mass spectrometry is presented for the determination and speciation of trace elements in the biomedical field. The advantages and limitations of the methods based on these techniques, problems of interferences and their resolution, elements that can and cannot be determined relative to their reference values in various biological materials, the current status, and future developments are discussed. Interfacing liquid, gas, and supercritical fluid chromatography with these plasma detectors also is examined. Practical illustrations are given based upon a survey of recent literature.
RP BARNES, RM (reprint author), UNIV MASSACHUSETTS, DEPT CHEM, LEDERLE GRAD RES CTR TOWERS, AMHERST, MA 01003 USA.
CR ALIMONTI A, 1989, J ANAL ATOM SPECTROM, V4, P577, DOI 10.1039/ja9890400577
   Alimonti A, 1987, J Trace Elem Electrolytes Health Dis, V1, P79
   AMARASIRIWARDEN.CJ, 1990, J ANAL AT SPECTROM, V5
   AMARASIRIWARDEN.CJ, 1990, 1990 WINT C PLASM SP, P156
   BAMIRO FO, 1988, J ANAL ATOM SPECTROM, V3, P279, DOI 10.1039/ja9880300279
   BEAUCHEMIN D, 1989, J ANAL ATOM SPECTROM, V4, P285, DOI 10.1039/ja9890400285
   BEHNE D, 1989, FRESEN Z ANAL CHEM, V335, P802, DOI 10.1007/BF01204091
   BONGERS J, 1988, ANAL CHEM, V60, P2683, DOI 10.1021/ac00175a008
   BRATTER P, 1988, TRACE ELEMENT ANAL C, V5, P145
   BRATTER P, 1988, TRACE ELEMENT ANAL C, V5, P120
   BROEKAERT JAC, 1987, ANAL CHIM ACTA, V196, P1, DOI 10.1016/S0003-2670(00)83065-2
   BROEKAERT JAC, 1987, INDUCTIVELY COUPLE 2, pCH12
   BROWN AA, 1988, J ANAL ATOM SPECTROM, V3, pR45, DOI 10.1039/ja988030045r
   BROWN AA, 1989, J ANAL ATOM SPECTROM, V4, pR47, DOI 10.1039/ja989040047r
   BUSHEE DS, 1988, ANALYST, V113, P1167, DOI 10.1039/an9881301167
   BUSHEE DS, 1989, J ANAL ATOM SPECTROM, V4, P773, DOI 10.1039/ja9890400773
   CALABRESE EJ, 1989, REGUL TOXICOL PHARM, V10, P123, DOI 10.1016/0273-2300(89)90019-6
   CAMPBELL MJ, 1989, J ANAL ATOM SPECTROM, V4, P235, DOI 10.1039/ja9890400235
   CAROLI S, 1988, SPECTROCHIM ACTA B, V43, P371, DOI 10.1016/0584-8547(88)80065-X
   CREED JT, 1988, J ANAL ATOM SPECTROM, V3, P923, DOI 10.1039/ja9880300923
   CREWS HM, 1989, ANALYST, V114, P895, DOI 10.1039/an9891400895
   CREWS HM, 1989, J ANAL ATOM SPECTROM, V5, pR75
   DALGARNO BG, 1988, BIOMED ENVIRON MASS, V16, P377, DOI 10.1002/bms.1200160174
   DEAN JR, 1987, J ANAL ATOM SPECTROM, V2, P607, DOI 10.1039/ja9870200607
   DEAN JR, 1989, APPLICATIONS INDUCTI, pCH6
   DELANEY MF, 1983, SPECTROCHIM ACTA B, V38, P399, DOI 10.1016/0584-8547(83)80138-4
   DELVES HT, 1988, J ANAL ATOM SPECTROM, V3, P343, DOI 10.1039/ja9880300343
   DEVER M, 1989, J ANAL ATOM SPECTROM, V4, P361, DOI 10.1039/ja9890400361
   DURRANT SF, 1989, MICRONUTRIENT ANAL, P111
   EBDON L, 1990, MICROCHEM J, V41, P219, DOI 10.1016/0026-265X(90)90121-K
   EBDON L, 1987, ANALYST, V112, P1, DOI 10.1039/an9871200001
   EBDON L, 1986, ANALYST, V111, P1113, DOI 10.1039/an9861101113
   FIROR RL, 1989, AM LAB, V21, P40
   FORBES KA, 1989, ADV CHROMATOGR, V1, P487
   GALANTE LJ, 1988, ANAL CHEM, V60, P1370, DOI 10.1021/ac00165a004
   GARDINER PE, 1987, J ANAL ATOM SPECTROM, V2, P375, DOI 10.1039/ja9870200375
   GARDINER PE, 1988, J ANAL ATOM SPECTROM, V3, P163, DOI 10.1039/ja9880300163
   GARDINER PHE, 1987, TOP CURR CHEM, V141, P145
   GRAY AL, 1989, APPLICATIONS INDUCTI, pCH1
   HAGEN DF, 1987, SPECTROCHIM ACTA B, V42, P253, DOI 10.1016/0584-8547(87)80067-8
   HAGEN DF, 1983, SPECTROCHIM ACTA B, V38, P377, DOI 10.1016/0584-8547(83)80136-0
   HEITKEMPER D, 1989, J ANAL ATOM SPECTROM, V4, P279, DOI 10.1039/ja9890400279
   HIEFTJE GM, 1989, ANAL CHIM ACTA, V216, P1, DOI 10.1016/S0003-2670(00)82002-4
   HOOKER DB, 1989, ANAL CHEM, V61, P2207, DOI 10.1021/ac00194a018
   HOUK RS, 1988, MASS SPECTROM REV, V7, P425, DOI 10.1002/mas.1280070404
   IGARASHI Y, 1989, J ANAL ATOM SPECTROM, V4, P571, DOI 10.1039/ja9890400571
   JANGHORBANI M, 1988, ANALYST, V113, P405, DOI 10.1039/an9881300405
   JANGHORBANI M, 1989, APPLICATIONS INDUCTI, pCH5
   JOSEPH MJ, 1989 PITTS C ATL
   KAWAGUCHI H, 1975, CLIN CHEM, V21, P591
   KAWAGUCHI H, 1975, ANAL CHEM, V47, P1029, DOI 10.1021/ac60357a064
   KELIHER PN, 1987, INDUCTIVELY COUPLED, pCH16
   LASZTITY A, 1989, J ANAL ATOM SPECTROM, V4, P737, DOI 10.1039/ja9890400737
   LASZTITY A, 1989, J ANAL ATOM SPECTROM, V4, P761, DOI 10.1039/ja9890400761
   LEIS F, 1989, FRESEN Z ANAL CHEM, V333, P2, DOI 10.1007/BF00572605
   LUFFER DR, 1988, ANAL CHEM, V60, P1365, DOI 10.1021/ac00165a003
   LYON TDB, 1988, J ANAL ATOM SPECTROM, V3, P265, DOI 10.1039/ja9880300265
   MAESSEN FJMJ, 1987, INDUCTIVELY COUPLE 2, pCH5
   MARSHALL J, 1989, J ANAL ATOM SPECTROM, V4, pR111, DOI 10.1039/ja989040111r
   MCGREGOR DA, 1988, ANAL CHEM, V60, pA1089, DOI 10.1021/ac00170a001
   MICHEL R, 1987, CRIT REV BIOCOMPAT, V3, P235
   MOTLEY CB, 1989, APPL SPECTROSC, V43, P737, DOI 10.1366/0003702894202238
   NIXON DE, 1986, CLIN CHEM, V32, P1660
   PASCHAL DC, 1989, SPECTROCHIM ACTA B, V44, P1229, DOI 10.1016/0584-8547(89)80121-1
   PAUDYN A, 1989, SCI TOTAL ENVIRON, V89, P343, DOI 10.1016/0048-9697(89)90278-7
   POLK D, 1990, PITTSBURGH C NEW YOR
   QUIMBY BD, 1990, J ANAL CHEM+, V62, P1027
   RAMSEY M H, 1987, Analytical Proceedings, V24, P260, DOI 10.1039/ap9872400260
   ROUTH MW, 1987, SPECTROSCOPY, V2, P45
   RUSS GP, 1989, APPLICATIONS INDUCTI, pCH4
   SCHRAMEL P, 1988, BIOL TRACE ELEM RES, V16, P67, DOI 10.1007/BF02795335
   SCHRAMEL P, 1988, SPECTROCHIM ACTA B, V43, P881, DOI 10.1016/0584-8547(88)80194-0
   SCHUETTE S, 1988, ANALYST, V113, P1837, DOI 10.1039/an9881301837
   SHIRAISHI K, 1989, HEALTH PHYS, V57, P551, DOI 10.1097/00004032-198910000-00005
   SIRIRAKS A, 1990, ANAL CHEM, V62, P1185, DOI 10.1021/ac00210a018
   SUBRAMANIAN KS, 1986, PROG ANAL SPECTROSC, V9, P237
   SUBRAMANIAN KS, 1988, PROG ANAL SPECTROSC, V11, P511
   SULLIVAN JJ, 1990, ANAL CHEM, V62, P1034, DOI 10.1021/ac00209a014
   SUN XF, 1987, ANALYST, V112, P1223, DOI 10.1039/an9871201223
   SUYANI H, 1989, APPL SPECTROSC, V43, P962, DOI 10.1366/0003702894203732
   TEMPLETON DM, 1989, BIOL TRACE ELEM RES, V22, P17, DOI 10.1007/BF02917413
   THOMPSON M, 1985, ANALYST, V110, P443, DOI 10.1039/an9851000443
   TING BTG, 1988, J ANAL ATOM SPECTROM, V3, P325, DOI 10.1039/ja9880300325
   TING BTG, 1989, ANALYST, V114, P667, DOI 10.1039/an9891400667
   TOLG G, 1988, FRESEN Z ANAL CHEM, V331, P226, DOI 10.1007/BF00481889
   TSUNODA A, 1986, ANAL SCI, V2, P99
   UDEN PC, 1989, ENVANAL USING CHROMA, P96
   ULDEN PC, 1989, J CHROMATOGR, V468, P319
   VANHOE H, 1989, ANAL CHEM, V61, P1851, DOI 10.1021/ac00192a014
   VEILLON C, 1986, ANAL CHEM, V58, pA851, DOI 10.1021/ac00121a001
   VICZIAN M, 1990, J ANAL AT SPECTROM, V5
   WANG XR, 1989, J ANAL ATOM SPECTROM, V4, P727, DOI 10.1039/ja9890400727
   WHITTAKER PG, 1989, ANALYST, V114, P675, DOI 10.1039/an9891400675
   WILLIAMS T R, 1986, American Biotechnology Laboratory, V4, P56
   WILLIAMS TR, 1986, AM BIOTECHNOL LAB, V4, P54
   WILLIAMS TR, 1986, AM BIOTECHNOL LAB, V4, P56
   WOODHEAD JC, 1988, PEDIATR RES, V23, P495, DOI 10.1203/00006450-198805000-00012
NR 97
TC 2
Z9 2
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0097-6156
J9 ACS SYM SER
JI ACS Symp. Ser.
PY 1991
VL 445
BP 158
EP 180
PG 23
WC Chemistry, Multidisciplinary
SC Chemistry
GA EV292
UT WOS:A1991EV29200012
DA 2018-10-19
ER

PT J
AU BAQUEY, C
   DUPUY, B
   JANVIER, G
   BORDENAVE, L
   CAIX, J
   BASSECATHALINAT, B
AF BAQUEY, C
   DUPUY, B
   JANVIER, G
   BORDENAVE, L
   CAIX, J
   BASSECATHALINAT, B
TI RATIONALE FOR THE DESIGN OF BIOMATERIALS AND THE EVALUATION OF THEIR
   BIOCOMPATIBILITY
SO BIORHEOLOGY
LA English
DT Article
DE BIOMATERIALS; BIOCOMPATIBILITY; BIOARTIFICIAL PANCREAS; VASCULAR
   SUBSTITUTES
AB The biocompatibility of a material can be considered as the ideally expectable result of its interactions with living tissues with which it is interfaced. This property determines the ability of devices involving this material in their constitution, to correctly assume their ascribed function; reciprocally a bad fitting, between devices and their intended use, coming from a non-optimized design or from an inappropriate prescription, may alter the original biocompatibility of constitutive materials. Accordingly, the actual biocompatibility of a biomaterial depends upon both its intrinsic properties and the application in which it is involved. Such considerations must be taken into account by specialists who try to design more performant biomaterials, or new assist devices, should they be implantable or not; but they draw also methodological guidelines for the evaluation of the biocompatibility of these biomedical products.
RP BAQUEY, C (reprint author), UNIV BORDEAUX 2,INSERM,U306,146 RUE LEO SAIGNAT,F-33076 BORDEAUX,FRANCE.
CR BAMFORD CH, 1985, BLOOD COMPATIBLE MAT, P159
   Baquey C., 1981, ITBM, V2, P378
   BORDENAVE L, 1989, BIOMATERIALS, V10, P235, DOI 10.1016/0142-9612(89)90099-9
   EBERT CD, 1982, J BIOMED MATER RES, V16, P629, DOI 10.1002/jbm.820160510
   FOUGNOT C, 1979, ANN BIOMED ENG, V7, P429, DOI 10.1007/BF02364219
   GIN H, IN PRESS J MICROENCA
   JACOBS HA, 1989, J BIOMED MATER RES, V23, P611, DOI 10.1002/jbm.820230606
   KUSSEROW BK, 1973, T AM SOC ART INT ORG, V19, P8
   Lin J Y, 1985, Trans Am Soc Artif Intern Organs, V31, P468
   MCREA JC, 1981, T AM SOC ART INT ORG, V27, P511
   WILLIAMS DF, 1987, PROGR BIOMEDICAL ENG, V4
NR 11
TC 1
Z9 1
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0006-355X
J9 BIORHEOLOGY
JI Biorheology
PY 1991
VL 28
IS 5
BP 463
EP 472
PG 10
WC Biophysics; Engineering, Biomedical; Hematology
SC Biophysics; Engineering; Hematology
GA GM822
UT WOS:A1991GM82200006
PM 1782396
DA 2018-10-19
ER

PT J
AU ZIATS, NP
   TOPHAM, NS
   PANKOWSKY, DA
   ANDERSON, JM
AF ZIATS, NP
   TOPHAM, NS
   PANKOWSKY, DA
   ANDERSON, JM
TI ANALYSIS OF PROTEIN ADSORPTION ON RETRIEVED HUMAN VASCULAR GRAFTS USING
   IMMUNOGOLD LABELING WITH SILVER ENHANCEMENT
SO CELLS AND MATERIALS
LA English
DT Article
DE BIOMATERIALS; BIOCOMPATIBILITY; PROTEIN ADSORPTION; VASCULAR GRAFTS;
   THROMBOSIS; IMMUNOGOLD LABELING; SILVER ENHANCEMENT
ID COLLOIDAL-GOLD; ELECTRON-MICROSCOPY; ARTIFICIAL SURFACES; HUMAN-PLASMA;
   FIBRINOGEN; BIOMATERIALS; BLOOD; IMMUNOCYTOCHEMISTRY; FIBRONECTIN;
   MECHANISM
AB The adsorption of proteins on biomedical materials such as vascular grafts is important in modulating thrombosis, one eventual cause of vascular graft failure. We have identified proteins expressed on the surfaces of retrieved vascular grafts to determine if certain proteins were present at the end stage of vascular failure. Scanning electron microscopic analysis of protein adsorption on the surfaces of retrieved vascular prostheses was determined using antibodies to human blood proteins fibrinogen, fibronectin, Hageman factor (factor XII and factor VIII/von Willebrand Factor. The detection of these proteins on the blood contacting surface was evaluated by immunogold labelling with protein A-gold beads followed by silver enhancement. Fibronectin was the most abundant protein detected on retrieved expanded polytetrafluoroethylene or umbilical vein grafts. Protein adsorption was disperse for all proteins and one protein, fibronectin, was found in great amounts on all surfaces. Proteins such as fibronectin may be important in the adhesion and activation of platelets and leukocytes and thus contribute to the development of thrombosis. These analyses of human vascular grafts indicate that surface proteins can be readily detected by our methods and thus may be useful in determination of specific proteins important in the thrombogenicity and/or biocompatibility of cardiovascular devices.
C1 CASE WESTERN RESERVE UNIV,INST PATHOL,DEPT PATHOL,2085 ADELBERT RD,CLEVELAND,OH 44106.
   CASE WESTERN RESERVE UNIV,DEPT BIOMED ENGN,CLEVELAND,OH 44106.
   CASE WESTERN RESERVE UNIV,DEPT MACROMOLEC SCI,CLEVELAND,OH 44106.
CR ANDERSON JM, 1985, ASAIO, V8, P79
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   BALE MD, 1989, BLOOD, V74, P2698
   BATTEIGER BE, 1988, HDB IMMUNOBLOTTING P, V1, P145
   BELLISSIMO JA, 1984, T AM SOC ART INT ORG, V30, P359
   BRASH JL, 1988, BLOOD, V71, P932
   BREEMHAAR W, 1984, BIOMATERIALS, V5, P269, DOI 10.1016/0142-9612(84)90071-1
   CHUANG HYK, 1985, J BIOMED MATER RES, V19, P813, DOI 10.1002/jbm.820190707
   CHUANG HYK, 1984, J BIOMED MATER RES, V18, P547, DOI 10.1002/jbm.820180508
   COX D P, 1986, American Biotechnology Laboratory, V4, P22
   DEHARVEN E, 1984, J CELL BIOL, V99, P53, DOI 10.1083/jcb.99.1.53
   ESQUIVEL CO, 1986, J SURG RES, V41, P1, DOI 10.1016/0022-4804(86)90002-8
   GODING JW, 1978, J IMMUNOL METHODS, V20, P241, DOI 10.1016/0022-1759(78)90259-4
   GOODMAN S L, 1979, Scanning Electron Microscopy, P619
   GOODMAN SL, 1987, SCANNING MICROSCOPY, V1, P727
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   HATTON MWC, 1989, AM J PATHOL, V135, P499
   HODGES GM, 1987, SCANNING MICROSCOPY, V1, P301
   HORBETT T, 1989, TECHNIQUES BIOCOMPAT, V2, P183
   HORBETT TA, 1984, THROMB RES, V36, P599, DOI 10.1016/0049-3848(84)90199-3
   MATSUDA T, 1984, T AM SOC ART INT ORG, V30, P353
   MURTHY KD, 1987, SCANNING MICROSCOPY, V1, P765
   OLIVER JA, 1987, SCANNING MICROSCOPY, V1, P745
   PANKOWSKY DA, 1990, J VASC SURG, V11, P599, DOI 10.1067/mva.1990.18272
   PARK K, 1986, J COLLOID INTERF SCI, V111, P197, DOI 10.1016/0021-9797(86)90019-6
   PARK K, 1987, SCANNING MICROSCOPY, V1, P339
   PASQUINELLI G, 1987, SCANNING MICROSCOPY, V1, P1327
   PITT WG, 1986, J COLLOID INTERF SCI, V111, P343, DOI 10.1016/0021-9797(86)90039-1
   RATNOFF OD, 1983, ARCH DERMATOL, V119, P432, DOI 10.1001/archderm.119.5.432
   RICCITELLI SD, 1984, T AM SOC ART INT ORG, V30, P420
   SCHOEN FJ, 1989, INTERVENTIONAL SURGE, P241
   SPRINGALL DR, 1984, HISTOCHEMISTRY, V81, P603, DOI 10.1007/BF00489542
   VEITH FJ, 1986, J VASC SURG, V3, P104
   VROMAN L, 1988, B NEW YORK ACAD MED, V64, P352
   VROMAN L, 1980, BLOOD, V55, P156
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
   ZIATS NP, 1989, ATHEROSCLEROSIS ARTE, P289
   ZIATS NP, 1990, IN PRESS J LAB CLIN
NR 39
TC 20
Z9 20
U1 1
U2 3
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666
SN 1051-6794
J9 CELL MATER
JI Cells Mat.
PY 1991
VL 1
IS 1
BP 73
EP 82
PG 10
WC Cell Biology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Cell Biology; Research & Experimental Medicine; Materials Science
GA GK711
UT WOS:A1991GK71100009
DA 2018-10-19
ER

PT J
AU KIRKPATRICK, CJ
   MUELLERSCHULTE, D
   ROYE, M
   HOLLWEG, G
   GOSSEN, C
   RICHTER, H
   MITTERMAYER, C
AF KIRKPATRICK, CJ
   MUELLERSCHULTE, D
   ROYE, M
   HOLLWEG, G
   GOSSEN, C
   RICHTER, H
   MITTERMAYER, C
TI SURFACE MODIFICATION OF POLYMERS TO PERMIT ENDOTHELIAL-CELL GROWTH
SO CELLS AND MATERIALS
LA English
DT Review
DE ENDOTHELIAL CELLS; POLYMERS; SURFACE MODIFICATION; GRAFTING; TISSUE
   CULTURE; SEEDING; SCANNING ELECTRON MICROSCOPY
ID VASCULAR PROSTHESES INVITRO; POROUS ARTERIAL PROSTHESES; SMALL-CALIBER
   DACRON; POLYTETRAFLUOROETHYLENE GRAFTS; SMALL-DIAMETER; CULTURED HUMAN;
   BIOMEDICAL APPLICATIONS; EXTRACELLULAR-MATRIX; FIBRONECTIN; CAPILLARY
AB The interaction between endothelial cells (EC) and polymers has become relevant to medicine as a result of attempts to improve the biocompatibility of vascular prostheses. In man, endothelialization is minimal, so that vascular surgeons have attempted to pre-seed vascular grafts with autologous EC. The poor results of EC seeding of commonly used materials for vascular rafts, such as expanded polytetrafluoroethylene (ePTFE) or woven polyester (Dacron) has led to attempts to modify the surface of these and other polymers. Three principal modification techniques have been employed:  1. adsorption of bioactive molecules from applied solutions. Examples are fibronectin, collagen types I and IV and fibrin-containing mixtures. 2.  Formation of reactive groups. This includes carbon coating, plasma discharge and hydrolytic etching. We describe new experiments, using radiation induced grafting (RIG) techniques, with which polymers such as polyamide, polyethylene and ePTFE were surface modified to form electroneutral or positively or negatively charged groups. Scanning electron microscopy (SEM) following in vitro seeding of these modified polymers with both bovine and adult human EC showed that such techniques can be successfully applied to make an unreceptive polymer surface able to promote EC adhesion, spreading and growth. The numerous permutations available for RIG offer a promising method to improve vascular graft surfaces for EC seeding. Such modification techniques are readily applicable to industry. 3. Covalent coupling of bioactive molecules.  Techniques have been developed to allow proteins or oligopeptides to be covalently coupled via bifunctional spacer molecules on to polymer surfaces.
C1 RHEIN WESTFAL TH AACHEN,INST PATHOL,W-5100 AACHEN,GERMANY.
CR ALLEN BT, 1984, J VASC SURG, V1, P224, DOI 10.1067/mva.1984.avs0010224
   ANDERSON JS, 1987, SURGERY, V101, P577
   BEDDOWS CG, 1988, J APPL POLYM SCI, V35, P135, DOI 10.1002/app.1988.070350112
   BERGER K, 1972, ANN SURG, V175, P118, DOI 10.1097/00000658-197201000-00018
   BOYD KL, 1988, J BIOMED MATER RES, V22, P163, DOI 10.1002/jbm.820220302
   BREUERS W, 1987, KUNSTST-GER PLAST+, V77, P1273
   BREUERS W, 1988, ADV BIOMATER, V8, P297
   BREUERS W, 1989, THESIS TU AACHEN RWT
   CALLOW AD, 1987, ENDOTHELIAZATION VAS, P10
   CHAN V, 1979, THROMB RES, V5, P209
   CHARD RB, 1987, J THORAC CARDIOV SUR, V94, P132
   CLAGETT GP, 1982, SURGERY, V91, P87
   CLOWES AW, 1986, AM J PATHOL, V123, P220
   COHN D, 1984, J APPL POLYM SCI, V29, P2645, DOI 10.1002/app.1984.070290819
   CURTIS ASG, 1983, J CELL BIOL, V97, P1500, DOI 10.1083/jcb.97.5.1500
   CURTIS ASG, 1986, J CELL SCI, V86, P9
   DEBSKI R, 1982, T AM SOC ART INT ORG, V28, P456
   DILLEY R, 1979, J SURG RES, V27, P149, DOI 10.1016/0022-4804(79)90124-0
   ELDOR A, 1983, J CELL PHYSIOL, V114, P179, DOI 10.1002/jcp.1041140206
   ELLINGHORST G, 1983, RADIAT PHYS CHEM, V22, P635, DOI 10.1016/0146-5724(83)90073-0
   ESKIN SG, 1978, J BIOMED MATER RES, V12, P517, DOI 10.1002/jbm.820120406
   ESQUIVEL CO, 1986, J SURG RES, V41, P1, DOI 10.1016/0022-4804(86)90002-8
   FAJARDO LF, 1989, AM J CLIN PATHOL, V92, P241, DOI 10.1093/ajcp/92.2.241
   FASOL R, 1989, J VASC SURG, V9, P432, DOI 10.1067/mva.1989.vs0090432
   FASOL R, 1987, ENDOTHELIALIZATION V, P233
   FOXALL TL, 1986, J SURG RES, V41, P158, DOI 10.1016/0022-4804(86)90021-1
   GOMBOTZ W, 1985, RADIAT PHYS CHEM, V25, P549, DOI 10.1016/0146-5724(85)90134-7
   GOSPODAROWICZ D, 1977, EXP EYE RES, V25, P75, DOI 10.1016/0014-4835(77)90248-2
   GRAHAM LM, 1982, SURGERY, V91, P550
   GRAHAM LM, 1980, ARCH SURG-CHICAGO, V115, P1289
   GREISLER HP, 1989, ARCH SURG-CHICAGO, V124, P429
   GROSS JL, 1982, J CELL BIOL, V95, P974, DOI 10.1083/jcb.95.3.974
   GUPTA SK, 1980, AM J SURG, V140, P214, DOI 10.1016/0002-9610(80)90009-4
   HASEGAWA T, 1987, SURGERY, V102, P498
   HASSON JE, 1986, SURGERY, V100, P884
   HERRING M, 1978, SURGERY, V84, P498
   HERRING M, 1984, J VASC SURG, V1, P279, DOI 10.1067/mva.1984.avs0010279
   HERRING M, 1984, SURGERY, V96, P745
   HERRING MB, 1979, ANN SURG, V190, P84, DOI 10.1097/00000658-197907000-00019
   HORBETT TA, 1985, J COLLOID INTERF SCI, V104, P28, DOI 10.1016/0021-9797(85)90006-2
   HUSSAIN S, 1989, J VASC SURG, V9, P656, DOI 10.1067/mva.1989.vs0090656
   JAFFE EA, 1987, HUM PATHOL, V18, P234, DOI 10.1016/S0046-8177(87)80005-9
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   JAFFE EA, 1978, J EXP MED, V147, P1779, DOI 10.1084/jem.147.6.1779
   JAFFE EA, 1976, J EXP MED, V144, P209, DOI 10.1084/jem.144.1.209
   JANSEN B, 1985, J BIOMED MATER RES, V19, P1085, DOI 10.1002/jbm.820190918
   JARRELL BE, 1987, B NEW YORK ACAD MED, V63, P156
   JARRELL BE, 1986, SURGERY, V100, P392
   JARRELL BE, 1986, ANN SURG, V203, P6571
   KADLETZ M, 1987, THORAC CARDIOV SURG, V35, P143, DOI 10.1055/s-2007-1020277
   KAEHLER J, 1989, J VASC SURG, V9, P535, DOI 10.1067/mva.1989.vs0090535
   KELLER R, 1987, AM J PATHOL, V128, P299
   KEMPCZINSKI RF, 1987, SURGERY, V101, P439
   KENT KC, 1989, J VASC SURG, V9, P271, DOI 10.1067/mva.1989.vs0090271
   KEOUGH EM, 1984, J BIOMED MATER RES, V18, P281, DOI 10.1002/jbm.820180305
   KESLER KA, 1986, J VASC SURG, V3, P58
   KIRKPATRICK CJ, 1985, BIOCHIM BIOPHYS ACTA, V846, P120, DOI 10.1016/0167-4889(85)90117-X
   LESECHE G, 1989, SURGERY, V105, P36
   LEVIN EG, 1982, J CELL BIOL, V94, P631, DOI 10.1083/jcb.94.3.631
   LINDBLAD B, 1987, J BIOMED MATER RES, V21, P1013, DOI 10.1002/jbm.820210807
   LYDON MJ, 1986, BR POLYM J, V18, P22
   MADRI JA, 1980, LAB INVEST, V43, P303
   MATHISEN SR, 1986, J VASC SURG, V4, P33
   MCAUSLAN BR, 1987, J BIOMED MATER RES, V21, P921, DOI 10.1002/jbm.820210708
   MUELLER-SCHULTE D, 1990, Journal of Chromatography, V510, P115
   MUELLERSCHULTE D, 1982, POLYM B, V7, P395
   MUELLERSCHULTE D, 1987, Patent No. 214
   MUELLERSCHULTE D, 1982, POLYM B, V7, P77
   MUELLERSCHULTE D, 1987, Patent No. 3644987
   NICHOLS WK, 1981, T AM SOC ART INT ORG, V27, P208
   OERTENWALL P, 1989, J VASC SURG, V10, P374
   OERTENWALL P, 1987, J VASC SURG, V6, P17
   PLOW EF, 1981, J BIOL CHEM, V256, P9477
   PRATT KJ, 1989, J BIOMED MATER RES, V23, P1131, DOI 10.1002/jbm.820231004
   RAMALANJAONA G, 1986, J VASC SURG, V3, P264, DOI 10.1067/mva.1986.avs0030264
   RATNER BD, 1983, ANN BIOMED ENG, V11, P313, DOI 10.1007/BF02363290
   RATNER BD, 1980, J BIOMED MATER RES, V14, P665, DOI 10.1002/jbm.820140512
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   ROSENMAN JE, 1985, J VASC SURG, V2, P778, DOI 10.1067/mva.1985.avs0020778
   SAGE H, 1981, ARTERIOSCLEROSIS, V1, P427, DOI 10.1161/01.ATV.1.6.427
   SAUVAGE LR, 1974, ARCH SURG-CHICAGO, V109, P698
   SAUVAGE LR, 1975, ANN SURG, V182, P749, DOI 10.1097/00000658-197512000-00017
   SCHMIDT SP, 1987, ENDOTHELIALIZATION V, P145
   SCHNEIDER PA, 1988, SURGERY, V103, P456
   SCHOR AM, 1984, TISSUE CELL, V16, P677, DOI 10.1016/0040-8166(84)90002-8
   SEEGER JM, 1985, J SURG RES, V38, P641, DOI 10.1016/0022-4804(85)90087-3
   SENTISSI JM, 1986, SURGERY, V99, P337
   SHAREFKIN JB, 1982, SURGERY, V92, P385
   SHARP WV, 1978, T AM SOC ART INT ORG, V24, P223
   SHINDO S, 1987, J VASC SURG, V6, P325, DOI 10.1067/mva.1987.avs0060325
   STANLEY JC, 1982, SURGERY, V92, P994
   STERN D, 1986, J CELL BIOL, V102, P1971, DOI 10.1083/jcb.102.5.1971
   THORNTON SC, 1983, SCIENCE, V222, P623, DOI 10.1126/science.6635659
   VANWACHEM PB, 1989, BIOMATERIALS, V10, P532, DOI 10.1016/0142-9612(89)90058-6
   WEKSLER BB, 1977, P NATL ACAD SCI USA, V74, P3922, DOI 10.1073/pnas.74.9.3922
   WILLIAMS SK, 1990, SCANNING MICROSCOPY, V4, P181
   YASUDA H, 1982, BIOMATERIALS, V3, P68, DOI 10.1016/0142-9612(82)90036-9
   YATES SG, 1978, ANN SURG, V188, P611, DOI 10.1097/00000658-197811000-00005
   ZILLA P, 1987, ENDOTHELIALIZATION V, P195
NR 99
TC 22
Z9 22
U1 0
U2 11
PU SCANNING MICROSCOPY INT
PI CHICAGO
PA PO BOX 66507, AMF O'HARE, CHICAGO, IL 60666
SN 1051-6794
J9 CELL MATER
JI Cells Mat.
PY 1991
VL 1
IS 2
BP 93
EP 108
PG 16
WC Cell Biology; Medicine, Research & Experimental; Materials Science,
   Biomaterials
SC Cell Biology; Research & Experimental Medicine; Materials Science
GA GK712
UT WOS:A1991GK71200001
DA 2018-10-19
ER

PT J
AU TIEN, HT
   SALAMON, Z
   OTTOVA, A
AF TIEN, HT
   SALAMON, Z
   OTTOVA, A
TI LIPID BILAYER-BASED SENSORS AND BIOMOLECULAR ELECTRONICS
SO CRITICAL REVIEWS IN BIOMEDICAL ENGINEERING
LA English
DT Review
ID CHEMISORBED MOLECULES; SELECTIVE SENSOR; CALCIUM-CHANNEL; MEMBRANES;
   ENZYME; BLM; SYSTEMS; GLUCOSE; DESIGN; ELECTROCHEMISTRY
AB The lipid bilayer postulated as the basic structural matrix of biological membranes is widely accepted.1  Experiments in the early 1960s have made direct studies of lipid bilayers possible.  At present, the planar bilayer lipid membrane (BLM) together with spherical lipid bilayers (liposomes), upon suitable modification, serves as a most appropriate model for biological membranes.  In recent years, advances in microelectronics and interest in ultrathin organic films, including BLMs, have resulted in a unique fusion of ideas toward the development of biosensors and transducers.  Furthermore, recent trends in interdisciplinary studies in chemistry, electronics, and biology have led to a new field or research:  biomolecular electronics.  This exciting new field of scientific-technological endeavor is part of a more general approach toward the development of a new, postsemiconductor electronic technology, namely, molecular electronics with a long-term goal of molecular computers.
   Experimental BLMs have been mainly used in the past as models of biological membranes.2,3  The methods of BLM studies may not be familiar to those outside biomedical research.  Therefore, a brief description of the experimental techniques will be given in Section IV.
   Recently, it has been demonstrated that BLMs, after suitable modification, can function as electrodes and exhibit nonlinear electronic properties.  These and other experimental findings relevant to sensor development and to "biomolecular electronic devices" (BED) will be covered in Section V, after a brief description of biomembranes which have been suggested as nature's molecular devices (Section III).  In the last section, the potential use of the BLM system together with its modifications in the development of a new class of organic diodes, switches, biosensors, electrochemical photocells, and biofuel cells will be presented (Section VI).  Additionally, this paper, besides presenting a review of our work and those of others on BLMs and liposomes in relation to biosensors and molecular electronics, reports a novel technique for obtaining BLMs (or lipid bilayers) on solid supports.  The presence of solid support on one side of the BLM greatly enhances its mechanical stability, while retaining the dynamic properties of the lipid bilayer.  Advantages of the new technique for self-assembling amphiphilic molecules on rigid substrates are discussed in terms of their possible uses.  That is, the new BLM system (s-BLMs) is potentially useful for technological applications in the area of biosensors, enzyme electrodes, and molecular electronics as well as biochips (Section IV.C).
   The dividing line between the present microscopic and the future molecular electronics is 1-mu-m.  Below this level, a new realm of quantum mechanics is starting to play a role and the classic rules of microelectronics ceases to function.  Taking into account that current high-density silicon technology can pack 50,000 transistors and more into a square millimeter, with a spacing between components on the order of 1 mm, together with the fact that below this dimensional level the physical properties of materials are fundamentally different, one has to come to the conclusion that microelectronic technology stands on the threshold of a new revolutionary change.  The era of this new type of electronics is going to be based on the power of molecules and atoms themselves, instead of the thin semi-conductor films used as a basis for the present microelectronics.
   Although in the world of molecules and atoms a number of physical phenomena can be used as reasonable candidates for the new post-semiconductor technology (specific electrical properties of molecules and atoms, quantum effects, and superconducting electronics and bioelectronics), there are two main directions in this field of research:  (1) molecular electronics based upon properties of molecules and atoms and (2) nanoelectronics using quantum effects.4  As expected, these new approaches will provide the means to develop the electronic circuits not only faster (a molecular circuit is expected to be 100,000 times faster than the ones in the present PC computers), but also with fundamentally new properties.  The latter is based on the fact that information-processing capabilities of molecules can be realized through the changes of electronic as well as their geometric structures.  This seems to be especially promising in the case of biological systems where the conformational properties of protein enzymes allow for ligand-receptor contact (lock-and-key) types of interaction.  This allows the recognition of specific molecular objects by exploring their shapes.5  The unique information processing capabilities of protein enzymes could be adapted for computers basically by changing von Neumann's approach and giving entirely new type of computer with a significantly increased computational power for such tasks as pattern recognition and process control.5  To reach this final goal in biomolecular electronics, researchers have to explore the possibility of developing bioelectronic devices from conceptually relatively simple biosensors to very advanced "biological electronic chips" which will function as a control-center processor.5,6
   Biosensors and simple bioelectronic devices have already been developing as a result of efforts on several scientific fronts.7-10  In this review, attention is focused upon BLM-based experiments as related to sensors and BED.  Thus, the BLM system may be viewed as a unique way to study the characteristic of a molecular junction free from the usual bulk-phase effects.  It will be seen that the approach used by various investigators is based upon a melange of ideas gathered from the fields of membrane biophysics, electrochemistry, photobiology, solid-state physics, and organic materials science.9.10
RP TIEN, HT (reprint author), MICHIGAN STATE UNIV,DEPT PHYSIOL,E LANSING,MI 48824, USA.
FU NIGMS NIH HHS [GM-14971]
CR AIZAWA M, 1977, J SOL-PHASE BIOCHEM, V2, P111
   ANTOLINI R, 1982, TRANSPORT MEMBRANES, P57
   ARNDT R, 1982, BIOCHEM PHARMACOL, V31, P3120, DOI 10.1016/0006-2952(82)90090-9
   ARNOLD MA, 1987, BIOSENSORS FUNDAMENT, pCH3
   BADLEY RA, 1987, PHILOS T ROY SOC B, V316, P143, DOI 10.1098/rstb.1987.0024
   BANGHAM AD, 1983, LIPOSOMES, P1
   BARBER J, 1979, TOPICS PHOTOSYNTHESI, V3, P115
   BARKER SA, 1987, BIOSENSORS FUNDAMENT, pCH6
   Bartlett P.N., 1987, BIOSENSORS FUNDAMENT
   BIRGE R, 1990, SOVIET E EUROPEAN RE, V7
   BLANK M, 1986, ELECTRICAL DOUBLE LA, P149
   BLANK M, 1970, SURFACE CHEM BIOL SY, P135
   BLUMENTHAL R, 1984, J BACTERIOL, V157, P321
   BROWN HD, 1971, CHEM CELL INTERFACE, P205
   BRYNDA E, 1985, CZECH J PHYS, V35, P873, DOI 10.1007/BF01959455
   BURKHANOV A, 1987, OTKRYT IZOBRET OTIZD, V13, P16
   CARTER FL, 1988, MOL ELECTRONIC DEVIC
   CASTLEDEN JA, 1969, J PHARM SCI, V58, P169
   CENAS NK, 1983, BIOELECTROCH BIOENER, V11, P61, DOI 10.1016/0302-4598(83)85101-0
   CENAS NK, 1984, BIOCHIM BIOPHYS ACTA, V767, P108
   CHERNY VV, 1989, BIOELECTROCH BIOENER, V21, P373, DOI 10.1016/0302-4598(89)85015-9
   CLARK LC, 1962, ANN NY ACAD SCI, V102, P29, DOI 10.1111/j.1749-6632.1962.tb13623.x
   CLARKSON MA, 1989, BYTE             MAY, P268
   Connolly J. S., 1988, PHOTOINDUCED ELECT D, P303
   CONRAD M, 1985, COMMUN ACM, V28, P464, DOI 10.1145/3532.3533
   CULLEN DC, 1988, BIOSENSORS, V3, P211
   CUNNANE VJ, J ELECTROANAL CHEM, V243, P455
   Danielsson B., 1987, BIOSENSORS FUNDAMENT, P575
   DATTA DB, 1987, MEMBRANE BIOCH
   DAUNERT S, 1989, BIOL SYNTHETIC MEMBR, P292
   DAVIS G, 1985, BIOSENSORS, V1, P161, DOI 10.1016/0265-928X(85)80002-X
   DAVISON SG, 1989, PROGR SURFACE SCI, V30, P1
   DELCASTI.J, 1966, SCIENCE, V153, P185, DOI 10.1126/science.153.3732.185
   DRYHURST G, 1988, REDOX CHEM INTERFACI, P529
   FABIANOWSKI W, 1989, LANGMUIR, V5, P35, DOI 10.1021/la00085a008
   FAULKNER LR, 1984, CHEM ENG NEWS   0227
   FAULKNER LR, 1984, CHEM ENG NEWS   0228, P411
   FISHERMAN AP, 1962, NATURE, V194, P979
   GORSKAYA I A, 1984, Biokhimiya, V49, P821
   GORTON L, 1984, J ELECTROANAL CHEM, V161, P103, DOI 10.1016/S0022-0728(84)80253-3
   Green M.J., 1987, BIOSENSORS FUNDAMENT
   Gregoriadis G, 1984, LIPOSOME TECHNOLOGY
   HAIR ML, 1971, CHEM BIOSURFACES, P234
   HALE PD, 1989, J AM CHEM SOC, V111, P3482, DOI 10.1021/ja00191a084
   Hameroff S., 1987, ULTIMATE COMPUTING
   HARRIS JR, 1989, SUBCELL BIOCH, V14, P97
   HENDRY SP, 1988, HORM METAB RES, V20, P37
   HONEYBOURNE CL, 1987, J PHYS CHEM SOLIDS, V48, P109, DOI 10.1016/0022-3697(87)90077-1
   HONG FT, 1989, MOL ELECT BIOSENSORS, P259
   HUCK H, 1984, ANALYST, V109, P147, DOI 10.1039/an9840900147
   IVANOV I, 1988, THIN LIQUID FILMS, P827
   Janata J., 1987, Proceedings of the Symposium on Chemical Sensors, P258
   KARADAGHI SE, 1984, BIOCHIM BIOPHYS ACTA, V778, P269
   KARUBE I, 1989, ANAL LETT, V22, P731
   KELL DB, 1985, J BIOELECTRICITY, V4, P317, DOI 10.3109/15368378509033261
   KELL DB, 1985, EUR BIOPHYS J BIOPHY, V12, P181
   KITANO H, 1988, BIOCHIM BIOPHYS ACTA, V942, P131, DOI 10.1016/0005-2736(88)90282-9
   KOSSI CN, 1981, J COLLOID INTERF SCI, V80, P426, DOI 10.1016/0021-9797(81)90201-0
   KRUGLYAKOV PM, 1988, THIN LIQUID FILMS, P767
   KRULL UJ, 1987, ANAL CHIM ACTA, V197, P203, DOI 10.1016/S0003-2670(00)84729-7
   KRULL VJ, 1986, FUNDAMENTALS APPLICA, P351
   KULYS JJ, 1981, ENZYME MICROB TECHNO, V3, P342
   KURIHARA K, 1987, 4TH INT C SOL STAT S, P569
   KUTNIK J, 1987, PHOTOCHEM PHOTOBIOL, V46, P413, DOI 10.1111/j.1751-1097.1987.tb04788.x
   LANE RF, 1973, J PHYS CHEM-US, V77, P1411, DOI 10.1021/j100630a019
   LANE RF, 1973, J PHYS CHEM-US, V77, P1401, DOI 10.1021/j100630a018
   LIEDBERG B, 1983, SENSOR ACTUATOR, V4, P299, DOI 10.1016/0250-6874(83)85036-7
   LIN AWC, 1977, J ELECTROANAL CHEM, V84, P411, DOI 10.1016/S0022-0728(77)80394-X
   LOEW LM, 1982, J BIOCHEM BIOPH METH, V6, P243, DOI 10.1016/0165-022X(82)90047-1
   LUO SF, 1989, ANAL CHEM, V61, P1069, DOI 10.1021/ac00185a005
   MARGULES GS, 1986, BIOELECTROCH BIOENER, V16, P361, DOI 10.1016/0302-4598(86)80060-5
   MARTIN MJ, 1987, MED BIOL ENG COMPUT, P597
   MARTONOSI AN, 1981, MEMBRANE TRANSPORT, P165
   MATSUMOTO G, 1987, J THEOR BIOL, V107, P649
   MAUZERALL D, 1909, LIGHT INDUCED CHARGE, P241
   Miller C, 1986, ION CHANNEL RECONSTI
   MITTAL KL, 1990, SURFACTANTS SOLUTION, V8, P133
   MIYANO K, 1985, JPN J APPL PHYS 1, V24, P1379, DOI 10.1143/JJAP.24.1379
   MOHANSSON G, 1985, BIOSENSORS, V1, P355
   MOSBACH K, 1983, NEW BIOSENSOR DEVICE, P65
   MOUNTZ JD, 1978, J BIOENERG BIOMEMBR, V10, P139, DOI 10.1007/BF00743104
   MOUNTZ JM, 1978, PHOTOCHEM PHOTOBIOL, V28, P395, DOI 10.1111/j.1751-1097.1978.tb07724.x
   MUELLER P, 1967, BIOCHEM BIOPH RES CO, V26, P398, DOI 10.1016/0006-291X(67)90559-1
   MUNN RW, 1988, J MOL ELECTRON, V4, P31
   MURRAY RW, 1984, ELECTROANAL CHEM, V13, P191
   OBOYLE KP, 1984, IMMUNOL COMMUN, V13, P85, DOI 10.3109/08820138409025453
   OKAHATA Y, 1987, ANN M CHEM SOC JPN, P26
   OLLSHER U, 1989, J AM CHEM SOC, V111, P9217
   OLSON JM, 1977, BROOKHAVEN SYM BIOL, V28, P105
   PICKUP JC, 1988, HORM METAB RES, V20, P34
   PYATNITSKY AM, 1984, BIOFIZIKA+, V29, P615
   REICHERT WM, 1987, THIN SOLID FILMS, V152, P345, DOI 10.1016/0040-6090(87)90426-3
   REIG F, 1981, FETT SEIFEN ANSTR, V83, P267
   RINGSDORF H, 1988, ANGEW CHEM INT EDIT, V27, P113, DOI 10.1002/anie.198801131
   Robertson JD, 1981, J CELL BIOL, V91, P189
   RUDNEV VS, 1984, BIOL MEMBRANY, V1, P1019
   SALAMON Z, 1988, PHOTOCHEM PHOTOBIOL, V48, P281, DOI 10.1111/j.1751-1097.1988.tb02822.x
   SALMON Z, 1989, J PHOTOCHEM PHOTOBIO, V3, P351
   SCHMIDT W, 1984, J MEMBRANE BIOL, V82, P113, DOI 10.1007/BF01868936
   SCHULTZ PG, 1988, SCIENCE, V240, P426, DOI 10.1126/science.2833815
   SEMENOVA AN, 1987, J PHOTOCHEM PHOTOBIO, V1, P185
   SETA P, 1989, ELECTROCHIM ACTA, V34, P1723, DOI 10.1016/0013-4686(89)85055-8
   SHARP M, 1971, ANAL CHIM ACTA, V54, P13, DOI 10.1016/S0003-2670(01)81850-X
   SHEN XC, 1986, BIOELECTROCH BIOENER, V16, P13
   SHUETZLE D, 1986, FUNDAMENTALS APPLICA
   SOKOLOV YV, 1985, J MEMBRANE BIOL, V2, P943
   SUTERLAND RM, 1987, BIOSENSORS FUNDAMENT, P655
   SZOKA F, 1980, ANNU REV BIOPHYS BIO, V9, P467, DOI 10.1146/annurev.bb.09.060180.002343
   TABUSHI I, 1989, J CHEM SOC PERK T 1, P383, DOI 10.1039/p19890000383
   TANCREDE P, 1983, J BIOCHEM BIOPH METH, V7, P299, DOI 10.1016/0165-022X(83)90055-6
   TAYLOR RF, 1987, BIOSENSORS BIOCHIPS
   THOMPSON M, 1983, TALANTA, V30, P919, DOI 10.1016/0039-9140(83)80214-8
   TIEN HT, 1986, BIOELECTROCH BIOENER, V15, P19, DOI 10.1016/0302-4598(86)80002-2
   TIEN HT, 1989, BIOELECTROCH BIOENER, V22, P211, DOI 10.1016/0302-4598(89)87040-0
   TIEN HT, 1984, BIOELECTROCH BIOENER, V13, P299, DOI 10.1016/0302-4598(84)87033-6
   TIEN HT, 1988, J CLIN LAB ANAL, V2, P256, DOI 10.1002/jcla.1860020414
   TIEN HT, 1988, J MOL ELECTRON, V4, pS1
   TIEN HT, 1976, PHOTOCHEM PHOTOBIOL, V24, P95, DOI 10.1111/j.1751-1097.1976.tb06805.x
   TIEN HT, 1988, J SURFACE SCI TECHNO, V4, P1
   TIEN HT, IN PRESS P S MOL ELE
   TIEN HT, 1974, BILAYER LIPID MEMBRA
   TSE DCS, 1977, ANAL CHEM, V49, P1589
   TSUCHIDA E, 1988, J PHYS CHEM-US, V92, P4255, DOI 10.1021/j100326a001
   Turner A. P. F., 1987, BIOSENSORS FUNDAMENT
   TURNER APF, 1988, AM BIOTECHNOL LAB, V6, P10
   VANROGGEN A, 1988, MOL ELECTRONIC DEVIC, P427
   VASSILEV PM, 1987, BIOCHIM BIOPHYS ACTA, V897, P324, DOI 10.1016/0005-2736(87)90428-7
   VASSILEV PM, 1987, CANCER RES, V47, P519
   VASSILEV PM, 1986, CANCER BIOCHEM BIOPH, V9, P85
   VASSILEV PM, 1989, SUBCELLULAR BIOCH, V14, pCH3
   WANGERMANN G, 1989, STUD BIOPHYS, V132, P9
   WARNER PG, 1987, BIOSENSORS FUNDAMENT, pCH7
   WILLIAMS DE, IN PRESS S BIOSENSOR
   YAMASAKI Y, 1989, CLIN CHIM ACTA, V180, P93, DOI 10.1016/0009-8981(89)90301-X
   YEGOROVA YM, 1984, ELEKTROKHIMIYA, V20, P1527
   YOSHIKAWA K, 1987, BIOCHEM BIOPH RES CO, V145, P1092, DOI 10.1016/0006-291X(87)91549-X
NR 136
TC 36
Z9 37
U1 2
U2 35
PU BEGELL HOUSE INC
PI NEW YORK
PA 79 MADISON AVE, SUITE 1205, NEW YORK, NY 10016-7892
SN 0278-940X
J9 CRIT REV BIOMED ENG
JI Crit. Rev. Biomed. Eng.
PY 1991
VL 18
IS 5
BP 323
EP 340
PG 18
WC Engineering, Biomedical
SC Engineering
GA FE201
UT WOS:A1991FE20100002
PM 2036800
DA 2018-10-19
ER

PT J
AU HANSEN, JT
   GASH, DM
AF HANSEN, JT
   GASH, DM
TI FUNCTIONAL-ASPECTS OF MAMMALIAN NEURAL TRANSPLANTATION
SO CRITICAL REVIEWS IN NEUROBIOLOGY
LA English
DT Review
DE NEURAL TRANSPLANTS; MAMMALIAN; PARKINSONS DISEASE; NEURODEGENERATION;
   NEURAL PLASTICITY; BLOOD-BRAIN BARRIER
ID NERVE GROWTH-FACTOR; ADRENAL CHROMAFFIN CELLS; ADULT-RAT-BRAIN; INDUCED
   NEURONOTROPHIC ACTIVITY; ADVANCED PARKINSONS-DISEASE; GENETICALLY
   MODIFIED CELLS; SUBSTANTIA NIGRA; CAUDATE-NUCLEUS; MEDULLARY TISSUE;
   BASAL GANGLIA
AB Although initially perceived as a method to study neural development and regeneration, neural transplantation has recently become a very promising approach in its own right as a therapeutic tool to treat neurodegenerative disorders. The development of several animal models which mimic aspects of clinical disorders such as Parkinson's disease, Alzheimer's disease, and Huntington's chorea, provides systems in which to study the potential benefits of grafts derived from different sources. Both fetal and adult donor tissues presently are under investigation. Additionally, cell lines and genetically engineered cells also are being developed as suitable graft material. Important aspects of graft-host interaction, including cell survival, host regeneration, immune interactions, improved behavior, and blood-brain barrier phenomena, may be studied in these transplant models. Advances in this field of biomedical research have led to clinical trials in patients afflicted with Parkinson's disease who now are undergoing transplantation therapy. Thus far, the results have been equivocal, raising important ethical questions about continued clinical studies until more is understood about how neural transplants function and interact with the host. Nevertheless, neural transplantation holds tremendous promise as a future therapeutic tool to treat progressive and irreversible neural disorders.
RP HANSEN, JT (reprint author), UNIV ROCHESTER, SCH MED, DEPT NEUROBIOL & ANAT, BOX 603, 601 ELMWOOD AVE, ROCHESTER, NY 14642 USA.
FU NINDS NIH HHS [NS 25778]
CR AEBISCHER P, 1988, BRAIN RES, V448, P364, DOI 10.1016/0006-8993(88)91278-4
   AGUAYO AJ, 1987, ANN NY ACAD SCI, V495, P1, DOI 10.1111/j.1749-6632.1987.tb23661.x
   AGUAYO AJ, 1984, NEUROSCI LETT, V45, P53, DOI 10.1016/0304-3940(84)90328-8
   AHLSKOG JE, 1990, MAYO CLIN PROC, V65, P305, DOI 10.1016/S0025-6196(12)62532-4
   ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X
   ALLEN GS, 1989, ARCH NEUROL-CHICAGO, V46, P487, DOI 10.1001/archneur.1989.00520410021016
   ANDY OJ, 1963, J NEUROSURG, V20, P860, DOI 10.3171/jns.1963.20.10.0860
   APPEL SH, 1981, ANN NEUROL, V10, P499, DOI 10.1002/ana.410100602
   APUZZO MLJ, 1990, NEUROSURGERY, V26, P746, DOI 10.1227/00006123-199005000-00003
   BACKLUND EO, 1985, J NEUROSURG, V62, P169, DOI 10.3171/jns.1985.62.2.0169
   BAKAY RAE, 1988, PROG BRAIN RES, V78, P463
   BANKIEWICZ KS, 1990, J NEUROSURG, V72, P231, DOI 10.3171/jns.1990.72.2.0231
   BANKIEWICZ KS, 1986, LIFE SCI, V39, P7, DOI 10.1016/0024-3205(86)90431-5
   BANKIEWICZ KS, 1988, PROG BRAIN RES, V78, P543
   Barbeau A., 1986, HDB CLIN NEUROLOGY, P87
   BARKER CF, 1977, ADV IMMUNOL, V25, P1
   BING G, 1988, BRAIN RES BULL, V20, P399, DOI 10.1016/0361-9230(88)90069-X
   BING G, 1987, Society for Neuroscience Abstracts, V13, P161
   BJORKLUND A, 1977, CELL TISSUE RES, V185, P289
   BJORKLUND A, 1980, BRAIN RES, V199, P307, DOI 10.1016/0006-8993(80)90692-7
   BJORKLUND A, 1979, BRAIN RES, V177, P555, DOI 10.1016/0006-8993(79)90472-4
   BJORKLUND A, 1976, NATURE, V262, P787, DOI 10.1038/262787a0
   BJORKLUND A, 1982, NATURE, V298, P652, DOI 10.1038/298652a0
   BJORKLUND A, 1980, CELL TISSUE RES, V212, P39
   Bjorklund A., 1985, NEURAL GRAFTING MAMM, P3
   BOHN MC, 1987, SCIENCE, V237, P913, DOI 10.1126/science.2887034
   BOTTENSTEIN JE, 1981, FUNCTIONALLY DIFFERE, P155
   BREGMAN BS, 1986, J COMP NEUROL, V244, P86, DOI 10.1002/cne.902440107
   BRIGHTMAN MW, 1982, CEREBROSPINAL FLUID, P36
   BROADWELL RD, 1987, J COMP NEUROL, V260, P47, DOI 10.1002/cne.902600105
   BRUNDIN P, 1986, EXP BRAIN RES, V65, P235
   BRUNDIN P, 1988, PROG BRAIN RES, V78, P441
   BRUNDIN P, 1988, DEV BRAIN RES, V39, P233, DOI 10.1016/0165-3806(88)90027-2
   BRUNDIN P, 1985, EXP BRAIN RES, V60, P204
   BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546
   BUZSAKI G, 1988, PROG BRAIN RES, V78, P69
   CATTANACH BM, 1977, NATURE, V269, P338, DOI 10.1038/269338a0
   COOPER IS, 1955, SCIENCE, V121, P217, DOI 10.1126/science.121.3137.217
   COOPER IS, 1965, ANNU REV MED, V16, P309, DOI 10.1146/annurev.me.16.020165.001521
   COTMAN CW, 1983, 15 COLD SPR HARB LAB, P275
   COYLE JT, 1979, ADV NEUROL, V23, P593
   DELCERRO M, 1988, PROG BRAIN RES, V78, P125
   DELCERRO M, 1985, INVEST OPHTH VIS SCI, V26, P1182
   DIFIGLIA M, 1988, J NEUROSCI, V8, P1112
   DOUPE AJ, 1985, J NEUROSCI, V5, P2143
   DOUPE AJ, 1985, J NEUROSCI, V5, P2119
   DUBACH M, 1988, PROG BRAIN RES, V78, P491
   DUNNETT SB, 1982, BRAIN RES, V251, P335, DOI 10.1016/0006-8993(82)90751-X
   DUNNETT SB, 1985, NEURAL GRAFTIN MAMMA, pCH59
   FEED WJ, 1984, NEURAL TRANSPLANTS D, P373
   FIANDACA MS, 1988, EXP NEUROL, V102, P76, DOI 10.1016/0014-4886(88)90080-5
   FINE A, 1988, PROG BRAIN RES, V78, P479
   Forno L. S., 1973, ADV NEUROL, V1, P453
   FREED WJ, 1990, PROG BRAIN RES, V82, P11
   FREED WJ, 1980, ANN NEUROL, V8, P510, DOI 10.1002/ana.410080508
   FREED WJ, 1983, SCIENCE, V222, P937, DOI 10.1126/science.6635666
   FREED WJ, 1981, NATURE, V292, P351, DOI 10.1038/292351a0
   FRIEDMANN T, 1972, SCIENCE, V175, P949, DOI 10.1126/science.175.4025.949
   FRIEDMANN T, 1983, GENE THERAPY FACT FI
   GAGE FH, 1988, J COMP NEUROL, V269, P147, DOI 10.1002/cne.902690112
   GAGE FH, 1987, NEUROSCIENCE, V23, P795, DOI 10.1016/0306-4522(87)90159-X
   GAGE FH, 1986, NEUROSCIENCE, V19, P241, DOI 10.1016/0306-4522(86)90018-7
   GASH D, 1980, SCIENCE, V210, P1367, DOI 10.1126/science.7434031
   GASH DM, 1985, NEUROBIOL AGING, V6, P131, DOI 10.1016/0197-4580(85)90031-4
   GASH DM, IN PRESS FERNSTROM S
   GIBSON MJ, 1984, ENDOCRINOLOGY, V114, P1938, DOI 10.1210/endo-114-5-1938
   GOETZ CG, 1990, NEUROLOGY, V40, P273, DOI 10.1212/WNL.40.2.273
   GOETZ CG, 1989, NEW ENGL J MED, V320, P337, DOI 10.1056/NEJM198902093200601
   GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424
   GUPTA M, 1985, DEV BRAIN RES, V19, P21, DOI 10.1016/0165-3806(85)90227-5
   HANSEN JT, 1988, PROG BRAIN RES, V78, P507
   HANSEN JT, 1990, PROG BRAIN RES, V82, P573
   HANSEN JT, 1988, EXP NEUROL, V102, P65, DOI 10.1016/0014-4886(88)90079-9
   HARRIS WA, 1983, TRENDS NEUROSCI, V6, P505, DOI 10.1016/0166-2236(83)90236-9
   HEFTI F, 1986, ANN NEUROL, V20, P275, DOI 10.1002/ana.410200302
   HEFTI F, 1985, BRAIN RES, V348, P283, DOI 10.1016/0006-8993(85)90446-9
   HEFTI F, 1983, ANN NEUROL, V13, P109, DOI 10.1002/ana.410130127
   HIRSCH EC, 1990, ANN NEUROL, V27, P676, DOI 10.1002/ana.410270615
   HURTIG H, 1989, ANN NEUROL, V25, P607, DOI 10.1002/ana.410250613
   ISACSON O, 1988, PROG BRAIN RES, V78, P13
   JAEGER CB, 1990, PROG BRAIN RES, V82, P41
   JANKOVIC J, 1989, NEW ENGL J MED, V321, P325
   JANKOVIC J, 1989, NEUROLOGY, V39, P1227, DOI 10.1212/WNL.39.9.1227
   JIAO S, 1988, PROG BRAIN RES, V78, P575
   KELLY PJ, 1989, MAYO CLIN PROC, V64, P282, DOI 10.1016/S0025-6196(12)65248-3
   KOPIN IJ, 1987, MPTP INDUCED NEUROTO, P163
   KORDOWER JH, 1986, INTEGRATIVE PSYCHIAT, V4, P64
   KORDOWER JH, 1990, J NEUROSURG, V73, P418, DOI 10.3171/jns.1990.73.3.0418
   KRIEGER DT, 1982, NATURE, V298, P468, DOI 10.1038/298468a0
   KRUM JM, 1989, EXP NEUROL, V103, P203, DOI 10.1016/0014-4886(89)90044-7
   KRUM JM, 1988, J COMP NEUROL, V271, P331, DOI 10.1002/cne.902710304
   LANGSTON JW, 1984, BRAIN RES, V292, P390
   Le Douarin N., 1982, NEURAL CREST
   LEDOURAIN NM, 1976, CIBA F S, V40, P71
   LINDER JC, 1987, NEUROSCI LETT, V82, P221, DOI 10.1016/0304-3940(87)90134-0
   LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529
   LINDVALL O, 1989, ARCH NEUROL-CHICAGO, V46, P615, DOI 10.1001/archneur.1989.00520420033021
   LINDVALL O, 1987, ANN NEUROL, V22, P457, DOI 10.1002/ana.410220403
   LUND RD, 1987, TRANSPLANT P, V19, P1128
   MADRAZO I, 1987, NEW ENGL J MED, V316, P831, DOI 10.1056/NEJM198704023161402
   MARTIN JB, 1986, NEW ENGL J MED, V315, P1267
   MASON DW, 1986, NEUROSCIENCE, V19, P685, DOI 10.1016/0306-4522(86)90292-7
   MOORE KL, 1988, DEV HUMAN, pCH4
   MORIHISA JM, 1984, EXP NEUROL, V84, P643, DOI 10.1016/0014-4886(84)90211-5
   NELSON PG, 1971, J CELL PHYSIOL, V77, P337, DOI 10.1002/jcp.1040770308
   NIETOSAMPEDRO M, 1982, SCIENCE, V217, P860, DOI 10.1126/science.7100931
   NIETOSAMPEDRO M, 1983, J NEUROSCI, V3, P2219
   NOTTER MFD, 1986, CELL TISSUE RES, V244, P69
   OLSON L, 1970, HISTOCHEMISTRY, V22, P1, DOI 10.1007/BF00310543
   OLSON L, 1970, ACTA PHYSIOL SCAND, P1
   OLSON L, 1972, Z ZELLFORSCH MIK ANA, V135, P175, DOI 10.1007/BF00315125
   OLSON L, 1982, BRAIN RES BULL, V9, P519, DOI 10.1016/0361-9230(82)90160-5
   OLSON L, 1985, SYNAPTIC PLASTICITY, P488
   OLSON L, 1984, NEURAL TRANSPLANTS D, P125
   ORDY JM, 1988, NEUROBIOL AGING, V9, P667, DOI 10.1016/S0197-4580(88)80131-3
   PERESE DA, 1989, BRAIN RES, V494, P285, DOI 10.1016/0006-8993(89)90597-0
   PERLOW MJ, 1979, SCIENCE, V204, P643, DOI 10.1126/science.571147
   PERLOW MJ, 1980, P NATL ACAD SCI-BIOL, V77, P5278, DOI 10.1073/pnas.77.9.5278
   PETERSON DI, 1989, NEUROLOGY, V39, P235, DOI 10.1212/WNL.39.2.235
   PRICE DL, 1983, ANNU REV NEUROSCI, P65
   Ranson SW, 1914, J COMP NEUROL, V24, P547
   REDMOND DE, 1986, LANCET, V1, P1125
   REIER PJ, 1988, PROG BRAIN RES, V78, P173
   ROSENBERG MB, 1988, SCIENCE, V242, P1575, DOI 10.1126/science.3201248
   ROSENSTEIN JM, 1979, J NEUROCYTOL, V8, P359, DOI 10.1007/BF01236126
   ROSENSTEIN JM, 1987, BRAIN RES, V414, P192, DOI 10.1016/0006-8993(87)91346-1
   ROSENSTEIN JM, 1984, NEURAL TRANSPLANTS D, P24
   Rubin E., 1988, PATHOLOGY
   SAGEN J, 1987, EXP BRAIN RES, V67, P380
   SAGEN J, 1986, BRAIN RES, V384, P189, DOI 10.1016/0006-8993(86)91238-2
   SCHMIDT RH, 1982, J NEUROCHEM, V38, P737, DOI 10.1111/j.1471-4159.1982.tb08693.x
   SCHMIDT RH, 1981, BRAIN RES, V218, P347, DOI 10.1016/0006-8993(81)91313-5
   SCHMIDT RH, 1983, ACTA PHYSIOL SCAND, P19
   SLADEK JR, 1988, J NEUROSURG, V68, P337, DOI 10.3171/jns.1988.68.3.0337
   SLADEK JR, 1988, SCIENCE, V240, P1386, DOI 10.1126/science.3375820
   SLADEK JR, 1986, BRAIN RES BULL, V17, P809, DOI 10.1016/0361-9230(86)90092-4
   SPRINGER JE, 1988, PROG BRAIN RES, V78, P401
   STENEVI U, 1980, PEPTIDES, V1, P111, DOI 10.1016/0196-9781(80)90108-4
   STENEVI U, 1976, BRAIN RES, V114, P1, DOI 10.1016/0006-8993(76)91003-9
   STROMBERG I, 1985, EXP BRAIN RES, V60, P335
   TANIUCHI M, 1986, P NATL ACAD SCI USA, V83, P4094, DOI 10.1073/pnas.83.11.4094
   TANIUCHI M, 1988, J NEUROSCI, V8, P664
   THOMAS GJ, 1984, BEHAV NEUROSCI, V98, P394, DOI 10.1037//0735-7044.98.3.394
   TISCHLER AS, 1980, LAB INVEST, V43, P399
   TUMILOWICZ JJ, 1970, CANCER RES, V30, P2110
   UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P69
   UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3
   UNSICKER K, 1985, DEV BIOL, V111, P425, DOI 10.1016/0012-1606(85)90495-6
   UNSICKER K, 1981, CELL TISSUE RES, V215, P341
   VALTIN H, 1982, ANN NY ACAD SCI, V394, P1, DOI 10.1111/j.1749-6632.1982.tb37405.x
   VALTIN H, 1967, AM J MED, V42, P814, DOI 10.1016/0002-9343(67)90098-8
   WATERS C H, 1989, Neurology, V39, P127
   WATERS CM, 1988, NEUROSCIENCE, V25, P419, DOI 10.1016/0306-4522(88)90249-7
   WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341
   WHITEHOUSE PJ, 1981, ANN NEUROL, V10, P122, DOI 10.1002/ana.410100203
   WIDNER H, 1988, PROG BRAIN RES, V78, P303
   WIEGAND SJ, 1988, BRAIN RES BULL, V20, P105, DOI 10.1016/0361-9230(88)90014-7
   WILLIAMS LR, 1986, P NATL ACAD SCI USA, V83, P9231, DOI 10.1073/pnas.83.23.9231
   WINN SR, 1989, EXP NEUROL, V105, P244, DOI 10.1016/0014-4886(89)90126-X
   WUERTHELE SM, 1981, EXP BRAIN RES, V44, P1
   WYATT RJ, 1988, PROG BRAIN RES, V78, P625
   ZALEWSKI AA, 1971, EXP NEUROL, V30, P510, DOI 10.1016/0014-4886(71)90151-8
NR 162
TC 4
Z9 4
U1 0
U2 0
PU BEGELL HOUSE INC
PI DANBURY
PA 50 NORTH ST, DANBURY, CT 06810 USA
SN 0892-0915
J9 CRIT REV NEUROBIOL
JI Crit. Rev. Neurobiol.
PY 1991
VL 6
IS 2
BP 79
EP 98
PG 20
WC Neurosciences
SC Neurosciences & Neurology
GA FY173
UT WOS:A1991FY17300001
PM 1934089
DA 2018-10-19
ER

PT J
AU MIMI, M
   LAND, DV
AF MIMI, M
   LAND, DV
TI NONRESONANT PERTURBATION MEASUREMENT OF ANTENNA ELECTROMAGNETIC-FIELD
   CONFIGURATIONS FOR BIOMEDICAL APPLICATIONS
SO JOURNAL OF PHOTOGRAPHIC SCIENCE
LA English
DT Article; Proceedings Paper
CT MEETING ON ADVANCES IN MEDICAL MICROWAVE IMAGING
CY NOV   17, 1989
CL LILLE, FRANCE
SP EUROPEAN ASSOC THERMOL
AB The nonresonant perturbation technique has been used to develop the measurement of antenna electromagnetic field configurations for medical applications.  Antenna near-field configurations and the contour patterns in phantom materials have been analysed numerically and experimentally measured.  This study has shown both methods to be in fair agreement.  The penetration depth naturally depends on lossy dielectric properties through "2-alpha" for wave propagation, and it also depends on the relative permittivity of the medium and the antenna form, the two factors causing the effective penetration distance to be less than the plane wave value.
RP MIMI, M (reprint author), UNIV GLASGOW,DEPT PHYS & ASTRON,GLASGOW G12 8QQ,SCOTLAND.
CR AUDET J, 1980, J MICROWAVE POWER, P177
   CHEUNG AY, 1981, J MICROWAVE POWER, P151
   LAND DV, 1988, ELECTRON LETT, P70
   ROBILLARD M, 1982, J MICROWAVE POWER, P97
   ROBILLARD M, 1980, 1980 P URSI S OND EL, P213
NR 5
TC 0
Z9 0
U1 0
U2 0
PU ROYAL PHOTOGRAPHIC SOC
PI BATH
PA OCTAGON-MILSOM ST, BATH, AVON, ENGLAND BA1 1DN
SN 0022-3638
J9 J PHOTOGR SCI
JI J. Photogr. Sci.
PY 1991
VL 39
IS 4
BP 161
EP 163
PG 3
WC Imaging Science & Photographic Technology
SC Imaging Science & Photographic Technology
GA GT261
UT WOS:A1991GT26100005
DA 2018-10-19
ER

PT J
AU MANSFIELD, P
   BOWTELL, RW
   BLACKBAND, SJ
   CAWLEY, M
AF MANSFIELD, P
   BOWTELL, RW
   BLACKBAND, SJ
   CAWLEY, M
TI INGRESS OF WATER INTO SOLID NYLON - DIFFUSION STUDIES BY NMR IMAGING
SO MAGNETIC RESONANCE IMAGING
LA English
DT Article; Proceedings Paper
CT 1ST INTERNATIONAL MEETING ON RECENT ADVANCES IN NMR APPLICATIONS TO
   POROUS MEDIA
CY NOV 14-16, 1990
CL UNIV BOLOGNA, BOLOGNA, ITALY
SP BANCA POPOLARE PESARESE & RAVENNATE, IST NAZL FIS NUCL, STELAR, ZURIGO ASSICURAZIONI, UNIV BOLOGNA, ASSOC NAZL INGEGNERI MINERARI, AGIP, SCHLUMBERGER ITALIANA, SELM PETR, CNR
HO UNIV BOLOGNA
DE NMR IMAGING; TRANSLATIONAL DIFFUSION
AB The ingress of fluids into solids is important in the study of interfacial problems since the surface properties of the solid may be considerably modified by the presence of the fluid. This is especially the case for many synthetic plastic materials like nylon, where water uptake at the surface can impair their characteristics in a range of biomedical and industrial applications. We have used NMR imaging to study the diffusion of water into solid blocks of nylon over a range of temperatures. The results have enabled the diffusion coefficient and its concentration dependence to be determined. Further modifications of the imaging method have been used to extract localised T1 and T2 values as a function of temperature and concentration. From these measurements we are able to measure the diffusional activation energies and the activation energies associated with the relaxation processes. The relaxation time results are interpreted in terms of a two-phase exchange model. The consequences of this model will be discussed.
RP MANSFIELD, P (reprint author), UNIV NOTTINGHAM,DEPT PHYS,UNIV PK,NOTTINGHAM NG7 2RD,ENGLAND.
OI Bowtell, Richard/0000-0001-8656-412X
NR 0
TC 7
Z9 7
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0730-725X
J9 MAGN RESON IMAGING
JI Magn. Reson. Imaging
PY 1991
VL 9
IS 5
BP 763
EP 765
DI 10.1016/0730-725X(91)90373-T
PG 3
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA GT656
UT WOS:A1991GT65600028
DA 2018-10-19
ER

PT J
AU KELLNER, R
AF KELLNER, R
TI REPORT OF THE WPAC-STUDY GROUP - EDUCATION IN ANALYTICAL-CHEMISTRY AT
   UNIVERSITY LEVEL 1989 90 - UPDATE AND REFLECTIONS
SO MIKROCHIMICA ACTA
LA English
DT Article
DE EDUCATION; ANALYTICAL CHEMISTRY; WPAC FECS
AB The importance of education and training grows with the complexity and practical need of a given subject. Especially in times of rapid evolution such as the introduction of new measurement principles and advanced computers into Analytical Chemistry (AC) a quick update of curricula is necessary. A basic equivalence of undergraduate curricula should be reached to stimulate the worldwide exchange of students. This is underlined by the increasing role of Analytical Chemistry as problem solving science and as main source for reliable data needed in product- and environmental quality control often as basis for far reaching political decision, such as the setting of quality standards.
   AC-curricula in Europa-as shown in a WPAC-enquiry in 1983/84-are, however, highly differentiated and suffer significantly from a historic burden. 110 from 229 universities still offered a conventional curriculum based on the classical scheme of chemical analysis and mainly linked to inorganic or physical chemistry. Modern physical methods or the treatment of problem solving in environmental, life and material sciences was much better treated in the 119 universities with a separate chair of AC. In its latest enquiry in 1989/90 (180 universities), WPAC still identified almost-equal-to 50% traditional, incomplete AC-curricula (21 European countries). However, only 13 institutions consider this as ideal for the future. The vast majority supports the inclusion of basic principles and modern methods into the-extended-AC-curricula as well as the exemplary treatment of major applications to materials sciences, food production, environmental systems, pharmaceutical and biomedical sciences, biotechnology as well as arts and archeology. WPAC activities are therefore aimed at deriving recommendations for future oriented curricula in AC-education and training.
   Finally a "hit list" of textbooks of Analytical Chemistry and future needs of AC-curricula including Ph.D. studies and postgraduate specialization extracted from the WPAC-enquiry 1989/90 will be presented and critically discussed.
RP KELLNER, R (reprint author), VIENNA TECH UNIV,INST ANALYT CHEM,GETREIDEMARKT 9,A-1060 VIENNA,AUSTRIA.
CR KELLNER R, 1988, ANAL CHEM, V60, pA623
   KELLNER R, 1985, TRAC, V4
   KELLNER R, 1984, FRESNIUS Z ANAL CHEM, V319
   MALISSA H, 1979, FRESENIUS Z ANAL CHE, V297
   MALISSA H, 1981, FRESENIUS Z ANAL CHE, V305
   1988, REPORT COMMISSION MU
NR 6
TC 4
Z9 4
U1 0
U2 2
PU SPRINGER-VERLAG WIEN
PI VIENNA
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA
SN 0026-3672
J9 MIKROCHIM ACTA
JI Mikrochim. Acta
PY 1991
VL 2
IS 1-6
BP 555
EP 564
PG 10
WC Chemistry, Analytical
SC Chemistry
GA GK819
UT WOS:A1991GK81900053
DA 2018-10-19
ER

PT J
AU GRIESSER, HJ
AF GRIESSER, HJ
TI DEGRADATION OF POLYURETHANES IN BIOMEDICAL APPLICATIONS - A REVIEW
SO POLYMER DEGRADATION AND STABILITY
LA English
DT Review
ID RAY PHOTOELECTRON-SPECTROSCOPY; POLY(ETHER URETHANE UREA); SOLUTION-CAST
   EXTRACTS; FT-IR; SURFACE; BIODEGRADATION; BIOMER; ESCA; BIOMATERIALS;
   INVITRO
AB Polyurethanes are used in biomedical devices because they constitute one of the few classes of polymers that are highly elastomeric and show good biocompatibility.  However, there is continuing debate in the literature regarding their long term stability in biomedical environments, and the validity of using polyurethanes for extended implant applications is still very much in question.  While evidence of polymer degradation in explanted devices has been reported by a number of workers, other studies conclude that degradation is minimal.  This review discusses possible pathways of biomedical degradation, such as enzymatic and oxidative attack, as well as observed effects such as cracking and calcification.  Metal catalyzed degradation may also occur in devices such as pacemaker leads.  While a number of model studies have assessed various modes of degradation, reliable accelerated tests for the prediction of the rates of biomedical ageing effects have apparently not been established.  The role of additives and surface contaminants in biocompatibility and degradation is also discussed.  Finally, as important interactions between a polyurethane polymer and the host body occur at the interface, the surface analysis of polyurethanes is discussed, and it is concluded that proper characterization of the implant surface before and after degradation studies is important for the understanding of degradation, in particular to exclude effects caused not by the polyurethane itself, but by surface contaminants which appear to have been present on the majority of materials subjected to detailed characterization so far.
RP GRIESSER, HJ (reprint author), CSIRO,DIV CHEM & POLYMERS,PRIVATE BAG 10,CLAYTON,VIC 3168,AUSTRALIA.
RI Griesser, Hans/E-5628-2011
OI Griesser, Hans/0000-0003-1072-7863
CR ANDERSON JM, 1986, NATO ASI SER E, V106, P29
   ANDERSON JM, 1984, PROGR BIOMEDICAL ENG, V1, P143
   Andrade J. D., 1988, POLYM SURFACE DYNAMI
   ANDRADE JD, 1990, 1990 ACS SPR M BOST
   BRIGGS D, 1987, POLYM SURFACES INTER, P33
   BYRD CL, 1987, PROGR BIOMEDICAL ENG, V3, P65
   CASTNER D G, 1990, Journal of Biomaterials Science Polymer Edition, V1, P191
   CHAWLA AS, 1988, BIOMATER ARTIF CELL, V16, P785, DOI 10.3109/10731198809117569
   CHIEN JCW, 1978, ADV CHEM SER, V169, P175
   CHINN JA, 1989, J COLLOID INTERF SCI, V127, P67, DOI 10.1016/0021-9797(89)90008-8
   COLEMAN DL, 1981, T AM SOC ART INT ORG, V27, P97
   COLEMAN DL, 1981, T AM SOC ART INT ORG, V27, P708
   COURY A, 1988, 3RD P WORLD BIOM C K, P432
   Coury A J, 1988, J Biomater Appl, V3, P130, DOI 10.1177/088532828800300202
   COURY AJ, 1987, LIFE SUPPORT SYST, V5, P25
   DARBY RT, 1968, APPL MICROBIOL, V16, P900
   DARBY TD, 1978, TOXICOL APPL PHARM, V46, P449, DOI 10.1016/0041-008X(78)90090-X
   Fadley C. S., 1976, Progress in Solid State Chemistry, P265, DOI 10.1016/0079-6786(76)90013-3
   FROMMELT H, 1987, MAKROMOL CHEM-M SYMP, V12, P281, DOI 10.1002/masy.19870120114
   GILDING DK, 1987, LIFE SUPPORT SYST, V5, P19
   GLASMACHER B, 1987, PROGR BIOMEDICAL ENG, V3, P151
   GRAHAM SW, 1981, J BIOMED MATER RES, V15, P349, DOI 10.1002/jbm.820150307
   GRAHAM SW, 1981, J BIOMED MATER RES, V15, P465, DOI 10.1002/jbm.820150403
   GRASEL TG, 1990, J BIOMED MATER RES, V24, P605, DOI 10.1002/jbm.820240507
   GRIESSER HJ, 1990, POLYM MATER SCI ENG, V62, P828
   GROBE GL, 1988, APPL SPECTROSC, V42, P980, DOI 10.1366/0003702884430506
   GROBE GL, 1987, J BIOMED MATER RES, V21, P211, DOI 10.1002/jbm.820210206
   GROBE GL, 1988, APPL SPECTROSC, V42, P989, DOI 10.1366/0003702884430489
   HANSEN RH, 1964, J POLYM SCI PART A, V2, P587, DOI 10.1002/pol.1964.100020204
   HEARN MJ, 1988, MACROMOLECULES, V21, P2950, DOI 10.1021/ma00188a011
   HEARN MJ, 1987, SURF INTERFACE ANAL, V10, P384, DOI 10.1002/sia.740100803
   HENNIG E, 1988, INT J ARTIF ORGANS, V11, P416
   HENNIG E, 1984, PROGR BIOMEDICAL ENG, V1, P109
   HERCULES DM, 1988, POLYM MATER SCI ENG, V59, P724
   HETENYI J, 1987, PROGR BIOMEDICAL ENG, V3, P51
   HORBETT TA, 1982, ADV CHEM SER, V199, P233
   Hu C. B., 1980, AM CHEM SOC DIV POLY, V21, P156
   HUNTER SK, 1982, T AM SOC ART INT ORG, V28, P473
   KNUTSON K, 1982, ACS ADV CHEM SER, V199, P109
   LELAH MD, 1983, J BIOMED MATER RES, V17, P1, DOI 10.1002/jbm.820170102
   LEMM W, 1984, POLYURETHANES BIOMED, V1, P103
   LEMM W, 1984, BIOMATERIALS BIOMECH, P319
   LEMM W, 1980, P EUR SOC ARTIF ORGA, V7, P86
   LOPEZ LC, 1988, J APPL POLYM SCI, V36, P1401, DOI 10.1002/app.1988.070360611
   LUBIN M, 1986, PACE, V9, P1154, DOI 10.1111/j.1540-8159.1986.tb06686.x
   MAHMUD NA, 1986, POLYM MAT SCI ENG, V55, P751
   MARCHANT RE, 1987, POLYMER, V28, P2032, DOI 10.1016/0032-3861(87)90037-1
   MARCHANT RE, 1986, J BIOMED MATER RES, V20, P153, DOI 10.1002/jbm.820200205
   MARCHANT RE, 1988, PROGR BIOMEDICAL ENG, V6, P297
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P1189
   NORMANN SJ, 1982, MACROPHAGES NATURAL
   OSAWA Z, 1988, POLYM DEGRAD STABIL, V20, P203, DOI 10.1016/0141-3910(88)90070-5
   PANDE GS, 1984, ELASTOMERICS, P17
   PAYNTER RW, 1988, J BIOMED MATER RES, V22, P687, DOI 10.1002/jbm.820220803
   PAYNTER RW, 1987, BIOMATERIALS, V8, P94, DOI 10.1016/0142-9612(87)90096-2
   PHILLIPS RE, 1987, PROGR BIOMEDICAL ENG, V3, P91
   PHUA SK, 1987, J BIOMED MATER RES, V21, P231, DOI 10.1002/jbm.820210207
   RATNER BD, 1988, J BIOMED MATER RES, V22, P509, DOI 10.1002/jbm.820220607
   RATNER BD, 1978, J APPL POLYM SCI, V22, P643, DOI 10.1002/app.1978.070220306
   RATNER BD, 1983, ANN BIOMED ENG, V11, P313, DOI 10.1007/BF02363290
   RATNER BD, 1987, POLYM SURFACES INTER, P231
   RATNER BD, 1982, ACS SYM SER, V199, P9
   RATNER BD, 1988, PROGR BIOMEDICAL ENG, V6
   RATNER BD, 1984, PROGR BIOMEDICAL ENG, V1, P41
   RATNER BD, 1987, PROGR BIOMEDICAL ENG, V3, P213
   RATNER BD, 1984, PROGR BIOMEDICAL ENG, V1, P399
   SALTHOUSE TN, 1976, J BIOMED MATER RES, V10, P197, DOI 10.1002/jbm.820100204
   SCOTT G, 1978, ADV CHEM SER, V169, P30
   SHUTTLEWORTH WA, 1986, APPL MICROBIOL BIOT, V23, P407
   SKALSKY M, 1987, PROGR BIOMEDICAL ENG, V3, P75
   SMITH R, 1987, J BIOMED MATER RES, V21, P1149, DOI 10.1002/jbm.820210908
   STOKES K, 1987, PROGR BIOMEDICAL ENG, V3, P109
   STOKES K, 1988, 3RD P WORLD BIOM C K, P434
   Stokes K B, 1988, J Biomater Appl, V3, P228, DOI 10.1177/088532828800300205
   STOKES KB, 1986, PACE, V9, P1160, DOI 10.1111/j.1540-8159.1986.tb06687.x
   STOKES KB, 1985, POLYM MATER SCI ENG, V53, P6
   SUNG CSP, 1979, J BIOMED MATER RES, V13, P161
   Szycher M, 1988, J Biomater Appl, V3, P297, DOI 10.1177/088532828800300207
   SZYCHER M, 1984, T SOC BIOMATER, V7, P24
   Thoma R J, 1988, J Biomater Appl, V3, P180, DOI 10.1177/088532828800300203
   THOMAS RJ, 1988, POLYM MATER SCI ENG, V59, P674
   TINGEY KG, 1988, PROGR BIOMEDICAL ENG, V6, P255
   ULRICH H, 1984, PROGR BIOMEDICAL ENG, V1, P165
   WILLIAMS DF, 1982, J MATER SCI, V17, P1233, DOI 10.1007/BF00752233
   WILLIAMS DF, 1986, BIOL BIOMECHANICAL P, P239
   WILLIAMS DF, 1988, MAY P C I MET MAT AU, P137
   WILSON RS, 1986, NATO ASI E, V106, P15
   WOUTERS LHG, 1987, PROGR BIOMED ENG, V3, P169
   ZDRAHALA RJ, 1986, MATER RES SOC S P, V55, P407
   ZDRAHALA RJ, 1987, PROGR BIOMEDICAL ENG, V3, P1
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
   ZHAO Q, 1987, POLYMER, V28, P2040, DOI 10.1016/0032-3861(87)90038-3
NR 92
TC 62
Z9 62
U1 5
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0141-3910
J9 POLYM DEGRAD STABIL
JI Polym. Degrad. Stabil.
PY 1991
VL 33
IS 3
BP 329
EP 354
DI 10.1016/0141-3910(91)90080-B
PG 26
WC Polymer Science
SC Polymer Science
GA GF010
UT WOS:A1991GF01000001
DA 2018-10-19
ER

PT B
AU TOLK, NH
   BRAU, CA
   EDWARDS, GS
   MARGARITONDO, G
   MCKINLEY, JT
AF TOLK, NH
   BRAU, CA
   EDWARDS, GS
   MARGARITONDO, G
   MCKINLEY, JT
BE SPRANGLE, P
TI THE VANDERBILT FREE-ELECTRON LASER CENTER FOR BIOMEDICAL AND MATERIALS
   RESEARCH
SO SHORT-WAVELENGTH RADIATION SOURCES
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT CONF ON SHORT-WAVELENGTH RADIATION SOURCES
CY JUL 21-26, 1991
CL SAN DIEGO, CA
SP SOC PHOTO OPT INSTRUMENTAT ENGINEERS
NR 0
TC 1
Z9 1
U1 0
U2 0
PU SPIE - INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA BELLINGHAM
BN 0-8194-0680-5
J9 P SOC PHOTO-OPT INS
PY 1991
VL 1552
BP 7
EP 13
DI 10.1117/12.50587
PG 7
WC Optics
SC Optics
GA BV30T
UT WOS:A1991BV30T00002
DA 2018-10-19
ER

PT J
AU PRESTON, RC
   SHAW, A
   ZEQIRI, B
AF PRESTON, RC
   SHAW, A
   ZEQIRI, B
TI PREDICTION OF INSITU EXPOSURE TO ULTRASOUND - AN ACOUSTICAL ATTENUATION
   METHOD
SO ULTRASOUND IN MEDICINE AND BIOLOGY
LA English
DT Article
DE BIOMEDICAL ULTRASOUND; SAFETY; STANDARDS; ULTRASOUND; HUMAN EXPOSURE
ID FINITE-AMPLITUDE DISTORTION; BIOMEDICAL FREQUENCIES; INTENSITIES; MODEL
AB The prediction of the acoustic levels occurring in a patient during ultrasound examination is important for the  assessment of equipment safety.  While considerable effort has been devoted to theoretical methods of predicting exposure levels, there is a need to develop simple experimental methods which are universally applicable to the wide range of ultrasonic fields generated by medical ultrasonic equipment.  This article outlines a number of methods that have been proposed and explores in detail a new experimental method based on the use of acoustical attenuators, made of low-density polyethylene, which are placed in the ultrasound beam between the transducer  and the measuring hydrophone.  Measurements of important acoustical quantities have been made using a measurement system based on a multielement hydrophone and comparisons made between this new method and other methods such as electrical attenuation and linear derating theory.  The acoustical attenuation technique has been systematically studied, and results are compared with reference levels obtained using tissue-mimicking material.
   A procedure involving making measurements with the attenuator placed first at the face of the transducer and then at the hydrophone has been developed.  By taking the mean value of these two measurements, it has been shown that this new method can simulate within +/- 10% the acoustic levels obtained using the reference.  It is concluded that it could be the basis of a universally applicable method.
RP PRESTON, RC (reprint author), NATL PHYS LAB,DIV RADIAT SCI & ACOUST,TEDDINGTON TW11 0LW,MIDDX,ENGLAND.
RI shaw, adam/G-4475-2012
OI shaw, adam/0000-0003-4531-2537
CR BACON DR, 1989, ULTRASOUND MED BIOL, V15, P355, DOI 10.1016/0301-5629(89)90047-1
   BACON DR, 1984, ULTRASOUND MED BIOL, V10, P189, DOI 10.1016/0301-5629(84)90217-5
   BEISSNER K, 1982, J ACOUST SOC AM, V71, P1406, DOI 10.1121/1.387835
   BJORNO L, 1976, ACOUSTICS VIBRATION, V2, P101
   CARSON PL, 1989, ULTRASOUND MED BIOL, V15, P27, DOI 10.1016/0301-5629(89)90210-X
   CARSTENSEN EL, 1980, ULTRASOUND MED BIOL, V6, P359, DOI 10.1016/0301-5629(80)90005-8
   CARSTENSEN EL, 1989, ULTRASOUND MED BIOL, V15, P31, DOI 10.1016/0301-5629(89)90211-1
   DUCK FA, 1988, ULTRASOUND MED BIOL, V14, P305, DOI 10.1016/0301-5629(88)90097-X
   DUCK FA, 1988, IEEE T ULTRASON FERR, V35, P232, DOI 10.1109/58.4173
   HARRIS GR, 1988, IEEE T ULTRASON FERR, V35
   KOSSOFF G, 1984, ULTRASOUND MED BIOL, V10, P197, DOI 10.1016/0301-5629(84)90218-7
   MUIR TG, 1980, ULTRASOUND MED BIOL, V6, P345, DOI 10.1016/0301-5629(80)90004-6
   PRESTON RC, 1991, ULTRASOUND MED BIOL, V17, P333, DOI 10.1016/0301-5629(91)90132-G
   PRESTON RC, 1988, IEEE T ULTRASON FERR, V35, P122, DOI 10.1109/58.4162
   RUF HJ, 1988, THESIS GEORGETOWN U
   STARRITT HC, 1986, PHYS MED BIOL, V31, P1401, DOI 10.1088/0031-9155/31/12/007
   STARRITT HC, 1985, J ACOUST SOC AM, V77, P302, DOI 10.1121/1.392272
   STRATMEYER ME, 1989, ULTRASOUND MED BIOL, V15, P35, DOI 10.1016/0301-5629(89)90212-3
   ZEQIRI B, 1988, IPSM REPORT I PHYSIC, V57, P27
   1981, AIUMNEMA UL11981 NAT
   1985, GUIDE MEASURING REPO
   1990, NCRP66 NAT COUNC RAD
   1983, NCRP74 NAT COUNC RAD
NR 23
TC 16
Z9 16
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0301-5629
J9 ULTRASOUND MED BIOL
JI Ultrasound Med. Biol.
PY 1991
VL 17
IS 4
BP 317
EP 332
DI 10.1016/0301-5629(91)90131-F
PG 16
WC Acoustics; Radiology, Nuclear Medicine & Medical Imaging
SC Acoustics; Radiology, Nuclear Medicine & Medical Imaging
GA GA349
UT WOS:A1991GA34900001
PM 1949344
DA 2018-10-19
ER

PT J
AU PRESTON, RC
   SHAW, A
   ZEQIRI, B
AF PRESTON, RC
   SHAW, A
   ZEQIRI, B
TI PREDICTION OF INSITU EXPOSURE TO ULTRASOUND - A PROPOSED STANDARD
   EXPERIMENTAL-METHOD
SO ULTRASOUND IN MEDICINE AND BIOLOGY
LA English
DT Article
DE BIOMEDICAL ULTRASOUND; SAFETY; STANDARDS; ULTRASOUND; HUMAN EXPOSURE
AB This article presents results for the prediction of in situ exposure levels using a new experimental technique based on the use of acoustical attenuators.  These are made of low-density polyethylene and are placed in the ultrasound beam between the transducer face and the measuring hydrophone.  The method has been tested for a number of different ultrasonic fields including those generated by diagnostic medical ultrasonic equipment.  Using a tissue-mimicking material as a reference, it is shown that it is possible to use this new method to simulate acoustic pressure levels to within +/- 10% and acoustic intensity and power levels within +/- 20%.  The method is proposed as the basis for a standard test method with wide applicability.
RP PRESTON, RC (reprint author), NATL PHYS LAB,DIV RADIAT SCI & ACOUST,TEDDINGTON TW11 0LW,MIDDX,ENGLAND.
RI shaw, adam/G-4475-2012
OI shaw, adam/0000-0003-4531-2537
CR BACON DR, 1984, ULTRASOUND MED BIOL, V10, P189, DOI 10.1016/0301-5629(84)90217-5
   PRESTON RC, 1991, ULTRASOUND MED BIOL, V17, P317, DOI 10.1016/0301-5629(91)90131-F
   PRESTON RC, 1988, IEEE T ULTRASON FERR, V35, P122, DOI 10.1109/58.4162
NR 3
TC 9
Z9 9
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0301-5629
J9 ULTRASOUND MED BIOL
JI Ultrasound Med. Biol.
PY 1991
VL 17
IS 4
BP 333
EP 339
DI 10.1016/0301-5629(91)90132-G
PG 7
WC Acoustics; Radiology, Nuclear Medicine & Medical Imaging
SC Acoustics; Radiology, Nuclear Medicine & Medical Imaging
GA GA349
UT WOS:A1991GA34900002
PM 1949345
DA 2018-10-19
ER

PT J
AU FELTON, JS
   TURTELTAUB, KW
   VOGEL, JS
   BALHORN, R
   GLEDHILL, BL
   SOUTHON, JR
   CAFFEE, MW
   FINKEL, RC
   NELSON, DE
   PROCTOR, ID
   DAVIS, JC
AF FELTON, JS
   TURTELTAUB, KW
   VOGEL, JS
   BALHORN, R
   GLEDHILL, BL
   SOUTHON, JR
   CAFFEE, MW
   FINKEL, RC
   NELSON, DE
   PROCTOR, ID
   DAVIS, JC
TI ACCELERATOR MASS-SPECTROMETRY IN THE BIO-MEDICAL SCIENCES - APPLICATIONS
   IN LOW-EXPOSURE BIO-MEDICAL AND ENVIRONMENTAL DOSIMETRY
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 5TH INTERNATIONAL CONF ON ACCELERATOR MASS SPECTROMETRY ( AMS-5 )
CY APR 23-27, 1990
CL PARIS, FRANCE
SP CNRS, CEA, INST NATL PHYS NUCL & PHYS PARTICLES, HIGH VOLTAGE ENGN EUROPA, ELECTROSTAT INT, ACCELERATOR MASS SPECTROMETRY, ALCATEL
ID DNA ADDUCTS; P-32-POSTLABELING ANALYSIS; ENHANCED SENSITIVITY;
   METABOLITES; IDENTIFICATION; BINDING; RAT
AB We are utilizing accelerator mass spectrometry as a sensitive detector for tracking the disposition of radioisotopically labeled molecules in the biomedical sciences.  These applications have shown the effectiveness of AMS as a tool to quantify biologically important molecules at extremely low levels.  For example, AMS is being used to determine the amount of carcinogen covalently bound to animal DNA (DNA adduct) at levels relevent to human exposure.  Detection sensitivities are 1 carcinogen molecule bound in 10(11) to 10(12) DNA bases, depending on the specific activity of the radiolabeled carcinogen.  Studies have been undertaken in our laboratory utilizing heterocyclic amine food-borne carcinogens and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a potent environmental carcinogen, to study the metabolism of carcinogens at low doses.  In addition, AMS is being used to detect the presence of rare proteins (mutant forms of protamine) in human sperm.  Approximately 1 per 10(6) sperm analyzed contain the rare form of the protamine.  Protamine isolated from this small number of cells is being analyzed by AMS, following C-14 labeling.  Thus, AMS can be used to verify the identity of an extremely small amount of biological material.  Furthermore, an additional improvement of 2 orders of magnitude in the sensitivity of biomedical tracer studies is suggested by preliminary work with bacterial hosts depleted in radiocarbon.  Other problems in the life sciences where detection sensitivity or sample sizes are limitations should also benefit from AMS.  Studies are underway to measure the molecular targeting of cancer chemotherapeutics in human tissue and to pursue applications for receptor biology.  We are also applying other candidate isotopes, such as H-3 (double labeling with C-14) and Ca-41 (bone absorption) to problems in biology.  The detection of Cl-36 and Al-26 have applications for determination of human neutron exposure and understanding neurological toxicity, respectively.  The results described here with C-14-labeled molecules coupled with new isotope applications clearly show AMS technology to be an important new tool for the biomedical sciences community.
C1 UNIV CALIF LAWRENCE LIVERMORE NATL LAB,DIV NUCL CHEM,LIVERMORE,CA 94550.
   UNIV CALIF LAWRENCE LIVERMORE NATL LAB,CTR ACCELERATOR MASS SPECTROMETRY,LIVERMORE,CA 94550.
RP FELTON, JS (reprint author), UNIV CALIF LAWRENCE LIVERMORE NATL LAB,DIV BIOMED SCI,7000 E AVE,LIVERMORE,CA 94550, USA.
RI Caffee, Marc/K-7025-2015
OI Caffee, Marc/0000-0002-6846-8967
CR BASSOSI R, 1983, ANGEW CHEM, V95, P55
   DINH TV, 1987, ANAL CHEM, V59, P1093
   DINH TV, 1987, APPL SPECTROSC, V41, P605
   DUNN BP, 1988, CARCINOGENESIS, V9, P1055, DOI 10.1093/carcin/9.6.1055
   ELMORE D, 1987, SCIENCE, V236, P543, DOI 10.1126/science.236.4801.543
   ELMORE D, 1987, BIOL TRACE ELEM RES, V12, P231, DOI 10.1007/BF02796683
   FELTON JS, 1986, ENVIRON HEALTH PERSP, V67, P17, DOI 10.2307/3430312
   GRIVAS S, 1985, ACTA CHEM SCAND B, V39, P213, DOI 10.3891/acta.chem.scand.39b-0213
   GUPTA RC, 1984, P NATL ACAD SCI-BIOL, V81, P6943, DOI 10.1073/pnas.81.22.6943
   GUPTA RC, 1985, CANCER RES, V45, P5656
   GUPTA RC, 1988, CARCINOGENESIS, V9, P1697
   HARRIS CC, 1985, P NATL ACAD SCI USA, V82, P6672, DOI 10.1073/pnas.82.19.6672
   HSU IC, 1981, CANCER RES, V41, P1091
   LITCHFIELD JH, 1977, ADV APPL MICROBIOL, V22, P266
   MEIRAV O, 1990, NUCL INSTRUM METH B, V52, P536, DOI 10.1016/0168-583X(90)90472-7
   MOHAMED GB, 1984, J CHROMATOGR, V314, P211, DOI 10.1016/S0021-9673(01)97735-0
   RAHN RO, 1982, BIOCHEM BIOPH RES CO, V109, P262, DOI 10.1016/0006-291X(82)91594-7
   RANDERATH K, 1988, CARCINOGENESIS, V9, P2285, DOI 10.1093/carcin/9.12.2285
   REDDY MV, 1986, CARCINOGENESIS, V7, P1543, DOI 10.1093/carcin/7.9.1543
   SANDERS MJ, 1985, ANAL CHEM, V57, P1148, DOI 10.1021/ac00283a042
   TURESKY RJ, 1988, FOOD CHEM TOXICOL, V26, P105, DOI 10.1016/0278-6915(88)90106-8
   TURTELTAUB KW, 1990, CARCINOGENESIS, V11, P43, DOI 10.1093/carcin/11.1.43
   TURTELTAUB KW, 1990, P NATL ACAD SCI USA, V87, P5288, DOI 10.1073/pnas.87.14.5288
   VAHAKANGAS K, 1985, ENVIRON HEALTH PERSP, V62, P101, DOI 10.2307/3430099
   VOGEL JS, 1987, RADIOCARBON, V29, P323
   VOGEL JS, 1990, NUCL INSTRUM METH B, V52, P524, DOI 10.1016/0168-583X(90)90470-F
   VOGEL JS, 1990, RADIOCARBON, V32, P81
   YAMASHITA K, 1990, MUTAGENESIS, V3, P515
   1988, A4345 UN SCI COMM EF
NR 29
TC 43
Z9 44
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD DEC
PY 1990
VL 52
IS 3-4
BP 517
EP 523
DI 10.1016/0168-583X(90)90469-B
PG 7
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA EV368
UT WOS:A1990EV36800062
DA 2018-10-19
ER

PT J
AU VOGEL, JS
   TURTELTAUB, KW
   FELTON, JS
   GLEDHILL, BL
   NELSON, DE
   SOUTHON, JR
   PROCTOR, ID
   DAVIS, JC
AF VOGEL, JS
   TURTELTAUB, KW
   FELTON, JS
   GLEDHILL, BL
   NELSON, DE
   SOUTHON, JR
   PROCTOR, ID
   DAVIS, JC
TI APPLICATION OF AMS TO THE BIO-MEDICAL SCIENCES
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 5TH INTERNATIONAL CONF ON ACCELERATOR MASS SPECTROMETRY ( AMS-5 )
CY APR 23-27, 1990
CL PARIS, FRANCE
SP CNRS, CEA, INST NATL PHYS NUCL & PHYS PARTICLES, HIGH VOLTAGE ENGN EUROPA, ELECTROSTAT INT, ACCELERATOR MASS SPECTROMETRY, ALCATEL
ID ACCELERATOR MASS-SPECTROMETRY; RADIOCARBON; ISOTOPE
AB Radio-isotopic tracers are a useful tool in numerous areas of biomedical research, including metabolism, pharmacokinetics, and the detailed study of biomolecular interactions.  Accelerator mass spectrometry was suggested as a tool for the biomedical sciences shortly after its invention, but few attempts to use its sensitivity in such research have been reported.  We have examined some of the strengths and limitations of the technique and find that AMS has a sensitivity advantage over decay-counting for the long-lived radio-isotopes and for shorter-lived, common radiotracers.  The advantage can be translated into the use of much smaller sample sizes and much lower radio-isotope concentrations, both of which present new opportunities for biochemical tracing and human research.  New approaches to separation and preparation of the material to be assayed for radio-tracers will be developed to take advantage of the sensitivity and specificity.  Most biochemical laboratories have used radioactive isotopes as tracers and their facilities have been contaminated with unacceptably high levels of these tracers.  Careful protocols and/or new facilities are required to prevent contamination of the AMS samples.
C1 UNIV CALIF LAWRENCE LIVERMORE NATL LAB,DIV BIOMED SCI,LIVERMORE,CA 94550.
RP VOGEL, JS (reprint author), UNIV CALIF LAWRENCE LIVERMORE NATL LAB,CTR ACCELERATOR MASS SPECTROMETRY,LIVERMORE,CA 94550, USA.
CR BROWN TA, 1988, RADIOCARBON, V30, P171
   ELMORE D, 1987, BIOL TRACE ELEM RES, V12, P231, DOI 10.1007/BF02796683
   ELMORE D, 1986, NUCL INSTRUM METH B, V5, P106
   FELTON JS, 1990, NUCL INSTRUM METH B, V52, P517, DOI 10.1016/0168-583X(90)90469-B
   FINK D, 1990, NUCL INSTRUM METH B, V47, P79, DOI 10.1016/0168-583X(90)90049-Z
   FOWLER AJ, 1986, RADIOCARBON, V28, P441
   GILLESPIE R, 1986, RADIOCARBON, V28, P1065
   GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114
   KEILSON J, 1978, 1ST P C RAD DAT ACC, P391
   KILIUS LR, 1987, NUCL INSTRUM METH B, V29, P72, DOI 10.1016/0168-583X(87)90207-2
   LOY TH, 1990, ANTIQUITY, V64, P110, DOI 10.1017/S0003598X00077346
   MATZKU S, 1977, IMMUNOCHEMISTRY, V14, P367, DOI 10.1016/0019-2791(77)90238-5
   NELSON DE, 1986, RADIOCARBON, V28, P170
   PARAS P, 1985, DOE S SERIES, V56
   Shamberger RJ, 1984, BIOCH ESSENTIAL ULTR, P201
   SHARMA P, 1987, NUCL INSTRUM METH B, V29, P63, DOI 10.1016/0168-583X(87)90205-9
   SHARMA P, 1987, NUCL INSTRUM METH B, V29, P335, DOI 10.1016/0168-583X(87)90261-8
   SOUTHON JR, 1990, NUCL INSTRUM METH B, V52, P301, DOI 10.1016/0168-583X(90)90426-U
   STAFFORD TW, 1988, GEOCHIM COSMOCHIM AC, V52, P2257, DOI 10.1016/0016-7037(88)90128-7
   TURTELTAUB KW, 1990, UNPUB P NATL ACAD SC
   VOGEL J, UNPUB
   VOGEL JS, 1987, RADIOCARBON, V29, P323
   VOGEL JS, 1990, RADIOCARBON, V32, P81
NR 23
TC 41
Z9 41
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD DEC
PY 1990
VL 52
IS 3-4
BP 524
EP 530
DI 10.1016/0168-583X(90)90470-F
PG 7
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA EV368
UT WOS:A1990EV36800063
DA 2018-10-19
ER

PT J
AU LABOW, RS
   BARRY, YA
   TOCCHI, M
   KEON, WJ
AF LABOW, RS
   BARRY, YA
   TOCCHI, M
   KEON, WJ
TI THE EFFECT OF MONO(2-ETHYLHEXYL)PHTHALATE ON AN ISOLATED PERFUSED RAT
   HEART-LUNG PREPARATION
SO ENVIRONMENTAL HEALTH PERSPECTIVES
LA English
DT Article; Proceedings Paper
CT CONF ON ADVANCES IN LEAD RESEARCH : IMPLICATIONS FOR ENVIRONMENTAL
   HEALTH
CY JAN 09-11, 1989
CL RESEARCH TRIANGLE PARK, NC
SP NIEHS, NICHHD
ID PHTHALATE-ESTERS; TRIMELLITIC ANHYDRIDE; PULMONARY HEMORRHAGE; MEHP;
   SYSTEMS; STORAGE; MUSCLE; BLOOD
AB Di(2-ethylhexyl)phthalate (DEHP), the plasticizer used in the biomedical production of blood storage bags, hemodialysis systems, cardiopulmonary bypass (CPB) circuitry, and intubation tubes, is extracted from the plastic material when it comes into contact with biological fluids and is converted to its principal metabolite, mono(2-ethylhexyl)phthalate (MEHP).  We have shown that MEHP causes cardiac and respiratory arrest, as well as hypotension, when infused into anesthetized rats.  Using a well-ventilated in vitro rat heart-lung preparation, we investigated the effect of MEHP on pulmonary artery pressure (PAP) and found that MEHP had a hypertensive effect on the pulmonary vasculature ending in constriction and edema.  There was significant increase of 0.58 mm Hg/min in the PAP of isolated rat lungs when perfused with MEHP dissolved in Krebs-Henseleit (K-H) buffer (p = 0.0003).  The rat lungs that were perfused with K-H buffer only increased 0.094 mm Hg/min during the same perfusion time of 20 min.  The water gained during this time was 0.22 g/min with MEHP in the buffer compared to 0.04 g/min with buffer alone.  The pO2 in the effluent did not decrease during the perfusion time.  The concentration of MEHP in the rat lungs after perfusion varied from 20 to 40-mu-g/g.  Although the mechanism of action of MEHP on PAP is too complex to be fully elucidated by this model, the increase in PAP which we have demonstrated is significant and adds yet another toxic effect of this major metabolite of the ubiquitous plasticizer, DEHP.
C1 CANADIAN RED CROSS,OTTAWA CTR,OTTAWA,ONTARIO,CANADA.
RP LABOW, RS (reprint author), UNIV OTTAWA,OTTAWA CIVIC HOSP,INST HEART,1053 CARLING AVE,OTTAWA K1Y 4E9,ONTARIO,CANADA.
CR ACOTT PD, 1987, B ENVIRON CONTAM TOX, V38, P363, DOI 10.1007/BF01606599
   AHMAD D, 1979, LANCET, V2, P328
   AUTIAN J, 1978, VOX SANG, V34, P244
   BARRY YA, 1988, BLOOD, V72, P1438
   BARRY YA, 1989, J THORAC CARDIOV SUR, V97, P900
   BARRYYA, UNPUB TOXICOL APPL P
   CARILLI AD, 1978, CHEST, V74, P311
   EAGLE H, 1959, SCIENCE, V130, P432, DOI 10.1126/science.130.3373.432
   FANBURG B L, 1988, Chest, V93, p101S, DOI 10.1378/chest.93.3.101S
   FAWCETT IW, 1977, CLIN ALLERGY, V7, P1, DOI 10.1111/j.1365-2222.1977.tb01418.x
   FURCHGOTT RF, 1983, CIRC RES, V53, P557, DOI 10.1161/01.RES.53.5.557
   GANGOLLI SD, 1982, ENVIRON HEALTH PERSP, V45, P77, DOI 10.2307/3429387
   HERBERT FA, 1979, CHEST, V76, P546, DOI 10.1378/chest.76.5.546
   KARNOVSKY MH, 1970, J GEN PHYSIOL, V52, P645
   KENNEDY T, 1988, Chest, V93, p149S, DOI 10.1378/chest.93.3_Supplement.149S
   LABOW RS, 1986, J TOXICOL ENV HEALTH, V19, P591, DOI 10.1080/15287398609530955
   LABOW RS, 1988, ENV HLTH PERSPECT, V78, P178
   MITCHELL FE, 1986, BIOCHEM PHARMACOL, V35, P2941, DOI 10.1016/0006-2952(86)90490-9
   MOSELEY RV, 1970, ANN SURG, V171, P336, DOI 10.1097/00000658-197003000-00003
   NEELY JR, 1967, AM J PHYSIOL, V212, P804
   NEWMAN J H, 1988, Chest, V93, p139S
   PFUDERER P, 1975, B ENVIRON CONTAM TOX, V13, P275, DOI 10.1007/BF01685335
   REDDY JK, 1984, CRC CRIT R TOXICOL, V12, P1
   ROCK G, 1978, TRANSFUSION, V18, P553, DOI 10.1046/j.1537-2995.1978.18579036383.x
   ROCK G, 1987, NEW ENGL J MED, V316, P1218
   ROTH B, 1988, EUR J PEDIATR, V147, P41, DOI 10.1007/BF00442609
   RUBIN RJ, 1976, TOXICOL APPL PHARM, V37, P154
   TAVARES IA, 1984, EUR J PHARMACOL, V106, P449, DOI 10.1016/0014-2999(84)90738-6
   TOMITA I, 1986, ENVIRON HEALTH PERSP, V65, P249, DOI 10.2307/3430190
   ZEISS CR, 1977, J ALLERGY CLIN IMMUN, V60, P96, DOI 10.1016/0091-6749(77)90033-1
NR 30
TC 16
Z9 19
U1 0
U2 3
PU NATL INST ENVIRON HEALTH SCI
PI RES TRIANGLE PK
PA PO BOX 12233, RES TRIANGLE PK, NC 27709
SN 0091-6765
J9 ENVIRON HEALTH PERSP
JI Environ. Health Perspect.
PD NOV
PY 1990
VL 89
BP 189
EP 193
DI 10.2307/3430916
PG 5
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA EV023
UT WOS:A1990EV02300028
PM 2088746
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU LAURENCIN, CT
   PIERREJACQUES, HM
   LANGER, R
AF LAURENCIN, CT
   PIERREJACQUES, HM
   LANGER, R
TI TOXICOLOGY AND BIOCOMPATIBILITY CONSIDERATIONS IN THE EVALUATION OF
   POLYMERIC MATERIALS FOR BIOMEDICAL APPLICATIONS
SO CLINICS IN LABORATORY MEDICINE
LA English
DT Article
C1 MIT,77 MASSACHUSETTS AVE,BLDG E25,ROOM 342,CAMBRIDGE,MA 02139.
NR 0
TC 15
Z9 15
U1 0
U2 4
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0272-2712
J9 CLIN LAB MED
JI Clin. Lab. Med.
PD SEP
PY 1990
VL 10
IS 3
BP 549
EP 570
PG 22
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA DY137
UT WOS:A1990DY13700010
PM 2253450
DA 2018-10-19
ER

PT J
AU MALMQVIST, KG
AF MALMQVIST, KG
TI QUANTITATIVE PIXE ANALYSIS OF BIOMEDICAL MATERIAL - SAMPLE PREPARATION,
   IRRADIATION AND QUALITY-CONTROL
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 5TH INTERNATIONAL CONF ON PARTICLE INDUCED X-RAY EMISSION AND ITS
   ANALYTICAL APPLICATIONS
CY AUG, 1989
CL FREE UNIV, AMSTERDAM, NETHERLANDS
SP FREE UNIV AMSTERDAM, DEPT PHYS & ASTRON, HIGH VOLTAGE ENGN EUROPA, NATL ELECTROSTAT, KLM ROYAL DUTCH AIRLINES
HO FREE UNIV
RP MALMQVIST, KG (reprint author), LUND INST SCI TECHNOL,DEPT NUCL PHYS,SOLVEGATAN 14,S-22362 LUND,SWEDEN.
CR ANNEGARN HJ, 1988, NUCL INSTRUM METH B, V35, P415, DOI 10.1016/0168-583X(88)90303-5
   CAMPBELL JL, 1989, SCANNING MICROSCOPY, V3, P449
   CAMPBELL JL, 1986, NUCL INSTRUM METH B, V14, P204, DOI 10.1016/0168-583X(86)90045-5
   CAMPBELL JL, 1990, NUCL INSTRUM METH B, V49, P115, DOI 10.1016/0168-583X(90)90227-L
   CHAUDHRI MA, 1981, NUCL INSTRUM METHODS, V181, P327
   CHOLEWA M, 1989, NUCL INSTRUM METH B, V40-1, P651, DOI 10.1016/0168-583X(89)91068-9
   DOOLITTLE LR, 1986, NUCL INSTRUM METH B, V15, P227, DOI 10.1016/0168-583X(86)90291-0
   DUFLOU H, 1987, BIOL TRACE ELEM RES, V13, P1, DOI 10.1007/BF02796617
   FOLKMANN F, 1984, NUCL INSTRUM METH B, V3, P11, DOI 10.1016/0168-583X(84)90327-6
   HASSELMANN I, 1977, NUCL INSTRUM METHODS, V142, P163, DOI 10.1016/0029-554X(77)90825-4
   HULT M, 1989, THESIS, P89
   IYENGAR GV, 1977, J RADIOANAL CHEM, V39, P301, DOI 10.1007/BF02517236
   LI HK, 1990, NUCL INSTRUM METH B, V49, P85
   LINDH U, 1990, NUCL INSTR METH B, V49
   LIPWORTH AD, 1990, NUCL INSTRUM METH B, V49, P173, DOI 10.1016/0168-583X(90)90237-O
   LOVESTAM NEG, 1989, NUCL INSTRUM METH B, V43, P104, DOI 10.1016/0168-583X(89)90087-6
   MAENHAUT W, 1988, NUCL INSTRUM METH B, V35, P388, DOI 10.1016/0168-583X(88)90300-X
   MAENHAUT W, 1987, FRESEN Z ANAL CHEM, V326, P736, DOI 10.1007/BF00473543
   MAENHAUT W, 1984, NUCL INSTRUM METH B, V3, P135, DOI 10.1016/0168-583X(84)90350-1
   MANGELSON NF, 1977, NUCL INSTRUM METHODS, V142, P133, DOI 10.1016/0029-554X(77)90821-7
   MANGELSON NF, IN PRESS SCANNING MI
   MARTINSSON BG, 1987, NUCL INSTRUM METH B, V22, P356, DOI 10.1016/0168-583X(87)90358-2
   MOLLER B, 1984, SWED DENT J, V8, P67
   PAKARINEN P, 1990, NUCL INSTRUM METH B, V49, P241, DOI 10.1016/0168-583X(90)90253-Q
   PAKARINEN P, 1986, THESIS TURKU
   PALLON J, 1981, NUCL INSTRUM METHODS, V181, P71, DOI 10.1016/0029-554X(81)90583-8
   PALLON J, 1987, BIOL TRACE ELEM RES, V13, P401
   PALLON J, COMMUNICATION
   PINHEIRO T, 1989, 5TH IN C PIXE AMST
   PINHEIRO T, IN PRESS BIOL TRACE
   RAISANEN J, 1987, BIOL TRACE ELEM RES, V12, P55, DOI 10.1007/BF02796666
   RAISANEN J, 1987, APPL RADIAT ISOTOPES, V38, P573
   SALFORD LG, THESIS
   SIMONOFF M, 1988, NUCL INSTRUM METH B, V31, P442, DOI 10.1016/0168-583X(88)90344-8
   SWANN CP, 1984, NUCL INSTRUM METH B, V3, P392, DOI 10.1016/0168-583X(84)90403-8
   SWIETLICKI E, 1987, NUCL INSTRUM METH B, V22, P264, DOI 10.1016/0168-583X(87)90340-5
   SWIETLICKI E, COMMUNICATION
   SZOKEFALVINAGY Z, 1987, NUCL INSTRUM METH B, V22, P156, DOI 10.1016/0168-583X(87)90315-6
   TAPPER UAS, 1987, NUCL INSTRUM METH B, V22, P176, DOI 10.1016/0168-583X(87)90320-X
   THEMNER K, 1990, NUCL INSTRUM METH B, V49, P52, DOI 10.1016/0168-583X(90)90215-G
   VARGA L, 1984, NUCL INSTRUM METH B, V3, P357, DOI 10.1016/0168-583X(84)90394-X
   VERSIECK J, 1987, BIOL TRACE ELEM RES, V12, P45, DOI 10.1007/BF02796665
   WATJEN U, 1987, NUCL INSTRUM METH B, V22, P29, DOI 10.1016/0168-583X(87)90288-6
   WATJEN U, 1983, THESIS
   WATTERSON JIW, 1987, NUCL INSTRUM METH B, V28, P554, DOI 10.1016/0168-583X(87)90502-7
   WILLIAMS ET, 1984, NUCL INSTRUM METH B, V3, P211, DOI 10.1016/0168-583X(84)90365-3
   XENOULIS AC, 1983, J RADIOANAL CHEM, V77, P207, DOI 10.1007/BF02525367
   YAGI M, 1987, J RADIOAN NUCL CH AR, V116, P213, DOI 10.1007/BF02037224
NR 48
TC 10
Z9 10
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD APR
PY 1990
VL 49
IS 1-4
BP 183
EP 190
DI 10.1016/0168-583X(90)90239-Q
PG 8
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA DE299
UT WOS:A1990DE29900035
DA 2018-10-19
ER

PT J
AU KUTAY, S
   TINCER, T
   HASIRCI, N
AF KUTAY, S
   TINCER, T
   HASIRCI, N
TI POLYURETHANES AS BIOMEDICAL MATERIALS
SO BRITISH POLYMER JOURNAL
LA English
DT Article
C1 MIDDLE E TECH UNIV,FAC ARTS & SCI,DEPT CHEM,ANKARA 06531,TURKEY.
OI HASIRCI, Nesrin/0000-0002-4497-0194
CR AUTIAN J, 1977, ARTIF ORGANS, V1, P53
   BORETOS JW, 1967, SCIENCE, V158, P1481, DOI 10.1126/science.158.3807.1481
   BORETOS JW, 1973, CONCISE GUIDE BIOMEC, P10
   BURKE A, 1988, J BIOACT COMPAT POLY, V3, P232
   FLEMING DG, 1981, BIOMEDICAL MATERIALS, P255
   GOLAN J, 1982, P BRUSSELS INT C BUR
   HASIRCI N, 1987, BIOACT COMPT POLYM, V2, P131
   Leininger R I, 1968, Ann N Y Acad Sci, V146, P11, DOI 10.1111/j.1749-6632.1968.tb20267.x
   LYMAN DJ, 1969, P ARTIFICIAL HEART P, P113
   LYMAN DONALD J., 1967, J BIOMED MAT RES, V1, P17, DOI 10.1002/jbm.820010105
   MIRKOVITCH V, 1962, T AM SOC ART INT ORG, V8, P79
   NYILAS E, 1970, 23RD P C ENG MED BIO, P147
   PARK GB, 1978, BIOMATER ARTIF CELL, V6, P1
   PIERCE WS, 1975, POLYM MED SURGERY, P263
   REMBAUM A, 1973, BIOMAT MED DEV ARTIF, V1, P53
   SHARP MV, 1966, T AM SOC ART INT ORG, V12, P1979
   SZYCHER M, 1984, PLASTIC TECHNOLOGY, P45
   TRAPPE G, 1968, ADV POLYURETHANE TEC, P89
   Wilkes G.L., 1975, POLYM MED SURGERY, P45
   WONG EW, 1969, URETHANE POLYETHER B
NR 20
TC 21
Z9 21
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0007-1641
J9 BRIT POLYM J
PY 1990
VL 23
IS 3
BP 267
EP 272
DI 10.1002/pi.4980230316
PG 6
WC Polymer Science
SC Polymer Science
GA DZ653
UT WOS:A1990DZ65300013
DA 2018-10-19
ER

PT J
AU MADHAVAN, C
   SRINIVASAN, TT
   XU, QC
   NEWNHAM, RE
   GURURAJA, TR
   MEYER, P
AF MADHAVAN, C
   SRINIVASAN, TT
   XU, QC
   NEWNHAM, RE
   GURURAJA, TR
   MEYER, P
TI PROPERTIES OF FIRED 0-3 PIEZOELECTRIC MATERIALS FOR BIOMEDICAL
   ULTRASONIC-IMAGING APPLICATIONS
SO FERROELECTRICS
LA English
DT Article; Proceedings Paper
CT INDO/UNITED-STATES WORKSHOP ON ELECTRONIC CERAMICS AND MATERIALS
CY JAN 14-16, 1989
CL POONA, INDIA
SP USN, OFF NAVAL RES, DEPT SCI & TECHNOL INDIA, COUNCIL SCI & IND RES INDIA, DEF RES & DEV ORG INDIA, DEPT ELECTR INDIA, TATA RES DEV & DESIGN CTR INDIA, PUBLIC & PRIVATE SECTOR IND INDIA
RP MADHAVAN, C (reprint author), PENN STATE UNIV,MAT RES LAB,UNIVERSITY PK,PA 16802, USA.
CR BANNO H, 1983, FERROELECTRICS, V5, P3
   DRAGAN M, 1987, THESIS PENNSYLVANIA, P118
   Gururaja T. R., 1986, IEEE 1986 Ultrasonics Symposium Proceedings (Cat. No.86CH2375-4), P703
   Hadjicostis AN, 1984, FERROELECTRICS, V60, P107, DOI 10.1080/00150198408017515
   HIROZHI T, 1983, FERROELECTRICS, V51, P71
   JOHN R, 1987, AM CERA SOC B, V66, P664
   Newnham RE, 1984, FERROELECTRICS, V60, P15, DOI 10.1080/00150198408017505
   Newnham R. E., 1986, Ferroelectrics, V68, P1, DOI 10.1080/00150198608238734
   NEWNHAM RE, 1980, MATERIALS ENG, V112, P93
   XU QC, 1987, J WAVE MAT INTERACTI, V2, P105
NR 10
TC 2
Z9 2
U1 0
U2 0
PU GORDON BREACH SCI PUBL LTD
PI READING
PA C/O STBS LTD PO BOX 90, READING, BERKS, ENGLAND RG1 8JL
SN 0015-0193
J9 FERROELECTRICS
PY 1990
VL 102
BP 235
EP 242
DI 10.1080/00150199008221483
PG 8
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA DK127
UT WOS:A1990DK12700024
DA 2018-10-19
ER

PT J
AU DIXON, AJ
AF DIXON, AJ
TI PRINCIPLES AND APPLICATIONS OF CONFOCAL FLUORESCENCE MICROSCOPY
SO INSTITUTE OF PHYSICS CONFERENCE SERIES
LA English
DT Article
AB Confocal microscopy allows direct non-invasive visualisation and analysis of three-dimensional structure in complex or fragile material.  This paper describes the basic principles of the confocal imaging technique and its particular applications in fluorescence microscopy.  Both biomedical and materials science applications are briefly discussed.
RP DIXON, AJ (reprint author), BIORAD LASERSHARP,MAYLANDS AVE,HEMEL HEMPSTEAD,HERTS,ENGLAND.
CR BRAKENHOFF GJ, 1989, J MICROSC-OXFORD, V153, P151, DOI 10.1111/j.1365-2818.1989.tb00555.x
   FINE A, 1988, TRENDS NEUROSCI, V11, P346, DOI 10.1016/0166-2236(88)90056-2
   WHITE JG, 1987, J CELL BIOL, V105, P41, DOI 10.1083/jcb.105.1.41
   WILSON T, 1988, J MICROSC-OXFORD, V149, P51, DOI 10.1111/j.1365-2818.1988.tb04561.x
NR 4
TC 0
Z9 0
U1 0
U2 7
PU IOP PUBLISHING LTD
PI BRISTOL
PA TECHNO HOUSE, REDCLIFFE WAY, BRISTOL, ENGLAND BS1 6NX
SN 0951-3248
J9 INST PHYS CONF SER
JI Inst. Phys. Conf. Ser.
PY 1990
IS 98
BP 643
EP 650
PG 8
WC Physics, Multidisciplinary
SC Physics
GA FP296
UT WOS:A1990FP29600151
DA 2018-10-19
ER

PT J
AU VANDERLEI, B
AF VANDERLEI, B
TI ELECTRON-MICROSCOPY OF IMPLANTED BIOMEDICAL MATERIALS
SO ULTRAMICROSCOPY
LA English
DT Meeting Abstract
C1 STATE UNIV GRONINGEN HOSP,DEPT SURG,9700 RB GRONINGEN,NETHERLANDS.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3991
J9 ULTRAMICROSCOPY
JI Ultramicroscopy
PD DEC
PY 1989
VL 31
IS 4
BP 474
EP 474
DI 10.1016/0304-3991(89)90392-6
PG 1
WC Microscopy
SC Microscopy
GA CP773
UT WOS:A1989CP77300061
DA 2018-10-19
ER

PT J
AU HEIMKE, G
AF HEIMKE, G
TI BIOMATERIALS HIGHLIGHTS .2. MATERIALS FOR BIOMEDICAL APPLICATIONS - HIGH
   LONG-TERM SUCCESS RATES MIGHT POSE NEW PROBLEMS
SO ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH
LA English
DT Article
RP HEIMKE, G (reprint author), CLEMSON UNIV,COLL ENGN,DEPT BIOENGN,CLEMSON,SC 29631, USA.
CR BETTS F, 1989, 15TH T ANN M SOC BIO, P145
   BLACK J, 1988, J BONE JOINT SURG BR, V70, P517
   COOK SD, 1985, CLIN ORTHOPAEDICS, V194, P236
   GILLESPIE WJ, 1988, J BONE JOINT SURG BR, V70, P539
   GRISS P, 1977, ARCH ORTHOP TRAUM SU, V90, P29, DOI 10.1007/BF00415892
   GRISS P, 1981, BIOCOMPATIBILITY CLI, V1, P155
   HEIMKE G, 1989, ANGEW CHEM INT EDIT, V28, P111, DOI 10.1002/anie.198901111
   HEIMKE G, 1989, ANGEW CHEM ADV MATER, V101, P113
   HEIMKE G, 1989, ADV MATER, P7
   SCHULTE W, 1981, ZAHNARZTL MITT, V71
   SEMLITSCH M, 1977, J BIOMED MATER RES, V11, P537, DOI 10.1002/jbm.820110409
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   STEINEMANN SG, 1985, TITANIUM SCI TECHNOL, V2, P1373
NR 13
TC 1
Z9 1
U1 0
U2 1
PU VCH PUBLISHERS INC
PI DEERFIELD BEACH
PA 303 NW 12TH AVE, DEERFIELD BEACH, FL 33442-1788
SN 0570-0833
J9 ANGEW CHEM INT EDIT
JI Angew. Chem.-Int. Edit. Engl.
PD JUL
PY 1989
VL 28
IS 7
BP 956
EP 958
DI 10.1002/anie.198909561
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA AH967
UT WOS:A1989AH96700030
DA 2018-10-19
ER

PT J
AU HEIMKE, G
AF HEIMKE, G
TI BIOMATERIALS HIGHLIGHTS - MATERIALS FOR BIOMEDICAL APPLICATIONS - BONE
   AND JOINT REPLACEMENTS
SO ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH
LA English
DT Editorial Material
RP HEIMKE, G (reprint author), CLEMSON UNIV,DEPT BIOENGN,CLEMSON,SC 29634, USA.
CR DHOEDT B, 1986, DEUT ZAHNAERZTL Z, V41, P1068
   DHOEDT B, 1985, FORTSCHR ZAHNARZTL I, V1, P150
   DHOEDT B, 1986, DTSCH Z ZAHNARZTL IM, V2, P6
   EBERT R, 1979, 12TH INT C MED BIOL
   HEIMKE G, 1989, ANGEW CHEM INT EDIT, V28, P111, DOI 10.1002/anie.198901111
   HEIMKE G, 1989, ADV MATER, P7
   HEIMKE G, 1985, BIOMECHANICS CURRENT, P141
   MOUNTVALA AJ, 1973, AM CERAM SOC BULL, V52, P479
   VOLZ RG, 1988, CLIN ORTHOP RELAT R, V226, P38
NR 9
TC 0
Z9 0
U1 0
U2 3
PU VCH PUBLISHERS INC
PI DEERFIELD BEACH
PA 303 NW 12TH AVE, DEERFIELD BEACH, FL 33442-1788
SN 0570-0833
J9 ANGEW CHEM INT EDIT
JI Angew. Chem.-Int. Edit. Engl.
PD APR
PY 1989
VL 28
IS 4
BP 518
EP 520
DI 10.1002/anie.198905181
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA U8005
UT WOS:A1989U800500043
DA 2018-10-19
ER

PT J
AU EDWARDS, GS
   TOLK, NH
AF EDWARDS, GS
   TOLK, NH
TI VANDERBILT-UNIVERSITY FEL CENTER FOR BIOMEDICAL AND MATERIALS RESEARCH
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS
   SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT
LA English
DT Article
RP EDWARDS, GS (reprint author), VANDERBILT UNIV,DEPT PHYS & ASTRON,NASHVILLE,TN 37235, USA.
CR EDWARDS G, 1987, IN PRESS 6TH P INT C
   EDWARDS GS, 1984, PHYS REV LETT, V53, P1284, DOI 10.1103/PhysRevLett.53.1284
   OSSOFF R, 1987, IN PRESS 6TH P INT C
   POWELL J, 1987, PHYS REV A, V25, P3929
   TOLK N, 1987, IN PRESS 6TH P INT C
   VANZANDT LL, 1986, PHYS REV LETT, V57, P2085, DOI 10.1103/PhysRevLett.57.2085
NR 6
TC 3
Z9 3
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-9002
J9 NUCL INSTRUM METH A
JI Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc.
   Equip.
PD OCT
PY 1988
VL 272
IS 1-2
BP 37
EP 39
DI 10.1016/0168-9002(88)90191-X
PG 3
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Nuclear; Physics, Particles & Fields
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA Q3255
UT WOS:A1988Q325500009
DA 2018-10-19
ER

PT J
AU LUDBROOK, J
AF LUDBROOK, J
TI MATERIAL NEEDS FOR BIOMEDICAL APPLICATIONS
SO BIOMATERIALS
LA English
DT Meeting Abstract
C1 BAKER MED RES INST,PRAHRAN,VIC 3181,AUSTRALIA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 1988
VL 9
IS 3
BP 291
EP 291
DI 10.1016/0142-9612(88)90103-2
PG 1
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA N6578
UT WOS:A1988N657800019
DA 2018-10-19
ER

PT J
AU HUANG, HN
   PERSICO, DF
   LAGOW, RJ
   CLARK, LC
AF HUANG, HN
   PERSICO, DF
   LAGOW, RJ
   CLARK, LC
TI SYNTHESIS OF UNUSUAL PERFLUOROCARBON ETHERS AND AMINES CONTAINING BULKY
   FLUOROCARBON GROUPS - NEW BIOMEDICAL MATERIALS
SO JOURNAL OF ORGANIC CHEMISTRY
LA English
DT Article
C1 UNIV TEXAS,DEPT CHEM,AUSTIN,TX 78712.
   CHILDRENS HOSP MED CTR,CINCINNATI,OH 45229.
CR ABE T, 1979, J FLUORINE CHEM, V13, P519, DOI 10.1016/S0022-1139(00)83098-5
   ADCOCK JL, 1976, J FLUORINE CHEM, V7, P197, DOI 10.1016/S0022-1139(00)83996-2
   ADCOCK JL, 1975, J ORG CHEM, V40, P3271, DOI 10.1021/jo00910a024
   BANKS RE, 1982, PREPARATION PROPERTI, P45
   CHANG C, 1982, RADIAT PHYS CHEM, V19, P361, DOI 10.1016/0146-5724(82)90002-4
   CLARK LC, 1973, SCIENCE, V181, P680, DOI 10.1126/science.181.4100.680
   CLARK WC, IN PRESS
   DANIELSON RD, 1979, ENCY CHEM TECHNOL, V10, P874
   EVANS TW, 1936, IND ENG CHEM, V28, P1184
   FLORIN RE, 1972, J CHEM PHYS, V57, P1791, DOI 10.1063/1.1678473
   GERHARDT GE, 1978, J ORG CHEM, V43, P4505, DOI 10.1021/jo00417a026
   GORDON AS, 1962, J CHEM PHYS, V36, P1130
   HUANG H, IN PRESS
   HUANG HK, UNPUB
   LIU EKS, 1979, J FLUORINE CHEM, V13, P71
   MARASCHIN NJ, 1975, J AM CHEM SOC, V97, P513, DOI 10.1021/ja00836a008
   MUSHER JI, 1962, J CHEM PHYS, V36, P1086, DOI 10.1063/1.1732644
   NAGASE S, COMMUNICATION
   Norris JF, 1932, J AM CHEM SOC, V54, P2088, DOI 10.1021/ja01344a062
   OLAH GA, 1966, J AM CHEM SOC, V88, P3310, DOI 10.1021/ja00966a024
   PERSICO DF, 1985, J ORG CHEM, V50, P5156, DOI 10.1021/jo00225a036
   PETRAKIS L, 1961, J CHEM PHYS, V35, P1243, DOI 10.1063/1.1732030
   RIESS JG, 1978, ANGEW CHEM INT EDIT, V17, P621, DOI 10.1002/anie.197806213
   SEYDENPENNE J, 1965, B SOC CHIM FR, V3, P700
   SHIMP LA, 1977, J ORG CHEM, V42, P3437, DOI 10.1021/jo00441a025
   SHOULDERS BA, IN PRESS
   Simons J. H, 1950, FLUORINE CHEM, V1, P414
   SIMONS JH, 1954, FLUORINE CHEM, V2, P1350
   STACEY M, 1960, ADVANCES FLUORINE CH, V1, P166
   TIRES GVD, 1955, J AM CHEM SOC, V77, P4837
   TOY MS, 1975, J FLUORINE CHEM, V5, P25, DOI 10.1016/S0022-1139(00)82910-3
NR 31
TC 21
Z9 21
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0022-3263
J9 J ORG CHEM
JI J. Org. Chem.
PD JAN 8
PY 1988
VL 53
IS 1
BP 78
EP 85
DI 10.1021/jo00236a016
PG 8
WC Chemistry, Organic
SC Chemistry
GA L7413
UT WOS:A1988L741300016
DA 2018-10-19
ER

PT J
AU GRAHAM, JW
AF GRAHAM, JW
TI BIOMEDICAL MATERIALS EMERGE THROUGH TEAMWORK
SO ADVANCED MATERIALS & PROCESSES
LA English
DT Article
RP GRAHAM, JW (reprint author), ASTROMET ASSOCIATES INC,CINCINNATI,OH, USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA SUBSCRIPTIONS SPECIALIST CUSTOMER SERVICE, MATERIALS PARK, OH 44073-0002
SN 0026-0665
J9 ADV MATER PROCESS
JI Adv. Mater. Process.
PD JAN
PY 1988
VL 133
IS 1
BP 41
EP 42
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA L8262
UT WOS:A1988L826200003
DA 2018-10-19
ER

PT J
AU SMITH, TI
   SCHWETTMAN, HA
   ROHATGI, R
   LAPIERRE, Y
   EDIGHOFFER, J
AF SMITH, TI
   SCHWETTMAN, HA
   ROHATGI, R
   LAPIERRE, Y
   EDIGHOFFER, J
TI DEVELOPMENT OF THE SCA/FEL FOR USE IN BIOMEDICAL AND MATERIALS SCIENCE
   EXPERIMENTS
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS
   SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT
LA English
DT Article
RP SMITH, TI (reprint author), STANFORD UNIV,HIGH ENERGY PHYS LAB,STANFORD,CA 94305, USA.
CR BRAU CA, 1979, DEC P INT C LAS 79
   BROWN KL, SLAC911974
   RAND RE, 1984, RECIRCULATING ELECTR, P95
   SHIH CC, 1983, IEEE J QUANTUM ELECT, V19, P369, DOI 10.1109/JQE.1983.1071851
   Smith T. I., 1982, PHYSICS QUANTUM ELEC, V8, P77
   SMITH TI, 1986, 1986 P SLAC LIN ACC
NR 6
TC 37
Z9 37
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-9002
J9 NUCL INSTRUM METH A
JI Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc.
   Equip.
PD SEP 1
PY 1987
VL 259
IS 1-2
BP 1
EP 7
DI 10.1016/0168-9002(87)90421-9
PG 7
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Nuclear; Physics, Particles & Fields
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA J7656
UT WOS:A1987J765600002
DA 2018-10-19
ER

PT J
AU PETERSEN, RV
AF PETERSEN, RV
TI INVITRO ALTERNATIVES TO ANIMAL TESTING FOR TOXICITY OF RAW-MATERIALS AND
   BIOMEDICAL POLYMERS - PROPOSED TEST
SO PHARMACOPEIAL FORUM
LA English
DT Article
RP PETERSEN, RV (reprint author), US PHARMACOPEIAL CONVENT INC,SUBCOMM INVITRO TOXIC,ROCKVILLE,MD 20852, USA.
CR BENSON WH, 1986, DRUG CHEM TOXICOL, V9, P275
   Bulich A. A., 1979, AQUAT TOXICOL, P98
   BULICH AA, 1986, TOXICITY TESTING USI, V1, P57
   BURTON SA, 1986, J BIOMED MATER RES, V20, P827, DOI 10.1002/jbm.820200613
   Johnson F. H., 1974, THEORY RATE PROCESSE
   KAISER KL, 1987, IN PRESS TOXICITY AS, V2
   QURESHI AA, 1987, 3RD INT S TOX TEST U
   WALKER JD, 1987, J WATER POLLUT CON F, V59, P614
NR 8
TC 0
Z9 0
U1 0
U2 1
PU US PHARMACOPEIAL CONVENTION
PI ROCKVILLE
PA 12601 TWINBROOK PKWY, ROCKVILLE, MD 20852
SN 0363-4655
J9 PHARMACOPEIAL FORUM
JI Pharmacop. Forum
PD SEP-OCT
PY 1987
VL 13
IS 5
BP 2937
EP 2938
PG 2
WC Medicine, Legal; Pharmacology & Pharmacy
SC Legal Medicine; Pharmacology & Pharmacy
GA J9959
UT WOS:A1987J995900001
DA 2018-10-19
ER

PT J
AU WILLIAMS, D
AF WILLIAMS, D
TI BIOMEDICAL MATERIALS - MATERIALS-RESEARCH-SOCIETY, BOSTON, USA, 3-6
   DECEMBER, 1985
SO BIOMATERIALS
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 1986
VL 7
IS 2
BP 158
EP 159
DI 10.1016/0142-9612(86)90077-3
PG 2
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA A7518
UT WOS:A1986A751800016
DA 2018-10-19
ER

PT J
AU HAYASHI, K
AF HAYASHI, K
TI APPLICATION OF RADIATION TECHNOLOGY IN BIOMEDICAL MATERIALS -
   FUNDAMENTALS AND APPLIED
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article
RP HAYASHI, K (reprint author), OSAKA UNIV,INST SCI & IND RES,8-1 MIHOGAOKA,IBARAKI,OSAKA 567,JAPAN.
CR ARAKAWA M, 1977, CAN J PHYSIOL PHARM, V55, P1378, DOI 10.1139/y77-183
   CHANG TMS, 1972, ARTIFICIAL CELLS
   GOLDMAN R, 1971, BIOCHEMISTRY-US, V10, P165
   HAYASHI K, 1978, MEM I SCI IND RES OS, V34, P75
   IMAI K, 1970, Biochimica et Biophysica Acta, V200, P189, DOI 10.1016/0005-2795(70)90163-7
   ISHIKAWA T, 1980, J BIOL CHEM, V255, P764
   KAETSU I, 1979, BIOTECHNOL BIOENG, V21, P847, DOI 10.1002/bit.260210508
   KAETSU I, 1979, BIOTECHNOL BIOENG, V21, P863, DOI 10.1002/bit.260210509
   KONDO T, 1976, MICROENCAPSULATION, P163
   MIKI M, 1982, BIOTECHNOL BIOENG, V24, P1587
   MOULLEC JML, 1977, J BIOL CHEM, V252, P2611
   TAMURA M, UNPUB
   THOMAS D, 1974, BIOCHEMISTRY-US, V13, P2995, DOI 10.1021/bi00711a032
   WILTING J, 1974, J BIOL CHEM, V249, P6325
NR 14
TC 2
Z9 2
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PY 1986
VL 27
IS 4
BP 317
EP 321
PG 5
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA A9042
UT WOS:A1986A904200009
DA 2018-10-19
ER

PT J
AU CHARLES, HK
   WEINER, JA
   BLUM, NA
AF CHARLES, HK
   WEINER, JA
   BLUM, NA
TI MATERIALS CHARACTERIZATION AND ANALYSIS - APPLICATIONS IN BIOMEDICAL
   ELECTRONICS
SO SAMPE QUARTERLY-SOCIETY FOR THE ADVANCEMENT OF MATERIAL AND PROCESS
   ENGINEERING
LA English
DT Article
RP CHARLES, HK (reprint author), JOHNS HOPKINS UNIV,APPL PHYS LAB,JOHNS HOPKINS RD,LAUREL,MD 20707, USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAMPE PUBLISHERS
PI COVINA
PA 1161 PARKVIEW DRIVE, COVINA, CA 91722
SN 0036-0821
J9 SAMPE QUART
PD JAN
PY 1986
VL 17
IS 2
BP 40
EP 49
PG 10
WC Engineering, Multidisciplinary; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA AYJ62
UT WOS:A1986AYJ6200006
DA 2018-10-19
ER

PT J
AU HIRANO, S
   NOISHIKI, Y
   KINUGAWA, J
AF HIRANO, S
   NOISHIKI, Y
   KINUGAWA, J
TI CHITIN AND CHITOSAN FOR USE AS A NOVEL BIOMEDICAL MATERIAL
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 TOTTORI UNIV,DEPT AGR BIOCHEM,TOTTORI 680,JAPAN.
NR 0
TC 0
Z9 0
U1 1
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PY 1985
VL 190
IS SEP
BP 130
EP PME
PG 0
WC Chemistry, Multidisciplinary
SC Chemistry
GA APH03
UT WOS:A1985APH0303390
DA 2018-10-19
ER

PT J
AU SOSA, K
   MORI, A
   SISIDO, M
   IMANISHI, Y
AF SOSA, K
   MORI, A
   SISIDO, M
   IMANISHI, Y
TI SYNTHESIS OF POLYETHERURETHANES CONTAINING L-SERINE DIPEPTIDE AND THEIR
   USE AS MATERIALS FOR BIOMEDICAL FILMS
SO BIOMATERIALS
LA English
DT Article
C1 KYOTO UNIV,MED POLYMERS & BIOMAT RES CTR,SAKYO KU,KYOTO 606,JAPAN.
RP SOSA, K (reprint author), KYOTO UNIV,FAC ENGN,DEPT POLYMER CHEM,SAKYO KU,KYOTO 606,JAPAN.
CR BLACKWELL J, 1979, POLYMER, V20, P13, DOI 10.1016/0032-3861(79)90035-1
   BONART R, 1969, J MACROMOL SCI PHYS, VB  3, P337, DOI 10.1080/00222346908205099
   BROWN HH, 1959, ANAL CHEM, V31, P1844, DOI 10.1021/ac60155a049
   Fischer E, 1906, BER DTSCH CHEM GES, V39, P2942, DOI 10.1002/cber.190603903106
   Fruton JS, 1942, J BIOL CHEM, V146, P0463
   HASSALL CH, 1967, J CHEM SOC C, P997, DOI 10.1039/j39670000997
   HOLLAND RV, 1980, ANGEW MAKROMOL CHEM, V88, P209, DOI 10.1002/apmc.1980.050880116
   HU CB, 1982, J APPL POLYM SCI, V27, P2167, DOI 10.1002/app.1982.070270627
   IMAI Y, 1972, J BIOMED MATER RES, V6, P165, DOI 10.1002/jbm.820060305
   IMANISHI Y, 1981, POLYMER, V22, P1548, DOI 10.1016/0032-3861(81)90328-1
   IMANISHI Y, 1983, Membrane, V8, P75
   Imanishi Y., 1976, ADV POLYM SCI, V20, P1
   KATO T, 1971, PROTEIN NUCLEIC ACID, V16, P56
   KINIWA H, 1983, POLYM COMMUN, V24, P188
   KURITA T, 1980, MEMBRANE SEPARATION, P303
   LYMAN DJ, 1975, T AM SOC ART INT ORG, V21, P49
   MICHAELS AS, 1961, J POLYM SCI, V50, P393, DOI 10.1002/pol.1961.1205015411
   MORI A, 1984, POLYMER, V25, P1837, DOI 10.1016/0032-3861(84)90259-3
   RATNER BD, 1982, ACS SYM SER, V199, P9
   RILEY G, 1957, J CHEM SOC, P1373, DOI 10.1039/jr9570001373
   SORM M, 1979, J POLYM SCI POLYM S, V66, P349
   TAKIGAMI S, 1979, J APPL POLYM SCI, V24, P1419, DOI 10.1002/app.1979.070240603
   TERASHIMA S, 1973, TETRAHEDRON, V29, P1487, DOI 10.1016/S0040-4020(01)83388-3
   WAKI M, 1968, B CHEM SOC JPN, V41, P669, DOI 10.1246/bcsj.41.669
   YASUDA H, 1971, J POLYM SCI A2, V9, P1117, DOI 10.1002/pol.1971.160090608
   1976, SHIN ZIKKEN KAGAKU K, V9, P242
NR 26
TC 16
Z9 16
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PY 1985
VL 6
IS 5
BP 312
EP 324
DI 10.1016/0142-9612(85)90087-0
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA ARU26
UT WOS:A1985ARU2600004
PM 3931715
DA 2018-10-19
ER

PT J
AU NAIR, PD
   SREENIVASAN, K
   JAYABALAN, M
AF NAIR, PD
   SREENIVASAN, K
   JAYABALAN, M
TI CHARACTERIZATION OF A POLYESTER MATERIAL FOR BIOMEDICAL APPLICATIONS
SO BIOMATERIALS MEDICAL DEVICES AND ARTIFICIAL ORGANS
LA English
DT Article
RP NAIR, PD (reprint author), SREE CHITRA TIRUNAL INST MED SCI & TECHNOL,DIV TECH EVALUAT BIOMAT,TRIVANDRUM 695012,INDIA.
CR BOUKEL J, 1967, J APPL POLYM SCI, V11, P1983
   BRUCK SD, 1974, BLOOD COMPATIBILITY, P113
   DIDELY MA, 1972, J APPL POLYM SCI, V16, P493
   DROTT EE, 1977, CHROMATOGRAPHIC SCI, V8
   EDE PS, 1971, J CHROMATOGR SCI, V9, P275, DOI 10.1093/chromsci/9.5.275
   ERIKSSON KE, 1972, BIODETERIORATION MAT, V2, P116
   GUIDOIN R, 1980, MECHANICAL PROPERTIE, P547
   GUIDOIN R, 1980, MECHANICAL PROPERTIE, P549
   GUMARGALIEVA KZ, 1982, BIOMATERIALS, V3, P177, DOI 10.1016/0142-9612(82)90008-4
   ILLERS KH, 1980, COLLOID POLYM SCI, V258, P117, DOI 10.1007/BF01498267
   MERILL EW, 1977, AM NY ACAD SCI, V6, P283
   NAIR PB, UNPUB
   NAIR PD, 1985, 2ND INT C POL MED CA
   PANARIS R, 1970, J POLYM SCI, V16, P493
   RICHARDSON MJ, 1978, POLYM CHARACTERISATI, P225
   SAWYER PN, 1979, J BIOMED MATER RES, V13, P937, DOI 10.1002/jbm.820130611
   SCREENIVASAN KR, UNPUB
   SNYDER LR, 1979, INTRO MODERN LIQUID, P523
   SREENIVASAN K, 1983, B MATER SCI, V5, P123
   Williams DF, 1979, CORROSION DEGRADATIO, P61
   Williams DF, 1981, ENG MED, V10, P5, DOI DOI 10.1243/EMED_JOUR_1981_010_004_02
   WILLIAMS DF, 1977, J BIOENG, V1, P251
   1980, NIH802186 US DEP HLT
NR 23
TC 0
Z9 0
U1 0
U2 0
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016
SN 0090-5488
J9 BIOMATER ARTIF CELL
PY 1985
VL 13
IS 3-4
BP 115
EP 131
DI 10.3109/10731198509118846
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA D7603
UT WOS:A1985D760300001
PM 2944551
DA 2018-10-19
ER

PT J
AU WAGNER, AB
AF WAGNER, AB
TI THE LEGAL IMPACT OF PATIENT MATERIALS USED FOR PRODUCT DEVELOPMENT IN
   THE BIOMEDICAL INDUSTRY
SO CLINICAL RESEARCH
LA English
DT Article
RP WAGNER, AB (reprint author), UNIV CALIF BERKELEY,UNIV COUNSEL,590 UNIV HALL,BERKELEY,CA 94720, USA.
NR 0
TC 4
Z9 4
U1 0
U2 0
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086
SN 0009-9279
J9 CLIN RES
JI Clin. Res.
PY 1985
VL 33
IS 4
BP 444
EP 447
PG 4
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA ARV18
UT WOS:A1985ARV1800002
PM 4053501
DA 2018-10-19
ER

PT J
AU BROWN, J
   DILLMAN, R
   WAGNER, A
   HEMBREE, W
   ROSENBERG, L
   JAMESON, R
   SOLOMONS, N
   CADMAN, E
   CAPLAN, A
AF BROWN, J
   DILLMAN, R
   WAGNER, A
   HEMBREE, W
   ROSENBERG, L
   JAMESON, R
   SOLOMONS, N
   CADMAN, E
   CAPLAN, A
TI THE-AMERICAN-FEDERATION-FOR-CLINICAL-RESEARCH - PUBLIC-POLICY SYMPOSIUM
   - THE LEGAL, ETHICAL, AND ECONOMIC-IMPACT OF PATIENT MATERIALS USED FOR
   PRODUCT DEVELOPMENT IN THE BIOMEDICAL INDUSTRY - DISCUSSION
SO CLINICAL RESEARCH
LA English
DT Editorial Material
C1 HASTINGS CTR,360 BROADWAY,HASTINGS ON HUDSON,NY 10706.
   UNIV CALIF BERKELEY,BERKELEY,CA 94720.
   YALE UNIV,SCH MED,NEW HAVEN,CT 06510.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086
SN 0009-9279
J9 CLIN RES
JI Clin. Res.
PY 1985
VL 33
IS 4
BP 455
EP 458
PG 4
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA ARV18
UT WOS:A1985ARV1800005
DA 2018-10-19
ER

PT J
AU SOUYRIS, F
   PELLEQUER, C
   PAYROT, C
   SERVERA, C
AF SOUYRIS, F
   PELLEQUER, C
   PAYROT, C
   SERVERA, C
TI CORAL, A NEW BIOMEDICAL MATERIAL - EXPERIMENTAL AND 1ST CLINICAL
   INVESTIGATIONS ON MADREPORARIA
SO JOURNAL OF MAXILLOFACIAL SURGERY
LA English
DT Article
C1 UNIV HOSP CTR MONTPELLIER, DEPT MAXILLOFACIAL SURG & STOMATOL, MONTPELLIER, FRANCE.
CR Anderson K J, 1964, Clin Orthop Relat Res, V33, P220
   CHIROFF RT, 1975, J BIOMED MATER RES, V11, P165
   ENNEKING WF, 1972, CLIN ORTHOP RELAT R, P28
   GUILLEMIN G, 1981, CR ACAD SCI III-VIE, V293, P371
   HOLMES RE, 1979, PLAST RECONSTR SURG, V63, P626, DOI 10.1097/00006534-197905000-00004
   LEVET Y, 1983, ANN CHIR PLAST ESTH, V28, P180
   PATEL A, 1980, CHIRURGIE, V106, P199
   Schuhmacher H., 1976, KORALLENRIFFE
   SOUYRIS F, 1973, ANN CHIR PLAST ESTH, V18, P149
   SOUYRIS F, 1983, REV CHIR ORTHOP, V69, P577
   Tessier P, 1967, Ann Chir Plast, V12, P273
   WOLFE SA, 1982, J MAXILLOFAC SURG, V10, P212, DOI 10.1016/S0301-0503(82)80043-X
NR 12
TC 35
Z9 38
U1 0
U2 3
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0301-0503
J9 J MAXILLOFAC SURG
PY 1985
VL 13
IS 2
BP 64
EP 69
DI 10.1016/S0301-0503(85)80018-7
PG 6
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA AFY94
UT WOS:A1985AFY9400003
PM 2860194
DA 2018-10-19
ER

PT J
AU MARCHANT, RE
   ANDERSON, JM
AF MARCHANT, RE
   ANDERSON, JM
TI TISSUE MATERIAL INTERACTIONS OF BIOMEDICAL POLYMERS
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 CASE WESTERN RESERVE UNIV,DEPT MACROMOLEC SCI,CLEVELAND,OH 44106.
   CASE WESTERN RESERVE UNIV,DEPT PATHOL,CLEVELAND,OH 44106.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PY 1984
VL 188
IS AUG
BP 65
EP PMSE
PG 0
WC Chemistry, Multidisciplinary
SC Chemistry
GA ABA40
UT WOS:A1984ABA4002932
DA 2018-10-19
ER

PT J
AU WHITFORD, MJ
AF WHITFORD, MJ
TI THE CHEMISTRY OF SILICONE MATERIALS FOR BIOMEDICAL DEVICES AND
   CONTACT-LENSES
SO BIOMATERIALS
LA English
DT Note
RP WHITFORD, MJ (reprint author), CLM GRP LTD,CHILDS PL,LONDON SW5 9RX,ENGLAND.
CR ARKLES BC, 1981, MED DEVICE DIAGNOSTI, V3
   BRADLEY S, 1970, J MACROMOL SCI CHEM, V4, P529
   Chen RY, 1979, US Patent, Patent No. [4,143,949, 4143949]
   COURTNEY JM, 1980, MED BIOL ENG COMPUT, V18, P538, DOI 10.1007/BF02443332
   ELLIS E, 1979, Patent No. 4152508
   Gaylord N., 1974, Oxygen-Permeable Contact Lens Composition, Methods and Article of Manufacture, Patent No. [US3808178 A, 3808178]
   LEE H, 1970, J MACROMOL SCI CHEM, VA  4, P757, DOI 10.1080/00222337008074374
   LEMM W, 1980, MED BIOL ENG COMPUT, V18, P521, DOI 10.1007/BF02443330
   REFOJO MF, 1976, CONTACT LENSES S, V1
   TIGHE BJ, 1980, MACROMOL CHEM, V1, P416
   WILLIAMS DF, 1971, BIOMED ENG 3, P153
   WILLIAMS DF, 1971, BIOMED ENG 3, P205
   2012070
   BIOMEDICAL PROPERTIE
   1969, CHEM SILICONE ELASTO, V18, P221
   BIOMEDICAL USES POLY
   SILICONES COPOLYMERS
   4188546
   4242483
   2813558
NR 20
TC 5
Z9 5
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PY 1984
VL 5
IS 5
BP 298
EP 300
DI 10.1016/0142-9612(84)90077-2
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA TK781
UT WOS:A1984TK78100010
PM 6487713
DA 2018-10-19
ER

PT J
AU BAIER, RE
AF BAIER, RE
TI INTERFACIAL FACTORS IN THE DESIGN OF BIOMEDICAL MATERIALS
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
C1 CALSPAN CORP,CTR ADV TECHNOL,BUFFALO,NY 14225.
   SUNY BUFFALO,DEPT BIOPHYS,BUFFALO,NY 14214.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PY 1984
VL 45
IS 2
BP A25
EP A25
PG 1
WC Biophysics
SC Biophysics
GA SC967
UT WOS:A1984SC96700069
DA 2018-10-19
ER

PT J
AU SCHWAN, HP
AF SCHWAN, HP
TI PROPERTIES OF BIOLOGICAL-MATERIALS AND BIOMEDICAL APPLICATIONS
SO IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
LA English
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 0
U2 1
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 0018-9294
J9 IEEE T BIO-MED ENG
JI IEEE Trans. Biomed. Eng.
PY 1984
VL 31
IS 8
BP 571
EP 571
PG 1
WC Engineering, Biomedical
SC Engineering
GA TF118
UT WOS:A1984TF11800080
DA 2018-10-19
ER

PT J
AU SCHWAN, HP
AF SCHWAN, HP
TI ELECTRICAL AND ACOUSTIC PROPERTIES OF BIOLOGICAL-MATERIALS AND
   BIOMEDICAL APPLICATIONS
SO IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
LA English
DT Article
C1 DREXEL UNIV,INST BIOMED ENGN & SCI,PHILADELPHIA,PA 19104.
RP SCHWAN, HP (reprint author), UNIV PENN,DEPT BIOENGN,PHILADELPHIA,PA 19104, USA.
CR ANNE A, 1961, BIOL EFFECTS MICROWA, V1, P153
   CARSTENSEN EL, 1953, J ACOUST SOC AM, V25, P286, DOI 10.1121/1.1907033
   CARSTENSEN EL, 1959, J ACOUST SOC AM, V31, P185, DOI 10.1121/1.1907690
   CARSTENSEN EL, 1959, J ACOUST SOC AM, V31, P305, DOI 10.1121/1.1907716
   CARSTENSEN EL, 1976, ULTRASONIC BIOPHYSIC, V7, P38
   COLE KS, 1968, MEMBRANES IONS IMPUL
   EDMONDS PD, 1970, BIOCHIM BIOPHYS ACTA, V200, P174, DOI 10.1016/0005-2795(70)90058-9
   EDMONDS PD, 1976, ULTRASONIC BIOPHYSIC, V7, P50
   FOSTER KR, 1980, BIOPHYS J, V29, P271, DOI 10.1016/S0006-3495(80)85131-9
   FOSTER KR, 1984, BIOPHYS J, V45, P975, DOI 10.1016/S0006-3495(84)84242-3
   FOSTER KR, 1978, IEEE T BIO-MED ENG, V25, P313, DOI 10.1109/TBME.1978.326313
   FOSTER KR, UNPUB DIELECTRIC P A, V6
   FRICKE H, 1956, NATURE, V177, P134, DOI 10.1038/177134a0
   GRANT EH, 1965, ANN NY ACAD SCI, V125, P418, DOI 10.1111/j.1749-6632.1965.tb45407.x
   KRITIKOS HN, 1975, IEEE T BIO-MED ENG, V22, P457, DOI 10.1109/TBME.1975.324465
   KRITIKOS HN, 1981, J MICROWAVE POWER EE, V16, P327, DOI 10.1080/16070658.1981.11689256
   PAULY H, 1959, Z NATURFORSCH PT B, V14, P125
   PAULY H, 1971, J ACOUST SOC AM, V50, P692, DOI 10.1121/1.1912685
   PAULY H, 1966, BIOPHYS J, V6, P621, DOI 10.1016/S0006-3495(66)86682-1
   PAULY H, 1976, ULTRASONIC BIOPHYSIC, V7, P54
   PENNOCK BE, 1969, J PHYS CHEM-US, V73, P2600, DOI 10.1021/j100842a024
   RAJEWSKY B, 1948, NATURWISSENSCHAFTEN, V35, P315, DOI 10.1007/BF00626639
   RAJEWSKY B, 1938, ULTRAKURZWELLEN ERGE, V1
   SALATI OM, 1962, ELECTRON IND     NOV
   SCHWAN H, 1954, Z NATURFORSCH B, V9, P245
   Schwan H, 1965, THERAPEUTIC HEAT COL, P63
   SCHWAN H P, 1954, Am J Phys Med, V33, P371
   SCHWAN H P, 1957, Adv Biol Med Phys, V5, P147
   Schwan H. P., 1983, BIOL EFFECTS DOSIMET, P213
   Schwan H. P., 1963, PHYSICAL TECHNIQUE B, V6, P323, DOI DOI 10.1002/JCP.1030660505
   SCHWAN HERMAN P., 1963, BIOPHYSIK, V1, P198, DOI 10.1007/BF01195396
   SCHWAN HP, 1953, P IRE, V41, P1735, DOI 10.1109/JRPROC.1953.274358
   SCHWAN HP, 1962, J PHYS CHEM-US, V66, P2626, DOI 10.1021/j100818a066
   SCHWAN HP, 1980, P IEEE, V68, P104, DOI 10.1109/PROC.1980.11589
   SCHWAN HP, 1957, CIRC RES, V5, P439, DOI 10.1161/01.RES.5.4.439
   SCHWAN HP, 1962, BIOPHYS J, V2, P395, DOI 10.1016/S0006-3495(62)86863-5
   SCHWAN HP, 1965, ANN NY ACAD SCI, V125, P344, DOI 10.1111/j.1749-6632.1965.tb45401.x
   SCHWAN HP, 1982, J MICROWAVE POWER EE, V17, P1
   SCHWAN HP, 1982, BRIT J CANCER, V45, P220
   SCHWAN HP, 1983, BLUT, V46, P185, DOI 10.1007/BF00320638
   SCHWAN HP, 1958, THERAPEUTIC HEAT, V2, P55
   SCHWAN HP, 1969, J ELECTROCHEMICAL SO, V116, P170
   SCHWAN HP, UNPUB BIOL EFFECTS D
   SCHWAN HP, 1983, P C BIOPHYS CORRELAT
   SCHWAN HP, 1959, 1ST P NAT BIOPH C, P348
   SCHWAN HP, 1953, T AIEE, P114
   Schwartz H. F., 1981, BIOPHYSICAL APPROACH, P3
   SCHWARZ G, 1962, J PHYS CHEM-US, V66, P2636, DOI 10.1021/j100818a067
   STOY RD, 1982, PHYS MED BIOL, V27, P501, DOI 10.1088/0031-9155/27/4/002
   WAY WI, 1981, BIOELECTROMAGNETICS, V2, P341, DOI 10.1002/bem.2250020406
NR 50
TC 19
Z9 19
U1 1
U2 1
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017-2394
SN 0018-9294
J9 IEEE T BIO-MED ENG
JI IEEE Trans. Biomed. Eng.
PY 1984
VL 31
IS 12
BP 872
EP 878
DI 10.1109/TBME.1984.325251
PG 7
WC Engineering, Biomedical
SC Engineering
GA AAV20
UT WOS:A1984AAV2000022
PM 6396212
DA 2018-10-19
ER

PT J
AU MARCONI, W
   DIGREGORIO, F
   MANTOVANI, E
   SISTO, R
   TOGNA, G
AF MARCONI, W
   DIGREGORIO, F
   MANTOVANI, E
   SISTO, R
   TOGNA, G
TI CHARACTERIZATION OF 2 CRYSTALLINE POLYURETHANE HOMOPOLYMERS AS POTENTIAL
   MATERIALS FOR BIOMEDICAL APPLICATIONS
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
C1 UNIV CATTOLICA SACRO CUORE, I-00168 ROME, ITALY.
RP MARCONI, W (reprint author), ASSORENI, I-00015 MONTEROTONDO, ITALY.
CR BIESTER FD, 1982, INT J ARTIF ORGANS, V5, P191
   BRUCK S, 1980, PROPERTIES BIOMATERI, P122
   KUTSON K, 1981, POLYM SCI TECHNOL BI, V14, P173
   LELAH MD, 1983, J BIOMED MATER RES, V17, P1, DOI 10.1002/jbm.820170102
   LYMAN DJ, 1981, STRUCTURAL ORDER POL, P205
   MANTOVANI E, INT J ARTIF ORG
   MANTOVANI F, 1980, INT J ARTIF ORGANS, V3, P305
   PATRONO C, 1980, THROMB RES, V17, P317, DOI 10.1016/0049-3848(80)90066-3
   SAUNDERS JH, 1964, POLYURETHANES CHEM 2, V16, P769
   SHUMAN MA, 1980, J CLIN INVEST, V65, P307, DOI 10.1172/JCI109673
   SORENSON RW, 1968, PREPARATIVE METHODS, P126
   STOKES K, 1982, BIOMATERIALS, V3, P225, DOI 10.1016/0142-9612(82)90024-2
NR 12
TC 2
Z9 2
U1 0
U2 0
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PY 1984
VL 7
IS 6
BP 349
EP 352
PG 4
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA TY484
UT WOS:A1984TY48400012
PM 6549308
DA 2018-10-19
ER

PT J
AU KRISHNAN, VK
   PAL, SN
AF KRISHNAN, VK
   PAL, SN
TI CRITERIA FOR DEVELOPING BIOMEDICAL DEVICES FROM POLYMERIC MATERIALS
SO POLYMER-PLASTICS TECHNOLOGY AND ENGINEERING
LA English
DT Article
C1 SREE CHITRA TIRUNAL INST MED SCI & TECHNOL,DEPT BIOMED ENGN,DIV POLYMER TECHNOL,TRIVANDRUM 695012,INDIA.
CR ANDRADE JD, 1979, J POLYM SCI POL SYM, P313
   Brash J L, 1969, J Biomed Mater Res, V3, P175, DOI 10.1002/jbm.820030114
   BRUCK SD, 1980, PROPERTIES BIOMATERI, P1
   COOPER J, 1974, PLASTIC CONTAINERS P
   DUNCAN MN, 1975, EVALUATION POTENTIAL
   KRISHNAN VK, 1982, PLAST IND, V9, P5
   NASS LI, 1976, ENCY PVC, V1, P9
   RATNER BD, 1980, J BIOMED MATER RES, V14, P655
   RATNER BD, 1975, BIOMEDICAL APPLICATI, P159
   SHARMA CP, 1982, POLYM-PLAST TECHNOL, V18, P233, DOI 10.1080/03602558208067723
   WILLIAMS DF, 1981, FUNDAMENTAL ASPECTS, V2, P113
   WILLIAMS DF, 1973, IMPLANTS SURGERY, P359
   1979, NIH802186 PUBL
   1980, NIH802185 PUBL
NR 14
TC 13
Z9 13
U1 0
U2 0
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016
SN 0360-2559
J9 POLYM-PLAST TECHNOL
JI Polym.-Plast. Technol. Eng.
PY 1984
VL 23
IS 2
BP 185
EP 192
DI 10.1080/03602558408070049
PG 8
WC Polymer Science
SC Polymer Science
GA ACT22
UT WOS:A1984ACT2200004
DA 2018-10-19
ER

PT J
AU ANDERSON, JM
AF ANDERSON, JM
TI SPECIAL REPORT - BIOMEDICAL MATERIALS RESEARCH IN JAPAN
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Review
C1 CASE WESTERN RESERVE UNIV,DEPT MACROMOLEC SCI,CLEVELAND,OH 44106.
RP ANDERSON, JM (reprint author), CASE WESTERN RESERVE UNIV,DEPT PATHOL,CLEVELAND,OH 44106, USA.
CR AKAO M, 1981, J MATER SCI, V16, P809, DOI 10.1007/BF00552220
   FUKADA E, 1980, BIOMEDICAL POLYM POL, P31
   FURUSAWA K, 1979, KOBUNSHI RONBUNSHU, V36, P273, DOI 10.1295/koron.36.273
   FURUSAWA K, UNPUB J BIOMED MATER
   HAYAKAWA I, UNPUB J PROSTHET DEN
   HAYASHI K, 1980, ARTIFICIAL ORGANS J, V9, P629
   HAYASHI K, 1981, ARTIF ORGANS JPN, V10, P667
   HOSAKA S, 1979, J APPL POLYM SCI, V23, P2089, DOI 10.1002/app.1979.070230719
   HOSAKA S, 1980, J BIOMED MATER RES, V14, P557, DOI 10.1002/jbm.820140503
   HOSAKA S, UNPUB J BIOMED MATER
   ICHIMURA K, 1980, J POLYM SCI POL CHEM, V18, P891, DOI 10.1002/pol.1980.170180310
   IKADA Y, 1981, J BIOMED MATER RES, V15, P697, DOI 10.1002/jbm.820150507
   IMACHI K, 1980, ARTIF ORGANS JPN, V9, P593
   IMACHI K, 1981, ARTIF ORGANS JPN, V10, P406
   IMACHI K, 1979, 2ND P M ISAO, P257
   IMAI Y, 1979, 2ND P M ISAO, P249
   Imai Y., 1980, ARTIF ORGANS, V9, P911
   IMAI Y, 1980, ARTIF ORGANS JPN, V9, P260
   IMAI Y, J DENT RES
   IMAI Y, UNPUB J BIOMED MATER
   ISHIHARA Y, 1981, POLYM PREPR JPN, V30, P275
   JOHNSON DR, 1981, MACROMOLECULES, V14, P118, DOI 10.1021/ma50002a024
   KADOMA Y, 1981, MACROMOL CHEM PHYS, V182, P273
   KADOMA Y, 1978, KOBUNSHI RONBUNSHU, V35, P423, DOI 10.1295/koron.35.423
   KAIFU K, J BIOMED MATER RES
   KATAOKA K, 1980, J BIOMED MATER RES, V14, P817, DOI 10.1002/jbm.820140613
   KATAOKA K, 1980, MAKROMOL CHEM, V181, P1363
   KATAOKA K, 1980, BIOMATERIALS 1980, P493
   KATAOKA K, 1981, ARTIF ORGANS JPN, V10, P106
   MAEDA M, 1980, MAKROMOL CHEM, V181, P2251
   MAEDA M, 1980, MAKROMOL CHEM, V181, P2245
   MASUHO Y, 1980, GANN, V71, P759
   MASUHO Y, 1979, BIOCHEM BIOPH RES CO, V90, P320, DOI 10.1016/0006-291X(79)91627-9
   MATSUMOTO H, UNPUB EFFECT COPOLYM
   MORI Y, 1982, J BIOMED MATER RES, V16, P17, DOI 10.1002/jbm.820160105
   NAKABAYASHI N, 1982, J BIOMED MATER RES, V16, P265, DOI 10.1002/jbm.820160307
   NAKABAYASHI N, 1980, KIDNEY LIVER SUPPO 1, P57
   NAKABAYASHI N, 1980, BIOMEDICAL POLYM POL, P85
   NAKABAYSHI N, UNPUB ADHESION POLYM
   Nakajima A, 1980, BIOMEDICAL POLYM, P243
   NAKANISHI E, 1980, POLYM BULL, V3, P655, DOI 10.1007/BF00285302
   NISHIMURA T, 1980, MAKROMOL CHEM-RAPID, V1, P573
   NOISHIKI Y, 1980, Japanese Journal of Surgery, V10, P77, DOI 10.1007/BF02468652
   NOISHIKI Y, 1980, ARTIF ORGANS JPN, V9, P928
   NOISHIKI Y, 1981, ARTIF ORGANS JPN, V10, P494
   NOISHIKI Y, 1980, ARTIF ORG, V9, P678
   NOISHIKI Y, UNPUB J BIOMED MATER
   OGATA N, 1981, J APPL POLYM SCI, V26, P2293, DOI 10.1002/app.1981.070260716
   OKAHATA Y, 1979, J AM CHEM SOC, V101, P5231, DOI 10.1021/ja00512a020
   OKANO T, 1978, POLYM J, V10, P223, DOI 10.1295/polymj.10.223
   OKANO T, 1981, ARTIF ORGANS JPN, V10, P671
   OKANO T, 1979, 2ND P M ISAO, P253
   OSADA Y, 1979, ACS SYM SER, V108, P253
   SAKAI Y, 1980, ULTRAFILTRATION MEMB, P99
   SAKURAI Y, 1980, BIOMEDICAL POLYM, P335
   SHIMIZU Y, 1978, BIOMATER ARTIF CELL, V6, P375, DOI 10.3109/10731197809119795
   SUGITACHI A, 1980, T AM SOC ART INT ORG, V26, P274
   SUGITACHI A, J BIOMED MATER RES
   SUNAMOTO J, 1980, J BIOCHEM-TOKYO, V88, P1219, DOI 10.1093/oxfordjournals.jbchem.a133089
   SUZUKI S, 1982, J BIOMED MATER RES, V16, P275, DOI 10.1002/jbm.820160308
   TAHARA H, 1981, POLYM PREPR JPN, V30, P307
   TAKAHARA A, 1981, REP PROGR POLYM PHYS, V24
   TAKAMATSU T, 1979, KOBUNSHI RONBUNSHU, V36, P231, DOI 10.1295/koron.36.231
   TAKAMATSU T, 1980, KOBUNSHI RONBUNSHU, V37, P781, DOI 10.1295/koron.37.781
   TAKANASHI M, 1981, POLYM PREP JPN, V30, P133
   TAKANO H, 1981, ARTIF ORGANS JPN, V10, P647
   TANAKA T, J DENT RES
   TANZAWA H, 1980, BIOMEDICAL POLYM, P189
   TSURUTA T, 1980, POLYM AMINES AMMONIU, P163
   TSURUTA T, 1980, BIOMEDICAL POLYM POL, P431
   UNOKI M, 1981, POLYM PREPR JPN, V30, P306
   WANG CL, 1978, BIOCHIM BIOPHYS ACTA, V544, P555, DOI 10.1016/0304-4165(78)90330-6
   WANG CL, 1978, BIOCHIM BIOPHYS ACTA, V544, P568, DOI 10.1016/0304-4165(78)90331-8
   Yamagata S, 1979, J Microsurg, V1, P208
   YOSHIZATO K, 1981, DEV GROWTH DIFFER, V23, P175
NR 75
TC 2
Z9 2
U1 0
U2 0
PU JOHN WILEY & SONS INC
PI NEW YORK
PA 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PY 1982
VL 16
IS 5
BP 721
EP 733
DI 10.1002/jbm.820160518
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA PG378
UT WOS:A1982PG37800017
PM 6752149
DA 2018-10-19
ER

PT J
AU GOGOLEWSKI, S
   PENNINGS, AJ
AF GOGOLEWSKI, S
   PENNINGS, AJ
TI BIODEGRADABLE MATERIALS OF POLYLACTIDES, .4. POROUS BIOMEDICAL MATERIALS
   BASED ON MIXTURES OF POLYLACTIDES AND POLYURETHANES
SO MAKROMOLEKULARE CHEMIE-RAPID COMMUNICATIONS
LA English
DT Article
C1 STATE UNIV GRONINGEN,DEPT POLYMER CHEM,9747 AG GRONINGEN,NETHERLANDS.
CR AK Schneider, 1972, [US Patent, 3, 636, 956], Patent No. [3636956, 3,636,956]
   ANNIS D, 1979, SHELL POLYM, V3, P52
   BORETOS JOHN W., 1968, J BIOMED MAT RES, V2, P121, DOI 10.1002/jbm.820020109
   Bruck S. D, 1977, J BIOMED MATER RES S, V8, P1
   BRUCK SD, 1977, BIOMATER ARTIF CELL, V5, P97, DOI 10.3109/10731197709118667
   BRUCK SD, 1977, J POLYM SCI PS, V66, P283
   ELING B, 1982, POLYMER, V23, P1587, DOI 10.1016/0032-3861(82)90176-8
   FORBES CD, 1978, BRIT MED BULL, V34, P201, DOI 10.1093/oxfordjournals.bmb.a071492
   GOGOLEWSKI S, UNPUB
   GOGOLEWSKI S, Patent No. 8202893
   GOGOLEWSKI S, Patent No. 8202894
   GOGOLEWSKI S, UNPUB BIOMATERIALS
   GOGOLEWSKI S, J APPL POLYM SCI
   HALPERN BD, 1977, ENCY POLYM SCI TEC S, V2
   HOFFMANN AS, 1977, J APPL POLYM SCI APP, V31, P313
   KATZ AR, 1970, SURG GYNECOL OBSTETR, V131, P701
   KINLEY CE, 1980, J CARDIOVASC SURG, V21, P163
   KULKARNI R K, 1971, Journal of Biomedical Materials Research, V5, P169, DOI 10.1002/jbm.820050305
   KULKARNI RK, 1966, ARCH SURG-CHICAGO, V93, P839
   LIPATOVA TE, 1979, J POLYM SCI PS, V66, P239
   LOMMEN E, UNPUB
   OPPENHEIMER E, 1961, CANCER RES, V21, P132
   REED AM, 1981, POLYMER, V22, P494, DOI 10.1016/0032-3861(81)90168-3
   RUDERMAN RJ, 1972, T AM SOC ART INT ORG, V18, P30
   SCHINDLER A, 1977, CONT TOPICS POLYM SC, V2
   Tanquary A. C., 1974, CONTROLLED RELEASE B
   VERT M, 1981, MAKROMOL CHEM S, V5, P30, DOI DOI 10.1002/MACP.1981.020051981103
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
NR 28
TC 69
Z9 68
U1 2
U2 13
PU HUTHIG & WEPF VERLAG
PI BASEL
PA AUF DEM WOLF 4, CH-4052 BASEL, SWITZERLAND
SN 0173-2803
J9 MAKROMOL CHEM-RAPID
PY 1982
VL 3
IS 12
BP 839
EP 845
PG 7
WC Polymer Science
SC Polymer Science
GA PW992
UT WOS:A1982PW99200001
DA 2018-10-19
ER

PT J
AU MIURA, Y
   AOYAGI, S
   ARITA, Y
   MIYAMOTO, K
AF MIURA, Y
   AOYAGI, S
   ARITA, Y
   MIYAMOTO, K
TI A NEW METHOD FOR ESTIMATING BLOOD COMPATIBILITY OF BIOMEDICAL MATERIALS
SO ARTIFICIAL ORGANS
LA English
DT Meeting Abstract
C1 OSAKA UNIV,FAC PHARMACEUT SCI,DEPT BIOCHEM ENGN,OSAKA,JAPAN.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PY 1981
VL 5
IS 3
BP 308
EP 308
PG 1
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA MM858
UT WOS:A1981MM85800034
DA 2018-10-19
ER

PT J
AU ROBAYE, G
   WEBER, G
   DELBROUCK, JM
   ROELANDTS, I
   BARTSCH, P
   COLLIGNON, A
AF ROBAYE, G
   WEBER, G
   DELBROUCK, JM
   ROELANDTS, I
   BARTSCH, P
   COLLIGNON, A
TI ATTEMPTS TO IMPROVE PIXE QUANTITATIVE TRACE-ELEMENT ANALYSIS OF
   BIOMEDICAL MATERIALS
SO NUCLEAR INSTRUMENTS & METHODS
LA English
DT Article
C1 UNIV LIEGE,DEPT GEOCHEM,B-4000 LIEGE,BELGIUM.
   UNIV LIEGE,DEPT INTERNAL MED,B-4000 LIEGE,BELGIUM.
RP ROBAYE, G (reprint author), UNIV LIEGE,DEPT NUCL PHYS,B-4000 LIEGE,BELGIUM.
CR DIDEBERG O, UNPUBLISHED
   KASPEREK K, 1972, IAEASM15735
   LEAR RD, 1976, ADV XRAY ANAL, V19, P521
   LECOMTE R, 1979, INT J NUCL MED BIOL, V6, P207, DOI 10.1016/0047-0740(79)90040-8
   MOLOKHIA M, 1967, ARCH ENV HLTH, V15, P746
   ROBAYE G, NUCL INSTR METH
   VIS RD, 1979, RADIOCHEM RADIOA LET, V41, P245
   WEBER G, 1980, NUCL INSTRUM METHODS, V168, P551, DOI 10.1016/0029-554X(80)91309-9
NR 8
TC 5
Z9 5
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0029-554X
J9 NUCL INSTRUM METHODS
PY 1981
VL 181
IS 1-3
BP 59
EP 62
DI 10.1016/0029-554X(81)90580-2
PG 4
WC Instruments & Instrumentation; Nuclear Science & Technology
SC Instruments & Instrumentation; Nuclear Science & Technology
GA LH811
UT WOS:A1981LH81100013
DA 2018-10-19
ER

PT J
AU MIURA, Y
   AOYAGI, S
   IKEDA, F
   MIYAMOTO, K
AF MIURA, Y
   AOYAGI, S
   IKEDA, F
   MIYAMOTO, K
TI ANTI-COAGULANT ACTIVITY OF ARTIFICIAL BIOMEDICAL MATERIALS WITH
   CO-IMMOBILIZED ANTI-THROMBIN-III AND HEPARIN
SO BIOCHIMIE
LA English
DT Article
RP MIURA, Y (reprint author), OSAKA UNIV,FAC PHARMACEUT SCI,DEPT BIOCHEM ENGN,SUITA,OSAKA 565,JAPAN.
CR ABLIGAARD U, 1969, SCAND J CLIN LAB INV, V24, P23
   ANDERSON MM, 1974, THROMBOSIS RESEARCH, V5, P439
   ANDERSSON LO, 1977, J IMMUNOL METHODS, V14, P271, DOI 10.1016/0022-1759(77)90138-7
   ARONSON DL, 1969, BIOCHIM BIOPHYS ACTA, V188, P25, DOI 10.1016/0005-2795(69)90041-5
   ASAI K, 1976, JPN J CLIN PATHOL, V27, P143
   BINDER B, 1973, THROMB DIATH HAEMOST, V30, P280, DOI 10.1055/s-0038-1649075
   BJORK I, 1976, EUR J BIOCHEM, V68, P507, DOI 10.1111/j.1432-1033.1976.tb10838.x
   DAMUS PS, 1973, NATURE, V246, P355, DOI 10.1038/246355a0
   DAMUS PS, 1974, BIOCHEM BIOPH RES CO, V61, P1147, DOI 10.1016/S0006-291X(74)80403-1
   EINARSSON R, 1977, BIOCHIM BIOPHYS ACTA, V490, P104, DOI 10.1016/0005-2795(77)90110-6
   FUJIKAWA K, 1972, BIOCHEMISTRY-US, V11, P4892, DOI 10.1021/bi00776a003
   GOOSEN MFA, 1979, J BIOMED MATER RES, V13, P347, DOI 10.1002/jbm.820130302
   GOTT VL, 1963, SCIENCE, V142, P1297, DOI 10.1126/science.142.3597.1297
   HOFFMAN AS, 1972, T AM SOC ART INT ORG, V18, P10
   HOLMER E, 1979, EUR J BIOCHEM, V93, P1, DOI 10.1111/j.1432-1033.1979.tb12787.x
   HOOH M, 1976, FEBS LETT, V66, P90
   IVERIUS PH, 1971, BIOCHEM J, V124, P677, DOI 10.1042/bj1240677
   JESTY J, 1979, J BIOL CHEM, V254, P1044
   JESTY J, 1978, ARCH BIOCHEM BIOPHYS, V185, P165, DOI 10.1016/0003-9861(78)90156-X
   JOIST JH, 1975, HEPARIN STRUCTURE FU, P255
   LARGERGREN H, 1971, T AM SOC ARTIF INT O, V17, P10
   LI EHH, 1976, ARCH BIOCHEM BIOPHYS, V175, P153, DOI 10.1016/0003-9861(76)90494-X
   MERKER RL, 1969, ARTIFICIAL HEART PRO, P29
   MIURA Y, UNPUBLISHED
   MIURA Y, 1979, ARTIF ORGANS, V8, P288
   MIURA Y, 1978, ARTIF ORGANS, V7, P193
   MORITA T, 1977, J BIOCHEM-TOKYO, V82, P1495, DOI 10.1093/oxfordjournals.jbchem.a131840
   MUSTARD JF, 1970, PHARMACOL REV, V22, P97
   REMBAUM A, 1969, NASA6910299 TECH BRI
   ROSENBERG RD, 1973, J BIOL CHEM, V248, P6490
   SAKURAGAWA N, 1976, JPN J CLIN PATHOL, V27, P130
   SCHMER G, 1972, T AM SOC ART INT ORG, V18, P321
   SCHMER G, 1976, T AM SOC ART INT ORG, V22, P654
   YEN S P S, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P83
   YIN ET, 1968, J BIOL CHEM, V243, P112
NR 35
TC 1
Z9 1
U1 0
U2 0
PU EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS CEDEX 15
PA 141 RUE JAVEL, 75747 PARIS CEDEX 15, FRANCE
SN 0300-9084
J9 BIOCHIMIE
JI Biochimie
PY 1980
VL 62
IS 8-9
BP 595
EP 601
DI 10.1016/S0300-9084(80)80106-4
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA KH488
UT WOS:A1980KH48800011
PM 7417594
DA 2018-10-19
ER

PT J
AU MIGLIARESI, C
   NICOLAIS, L
AF MIGLIARESI, C
   NICOLAIS, L
TI COMPOSITE-MATERIALS FOR BIOMEDICAL APPLICATIONS
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
RP MIGLIARESI, C (reprint author), UNIV NAPLES,IST PRINCIPI INGN CHIM,I-80125 NAPLES,ITALY.
CR BRUCK SD, 1973, J BIOMED MATER RES, V7, P387, DOI 10.1002/jbm.820070503
   Ferry JD, 1936, CHEM REV, V18, P373, DOI 10.1021/cr60061a001
   HOFFMAN AS, 1975, POLYM MED SURG, P33
   KENEDI RM, 1975, PHYS MED BIOL, V20, P699, DOI 10.1088/0031-9155/20/5/001
   KRONENTAL RL, 1975, POLYMERS MEDICINE SU
   LYMAN DJ, 1975, POLYM MED SURG, P29
   MATZ R, 1980, HYDRODYNAMIC ASPECTS
   MIGLIARESI C, UNPUBLISHED
   NICOLAIS L, 1975, POLYM ENG SCI, V15, P137, DOI 10.1002/pen.760150305
   SPRINCL L, 1973, J BIOMED MATER RES, V7, P123, DOI 10.1002/jbm.820070110
   WADDOUPS ME, 1975, POLYM ENG SCI, V15, P160, DOI 10.1002/pen.760150307
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
NR 12
TC 20
Z9 20
U1 2
U2 5
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PY 1980
VL 3
IS 2
BP 114
EP 118
PG 5
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA JQ853
UT WOS:A1980JQ85300013
PM 7364506
DA 2018-10-19
ER

PT J
AU HASTINGS, GW
AF HASTINGS, GW
TI BIOMEDICAL-ENGINEERING AND MATERIALS FOR ORTHOPEDIC IMPLANTS
SO JOURNAL OF PHYSICS E-SCIENTIFIC INSTRUMENTS
LA English
DT Review
RP HASTINGS, GW (reprint author), N STAFFORDSHIRE POLYTECH, STRAFFORDSHIRE AREA HLTH, INST MED, BIOMED ENGN UNIT, STOKE ON TRENT, STAFFORDSHIRE, ENGLAND.
CR ADAMS D, 1978, J BIOMED MATER RES, V12, P35, DOI 10.1002/jbm.820120104
   ANNIS D, 1978, 3RD INT C MAT MED BI
   BANDHARI V, 1975, 15TH P ANN INT C ED
   BARDOS I, 1978, 1978 INT S BIOM DENT
   BASSETT CAL, 1968, CALC TISS RES, V1, P252
   Bechtol C. O., 1975, ORTHOP REV, V4, P23
   BJORK V O, 1972, Scandinavian Journal of Thoracic and Cardiovascular Surgery, V6, P109, DOI 10.3109/14017437209134787
   BLACK J, 1978, J BONE JOINT SURG BR, V60, P303
   BLACK J, 1976, J BIOMED MATER RES, V10, P377, DOI 10.1002/jbm.820100307
   BLOCH B, 1958, J BONE JOINT SURG BR, V40, P804
   BLOCH B, 1973, PLASTICS MATERIALS S
   BONFIELD W, 1977, NATURE, V270, P453, DOI 10.1038/270453a0
   Bourne GH, 1972, BIOCH PHYSL BONE
   BOUTIN P, 1972, REV CHIR ORTHOP, V58, P229
   BOUTIN P, 1974, REV CHIR ORTHOP, V60, P233
   BRADLEY J, 1980, 3RD INT C MAT US MED
   BRADLEY JS, 1980, BIOMATERIALS, V1, P38, DOI 10.1016/0142-9612(80)90057-5
   BRADLEY JS, 1977, ENG MED, V6, P25
   BRADLEY JS, ENG MED
   BRAIDEN PM, 1978, 1978 BIOC S KEEL
   BREIER M, 1978, 3RD INT C MAT US MED
   BROCKHURST PJ, 1977, MED PROG TECHNOL, V5, P73
   BRUCK SD, 1978, BIOMATER ARTIF CELL, V6, P57, DOI 10.3109/10731197809118692
   CARNOCHAN JM, 1860, ARCH MED, V284
   CHARNLEY J, 1970, CLIN ORTHOP RELAT R, P7
   CHARNLEY J, 1965, J Bone Joint Surg Br, V47, P354
   CHARNLEY J, 1964, J BONE JOINT SURG BR, V46, P518
   CHRISTIANSEN T, 1969, ACTA CHIR SCAND, V135, P43
   CLARK AE, 1976, J BIOMED MATER RES, V10, P161, DOI 10.1002/jbm.820100202
   CURREY JD, 1969, J BIOMECH, V2, P477, DOI 10.1016/0021-9290(69)90023-2
   DENISSEN H, 1978, 1978 BIOC S KEEL LON
   DORRE E, 1976, J BIOMED MATER RES, V10, P493, DOI 10.1002/jbm.820100404
   DORRE E, 1975, ARCH ORTHOP TRAUM SU, V83, P269, DOI 10.1007/BF00416280
   DOWLING JM, 1978, J BONE JOINT SURG BR, V60, P375
   ELMESSIERY MA, 1979, J BIOMED ENG, V1, P63
   EVANS FG, 1973, MECHANICAL PROPERTIE
   FARLING GM, 1978, 3RD INT C MAT US MED
   FREEMAN MAR, 1978, CLIN ORTHOP, V134
   FROST HM, 1973, ORTHOPAEDIC LECTURES, V5
   FU JC, 1978, J BIOMED MATER RES, V12, P249, DOI 10.1002/jbm.820120302
   GENTLE CR, 1978, 1978 BIOC S KEEL LON
   GERENDAS N, 1959, THER HUNG, V7, P8
   GLUCK T, 1891, ARCH KLIN CHIR, V41, P186
   GREENSPAN DC, 1976, J BIOMED MATER RES, V10, P503, DOI 10.1002/jbm.820100405
   GRENOBLE DE, 1975, BIOMATER ARTIF CELL, V3, P245, DOI 10.3109/10731197509118625
   GRISS P, 1975, ARCH ORTHOP TRAUM SU, V81, P259, DOI 10.1007/BF00416952
   HASTINGS GW, 1978, COMPOSITES, V9, P193, DOI 10.1016/0010-4361(78)90345-2
   HASTINGS GW, 1979, WEAR, V55, P1, DOI 10.1016/0043-1648(79)90175-3
   HASTINGS GW, 1975, PLASTICS MEDICI 0801
   HAUBOLD A, 1978, 1978 INT S BIOM DENT
   HEIMKE G, 1974, ARCH ORTHOP TRAUM SU, V78, P216, DOI 10.1007/BF02433478
   HENCH LL, 1979, BIOMATER ARTIF CELL, V7, P339, DOI 10.3109/10731197909117590
   HENCH LL, 1977, CERAMURGIA INT, V7, P252
   HENRICHSEN E, 1952, Acta Orthop Scand, V22, P141, DOI 10.3109/17453675208989001
   HODOSH M, 1978, J BIOMED MATER RES, V12, P167, DOI 10.1002/jbm.820120204
   HUNTER J, 1965, AM J SURG, V109, P325, DOI 10.1016/S0002-9610(65)80081-2
   JUDET J, 1954, RESECTION RECONSTRUC
   KATO K, 1979, BIOMATER ARTIF CELL, V7, P291, DOI 10.3109/10731197909117584
   KATZ JL, 1971, J BIOMECH, V4, P455, DOI 10.1016/0021-9290(71)90064-9
   KATZ JL, 1979, S MECHANICAL PROPERT
   KOROSTOFF E, 1979, 1978 S U PENNS PHIL
   LACH S, 1979, THESIS N STAFFORDSHI
   LEAKE DL, 1976, J BIOMED MATER RES, V10, P555, DOI 10.1002/jbm.820100412
   Lorenz M., 1978, Engineering in Medicine, V7, P241
   LORENZ M, 1978, SULZER TECH REV, V1, P31
   MAIER HR, 1978, 3RD INT C MATS US ME
   MARK H F, 1968, Pure and Applied Chemistry, V16, P201, DOI 10.1351/pac196816020201
   McKee G K, 1966, J Bone Joint Surg Br, V48, P245
   MCKIBBIN B, 1978, J BONE JOINT SURG BR, V60, P150
   MERCER R, 1966, ANTHOLOGY ORTHOPAEDI, P194
   MORSCHER E, 1976, ADV ARTIFICIAL HIP K, P403
   NEUMANN AW, 1975, J BIOMED MATER RES, V9, P127, DOI 10.1002/jbm.820090203
   PARK GB, 1978, BIOMATER ARTIF CELL, V6, P1
   Paul J. P., 1976, ADV HIP KNEE JOINT T, P53
   PAUL JP, 1973, PERSPECTIVES BIOMEDI
   PAUWELS F, 1973, BIOMECHANICS DISEASE
   PERREN SM, 1969, ACTA ORTHOP SCAND, P17
   PERREN SM, 1969, ACTA ORTHOP SCAND, P5
   PHOENIX OF, UNPUBLISHED
   Pilla AA, 1977, J ELECTROCHEM SOC, V124, P1697, DOI 10.1149/1.2133139
   PILLIAR RM, 1976, J BIOMED MATER RES, V10, P893, DOI 10.1002/jbm.820100608
   POLLACK S, IN PRESS
   PUGH PDG, 1968, NELSON HIS SURGEONS
   ROSTOKER W, 1976, J BIOMED MATER RES, V10, P303, DOI 10.1002/jbm.820100211
   SAGI L, 1978, 3RD JNT C MAT MED BI
   SALZER M, 1976, J BIOMED MATER RES, V10, P847, DOI 10.1002/jbm.820100604
   SALZER M, 1976, ARTIFICIAL HIP KNEE
   SCLIPPA E, 1973, J BIOMED MATER RES, V7, P59, DOI 10.1002/jbm.820070105
   SEMLITSCH M, 1977, J BIOMED MATER RES, V11, P537, DOI 10.1002/jbm.820110409
   SEMPLE JC, 1976, J BONE JOINT SURG BR, V58, P253
   SHIM HS, 1977, J BIOMED MATER RES, V11, P435, DOI 10.1002/jbm.820110310
   SMITHPETERSEN MN, 1978, CLIN ORTHOP RELAT R, V134, P5
   SPECTOR M, 1978, J BIOMED MATER RES, V12, P665, DOI 10.1002/jbm.820120508
   SPENCE WT, 1954, J NEUROSURG, V11, P219, DOI 10.3171/jns.1954.11.3.0219
   SVENSSON NL, 1977, J BIOMECH, V10, P581
   TAGAI H, 1978, 1978 BIOC S KEEL LON
   Thompson F R, 1966, Clin Orthop Relat Res, V44, P73
   Vaughan JM, 1975, PHYSL BONE
   VOLZ RG, 1978, J BONE JOINT SURG AM, V60, P662, DOI 10.2106/00004623-197860050-00013
   WILLIAMS DF, 1973, IMPLANTS SURGERY
   WILTSE LL, 1957, J BONE JOINT SURG AM, V39, P961, DOI 10.2106/00004623-195739040-00019
   WOOD CB, 1976, ANN ROY COLL SURG, V58, P401
NR 102
TC 8
Z9 9
U1 1
U2 2
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0022-3735
J9 J PHYS E SCI INSTRUM
PY 1980
VL 13
IS 6
BP 599
EP 607
DI 10.1088/0022-3735/13/6/001
PG 9
WC Instruments & Instrumentation
SC Instruments & Instrumentation
GA JY187
UT WOS:A1980JY18700001
PM 6993661
DA 2018-10-19
ER

PT J
AU WALTON, AG
AF WALTON, AG
TI SYNTHETIC POLYPEPTIDES AS BIOMEDICAL MATERIALS
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 CASE WESTERN RESERVE UNIV,DEPT MACROMOLEC SCI,CLEVELAND,OH 44106.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PY 1979
IS APR
BP 133
EP 133
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA GN806
UT WOS:A1979GN80601578
DA 2018-10-19
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI POLYMERIC BIOMEDICAL MATERIALS SYMPOSIUM, MANCHESTER, 18-19 APRIL 1978 -
   PREFACE
SO BRITISH POLYMER JOURNAL
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0007-1641
J9 BRIT POLYM J
PY 1978
VL 10
IS 4
BP 231
EP 231
PG 1
WC Polymer Science
SC Polymer Science
GA GK234
UT WOS:A1978GK23400001
DA 2018-10-19
ER

PT J
AU GIBBONS, DF
AF GIBBONS, DF
TI POLYMERIC BIOMEDICAL MATERIALS
SO BRITISH POLYMER JOURNAL
LA English
DT Article
RP GIBBONS, DF (reprint author), CASE WESTERN RESERVE UNIV,DEPT BIOMED ENGN & PATHOL,CLEVELAND,OH 44106, USA.
NR 0
TC 4
Z9 4
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0007-1641
J9 BRIT POLYM J
PY 1978
VL 10
IS 4
BP 232
EP 237
DI 10.1002/pi.4980100403
PG 6
WC Polymer Science
SC Polymer Science
GA GK234
UT WOS:A1978GK23400002
DA 2018-10-19
ER

PT J
AU IMAI, Y
   KUO, YS
   WATANABE, A
   MASUHARA, E
AF IMAI, Y
   KUO, YS
   WATANABE, A
   MASUHARA, E
TI EVALUATION OF POLYSULFONE AS A POTENTIAL BIOMEDICAL MATERIAL
SO JOURNAL OF BIOENGINEERING
LA English
DT Note
RP IMAI, Y (reprint author), TOKYO MED & DENT UNIV,INST MED & DENT ENGN,TOKYO 113,JAPAN.
CR AUTIAN J, 1977, ARTIF ORGANS, V1, P53
   HOMSY C A, 1970, Journal of Biomedical Materials Research, V4, P341, DOI 10.1002/jbm.820040306
   IMAI Y, 1975, ARTIFICIAL ORGANS JA, V4, P344
   KOJIMA K, 1975, Bulletin of Tokyo Medical and Dental University, V22, P263
   LAWRENCE H, 1971, PB205740, P65
   TAYLOR JA, 1973, T AM SOC ART INT ORG, V19, P175
   WATANABE A, 1976, REPORTS I MED DENT E, V10, P69
   WILSNACK KE, 1976, BIOMAT MED DIV ART O, V4, P235
NR 8
TC 3
Z9 3
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
J9 J BIOENG
PY 1978
VL 2
IS 1-2
BP 103
EP 107
PG 5
WC Engineering, Biomedical
SC Engineering
GA EZ227
UT WOS:A1978EZ22700012
PM 681310
DA 2018-10-19
ER

PT J
AU LYMAN, DJ
AF LYMAN, DJ
TI NEW PROGRESS IN BIOMEDICAL POLYMER MATERIALS
SO PURE AND APPLIED CHEMISTRY
LA English
DT Article
C1 UNIV UTAH,DEPT BIOENGN,SALT LAKE CITY,UT 84112.
   UNIV UTAH,DEPT SURG,SALT LAKE CITY,UT 84112.
RP LYMAN, DJ (reprint author), UNIV UTAH,DEPT MAT SCI & ENGN,SALT LAKE CITY,UT 84112, USA.
CR Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   BAIER RE, 1971, FED PROC, V30, P1523
   Bellamy L.J., 1975, INFRARED SPECTRA COM, V1-2
   BOWER R, 1960, SURGERY, V47, P132
   COLLINS HA, 1960, AM J SURG, V99, P40, DOI 10.1016/0002-9610(60)90246-4
   DALE WA, 1963, SURGERY, V53, P52
   DUTTON RC, 1968, T AM SOC ART INT ORG, V14, P57
   GLYNN MF, 1966, J CLIN INVEST, V45, P1013
   GOTT VL, 1971, FED PROC, V30, P1679
   GOZNA ER, 1974, CAN J SURG, V17, P176
   HOKANSON DE, 1968, SURG GYNECOL OBSTETR, V127, P57
   JENKINS CSP, 1973, J LAB CLIN MED, V81, P280
   KARDOS IL, 1974, BIOMAT MED DEV ART O, V4, P387
   KIM SW, 1973, PREPRINTS DIV PLASTI, V165, P36
   KIM SW, 1973, APPL POLYM S, V22, P289
   KINELY CE, 1974, SURGERY, V75, P28
   KNUTSON K, UNPUBLISHED
   LANDE AJ, 1970, T AM SOC ART INT ORG, V16, P352
   LAWSON JH, 1975, T AM SOC ART INT ORG, V21, P368
   Lyman D. J., 1971, THROMB DIATH HAEMO, V42, P109
   LYMAN DJ, 1971, T AM SOC ART INT ORG, V17, P456
   LYMAN DJ, 1975, T AM SOC ART INT ORG, V21, P49
   LYMAN DJ, 1974, T AM SOC ART INT ORG, VB 20, P474
   LYMAN DJ, 1972, T AM SOC ART INT ORG, V18, P19
   LYMAN DJ, 1970, THROMB DIATH HAEMOST, V23, P120, DOI 10.1055/s-0038-1654126
   LYMAN DJ, THESIS
   LYMAN DJ, 1977, T AM SOC ARTIF INT O, V23
   LYMAN DJ, 1977, J BIOMED MAT RES, V11
   MUSTARD JF, 1967, FED PROC, V26, P106
   NAJAFI H, 1967, J THORAC CARDIOV SUR, V53, P243
   NYILAS E, 1970, 23 C ENG MED BIOL, V12, P147
   NYILAS E, 1973, PB226839
   PACKHAM MA, 1969, J LAB CLIN MED, V73, P686
   PETSCHEK H, 1968, T AM SOC ART INT ORG, V14, P256
   SALZMAN EW, 1971, FED PROC, V30, P1503
   SCARBOROUGH DE, 1969, LAB INVEST, V20, P164
   Seare W. J., 1974, ANNU REV MATER SCI, V4, P415
   ZUCKER MB, 1969, P SOC EXP BIOL MED, V131, P318
NR 38
TC 5
Z9 5
U1 0
U2 1
PU BLACKWELL SCIENCE LTD
PI OXFORD
PA OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL
SN 0033-4545
J9 PURE APPL CHEM
JI Pure Appl. Chem.
PY 1978
VL 50
IS 5
BP 427
EP 433
DI 10.1351/pac197850050427
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA FK795
UT WOS:A1978FK79500006
OA Bronze
DA 2018-10-19
ER

PT J
AU GIBBONS, DF
AF GIBBONS, DF
TI BIOMEDICAL MATERIALS
SO ANNUAL REVIEW OF BIOPHYSICS AND BIOENGINEERING
LA English
DT Review
C1 CASE WESTERN RESERVE UNIV,DEPT BIOMED ENGN,CLEVELAND,OH 44106.
CR ANDERSON JM, 1974, BIOMAT MED DEV ARTIF, V3, P235
   BAIER RE, 1970, SURFACE CHEM BIOL SY, P235
   Beall A C Jr, 1973, Ann Thorac Surg, V15, P601
   BERNHARD WF, 1969, J THORAC CARDIOV SUR, V58, P801
   Bokros J. C., 1972, CHEMISTRY PHYSICS CA, V9, P103
   BOKROS JC, COMMUNICATION
   BORETOS JOHN W., 1968, J BIOMED MAT RES, V2, P121, DOI 10.1002/jbm.820020109
   Buehler WJ, 1968, OCEAN ENGNG, V1, P105
   CALNAN J S, 1971, British Journal of Plastic Surgery, V24, P113, DOI 10.1016/S0007-1226(71)80029-2
   CASTLEMAN LS, 1974, FINAL REP JA HARTFOR
   CHARNLEY J, 1964, J BONE JOINT SURG BR, V46, P518
   COLEMAN DL, 1974, J BIOMED MATER RES, V8, P65, DOI 10.1002/jbm.820080308
   DAVIS SD, 1972, J BIOMED MATER RES, V6, P425, DOI 10.1002/jbm.820060509
   DYMOND AM, 1970, J NEUROSURG, V33, P574, DOI 10.3171/jns.1970.33.5.0574
   FERGUSON AB, 1962, J BONE JOINT SURG AM, V44, P323, DOI 10.2106/00004623-196244020-00009
   FERGUSON AB, 1960, J BONE JOINT SURG AM, V42, P77, DOI 10.2106/00004623-196042010-00007
   FRAZZA E J, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P43
   FUNCKBENTANO JL, 1974, BIOMAT MED DEV ARTIF, V3
   GIBBONS DF, UNPUBLISHED RESULTS
   GOTT VL, 1969, NIH P ARTIF HEART PR, P181
   GUESS W L, 1968, Journal of Biomedical Materials Research, V2, P313, DOI 10.1002/jbm.820020304
   HENSCH LL, 1973, J BIOMED MATER RES S, V4, P25
   HENSCH LL, 1973, NSF ANN REP
   HOFFMAN AS, 1972, T AM SOC ART INT ORG, V18, P10
   HOMSY CA, 1970, J MACROMOL SCI CHEM, VA  4, P615, DOI 10.1080/00222337008074366
   HOMSY CA, 1972, CLIN ORTHOPAEDICS, V89, P220
   HULBERT SF, 1973, J BIOMED MATER RES S, V7, P43
   HULBERT SF, 1973, J BIOMED MATER RES S, V7, P25
   HULBERT SF, 1973, J BIOMED MATER RES S, V7, P63
   JANACEK J, 1973, J MACROMOL SCI R M C, VC  9, P1
   JECMEN RM, 1973, J BIOMED MATER RES, V7, P369, DOI 10.1002/jbm.820070408
   JHON MS, 1973, J BIOMED MATER RES, V7, P509, DOI 10.1002/jbm.820070604
   KADEFORS R, 1970, MED BIOL ENG, V8, P129, DOI 10.1007/BF02509321
   KAMINSKL EDWARD J., 1968, J BIOMED MAT RES, V2, P81, DOI 10.1002/jbm.820020106
   KASTER RL, 1970, T AM SOC ART INT ORG, V16, P233
   KULKARNI R K, 1971, Journal of Biomedical Materials Research, V5, P169, DOI 10.1002/jbm.820050305
   KUSSEROW BK, 1972, B NEW YORK ACAD MED, V48, P468
   LAING PATRICK G., 1967, J BIOMED MAT RES, V1, P135, DOI 10.1002/jbm.820010113
   LEE HB, 1972, POLYM PREPR, V13, P729
   LEONARD F, 1966, J APPL POLYM SCI, V10, P259, DOI 10.1002/app.1966.070100208
   Leonard F, 1970, ADHESION BIOL SYSTEM, P185
   LEVITSKY S, 1962, SURGERY, V52, P64
   LILLEHEI CW, 1972, 8TH P BIEN CARD C DU
   LYMAN DJ, 1971, T AM SOC ART INT ORG, V17, P456
   LYMAN DJ, 1974, T AM SOC ART INT ORG, VB 20, P474
   LYMAN DJ, 1965, T AM SOC ART INT ORG, V11, P301
   LYMAN DJ, 1970, THROMB DIATH HAEMOST, V23, P120, DOI 10.1055/s-0038-1654126
   LYMAN DJ, 1969, NIH P ARTIF HEART PR, P113
   LYMAN DJ, 1972, ACTUAL NEPHROL, V13, P96
   MASON R G, 1973, Biomaterials Medical Devices and Artificial Organs, V1, P131
   MASON RG, 1972, B NEW YORK ACAD MED, V48, P407
   MCFADDEN JT, 1969, J NEUROSURG, V31, P373, DOI 10.3171/jns.1969.31.4.0373
   MOONEY V, 1973, 1ST P INT C BIOM EL, P112
   NOSE Y, 1971, T AM SOC ART INT ORG, V17, P482
   Nose Y., COMMUNICATION
   NYILAS E, 1972, J BIOMED MAT RES S, V3, P129
   NYILAS E, 1972, J BIOMED MAT RES S, V3, P97
   PICHA G, 1975, P C MATER MED BIOL
   Robb W L, 1968, Ann N Y Acad Sci, V146, P119, DOI 10.1111/j.1749-6632.1968.tb20277.x
   ROBB WL, 1971, BIOMATERIALS, P313
   ROSTOKER W, 1973, J BIOMED MATER RES, V7, P43
   ROSTOKER W, COMMUNICATION
   RUBIN AL, 1969, BIOMATERIALS, P157
   SALTHOUSE TN, 1972, J BIOMED MATER RES, V6, P105, DOI 10.1002/jbm.820060210
   Seare W. J., 1974, ANNU REV MATER SCI, V4, P415
   SEMLITSCH M, 1973, SULZER TECH REV, V2, P1
   SRINIVASAN S, 1969, J ASSOC ADV MED INST, V3, P1161
   SYMEONIDES PP, 1973, J ALLERGY CLIN IMMUN, V51, P251, DOI 10.1016/0091-6749(73)90145-0
   VROMAN L, 1967, BLOOD CLOTTING ENZYM, P279
   WESOLOWSKI SA, 1972, B NEW YORK ACAD MED, V48, P331
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   WILLERT HG, 1972, 5TH INT S ARTHR HIP, P11
   WINTER GD, 1970, P ROY SOC MED, V63, P1111
   WOOD N K, 1970, Journal of Biomedical Materials Research, V4, P1, DOI 10.1002/jbm.820040102
   YAMADA S, 1968, 682 DEF CER INF CTR
   1972, B NY ACAD MED, V48, P216
   1971, FED P, P30
   F36172 ASTM STAND RE
NR 78
TC 5
Z9 5
U1 0
U2 3
PU ANNUAL REVIEWS INC
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139
SN 0084-6589
J9 ANNU REV BIOPHYS BIO
PY 1975
VL 4
BP 367
EP 375
DI 10.1146/annurev.bb.04.060175.002055
PG 9
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA AG638
UT WOS:A1975AG63800016
PM 1098561
DA 2018-10-19
ER

PT J
AU CHATFIELD, V
AF CHATFIELD, V
TI BIOMEDICAL MATERIALS - IMPLANTS HAVE A HOSTILE HOST
SO MATERIALS ENGINEERING
LA English
DT Article
CR BRALEY SA, SILICONES ARTIFICIAL
   DUSTOOR MR, 1973, POWDER METALLURGY IN, V5
   HARTH GH, MCIC7418 BATT COL LA
   NIESZ DE, MCIC7421 BATT COL LA
   ROSE RM, 1972, ORTHOPEDIC IMPLANTS
   WEISMAN S, ANN NEW YORK ACADEMY, V146
   SP5958 NASA
NR 7
TC 0
Z9 0
U1 0
U2 0
PU PENTON PUBL INC
PI CLEVELAND
PA 1100 SUPERIOR AVE, CLEVELAND, OH 44114
SN 0025-5319
J9 MATER ENG
PY 1975
VL 81
IS 3
BP 14
EP &
PG 0
WC Materials Science, Multidisciplinary
SC Materials Science
GA AQ174
UT WOS:A1975AQ17400001
DA 2018-10-19
ER

PT J
AU BRUCK, SD
AF BRUCK, SD
TI BIOMEDICAL APPLICATIONS OF POLYMERIC MATERIALS AND THEIR INTERACTIONS
   WITH BLOOD COMPONENTS - CRITICAL REVIEW OF CURRENT DEVELOPMENTS
SO POLYMER
LA English
DT Review
C1 NHLI,BETHESDA,MD 20014.
CR AISENBERG S, 1973, PB229810 NAT TECHN I
   ALTSCHUL R, 1954, ENDOTHELIUM ITS DEVE
   ANDRADE JD, 1971, T AM SOC ART INT ORG, V17, P222
   ANDRADE JD, 1973, T AM SOC ART INT ORG, V19, P1
   ANDRADE JD, 1972, T AM SOC ART INT ORG, V18, P473
   BARBER AJ, 1971, BIOCHIM BIOPHYS ACTA, V252, P533, DOI 10.1016/0304-4165(71)90156-5
   BARDELMEYER GH, 1973, BIOPOLYMERS, V12, P2289, DOI 10.1002/bip.1973.360121008
   Berger S, 1974, Prog Hemost Thromb, V2, P273
   BERNSTEIN EF, 1971, FED PROC, V30, P1510
   BIGGS R, 1962, HUMAN BLOOD COAGULAT
   BOSMANN HB, 1971, BIOCHEM BIOPH RES CO, V43, P1118, DOI 10.1016/0006-291X(71)90578-X
   BRASH JL, 1973, J BIOMED MATER RES, V7, P313, DOI 10.1002/jbm.820070405
   BRASH JL, 1972, PB210665 NAT TECHN I
   BRASH JL, 1973, PB223165 NAT TECHN I
   BRUCK S D, 1973, Biomaterials Medical Devices and Artificial Organs, V1, P191
   BRUCK S D, 1971, Journal of Biomedical Materials Research, V5, P139, DOI 10.1002/jbm.820050303
   BRUCK S D, 1973, Biomaterials Medical Devices and Artificial Organs, V1, P79
   BRUCK SD, 1972, J BIOMED MATER RES, V6, P173, DOI 10.1002/jbm.820060306
   BRUCK SD, 1973, J BIOMED MATER RES, V7, P387, DOI 10.1002/jbm.820070503
   BRUCK SD, 1972, T AM SOC ART INT ORG, V18, P1
   BRUCK SD, 1973, NATURE, V243, P416, DOI 10.1038/243416a0
   BRUCK SD, 1975, POLYMER, V16, P25, DOI 10.1016/0032-3861(75)90091-9
   BRUCK SD, 1974, BLOOD COMPATIBLE SYN
   BRUCK SD, 1973, INT J RAD STERILIZ, V1, P177
   BUTLER WT, 1966, J BIOL CHEM, V241, P3882
   CASTINO F, 1974, 20TH A M AM SOC ART, V3, P12
   CAZENAVE JP, 1974, J LAB CLIN MED, V83, P797
   CHANG EP, 1973, BIOPOLYMERS, V12, P1063, DOI 10.1002/bip.1973.360120510
   CHANG TMS, 1973, T AM SOC ART INT ORG, V19, P314
   CHANG TMS, 1964, SCIENCE, V146, P524, DOI 10.1126/science.146.3643.524
   CHANG TMS, 1972, ARTIFICIAL CELLS
   CLARK RE, 1973, J THORAC CARDIOV SUR, V66, P202
   CREASY WS, 1974, 20TH M AM SOC ART IN, V3, P14
   CREASY WS, 1973, PB225636 NAT TECHN I
   CREASY WS, 1972, PB211790 NAT TECHN I
   DEHL RE, 1973, BIOPOLYMERS, V12, P2329, DOI 10.1002/bip.1973.360121011
   Dickerson R. E., 1969, STRUCTURE ACTION PRO
   DISCHE Z, 1966, SMALL BLOOD VESSEL I
   FENSTERMAKER CA, 1974, PB232629 NAT TECHN I
   GAARDER A., 1961, NATURE, V192, P531, DOI 10.1038/192531a0
   GANGULY P, 1974, NATURE, V247, P306, DOI 10.1038/247306a0
   GLUSA E, 1974, THROMB DIATH HAEMOST, V31, P172, DOI 10.1055/s-0038-1649155
   GOTT VL, 1961, SURGERY, V50, P382
   GRANT ME, 1973, J BIOL CHEM, V248, P7432
   Grassmann W, 1935, BIOCHEM Z, V277, P320
   GRAY WR, 1973, NATURE, V246, P461, DOI 10.1038/246461a0
   GRODE GA, 1974, 20TH A M AM SOC ART, V3, P29
   HALPERN BD, 1972, PB212724 NAT TECHN I
   HALPERN BD, 1973, PB215886 NAT TECHN I
   HALPERN BD, 1971, PB200987 NAT TECHN I
   HALPERN BD, 1974, PB230310 NAT TECHN I
   HELLEM AJ, 1961, BRIT J HAEMATOL, V7, P42, DOI 10.1111/j.1365-2141.1961.tb00318.x
   HELLEM AJ, 1960, SCANDINAVIAN J CHE S, V12, P51
   HOFFMAN AS, 1972, T AM SOC ART INT ORG, V18, P10
   HOVIG T, 1968, SER HAEMATOL, V1, P3
   HUGUES J, 1970, THROMB DIATH HAEMOST, V24, P395, DOI 10.1055/s-0038-1654249
   INDEGLIA RA, 1970, T AM SOC ART INT ORG, V16, P37
   JAFFE EA, 1972, 3RD C INT SOC THROMB, P366
   JENKINS CSP, 1973, J LAB CLIN MED, V81, P280
   JIMENEZ S, 1973, BIOCHEM BIOPH RES CO, V52, P106, DOI 10.1016/0006-291X(73)90960-1
   JIRGENCENS B, 1962, SHORT TXB COLLOID CH, P377
   KAHN RH, 1973, IN VITRO CELL DEV B, V8, P451
   KAHN RH, 1973, PB226863 NAT TECHN I
   KARDOS JL, 1974, PB230309 NAT TECHN I
   KETTERINGHAM JM, 1973, T AM SOC ART INT ORG, V19, P61
   KETTERINGHAM JM, 1974, PB231328 NAT TECHN I
   KUSSEROW B, 1971, FED PROC, V30, P1516
   KUSSEROW BK, 1971, T AM SOC ART INT ORG, V17, P1
   KWAAN HC, 1965, CIRC RES, V17, P477, DOI 10.1161/01.RES.17.6.477
   LAGERGREN H, 1964, THORAXCHIRURGIE, V12, P172
   LAGERGREN HR, 1971, T AM SOC ART INT ORG, V17, P10
   LAMPERT RH, 1972, J BIOMED MATER RES, V6, P499, DOI 10.1002/jbm.820060604
   LAZAROW A, 1966, SMALL BLOOD VESSEL I
   Lechler E, 1967, Thromb Diath Haemorrh Suppl, V22, P139
   Leininger R I, 1972, CRC Crit Rev Bioeng, V1, P333
   LEININGER RI, 1966, SCIENCE, V152, P1625, DOI 10.1126/science.152.3729.1625
   LEININGER RI, 1966, T AM SOC ART INT ORG, V12, P151
   LEONARD F, 1969, T AM SOC ART INT ORG, V15, P15
   LITWAK RS, 1972, B NEW YORK ACAD MED, V48, P406
   LOVELOCK JE, 1951, NATURE, V167, P39, DOI 10.1038/167039a0
   LUFT JH, 1966, FED PROC, V25, P1773
   MAJNO G., 1965, HANDBOOK PHYSIOL, V3, P2293
   MARSHALL D W, 1970, Journal of Biomedical Materials Research, V4, P357, DOI 10.1002/jbm.820040307
   Mason R G, 1972, Prog Hemost Thromb, V1, P141
   MERKER RL, 1969, P ARTIFICIAL HEART P, P29
   MERRILL EW, 1966, T AM SOC ART INT ORG, V12, P139
   MEYER CH, 1974, PB228964 NAT TECHN I
   MOACANIN J, 1974, PB232641 NAT TECHN I
   MOHANDAS N, 1974, J BIOMED MATER RES, V8, P119, DOI 10.1002/jbm.820080203
   MONSON JM, 1973, P NATL ACAD SCI USA, V70, P3521, DOI 10.1073/pnas.70.12.3521
   MORRISSEY BW, 1974, J COLLOID INTERF SCI, V46, P152, DOI 10.1016/0021-9797(74)90036-8
   MUGGLI R, 1973, Thrombosis Research, V3, P715, DOI 10.1016/0049-3848(73)90018-2
   MURPHY EA, 1962, CAN MED ASSOC J, V87, P259
   MUSTARD JF, 1969, RESEARCH ACUTE MYOCA, pR4
   Nemerson Y, 1972, Prog Hemost Thromb, V1, P1
   NOSSEL HL, 1969, NATURE, V221, P75, DOI 10.1038/221075a0
   NYILAS E, 1974, 20TH M AM SOC ART IN, V3, P52
   NYILAS E, 1974, PB231776 NAT TECHN I
   PACKHAM MA, 1969, J LAB CLIN MED, V73, P686
   PARTRIDG.SM, 1967, NATURE, V213, P1123, DOI 10.1038/2131123a0
   PATEL DJ, 1969, CIRC RES, V25, P765, DOI 10.1161/01.RES.25.6.765
   QUICK AJ, 1954, AM J MED SCI, V228, P207, DOI 10.1097/00000441-195408000-00009
   RAMACHANDRAN GN, 1968, BIOPOLYMERS, V6, P1649, DOI 10.1002/bip.1968.360061109
   RAMACHANDRAN GN, 1967, TREATISE COLLAGEN, V1, pCH3
   RATNOFF OD, 1973, SCIENCE, V179, P1291, DOI 10.1126/science.179.4080.1291
   RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8
   ROTHEN A, 1945, REV SCI INSTRUM, V16, P26, DOI 10.1063/1.1770315
   ROTHEN A, 1974, PROGR SURFACE MEMBRA, V8
   ROZELLE LT, 1974, PB231324 NAT TECHN I
   SALZMAN EW, 1971, BLOOD-J HEMATOL, V38, P509
   SALZMAN EW, 1967, SURGERY, V61, P1
   SANDBERG LB, 1969, BIOCHEMISTRY-US, V8, P2940, DOI 10.1021/bi00835a037
   SCHOFIELD JD, 1974, BIOCHEMISTRY-US, V13, P1801, DOI 10.1021/bi00706a004
   Scott H, 1973, Biomater Med Devices Artif Organs, V1, P681
   SCOTT H, 1974, PB230308 NAT TECHN I
   SCOTT H, 1971, PB206499 NAT TECHN I
   SHIO H, 1972, NATURE-NEW BIOL, V236, P45
   SMITH DW, 1972, J BIOL CHEM, V247, P2427
   Spaet T H, 1966, Thromb Diath Haemorrh Suppl, V21, P67
   STATTON WO, 1973, PB229335 NAT TECHN I
   Stemerman M B, 1974, Prog Hemost Thromb, V2, P1
   STEMERMAN MB, 1971, LAB INVEST, V24, P179
   STORMORKEN H, 1971, FED PROC, V30, P1551
   SWEDENBORG J, 1974, THROMB RES, V4, P687, DOI 10.1016/0049-3848(74)90223-0
   THOMAS J, 1963, NATURE, V200, P651, DOI 10.1038/200651a0
   THOMSON C, 1973, THROMB DIATH HAEMOST, V30, P547, DOI 10.1055/s-0038-1649133
   TODD A S, 1964, J Clin Pathol, V17, P324, DOI 10.1136/jcp.17.3.324
   UITTO J, 1973, BIOCHEM BIOPH RES CO, V55, P904, DOI 10.1016/0006-291X(73)91229-1
   Vroman L, 1969, J Biomed Mater Res, V3, P43, DOI 10.1002/jbm.820030106
   VROMAN L, 1971, FED PROC, V30, P1494
   WEEKS JR, 1969, J PHARM PHARMACOL, V21, P103, DOI 10.1111/j.2042-7158.1969.tb08205.x
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   WILNER GD, 1971, AM J PHYSIOL, V220, P1074
   WILNER GD, 1968, J CLIN INVEST, V47, P2608, DOI 10.1172/JCI105943
   YAMADA H, 1970, STRENGTH BIOLOGICAL
   YASUDA H, 1973, J APPL POLYM SCI, V17, P1519, DOI 10.1002/app.1973.070170517
   YASUDA H, 1973, J APPL POLYM SCI, V17, P137, DOI 10.1002/app.1973.070170111
   YASUDA H, 1973, PB229097 NAT TECHN I
   ZUCKER MB, 1969, P SOC EXP BIOL MED, V131, P318
NR 139
TC 24
Z9 25
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0032-3861
J9 POLYMER
JI Polymer
PY 1975
VL 16
IS 6
BP 409
EP 417
DI 10.1016/0032-3861(75)90249-9
PG 9
WC Polymer Science
SC Polymer Science
GA AF355
UT WOS:A1975AF35500005
DA 2018-10-19
ER

PT J
AU LEMAY, I
   LAPPI, VG
   WHITE, WE
AF LEMAY, I
   LAPPI, VG
   WHITE, WE
TI MATERIALS FOR BIOMEDICAL APPLICATIONS
SO POLYMER ENGINEERING AND SCIENCE
LA English
DT Article
C1 UNIV SASKATCHEWAN,DIV BIOMED ENGN,SASKATOON,SASKATCHEWAN,CANADA.
CR BENSON J, 1971, J BIOMED MATER RES S, V2, P41
   CAHOON JR, 1975, COMMUNICATION
   COOK W E, 1972, Journal of Biomedical Materials Research Biomedical Materials Symposium, V2, P443
   HENTRICH R L, 1971, Journal of Biomedical Materials Research, V5, P25, DOI 10.1002/jbm.820050104
   HIRSCHHORN JS, 1971, J BIOMED MATER RES S, V2, P49
   HULBERT SF, 1972, MATER RES BULL, V7, P1239, DOI 10.1016/0025-5408(72)90103-1
   KLAWITTER J J, 1972, Journal of Biomedical Materials Research Biomedical Materials Symposium, V2, P161
   KROUSKOP TA, 1973, 73WABIO36 ASME PAP
   MATHER BS, 1968, J BIOMECH, V4, P331
   Mooney V, 1971, J BIOMED MATER RES S, V2, P143
   MURPHY P V, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P59
   MUSIKANT S, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P225
   PILLIAR RM, 1974, 13TH ANN C MET
   PREDECKI P, 1972, J BIOMED MATER RES, V6, P201
   ROSE RM, 1974, TECHNOL REV US   MAR, P33
   WEISMAN S, 1967, BIOMECHANICS HUMAN F, P87
   WEISMAN S, 1973, 1973 P NEW ENGL C BI, P124
   WELSH RP, 1971, J BIOMED MATER RES 1, V2, P231
   WHITE WE, 1975, MICROSTRUCTURAL SCIE
   Williams D. F., 1972, Metals and Materials, V6, P387
   1973, ASTM STANDARDS SURGI
NR 21
TC 4
Z9 4
U1 0
U2 0
PU SOC PLASTICS ENG INC
PI BROOKFIELD CENTER
PA 14 FAIRFIELD DR, BROOKFIELD CENTER, CT 06804-0403
SN 0032-3888
J9 POLYM ENG SCI
JI Polym. Eng. Sci.
PY 1975
VL 15
IS 11
BP 789
EP 794
DI 10.1002/pen.760151105
PG 6
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA AX783
UT WOS:A1975AX78300004
DA 2018-10-19
ER

PT J
AU ABODEELY, RA
   BORICK, PM
AF ABODEELY, RA
   BORICK, PM
TI TISSUE-CULTURE AS A METHOD FOR EVALUATION OF BIOMEDICAL MATERIALS
SO IN VITRO-JOURNAL OF THE TISSUE CULTURE ASSOCIATION
LA English
DT Meeting Abstract
C1 ETHICON INC,SOMERVILLE,NJ 08876.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU SOC IN VITRO BIOLOGY
PI LARGO
PA 9315 LARGO DR WEST, STE 25, LARGO, MD 20774
SN 0073-5655
J9 IN VITRO CELL DEV B
PY 1973
VL 8
IS 5
BP 415
EP &
PG 0
WC Pathology
SC Pathology
GA P5636
UT WOS:A1973P563600069
DA 2018-10-19
ER

PT J
AU SIMMONDS, RC
   YOUNG, EL
   HOLLAND, JM
   BOYD, J
AF SIMMONDS, RC
   YOUNG, EL
   HOLLAND, JM
   BOYD, J
TI ANIMAL MAINTENANCE FOR BIOMEDICAL EVALUATION OF LUNAR MATERIAL
SO JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION
LA English
DT Article
CR BENSCHOTER CA, 1970, SCIENCE, V169, P470, DOI 10.1126/science.169.3944.470
   BOYD JF, 1972, LAB ANIM SCI, V22, P416
   KEMMERER WW, 1969, BIOSCIENCE, V19, P712, DOI 10.2307/1294901
NR 3
TC 3
Z9 3
U1 0
U2 0
PU AMER VETERINARY MEDICAL ASSOC
PI SCHAUMBURG
PA 1931 N MEACHAM RD SUITE 100, SCHAUMBURG, IL 60173-4360
SN 0003-1488
J9 J AM VET MED ASSOC
JI J. Am. Vet. Med. Assoc.
PY 1972
VL 161
IS 6
BP 720
EP &
PG 0
WC Veterinary Sciences
SC Veterinary Sciences
GA N5152
UT WOS:A1972N515200039
PM 4403463
DA 2018-10-19
ER

EF